data_2in2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2in2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo . . . . . 0 N--CA 1.471 0.197 0 CA-C-O 121.606 0.586 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -66.92 -39.29 87.32 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.417 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 m -67.89 -44.47 76.93 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.688 0.795 . . . . 0.0 110.237 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -68.53 -36.31 78.66 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.451 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -63.17 -42.72 99.45 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.772 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.47 83.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.251 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.3 tp -69.96 -32.76 71.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.371 0.605 . . . . 0.0 110.504 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.4 m -76.9 -37.28 55.73 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.643 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.2 tp -68.44 -34.53 76.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.4 tp -54.09 -55.66 25.47 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.909 0.884 . . . . 0.0 111.568 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -72.97 -17.5 61.46 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.084 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HB2' ' HZ2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -90.23 -61.66 1.63 Allowed 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.95 -172.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -124.97 9.35 8.13 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -171.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 65.0 mt -110.81 134.72 52.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.706 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.65 167.38 23.93 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.833 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 m -92.49 125.97 37.37 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.1 mt -113.59 123.24 69.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 9.7 m -84.99 98.63 10.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.6 p -99.93 -170.25 1.86 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.457 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 30.1 t -71.53 -33.98 69.64 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.851 0.358 . . . . 0.0 110.495 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -75.59 -26.02 57.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.39 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.08 -171.3 30.06 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.493 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -91.75 104.19 16.67 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -114.02 -169.7 1.57 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.003 -174.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 10.9 m -92.05 128.9 38.07 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.965 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.94 127.23 7.71 Favored Glycine 0 N--CA 1.421 -2.312 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 174.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.4 tp -103.45 122.85 45.75 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.66 137.19 18.47 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.429 HG13 ' CE1' ' A' ' 178' ' ' PHE . 47.4 mm -97.66 -55.87 5.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -164.08 150.61 11.42 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.4 t70 58.29 -98.67 0.09 Allowed 'General case' 0 C--O 1.213 -0.839 0 O-C-N 124.21 0.944 . . . . 0.0 112.113 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 7.5 mpt_? -129.02 9.34 5.74 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.4 t -83.4 118.61 31.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.378 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.6 t -123.48 169.8 11.03 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.12 141.1 39.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.4 tp -151.15 150.59 27.65 Favored Pre-proline 0 CA--C 1.572 1.817 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.12 159.87 44.64 Favored 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 122.341 2.027 . . . . 0.0 112.771 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.8 m -82.01 -48.51 11.35 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -66.89 -8.48 29.52 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.38 -23.31 61.87 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 96.6 mt-30 58.85 84.01 0.21 Allowed Pre-proline 0 C--O 1.252 1.198 0 C-N-CA 125.601 1.561 . . . . 0.0 113.103 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -88.53 136.28 3.23 Favored 'Trans proline' 0 N--CA 1.438 -1.791 0 C-N-CA 122.816 2.344 . . . . 0.0 109.558 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.34 -176.83 51.61 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.91 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -75.03 -25.4 58.69 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.441 1.115 . . . . 0.0 108.042 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -129.5 138.38 51.35 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.89 167.28 16.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 41.8 mt -100.93 114.33 28.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.16 109.5 23.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.4 m120 61.78 23.8 14.05 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.544 0.688 . . . . 0.0 110.976 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 -13.68 63.55 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.564 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -85.15 128.21 34.57 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.442 0.697 . . . . 0.0 109.779 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.31 128.92 37.82 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.563 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.6 tp -144.53 150.24 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -105.64 147.99 27.86 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.934 0.397 . . . . 0.0 109.968 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.3 129.9 43.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -79.87 -53.17 7.02 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -132.73 133.74 43.87 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.222 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.78 110.42 12.15 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.927 -174.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -111.29 99.34 8.18 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -75.63 102.41 5.32 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 177' ' ' TYR . 41.4 tp -97.29 105.02 17.1 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 122.078 0.942 . . . . 0.0 112.415 -167.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.39 -179.85 3.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 11.8 t70 -79.87 137.34 54.07 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -42.02 -34.73 2.79 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 124.306 3.337 . . . . 0.0 114.014 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.06 22.06 1.25 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 71.43 18.14 5.58 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.186 0.994 . . . . 0.0 112.857 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 55.6 mt -84.93 132.87 30.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 131' ' ' THR . 0.8 OUTLIER -80.91 126.19 31.05 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -170.131 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.1 tp -99.06 -15.74 18.92 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 169.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 60.89 30.16 19.47 Favored 'General case' 0 C--N 1.363 1.154 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.854 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 18.7 tp -124.91 144.23 50.44 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.886 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.7 m -137.5 122.48 18.99 Favored 'General case' 0 C--N 1.286 -2.193 0 O-C-N 121.894 -0.504 . . . . 0.0 109.762 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.3 t -101.68 131.19 50.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -139.38 140.92 37.57 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.665 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.5 m -97.44 107.46 19.98 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.431 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 15.6 tp -86.45 143.14 27.92 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -175.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.563 ' O ' HD11 ' A' ' 54' ' ' ILE . 38.0 t70 -84.64 80.91 9.08 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 119.266 -0.974 . . . . 0.0 112.057 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -120.22 142.65 48.82 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -61.32 -59.88 4.61 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -70.92 149.36 46.81 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -101.01 149.85 23.51 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.967 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -81.12 145.81 30.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.3 tpt85 -70.52 128.93 37.84 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -61.47 96.72 0.06 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.469 0.652 . . . . 0.0 111.368 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -92.44 20.71 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 122.095 0.95 . . . . 0.0 109.538 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -73.95 -35.06 64.51 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.959 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.5 -5.37 85.83 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.992 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -103.55 5.74 36.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.484 0.659 . . . . 0.0 109.639 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.3 mt -74.81 133.6 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.6 t -111.03 100.62 9.27 Favored 'General case' 0 N--CA 1.396 -3.158 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -87.6 1.6 53.21 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.913 0.863 . . . . 0.0 110.131 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.82 112.27 24.17 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 168.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.2 mt -116.56 -61.11 1.77 Allowed 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.581 0.705 . . . . 0.0 112.029 -168.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 33.4 tt0 -63.69 123.2 18.27 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.355 -168.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.13 -11.66 51.95 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.13 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.9 t -95.65 142.36 13.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -77.46 128.84 34.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -122.7 151.51 41.47 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.753 0.787 . . . . 0.0 111.22 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 m -116.02 135.38 54.01 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.948 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.433 HD21 ' HB2' ' A' ' 160' ' ' HIS . 2.4 tm? -97.01 111.45 23.67 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -107.58 105.72 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.8 p -111.59 130.36 65.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-O 121.217 0.532 . . . . 0.0 110.966 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 75.3 t60 -130.92 92.19 3.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.065 0.936 . . . . 0.0 108.657 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.1 m -115.42 -175.27 2.67 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -69.69 -36.81 76.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -77.89 -60.07 2.52 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.817 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 104' ' ' HIS . 57.2 m-85 -84.9 87.06 7.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.778 -177.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.6 p -80.66 88.86 5.72 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.361 0.6 . . . . 0.0 112.347 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 58.97 70.2 0.67 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.43 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 33.1 m -97.13 108.41 21.13 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 69.2 mt -98.29 100.34 10.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.0 tp -113.63 115.25 27.61 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.728 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.53 120.89 19.75 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.9 m -102.13 -20.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.3 -158.87 14.08 Favored Glycine 0 N--CA 1.432 -1.622 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.152 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.14 127.08 9.01 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.849 2.366 . . . . 0.0 111.944 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 20.9 m -89.42 149.46 4.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.751 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.3 p -128.21 166.01 19.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.362 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.5 ttt -98.46 127.05 44.22 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.688 -0.632 . . . . 0.0 111.187 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.02 -52.13 5.61 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.09 -122.99 7.7 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.0 tt -111.29 112.02 23.5 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.293 -1.883 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 N--CA 1.447 -1.231 0 CA-C-O 121.313 0.464 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.526 ' HB ' ' SD ' ' A' ' 134' ' ' MET . 18.4 p -117.4 132.83 56.5 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.857 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -123.3 132.07 53.88 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -176.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 74.63 47.97 0.12 Allowed 'General case' 0 C--O 1.239 0.533 0 O-C-N 124.801 1.313 . . . . 0.0 111.825 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.526 ' SD ' ' HB ' ' A' ' 131' ' ' THR . 0.1 OUTLIER -97.64 139.28 33.77 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.253 174.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.5 HG23 ' HB3' ' A' ' 170' ' ' SER . 3.4 tt -101.43 130.07 51.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -128.09 132.13 49.01 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.343 0.592 . . . . 0.0 111.128 -171.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -120.62 134.13 55.31 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.188 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 166' ' ' ARG . 10.7 t70 -83.95 96.31 8.8 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -156.45 124.15 5.51 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.868 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.5 99.7 0.32 Allowed 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 124.175 0.922 . . . . 0.0 109.44 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.2 t -105.61 147.31 28.59 Favored 'General case' 0 N--CA 1.407 -2.576 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.365 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -87.28 94.19 9.6 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.1 t -45.76 143.83 1.92 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 124.548 1.139 . . . . 0.0 113.526 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.19 -2.27 2.31 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.079 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -90.3 40.29 1.0 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.719 0.408 . . . . 0.0 112.071 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 74.8 m -60.97 117.31 5.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.175 0.512 . . . . 0.0 110.954 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.524 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 101.45 2.28 53.56 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.68 122.96 31.43 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 112.203 -0.359 . . . . 0.0 112.203 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.571 HG12 ' SG ' ' A' ' 151' ' ' CYS . 54.3 t -74.15 108.1 5.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 124.005 0.922 . . . . 0.0 109.264 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.2 tp -88.67 104.17 16.62 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.665 ' SG ' HG13 ' A' ' 156' ' ' ILE . 84.0 m -145.49 174.92 10.73 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -173.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.31 -177.4 5.74 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.6 m -59.53 102.39 0.14 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.035 0.445 . . . . 0.0 111.819 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.91 26.64 72.18 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.18 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -141.4 105.56 4.8 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.665 HG13 ' SG ' ' A' ' 151' ' ' CYS . 2.5 mp -91.81 119.88 39.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -92.24 -34.88 14.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.974 0.892 . . . . 0.0 109.809 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.73 -156.35 27.52 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.6 pt -134.19 140.81 45.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.779 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.433 ' HB2' HD21 ' A' ' 101' ' ' LEU . 20.9 t60 -67.96 105.42 2.0 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.41 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.41 -38.39 13.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.42 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.49 87.8 0.07 OUTLIER Glycine 0 N--CA 1.426 -2.019 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.649 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.88 155.67 21.22 Favored Glycine 0 N--CA 1.428 -1.847 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -151.77 135.21 16.09 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 65.97 -133.26 34.24 Favored Glycine 0 C--N 1.313 -0.74 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 99.2 mtt180 -87.21 6.17 34.46 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -117.05 101.72 8.72 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.86 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.31 107.37 3.09 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -93.31 118.91 31.84 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.777 0.799 . . . . 0.0 111.751 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.5 ' HB3' HG23 ' A' ' 135' ' ' ILE . 30.9 t -120.12 151.09 39.57 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.398 -1.273 . . . . 0.0 107.578 176.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.3 142.72 27.45 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -80.42 105.63 11.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 123.869 0.73 . . . . 0.0 110.575 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.03 88.09 7.45 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -90.51 151.06 21.52 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -60.17 -26.61 66.45 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -50.4 -37.11 35.91 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.36 1.064 . . . . 0.0 112.094 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.446 ' CD1' HD22 ' A' ' 62' ' ' LEU . 46.7 m-85 -75.86 -17.82 59.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.991 0.424 . . . . 0.0 111.846 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.429 ' CE1' HG13 ' A' ' 30' ' ' ILE . 73.9 m-85 -109.51 8.79 25.31 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.46 -174.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 83.0 t . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 174.619 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 N--CA 1.475 0.436 0 N-CA-C 112.663 0.217 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.21 -38.83 91.66 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.256 0.55 . . . . 0.0 110.036 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 m -71.77 -41.38 68.42 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.199 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.15 -49.27 78.52 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.225 0.61 . . . . 0.0 111.207 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -63.78 -44.41 93.47 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.082 0.468 . . . . 0.0 110.845 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.07 -41.92 90.1 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.594 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.0 tp -66.79 -33.51 75.78 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.092 0.557 . . . . 0.0 111.428 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -78.51 -46.05 20.49 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 120.749 0.309 . . . . 0.0 110.299 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.7 tp -55.82 -35.67 66.61 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.952 0.901 . . . . 0.0 109.835 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.422 ' HA ' HD13 ' A' ' 15' ' ' ILE . 50.7 tp -52.68 -50.02 64.13 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.473 1.509 . . . . 0.0 112.791 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -81.05 -22.79 39.03 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.386 0.612 . . . . 0.0 110.738 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -91.0 -46.55 8.08 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.056 -169.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -128.73 3.27 5.46 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 11' ' ' LEU . 53.8 mt -115.83 137.15 50.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.464 -176.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.82 169.4 21.78 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.905 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 94.8 m -98.23 123.15 42.16 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 65.5 mt -110.56 115.52 50.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 11.4 m -88.57 103.81 16.25 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 81.6 p -89.87 -165.8 1.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.865 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -69.42 -19.69 63.79 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.221 0.534 . . . . 0.0 110.127 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -97.7 -45.07 6.5 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.83 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.31 -179.73 48.49 Favored Glycine 0 CA--C 1.497 -1.031 0 C-N-CA 119.242 -1.456 . . . . 0.0 112.592 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 2.8 mp0 -78.27 107.94 11.24 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.474 ' HB3' ' O ' ' A' ' 146' ' ' CYS . 26.5 m-85 -117.01 -177.57 3.23 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 33.0 m -97.34 138.37 34.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.14 143.23 16.02 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 tp -113.56 122.0 45.92 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.31 110.21 3.54 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 175.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.1 mm -71.77 -51.27 33.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 122.354 0.262 . . . . 0.0 110.963 -174.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -170.85 147.33 2.71 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.442 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 38.1 t70 60.53 -81.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.968 1.307 . . . . 0.0 112.943 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 14.4 ptp180 -149.85 13.19 0.8 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.769 0.795 . . . . 0.0 110.246 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.44 113.79 26.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.68 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.7 m -120.12 156.13 31.66 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -137.44 144.65 31.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 117.885 0.311 . . . . 0.0 110.544 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.409 HG23 HD21 ' A' ' 75' ' ' LEU . 14.7 tt -157.12 146.7 15.3 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 6.8 Cg_endo -51.45 141.41 41.56 Favored 'Trans proline' 0 C--N 1.363 1.304 0 C-N-CA 122.907 2.405 . . . . 0.0 113.393 177.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.3 m -57.07 -48.19 79.15 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.929 0.892 . . . . 0.0 113.123 -176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -66.75 -1.5 3.92 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.47 -25.08 60.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.661 ' O ' ' HB ' ' A' ' 20' ' ' THR . 29.4 mm-40 61.6 82.43 0.22 Allowed Pre-proline 0 N--CA 1.467 0.396 0 C-N-CA 125.462 1.505 . . . . 0.0 114.425 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -85.17 124.75 2.92 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.793 2.329 . . . . 0.0 109.984 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.96 -125.51 0.67 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.776 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -96.11 -59.77 1.77 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.616 0.722 . . . . 0.0 109.293 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 42.4 p-10 -124.19 125.5 44.53 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.449 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.84 148.18 16.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.532 -173.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.1 mt -79.93 102.14 9.02 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.938 0.399 . . . . 0.0 110.175 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 17' ' ' THR . 7.5 p -94.29 90.0 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 122.063 0.935 . . . . 0.0 109.055 176.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m120 62.39 8.1 2.64 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.934 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.43 -32.47 1.96 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.932 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -82.77 125.14 30.94 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -88.05 96.6 10.57 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.444 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.4 tp -101.31 132.65 46.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.359 -171.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -82.44 121.52 26.85 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.095 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.8 t -84.06 132.93 30.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -79.31 -48.16 14.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.968 0.413 . . . . 0.0 110.963 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.26 138.71 31.58 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -115.47 98.65 6.85 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.439 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 80.0 m-85 -84.07 129.88 34.89 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.758 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -84.42 112.15 20.1 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 173.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 53.1 tp -90.31 99.0 12.1 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.539 0.685 . . . . 0.0 109.346 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.86 148.47 16.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.378 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.26 141.26 57.39 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.57 -3.22 0.55 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 123.944 3.096 . . . . 0.0 114.546 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.88 -2.86 41.84 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.0 t30 77.89 6.45 2.75 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 125.683 1.593 . . . . 0.0 111.273 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.577 ' HB ' ' ND2' ' A' ' 132' ' ' ASN . 50.9 mm -96.43 150.44 4.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 131' ' ' THR . 52.9 t30 -70.83 126.92 30.91 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -177.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 54.1 tp -92.08 -13.22 31.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 21.1 tp10 66.96 23.95 9.71 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.566 175.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.5 mt -117.42 135.19 54.06 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.563 -0.711 . . . . 0.0 111.753 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.5 m -114.38 130.25 56.68 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 94.1 t -102.04 120.47 51.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.409 HD21 HG23 ' A' ' 37' ' ' ILE . 2.4 mm? -103.51 127.11 50.97 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.392 -175.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 m -87.53 88.91 7.8 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.4 tt -89.99 124.26 34.6 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.444 ' O ' HD11 ' A' ' 54' ' ' ILE . 32.7 t70 -74.9 80.84 2.14 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-O 121.995 0.903 . . . . 0.0 110.275 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -100.41 131.57 46.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.31 -175.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -74.77 -24.49 58.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.586 0.708 . . . . 0.0 109.82 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -88.82 119.6 29.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.153 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -77.31 113.28 14.91 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -62.67 138.68 58.56 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -74.65 142.97 44.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.515 ' OD1' ' HB2' ' A' ' 87' ' ' ARG . 10.0 t70 -67.66 99.06 0.75 Allowed 'General case' 0 C--N 1.311 -1.101 0 O-C-N 123.414 0.446 . . . . 0.0 111.535 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -90.65 19.14 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.781 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.515 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 85.3 mtm180 -71.44 -24.94 62.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.607 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.48 -19.22 79.64 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.817 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -93.54 -12.51 29.43 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.606 -0.349 . . . . 0.0 111.22 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.8 mt -64.76 120.93 12.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.318 0.58 . . . . 0.0 110.26 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 155' ' ' LYS . 5.7 p -105.67 112.56 25.69 Favored 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.712 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -84.43 -10.0 57.9 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.356 0.598 . . . . 0.0 110.316 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -85.76 117.74 24.82 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.5 mt -117.34 -53.71 2.43 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -168.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.18 115.11 5.18 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -167.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.88 1.29 58.62 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.524 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.17 160.49 2.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -73.33 155.12 39.75 Favored 'General case' 0 C--O 1.21 -0.981 0 C-N-CA 123.396 0.678 . . . . 0.0 109.605 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -159.05 152.22 22.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.759 0.79 . . . . 0.0 112.146 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 94.9 m -143.96 132.81 22.61 Favored 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 125.801 1.64 . . . . 0.0 107.916 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.2 tp -98.16 119.98 37.76 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.9 t -100.96 116.61 44.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.05 123.98 66.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.411 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 28.1 t60 -130.12 79.8 1.92 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.6 m -139.85 -165.81 1.96 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.83 -175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -71.42 -53.75 12.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -67.66 -39.6 84.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.13 0.49 . . . . 0.0 111.321 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -126.43 95.0 4.22 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.5 m -92.32 120.54 32.96 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.138 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.411 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 4.3 t30 61.97 42.89 9.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.858 0.837 . . . . 0.0 109.186 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.9 m -108.22 115.88 30.93 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.088 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 87.3 mt -90.09 109.19 20.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.3 tp -108.45 114.62 28.61 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 123.041 0.536 . . . . 0.0 109.983 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.38 145.77 49.17 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.834 0.349 . . . . 0.0 111.781 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.5 t -115.47 -51.43 4.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.841 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 113.0 -121.56 5.58 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -98.29 135.4 0.33 Allowed 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 122.989 2.459 . . . . 0.0 113.044 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.4 m -103.63 155.53 5.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.899 -0.501 . . . . 0.0 112.278 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.436 ' O ' HG13 ' A' ' 135' ' ' ILE . 17.5 p -131.88 178.75 6.53 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.65 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 46.5 ttm -114.2 140.32 48.65 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 121.483 -0.76 . . . . 0.0 111.165 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.463 ' HB3' ' HB2' ' A' ' 136' ' ' ARG . . . -104.75 -53.64 2.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.36 -117.69 5.95 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.798 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.9 tp -96.14 114.78 26.51 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.201 0.6 . . . . 0.0 109.892 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 C--N 1.31 -1.129 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo . . . . . 0 C--O 1.243 0.729 0 N-CA-C 109.823 -0.876 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 20.8 p -127.21 128.97 46.93 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.179 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.577 ' ND2' ' HB ' ' A' ' 68' ' ' ILE . 41.8 p30 -110.25 171.07 7.67 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.715 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.51 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.9 mpt_? 67.32 23.8 9.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.813 0.845 . . . . 0.0 110.884 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.8 mmt -81.84 128.62 34.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.583 0.706 . . . . 0.0 111.687 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.44 HG23 ' HB2' ' A' ' 170' ' ' SER . 3.4 tt -96.88 136.84 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.629 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.463 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . 34.7 ttm180 -116.61 135.97 53.36 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.501 0.501 . . . . 0.0 111.097 -170.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.5 140.34 31.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.659 -0.496 . . . . 0.0 109.659 173.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.26 110.04 19.36 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -163.32 147.92 11.05 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.56 87.26 2.12 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.0 p -81.2 128.61 33.97 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.984 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -76.63 111.99 12.71 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.7 m -70.53 129.5 39.38 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.333 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 129.38 -37.38 2.2 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.601 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -75.37 52.03 0.59 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.077 0.951 . . . . 0.0 112.913 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 25' ' ' PHE . 56.9 m -63.4 147.86 50.07 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.395 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 93.53 1.25 66.37 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.749 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.98 129.56 38.35 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.6 109.2 8.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-O 121.195 0.521 . . . . 0.0 110.56 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.7 tp -89.33 99.71 12.65 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 23.4 p -126.82 -172.6 2.68 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.561 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.455 ' HB1' ' HB2' ' A' ' 155' ' ' LYS . . . -157.79 -169.57 2.89 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.4 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 20.7 p -62.79 96.02 0.08 Allowed 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.708 0.63 . . . . 0.0 110.849 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.23 25.17 76.05 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.549 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.461 ' HB3' ' OG ' ' A' ' 91' ' ' SER . 39.1 mttp -142.56 154.78 44.75 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 117.279 0.54 . . . . 0.0 109.665 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 151' ' ' CYS . 86.4 mt -137.22 128.17 40.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -100.25 -43.81 6.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.623 0.725 . . . . 0.0 110.23 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 172.92 -154.59 21.1 Favored Glycine 0 N--CA 1.416 -2.668 0 C-N-CA 120.283 -0.961 . . . . 0.0 111.14 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.6 pt -131.98 143.31 40.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 120.567 0.222 . . . . 0.0 110.628 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -58.58 126.2 26.61 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.352 1.061 . . . . 0.0 110.691 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.1 t -110.08 -63.88 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.32 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.44 108.79 0.61 Allowed Glycine 0 N--CA 1.421 -2.312 0 C-N-CA 119.901 -1.143 . . . . 0.0 112.293 -175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.94 115.0 4.37 Favored Glycine 0 N--CA 1.427 -1.954 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 175.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -114.74 97.61 6.37 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.487 0.661 . . . . 0.0 110.502 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.13 -98.49 0.64 Allowed Glycine 0 N--CA 1.425 -2.034 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.654 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.485 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 6.4 mpt_? -110.98 -0.7 16.62 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.619 -0.291 . . . . 0.0 111.055 -174.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -119.18 120.62 37.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.602 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.28 120.77 5.84 Favored Glycine 0 N--CA 1.418 -2.538 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -108.14 118.67 37.35 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.574 0.702 . . . . 0.0 109.931 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.44 ' HB2' HG23 ' A' ' 135' ' ' ILE . 28.6 m -115.83 157.5 24.33 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.693 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -98.81 132.54 44.09 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 10.8 pt20 -87.64 103.3 15.44 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.947 0.88 . . . . 0.0 110.655 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . 0.337 0.0 OUTLIER -85.11 79.79 9.47 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.18 0.991 . . . . 0.0 111.716 177.155 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -57.86 145.01 36.75 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.526 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.476 ' O ' HG22 ' A' ' 179' ' ' VAL . 20.2 ptmt -56.13 -25.41 45.96 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.358 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -58.66 -29.99 67.0 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.843 0.857 . . . . 0.0 112.311 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -74.81 -20.5 59.75 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.112 0.482 . . . . 0.0 110.78 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -101.68 11.14 39.35 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.501 0.667 . . . . 0.0 109.498 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 175' ' ' LYS . 92.5 t . . . . . 0 N--CA 1.425 -1.708 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo . . . . . 0 CA--C 1.536 0.592 0 N-CA-C 112.935 0.321 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -69.51 -40.64 76.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.66 -40.59 97.24 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.931 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -64.23 -40.05 95.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.857 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.18 -42.91 93.17 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.126 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.96 82.27 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.112 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.87 -35.68 80.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -82.84 -37.4 24.44 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.877 -0.514 . . . . 0.0 111.332 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.02 -41.17 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.411 HD11 ' HD1' ' A' ' 104' ' ' HIS . 54.5 tp -53.51 -51.42 62.88 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.638 1.175 . . . . 0.0 112.335 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -70.54 -12.82 61.82 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -125.38 -42.01 2.0 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -106.46 -18.06 14.09 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -169.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.5 mt -89.16 105.36 15.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.29 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.2 mtp -105.45 140.22 38.88 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.325 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 m -99.38 116.03 30.59 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.3 mt -111.02 118.48 57.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.352 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.8 m -85.4 109.12 18.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 73.3 p -96.02 -157.54 0.59 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.505 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.5 m -84.01 3.31 34.96 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 121.193 0.521 . . . . 0.0 109.946 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -115.66 -39.52 3.51 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.158 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.61 -153.14 23.99 Favored Glycine 0 CA--C 1.498 -1.022 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -92.76 115.58 28.24 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.263 0.554 . . . . 0.0 110.823 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -116.48 169.6 9.2 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.6 m -98.54 127.8 44.62 Favored 'General case' 0 N--CA 1.41 -2.443 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.268 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.68 129.44 9.29 Favored Glycine 0 N--CA 1.412 -2.956 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -100.08 116.43 32.09 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.023 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.6 113.98 4.66 Favored Glycine 0 C--O 1.212 -1.253 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.1 mm -90.87 -50.64 12.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 116.964 0.382 . . . . 0.0 111.593 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -156.09 121.22 4.75 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.831 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.432 ' OD1' ' HG3' ' A' ' 82' ' ' LYS . 28.9 t70 67.18 -79.98 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.148 0.905 . . . . 0.0 113.266 168.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -140.46 11.88 2.33 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.794 0.838 . . . . 0.0 109.54 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.4 t -91.95 115.22 30.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.305 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -120.78 139.22 53.43 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.4 t -114.64 135.27 55.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 120.581 0.229 . . . . 0.0 111.082 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.5 tt -146.54 145.03 21.98 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 59.9 Cg_exo -57.8 138.91 88.41 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.465 2.11 . . . . 0.0 112.415 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.668 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 21.5 m -60.94 -41.69 96.76 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -71.01 -0.27 9.03 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.91 -15.5 60.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.615 ' O ' ' HB ' ' A' ' 20' ' ' THR . 82.8 mm-40 60.44 82.0 0.23 Allowed Pre-proline 0 CA--C 1.518 -0.283 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 175.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.19 158.98 11.33 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.46 2.107 . . . . 0.0 109.579 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.36 -141.55 11.1 Favored Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.446 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -88.21 -15.22 36.53 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.02 151.77 39.07 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.13 153.98 39.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 7.2 mp -103.57 105.4 15.63 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.829 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.51 92.97 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 66.09 8.24 5.34 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.596 1.558 . . . . 0.0 110.564 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.63 -24.83 3.31 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.66 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 46.5 mt-30 -75.12 106.73 6.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.594 0.197 . . . . 0.0 111.062 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -68.9 103.53 1.83 Allowed 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.4 tp -112.06 121.46 64.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-O 121.241 0.543 . . . . 0.0 109.693 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -75.48 110.32 9.77 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.9 t -65.9 135.4 28.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.58 -63.14 1.31 Allowed 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -144.77 144.46 31.19 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -108.14 111.0 22.79 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.473 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 61.9 m-85 -96.59 113.18 24.72 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -77.15 114.18 15.68 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -88.92 94.86 10.09 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.1 t -112.33 149.29 14.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -65.48 142.08 98.22 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.56 -22.55 17.06 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.498 2.799 . . . . 0.0 114.193 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -94.83 14.45 21.39 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 122.058 0.933 . . . . 0.0 109.761 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 66.54 26.69 9.85 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.61 1.164 . . . . 0.0 111.943 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.8 mm -86.3 137.27 21.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 131' ' ' THR . 63.3 t30 -92.13 135.0 34.33 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.811 -171.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -123.01 2.45 9.33 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.701 172.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.668 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 4.9 tp10 62.84 23.35 13.94 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.179 1.392 . . . . 0.0 111.864 174.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.7 tt -95.8 120.89 36.87 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 121.666 -0.646 . . . . 0.0 110.141 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 m -114.89 127.39 55.67 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 60.8 t -99.74 107.75 21.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.5 mt -95.69 117.76 31.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.9 m -97.6 103.69 15.65 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -78.17 141.04 38.95 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.257 0.551 . . . . 0.0 111.479 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -91.32 83.25 5.45 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.566 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 11.0 mmm180 -134.06 175.14 9.75 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.806 -174.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -108.33 -28.6 9.32 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 123.325 0.391 . . . . 0.0 111.073 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.566 ' OE1' ' HB3' ' A' ' 79' ' ' ARG . 1.5 pm0 -70.4 127.25 32.11 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-O 121.281 0.562 . . . . 0.0 111.192 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.432 ' HG3' ' OD1' ' A' ' 32' ' ' ASP . 41.4 tttp -92.33 109.54 20.92 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -73.35 139.39 45.97 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.586 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -49.94 123.19 7.68 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.525 1.13 . . . . 0.0 110.001 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -81.49 114.73 20.41 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.892 178.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.9 pt -93.8 25.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.997 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -68.3 -27.02 65.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.911 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.73 -9.23 86.45 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.252 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -100.86 -8.97 22.07 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.77 124.51 22.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.5 t -113.3 114.25 26.42 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.446 ' OE2' ' HG3' ' A' ' 176' ' ' GLN . 45.8 mt-10 -84.47 -20.25 32.02 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.233 0.539 . . . . 0.0 110.186 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -90.04 123.74 34.18 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 170.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.7 mt -113.93 -56.75 2.36 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.981 0.896 . . . . 0.0 111.228 -168.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -59.68 126.53 27.98 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.618 -170.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.78 -27.1 8.07 Favored Glycine 0 N--CA 1.436 -1.304 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.117 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.02 156.82 3.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 120.834 0.349 . . . . 0.0 110.384 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -89.21 143.67 26.67 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.71 162.25 33.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.658 0.742 . . . . 0.0 112.097 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 88.3 m -124.93 141.62 52.0 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.904 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -107.88 120.87 43.5 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 111' ' ' THR . 37.8 t -116.51 111.32 34.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 120.894 0.378 . . . . 0.0 110.059 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.4 p -113.21 141.04 30.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.411 ' HD1' HD11 ' A' ' 11' ' ' LEU . 6.0 t60 -133.45 95.72 3.56 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.725 0.774 . . . . 0.0 109.37 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.2 t -104.44 -172.86 2.18 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -88.59 -42.84 11.8 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.54 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -70.44 -49.48 48.25 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -95.57 79.44 3.39 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.9 m -79.96 107.83 13.05 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.171 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.0 t30 58.77 71.82 0.56 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.016 0.926 . . . . 0.0 113.02 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 22.7 m -98.77 107.74 20.26 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.9 mt -95.62 94.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.1 tp -103.76 114.43 28.69 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.636 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.56 96.38 6.8 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.08 -35.82 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.979 -176.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 113.4 -135.17 12.38 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.579 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.95 130.01 10.15 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 123.038 2.492 . . . . 0.0 112.345 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.411 ' HB ' HD11 ' A' ' 135' ' ' ILE . 31.2 m -105.57 138.23 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-O 121.531 0.682 . . . . 0.0 111.129 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.4 m -122.59 145.52 48.27 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.019 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 57.9 ttp -83.45 122.0 27.93 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -82.36 -32.61 29.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.121 0.486 . . . . 0.0 111.364 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.78 -86.59 1.51 Allowed Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -152.03 138.27 18.38 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.9 mm . . . . . 0 C--N 1.301 -1.504 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.753 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo . . . . . 0 N--CA 1.434 -1.998 0 N-CA-C 109.574 -0.971 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.52 ' HB ' ' SD ' ' A' ' 134' ' ' MET . 33.3 p -107.59 102.76 11.99 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-O 121.764 0.792 . . . . 0.0 110.226 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -103.65 164.0 11.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 67.81 38.12 2.99 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.736 0.814 . . . . 0.0 109.437 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.52 ' SD ' ' HB ' ' A' ' 131' ' ' THR . 57.1 mtt -119.24 164.23 15.94 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-O 121.798 0.809 . . . . 0.0 113.105 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.51 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 12.9 tt -123.15 151.42 27.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 124.712 1.205 . . . . 0.0 108.317 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -128.29 142.56 51.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.067 0.46 . . . . 0.0 111.889 -174.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -144.56 137.34 26.72 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.892 169.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.96 104.65 16.48 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.792 0.806 . . . . 0.0 111.662 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -162.56 138.07 7.12 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 125.808 1.643 . . . . 0.0 107.45 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.04 98.97 2.64 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.5 m -53.03 138.51 30.45 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 124.951 1.3 . . . . 0.0 112.836 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 145' ' ' GLN . 62.8 tttp -99.85 140.22 34.37 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.7 m -63.92 139.12 58.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 122.529 0.332 . . . . 0.0 110.263 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.34 33.47 9.4 Favored Glycine 0 C--O 1.219 -0.823 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 3.4 tp-100 -116.89 -6.13 11.49 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.603 0.716 . . . . 0.0 109.432 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.417 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 42.2 t -69.78 129.0 38.37 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.704 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.34 -7.66 58.39 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.095 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.75 140.28 42.22 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.526 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.34 120.67 35.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.729 0.776 . . . . 0.0 110.774 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 42.3 tp -88.2 106.04 17.93 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.0 p -140.99 168.67 19.23 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.747 0.784 . . . . 0.0 112.577 -172.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.54 -179.1 6.71 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.4 t -57.41 101.22 0.06 Allowed 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.938 0.875 . . . . 0.0 111.937 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.3 14.88 74.52 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.275 -1.33 . . . . 0.0 113.092 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -135.64 108.74 7.69 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 117.251 0.526 . . . . 0.0 111.045 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.13 126.26 57.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -97.87 -33.63 11.16 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 123.896 0.747 . . . . 0.0 110.959 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 165.54 -159.85 33.11 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 119.441 -1.361 . . . . 0.0 112.675 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.6 pt -121.86 137.75 54.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -69.34 125.96 28.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.0 p -96.69 -46.7 12.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.316 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.77 156.34 11.36 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -131.08 156.73 21.91 Favored Glycine 0 N--CA 1.428 -1.852 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.528 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -154.95 144.16 21.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.97 -122.68 5.9 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -117.84 13.21 14.03 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -121.43 136.88 54.91 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.017 0.437 . . . . 0.0 111.971 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -106.94 130.14 10.03 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -112.44 140.71 46.95 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.198 0.523 . . . . 0.0 109.96 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.51 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 18.6 m -131.15 154.7 48.07 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.41 139.56 30.56 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.67 116.35 19.8 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 123.37 0.419 . . . . 0.0 110.964 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 81.9 mt -89.02 94.38 9.93 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -84.08 140.66 31.67 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.093 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -69.16 -20.84 64.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.442 0.639 . . . . 0.0 109.6 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.446 ' HG3' ' OE2' ' A' ' 92' ' ' GLU . 69.4 mt-30 -58.21 -21.75 49.07 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.506 1.523 . . . . 0.0 112.23 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -86.99 -23.42 25.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.93 0.395 . . . . 0.0 110.726 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.4 ' CG ' HG23 ' A' ' 30' ' ' ILE . 49.2 m-85 -106.5 18.72 21.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.154 0.502 . . . . 0.0 112.017 -169.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--N 1.296 -1.73 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.629 176.477 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo . . . . . 0 N--CA 1.483 0.903 0 CA-C-O 121.617 0.59 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -61.21 -37.27 82.39 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.057 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.4 m -64.52 -37.43 87.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.506 0.722 . . . . 0.0 109.608 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.35 -44.83 82.18 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.915 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.83 -45.98 88.75 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.944 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.48 98.75 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.02 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.84 -37.7 85.45 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 123.346 0.658 . . . . 0.0 110.438 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 m -76.41 -31.62 58.03 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.527 0.679 . . . . 0.0 110.325 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -73.69 -31.14 63.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.303 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.511 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 62.2 tp -51.68 -56.32 14.37 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.436 1.094 . . . . 0.0 112.05 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -83.02 10.26 8.41 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.221 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -117.91 -59.79 1.87 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -122.72 -6.81 8.56 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.511 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 50.5 mt -89.19 103.32 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 mmt -115.58 126.03 53.7 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.25 0.548 . . . . 0.0 111.002 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.4 m -70.2 96.82 1.13 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.864 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 58.5 mt -89.86 111.9 23.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 121.16 0.505 . . . . 0.0 109.908 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.8 m -86.5 107.6 18.17 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 80.5 p -89.74 -157.75 0.48 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.776 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 t -85.57 -9.45 57.32 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -106.3 -38.06 6.35 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.03 -160.4 27.45 Favored Glycine 0 CA--C 1.493 -1.326 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.804 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -99.86 112.27 24.54 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -112.73 159.3 19.08 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.544 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 17.9 m -86.65 116.26 24.65 Favored 'General case' 0 N--CA 1.408 -2.556 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.47 129.26 9.81 Favored Glycine 0 N--CA 1.417 -2.624 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.2 tp -105.4 115.9 31.04 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 120.839 0.352 . . . . 0.0 110.549 -178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.7 136.48 23.17 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.3 mm -100.61 -56.34 5.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 117.566 0.683 . . . . 0.0 109.537 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.595 ' NE2' ' HB3' ' A' ' 178' ' ' PHE . 0.1 OUTLIER -172.97 167.94 4.95 Favored 'General case' 0 CA--C 1.46 -2.494 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 52.06 -135.57 1.47 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.67 25.73 10.44 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -92.61 112.87 26.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.272 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 43.2 t -122.14 139.71 53.42 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.15 140.77 26.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 122.225 0.21 . . . . 0.0 110.585 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 tt -151.78 147.44 20.05 Favored Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -63.94 147.26 92.02 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.158 1.905 . . . . 0.0 112.066 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.0 m -64.44 -37.66 88.29 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -76.09 5.24 7.01 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.42 -19.65 57.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.477 ' O ' ' HB ' ' A' ' 20' ' ' THR . 78.6 mt-30 57.22 76.6 0.47 Allowed Pre-proline 0 C--O 1.251 1.158 0 C-N-CA 125.414 1.486 . . . . 0.0 113.361 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -92.29 164.8 3.02 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 122.346 2.031 . . . . 0.0 110.724 175.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.34 -152.09 10.96 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.06 -1.44 54.41 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -144.87 126.13 14.76 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.18 155.39 39.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.063 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 8.8 mp -92.26 102.06 14.56 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.3 p -87.82 105.46 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.052 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 74.03 -3.9 2.41 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.611 0.764 . . . . 0.0 110.81 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.51 -9.3 11.78 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -97.67 118.26 33.79 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 14.9 ptpt -77.19 134.63 38.59 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 118.28 -1.368 . . . . 0.0 112.738 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 77' ' ' LEU . 5.3 tp -131.49 141.12 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 114.251 -1.341 . . . . 0.0 108.346 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -86.47 139.66 30.68 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.6 t -93.01 139.93 17.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -79.68 -71.34 0.45 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -126.15 139.38 53.41 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -99.88 90.97 4.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.408 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 93.8 m-85 -79.2 109.97 14.03 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.155 0.502 . . . . 0.0 110.523 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -77.14 104.42 7.63 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.7 tp -80.26 87.89 5.53 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 122.181 0.991 . . . . 0.0 109.245 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -119.64 163.52 16.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 113.848 -1.523 . . . . 0.0 108.397 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.58 137.15 48.05 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.53 -23.9 11.55 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.667 2.911 . . . . 0.0 114.348 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -82.77 13.53 3.79 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 122.379 0.272 . . . . 0.0 111.384 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.9 m120 79.21 10.19 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 125.383 1.473 . . . . 0.0 112.347 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.5 mt -86.47 119.84 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.597 ' O ' ' HA ' ' A' ' 131' ' ' THR . 74.6 m-20 -81.07 157.67 25.32 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.882 -173.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -109.36 -0.97 18.78 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 61.72 30.05 18.29 Favored 'General case' 0 C--N 1.364 1.218 0 CA-C-O 122.83 1.3 . . . . 0.0 108.634 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.9 tp -133.01 142.89 49.07 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.584 -170.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.0 m -138.08 140.3 39.92 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.255 0.55 . . . . 0.0 110.657 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 92.7 t -105.98 122.25 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.8 mt -102.38 113.69 27.23 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.7 m -87.6 107.55 18.65 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.404 ' HB3' HG12 ' A' ' 54' ' ' ILE . 66.0 mt -80.48 141.31 35.34 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.725 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.52 74.72 10.35 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 122.045 0.926 . . . . 0.0 111.6 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -125.12 161.59 26.49 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.436 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -93.23 -49.57 5.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -66.96 148.16 52.3 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -119.27 173.18 7.1 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.388 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -82.56 179.64 7.72 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -73.75 127.93 34.13 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.01 90.16 1.15 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -92.61 20.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.755 -0.591 . . . . 0.0 112.162 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -68.69 -29.74 68.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.811 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.72 -27.54 73.77 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -85.1 -8.82 58.48 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 122.9 -0.177 . . . . 0.0 110.699 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.4 mt -66.54 131.69 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 t -124.44 111.48 15.78 Favored 'General case' 0 N--CA 1.387 -3.589 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -86.84 5.46 36.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.495 1.14 . . . . 0.0 108.935 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.83 110.57 22.02 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 169.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.5 -29.76 0.62 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -171.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -68.1 103.02 1.43 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.113 0.482 . . . . 0.0 111.747 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.38 -0.43 34.94 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.604 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.0 t -91.53 138.71 19.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -79.7 116.72 20.05 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -115.59 172.25 7.23 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.821 0.82 . . . . 0.0 112.097 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.6 m -128.79 141.25 51.37 Favored 'General case' 0 N--CA 1.422 -1.857 0 C-N-CA 124.908 1.283 . . . . 0.0 108.719 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.8 tp -106.12 122.19 45.69 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -113.96 107.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.815 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.4 m -107.85 138.91 31.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -139.28 107.99 5.93 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.325 0.583 . . . . 0.0 110.002 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.3 p -144.27 -172.58 3.81 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.46 -25.76 41.85 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.401 176.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -73.68 -51.27 17.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.419 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -115.79 84.35 2.09 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.8 m -80.14 96.32 6.49 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.355 0.597 . . . . 0.0 111.005 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.2 t30 60.15 70.71 0.61 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.755 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.3 m -101.34 108.03 19.54 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.08 108.67 24.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.0 tp -125.15 123.88 40.6 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.875 0.369 . . . . 0.0 111.563 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.86 102.65 4.8 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.1 m -78.39 -26.54 14.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.243 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 106.85 -149.53 16.6 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 119.94 -1.124 . . . . 0.0 111.1 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.95 122.25 8.63 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.745 2.297 . . . . 0.0 112.901 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.8 m -89.57 145.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.949 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.5 p -128.45 172.8 10.79 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.246 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 28.2 ttt -114.45 136.64 52.78 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.74 -26.84 12.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.335 0.588 . . . . 0.0 109.419 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.53 -88.89 1.46 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 131' ' ' THR . 4.9 mp -131.99 155.99 47.0 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 11.1 tt . . . . . 0 C--N 1.304 -1.372 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 50.7 Cg_endo . . . . . 0 N--CA 1.428 -2.358 0 N-CA-C 110.816 -0.494 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.1 p -103.69 133.45 48.67 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.41 ' OD1' ' HD2' ' A' ' 133' ' ' ARG . 29.0 t-20 -108.19 159.9 16.24 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -175.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 5.5 mpt_? 65.72 38.8 5.1 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.563 1.145 . . . . 0.0 110.638 -177.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.468 ' HE3' ' HA ' ' A' ' 134' ' ' MET . 16.5 mmt -85.55 118.42 25.06 Favored 'General case' 0 C--O 1.252 1.214 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.256 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 170' ' ' SER . 5.4 tt -99.84 136.34 31.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 144.58 51.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.752 0.31 . . . . 0.0 111.311 -172.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.95 163.81 31.38 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.907 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.27 99.95 12.84 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 124.227 0.955 . . . . 0.0 108.669 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -171.34 124.35 0.6 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.485 1.114 . . . . 0.0 109.65 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -70.46 102.81 2.29 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.941 176.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.8 t -119.81 155.73 32.0 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -127.21 165.44 19.61 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.721 0.296 . . . . 0.0 110.505 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.4 m -60.74 129.38 41.22 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.287 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.27 -20.41 9.04 Favored Glycine 0 C--O 1.215 -1.049 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -93.42 23.71 4.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.183 0.992 . . . . 0.0 108.386 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.1 m -79.12 137.88 37.68 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.415 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.544 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 97.55 0.43 59.35 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.57 126.58 37.81 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 121.566 -0.349 . . . . 0.0 112.643 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -73.25 113.0 10.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 123.318 0.647 . . . . 0.0 109.465 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 52.3 tp -94.18 106.45 18.42 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.5 p -147.02 163.23 36.91 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.675 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.77 177.8 6.58 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.1 t -64.38 108.46 1.63 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.956 0.884 . . . . 0.0 110.946 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 83.27 2.37 90.36 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.262 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -136.35 108.38 7.18 Favored 'General case' 0 C--O 1.211 -0.956 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.1 mt -97.68 130.92 45.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -103.41 -31.97 9.75 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.147 0.498 . . . . 0.0 110.691 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.4 -154.84 25.91 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.283 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.9 pt -132.28 148.08 32.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 116.911 0.355 . . . . 0.0 110.597 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.409 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 23.8 t-80 -68.14 131.16 44.91 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.203 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.6 m -105.47 -59.96 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.56 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -156.93 142.89 9.06 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.019 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -131.67 143.99 15.57 Favored Glycine 0 N--CA 1.423 -2.232 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.894 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -119.76 105.99 11.68 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.638 0.732 . . . . 0.0 109.911 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 74.2 -130.76 12.75 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -177.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 34.0 ptt180 -90.14 9.09 29.67 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.961 0.41 . . . . 0.0 110.982 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -111.37 94.72 5.12 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.618 0.723 . . . . 0.0 110.063 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.9 123.93 6.9 Favored Glycine 0 N--CA 1.422 -2.283 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.55 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -104.27 127.52 51.91 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.951 0.881 . . . . 0.0 109.557 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.486 ' HB2' HG23 ' A' ' 135' ' ' ILE . 19.4 m -124.62 166.29 16.38 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.36 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -100.56 129.49 46.5 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 4.0 pt20 -85.18 115.88 23.22 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.922 0.868 . . . . 0.0 110.319 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.09 93.4 9.35 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.954 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -73.3 146.73 45.12 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -75.3 -6.3 49.12 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.334 0.588 . . . . 0.0 110.907 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.09 -33.42 74.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.077 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -75.33 -27.0 59.07 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.173 0.511 . . . . 0.0 110.899 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.595 ' HB3' ' NE2' ' A' ' 31' ' ' HIS . 82.7 m-85 -102.1 0.99 35.75 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.897 -170.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--N 1.293 -1.886 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.189 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 C--O 1.242 0.716 0 N-CA-C 113.272 0.451 . . . . 0.0 113.272 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -76.56 -40.13 50.69 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -60.89 -46.21 91.54 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.851 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.45 -49.52 77.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.332 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -58.57 -46.8 86.15 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 123.498 0.499 . . . . 0.0 110.781 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.61 -35.14 78.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.6 tp -71.38 -42.14 68.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.049 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -70.73 -33.09 70.47 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.022 -0.423 . . . . 0.0 111.46 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.6 tp -67.27 -40.53 86.2 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.733 0.813 . . . . 0.0 108.927 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.441 HD22 HD21 ' A' ' 110' ' ' ASN . 18.5 tp -53.51 -50.49 65.3 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.742 1.217 . . . . 0.0 111.591 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -73.36 -3.61 28.3 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.783 -1.098 . . . . 0.0 113.447 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -126.42 -47.98 1.57 Allowed 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -115.84 -10.49 11.69 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -171.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 29.8 mt -99.19 115.34 39.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.101 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 mmt -127.65 146.37 50.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.465 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 22.7 m -78.56 132.41 37.15 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.7 mt -125.93 110.8 24.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 98.4 m -77.03 103.72 7.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.2 p -94.55 -168.68 1.88 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.008 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -71.12 -16.11 62.54 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 120.842 0.353 . . . . 0.0 111.047 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -110.11 9.63 24.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.84 -162.41 14.01 Favored Glycine 0 C--N 1.31 -0.869 0 C-N-CA 119.49 -1.338 . . . . 0.0 113.642 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -86.48 101.27 13.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.312 0.577 . . . . 0.0 111.738 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -106.92 -179.25 3.88 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 t -127.44 139.28 52.92 Favored 'General case' 0 N--CA 1.408 -2.571 0 C-N-CA 119.005 -1.078 . . . . 0.0 109.028 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.59 137.63 14.41 Favored Glycine 0 N--CA 1.415 -2.737 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.7 tp -101.84 118.41 36.86 Favored 'General case' 0 C--N 1.29 -2.01 0 O-C-N 123.811 0.359 . . . . 0.0 110.175 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.47 132.38 22.76 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mm -100.11 -53.03 8.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 117.624 0.712 . . . . 0.0 109.933 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -161.94 151.02 15.69 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.495 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.4 ' C ' ' HD2' ' A' ' 33' ' ' ARG . 4.6 t70 53.72 -92.24 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 125.333 1.453 . . . . 0.0 112.695 177.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.4 ' HD2' ' C ' ' A' ' 32' ' ' ASP . 9.3 mpt_? -132.0 7.74 4.36 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.398 0.618 . . . . 0.0 110.033 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.0 t -77.82 112.83 16.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.573 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.7 m -121.94 142.84 49.88 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.3 p -115.91 141.39 33.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 120.743 0.306 . . . . 0.0 110.571 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 tt -154.47 149.42 20.24 Favored Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.57 144.9 95.13 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 122.279 1.986 . . . . 0.0 112.781 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.583 ' HB ' ' OG1' ' A' ' 73' ' ' THR . 9.6 t -86.52 -10.29 54.39 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -79.02 -2.51 40.67 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.282 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.73 -27.74 20.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.001 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.424 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 13.5 mm-40 60.04 87.46 0.14 Allowed Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.653 1.181 . . . . 0.0 114.171 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.48 149.08 18.74 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.156 1.904 . . . . 0.0 109.194 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.01 -157.35 30.09 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.478 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -82.2 -30.24 31.0 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -139.58 136.29 34.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 23.9 m -136.68 157.68 36.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 120.755 0.312 . . . . 0.0 111.644 -174.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 86.6 mt -89.81 109.88 20.85 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 17' ' ' THR . 81.8 t -97.77 88.55 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.251 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 63.52 18.47 11.09 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.519 1.152 . . . . 0.0 109.934 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.18 -38.69 2.03 Favored Glycine 0 N--CA 1.436 -1.3 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.128 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -81.03 120.11 24.39 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.773 -0.251 . . . . 0.0 110.371 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 39.1 ttpt -80.59 110.41 16.04 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.2 tp -103.82 150.19 7.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -99.52 139.52 35.06 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 118.272 -1.371 . . . . 0.0 107.824 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.43 124.96 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 57.7 tttm -70.86 -52.25 21.47 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.34 0.59 . . . . 0.0 109.839 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.2 m-20 -138.71 138.25 37.55 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.602 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -115.55 112.51 22.3 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.449 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 63.9 m-85 -109.88 111.62 23.15 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.527 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -78.6 116.24 18.84 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.557 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 37.8 tp -90.73 101.97 14.72 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.1 t -123.89 140.8 46.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -81.78 130.94 58.98 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.98 5.23 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.081 3.187 . . . . 0.0 116.044 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.7 14.57 16.74 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.9 t30 70.66 40.06 1.06 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.011 1.324 . . . . 0.0 109.007 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 53.3 mt -120.06 122.02 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.62 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.627 ' O ' ' HA ' ' A' ' 131' ' ' THR . 50.4 t30 -64.54 150.29 47.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.598 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.557 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 39.1 tp -126.52 -9.58 6.26 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.716 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 72.5 -20.59 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.673 1.189 . . . . 0.0 113.108 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.67 118.69 11.99 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.583 ' OG1' ' HB ' ' A' ' 39' ' ' THR . 55.0 m -106.83 114.28 28.28 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 64.2 t -92.97 104.88 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.75 124.42 42.1 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.253 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.8 m -98.05 93.78 6.48 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -71.05 137.55 49.07 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.23 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.78 76.89 10.17 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.429 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -101.47 128.84 47.51 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.305 -1.771 . . . . 0.0 107.23 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.55 -50.74 64.04 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.365 0.415 . . . . 0.0 111.457 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -74.02 160.09 31.79 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 121.242 0.544 . . . . 0.0 110.62 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.493 ' HZ3' ' CG ' ' A' ' 85' ' ' ASP . 58.1 tttm -99.52 142.55 30.85 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.604 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -80.8 162.3 24.1 Favored 'General case' 0 C--O 1.257 1.448 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 175.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -77.18 132.48 38.79 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.493 ' CG ' ' HZ3' ' A' ' 82' ' ' LYS . 44.9 m-20 -80.24 96.17 6.52 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.785 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.4 pt -96.0 20.32 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.767 0.794 . . . . 0.0 109.523 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -65.32 -28.16 69.12 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.837 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.72 -5.99 89.42 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.643 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -96.16 -3.06 45.1 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.282 0.563 . . . . 0.0 110.584 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.6 mt -70.22 120.07 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.987 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 p -108.68 105.08 14.53 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.544 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 1.0 OUTLIER -80.2 -12.48 59.64 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.299 177.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.35 118.98 21.76 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.501 HD11 ' NE2' ' A' ' 172' ' ' GLN . 21.6 mt -112.65 -63.84 1.38 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.394 0.616 . . . . 0.0 112.3 -169.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 16.9 pt-20 -54.69 126.95 26.03 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -166.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.87 -38.28 3.2 Favored Glycine 0 N--CA 1.432 -1.582 0 CA-C-N 114.488 -1.233 . . . . 0.0 113.011 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.3 t -78.52 138.64 19.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.997 0.427 . . . . 0.0 110.897 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 7.4 m-20 -80.97 102.4 10.12 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 176.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.9 163.54 24.24 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.554 0.693 . . . . 0.0 111.16 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.6 m -129.28 139.04 51.94 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.5 tp -112.65 125.09 53.91 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 111' ' ' THR . 7.6 p -117.89 122.4 69.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.412 0.625 . . . . 0.0 110.832 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 t -111.72 139.13 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.743 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -126.5 79.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.258 1.028 . . . . 0.0 109.806 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.9 t -116.91 -177.82 3.29 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -71.33 -45.28 63.38 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.091 0.472 . . . . 0.0 110.374 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -82.28 -47.39 12.46 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.515 0.674 . . . . 0.0 109.885 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -88.69 76.6 8.04 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.761 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 22.5 m -94.44 101.11 13.02 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.921 0.391 . . . . 0.0 110.008 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.441 HD21 HD22 ' A' ' 11' ' ' LEU . 27.1 t-20 64.45 62.9 0.78 Allowed 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.927 1.346 . . . . 0.0 110.033 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 24.6 m -96.54 96.15 8.48 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.344 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 54.1 mt -100.99 97.03 5.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.7 tp -120.2 137.17 54.35 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -68.67 146.08 53.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.2 t -102.72 -51.4 9.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 119.54 -168.58 13.56 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -177.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.59 116.8 4.13 Favored 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.704 2.27 . . . . 0.0 112.278 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 26.8 m -87.29 155.72 3.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.091 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.0 p -136.84 169.61 17.46 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 123.129 0.572 . . . . 0.0 109.592 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.2 ttt -87.82 142.68 27.62 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -95.84 -39.54 9.78 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.037 0.446 . . . . 0.0 110.976 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 133' ' ' ARG . . . 99.36 -111.68 4.27 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.94 112.19 10.43 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.284 1.04 . . . . 0.0 110.911 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 7.6 tp . . . . . 0 C--N 1.28 -2.453 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -177.366 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 N--CA 1.441 -1.573 0 N-CA-C 117.017 1.891 . . . . 0.0 117.017 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 97.6 m -92.01 130.73 37.69 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 164.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.31 97.18 0.39 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 20.3 mtm-85 62.76 80.35 0.23 Allowed 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.255 1.026 . . . . 0.0 110.767 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.5 ttt -103.61 169.75 8.34 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.415 -172.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.419 HG21 ' HB2' ' A' ' 170' ' ' SER . 7.7 tt -117.32 142.34 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.017 0.527 . . . . 0.0 109.869 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -137.37 146.53 44.62 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 123.719 0.807 . . . . 0.0 109.659 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -151.4 159.51 44.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 120.373 0.13 . . . . 0.0 111.287 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -83.22 113.51 20.72 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -165.55 126.12 1.86 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -174.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.45 101.96 1.34 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 44.4 m -78.77 138.94 38.46 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.923 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -111.3 154.47 24.46 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.9 t -86.76 138.69 31.4 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.0 -13.87 28.94 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.124 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.31 5.72 50.93 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.376 0.607 . . . . 0.0 111.432 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 41.9 t -62.32 135.12 57.31 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.524 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 103.57 -14.53 53.82 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.848 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.71 141.9 46.24 Favored Glycine 0 C--O 1.241 0.562 0 O-C-N 123.969 0.452 . . . . 0.0 113.726 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.5 t -81.27 114.46 22.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.319 0.58 . . . . 0.0 109.771 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 39.5 tp -87.35 106.27 17.83 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.6 p -140.82 -171.71 3.3 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.205 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.16 -173.47 4.45 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.8 t -70.48 99.57 1.64 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.283 1.04 . . . . 0.0 111.297 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.99 12.58 70.91 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.595 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -137.21 140.69 41.9 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 85.9 mt -126.95 124.34 64.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -96.98 -35.45 10.85 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.131 0.491 . . . . 0.0 110.629 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.464 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 164.01 -154.32 25.14 Favored Glycine 0 N--CA 1.427 -1.925 0 C-N-CA 119.305 -1.426 . . . . 0.0 113.16 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.5 pt -125.01 134.06 67.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 122.56 0.344 . . . . 0.0 111.15 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.435 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 68.9 t60 -67.42 128.58 36.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.441 0.696 . . . . 0.0 109.828 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.49 -15.42 9.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.29 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.25 -159.63 24.44 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 176.9 -176.5 48.05 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -147.93 145.83 28.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.2 -110.62 3.35 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.024 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 46.0 mtm105 -120.27 7.71 10.78 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -110.69 129.13 55.91 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.835 0.35 . . . . 0.0 110.276 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -105.31 142.39 15.51 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.0 143.77 49.7 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.536 0.684 . . . . 0.0 110.827 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' A' ' 160' ' ' HIS . 74.1 m -138.79 159.8 41.23 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.348 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -96.58 119.15 34.54 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.501 ' NE2' HD11 ' A' ' 94' ' ' LEU . 3.0 pt20 -76.56 122.01 24.0 Favored 'General case' 0 C--O 1.253 1.274 0 CA-C-O 121.948 0.88 . . . . 0.0 111.315 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.464 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 95.4 mt -83.57 99.88 10.45 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -88.55 138.24 31.6 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.544 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 9.7 ptpp? -69.55 -13.88 62.56 Favored 'General case' 0 C--O 1.21 -0.995 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.877 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -61.35 -22.85 65.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.931 1.292 . . . . 0.0 110.562 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -85.34 -33.62 22.02 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.379 0.609 . . . . 0.0 109.428 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -91.76 3.5 54.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.016 -169.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--N 1.294 -1.815 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.396 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo . . . . . 0 C--O 1.241 0.637 0 CA-C-O 121.134 0.389 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -79.92 -32.39 40.15 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.588 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 19.3 m -61.48 -44.5 96.97 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.428 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -54.94 -51.55 65.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.055 0.942 . . . . 0.0 109.038 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.04 -45.19 94.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.432 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.39 75.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.331 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 4' ' ' THR . 92.8 mt -61.8 -47.67 84.06 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.058 0.456 . . . . 0.0 109.878 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 11.1 m -66.21 -49.98 65.43 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.309 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.9 tp -57.08 -45.65 83.17 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.58 0.752 . . . . 0.0 111.292 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.519 HD13 HD21 ' A' ' 110' ' ' ASN . 9.3 tt -64.59 -43.84 92.55 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -76.25 -9.39 58.6 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 9' ' ' SER . 68.0 mttm -99.93 -65.63 0.95 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.896 0.379 . . . . 0.0 111.247 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -108.71 -5.48 16.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -168.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 47.6 mt -95.82 139.7 18.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.336 -176.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.445 ' HB3' HG12 ' A' ' 49' ' ' VAL . 57.1 mtm -140.53 163.16 33.58 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.047 0.939 . . . . 0.0 109.306 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 96.5 m -103.11 119.74 39.41 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 71.1 mt -110.96 112.63 41.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.076 0.465 . . . . 0.0 110.179 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 59.9 m -80.35 107.9 13.52 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 p -97.6 -166.96 1.45 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.362 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -78.65 -2.89 41.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.348 0.594 . . . . 0.0 110.302 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -106.44 -43.09 4.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.295 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.59 -160.44 33.94 Favored Glycine 0 C--O 1.246 0.889 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.651 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -81.83 96.09 7.51 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.336 0.654 . . . . 0.0 109.422 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -99.64 159.53 14.97 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.411 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 95.0 m -94.5 127.74 40.63 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.91 121.73 7.03 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.96 113.02 26.26 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.8 134.94 21.07 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 50.8 mm -100.97 -48.85 11.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 117.298 0.549 . . . . 0.0 110.219 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.586 ' CD2' ' HB3' ' A' ' 85' ' ' ASP . 22.8 t-80 -166.66 139.81 3.82 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.131 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t70 61.21 -92.62 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.631 0 O-C-N 124.257 0.973 . . . . 0.0 112.745 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -131.86 5.75 4.26 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.406 0.622 . . . . 0.0 109.975 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.8 t -85.51 117.42 30.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.675 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.4 m -125.45 157.24 37.41 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.3 145.06 23.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 120.771 0.319 . . . . 0.0 111.67 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 tt -160.34 140.56 8.53 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.742 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 73.7 Cg_exo -57.66 134.58 63.96 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.909 2.406 . . . . 0.0 113.46 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.481 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 25.3 m -64.02 -33.58 76.06 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 124.276 1.031 . . . . 0.0 112.727 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -64.19 -12.25 38.65 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.19 -25.76 59.88 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 53.35 84.89 0.2 Allowed Pre-proline 0 C--O 1.242 0.667 0 C-N-CA 124.936 1.295 . . . . 0.0 112.816 -176.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -83.88 152.22 12.89 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 C-N-CA 121.935 1.756 . . . . 0.0 110.619 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.59 -162.35 37.07 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.162 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -93.37 10.03 33.9 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.083 0.944 . . . . 0.0 110.415 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -160.36 124.75 3.71 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.65 149.76 29.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.533 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 93.9 mt -85.48 114.11 22.26 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 17' ' ' THR . 39.2 t -102.28 102.32 13.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.217 175.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.6 m120 59.04 25.06 13.4 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.621 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.01 -7.38 44.35 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.943 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -106.83 118.62 37.17 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.542 -0.387 . . . . 0.0 110.48 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -73.44 124.69 26.29 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.68 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -119.94 122.8 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.925 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -71.52 124.69 25.22 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.309 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.7 t -84.22 139.99 16.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.48 -176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.535 ' HZ2' ' HB3' ' A' ' 57' ' ' LYS . 8.6 mtpm? -97.87 -69.77 0.75 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.032 0.92 . . . . 0.0 109.785 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -116.04 143.47 45.42 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.926 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -146.32 96.96 2.86 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -106.58 139.33 41.21 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.87 128.53 44.54 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.074 174.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.03 110.21 14.05 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.86 129.45 69.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.496 ' OD2' ' HG2' ' A' ' 66' ' ' GLU . 22.1 t70 -66.33 143.92 98.48 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -175.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.31 -17.25 0.5 Allowed 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 123.917 3.078 . . . . 0.0 115.141 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.496 ' HG2' ' OD2' ' A' ' 64' ' ' ASP . 19.0 mm-40 -83.47 3.78 30.69 Favored 'General case' 0 CA--C 1.555 1.158 0 O-C-N 121.633 -0.667 . . . . 0.0 111.178 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.7 t30 73.78 18.8 3.32 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.435 1.494 . . . . 0.0 109.343 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.0 mm -99.44 136.1 32.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 131' ' ' THR . 91.7 m-20 -73.51 148.39 43.14 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.591 0.234 . . . . 0.0 111.411 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 64' ' ' ASP . 73.0 mt -103.97 -13.22 16.41 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 172.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.481 ' OE1' ' HB ' ' A' ' 39' ' ' THR . 2.7 tp10 60.05 31.25 20.53 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 114.176 -1.374 . . . . 0.0 109.34 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.0 tp -115.82 120.58 39.73 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.881 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -104.38 130.94 52.22 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -91.86 100.28 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 171.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.6 tp -96.54 116.28 28.82 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.771 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -104.93 109.43 21.42 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.574 0.702 . . . . 0.0 109.107 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.41 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 88.7 mt -93.82 153.46 18.27 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.765 -175.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -88.22 80.08 7.67 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -118.3 115.02 23.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.756 -1.565 . . . . 0.0 108.014 -171.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -81.43 -10.13 59.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.521 0.677 . . . . 0.0 112.627 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -90.74 87.84 6.84 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -78.64 139.69 38.51 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.994 -0.683 . . . . 0.0 111.721 -172.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -77.33 147.63 36.06 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.57 -172.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -70.76 140.24 51.28 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.347 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.586 ' HB3' ' CD2' ' A' ' 31' ' ' HIS . 6.5 p-10 -70.45 107.0 3.62 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.952 0.882 . . . . 0.0 109.399 173.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.8 pt -93.47 22.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.401 ' H ' ' C ' ' A' ' 85' ' ' ASP . 35.4 ttt-85 -66.1 -30.77 71.34 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.645 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.38 -12.77 84.24 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.357 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -91.11 -10.45 41.9 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.434 -0.451 . . . . 0.0 110.227 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.5 mt -66.58 133.71 30.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.571 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.3 t -113.54 110.59 20.51 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -87.78 4.41 44.46 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.663 0.744 . . . . 0.0 110.818 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.36 119.51 37.17 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.88 -2.266 . . . . 0.0 104.88 172.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mp -120.5 -49.66 2.24 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -169.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -57.24 129.91 43.87 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.83 -1.78 78.78 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.5 173.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.483 ' O ' HG21 ' A' ' 118' ' ' VAL . 22.1 t -101.16 155.78 4.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 3.0 p-10 -95.59 148.48 22.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 118.718 0.69 . . . . 0.0 110.545 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.83 165.83 25.5 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.949 0.88 . . . . 0.0 112.823 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.507 ' OG1' ' HG2' ' A' ' 114' ' ' GLU . 26.7 m -122.86 138.56 54.62 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 125.002 1.321 . . . . 0.0 108.749 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.7 tp -99.2 117.11 32.93 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -113.27 112.06 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.85 142.75 24.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.189 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -136.6 100.48 4.35 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.704 0.764 . . . . 0.0 109.096 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.6 p -136.07 176.16 8.94 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.71 -30.73 71.45 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.849 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -77.39 -50.11 13.45 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.002 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -109.02 81.08 1.39 Allowed 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.19 98.28 9.28 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 120.793 0.33 . . . . 0.0 111.294 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.519 HD21 HD13 ' A' ' 11' ' ' LEU . 27.1 t-20 68.48 70.6 0.3 Allowed 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.175 0.988 . . . . 0.0 110.349 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 51.6 m -108.75 107.97 18.62 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 73.0 mt -108.92 102.25 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.712 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.0 tp -123.13 113.92 19.63 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.727 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.507 ' HG2' ' OG1' ' A' ' 100' ' ' THR . 45.6 mt-10 -73.88 123.41 24.18 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.7 m -91.24 -43.45 14.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.839 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.69 -152.11 19.77 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 98' ' ' ASP . 59.9 Cg_endo -71.87 144.3 43.06 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.921 2.414 . . . . 0.0 112.121 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 97' ' ' VAL . 35.5 m -106.53 137.98 34.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.24 0.543 . . . . 0.0 110.973 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.3 p -110.16 173.73 6.19 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.982 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 38.9 tpp -110.41 132.68 53.97 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.676 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -99.4 -45.02 5.98 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.302 0.572 . . . . 0.0 109.585 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.09 -79.5 0.53 Allowed Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.46 155.43 41.18 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.0 tt . . . . . 0 C--N 1.309 -1.168 0 CA-C-O 120.885 0.374 . . . . 0.0 110.018 -179.208 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 C--O 1.25 1.09 0 N-CA-C 110.144 -0.752 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 9.6 m -120.74 138.55 53.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.332 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -119.74 168.37 11.14 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 172' ' ' GLN . 11.0 tpp180 65.62 42.84 3.48 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.673 1.589 . . . . 0.0 109.605 175.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.1 mtp -108.12 140.94 40.58 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-O 121.978 0.894 . . . . 0.0 112.301 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.524 HG21 ' HB3' ' A' ' 170' ' ' SER . 5.9 tt -105.02 146.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.894 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 23.8 ttm180 -128.97 137.23 51.25 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -173.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -131.51 131.27 43.3 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -80.88 97.0 7.2 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.773 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -156.09 134.81 11.78 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -72.78 109.41 6.36 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 13.1 t -140.03 171.29 14.4 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 143' ' ' THR . 37.9 ttpt -114.82 142.57 46.37 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 13.4 t -80.36 165.43 22.28 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 146' ' ' CYS . . . 105.69 -17.78 41.91 Favored Glycine 0 C--N 1.303 -1.298 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -94.09 28.61 2.41 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.742 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 33.7 t -76.74 141.64 40.74 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 113.14 -1.845 . . . . 0.0 109.241 -174.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.411 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 93.04 -4.26 74.44 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.62 134.35 26.03 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.6 p -76.12 119.48 24.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 122.086 0.946 . . . . 0.0 111.348 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.3 tp -90.1 102.0 14.71 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 20.3 p -147.66 174.22 11.98 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.38 0.609 . . . . 0.0 111.929 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.92 172.91 12.06 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.7 t -64.74 103.74 0.74 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.962 0.887 . . . . 0.0 111.297 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.18 6.14 66.94 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.621 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -140.56 103.02 4.45 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 117.239 0.52 . . . . 0.0 111.428 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 88.2 mt -97.28 123.8 49.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -95.93 -42.83 8.1 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.36 0.6 . . . . 0.0 110.336 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 171.78 -157.7 28.07 Favored Glycine 0 N--CA 1.425 -2.098 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.46 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 28.3 pt -127.21 145.87 34.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -63.76 129.3 39.57 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 123.502 0.721 . . . . 0.0 109.426 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.443 ' HA ' ' SG ' ' A' ' 146' ' ' CYS . 62.1 t -117.27 -48.69 4.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 O-C-N 123.212 0.32 . . . . 0.0 110.754 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -133.64 108.33 0.73 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.314 -1.422 . . . . 0.0 112.86 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.19 108.25 3.66 Favored Glycine 0 C--N 1.3 -1.437 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -120.01 90.65 3.37 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 59.65 -106.63 1.01 Allowed Glycine 0 C--O 1.229 -0.192 0 O-C-N 123.821 0.7 . . . . 0.0 113.185 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -94.81 8.2 43.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -122.29 115.8 22.97 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.102 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -97.05 115.91 5.36 Favored Glycine 0 N--CA 1.42 -2.423 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -102.0 129.28 48.25 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.159 0.504 . . . . 0.0 110.276 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.524 ' HB3' HG21 ' A' ' 135' ' ' ILE . 29.0 t -127.25 156.69 41.49 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.257 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.401 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -101.43 140.72 35.34 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 66.6 mt-30 -76.26 121.19 22.58 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 123.517 0.511 . . . . 0.0 110.974 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.58 85.27 4.47 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -83.63 144.61 29.32 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.449 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -73.68 -14.64 61.19 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.925 0.393 . . . . 0.0 110.595 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -65.58 -19.32 65.87 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.632 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -79.78 -25.4 40.97 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 121.932 -0.48 . . . . 0.0 109.917 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -101.24 50.37 0.86 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.788 0.804 . . . . 0.0 110.327 -174.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--N 1.291 -1.94 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.472 174.171 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 CA--C 1.538 0.676 0 CA-C-O 121.209 0.42 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -63.31 -41.94 98.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.455 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 m -63.38 -40.4 97.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.651 0.78 . . . . 0.0 109.521 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -64.31 -43.6 94.18 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.236 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -63.56 -46.26 86.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.966 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 11' ' ' LEU . . . -54.33 -50.23 67.9 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 124.074 0.859 . . . . 0.0 111.699 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -64.95 -35.38 80.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 m -72.26 -42.48 65.55 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.016 0.436 . . . . 0.0 110.699 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.8 tp -65.79 -39.94 91.45 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.779 0.832 . . . . 0.0 109.535 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 6.0 tt -56.0 -50.9 69.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.299 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -83.56 15.03 3.33 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -123.95 -56.27 1.66 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -118.09 -5.22 10.96 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -171.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.475 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 42.2 mt -96.53 121.46 47.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.935 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 19.8 ptp -140.85 153.94 45.98 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.726 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.84 111.53 20.27 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.3 mt -104.7 113.25 41.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.777 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.6 m -76.44 107.46 8.72 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.9 p -87.56 -149.88 0.16 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.3 p -52.91 -42.03 64.96 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.122 0.569 . . . . 0.0 112.094 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -129.56 -60.66 1.04 Allowed 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.25 158.5 20.55 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 119.643 -1.265 . . . . 0.0 114.467 -172.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -86.74 112.15 21.4 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -105.77 174.4 5.9 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.458 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 35.1 m -87.3 114.99 24.41 Favored 'General case' 0 N--CA 1.411 -2.399 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.595 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.59 110.8 3.9 Favored Glycine 0 N--CA 1.41 -3.036 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.6 tp -94.32 109.08 20.94 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.28 133.19 28.28 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 48.0 mm -109.82 -54.51 5.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 117.331 0.565 . . . . 0.0 111.148 -177.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -154.53 123.26 6.2 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.737 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 66.72 -86.28 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.865 0.728 . . . . 0.0 112.82 169.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 83.7 mtm180 -132.7 10.52 4.33 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.93 0.871 . . . . 0.0 109.463 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.2 t -91.65 123.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.838 -1.073 . . . . 0.0 111.184 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.9 p -127.01 148.36 50.11 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.07 130.38 57.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.264 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.7 mm -130.26 136.24 28.69 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 124.584 1.154 . . . . 0.0 108.43 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.88 142.97 95.11 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.292 1.994 . . . . 0.0 111.387 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.1 m -62.51 -47.32 84.47 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 122.145 0.178 . . . . 0.0 111.435 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -61.77 -14.83 36.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.675 0.79 . . . . 0.0 112.838 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.76 -25.19 60.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 58.09 88.0 0.13 Allowed Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 124.594 1.158 . . . . 0.0 113.863 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -83.1 149.66 13.62 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.864 1.709 . . . . 0.0 109.835 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -157.35 33.06 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.459 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.72 -17.25 27.06 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.973 0.892 . . . . 0.0 110.093 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -137.12 131.03 32.06 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 m -117.17 164.24 13.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 5.7 mp -113.49 110.59 20.52 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.146 178.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.7 t -87.75 94.24 4.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 t30 51.75 62.33 2.76 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 124.549 1.14 . . . . 0.0 109.024 -174.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.06 -34.36 3.42 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.018 -0.992 . . . . 0.0 114.03 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 24.1 mt-30 -72.21 108.89 5.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.169 0.485 . . . . 0.0 111.993 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -68.78 122.62 18.95 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.4 127.7 50.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -78.18 127.68 32.63 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.784 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.2 140.39 18.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.573 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.424 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 60.5 tttm -89.32 -59.01 2.33 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.277 0.561 . . . . 0.0 110.16 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.2 m-20 -136.34 149.78 48.55 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.357 -177.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -132.23 107.87 8.87 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -117.53 126.68 53.0 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -77.0 133.28 39.19 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.459 -0.896 . . . . 0.0 108.871 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.9 tp -91.24 104.5 17.04 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.62 0.724 . . . . 0.0 109.44 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 69' ' ' ASN . 20.5 m -119.62 160.02 20.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.406 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.01 147.42 47.98 Favored Pre-proline 0 C--N 1.289 -2.022 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -45.2 -13.95 0.08 OUTLIER 'Trans proline' 0 CA--C 1.564 1.982 0 C-N-CA 124.266 3.311 . . . . 0.0 116.074 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -77.19 -2.32 33.9 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.486 -0.759 . . . . 0.0 111.011 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 75.63 12.52 3.07 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.962 1.705 . . . . 0.0 109.998 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.5 mm -90.41 134.44 29.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 114.119 -1.4 . . . . 0.0 107.405 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 131' ' ' THR . 57.3 t30 -79.99 147.55 31.51 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.999 0.428 . . . . 0.0 111.395 -173.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.0 mt -99.32 -6.18 28.37 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 75.39 16.35 2.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 123.169 1.462 . . . . 0.0 109.823 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.25 136.27 50.58 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.669 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.0 m -116.52 128.94 55.9 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.5 t -82.99 101.18 7.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -98.08 111.88 24.04 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.2 m -94.77 110.92 22.73 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.77 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 95.8 mt -86.32 142.32 28.58 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.863 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -88.68 86.84 7.07 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -122.65 131.76 53.96 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -68.34 -34.5 76.22 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.298 0.374 . . . . 0.0 111.222 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -86.45 104.31 15.8 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -79.1 142.36 36.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.302 0.573 . . . . 0.0 110.445 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -83.63 145.48 28.79 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.31 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -57.27 120.17 7.68 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.112 -1.403 . . . . 0.0 108.69 175.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 4.6 p30 -74.85 117.7 16.98 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.234 -1.387 . . . . 0.0 109.906 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.0 pt -97.17 28.53 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.52 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.8 ttm105 -59.94 -37.14 78.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.99 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.96 -7.45 70.65 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.489 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -96.74 -10.54 26.6 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.425 0.612 . . . . 0.0 110.943 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.6 mt -66.53 123.54 19.76 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-O 121.144 0.497 . . . . 0.0 110.315 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.8 p -100.74 115.92 31.41 Favored 'General case' 0 N--CA 1.407 -2.623 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.552 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 1.3 pm0 -71.38 -29.77 65.34 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.536 175.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.12 115.44 18.79 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.1 mt -106.83 -60.77 1.63 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.875 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.93 131.53 45.66 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.157 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.02 -22.29 33.73 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.661 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.8 t -92.29 148.31 4.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.02 125.23 38.53 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.695 0.76 . . . . 0.0 109.835 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.76 154.37 18.68 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 122.08 0.943 . . . . 0.0 113.121 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.9 m -127.38 125.91 41.52 Favored 'General case' 0 N--CA 1.417 -2.079 0 C-N-CA 125.432 1.493 . . . . 0.0 107.95 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -95.48 118.85 32.95 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -111.91 112.49 40.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.475 HG12 ' NE2' ' A' ' 145' ' ' GLN . 7.4 p -114.89 135.78 53.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.6 0.714 . . . . 0.0 111.101 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -129.58 84.82 2.25 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.8 t -130.51 174.94 9.4 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.018 -174.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -70.64 -31.54 68.52 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -69.74 -51.92 29.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.952 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.562 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 79.1 m-85 -138.5 119.85 14.8 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.124 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.2 m -107.66 112.76 25.62 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 -175.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 74.06 27.16 1.61 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.457 1.103 . . . . 0.0 111.221 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.562 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 13.7 m -79.8 117.06 20.34 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.658 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.2 mt -101.59 99.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.8 tp -102.31 111.83 24.28 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.279 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -82.52 108.56 16.02 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.84 -54.61 9.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.431 -172.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 125.43 -164.12 19.13 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.32 135.94 52.77 Favored 'Trans proline' 0 C--O 1.244 0.8 0 C-N-CA 122.935 2.424 . . . . 0.0 112.771 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.1 m -110.81 160.34 10.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.273 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.7 t -143.36 159.71 41.87 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.8 ttt -89.24 131.49 35.33 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -90.91 -50.32 5.94 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.57 0.7 . . . . 0.0 109.206 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.48 -103.56 0.76 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 pp -126.58 158.18 36.92 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.563 0.22 . . . . 0.0 111.448 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.8 tt . . . . . 0 C--N 1.311 -1.099 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.502 177.341 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 N--CA 1.44 -1.666 0 N-CA-C 110.013 -0.803 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 31.7 p -112.06 143.02 43.76 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.52 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -139.13 159.49 42.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.424 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 16.2 mtp180 75.98 27.25 0.94 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.604 1.562 . . . . 0.0 109.126 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 131.56 36.15 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.062 -175.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.469 HG21 ' HB3' ' A' ' 170' ' ' SER . 2.0 tt -98.91 136.54 29.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.049 -1.432 . . . . 0.0 107.764 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -121.69 142.9 49.7 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.432 0.634 . . . . 0.0 111.522 -172.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.16 140.51 46.6 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.252 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 166' ' ' ARG . 16.8 t70 -94.91 105.31 17.23 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -159.23 143.54 15.3 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.21 100.19 0.44 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.181 0.515 . . . . 0.0 109.664 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.0 p -65.39 161.02 20.66 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -133.68 137.82 45.52 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.5 m -84.39 152.15 24.23 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.01 -7.32 76.54 Favored Glycine 0 N--CA 1.459 0.209 0 C-N-CA 119.979 -1.105 . . . . 0.0 111.601 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.475 ' NE2' HG12 ' A' ' 103' ' ' VAL . 11.9 mm100 -92.1 2.69 56.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.048 0.928 . . . . 0.0 108.676 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 27.8 m -61.92 127.37 31.08 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.882 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.458 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 103.52 -11.7 54.08 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.153 -1.023 . . . . 0.0 111.192 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.12 137.93 36.33 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.4 p -77.61 123.83 34.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.743 0.782 . . . . 0.0 111.277 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 28.4 tp -91.84 100.28 12.99 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.6 p -125.57 -173.86 2.93 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.885 -173.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -155.07 -175.84 5.64 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.2 t -62.45 99.7 0.15 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.828 0.823 . . . . 0.0 111.311 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.2 20.75 79.29 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.568 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 97.4 mttt -138.44 148.06 43.99 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.648 0.379 . . . . 0.0 110.369 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 91.1 mt -132.45 126.45 55.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -96.14 -49.98 5.02 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.731 0.776 . . . . 0.0 109.637 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.465 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 178.81 -152.18 11.06 Favored Glycine 0 N--CA 1.42 -2.387 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.055 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 pt -126.46 151.97 33.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 117.121 0.461 . . . . 0.0 110.352 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -63.46 118.42 8.09 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.0 t -91.7 -62.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.33 -139.8 5.11 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.973 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.81 137.99 5.32 Favored Glycine 0 C--N 1.288 -2.128 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -110.13 130.38 55.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.24 -125.26 8.42 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.642 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 10.9 mtm180 -106.21 -7.08 18.03 Favored 'General case' 0 C--O 1.214 -0.777 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.461 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -96.31 106.24 18.43 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.611 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.66 132.02 11.07 Favored Glycine 0 N--CA 1.418 -2.562 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -115.61 127.82 55.49 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.684 0.755 . . . . 0.0 110.695 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.469 ' HB3' HG21 ' A' ' 135' ' ' ILE . 37.7 t -120.34 155.09 34.07 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.447 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -108.74 134.27 51.69 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 11.0 pt20 -78.07 117.36 19.31 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 124.015 0.822 . . . . 0.0 110.725 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.465 ' HG ' ' HA2' ' A' ' 158' ' ' GLY 0.304 0.7 OUTLIER -99.37 75.35 1.97 Allowed 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.226 1.013 . . . . 0.0 111.831 177.282 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -59.49 144.74 46.31 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.324 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -61.17 -20.21 62.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.832 0.853 . . . . 0.0 110.94 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -59.33 -29.05 67.37 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.689 1.195 . . . . 0.0 110.925 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -82.14 -8.04 59.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.715 0.293 . . . . 0.0 111.341 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -128.46 28.1 5.48 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.245 0.863 0 CA-C-O 121.324 0.583 . . . . 0.0 112.507 -179.723 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo . . . . . 0 CA--C 1.543 0.952 0 N-CA-C 116.262 1.601 . . . . 0.0 116.262 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -70.03 -34.27 73.05 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.52 -174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.5 m -72.72 -33.64 66.57 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.136 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -61.9 -48.29 81.11 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.536 0.735 . . . . 0.0 109.376 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -63.81 -47.94 78.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.011 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.48 81.0 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.473 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 tp -65.62 -36.72 84.53 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 122.794 0.438 . . . . 0.0 111.232 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -71.87 -44.41 63.81 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.949 0.404 . . . . 0.0 110.414 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.9 tp -65.84 -36.97 84.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.522 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.467 ' HA ' HD12 ' A' ' 15' ' ' ILE . 37.4 tp -51.57 -56.82 11.32 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.364 1.465 . . . . 0.0 112.254 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -79.18 7.81 6.98 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -131.37 -49.98 1.0 Allowed 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -118.05 0.11 11.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 11' ' ' LEU . 50.0 mt -113.18 106.83 21.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.882 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -123.35 160.16 27.35 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.925 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.486 ' CG2' ' HB3' ' A' ' 24' ' ' GLU . 80.5 m -90.3 121.5 32.36 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 174.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.3 mt -106.5 124.48 62.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 p -79.31 98.97 6.9 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.741 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.2 p -98.59 -173.61 2.59 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.1 t -69.93 -34.82 73.97 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -84.77 -5.29 59.32 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.77 -162.82 24.48 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.081 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.486 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 40.2 mt-10 -94.53 111.13 22.88 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.893 0.378 . . . . 0.0 110.861 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -116.67 -178.77 3.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.384 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.7 m -98.11 136.81 37.82 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.7 126.47 6.63 Favored Glycine 0 N--CA 1.418 -2.549 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -96.79 119.59 35.55 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.5 121.94 5.59 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.6 mm -85.04 -53.94 9.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 117.388 0.594 . . . . 0.0 109.788 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -164.53 154.69 14.25 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 54.27 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.3 ptt180 -139.64 10.48 2.46 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.705 1.202 . . . . 0.0 108.956 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.15 114.55 31.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.125 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -125.11 156.36 38.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -117.09 135.5 57.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.405 ' O ' ' HB ' ' A' ' 73' ' ' THR . 10.1 tp -141.53 148.73 51.52 Favored Pre-proline 0 CA--C 1.559 1.309 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -76.2 145.4 27.44 Favored 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 121.964 1.776 . . . . 0.0 112.787 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.513 HG22 ' OG1' ' A' ' 73' ' ' THR . 0.2 OUTLIER -74.41 -18.56 60.64 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -73.47 -21.42 60.44 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.658 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.55 -26.15 45.61 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 63.44 90.63 0.09 OUTLIER Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.735 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.14 152.48 24.23 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 121.962 1.775 . . . . 0.0 110.203 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.61 -157.65 26.72 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 119.971 -1.109 . . . . 0.0 113.142 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.74 -34.41 30.49 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.573 0.702 . . . . 0.0 110.902 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -137.84 138.88 39.59 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.71 144.95 36.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.224 0.535 . . . . 0.0 111.311 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.74 101.26 12.07 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.5 p -96.98 94.55 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 122.033 0.92 . . . . 0.0 110.492 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.6 t30 55.97 23.42 6.67 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.134 1.374 . . . . 0.0 112.019 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.52 -49.67 0.8 Allowed Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.808 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -85.09 119.2 25.21 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.12 108.45 12.62 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.462 HD11 ' O ' ' A' ' 78' ' ' ASP . 9.4 tp -112.76 143.54 22.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.439 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -78.94 131.59 36.42 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.114 0.483 . . . . 0.0 110.783 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.5 t -89.68 125.94 42.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -78.66 -59.52 2.75 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.462 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -136.21 159.64 41.13 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -140.74 100.55 3.87 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -174.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.473 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 59.4 m-85 -97.08 113.56 25.13 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -82.56 111.19 18.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.31 104.55 6.89 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -174.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.87 133.9 62.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -71.63 145.07 89.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.73 -20.02 4.14 Favored 'Trans proline' 0 CA--C 1.552 1.39 0 C-N-CA 123.867 3.045 . . . . 0.0 115.3 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -86.58 9.12 19.49 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.752 -0.592 . . . . 0.0 111.175 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 71.78 26.38 3.04 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 123.433 1.587 . . . . 0.0 109.931 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.4 mt -97.57 127.94 49.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.516 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -89.06 155.33 19.53 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.059 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.253 0.0 OUTLIER -132.22 18.94 4.45 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.795 0.807 . . . . 0.0 110.896 173.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 70.05 -20.8 0.18 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.338 1.855 . . . . 0.0 114.593 173.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.18 119.15 5.47 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.513 ' OG1' HG22 ' A' ' 39' ' ' THR . 20.5 m -117.9 112.85 20.89 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 171.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 44.0 t -81.86 105.57 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.83 113.67 26.01 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.9 m -99.11 105.34 17.41 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 120.876 0.37 . . . . 0.0 110.035 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.9 mp -77.98 139.38 39.16 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.579 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.462 ' O ' HD11 ' A' ' 54' ' ' ILE . 36.5 t70 -89.48 96.14 10.57 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.752 177.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -155.53 152.2 28.56 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.62 0.724 . . . . 0.0 112.488 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -89.16 -12.42 41.05 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.368 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -74.07 132.82 42.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.009 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -108.35 121.82 45.7 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.729 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -76.8 144.07 39.38 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -59.66 131.11 49.92 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.83 96.76 0.14 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.876 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -93.71 18.27 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 122.204 1.002 . . . . 0.0 110.388 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -62.87 -32.22 73.42 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.166 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.14 2.48 87.65 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.923 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -103.14 -8.77 20.2 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 117.136 0.468 . . . . 0.0 110.731 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.4 mt -67.57 128.7 31.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.9 t -95.04 107.72 19.78 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -62.89 -23.13 67.19 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.778 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -106.05 111.55 24.22 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mp -102.81 -51.23 3.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.18 137.03 56.72 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -172.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.15 8.1 31.9 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.89 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.437 ' O ' HG21 ' A' ' 118' ' ' VAL . 40.4 t -122.31 150.37 25.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 O-C-N 122.183 -0.598 . . . . 0.0 109.717 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -82.18 122.63 28.14 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -115.0 160.7 19.28 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.98 0.895 . . . . 0.0 113.152 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 37.6 m -122.76 135.51 54.58 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.059 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.5 tp -100.19 124.99 46.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -113.77 117.65 56.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.454 ' HB ' ' OG1' ' A' ' 111' ' ' THR . 23.9 t -112.03 138.17 41.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -136.66 92.62 2.77 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.9 p -138.7 -169.74 2.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.127 -174.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -56.51 -59.34 5.12 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.021 0.928 . . . . 0.0 112.142 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -92.71 -35.62 13.37 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.407 0.622 . . . . 0.0 110.517 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -99.17 84.15 2.98 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.488 0.661 . . . . 0.0 109.765 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.57 111.04 22.63 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.344 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 65.17 37.16 6.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.286 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.454 ' OG1' ' HB ' ' A' ' 103' ' ' VAL . 32.5 p -79.61 94.22 5.63 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.013 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.72 103.41 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.5 tp -117.43 114.31 23.32 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.655 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 0.3 OUTLIER -77.66 143.53 38.09 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.979 177.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 36.0 m -111.43 -31.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 119.949 -0.701 . . . . 0.0 111.844 -176.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.78 -155.03 16.53 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.064 -1.065 . . . . 0.0 111.555 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.92 124.35 10.53 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.845 2.363 . . . . 0.0 111.978 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 97' ' ' VAL . 35.0 m -96.93 134.07 36.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.348 0.594 . . . . 0.0 110.895 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.6 p -128.38 163.68 24.31 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.755 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.3 ttt -84.47 133.13 34.49 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 118.551 0.614 . . . . 0.0 110.013 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -82.09 -37.82 25.77 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 121.832 0.825 . . . . 0.0 108.801 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.94 -102.83 2.21 Favored Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.97 149.4 47.52 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.4 pt . . . . . 0 C--N 1.288 -2.069 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.0 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.45 -1.053 0 CA-C-O 121.727 0.636 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.9 t -125.17 118.63 26.51 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -106.35 156.93 18.01 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.581 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 74.22 57.02 0.09 Allowed 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.051 1.341 . . . . 0.0 111.508 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.0 mmt -113.28 143.03 45.11 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 113.064 -1.88 . . . . 0.0 108.832 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 170' ' ' SER . 18.1 tt -106.96 141.79 21.31 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.456 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 24.4 ttm-85 -118.96 132.97 56.1 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 122.634 0.374 . . . . 0.0 110.427 -173.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -136.29 134.62 38.18 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.637 172.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -87.84 91.31 8.71 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.869 0.842 . . . . 0.0 110.342 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -158.06 136.68 11.2 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.52 87.29 2.64 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.54 0.686 . . . . 0.0 111.398 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.6 p -94.48 161.09 14.36 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.798 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -118.31 136.16 53.87 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.0 m -61.22 124.98 22.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.594 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 132.45 -15.9 4.92 Favored Glycine 0 C--N 1.299 -1.517 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.547 ' HA ' HE21 ' A' ' 145' ' ' GLN . 0.0 OUTLIER -97.79 18.09 16.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.25 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.9 m -62.7 130.92 47.13 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.021 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.43 -1.21 66.47 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.62 138.99 26.87 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.65 124.72 38.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.859 0.838 . . . . 0.0 111.472 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.7 tp -92.19 108.85 20.25 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.5 p -141.75 177.57 8.07 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.172 0.51 . . . . 0.0 111.813 -173.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.96 179.52 8.61 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.9 m -54.71 101.1 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.17 0.588 . . . . 0.0 111.876 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 69.15 23.31 76.22 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.667 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -136.26 118.34 15.41 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 98.7 mt -108.14 129.24 62.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -103.45 -45.47 4.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.262 0.553 . . . . 0.0 110.899 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.447 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 176.82 -157.86 23.36 Favored Glycine 0 N--CA 1.421 -2.359 0 C-N-CA 118.968 -1.587 . . . . 0.0 112.586 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.4 pt -126.49 141.77 44.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -63.58 130.79 45.78 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.216 0.606 . . . . 0.0 110.357 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.0 t -101.14 -49.2 11.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -173.06 160.99 31.97 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.697 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -107.59 129.54 9.7 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -126.86 95.27 4.27 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.27 -125.04 17.5 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -101.44 21.5 14.1 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.318 0.58 . . . . 0.0 111.174 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -122.77 124.47 43.41 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.048 0.451 . . . . 0.0 110.146 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -102.26 131.56 10.65 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -109.12 133.63 52.76 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.512 ' O ' HG23 ' A' ' 135' ' ' ILE . 41.9 m -130.62 150.44 51.81 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.759 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -88.81 135.46 33.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -82.96 95.65 8.06 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 123.485 0.49 . . . . 0.0 110.623 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.447 ' HG ' ' HA2' ' A' ' 158' ' ' GLY 0.306 1.0 OUTLIER -83.08 76.46 9.85 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-O 122.745 1.259 . . . . 0.0 112.299 177.909 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -75.71 153.35 37.14 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.209 -1.359 . . . . 0.0 111.88 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -59.7 -23.91 63.53 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.383 1.073 . . . . 0.0 112.046 -174.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -58.87 -22.89 60.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.728 1.211 . . . . 0.0 112.052 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -96.14 -9.83 29.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.937 0.399 . . . . 0.0 111.695 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -111.59 18.48 19.02 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.416 0.627 . . . . 0.0 110.756 -175.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.309 -1.189 0 CA-C-N 115.384 -0.826 . . . . 0.0 108.818 178.367 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--O 1.241 0.666 0 N-CA-C 113.681 0.608 . . . . 0.0 113.681 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -68.44 -30.2 69.02 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.016 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 m -70.36 -41.82 72.64 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.238 0.615 . . . . 0.0 109.357 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.24 -50.11 74.95 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.808 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -65.04 -42.66 94.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.647 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.29 82.89 Favored 'General case' 0 C--O 1.216 -0.684 0 O-C-N 123.516 0.51 . . . . 0.0 110.856 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.63 -39.99 95.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.146 0.498 . . . . 0.0 110.719 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -68.48 -43.48 76.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.005 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.7 tp -68.12 -39.07 82.84 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.276 0.631 . . . . 0.0 109.913 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.433 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 7.8 tt -55.31 -47.94 74.86 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.896 0.878 . . . . 0.0 110.25 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -79.09 14.94 1.26 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.978 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 -64.36 0.96 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -116.37 4.49 13.4 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.453 ' CG2' ' HB3' ' A' ' 104' ' ' HIS . 1.7 mp -87.36 115.03 27.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.255 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.6 mmt -113.21 134.13 54.73 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.043 -174.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 89.8 m -92.8 103.58 15.92 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.7 mt -101.37 121.13 51.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 121.198 0.523 . . . . 0.0 110.544 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -87.41 108.15 18.87 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.2 p -102.92 -166.59 1.29 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.51 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.3 t -66.28 -43.15 87.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.071 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 22' ' ' LYS . 40.6 mmtm -89.39 -9.94 48.4 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -172.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.14 -165.82 33.39 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.19 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -108.59 103.33 12.42 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.406 ' CD1' ' HB3' ' A' ' 146' ' ' CYS . 83.4 m-85 -113.52 175.0 5.64 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.087 -174.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.6 m -93.78 136.33 34.18 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.84 145.31 16.75 Favored Glycine 0 N--CA 1.416 -2.691 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.4 tp -105.4 119.96 40.39 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.206 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.68 139.77 25.03 Favored Glycine 0 N--CA 1.428 -1.847 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 40.4 mm -99.31 -49.73 11.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -174.86 153.99 1.81 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.543 ' OD1' ' HG2' ' A' ' 82' ' ' LYS . 36.1 m-20 51.02 -94.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.575 1.172 . . . . 0.0 113.186 176.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 17.7 ptp180 -127.06 6.11 6.51 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.511 -176.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 64.6 t -92.77 118.71 39.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -132.45 159.92 37.93 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 m -123.27 146.6 28.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 122.155 -0.341 . . . . 0.0 111.011 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.8 tt -158.13 147.12 14.58 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 45.1 Cg_exo -60.75 142.12 96.85 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 122.496 2.131 . . . . 0.0 112.8 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.1 m -59.73 -37.9 80.2 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -71.21 -2.06 14.68 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.41 -30.29 57.39 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 60.46 89.13 0.11 Allowed Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.123 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.41 154.82 28.18 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.206 1.937 . . . . 0.0 110.507 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.32 -166.02 29.88 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.436 -0.887 . . . . 0.0 111.859 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -81.85 -18.7 42.99 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 122.104 0.954 . . . . 0.0 109.126 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -147.37 148.15 31.05 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 m -142.52 -172.81 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 1.2 pt? -138.63 127.64 23.93 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 17' ' ' THR . 5.2 p -115.85 116.1 51.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.757 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 65.56 19.85 11.56 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.051 0.94 . . . . 0.0 109.465 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.23 -15.41 59.07 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.318 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 83.1 mt-30 -78.42 121.66 24.8 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 122.461 0.304 . . . . 0.0 110.263 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -67.65 126.18 28.56 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 78' ' ' ASP . 9.3 tp -146.19 133.83 15.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.586 0.708 . . . . 0.0 110.551 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -85.37 145.4 27.5 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.585 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.77 148.31 5.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -97.82 -57.03 2.33 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -141.76 166.96 23.28 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.502 ' HZ1' ' HB2' ' A' ' 59' ' ' LYS . 10.1 mtmp? -139.89 95.25 2.87 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.463 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 84.6 m-85 -81.37 111.37 17.68 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.5 103.73 4.95 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -80.82 101.83 9.62 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.4 155.7 9.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.69 138.44 83.07 Favored Pre-proline 0 C--N 1.311 -1.068 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -47.4 -29.06 9.32 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.056 3.171 . . . . 0.0 114.442 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -93.16 16.72 12.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.704 0.288 . . . . 0.0 110.986 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 71.87 20.18 4.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.298 1.039 . . . . 0.0 112.327 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.4 mm -87.69 149.89 3.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 131' ' ' THR . 56.4 t30 -69.87 142.89 52.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.472 HD23 ' HD2' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -118.27 -29.72 5.46 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 69.06 17.39 8.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.603 1.161 . . . . 0.0 111.281 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.15 135.43 54.19 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.1 m -128.15 130.29 47.86 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 120.826 0.346 . . . . 0.0 110.13 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 46.4 t -90.46 109.68 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -91.61 121.98 33.77 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.4 m -104.86 105.5 15.59 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 91.8 mt -82.65 168.68 17.04 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.419 ' O ' HD12 ' A' ' 54' ' ' ILE . 18.7 t70 -93.64 89.88 6.4 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 171.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -129.61 116.01 18.24 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.302 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.78 -29.77 36.09 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.53 140.22 51.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.813 -1.54 . . . . 0.0 110.739 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.543 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 60.5 mttm -90.26 105.55 17.89 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -77.64 144.88 37.07 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 166.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -59.04 126.95 29.81 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 124.008 0.818 . . . . 0.0 112.376 -172.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 12.7 p-10 -69.74 102.87 2.0 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.09 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -93.12 23.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.633 -0.667 . . . . 0.0 111.794 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -62.8 -40.11 96.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.067 -175.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.35 -0.48 89.11 Favored Glycine 0 C--N 1.317 -0.511 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.606 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -98.97 -14.11 19.65 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.8 mt -64.46 122.51 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.441 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.1 m -122.89 95.58 4.68 Favored 'General case' 0 N--CA 1.397 -3.112 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.97 -14.92 57.52 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -88.48 95.17 10.12 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 171.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.404 HD11 ' N ' ' A' ' 95' ' ' GLU . 2.2 pp -125.79 -21.54 4.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 -162.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.404 ' N ' HD11 ' A' ' 94' ' ' LEU . 12.1 pt-20 -68.44 134.05 49.58 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.797 -1.161 . . . . 0.0 113.656 -172.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.35 -13.99 56.85 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.684 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 118' ' ' VAL . 16.0 t -93.45 157.02 3.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -96.22 148.96 22.18 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.8 158.87 38.98 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.034 0.921 . . . . 0.0 112.64 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.0 m -123.63 131.83 53.71 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.076 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.2 tp -94.97 115.83 27.93 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.99 109.24 27.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.435 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 47.2 t -113.97 131.89 64.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.453 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 9.7 t60 -140.85 93.71 2.63 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -121.36 179.7 4.34 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.503 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -75.63 -37.73 59.49 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.214 -0.595 . . . . 0.0 111.287 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -86.62 -22.98 25.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.178 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -125.05 76.9 1.58 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.4 m -88.56 129.39 35.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.351 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 57.38 68.03 0.9 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.902 1.281 . . . . 0.0 113.458 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.435 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 27.3 m -107.78 99.8 9.24 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.189 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.4 mt -100.76 96.61 4.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.8 tp -110.34 106.22 15.52 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.546 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.17 115.84 14.12 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.9 m -94.98 -19.63 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.19 -159.5 17.94 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.63 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.01 133.61 36.46 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.42 2.747 . . . . 0.0 112.586 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 97' ' ' VAL . 35.4 m -111.31 159.35 11.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.154 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.5 t -142.11 167.03 23.1 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.6 ttt -87.54 129.35 35.12 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.49 -26.13 18.95 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.282 0.563 . . . . 0.0 110.696 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.62 -106.99 2.59 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.51 116.73 23.66 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.2 mm . . . . . 0 C--N 1.302 -1.476 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.782 -179.403 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 N--CA 1.449 -1.135 0 CA-C-O 121.37 0.487 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 24.6 m -121.96 120.46 34.49 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -98.95 158.77 15.42 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.472 ' HD2' HD23 ' A' ' 70' ' ' LEU . 98.9 mtt180 64.27 62.01 0.86 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 122.514 1.15 . . . . 0.0 110.813 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 54.8 ttm -124.78 145.57 49.67 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.566 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 170' ' ' SER . 1.4 tt -109.38 134.77 50.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -120.51 140.21 51.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.158 0.504 . . . . 0.0 111.772 -173.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.402 ' HB3' HG12 ' A' ' 118' ' ' VAL . 26.5 p90 -141.74 132.38 25.52 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.466 172.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.37 81.03 4.91 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.976 0.893 . . . . 0.0 109.634 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -144.52 127.74 16.72 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.43 105.88 4.31 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.193 0.52 . . . . 0.0 111.15 -176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.3 p -89.59 174.36 7.8 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -114.39 172.67 6.88 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.1 t -84.93 146.89 27.02 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.3 56.68 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -106.37 14.77 26.92 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.428 0.633 . . . . 0.0 110.369 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.444 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 47.2 t -71.07 129.46 39.02 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.329 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.15 2.68 62.14 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.327 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.23 131.82 38.94 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.2 t -76.92 109.53 11.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 28.7 tp -88.0 106.0 17.84 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.7 p -136.75 178.36 7.13 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.957 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.83 -178.95 6.17 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.5 m -64.92 97.24 0.22 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.193 0.52 . . . . 0.0 110.931 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.52 11.41 68.8 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.877 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.75 143.11 33.32 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 117.089 0.445 . . . . 0.0 110.749 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 75.8 mt -122.62 130.83 74.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -105.22 -34.12 8.01 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.222 0.534 . . . . 0.0 111.328 -175.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 168.9 -159.6 32.75 Favored Glycine 0 N--CA 1.426 -1.967 0 C-N-CA 119.884 -1.151 . . . . 0.0 112.1 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 27.5 pt -132.58 135.78 57.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.838 0.351 . . . . 0.0 110.663 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -64.84 118.69 9.37 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 123.62 0.768 . . . . 0.0 110.179 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.7 m -90.95 -36.05 7.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 120.87 0.367 . . . . 0.0 110.309 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.88 164.71 31.65 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -129.26 143.89 14.94 Favored Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -132.83 103.8 6.27 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.16 -108.31 2.45 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -104.58 -10.45 17.57 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -85.07 99.26 10.92 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 120.988 0.423 . . . . 0.0 111.451 -174.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.5 113.32 3.81 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -95.95 120.95 37.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 121.3 0.572 . . . . 0.0 109.614 -176.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.456 ' HB3' HG23 ' A' ' 135' ' ' ILE . 35.1 t -119.22 139.14 52.36 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.405 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -76.18 134.17 39.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -79.71 111.48 16.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.71 99.31 10.16 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -85.69 142.52 28.97 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.372 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -72.55 -19.13 61.56 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.734 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.461 ' O ' HG13 ' A' ' 179' ' ' VAL . 3.4 pt20 -75.16 -5.34 43.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.729 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -76.76 -26.03 54.09 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -106.97 1.02 24.16 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.069 -173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 176' ' ' GLN . 9.1 p . . . . . 0 N--CA 1.434 -1.243 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo . . . . . 0 CA--C 1.54 0.824 0 N-CA-C 114.621 0.97 . . . . 0.0 114.621 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -72.03 -41.45 67.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.241 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -62.31 -40.28 95.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.626 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.54 -36.83 71.13 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.45 0.167 . . . . 0.0 110.607 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.86 -48.88 79.8 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.47 96.35 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.357 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.4 -44.86 96.41 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.0 0.52 . . . . 0.0 110.419 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -63.03 -48.55 78.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.547 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.71 -41.73 98.0 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.279 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.423 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 26.1 tp -56.17 -58.92 5.89 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.809 1.243 . . . . 0.0 111.706 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -76.51 -2.23 31.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.819 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -109.37 -63.88 1.31 Allowed 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -108.96 -10.06 15.07 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -170.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.423 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 58.2 mt -91.77 109.89 21.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.025 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 67.6 mtm -116.39 139.93 49.9 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 120.592 0.234 . . . . 0.0 111.09 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.5 m -82.55 119.42 24.22 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.9 mt -109.11 108.3 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.2 m -81.85 104.79 12.48 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 77.1 p -91.88 -162.6 0.94 Allowed 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.937 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.7 t -81.41 -14.2 57.41 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -100.39 -34.38 9.99 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.287 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.04 -162.6 36.35 Favored Glycine 0 CA--C 1.502 -0.759 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.743 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.456 ' CD ' ' HB3' ' A' ' 106' ' ' ASN . 82.8 mt-10 -92.7 104.09 16.4 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -107.45 176.61 5.1 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.91 131.58 56.5 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-O 121.11 0.481 . . . . 0.0 109.983 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.44 131.65 10.14 Favored Glycine 0 N--CA 1.416 -2.633 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -98.51 115.72 29.19 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.86 122.35 8.2 Favored Glycine 0 N--CA 1.434 -1.482 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.0 mm -85.8 -57.51 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.315 0.578 . . . . 0.0 109.874 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -155.33 137.21 14.48 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.928 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 62.52 -85.91 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 O-C-N 124.641 1.213 . . . . 0.0 112.455 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -143.2 18.75 1.92 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.264 1.031 . . . . 0.0 109.989 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.6 t -92.51 113.56 27.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.5 p -122.19 155.49 35.7 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.423 ' HB ' HD11 ' A' ' 72' ' ' LEU . 27.1 m -117.73 145.42 23.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 120.732 0.301 . . . . 0.0 110.934 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.2 tt -146.49 141.51 16.37 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -60.4 143.44 99.48 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.724 1.616 . . . . 0.0 111.14 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.2 m -66.99 -40.15 87.31 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.124 0.487 . . . . 0.0 111.577 -174.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -70.97 -1.42 11.94 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.43 -17.5 61.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 122.073 -0.392 . . . . 0.0 110.327 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.622 ' O ' ' HB ' ' A' ' 20' ' ' THR . 16.9 mm100 63.93 74.43 0.43 Allowed Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 124.638 1.175 . . . . 0.0 113.174 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -89.15 -175.19 1.09 Allowed 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 122.67 2.247 . . . . 0.0 109.814 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.95 -160.1 8.23 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -81.67 -20.22 40.0 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.875 0.845 . . . . 0.0 109.232 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -132.41 141.64 48.95 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.76 160.37 42.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 90.5 mt -101.89 102.07 12.59 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.06 100.66 7.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 121.864 0.84 . . . . 0.0 108.894 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.8 t30 63.47 10.7 5.04 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.19 1.396 . . . . 0.0 110.355 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.9 -19.97 8.23 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.737 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -77.95 116.03 18.14 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 120.583 0.23 . . . . 0.0 110.384 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -70.29 111.93 6.24 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.656 0.741 . . . . 0.0 109.914 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.474 HD11 ' O ' ' A' ' 78' ' ' ASP . 9.5 tp -126.05 140.96 47.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.564 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -87.61 143.24 27.29 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.3 133.04 42.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -80.63 -62.78 1.57 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.09 0.472 . . . . 0.0 110.194 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -128.56 148.83 50.79 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.899 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -129.78 117.0 19.56 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.453 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.0 m-85 -111.45 117.63 33.57 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.635 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -76.31 107.72 8.76 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.3 tp -84.2 98.89 10.19 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.979 0.895 . . . . 0.0 109.123 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -127.3 160.06 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.412 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -67.89 148.3 98.45 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -32.17 -44.88 0.2 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.862 3.708 . . . . 0.0 115.072 173.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.16 16.43 2.42 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.993 -0.442 . . . . 0.0 112.122 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 t30 60.4 48.56 7.69 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 125.626 1.571 . . . . 0.0 109.753 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.0 mt -98.43 126.64 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 172.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 131' ' ' THR . 16.6 m120 -73.72 133.2 43.3 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.84 -171.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.4 tp -97.25 -2.95 41.61 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 69.54 5.65 5.29 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.452 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.423 HD11 ' HB ' ' A' ' 36' ' ' VAL . 20.0 tp -102.79 131.13 49.86 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.55 -0.719 . . . . 0.0 111.236 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.0 m -111.24 123.79 50.91 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 55.0 t -86.51 114.11 25.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.1 tp -102.3 111.94 24.43 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.654 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.5 m -87.32 100.09 12.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.79 125.54 29.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.474 ' O ' HD11 ' A' ' 54' ' ' ILE . 31.4 t70 -83.61 78.99 9.59 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.807 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.49 ' HD3' ' OE2' ' A' ' 81' ' ' GLU . 14.5 ttm180 -137.28 134.66 36.37 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -84.06 1.94 41.57 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.49 ' OE2' ' HD3' ' A' ' 79' ' ' ARG . 45.1 mt-10 -77.36 126.0 30.22 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 173.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -102.89 109.14 20.59 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.396 0.617 . . . . 0.0 109.684 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -79.47 173.1 12.93 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.32 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -72.73 143.27 48.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.196 0.522 . . . . 0.0 111.124 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.16 100.22 5.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 171.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 pt -99.15 19.01 2.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 122.559 1.171 . . . . 0.0 108.643 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -70.29 -34.98 73.41 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.421 -1.718 . . . . 0.0 112.645 -171.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.39 -12.48 82.09 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.189 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.66 -11.59 55.62 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.76 123.36 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 m -118.92 103.55 9.7 Favored 'General case' 0 N--CA 1.405 -2.675 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.14 1.52 31.51 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -89.54 119.69 30.19 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 27.3 mt -107.67 -50.41 3.07 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -166.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.66 127.67 32.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -167.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.69 16.31 52.39 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.085 -1.416 . . . . 0.0 114.083 172.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.8 t -115.48 132.81 63.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.815 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.97 113.09 4.71 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.173 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.0 150.95 26.48 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.471 0.653 . . . . 0.0 111.459 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.7 m -114.93 131.81 56.76 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 tp -96.43 119.6 35.21 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 111' ' ' THR . 40.5 t -113.15 111.8 37.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-O 121.2 0.524 . . . . 0.0 110.116 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 26.7 t -107.97 147.0 13.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -139.38 103.76 4.8 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.4 p -124.62 175.38 7.23 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.456 ' HB3' ' CD ' ' A' ' 24' ' ' GLU . 3.7 t30 -80.14 -43.6 21.36 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.78 0.324 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -68.63 -35.61 77.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.784 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -133.15 96.58 3.78 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.2 m -96.45 134.83 39.13 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.837 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 71.74 71.28 0.16 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.377 0.671 . . . . 0.0 111.488 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.618 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 7.2 m -97.68 93.68 6.53 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.1 mt -105.26 98.55 7.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.5 tp -122.75 125.49 45.61 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.443 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.04 134.95 41.28 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.2 -51.32 8.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 120.988 0.423 . . . . 0.0 111.268 -176.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.03 -162.93 22.49 Favored Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.31 123.38 8.18 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.925 2.417 . . . . 0.0 111.673 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.8 m -87.79 156.77 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.696 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.3 p -137.05 151.48 48.97 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.719 0.807 . . . . 0.0 110.257 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 56.7 ttp -89.56 126.69 35.7 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.82 -0.55 . . . . 0.0 109.604 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.32 -42.36 11.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.875 0.369 . . . . 0.0 110.436 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.12 -127.81 9.22 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 44.7 tp -95.16 115.59 27.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.244 0.545 . . . . 0.0 110.447 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.1 pt . . . . . 0 C--N 1.297 -1.69 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.595 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 N--CA 1.443 -1.498 0 CA-C-O 121.618 0.591 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 28.6 m -129.53 117.99 21.35 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 27.4 p-10 -103.85 163.83 12.09 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.896 -173.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.57 ' HD2' ' OE1' ' A' ' 172' ' ' GLN . 20.5 mmt180 55.73 47.85 19.61 Favored 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 124.59 1.181 . . . . 0.0 112.804 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 98.2 mmm -95.57 147.73 23.27 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.597 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.448 HG21 ' HB2' ' A' ' 170' ' ' SER . 3.4 tt -117.73 134.03 62.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 42.1 ptt85 -124.48 157.85 34.26 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.96 0.886 . . . . 0.0 110.405 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.497 ' HH ' ' CD2' ' A' ' 160' ' ' HIS . 10.9 p90 -137.42 149.56 47.0 Favored 'General case' 0 C--N 1.26 -3.326 0 CA-C-N 114.0 -1.455 . . . . 0.0 107.689 173.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.02 99.82 11.76 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -164.22 144.18 7.91 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.467 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -75.36 99.23 4.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.222 0.535 . . . . 0.0 110.94 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.6 t -132.03 177.61 7.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -158.87 168.54 26.52 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 120.728 0.299 . . . . 0.0 111.111 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 54.2 m -64.28 116.85 6.43 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.013 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.72 -35.57 0.54 Allowed Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -87.97 25.59 1.53 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 34.8 m -73.22 127.6 33.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.598 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.42 5.95 63.08 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.406 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.23 137.56 17.23 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.3 126.74 37.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.792 0.806 . . . . 0.0 110.764 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 42.5 tp -96.96 103.79 15.74 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 20.8 p -145.1 162.7 36.37 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.512 0.672 . . . . 0.0 112.331 -173.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.44 -176.27 3.55 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.4 p -60.41 99.42 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.343 0.592 . . . . 0.0 111.698 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 76.77 13.7 83.3 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.835 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -135.15 108.01 7.55 Favored 'General case' 0 C--O 1.21 -0.992 0 O-C-N 122.595 -0.356 . . . . 0.0 111.041 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 88.1 mt -98.63 129.68 48.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -101.47 -33.32 10.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.688 0.756 . . . . 0.0 110.603 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 160.9 -151.92 22.45 Favored Glycine 0 N--CA 1.421 -2.31 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.6 pt -133.01 149.3 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.497 ' CD2' ' HH ' ' A' ' 137' ' ' TYR . 20.2 t-80 -70.72 135.8 48.52 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.606 0.566 . . . . 0.0 111.398 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.29 -58.35 3.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.049 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.69 157.49 22.84 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -137.75 138.21 9.46 Favored Glycine 0 N--CA 1.419 -2.487 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -105.48 84.01 2.03 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 122.304 1.049 . . . . 0.0 110.663 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 80.91 -102.22 2.12 Favored Glycine 0 N--CA 1.419 -2.494 0 CA-C-N 114.398 -1.274 . . . . 0.0 113.013 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -98.42 -0.38 43.7 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -120.97 132.27 54.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -118.83 124.46 6.03 Favored Glycine 0 CA--C 1.476 -2.356 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.018 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -108.99 125.4 52.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.328 1.061 . . . . 0.0 111.645 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.448 ' HB2' HG21 ' A' ' 135' ' ' ILE . 19.8 m -120.56 161.39 21.4 Favored 'General case' 0 C--N 1.275 -2.639 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.36 138.68 32.04 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.57 ' OE1' ' HD2' ' A' ' 133' ' ' ARG . 58.4 tt0 -82.5 105.22 13.37 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.497 0.665 . . . . 0.0 109.63 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.5 mp -86.0 94.0 9.11 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -74.16 144.31 44.89 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -70.99 -21.93 62.24 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -64.48 -19.03 65.32 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.14 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -88.42 -15.1 36.36 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.827 -0.546 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.94 15.51 22.55 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.659 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--N 1.295 -1.772 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.857 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--O 1.241 0.643 0 N-CA-C 111.104 -0.383 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -64.99 -45.59 84.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.483 177.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -59.34 -49.28 78.43 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.52 0.728 . . . . 0.0 109.961 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.73 -36.48 82.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.859 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -65.77 -48.41 71.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.59 95.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.814 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.5 -47.22 79.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.654 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.2 m -62.75 -36.54 83.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.346 0.594 . . . . 0.0 110.746 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.9 tp -66.5 -49.25 67.2 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.062 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.409 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 60.8 tp -51.27 -52.59 43.61 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.775 1.23 . . . . 0.0 111.419 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -56.34 -21.03 21.87 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -174.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -137.49 -29.64 0.87 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 118.841 -1.144 . . . . 0.0 113.84 -177.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -107.05 -13.9 15.07 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.435 HG22 ' CG2' ' A' ' 26' ' ' THR . 27.3 mt -90.71 110.66 22.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.875 0.845 . . . . 0.0 111.562 -177.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.8 mtp -101.6 131.76 47.63 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.216 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 6.6 m -87.3 102.71 14.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 mt -100.35 111.95 31.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 121.64 0.733 . . . . 0.0 112.034 -174.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.3 m -84.05 106.81 15.99 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.378 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 28.0 p -96.69 -167.23 1.53 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.536 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m -73.19 -22.2 60.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 120.852 0.358 . . . . 0.0 110.281 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -92.45 -46.39 7.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.683 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.29 -167.56 33.27 Favored Glycine 0 CA--C 1.503 -0.677 0 C-N-CA 118.862 -1.637 . . . . 0.0 113.401 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -100.69 99.93 10.55 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -115.05 -168.63 1.41 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.173 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.435 ' CG2' HG22 ' A' ' 15' ' ' ILE . 90.3 m -111.83 135.53 52.33 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-O 121.243 0.544 . . . . 0.0 110.542 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.73 142.22 16.13 Favored Glycine 0 N--CA 1.409 -3.122 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.1 tp -114.52 118.26 33.25 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.321 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.17 119.66 5.0 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 46.5 mm -95.46 -51.81 10.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 117.714 0.757 . . . . 0.0 111.986 -173.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.513 ' O ' HG12 ' A' ' 34' ' ' VAL . 35.4 t-80 -156.28 111.39 2.9 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.566 -173.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 61.4 -77.87 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 170.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.594 ' HB3' ' NE ' ' A' ' 79' ' ' ARG . 1.1 ppt_? -120.02 -2.17 10.29 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 31' ' ' HIS . 14.3 p -100.97 118.85 48.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.719 -176.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.5 m -120.33 164.63 16.03 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.337 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.484 ' CG1' HD11 ' A' ' 72' ' ' LEU . 46.7 t -118.63 134.5 62.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tp -148.02 143.64 17.93 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.509 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 25.4 Cg_exo -69.61 155.28 66.84 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.36 2.04 . . . . 0.0 112.858 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.9 m -74.74 -44.58 49.09 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -63.6 -13.93 46.73 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.94 -24.28 63.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.068 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.412 ' O ' ' HB ' ' A' ' 20' ' ' THR . 25.2 mt-30 62.94 84.05 0.19 Allowed Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 123.756 0.822 . . . . 0.0 110.705 -177.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.55 121.46 6.0 Favored 'Trans proline' 0 C--O 1.258 1.505 0 C-N-CA 121.898 1.732 . . . . 0.0 110.179 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.2 -169.13 31.27 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.426 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -86.18 -14.4 44.12 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.426 0.631 . . . . 0.0 109.34 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -143.47 137.25 28.43 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.1 158.46 33.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.054 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 79.0 mt -105.6 115.22 29.88 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 17' ' ' THR . 6.0 p -87.78 90.39 3.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 71.75 -10.42 0.85 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.079 1.751 . . . . 0.0 110.632 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 148.94 -22.99 1.28 Allowed Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -73.44 113.85 11.0 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.445 ' HZ1' ' HB2' ' A' ' 53' ' ' LYS . 4.0 ttmp? -75.48 121.27 22.09 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 121.062 0.458 . . . . 0.0 110.799 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.417 ' CG2' HD11 ' A' ' 77' ' ' LEU . 10.6 tp -130.29 141.34 46.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.29 149.56 33.5 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.44 0.638 . . . . 0.0 111.401 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.5 t -94.01 126.97 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 172.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.483 ' HB3' HG23 ' A' ' 76' ' ' THR . 8.0 tmtm? -89.93 -43.81 10.33 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.766 -174.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -156.18 154.09 30.28 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -134.36 127.28 31.33 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.445 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 16.5 m-85 -123.13 108.64 13.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -81.19 136.93 35.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.15 76.2 9.29 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 122.402 1.096 . . . . 0.0 111.682 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.6 p -109.0 118.54 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.271 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 21.5 t70 -62.47 143.5 96.0 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.619 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.28 -21.24 22.19 Favored 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 123.796 2.997 . . . . 0.0 114.347 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -88.38 7.6 31.79 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.483 0.659 . . . . 0.0 109.242 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.275 40.6 m-80 67.85 63.62 0.39 Allowed 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 125.72 1.608 . . . . 0.0 112.252 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 18.1 mm -123.55 126.07 72.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 131' ' ' THR . 36.2 t30 -99.75 129.6 45.88 Favored 'General case' 0 C--O 1.203 -1.387 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -170.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.589 HD11 ' O ' ' A' ' 132' ' ' ASN . 40.0 tp -94.57 -8.18 38.92 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 117.607 0.185 . . . . 0.0 111.302 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 66.73 20.77 10.65 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.509 1.147 . . . . 0.0 109.316 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.484 HD11 ' CG1' ' A' ' 36' ' ' VAL . 20.4 tp -126.63 137.08 53.25 Favored 'General case' 0 N--CA 1.426 -1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 110.63 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 46.0 m -124.34 126.28 45.74 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-O 121.506 0.669 . . . . 0.0 110.472 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 91.7 t -79.78 113.64 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 175.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.19 114.96 28.01 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.495 HG22 ' HD3' ' A' ' 33' ' ' ARG . 53.2 m -92.97 115.68 28.35 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.417 HD11 ' CG2' ' A' ' 54' ' ' ILE . 18.1 tp -85.96 142.99 28.41 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.219 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -81.77 82.27 7.52 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 172.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.594 ' NE ' ' HB3' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -91.51 121.99 33.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -166.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -92.58 -42.85 9.44 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 167.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -98.48 118.28 34.81 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -98.25 158.14 15.75 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.577 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -103.59 146.0 29.21 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.423 ' NH2' ' HB3' ' A' ' 13' ' ' LYS . 57.3 ttp180 -55.44 134.54 50.54 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.692 1.597 . . . . 0.0 111.387 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 10.8 p-10 -75.06 96.05 3.15 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.562 1.172 . . . . 0.0 112.776 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.3 pt -96.99 22.75 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 122.299 1.047 . . . . 0.0 109.068 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.472 ' O ' ' HE3' ' A' ' 175' ' ' LYS . 48.1 ttp180 -60.25 -38.34 83.17 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.844 -175.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.99 -11.31 84.84 Favored Glycine 0 C--N 1.315 -0.588 0 C-N-CA 121.166 -0.54 . . . . 0.0 113.024 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.44 -13.1 50.31 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.593 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.4 mt -67.05 130.94 32.86 Favored 'Isoleucine or valine' 0 C--O 1.25 1.116 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.1 t -118.72 113.45 21.17 Favored 'General case' 0 N--CA 1.4 -2.925 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -75.55 -20.14 58.86 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -86.32 115.65 23.99 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.458 HD11 ' CD ' ' A' ' 172' ' ' GLN . 10.5 mt -108.31 -66.73 1.02 Allowed 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.9 0.857 . . . . 0.0 110.76 -171.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -58.9 134.73 57.19 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.673 -168.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.56 2.28 24.32 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.675 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.2 167.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.11 152.57 18.42 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.45 157.09 42.95 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.714 0.769 . . . . 0.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 26.2 m -112.63 133.58 54.6 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 48.1 tp -101.57 119.71 39.2 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.69 93.96 4.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.421 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 61.9 t -79.84 119.55 29.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -148.17 151.55 35.74 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.1 p -171.62 -174.81 1.45 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -92.32 -11.34 35.36 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.363 -1.335 . . . . 0.0 107.991 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -73.32 -49.78 25.6 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.092 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -136.67 113.11 10.0 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.903 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.9 p -101.27 164.87 11.57 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.195 -176.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 55.8 t30 44.43 70.8 0.3 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.689 1.196 . . . . 0.0 113.453 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.421 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 56.3 m -131.26 92.39 3.18 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.475 -0.766 . . . . 0.0 110.242 176.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.7 mt -88.13 101.49 11.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -120.6 117.3 27.21 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.839 0.352 . . . . 0.0 110.977 -173.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 10.1 pt-20 -74.93 130.03 38.69 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.037 0.446 . . . . 0.0 110.494 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -97.67 -45.04 12.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.905 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.91 -152.93 20.48 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.082 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.82 138.68 34.97 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 122.878 2.385 . . . . 0.0 113.554 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.8 m -102.87 146.85 10.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.87 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.9 p -130.95 153.7 48.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.618 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 44.0 ttp -96.98 116.28 28.92 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.362 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -82.74 -46.09 13.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.968 -176.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.43 -130.32 9.79 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.47 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.5 mt -93.82 100.28 12.5 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 131' ' ' THR . 38.3 mm . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 N--CA 1.448 -1.169 0 N-CA-C 110.59 -0.581 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 14.6 t -88.77 132.2 34.73 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.22 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.589 ' O ' HD11 ' A' ' 70' ' ' LEU . 34.9 t30 -75.83 81.28 2.75 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 65.58 63.55 0.62 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.64 0.733 . . . . 0.0 112.738 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 28.3 mtt -89.14 164.11 15.15 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.52 HG22 ' HB3' ' A' ' 170' ' ' SER . 6.8 tt -107.84 138.83 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.064 175.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -122.89 140.75 52.63 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.598 ' HH ' ' CD2' ' A' ' 160' ' ' HIS . 50.5 p90 -132.43 153.46 50.81 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.019 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -89.07 93.22 9.51 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.511 0.507 . . . . 0.0 109.934 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -174.77 135.85 0.4 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 125.395 1.478 . . . . 0.0 108.015 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.09 91.57 7.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.042 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.7 m -97.06 147.84 23.62 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -99.81 172.43 7.25 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -80.17 169.62 17.55 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 175.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 146' ' ' CYS . . . 90.57 -34.38 4.21 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -173.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -85.81 33.14 0.58 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.028 1.331 . . . . 0.0 107.622 175.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.509 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 42.8 t -89.51 138.19 31.67 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.737 -175.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.432 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 94.88 -1.41 65.46 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.45 127.94 29.62 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.39 115.33 17.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.054 0.454 . . . . 0.0 111.114 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 39.4 tp -89.5 107.86 19.32 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.0 p -146.98 162.49 38.65 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.548 0.69 . . . . 0.0 112.653 -174.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -128.94 -179.07 4.89 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 175.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.2 t -60.4 103.24 0.22 Allowed 'General case' 0 CA--C 1.556 1.192 0 CA-C-O 122.404 1.097 . . . . 0.0 112.072 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 77.35 15.07 81.87 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.629 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -135.35 109.81 8.49 Favored 'General case' 0 C--O 1.207 -1.145 0 O-C-N 122.307 -0.525 . . . . 0.0 111.646 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.6 mt -100.68 129.54 51.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -105.23 -41.41 5.55 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.611 0.719 . . . . 0.0 110.776 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.458 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 173.93 -170.38 43.5 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.63 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.8 pt -119.29 143.64 30.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.598 ' CD2' ' HH ' ' A' ' 137' ' ' TYR . 30.7 t-80 -70.05 136.5 50.39 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.36 -46.49 3.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.111 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.57 153.6 23.12 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -127.8 152.46 18.95 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.56 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -116.73 96.1 5.33 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.23 -119.03 9.1 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.104 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -84.79 -8.01 58.98 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.745 0.818 . . . . 0.0 110.647 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -108.61 100.95 10.14 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.443 -0.786 . . . . 0.0 111.429 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -79.94 134.65 13.86 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -107.21 129.84 54.81 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 122.121 0.962 . . . . 0.0 110.45 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.52 ' HB3' HG22 ' A' ' 135' ' ' ILE . 30.0 t -118.2 141.31 48.63 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.999 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.37 120.45 23.83 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.458 ' CD ' HD11 ' A' ' 94' ' ' LEU . 6.1 tt0 -78.27 109.0 12.0 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 123.776 0.673 . . . . 0.0 110.393 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 173' ' ' LEU . 3.2 pp -94.05 88.54 5.7 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.265 1.031 . . . . 0.0 109.453 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -80.85 138.72 36.2 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.871 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.472 ' HE3' ' O ' ' A' ' 87' ' ' ARG . 4.1 ttmp? -50.88 -35.14 31.31 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.542 1.137 . . . . 0.0 112.267 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -56.47 -25.63 51.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.627 0.771 . . . . 0.0 112.977 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -82.39 -13.74 56.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.673 0.273 . . . . 0.0 111.299 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -96.54 -8.27 32.38 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -173.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 C--N 1.306 -1.303 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.701 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo . . . . . 0 C--O 1.241 0.63 0 CA-C-O 121.045 0.352 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -67.01 -36.48 82.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.64 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -65.41 -48.77 71.66 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.727 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.05 -37.55 87.95 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.833 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -62.12 -48.48 79.97 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.802 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.14 95.05 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 123.932 0.77 . . . . 0.0 111.515 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.81 -43.35 96.53 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.868 0.365 . . . . 0.0 111.12 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 m -67.1 -31.71 72.37 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.462 0.649 . . . . 0.0 110.412 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.8 tp -74.14 -59.07 2.89 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.524 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.541 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 6.8 tt -50.21 -52.4 36.04 Favored 'General case' 0 C--O 1.247 0.957 0 C-N-CA 125.286 1.434 . . . . 0.0 113.341 -175.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -66.59 -4.03 7.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -172.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -129.07 -53.9 1.2 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -84.72 6.99 22.05 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -171.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.541 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 48.2 mm -102.4 123.63 55.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.122 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 18' ' ' ILE . 1.8 mpt? -101.71 97.06 7.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.417 ' HA ' HG22 ' A' ' 26' ' ' THR . 23.3 m -70.65 93.17 0.91 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 16' ' ' MET . 82.1 mt -93.48 118.55 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.966 -172.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 7.0 m -85.27 106.59 16.79 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.685 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 60.6 p -90.81 -163.32 1.01 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.761 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 m -79.75 -2.96 45.45 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -118.65 -33.25 4.33 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.69 -151.26 20.21 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 119.762 -1.209 . . . . 0.0 112.542 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -86.87 104.2 16.0 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.38 133.86 52.38 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.531 HG23 ' CD2' ' A' ' 104' ' ' HIS . 13.6 p -97.8 130.58 44.73 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-O 121.796 0.808 . . . . 0.0 113.078 -172.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.41 131.11 10.45 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.4 tp -89.81 114.06 25.72 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.5 103.89 1.69 Allowed Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.8 mm -71.44 -47.17 60.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 C-N-CA 123.129 0.572 . . . . 0.0 109.857 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -169.95 154.1 5.03 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.581 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t70 50.79 -95.48 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.715 1.26 . . . . 0.0 113.402 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 76' ' ' THR . 54.6 mtt180 -123.82 4.7 8.78 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 122.817 0.447 . . . . 0.0 111.073 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.05 113.91 26.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.256 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 p -126.9 137.47 53.16 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -110.75 138.49 38.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.98 149.91 26.29 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.16 149.78 83.11 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 122.248 1.966 . . . . 0.0 112.555 174.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.418 ' HB ' ' OG1' ' A' ' 73' ' ' THR . 8.9 t -79.43 -31.02 42.52 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 122.517 0.327 . . . . 0.0 110.995 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -72.66 -4.97 34.31 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.208 0.528 . . . . 0.0 111.024 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.27 -13.17 60.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.685 ' O ' ' HB ' ' A' ' 20' ' ' THR . 14.2 mm100 66.62 77.78 0.26 Allowed Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 125.145 1.378 . . . . 0.0 113.281 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.17 153.86 18.93 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.198 1.932 . . . . 0.0 110.297 176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.99 -164.32 13.93 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -83.38 -20.97 33.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.048 0.928 . . . . 0.0 108.59 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -143.72 149.6 37.41 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.8 m -143.33 170.42 10.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 73.3 mt -102.31 114.12 28.01 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.41 ' C ' ' H ' ' A' ' 51' ' ' GLY . 8.9 m -92.32 97.74 7.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.615 0.721 . . . . 0.0 109.617 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 69.53 -10.4 0.58 Allowed 'General case' 0 CA--C 1.564 1.517 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.96 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 154.84 -25.18 0.63 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 112.285 -0.326 . . . . 0.0 112.285 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -90.42 131.86 35.95 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 122.552 -0.381 . . . . 0.0 110.719 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.497 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -77.44 115.21 17.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.481 0.658 . . . . 0.0 109.677 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.8 tp -120.37 143.51 32.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.427 ' N ' ' HD2' ' A' ' 55' ' ' ARG . 2.8 mpt_? -89.87 141.07 28.98 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.685 0.755 . . . . 0.0 111.777 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.2 t -97.21 102.99 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -69.16 -62.4 1.39 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 123.675 0.609 . . . . 0.0 110.097 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -111.42 138.39 47.98 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -146.34 105.08 3.85 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-O 121.275 0.56 . . . . 0.0 109.589 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -107.92 129.67 55.08 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.276 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.45 131.43 34.19 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.5 tp -83.49 104.02 13.3 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.788 0.804 . . . . 0.0 109.997 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.53 141.51 43.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.936 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -83.49 142.46 43.17 Favored Pre-proline 0 C--N 1.279 -2.492 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.79 -11.69 7.59 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.562 2.841 . . . . 0.0 114.576 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -98.99 18.33 17.52 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.989 -0.444 . . . . 0.0 110.788 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 75.01 17.71 2.66 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.636 1.175 . . . . 0.0 112.65 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.8 mm -91.08 140.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 131' ' ' THR . 9.1 t-20 -98.1 152.49 19.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 72' ' ' LEU . 4.0 mm? -112.29 -7.27 14.01 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.55 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 67.77 -21.08 0.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.291 1.436 . . . . 0.0 112.252 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 70' ' ' LEU . 7.4 tt -79.4 133.3 36.56 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 124.067 0.947 . . . . 0.0 110.371 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.418 ' OG1' ' HB ' ' A' ' 39' ' ' THR . 20.4 m -117.45 133.44 55.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.2 t -98.47 108.79 22.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.3 mt -102.25 132.3 48.28 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 27.6 m -109.56 100.14 9.23 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.8 mt -87.04 155.62 20.07 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.768 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.92 93.52 2.68 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.511 ' NE ' ' HA ' ' A' ' 79' ' ' ARG . 2.5 mmp_? -106.55 108.47 19.99 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.393 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -83.19 -29.68 28.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -99.69 107.49 19.6 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 170.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -99.88 166.41 11.08 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.852 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -121.68 169.57 10.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -57.47 142.58 43.63 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.77 1.628 . . . . 0.0 112.117 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 14.6 t70 -75.86 96.0 3.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.885 0.85 . . . . 0.0 109.211 172.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.9 pt -84.91 10.71 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-O 121.813 0.815 . . . . 0.0 110.972 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -68.26 -24.71 64.92 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.4 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.91 -11.4 66.39 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.296 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -103.86 -4.55 23.37 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 117.138 0.469 . . . . 0.0 110.554 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -64.18 121.06 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.703 0.763 . . . . 0.0 110.708 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 m -93.32 114.99 27.57 Favored 'General case' 0 N--CA 1.391 -3.391 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.3 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -2.63 56.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 122.234 1.016 . . . . 0.0 108.958 175.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -113.34 113.72 25.65 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.58 -1.645 . . . . 0.0 107.347 176.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -115.98 -54.5 2.49 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.548 0.69 . . . . 0.0 111.674 -170.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -72.95 127.1 31.56 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.501 -168.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.93 -7.92 41.96 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.301 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 t -104.52 147.51 10.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 5.8 p-10 -89.23 145.45 25.4 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.15 155.59 45.25 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 122.156 0.979 . . . . 0.0 113.286 -175.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 27.1 m -111.27 127.83 55.74 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 113.565 -1.652 . . . . 0.0 107.387 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.9 tp -101.74 117.24 34.47 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.303 0.573 . . . . 0.0 109.933 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 t -94.01 97.14 6.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.475 ' O ' ' HB ' ' A' ' 111' ' ' THR . 15.6 m -88.34 126.63 41.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.531 ' CD2' HG23 ' A' ' 26' ' ' THR . 33.0 p-80 -153.93 153.82 32.71 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.352 0.596 . . . . 0.0 111.394 -173.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.4 p -154.58 -162.63 1.43 Allowed 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -84.91 -35.67 21.97 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 118.741 -1.183 . . . . 0.0 108.63 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -77.77 -36.37 50.66 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.417 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 104' ' ' HIS . 97.1 m-85 -115.37 93.2 4.19 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 m -112.22 150.77 30.41 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 71.76 19.15 4.99 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.687 0.795 . . . . 0.0 112.609 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 103' ' ' VAL . 43.7 m -80.47 101.13 8.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 82.5 mt -102.78 98.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.503 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.4 tp -112.72 105.89 14.13 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.669 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 6.5 pt-20 -79.67 139.65 37.32 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.821 -0.55 . . . . 0.0 111.917 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.0 m -107.63 -42.19 5.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.402 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 126.07 -158.06 20.17 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.615 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 98' ' ' ASP . 24.4 Cg_exo -64.37 126.04 16.21 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.682 2.921 . . . . 0.0 112.892 -178.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -92.08 151.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.371 0.605 . . . . 0.0 111.736 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.4 m -122.28 154.47 37.53 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -94.73 139.56 31.08 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.78 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.99 -23.62 19.49 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.06 -123.81 6.24 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.369 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -105.74 108.99 20.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.4 pt . . . . . 0 C--N 1.299 -1.611 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.59 178.677 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 N--CA 1.435 -1.914 0 N-CA-C 108.228 -1.489 . . . . 0.0 108.228 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.4 t -103.27 125.98 50.2 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-O 121.389 0.614 . . . . 0.0 109.523 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -83.3 134.42 34.93 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.007 -176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 63.04 49.78 3.33 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 124.126 0.891 . . . . 0.0 110.166 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 8.3 tpt -85.69 143.2 28.51 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.472 HG23 ' HB2' ' A' ' 170' ' ' SER . 14.5 tt -112.66 144.97 19.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -132.96 142.62 48.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.289 0.566 . . . . 0.0 111.347 -173.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -134.74 115.96 14.34 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.43 92.56 1.1 Allowed 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -167.86 117.77 0.8 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.63 110.68 1.04 Allowed 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.545 0.688 . . . . 0.0 110.494 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.6 m -121.15 153.51 37.42 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -88.33 123.93 33.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.044 0.449 . . . . 0.0 110.977 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.4 t -78.52 151.43 32.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.9 -15.53 40.42 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -106.84 35.07 3.13 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 10.0 m -69.94 146.67 51.0 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.233 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.92 3.51 42.38 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.54 145.63 40.81 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.86 116.36 31.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 120.924 0.392 . . . . 0.0 110.226 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.2 tp -89.45 104.95 17.46 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.0 p -141.52 -173.73 3.85 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.254 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 155' ' ' LYS . . . -161.54 -175.52 4.81 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 175.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.4 m -64.23 99.12 0.26 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 118.355 0.525 . . . . 0.0 110.765 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.15 18.66 71.4 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.98 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.412 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 74.5 mmtt -132.93 134.86 45.1 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -129.11 120.97 52.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -96.8 -46.19 6.35 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.8 0.687 . . . . 0.0 111.559 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.486 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 179.54 -176.03 47.37 Favored Glycine 0 N--CA 1.419 -2.477 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.715 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 22.7 pt -109.41 134.31 51.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 O-C-N 123.69 0.288 . . . . 0.0 110.228 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.428 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 11.2 t-80 -58.52 113.47 2.01 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 124.474 1.109 . . . . 0.0 110.25 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.5 t -88.27 -41.6 14.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.599 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.47 127.61 0.95 Allowed Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 119.022 -1.561 . . . . 0.0 113.103 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.431 ' HA2' ' HA2' ' A' ' 168' ' ' GLY . . . -78.68 79.5 1.55 Allowed Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 172.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -93.33 89.01 6.19 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 100.69 -147.3 17.89 Favored Glycine 0 N--CA 1.427 -1.915 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.392 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 43.1 ttm105 -85.57 -0.9 56.38 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.487 0.66 . . . . 0.0 110.223 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -124.52 124.93 43.35 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.887 -0.508 . . . . 0.0 110.064 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.431 ' HA2' ' HA2' ' A' ' 163' ' ' GLY . . . -84.25 126.46 7.62 Favored Glycine 0 N--CA 1.414 -2.8 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -109.71 127.15 54.4 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 121.213 0.53 . . . . 0.0 109.9 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.472 ' HB2' HG23 ' A' ' 135' ' ' ILE . 49.8 m -127.83 159.65 34.2 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -100.04 132.6 45.3 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -76.21 104.15 6.6 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.486 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -80.38 70.99 7.17 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.386 1.089 . . . . 0.0 111.431 177.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -63.1 139.94 58.82 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.186 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -53.14 -30.41 36.79 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 126.513 1.925 . . . . 0.0 111.499 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -62.29 -25.27 67.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -78.13 -20.48 52.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.571 0.701 . . . . 0.0 109.34 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -104.34 21.83 15.93 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.362 -171.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 52.6 t . . . . . 0 C--N 1.304 -1.404 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 173.554 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo . . . . . 0 N--CA 1.487 1.124 0 N-CA-C 116.163 1.563 . . . . 0.0 116.163 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -71.44 -38.58 71.34 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.929 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.2 m -71.25 -29.38 65.04 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.753 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.07 -43.57 74.34 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -64.82 -44.0 91.3 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.424 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.77 -49.35 71.11 Favored 'General case' 0 C--O 1.204 -1.318 0 O-C-N 123.97 0.794 . . . . 0.0 110.98 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 tp -63.67 -38.73 92.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.088 0.471 . . . . 0.0 111.423 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -71.12 -37.07 72.34 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.469 0.652 . . . . 0.0 110.893 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.86 -38.76 64.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.411 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.51 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 37.2 tp -49.61 -54.73 16.7 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 125.419 1.488 . . . . 0.0 112.568 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -72.53 -3.8 26.75 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -170.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -133.48 -29.89 1.33 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -120.87 -25.25 5.45 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.51 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 33.7 mt -95.26 105.96 17.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.3 mmt -122.51 149.54 43.77 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.118 0.485 . . . . 0.0 112.123 -175.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 m -80.2 124.46 28.81 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.9 mt -113.1 108.46 25.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.2 m -87.18 104.46 16.38 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.2 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 40.9 p -95.34 -156.6 0.52 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.465 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -75.88 -28.96 58.34 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -81.57 -38.16 26.58 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.27 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.84 -156.7 27.91 Favored Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 119.949 -1.119 . . . . 0.0 111.78 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.18 105.38 16.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.015 0.436 . . . . 0.0 110.703 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -107.66 176.07 5.27 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.0 m -115.56 134.5 55.0 Favored 'General case' 0 N--CA 1.408 -2.538 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.16 139.1 13.01 Favored Glycine 0 N--CA 1.412 -2.924 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.4 tp -102.11 118.24 36.48 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.08 114.31 3.83 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mm -78.77 -50.05 19.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -167.67 145.38 4.51 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.151 176.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' HB3' ' HG3' ' A' ' 82' ' ' LYS 0.314 1.2 p30 46.8 -96.11 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 177.259 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 37.4 ptt180 -117.07 2.35 12.66 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.153 0.502 . . . . 0.0 110.882 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.6 t -91.72 106.38 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.631 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.6 m -122.49 162.18 22.21 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 p -133.17 140.81 46.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.62 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.0 tt -153.02 147.53 19.1 Favored Pre-proline 0 CA--C 1.561 1.384 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.75 147.51 94.6 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.417 2.078 . . . . 0.0 112.483 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.4 m -62.05 -44.9 95.69 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.281 0.633 . . . . 0.0 112.612 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -65.46 2.53 0.88 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.36 -23.28 54.16 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.442 ' O ' ' HB ' ' A' ' 20' ' ' THR . 13.4 mm100 64.47 77.35 0.3 Allowed Pre-proline 0 C--O 1.25 1.119 0 C-N-CA 125.228 1.411 . . . . 0.0 111.664 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.34 128.84 9.91 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.673 2.249 . . . . 0.0 110.826 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.52 -163.62 38.65 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.801 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.81 -33.64 75.2 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.657 0.741 . . . . 0.0 110.912 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -139.84 141.03 36.7 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.15 154.0 23.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 120.57 0.224 . . . . 0.0 110.918 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 8.2 mp -96.36 105.28 17.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.026 0.441 . . . . 0.0 111.173 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.59 93.53 4.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 t30 65.88 9.37 6.03 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.682 1.193 . . . . 0.0 110.732 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.69 -22.85 5.44 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.564 HE21 ' HA ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -80.59 107.67 13.59 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -80.62 111.31 16.93 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.836 0.827 . . . . 0.0 109.204 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.456 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.1 tp -113.35 135.57 52.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.316 -174.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -68.69 132.8 47.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.858 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.89 126.92 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -77.67 -63.02 1.48 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.457 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -147.22 148.96 32.02 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -112.59 104.02 12.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.496 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.8 m-85 -81.55 95.18 7.06 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -75.23 123.0 24.53 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.11 102.96 15.29 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -177.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.9 132.56 60.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.3 145.25 86.47 Favored Pre-proline 0 C--N 1.307 -1.268 0 O-C-N 123.383 0.427 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.3 -21.98 73.43 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.558 2.172 . . . . 0.0 110.798 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.49 7.81 21.47 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.391 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 71.18 21.54 4.73 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.51 1.524 . . . . 0.0 113.15 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.5 mm -92.49 152.75 3.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 131' ' ' THR . 48.3 t30 -85.5 138.4 32.24 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.411 HD21 ' HH ' ' A' ' 177' ' ' TYR . 0.2 OUTLIER -98.43 -19.73 17.53 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.195 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 66.29 21.74 10.97 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 122.989 1.376 . . . . 0.0 109.475 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.3 tp -121.16 143.72 48.97 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.373 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.1 m -138.9 126.98 22.5 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.114 0.483 . . . . 0.0 110.388 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 60.6 t -86.87 110.79 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.7 tp -91.75 116.13 28.63 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.712 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.3 m -93.24 106.42 18.38 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.1 0.476 . . . . 0.0 109.882 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 8.3 mp -81.37 153.78 26.8 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.758 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.456 ' O ' HD11 ' A' ' 54' ' ' ILE . 22.8 t70 -83.41 74.68 10.05 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.84 0.829 . . . . 0.0 109.052 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -114.78 130.71 56.9 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.45 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -95.85 -39.64 9.72 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.72 129.13 38.68 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.578 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.476 ' HG3' ' HB3' ' A' ' 32' ' ' ASP . 51.7 tttp -89.02 102.86 15.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.301 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.403 ' H ' ' HA ' ' A' ' 32' ' ' ASP . 96.5 m-85 -70.47 156.34 39.5 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 172.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -49.7 132.49 21.77 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.779 1.232 . . . . 0.0 113.436 -173.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.62 97.06 9.4 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.613 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -97.79 22.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.854 0.835 . . . . 0.0 110.921 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -60.55 -41.66 94.99 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.138 -174.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.63 1.43 66.89 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 116.11 -0.496 . . . . 0.0 113.72 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -95.83 -6.78 38.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.98 0.39 . . . . 0.0 110.51 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.3 mt -72.04 109.67 4.44 Favored 'Isoleucine or valine' 0 C--O 1.261 1.692 0 CA-C-O 121.308 0.575 . . . . 0.0 110.004 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 p -94.97 105.69 17.63 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.514 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -82.0 -13.05 57.97 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.819 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -94.28 115.62 27.89 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.7 mt -112.73 -56.97 2.35 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.188 -164.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 32.1 tt0 -60.11 112.37 1.87 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -164.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 119.25 -18.87 10.16 Favored Glycine 0 C--O 1.251 1.169 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.529 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.45 147.05 5.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.94 129.24 35.3 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -124.41 160.71 27.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.391 0.615 . . . . 0.0 111.901 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.8 m -121.16 145.02 48.26 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 124.471 1.108 . . . . 0.0 108.721 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 160' ' ' HIS . 2.3 tm? -103.65 119.37 38.77 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.5 t -123.73 130.97 73.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.964 0.412 . . . . 0.0 112.071 -175.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.41 ' CG2' ' HB ' ' A' ' 111' ' ' THR . 17.4 m -125.38 142.84 40.96 Favored 'Isoleucine or valine' 0 C--O 1.254 1.326 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -71.65 -59.38 2.78 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.9 t -153.43 106.46 2.94 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 170.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 145' ' ' GLN . 28.1 t-20 -103.9 -74.59 0.64 Allowed 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -100.11 -26.39 13.97 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.164 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -148.79 156.07 41.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.3 m -84.74 131.89 34.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.601 0.239 . . . . 0.0 111.113 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 70.12 71.32 0.22 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.812 1.245 . . . . 0.0 111.967 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.41 ' HB ' ' CG2' ' A' ' 103' ' ' VAL . 34.7 m -111.56 107.92 17.25 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.563 176.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.5 mt -117.55 103.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.0 tp -123.46 124.49 43.0 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.307 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.2 140.82 56.1 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.695 0.76 . . . . 0.0 112.894 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.84 -57.16 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.136 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.77 -152.89 17.45 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.0 123.82 11.81 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 123.007 2.472 . . . . 0.0 112.306 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 27.3 m -96.97 157.63 3.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.9 p -133.29 164.83 26.21 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.647 0.379 . . . . 0.0 111.23 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 56.5 ttp -82.04 136.0 35.27 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' A' ' 136' ' ' ARG . . . -99.58 -52.79 3.38 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.521 0.677 . . . . 0.0 110.248 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.98 -110.53 3.76 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.817 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.0 tp -110.91 118.7 36.81 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mm . . . . . 0 C--N 1.302 -1.498 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.136 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.447 -1.247 0 N-CA-C 110.558 -0.593 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.5 m -122.2 127.41 49.96 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -111.51 158.96 18.56 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 111.133 0.049 . . . . 0.0 111.133 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 61.7 50.94 4.13 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 122.968 1.366 . . . . 0.0 111.334 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 90.2 mmm -113.87 157.03 22.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.029 -1.896 . . . . 0.0 110.258 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.525 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 12.4 tt -107.37 147.16 12.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 39.3 ttp85 -126.89 140.95 51.97 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.268 0.627 . . . . 0.0 110.207 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -150.31 148.77 29.24 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.488 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.92 111.48 18.83 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -164.47 146.47 8.56 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.21 93.1 1.42 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.1 t -87.96 145.29 26.09 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.141 -174.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 145' ' ' GLN . 17.8 tppt? -134.73 125.46 27.05 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.2 m -73.29 124.83 26.46 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.59 -41.46 1.28 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.505 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 3.4 pt20 -84.07 42.86 0.89 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.456 1.122 . . . . 0.0 109.604 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 33.4 m -82.82 147.06 28.58 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.835 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.19 7.18 59.67 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -68.92 119.63 9.95 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.04 108.17 6.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 37.0 tp -84.53 107.9 17.01 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.1 p -142.1 164.9 28.92 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.266 0.555 . . . . 0.0 112.049 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.39 178.17 7.61 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.5 t -60.96 102.88 0.22 Allowed 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.756 0.788 . . . . 0.0 111.669 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 84.08 6.23 86.74 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.02 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -134.02 126.55 30.44 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 117.331 0.566 . . . . 0.0 111.275 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 76.2 mt -112.81 122.12 66.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -97.48 -22.17 16.72 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.883 0.373 . . . . 0.0 111.169 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 149.75 -163.8 29.4 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.551 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 148' ' ' GLY . 27.3 pt -128.21 134.11 65.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 120.989 0.424 . . . . 0.0 111.324 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.441 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 36.4 t-80 -60.52 133.32 55.98 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 124.852 1.261 . . . . 0.0 111.925 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.33 -6.73 11.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.916 0.389 . . . . 0.0 110.884 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 123.47 -158.59 18.09 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.448 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 156.79 178.13 30.59 Favored Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -134.23 119.08 18.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 100.72 -123.04 7.81 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.433 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -113.26 6.59 17.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.891 0.377 . . . . 0.0 111.472 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -112.76 113.87 26.17 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.478 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.16 133.1 11.62 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -111.32 137.79 48.62 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.555 0.693 . . . . 0.0 109.93 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.525 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 16.2 m -135.41 153.31 51.84 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.915 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.432 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -81.43 132.94 35.34 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -64.7 -9.22 18.39 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.8 mt 49.32 29.39 2.71 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -40.49 121.4 1.41 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.546 1.139 . . . . 0.0 110.632 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -53.58 -25.71 18.47 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.411 ' O ' HG12 ' A' ' 179' ' ' VAL . 28.5 pt20 -63.56 -17.17 62.55 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 123.71 0.804 . . . . 0.0 112.672 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.411 ' HH ' HD21 ' A' ' 70' ' ' LEU . 16.3 m-30 -73.63 -23.32 59.87 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.758 -0.589 . . . . 0.0 111.012 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.41 12.05 34.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -170.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 176' ' ' GLN . 12.0 p . . . . . 0 C--N 1.301 -1.513 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 CA--C 1.534 0.504 0 CA-C-O 120.979 0.324 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -61.97 -39.5 92.36 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.13 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -69.21 -40.41 78.01 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.572 0.749 . . . . 0.0 109.462 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.76 -44.18 96.86 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.479 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -67.19 -50.26 61.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.254 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.41 84.49 Favored 'General case' 0 C--O 1.209 -1.037 0 C-N-CA 123.204 0.602 . . . . 0.0 111.845 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.01 -39.57 95.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.017 0.437 . . . . 0.0 111.101 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 m -74.86 -32.81 61.99 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.72 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.5 tp -73.38 -40.67 64.16 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.484 177.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 2.2 tm? -54.4 -52.89 60.3 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.256 1.422 . . . . 0.0 111.82 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -66.44 -7.59 20.48 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -170.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -126.29 -51.66 1.52 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -104.73 -2.87 24.33 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -170.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.525 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 56.5 mt -114.42 104.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.6 tpt -135.74 154.78 51.14 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.833 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.4 m -75.39 115.82 15.46 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.071 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 mt -99.58 99.74 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p -80.24 101.62 8.98 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.756 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 82.6 p -89.27 -166.15 1.52 Allowed 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.81 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -73.85 -20.91 60.3 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.879 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -101.18 -49.52 4.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.59 -157.12 8.52 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 118.82 -1.657 . . . . 0.0 113.537 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -109.38 94.72 5.18 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -100.69 160.77 14.09 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.9 m -99.49 123.69 43.98 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.3 123.68 7.94 Favored Glycine 0 N--CA 1.411 -2.996 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.8 tp -101.29 112.84 25.46 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.993 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.45 135.59 16.74 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.1 -50.88 6.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 117.716 0.758 . . . . 0.0 110.74 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -146.14 110.17 4.95 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.754 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.578 ' OD2' ' HG3' ' A' ' 33' ' ' ARG . 24.9 t70 56.73 -81.17 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 171.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.578 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -116.37 0.94 12.95 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.436 0.636 . . . . 0.0 111.61 179.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.0 t -88.57 114.9 27.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.914 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.1 t -125.95 144.63 50.61 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.84 139.86 29.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -148.89 143.5 17.17 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.49 154.72 73.27 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.957 1.772 . . . . 0.0 110.872 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -68.76 -42.15 77.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.563 0.697 . . . . 0.0 109.814 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -73.89 20.38 0.1 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.4 -23.36 21.08 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.319 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.563 ' O ' ' HB ' ' A' ' 20' ' ' THR . 24.6 mm-40 69.4 66.0 0.49 Allowed Pre-proline 0 N--CA 1.486 1.362 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -94.95 135.58 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 122.615 2.21 . . . . 0.0 110.816 172.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.71 -146.8 17.34 Favored Glycine 0 C--N 1.314 -0.652 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.966 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.14 -43.0 55.03 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.621 0.724 . . . . 0.0 109.258 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -123.65 139.63 53.8 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.9 p -125.95 153.04 33.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -92.35 120.41 32.85 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 51' ' ' GLY . 58.2 t -95.83 85.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 t30 70.79 -10.13 0.76 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.509 1.123 . . . . 0.0 112.085 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 156.73 -39.21 0.57 Allowed Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -78.37 126.78 31.27 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -90.91 146.89 23.52 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.497 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.5 tp -132.64 135.22 57.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -86.19 139.25 31.24 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.186 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -78.01 137.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.506 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -87.63 -48.86 7.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -164.01 151.16 11.97 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.28 101.01 7.87 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.499 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 84.4 m-85 -81.79 125.95 31.27 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.96 116.13 24.0 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -77.43 108.7 10.78 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.553 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.96 130.8 72.28 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -80.75 139.53 50.56 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -56.01 -12.25 6.96 Favored 'Trans proline' 0 CA--C 1.555 1.539 0 C-N-CA 123.725 2.95 . . . . 0.0 114.484 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -83.22 -4.07 58.04 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 121.997 0.903 . . . . 0.0 108.698 174.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.5 t30 67.73 70.29 0.34 Allowed 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.19 1.396 . . . . 0.0 110.257 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.3 mt -141.73 145.1 24.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.547 ' O ' ' HA ' ' A' ' 131' ' ' THR . 17.1 m120 -76.74 161.65 28.32 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.573 0.546 . . . . 0.0 111.264 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -129.29 -32.07 2.03 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.604 174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 71.17 4.22 4.98 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 123.052 1.406 . . . . 0.0 110.204 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.7 mt -94.96 119.05 32.84 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.045 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.7 m -110.89 117.6 33.82 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 96.7 t -79.52 109.36 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.4 tp -87.01 99.46 11.91 Favored 'General case' 0 N--CA 1.397 -3.123 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.886 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.0 m -85.39 105.5 16.07 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.7 mt -90.34 164.49 14.32 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.473 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.26 130.13 36.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -59.54 99.69 0.07 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.808 0.843 . . . . 0.0 111.878 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -115.51 -65.69 1.16 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -100.94 109.41 21.33 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HG3' ' OD1' ' A' ' 32' ' ' ASP . 53.6 tttm -69.4 116.82 10.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.041 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -70.21 145.88 51.11 Favored 'General case' 0 C--O 1.263 1.772 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -66.9 143.59 56.75 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.62 82.56 2.63 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.157 0.503 . . . . 0.0 111.22 -176.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.9 pt -89.83 11.1 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.685 0.755 . . . . 0.0 109.527 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.579 ' O ' ' HE2' ' A' ' 175' ' ' LYS . 57.4 ttp180 -66.85 -24.23 66.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.515 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.44 -24.41 75.1 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.406 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -86.46 -4.74 59.22 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 116.991 0.396 . . . . 0.0 111.167 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.3 mt -61.92 121.1 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.8 m -99.61 108.93 21.43 Favored 'General case' 0 N--CA 1.382 -3.827 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.346 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -71.45 -25.15 62.18 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.32 111.7 22.6 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.907 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.9 mt -107.91 -66.5 1.03 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.509 ' CB ' ' HA ' ' A' ' 119' ' ' THR . 16.5 pt-20 -74.96 152.67 38.78 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -162.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.03 -19.1 38.61 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 114.064 -1.426 . . . . 0.0 111.016 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.6 t -94.37 139.32 18.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.776 0.322 . . . . 0.0 110.316 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.51 119.11 20.64 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 174.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -110.78 164.52 12.68 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.03 0.919 . . . . 0.0 113.453 -174.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.4 m -122.2 140.01 53.09 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.449 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -106.71 122.6 46.68 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.47 121.25 66.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 120.861 0.362 . . . . 0.0 110.044 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.71 145.05 22.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -135.65 90.99 2.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.863 0.839 . . . . 0.0 110.433 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.7 p -120.17 -170.75 2.03 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -87.55 -31.52 19.86 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -70.85 -50.61 33.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.541 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -113.4 86.59 2.42 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.1 m -95.44 109.22 21.44 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.442 -176.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 71.37 35.01 1.6 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.864 0.727 . . . . 0.0 110.788 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.9 m -75.93 105.63 7.08 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 65.2 mt -103.54 105.93 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.795 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 tp -118.74 118.82 32.63 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 120.715 0.293 . . . . 0.0 111.537 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -74.97 119.65 19.43 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -95.39 -35.31 5.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.22 -170.61 20.79 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.022 -1.085 . . . . 0.0 111.943 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.75 119.46 6.4 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.15 2.567 . . . . 0.0 111.303 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.4 m -82.32 151.74 4.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.509 ' HA ' ' CB ' ' A' ' 95' ' ' GLU . 8.9 t -141.97 163.48 32.77 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 47.7 tpp -86.19 134.86 33.76 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.701 0.286 . . . . 0.0 110.301 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.19 -25.29 14.94 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.11 -94.4 1.58 Allowed Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.557 ' O ' HD11 ' A' ' 123' ' ' LEU . 4.1 pp -147.02 119.66 8.55 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.21 0.528 . . . . 0.0 110.383 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.3 tt . . . . . 0 C--N 1.308 -1.196 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.917 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo . . . . . 0 N--CA 1.431 -2.199 0 CA-C-O 121.335 0.473 . . . . 0.0 112.917 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 2.0 p -100.16 130.48 46.3 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -72.04 132.95 44.94 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -172.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 172' ' ' GLN . 36.1 mmt180 58.97 50.89 7.78 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.656 1.182 . . . . 0.0 110.507 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.3 tpt -79.53 118.86 21.77 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.134 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.484 HG23 ' HB2' ' A' ' 170' ' ' SER . 12.4 tt -90.39 138.17 20.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.257 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -127.83 146.23 50.67 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.803 -169.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -147.5 136.64 22.34 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.138 0.975 . . . . 0.0 108.704 175.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -98.96 110.24 22.88 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 122.239 1.019 . . . . 0.0 110.176 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -171.81 134.13 0.78 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.53 90.1 0.25 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.906 0.86 . . . . 0.0 110.805 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 m -104.64 140.07 38.57 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -62.87 103.45 0.45 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.814 0.816 . . . . 0.0 110.741 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.0 m -74.96 116.94 16.26 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.792 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.39 -25.0 2.02 Favored Glycine 0 C--N 1.312 -0.787 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.737 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -83.1 50.7 1.79 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.248 1.023 . . . . 0.0 110.343 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 30.8 m -60.09 137.67 58.05 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.395 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 109.99 -5.17 30.5 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.358 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.2 134.94 25.35 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.658 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.8 p -76.83 126.41 37.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.522 0.677 . . . . 0.0 110.611 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 51.8 tp -94.57 108.62 20.58 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.9 p -144.7 175.61 10.04 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.239 0.542 . . . . 0.0 111.714 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 155' ' ' LYS . . . -154.86 -177.9 6.84 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 175.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.1 t -64.21 103.07 0.58 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.586 0.708 . . . . 0.0 111.386 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.37 26.37 66.01 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.741 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 152' ' ' ALA . 59.9 mmtt -143.22 114.43 7.86 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.12 0.568 . . . . 0.0 110.626 -177.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 89.2 mt -113.5 123.95 69.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 169.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -99.49 -27.6 13.64 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.503 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 149.88 -149.58 21.52 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.5 pt -131.26 149.11 32.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 117.134 0.467 . . . . 0.0 111.21 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -68.56 115.77 8.34 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.841 0.856 . . . . 0.0 109.129 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.2 t -97.81 -36.44 5.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.07 -149.66 8.96 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -177.41 163.07 31.41 Favored Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -142.58 121.88 13.08 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.19 -126.42 9.41 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -104.6 2.34 30.58 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -92.89 112.64 24.68 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.081 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.18 135.0 13.37 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -117.52 119.8 36.15 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 122.122 0.963 . . . . 0.0 110.962 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.484 ' HB2' HG23 ' A' ' 135' ' ' ILE . 20.8 m -119.7 154.53 33.96 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.415 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -104.35 144.7 31.28 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.212 -177.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 133' ' ' ARG . 0.7 OUTLIER -81.89 118.1 22.66 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.189 0.93 . . . . 0.0 108.986 -177.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 66.9 mt -93.16 74.41 4.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -67.69 146.07 54.16 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.586 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.579 ' HE2' ' O ' ' A' ' 87' ' ' ARG . 94.7 mttt -57.36 -31.0 65.31 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.807 0.813 . . . . 0.0 110.324 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -68.69 -9.01 47.76 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.743 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -92.56 -23.26 19.12 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 121.921 -0.487 . . . . 0.0 110.05 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -102.17 18.82 19.91 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.217 -174.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--N 1.307 -1.277 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.048 179.279 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo . . . . . 0 CA--C 1.532 0.387 0 CA-C-O 120.734 0.223 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -67.53 -37.01 82.11 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.064 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -62.35 -49.58 75.0 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.65 0.78 . . . . 0.0 109.789 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.09 -43.99 90.33 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.949 0.9 . . . . 0.0 110.015 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -58.46 -47.73 83.05 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.007 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.16 80.96 Favored 'General case' 0 C--O 1.206 -1.185 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.964 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.05 -41.77 88.69 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.304 0.642 . . . . 0.0 110.321 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.0 m -65.29 -43.38 91.34 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.999 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.8 tp -66.53 -43.53 84.93 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.954 0.901 . . . . 0.0 109.666 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.428 ' HA ' HD12 ' A' ' 15' ' ' ILE . 16.5 tp -49.57 -59.57 3.65 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 126.134 1.774 . . . . 0.0 112.755 -176.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -80.49 11.07 3.95 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.141 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -123.01 -56.66 1.74 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.67 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -119.3 4.63 11.24 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 11' ' ' LEU . 33.4 mt -99.66 98.16 6.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.747 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.92 144.17 30.19 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.369 -175.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 45.5 m -79.95 115.31 19.45 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 172.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.8 mt -115.14 107.46 22.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.438 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.3 m -89.78 113.25 24.76 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 76.7 p -93.87 -157.46 0.55 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.595 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -83.32 0.72 44.57 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -112.52 -52.23 2.79 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.812 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 19' ' ' THR . . . -175.15 -160.14 22.51 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 119.823 -1.179 . . . . 0.0 111.943 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.14 105.88 18.11 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.82 169.42 8.85 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.5 m -99.69 123.45 43.97 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.13 118.89 6.11 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.1 tp -98.38 113.89 26.03 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.504 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.18 112.66 3.84 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.6 mm -86.65 -52.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 116.564 0.182 . . . . 0.0 110.789 -176.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -162.19 141.65 9.62 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.34 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.422 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 16.1 t70 59.37 -90.98 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 175.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -135.6 9.08 3.37 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.278 1.037 . . . . 0.0 108.709 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.467 HG12 ' CG1' ' A' ' 74' ' ' VAL . 53.9 t -80.72 108.81 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.777 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.0 m -113.01 145.47 40.79 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -112.5 133.97 56.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 O-C-N 122.185 -0.322 . . . . 0.0 111.29 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 tt -153.88 145.17 16.43 Favored Pre-proline 0 CA--C 1.566 1.571 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.621 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 31.3 Cg_exo -65.16 150.18 87.97 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.356 2.037 . . . . 0.0 113.009 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.0 m -58.1 -43.01 86.89 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.6 0.76 . . . . 0.0 112.686 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -69.59 -1.65 9.39 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.65 -32.7 62.34 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.426 ' O ' ' HB ' ' A' ' 20' ' ' THR . 25.6 mt-30 52.15 82.48 0.24 Allowed Pre-proline 0 C--O 1.248 1.024 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.46 143.13 16.96 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.965 2.443 . . . . 0.0 110.559 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.59 -136.41 7.54 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.559 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.33 -31.03 30.1 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 5.2 p-10 -136.55 153.4 51.0 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.24 -1.345 . . . . 0.0 107.622 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.53 158.39 42.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 76.7 mt -99.48 103.08 14.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 17' ' ' THR . 72.6 t -83.45 91.73 2.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 175.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 62.78 15.81 8.48 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.079 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.01 -18.36 7.95 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.251 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -84.63 119.73 25.56 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.262 0.225 . . . . 0.0 110.772 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -71.74 119.05 15.36 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.959 0.409 . . . . 0.0 111.986 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 78' ' ' ASP . 16.7 tt -132.72 139.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 174.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 41.7 mtp180 -82.25 157.45 23.89 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.527 0.679 . . . . 0.0 112.481 -177.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.58 140.4 16.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.439 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -93.8 -54.24 3.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -146.24 165.73 28.35 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -140.38 95.1 2.82 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.492 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.0 m-85 -83.3 100.59 10.73 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.7 102.3 2.27 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 tt -83.39 102.83 12.3 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-O 122.065 0.936 . . . . 0.0 109.143 -171.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 67.3 t -109.86 139.52 32.71 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.05 141.64 86.26 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.7 -10.22 2.34 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 123.513 2.808 . . . . 0.0 114.838 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -97.5 7.24 46.86 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 121.676 0.75 . . . . 0.0 109.862 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 73.61 23.26 2.44 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.123 1.369 . . . . 0.0 114.394 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.3 mm -96.89 140.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.542 ' O ' ' HA ' ' A' ' 131' ' ' THR . 5.0 m-20 -66.24 133.32 50.36 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 120.892 0.377 . . . . 0.0 111.341 -177.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.403 ' CD1' ' HB3' ' A' ' 133' ' ' ARG . 58.7 tp -94.37 -15.36 24.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 170.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 61.58 27.28 16.8 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.986 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -125.07 140.84 52.54 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.171 -173.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.9 m -134.32 130.2 36.64 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.373 0.606 . . . . 0.0 110.264 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 51.5 t -87.02 108.7 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -89.5 113.56 24.96 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -175.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.3 m -90.66 97.46 11.19 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.6 tp -78.11 150.16 33.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.439 ' O ' HD12 ' A' ' 54' ' ' ILE . 35.5 t70 -79.91 95.77 6.18 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 119.019 -1.073 . . . . 0.0 109.765 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 79' ' ' ARG . 4.4 mmp_? -133.12 110.07 9.92 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.315 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -85.92 -28.25 24.45 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 168.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -78.2 91.02 4.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 171.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 24.3 pttm -78.53 150.81 32.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -170.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -86.82 160.46 18.76 Favored 'General case' 0 C--O 1.256 1.403 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.811 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -81.35 140.97 34.45 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 5.5 p-10 -76.32 106.74 8.12 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 122.376 1.084 . . . . 0.0 110.19 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.7 pt -88.13 17.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 122.192 0.996 . . . . 0.0 109.468 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 85' ' ' ASP . 42.2 ttp180 -63.21 -27.51 69.41 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.812 -1.54 . . . . 0.0 111.947 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.61 -16.82 78.99 Favored Glycine 0 C--N 1.317 -0.483 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.708 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -93.36 -3.4 53.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.731 0.3 . . . . 0.0 110.384 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.5 mt -66.08 135.72 27.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.155 0.502 . . . . 0.0 110.564 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.8 t -125.63 103.75 8.01 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -87.54 -8.59 56.15 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.593 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.24 123.15 36.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.404 HD13 ' CD ' ' A' ' 172' ' ' GLN . 20.1 mt -106.38 -71.06 0.76 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -164.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 11.1 pt-20 -50.45 137.09 19.62 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -165.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.34 -14.05 33.26 Favored Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.658 174.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.05 144.06 18.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 122.415 -0.462 . . . . 0.0 110.368 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.13 116.87 21.25 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.28 159.5 14.95 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.396 0.617 . . . . 0.0 110.731 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.2 m -129.39 133.52 47.41 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.37 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.7 mt -90.91 125.72 35.84 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.413 ' HB ' ' CG1' ' A' ' 149' ' ' VAL . 30.5 t -117.69 107.63 22.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.6 t -109.02 147.71 13.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.522 ' CE1' HG21 ' A' ' 109' ' ' THR . 2.6 t-80 -140.0 106.91 5.41 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.8 p -128.74 -170.47 2.27 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -89.91 -34.94 15.87 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 176.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -63.06 -45.5 91.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.788 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . 0.265 9.3 p90 -133.53 96.55 3.73 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.603 1.192 . . . . 0.0 112.509 175.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.522 HG21 ' CE1' ' A' ' 104' ' ' HIS . 90.8 m -83.43 122.58 28.69 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.943 178.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.01 71.24 0.52 Allowed 'General case' 0 C--O 1.245 0.867 0 C-N-CA 124.321 1.048 . . . . 0.0 112.867 176.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.5 m -102.15 99.15 9.25 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.998 176.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.4 mt -95.19 110.62 24.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.7 tp -128.9 108.23 10.26 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.864 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -68.28 124.9 24.77 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.0 m -99.05 -27.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.613 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.92 -164.8 12.19 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 119.81 -1.186 . . . . 0.0 112.119 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.08 129.98 19.33 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.014 2.476 . . . . 0.0 112.668 -177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 31.2 m -96.27 161.54 2.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.381 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.8 p -144.35 164.69 30.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.738 1.215 . . . . 0.0 108.683 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 52.2 ttm -86.93 139.28 30.78 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 136' ' ' ARG . . . -105.37 -40.57 5.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.739 0.305 . . . . 0.0 111.465 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.73 -113.51 3.7 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.606 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.7 mt -93.22 120.6 33.68 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.009 0.524 . . . . 0.0 110.049 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.739 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 C--O 1.248 0.977 0 CA-C-O 121.141 0.392 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 22.3 p -109.1 135.03 50.91 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.814 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -111.27 164.35 12.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.404 ' HG3' ' HB2' ' A' ' 172' ' ' GLN . 12.7 tpp180 66.38 27.49 9.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.577 1.151 . . . . 0.0 108.976 173.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.417 ' HE1' ' HA ' ' A' ' 134' ' ' MET . 25.2 mmt -79.57 150.44 31.08 Favored 'General case' 0 C--O 1.251 1.152 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.429 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.465 HG23 ' HB2' ' A' ' 170' ' ' SER . 8.6 tt -115.57 141.87 30.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 173.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.445 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 39.4 ttt180 -127.25 139.34 52.98 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 123.216 0.606 . . . . 0.0 111.319 -171.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -149.23 144.02 26.27 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.01 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.67 107.41 19.16 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.886 0.741 . . . . 0.0 110.171 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -173.02 138.17 0.75 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.75 92.08 2.45 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.511 0.672 . . . . 0.0 110.103 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.2 t -79.19 165.92 22.75 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.531 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -120.25 163.13 18.24 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.6 t -78.56 153.63 31.05 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.78 -9.11 63.97 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -89.32 4.5 48.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.204 0.526 . . . . 0.0 111.315 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.621 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 48.0 t -58.11 120.74 9.15 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.453 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.43 -12.52 56.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.02 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.29 131.99 27.63 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.413 ' CG1' ' HB ' ' A' ' 102' ' ' VAL . 7.4 p -70.21 124.59 26.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.699 0.761 . . . . 0.0 111.219 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.1 tp -94.2 98.71 11.14 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 22.6 p -140.07 156.44 46.58 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.312 0.577 . . . . 0.0 111.586 -174.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -121.24 -173.18 2.56 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 t -71.75 79.51 0.85 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.005 0.907 . . . . 0.0 112.952 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 105.91 8.96 33.39 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.98 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -137.31 104.44 5.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 84.4 mt -93.86 120.14 42.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -94.82 -34.06 12.62 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.577 0.703 . . . . 0.0 110.538 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 165.19 -149.08 15.15 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.309 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.443 ' O ' ' HB3' ' A' ' 170' ' ' SER . 46.0 pt -135.01 149.21 28.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -66.63 133.36 50.12 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.295 0.638 . . . . 0.0 110.71 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 86.6 t -108.46 -59.69 3.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.09 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -159.58 153.39 24.42 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.282 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -115.56 125.86 6.88 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.409 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -112.24 97.49 6.67 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.7 -113.33 5.19 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -99.91 -6.35 26.85 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.963 0.411 . . . . 0.0 110.497 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -96.18 102.35 14.13 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.343 0.592 . . . . 0.0 110.792 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.24 119.7 4.96 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -105.41 123.84 48.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.854 0.835 . . . . 0.0 110.213 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.465 ' HB2' HG23 ' A' ' 135' ' ' ILE . 14.6 m -123.94 166.17 16.14 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.908 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.504 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -98.42 131.0 45.04 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.404 ' CD ' HD13 ' A' ' 94' ' ' LEU . 46.5 mt-30 -73.39 121.54 20.64 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 123.869 0.73 . . . . 0.0 109.885 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 89.0 mt -95.44 85.0 4.1 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -72.34 146.02 47.39 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.458 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -65.7 -24.99 67.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -48.18 -39.1 19.84 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.232 1.813 . . . . 0.0 111.56 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -83.35 -9.9 58.79 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.05 -0.406 . . . . 0.0 111.477 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -122.42 18.16 10.54 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 121.126 -0.229 . . . . 0.0 111.157 -174.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.242 0.671 0 CA-C-O 121.845 0.831 . . . . 0.0 111.662 179.401 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo . . . . . 0 C--O 1.243 0.753 0 CA-C-O 121.42 0.508 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -66.92 -34.21 77.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.738 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.9 m -67.64 -43.68 79.76 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.672 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.54 -43.0 95.36 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.929 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -61.4 -45.48 94.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.02 82.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.01 0.433 . . . . 0.0 111.269 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.5 -44.02 75.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.986 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 p -73.78 -34.53 64.71 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 120.722 0.296 . . . . 0.0 111.594 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.35 -40.72 95.32 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.737 0.815 . . . . 0.0 109.494 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.5 tp -48.97 -61.0 2.3 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 125.209 1.403 . . . . 0.0 113.649 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -80.91 11.85 3.69 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -172.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -127.0 -53.57 1.41 Allowed 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.16 0.505 . . . . 0.0 111.512 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -107.01 -9.6 16.18 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -171.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.3 mt -105.05 125.65 60.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 120.731 0.3 . . . . 0.0 110.932 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.08 135.73 27.6 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.934 0.397 . . . . 0.0 111.131 177.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.5 m -68.1 132.78 47.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.662 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.89 113.1 31.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 121.002 0.43 . . . . 0.0 110.161 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.9 m -78.08 104.83 8.89 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.6 p -90.89 -165.11 1.28 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.412 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.1 m -84.7 -7.6 59.16 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 121.049 0.452 . . . . 0.0 111.028 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -108.98 -46.21 3.65 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.223 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -166.17 -173.08 34.25 Favored Glycine 0 CA--C 1.497 -1.07 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.198 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -98.94 97.22 8.42 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -104.91 -173.69 2.36 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.2 p -124.52 145.28 49.65 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.58 150.26 18.7 Favored Glycine 0 N--CA 1.412 -2.964 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -107.48 118.81 37.71 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.75 119.9 5.1 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mm -83.66 -49.38 16.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 117.205 0.503 . . . . 0.0 109.656 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -170.56 157.12 5.7 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.174 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 5.3 m-20 53.75 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.292 1.037 . . . . 0.0 112.974 177.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -139.16 11.77 2.6 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.672 0.749 . . . . 0.0 109.078 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.0 t -88.25 112.79 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.893 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.4 m -128.82 152.85 48.03 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.9 m -115.65 148.97 18.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.0 tp -151.96 148.62 21.87 Favored Pre-proline 0 CA--C 1.564 1.499 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -67.26 147.77 79.06 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 121.92 1.746 . . . . 0.0 111.899 174.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.8 m -66.11 -41.36 90.67 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.036 0.446 . . . . 0.0 112.202 -176.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -65.76 -13.26 59.05 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.73 -26.95 63.61 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 62.79 87.37 0.13 Allowed Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.622 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.12 151.23 15.97 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 122.325 2.017 . . . . 0.0 110.066 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.14 -168.88 24.03 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.49 -13.47 59.82 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.205 0.526 . . . . 0.0 111.885 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -148.08 138.82 23.07 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.61 160.65 42.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.2 mt -93.31 107.68 19.46 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.3 p -90.07 84.22 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-O 122.864 1.316 . . . . 0.0 109.354 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.5 t30 62.36 20.69 12.01 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.614 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.87 -47.85 0.98 Allowed Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.545 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -66.9 124.7 23.7 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -80.22 123.23 27.76 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 78' ' ' ASP . 8.6 tp -122.35 125.68 73.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -72.88 123.83 24.19 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.478 0.656 . . . . 0.0 109.379 175.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.0 t -93.66 116.23 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.489 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 28.7 ttpp -68.4 -72.09 0.19 Allowed 'General case' 0 C--N 1.293 -1.883 0 O-C-N 123.499 0.499 . . . . 0.0 111.023 -175.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.489 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.4 m-20 -108.63 146.12 33.87 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 122.039 -0.413 . . . . 0.0 110.925 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -116.69 102.7 9.66 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.509 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 91.7 m-85 -89.56 94.63 9.94 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.613 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -71.18 98.64 1.73 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 174.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.3 tp -77.05 108.15 9.92 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 122.252 1.025 . . . . 0.0 112.563 -167.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.84 151.09 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.796 0 CA-C-N 113.415 -1.72 . . . . 0.0 107.225 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.39 140.11 89.91 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.13 -21.36 9.06 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.496 2.798 . . . . 0.0 114.821 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.22 8.54 23.58 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.053 0.454 . . . . 0.0 110.978 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.2 t30 73.36 68.03 0.11 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.821 1.649 . . . . 0.0 112.004 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.0 mt -143.2 147.3 20.56 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -90.52 156.1 18.41 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.418 1.008 . . . . 0.0 111.987 -174.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.428 ' HG ' ' HB2' ' A' ' 133' ' ' ARG . 8.7 mp -112.33 -11.73 13.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.479 174.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 68.26 25.07 7.27 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 123.267 1.508 . . . . 0.0 108.284 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 tp -125.19 142.08 51.71 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.417 -1.719 . . . . 0.0 109.426 -174.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.0 m -135.82 134.04 38.48 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 43.2 t -102.08 125.67 56.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.37 138.19 42.99 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.106 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.2 m -98.65 99.16 10.25 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.8 mt -80.44 104.97 11.34 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.419 ' O ' HD12 ' A' ' 54' ' ' ILE . 33.9 t70 -81.36 92.82 6.47 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -146.49 175.25 10.71 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.77 -22.75 23.13 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -78.97 123.07 26.93 Favored 'General case' 0 C--O 1.247 0.969 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.012 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 20.4 pttp -100.22 139.51 35.78 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.051 -177.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -75.78 157.11 33.86 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.477 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -64.97 131.34 46.36 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.966 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.58 93.29 2.01 Favored 'General case' 0 C--O 1.2 -1.549 0 CA-C-O 122.029 0.918 . . . . 0.0 112.565 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.4 pt -96.24 21.27 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 O-C-N 120.83 -1.168 . . . . 0.0 109.584 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -69.4 -31.71 70.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.664 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -79.73 -7.37 88.56 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.129 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 64.7 m-85 -97.94 -0.8 44.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.245 0.545 . . . . 0.0 109.897 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.57 116.94 8.03 Favored 'Isoleucine or valine' 0 C--O 1.254 1.316 0 CA-C-O 121.229 0.538 . . . . 0.0 110.853 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.6 t -102.26 107.15 18.1 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 174' ' ' LYS . 32.5 mt-10 -87.95 -6.56 57.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -95.15 118.01 31.21 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 175.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.436 HD13 ' CD ' ' A' ' 172' ' ' GLN . 12.8 mt -116.11 -60.56 1.85 Allowed 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.968 0.89 . . . . 0.0 110.966 -170.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 34.5 tt0 -64.8 120.04 11.75 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.651 -167.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 112.36 -22.1 18.33 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.529 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.1 t -91.57 141.42 14.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.82 123.96 28.68 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -110.43 158.58 18.32 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.674 0.749 . . . . 0.0 111.355 -177.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.8 m -123.86 123.96 41.6 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.858 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.6 tp -95.78 116.32 28.72 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.42 104.15 14.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 93.5 t -84.21 115.51 26.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -153.17 156.6 38.9 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 78.1 p -175.49 -152.69 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -84.61 -25.87 28.28 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 119.273 0.942 . . . . 0.0 108.585 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -87.48 -48.86 7.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.98 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -94.39 144.14 25.81 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 23.4 m -148.81 124.42 10.42 Favored 'General case' 0 C--N 1.281 -2.403 0 O-C-N 121.356 -0.84 . . . . 0.0 110.311 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.63 30.86 20.51 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.068 0.855 . . . . 0.0 113.073 173.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 95.3 m -83.88 87.35 7.09 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-O 122.08 0.943 . . . . 0.0 108.741 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 75.4 mt -77.16 102.22 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.174 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.3 tp -109.51 103.83 12.78 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.104 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -76.13 121.6 23.08 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.9 m -104.19 -10.16 9.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.11 -153.12 24.23 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.632 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.29 124.87 11.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.544 2.163 . . . . 0.0 112.704 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 16.6 m -92.58 160.12 2.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.199 177.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 p -130.91 159.11 38.38 Favored 'General case' 0 C--O 1.251 1.169 0 O-C-N 123.346 0.404 . . . . 0.0 111.155 -177.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 25.3 ttt -79.65 118.06 21.13 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 136' ' ' ARG . . . -75.4 -42.17 54.43 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 176.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.2 -100.21 2.65 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.171 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 124' ' ' ILE . 7.1 tt -130.52 145.56 51.88 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.453 ' N ' HD23 ' A' ' 123' ' ' LEU . 14.8 tt . . . . . 0 C--N 1.291 -1.938 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 N--CA 1.442 -1.508 0 CA-C-O 121.373 0.489 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.8 m -119.28 133.39 55.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 133' ' ' ARG . 3.0 t-20 -131.08 170.72 14.14 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.428 ' HB2' ' HG ' ' A' ' 70' ' ' LEU . 30.6 mmt180 64.48 41.62 5.51 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.211 1.004 . . . . 0.0 108.925 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.525 ' SD ' ' HB3' ' A' ' 169' ' ' PHE . 48.3 ttm -109.56 149.63 29.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.634 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.425 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 13.2 tt -115.19 147.61 18.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 123.765 0.826 . . . . 0.0 108.856 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.434 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . 43.7 ttp180 -127.62 143.95 51.12 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.116 0.484 . . . . 0.0 111.089 -174.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -149.14 136.23 19.9 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 171.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.97 91.01 7.07 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.867 1.317 . . . . 0.0 111.905 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -156.3 125.88 6.28 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.93 89.79 1.43 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.531 0.52 . . . . 0.0 110.624 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.0 p -79.27 170.1 17.12 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.885 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -110.14 141.8 42.52 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.346 0.593 . . . . 0.0 111.423 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.8 m -71.22 125.98 28.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 146' ' ' CYS . . . 125.52 -25.32 5.68 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -174.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -87.16 24.31 1.6 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.402 ' H ' ' C ' ' A' ' 144' ' ' GLY . 26.6 m -75.39 128.13 34.68 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.55 -177.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.74 1.4 49.43 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.264 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.79 135.8 28.74 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 86.5 t -90.32 120.09 38.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 CA-C-O 121.18 0.514 . . . . 0.0 110.58 -174.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.4 tp -92.1 106.71 18.66 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.9 p -142.22 -178.9 5.95 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.306 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.75 -175.42 5.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.3 m -61.02 101.8 0.17 Allowed 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 122.602 0.361 . . . . 0.0 111.617 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 73.11 22.7 78.79 Favored Glycine 0 C--O 1.244 0.734 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.12 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 58.2 mttp -140.81 114.17 8.66 Favored 'General case' 0 C--O 1.206 -1.213 0 O-C-N 122.887 -0.184 . . . . 0.0 111.115 -175.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.29 126.85 57.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.08 -38.07 9.89 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.719 0.771 . . . . 0.0 109.504 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 165.11 -160.22 33.48 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.849 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.74 145.29 33.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 120.704 0.288 . . . . 0.0 110.402 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -66.13 130.98 45.09 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.88 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.0 t -95.9 -56.68 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.43 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.17 164.09 29.26 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.03 125.35 8.54 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -111.16 81.75 1.49 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.93 -123.65 6.38 Favored Glycine 0 N--CA 1.422 -2.235 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -89.17 -13.94 37.21 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.208 0.527 . . . . 0.0 109.7 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -98.26 122.85 41.94 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.065 0.459 . . . . 0.0 111.424 -177.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.19 121.99 6.54 Favored Glycine 0 N--CA 1.422 -2.245 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.525 ' HB3' ' SD ' ' A' ' 134' ' ' MET . 84.3 m-85 -108.82 134.91 50.87 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.435 0.636 . . . . 0.0 110.993 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 134' ' ' MET . 18.8 m -133.11 158.99 41.4 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.966 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.491 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -92.71 140.9 29.05 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.436 ' CD ' HD13 ' A' ' 94' ' ' LEU . 78.6 mt-30 -84.58 124.49 31.48 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 121.475 0.655 . . . . 0.0 111.325 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 98.2 mt -93.63 92.78 7.7 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.469 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 68.2 mttm -87.09 150.45 23.99 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.501 ' O ' HG13 ' A' ' 179' ' ' VAL . 10.0 ptpp? -77.12 -13.68 59.91 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.958 -176.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -58.81 -22.43 58.51 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.602 1.161 . . . . 0.0 111.11 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 174' ' ' LYS . 45.5 m-85 -91.1 -8.74 47.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.196 0.522 . . . . 0.0 110.331 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -119.58 10.93 11.91 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.547 -175.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 175' ' ' LYS . 31.6 m . . . . . 0 C--N 1.313 -0.981 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo . . . . . 0 N--CA 1.483 0.872 0 N-CA-C 115.477 1.299 . . . . 0.0 115.477 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -59.14 -49.84 76.32 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.7 m -64.8 -39.54 93.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.89 0.476 . . . . 0.0 111.088 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.79 -41.79 78.23 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.006 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -62.35 -43.4 98.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.66 98.45 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.114 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.06 -33.06 75.14 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-O 121.246 0.546 . . . . 0.0 111.187 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -71.32 -53.57 13.74 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.9 tp -53.86 -44.37 70.3 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.8 0.84 . . . . 0.0 109.891 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' A' ' 15' ' ' ILE . 44.4 tp -51.65 -58.46 6.29 Favored 'General case' 0 C--O 1.206 -1.191 0 C-N-CA 125.522 1.529 . . . . 0.0 112.644 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -87.73 0.2 56.06 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -172.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -112.81 -44.1 3.35 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -121.75 3.49 10.07 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 11' ' ' LEU . 59.0 mt -112.72 130.23 66.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.166 0.508 . . . . 0.0 110.52 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.75 165.51 26.25 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.398 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.7 m -98.99 118.34 35.54 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.63 120.87 55.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.462 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 24.1 m -79.9 101.39 8.55 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.352 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.2 p -104.53 -174.31 2.51 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.281 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -75.16 -35.0 61.65 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -91.03 3.54 54.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.23 -174.32 27.96 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.167 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG2' ' HA ' ' A' ' 19' ' ' THR . 38.8 mt-10 -112.51 94.3 4.85 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -92.63 179.86 5.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.504 -171.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 20.3 m -86.61 124.28 32.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.719 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.0 130.81 10.38 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 175.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.0 tp -110.16 119.09 38.17 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.964 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.08 123.5 6.23 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 174.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mm -87.52 -44.11 15.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.402 ' ND1' ' HB3' ' A' ' 85' ' ' ASP . 62.6 t60 -171.85 144.18 1.73 Allowed 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.534 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.504 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 37.1 t70 60.32 -89.24 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.657 1.223 . . . . 0.0 112.083 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.649 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 36.0 ptt180 -140.25 11.13 2.36 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.998 0.904 . . . . 0.0 109.937 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.0 t -79.88 112.97 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.237 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 m -123.29 151.69 42.15 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 124.013 0.821 . . . . 0.0 110.235 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -125.77 141.85 44.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.7 tt -157.22 150.61 18.88 Favored Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -71.6 155.31 59.31 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.019 1.812 . . . . 0.0 112.202 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.6 m -71.16 -33.14 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.266 -0.271 . . . . 0.0 110.301 -177.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -66.15 -2.76 4.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.28 -28.23 59.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 69.38 81.06 0.2 Allowed Pre-proline 0 C--O 1.232 0.144 0 C-N-CA 125.336 1.454 . . . . 0.0 112.559 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -96.96 171.2 0.86 Allowed 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.777 2.318 . . . . 0.0 111.788 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.72 -143.31 6.95 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -91.1 -29.96 17.01 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.671 0.748 . . . . 0.0 110.075 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -141.23 135.33 30.6 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.75 -172.62 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.392 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.7 mt -113.25 128.14 56.38 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.39 96.88 4.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 58.29 20.37 7.16 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.188 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.02 -36.3 2.87 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.347 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -74.54 134.45 42.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.705 0.253 . . . . 0.0 110.832 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -75.83 111.89 11.67 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.53 HD12 ' O ' ' A' ' 78' ' ' ASP . 11.1 tp -120.14 140.22 44.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.074 0.464 . . . . 0.0 111.142 -174.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.532 ' N ' ' HD2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -97.85 138.84 34.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.8 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -100.32 109.63 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -70.02 -71.77 0.22 Allowed 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.904 0.753 . . . . 0.0 110.564 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -102.98 141.36 35.92 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -126.95 96.15 4.54 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -96.1 107.59 19.93 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -93.55 116.71 29.23 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.69 115.1 17.18 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.786 0.803 . . . . 0.0 111.534 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.21 145.5 32.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.466 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 14.7 t70 -70.99 145.81 92.07 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -46.33 -31.36 9.29 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.784 2.989 . . . . 0.0 113.981 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -82.5 5.9 19.2 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.03 0.443 . . . . 0.0 111.553 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 71.24 68.58 0.17 Allowed 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 125.281 1.432 . . . . 0.0 111.122 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 67.6 mt -131.16 139.87 49.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 131' ' ' THR . 0.9 OUTLIER -73.55 137.85 44.6 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -176.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 72' ' ' LEU . 72.2 mt -111.49 -2.16 15.61 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 63.72 -21.68 0.06 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 127.222 2.209 . . . . 0.0 113.812 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 70' ' ' LEU . 82.8 mt -70.28 118.98 13.79 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.17 0.51 . . . . 0.0 111.618 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.9 m -112.71 115.93 29.33 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.0 t -100.99 121.53 51.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -113.53 133.19 55.38 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.492 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 96.0 m -86.08 82.85 7.93 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 169.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.649 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 18.8 tp -76.87 132.18 39.0 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.53 ' O ' HD12 ' A' ' 54' ' ' ILE . 27.8 t70 -76.22 77.52 3.02 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 117.669 -1.612 . . . . 0.0 112.336 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -96.37 94.89 7.7 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -68.8 -12.71 61.81 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.449 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -98.29 100.97 12.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 8.2 ptpp? -62.43 136.83 58.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -172.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -81.62 152.79 27.0 Favored 'General case' 0 C--O 1.257 1.456 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.529 175.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -69.86 144.56 52.49 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.625 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.402 ' HB3' ' ND1' ' A' ' 31' ' ' HIS . 6.6 p-10 -72.01 97.45 1.88 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.916 0.865 . . . . 0.0 111.49 177.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.3 pt -91.2 18.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 121.596 0.712 . . . . 0.0 110.403 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -69.41 -30.87 68.92 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.774 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.39 -10.82 86.02 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.44 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -97.76 -5.18 35.54 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.7 mt -70.39 113.53 6.6 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 CA-C-O 121.301 0.572 . . . . 0.0 111.317 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -104.09 93.73 5.0 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.427 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 5.6 pt-20 -90.93 1.6 56.89 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.905 0.86 . . . . 0.0 111.049 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -97.17 110.2 22.79 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 167.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.417 HD13 ' HB ' ' A' ' 135' ' ' ILE . 6.4 mt -106.38 -57.36 2.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -164.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -42.02 113.94 0.49 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.445 1.498 . . . . 0.0 114.499 -168.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 -13.22 65.53 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.858 -1.064 . . . . 0.0 113.624 174.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 40.3 t -91.23 141.86 13.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 117.143 0.472 . . . . 0.0 110.68 -177.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -75.31 146.25 41.15 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.69 0.796 . . . . 0.0 111.614 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -138.61 170.46 15.97 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.053 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.5 m -135.39 148.47 49.37 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 tp -108.98 121.11 44.44 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 109.373 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.06 105.83 19.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.5 t -105.27 127.55 59.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -136.55 87.7 2.32 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.4 p -115.87 -172.38 2.15 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -79.49 -44.86 20.45 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 117.763 -1.575 . . . . 0.0 107.414 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.64 -42.19 78.36 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.809 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -105.89 91.39 3.72 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.0 m -87.76 100.38 12.8 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.591 -175.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 70.0 71.29 0.23 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.211 1.005 . . . . 0.0 113.203 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.1 m -108.83 95.33 5.58 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.6 mt -95.78 96.02 5.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.1 tp -113.42 123.42 50.03 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.977 -173.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.91 145.04 55.87 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.69 -39.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.559 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.62 -164.02 19.81 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.71 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 51.9 Cg_exo -58.38 129.35 32.27 Favored 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 123.712 2.941 . . . . 0.0 113.163 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.9 m -104.31 163.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.188 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.423 ' O ' HG13 ' A' ' 135' ' ' ILE . 42.8 p -129.61 174.75 9.38 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -116.71 131.35 56.97 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.57 -36.42 12.41 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.816 0.341 . . . . 0.0 111.227 -175.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.8 -105.76 3.19 Favored Glycine 0 CA--C 1.486 -1.74 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.82 138.58 51.01 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.404 HG13 ' HG3' ' A' ' 134' ' ' MET . 2.8 pp . . . . . 0 C--N 1.292 -1.901 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 N--CA 1.444 -1.41 0 CA-C-O 121.259 0.441 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 9.9 m -119.12 129.55 55.11 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -113.52 165.36 12.56 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.154 0.582 . . . . 0.0 109.944 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? 72.03 28.44 2.53 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.309 1.444 . . . . 0.0 109.402 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.404 ' HG3' HG13 ' A' ' 124' ' ' ILE . 95.4 mmm -86.92 126.24 34.56 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.616 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.454 HG23 ' HB3' ' A' ' 170' ' ' SER . 2.8 tt -99.26 143.77 12.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -132.28 139.79 48.37 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.95 0.405 . . . . 0.0 111.138 -170.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.482 ' CE1' ' HA3' ' A' ' 168' ' ' GLY . 37.0 p90 -140.41 135.86 32.49 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -93.72 117.31 29.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -176.09 143.52 0.55 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.74 92.86 0.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.911 0.862 . . . . 0.0 110.861 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.2 m -121.25 138.38 54.26 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -108.6 152.27 25.01 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.882 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -74.06 154.47 39.2 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 109.54 -16.67 31.45 Favored Glycine 0 C--N 1.307 -1.08 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -173.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -92.22 21.65 5.0 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 37.3 m -68.22 135.73 52.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.174 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.549 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 95.94 -4.74 65.78 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.15 135.82 30.09 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.24 115.22 25.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.278 0.561 . . . . 0.0 110.664 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.3 tp -85.38 101.53 12.66 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 18.0 p -151.73 168.94 23.46 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.675 0.75 . . . . 0.0 111.958 -172.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.85 -177.9 6.05 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.9 t -60.12 105.42 0.4 Allowed 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.976 0.893 . . . . 0.0 112.03 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.17 19.1 78.39 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.555 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -141.44 92.59 2.48 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 116.826 0.313 . . . . 0.0 110.683 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.3 mt -99.56 122.8 51.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -95.74 -36.12 11.29 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.591 0.71 . . . . 0.0 110.43 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 165.2 -156.33 28.24 Favored Glycine 0 N--CA 1.424 -2.166 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.663 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.9 pt -124.02 145.09 31.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -69.9 131.11 43.93 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 123.279 0.631 . . . . 0.0 110.135 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.65 11.11 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.762 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -129.86 -119.38 2.13 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.213 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 103.68 51.09 0.98 Allowed Glycine 0 CA--C 1.494 -1.261 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -106.92 96.81 6.7 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.83 -109.43 2.83 Favored Glycine 0 C--N 1.314 -0.668 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 41.3 mtm105 -111.38 14.67 21.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.017 0.437 . . . . 0.0 109.91 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -112.26 110.12 20.18 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.129 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.482 ' HA3' ' CE1' ' A' ' 137' ' ' TYR . . . -90.99 112.16 4.08 Favored Glycine 0 N--CA 1.411 -2.989 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -101.6 130.18 47.88 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.454 ' HB3' HG23 ' A' ' 135' ' ' ILE . 29.8 t -129.94 158.9 38.26 Favored 'General case' 0 C--N 1.265 -3.096 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.53 137.18 49.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -70.67 116.6 11.17 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 123.821 0.701 . . . . 0.0 112.174 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.2 mp -85.63 81.3 8.7 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.503 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -67.53 129.4 39.79 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.427 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 7.8 ptpp? -63.3 -16.21 59.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.768 0.318 . . . . 0.0 111.485 -177.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -58.37 -29.66 66.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.4 1.08 . . . . 0.0 110.73 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -80.75 -17.33 51.29 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.331 0.586 . . . . 0.0 110.29 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -111.68 0.33 16.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.284 -173.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.428 -1.539 0 CA-C-O 121.891 0.853 . . . . 0.0 109.027 177.442 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo . . . . . 0 N--CA 1.481 0.776 0 N-CA-C 112.827 0.28 . . . . 0.0 112.827 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -68.67 -39.66 80.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.956 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m -65.02 -46.71 80.23 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 122.938 0.495 . . . . 0.0 110.76 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.89 -29.17 58.38 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -63.91 -49.64 71.87 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.77 86.02 Favored 'General case' 0 C--O 1.194 -1.822 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.621 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.8 tp -57.47 -52.02 67.09 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.404 0.681 . . . . 0.0 111.446 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -67.9 -31.03 70.53 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.453 0.644 . . . . 0.0 110.302 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.7 tp -70.34 -52.94 18.99 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.42 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.444 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.4 tp -53.1 -54.5 34.68 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 126.344 1.858 . . . . 0.0 113.123 -176.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.2 mtp85 -62.21 -7.16 3.76 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -171.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -137.56 -50.65 0.62 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.416 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -91.36 -7.16 51.66 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -167.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 60.1 mt -115.89 113.58 43.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 42.1 ttm -140.37 136.98 33.69 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.771 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 50.7 m -63.6 135.31 56.7 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.202 0.601 . . . . 0.0 111.394 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 75.5 mt -129.11 126.53 64.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 92.1 m -89.6 110.24 21.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 72.4 p -91.99 -162.52 0.93 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.796 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 t -83.14 -1.14 52.13 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -104.51 -55.95 2.26 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.92 -158.02 21.18 Favored Glycine 0 CA--C 1.502 -0.727 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.817 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -89.85 113.58 25.2 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 116.773 0.287 . . . . 0.0 110.928 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -122.45 -172.65 2.51 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 104' ' ' HIS . 8.8 t -128.23 138.65 52.54 Favored 'General case' 0 N--CA 1.403 -2.79 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.257 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.96 148.59 18.22 Favored Glycine 0 N--CA 1.418 -2.54 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -111.08 118.32 35.68 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.61 111.55 3.44 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.3 mm -77.46 -45.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 85' ' ' ASP . 1.5 p-80 -179.58 161.54 1.04 Allowed 'General case' 0 CA--C 1.484 -1.585 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.601 177.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 52.17 -104.94 0.2 Allowed 'General case' 0 CA--C 1.554 1.125 0 O-C-N 124.511 1.132 . . . . 0.0 112.732 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -119.43 5.48 11.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.063 0.459 . . . . 0.0 109.872 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.1 t -85.59 107.54 16.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.704 -174.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -119.13 141.72 48.56 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.429 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.1 t -117.73 140.53 40.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 122.904 0.481 . . . . 0.0 111.536 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.6 tt -156.69 147.71 16.54 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 72.1 Cg_exo -55.87 154.4 26.96 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.736 2.291 . . . . 0.0 112.503 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -79.19 -28.86 42.68 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.099 -0.376 . . . . 0.0 111.407 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -73.31 -7.13 50.27 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.068 0.461 . . . . 0.0 111.178 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.78 -19.55 60.16 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.492 ' O ' ' HB ' ' A' ' 20' ' ' THR . 27.6 mt-30 53.11 78.61 0.39 Allowed Pre-proline 0 C--O 1.247 0.942 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 177.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -84.79 146.14 10.39 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.134 1.889 . . . . 0.0 110.097 173.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.81 -143.19 14.03 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.139 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -94.43 -20.53 19.63 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.16 0.505 . . . . 0.0 110.841 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -146.19 135.13 22.52 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.51 165.76 29.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 123.508 0.505 . . . . 0.0 110.408 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 78.3 mt -97.12 104.72 16.76 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -90.28 85.85 2.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 122.372 1.082 . . . . 0.0 109.739 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 66.76 14.96 10.01 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.514 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.51 -50.48 0.82 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.86 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.07 132.59 48.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.825 0.45 . . . . 0.0 111.28 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -78.66 124.84 28.6 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.8 tp -132.39 134.91 58.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.989 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -86.21 137.69 32.45 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.968 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.61 127.3 41.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -65.92 -62.8 1.3 Allowed 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.783 0.677 . . . . 0.0 109.661 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -152.87 148.44 27.16 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -132.93 151.55 52.03 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -172.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -125.37 123.18 38.8 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.933 -176.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -81.06 104.66 11.71 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 167.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 50.0 tp -88.44 111.24 21.56 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.33 179.91 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.813 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -77.19 140.66 65.97 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.79 -28.78 13.49 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.771 2.981 . . . . 0.0 114.766 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -87.9 10.41 18.81 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.472 0.653 . . . . 0.0 110.595 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.4 t30 65.49 70.15 0.45 Allowed 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 125.379 1.472 . . . . 0.0 111.274 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.8 mt -137.7 145.98 28.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.59 ' O ' ' HA ' ' A' ' 131' ' ' THR . 58.6 t30 -65.73 132.5 48.9 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.997 0.427 . . . . 0.0 110.742 -176.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.465 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 50.6 tp -105.72 -7.11 18.6 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 14.8 tp10 62.9 28.55 16.4 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.844 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.51 125.35 47.63 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.104 -172.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.1 m -123.15 123.02 39.87 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.6 t -100.84 120.4 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.5 128.63 53.67 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.3 m -85.92 86.71 7.35 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 tp -86.34 120.3 27.54 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.445 ' O ' ' HD2' ' A' ' 79' ' ' ARG . 33.1 t70 -63.42 101.79 0.35 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.326 0.584 . . . . 0.0 111.116 -177.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 26.9 mmm180 -126.42 117.89 23.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -77.05 -37.37 54.82 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -97.11 104.89 16.95 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -93.87 154.13 17.89 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -168.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -74.82 170.21 16.35 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.287 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -85.92 143.8 28.0 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.443 ' HA ' ' HB3' ' A' ' 31' ' ' HIS . 9.6 t70 -71.43 95.78 1.4 Allowed 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.043 0.925 . . . . 0.0 110.004 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.1 pt -86.82 9.37 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.117 0.961 . . . . 0.0 109.682 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -73.2 -28.08 61.98 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.32 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.54 -18.79 68.28 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.876 174.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -100.07 2.67 43.46 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 110.549 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.5 mt -76.43 127.15 37.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -94.66 112.68 24.43 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.2 0.52 28.1 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.179 -0.609 . . . . 0.0 112.311 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -113.76 122.57 47.5 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.08 -66.93 0.98 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -166.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -69.11 148.38 50.07 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -167.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.59 48.76 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 114.794 -1.093 . . . . 0.0 112.704 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.3 136.32 30.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 122.453 -0.439 . . . . 0.0 111.223 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.97 125.0 21.97 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.887 0.875 . . . . 0.0 109.974 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -120.2 161.03 21.75 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.518 0.675 . . . . 0.0 111.88 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 25.8 m -118.95 137.1 53.72 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 124.913 1.285 . . . . 0.0 107.941 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.3 tp -102.86 120.65 40.99 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 111' ' ' THR . 25.6 m -113.21 121.48 65.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.478 0.656 . . . . 0.0 110.715 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.45 143.88 37.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.311 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.466 ' O ' ' HB ' ' A' ' 26' ' ' THR . 17.4 t60 -146.94 90.56 1.91 Allowed 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.8 m -150.8 -177.91 6.27 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -64.47 -29.42 70.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.804 0.335 . . . . 0.0 111.044 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -59.76 -32.98 71.09 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.779 0.831 . . . . 0.0 112.046 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -175.73 128.47 0.24 Allowed 'General case' 0 C--O 1.245 0.845 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 p -93.14 123.41 36.39 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.442 ' OD1' HD22 ' A' ' 11' ' ' LEU . 93.8 m-20 65.0 71.0 0.46 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 90.8 m -115.52 117.83 31.46 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 174.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 66.4 mt -119.15 90.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.6 tp -127.16 132.66 50.47 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.522 -174.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 30.5 mp0 -66.35 136.65 56.1 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 124.266 1.027 . . . . 0.0 109.636 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.28 -7.65 12.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.46 -171.72 19.66 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.914 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.47 118.65 5.42 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.063 2.509 . . . . 0.0 112.038 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.46 145.52 12.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.882 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.5 m -125.75 150.56 47.62 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 21.7 ttt -71.97 135.69 46.52 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.4 -40.76 6.93 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.2 -99.87 2.34 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tt -138.28 118.91 13.97 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.295 -1.785 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.817 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.453 -0.902 0 CA-C-O 121.163 0.401 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 15.9 p -115.22 125.22 53.1 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.517 177.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -101.1 155.5 17.96 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 69.18 36.66 2.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.565 1.146 . . . . 0.0 107.932 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.404 ' HE2' ' HB3' ' A' ' 169' ' ' PHE . 8.4 tpt -85.21 147.58 26.52 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.515 -175.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.427 HG22 ' HB2' ' A' ' 170' ' ' SER . 14.7 tt -130.11 144.42 38.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -143.62 165.17 28.35 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.315 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -145.98 149.34 33.97 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -89.16 104.06 16.63 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.092 0.948 . . . . 0.0 110.424 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -167.89 136.17 2.38 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.92 91.21 4.17 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.528 0.68 . . . . 0.0 110.304 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -104.38 161.6 13.93 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.694 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -92.45 176.89 6.3 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.1 t -115.13 168.26 10.09 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 94.21 -4.89 71.12 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.918 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.433 ' HB2' ' CD2' ' A' ' 160' ' ' HIS . 16.8 mt-30 -95.1 15.1 19.89 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 8.1 m -59.01 118.17 5.51 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.39 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 113.95 -2.48 24.27 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -176.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.77 148.69 43.67 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 174.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.417 ' HB ' ' CG2' ' A' ' 102' ' ' VAL . 28.4 t -93.59 122.86 45.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.276 0.56 . . . . 0.0 110.745 -175.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.4 tp -94.86 105.02 16.93 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 14.3 p -145.8 170.9 15.61 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.031 0.443 . . . . 0.0 112.11 -172.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.03 178.83 6.99 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.1 t -55.62 106.22 0.23 Allowed 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 121.86 0.838 . . . . 0.0 111.959 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.8 19.08 76.51 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.238 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -143.28 106.05 4.49 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -92.46 128.1 44.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -98.66 -38.16 9.23 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.425 0.631 . . . . 0.0 110.863 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 170.58 -159.84 32.25 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.454 -1.355 . . . . 0.0 112.387 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.8 pt -118.64 144.08 27.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 120.96 0.41 . . . . 0.0 110.533 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.433 ' CD2' ' HB2' ' A' ' 145' ' ' GLN . 52.8 t60 -74.56 132.2 41.61 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.698 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.25 -6.13 11.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.278 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 149.0 -154.56 25.88 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 119.859 -1.162 . . . . 0.0 112.429 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.67 160.66 25.13 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -155.96 118.25 4.09 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.72 -117.38 4.58 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -110.62 8.31 22.71 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.061 0.458 . . . . 0.0 110.846 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -112.86 126.78 55.82 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.023 0.439 . . . . 0.0 110.416 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -99.85 138.23 13.73 Favored Glycine 0 CA--C 1.476 -2.361 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.404 ' HB3' ' HE2' ' A' ' 134' ' ' MET . 81.4 m-85 -113.5 132.81 55.54 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.773 0.797 . . . . 0.0 111.961 -173.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.427 ' HB2' HG22 ' A' ' 135' ' ' ILE . 54.3 m -141.08 164.2 30.91 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.821 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.31 138.4 47.83 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.42 ' OE1' ' HE3' ' A' ' 174' ' ' LYS . 79.5 mt-30 -74.41 116.99 15.71 Favored 'General case' 0 C--O 1.244 0.781 0 O-C-N 123.431 0.457 . . . . 0.0 111.253 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 63.6 mt -90.92 89.8 7.61 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.42 ' HE3' ' OE1' ' A' ' 172' ' ' GLN . 97.5 mttt -88.63 124.98 34.6 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.901 176.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -52.02 -17.73 1.14 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.136 1.374 . . . . 0.0 114.144 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -60.33 -27.76 67.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.406 1.082 . . . . 0.0 111.139 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -79.12 -19.27 51.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.802 0.334 . . . . 0.0 111.7 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -100.01 14.71 29.66 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 C--N 1.293 -1.882 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.35 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo . . . . . 0 N--CA 1.472 0.243 0 N-CA-C 110.194 -0.733 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -59.94 -36.33 76.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.919 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 m -70.05 -39.11 75.89 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 120.978 0.418 . . . . 0.0 110.133 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -69.94 -41.48 74.52 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.979 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -63.27 -42.74 99.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.501 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.43 -44.12 96.09 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.91 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.43 -48.53 81.35 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.096 0.559 . . . . 0.0 110.803 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 p -71.72 -37.58 70.59 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.9 tp -65.14 -45.98 82.78 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.624 0.77 . . . . 0.0 109.413 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.8 tp -48.7 -52.75 21.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.454 1.501 . . . . 0.0 112.526 -177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -76.74 -3.1 36.4 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.86 -53.86 2.61 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.849 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -104.04 -17.25 15.03 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -169.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.35 113.27 24.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.542 0.687 . . . . 0.0 110.418 -178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 90.3 mmm -116.16 153.28 32.1 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 m -101.11 121.54 41.99 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -112.61 123.8 68.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 O-C-N 121.928 -0.482 . . . . 0.0 111.603 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.5 m -80.82 102.9 10.29 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.254 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.2 p -102.31 -169.46 1.67 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -72.78 -20.54 61.15 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.997 0.427 . . . . 0.0 110.685 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -100.43 3.34 43.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.996 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.89 -175.62 16.53 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.994 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 mp0 -83.5 115.83 22.27 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.435 ' CD1' ' HB3' ' A' ' 146' ' ' CYS . 72.8 m-85 -122.36 -175.14 3.06 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 25.5 m -91.4 130.24 37.27 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.9 128.26 7.59 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -100.18 119.49 38.43 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.03 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.97 115.43 4.02 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 174.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.9 mm -84.52 -55.43 6.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 117.018 0.409 . . . . 0.0 111.169 -173.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -163.0 150.54 13.3 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.564 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 23.2 t70 54.7 -99.87 0.1 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.449 1.093 . . . . 0.0 111.98 173.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.564 ' HG2' ' OD2' ' A' ' 32' ' ' ASP . 14.1 ptp180 -126.65 14.56 7.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.697 0.76 . . . . 0.0 110.073 177.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.9 t -92.25 115.93 32.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.211 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -124.55 151.03 45.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.33 141.16 47.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 117.82 0.282 . . . . 0.0 111.752 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.3 tt -155.15 142.07 13.53 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 99.2 Cg_exo -49.03 144.17 16.42 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 123.702 2.935 . . . . 0.0 115.467 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.6 m -65.74 -37.21 85.76 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.432 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -63.61 -5.08 3.46 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.38 -18.05 29.23 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 54.94 86.77 0.16 Allowed Pre-proline 0 C--O 1.242 0.697 0 C-N-CA 124.959 1.304 . . . . 0.0 112.93 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -81.47 127.68 5.88 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.982 1.788 . . . . 0.0 110.119 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.54 -176.63 47.61 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.099 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -67.1 -37.2 83.51 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 120.855 0.36 . . . . 0.0 110.487 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -130.69 114.54 15.52 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.841 0.829 . . . . 0.0 109.716 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.94 176.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.162 -174.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.8 mt -113.34 112.65 24.05 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.38 89.36 2.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 59.57 30.92 20.59 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.287 1.435 . . . . 0.0 109.981 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.41 -33.71 5.0 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.045 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -71.52 118.54 14.46 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.457 0.303 . . . . 0.0 111.081 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 53' ' ' LYS . 12.1 mptt -75.25 132.92 41.41 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.441 HD13 ' HE ' ' A' ' 79' ' ' ARG . 6.6 tp -153.28 132.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.869 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -90.79 134.72 34.22 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -78.02 119.84 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.77 -66.72 0.85 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -102.66 128.47 49.34 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -106.15 118.21 36.03 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -114.78 94.45 4.77 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -75.57 118.78 18.79 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.79 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 3.5 mm? -87.4 83.77 7.27 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-O 122.842 1.305 . . . . 0.0 112.699 -177.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.51 148.71 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 172.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.46 135.45 41.08 Favored Pre-proline 0 C--N 1.269 -2.897 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.2 -25.32 4.37 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 124.034 3.156 . . . . 0.0 114.766 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -81.63 16.27 1.82 Allowed 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.976 -0.453 . . . . 0.0 111.582 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.0 m120 75.87 17.77 2.19 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.664 1.586 . . . . 0.0 112.383 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.3 mt -95.87 120.14 44.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.07 156.23 30.15 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 122.132 -0.355 . . . . 0.0 111.699 -174.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.444 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 60.4 tp -121.68 -9.96 8.83 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 13.6 tp10 65.44 20.01 11.67 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.931 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.21 144.89 41.92 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.323 -0.861 . . . . 0.0 110.577 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.4 m -124.0 117.79 25.53 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.5 t -94.61 118.51 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 CA-C-O 121.709 0.766 . . . . 0.0 108.999 177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 74.2 mt -106.08 124.0 48.9 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.268 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 m -97.24 98.34 9.92 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -70.79 136.47 48.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.227 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.518 ' HA ' ' NH1' ' A' ' 33' ' ' ARG . 38.7 t70 -84.41 73.87 10.44 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.623 1.202 . . . . 0.0 110.137 177.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.441 ' HE ' HD13 ' A' ' 54' ' ' ILE . 24.1 mmt180 -127.47 132.59 50.0 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.191 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -79.49 -20.75 46.51 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.39 109.85 9.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.281 -1.327 . . . . 0.0 107.848 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -106.78 170.73 7.77 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -113.37 169.33 9.04 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.411 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -73.5 125.7 28.55 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -72.81 104.78 4.11 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.21 1.005 . . . . 0.0 111.331 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.5 pt -94.12 21.93 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.959 0.885 . . . . 0.0 109.675 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -63.14 -32.98 74.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.602 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.49 0.42 89.17 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 116.178 -0.465 . . . . 0.0 113.507 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -103.77 -2.49 26.31 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 117.251 0.526 . . . . 0.0 110.551 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.67 126.68 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.342 0.591 . . . . 0.0 110.126 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.7 t -104.1 107.68 18.68 Favored 'General case' 0 N--CA 1.397 -3.099 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -87.03 -4.53 59.17 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.176 0.989 . . . . 0.0 108.488 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -94.17 115.82 28.15 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.422 HD22 ' CG ' ' A' ' 172' ' ' GLN . 26.3 mt -110.65 -63.32 1.41 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -169.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 17.0 pt-20 -58.26 121.99 12.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -168.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.28 -8.62 24.74 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.14 -0.936 . . . . 0.0 113.417 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 118' ' ' VAL . 21.9 t -108.81 144.65 16.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 117.34 0.57 . . . . 0.0 110.324 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.09 127.4 35.12 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -112.54 160.67 17.59 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.986 0.898 . . . . 0.0 112.042 -176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.1 m -122.73 137.65 54.85 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 tp -103.95 109.27 20.97 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.6 t -103.93 116.38 47.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.347 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.443 ' CG2' ' HB ' ' A' ' 111' ' ' THR . 28.3 m -122.0 151.91 25.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.282 0.563 . . . . 0.0 111.473 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -149.39 68.4 1.03 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 m -93.99 -150.25 0.29 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.57 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -73.18 -66.12 0.72 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.582 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -81.2 -36.85 29.58 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.48 86.09 6.68 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.392 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.5 p -97.15 117.2 30.82 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.21 42.97 5.13 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.448 1.118 . . . . 0.0 108.698 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.443 ' HB ' ' CG2' ' A' ' 103' ' ' VAL . 23.8 m -94.89 106.67 18.67 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.328 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.4 mt -97.86 98.45 7.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.5 tp -114.94 122.87 47.61 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.225 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -83.38 134.02 34.91 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 122.282 -0.261 . . . . 0.0 110.342 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 m -108.58 -14.49 9.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -175.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.97 -160.12 19.44 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.061 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.75 127.22 12.8 Favored 'Trans proline' 0 C--O 1.243 0.772 0 C-N-CA 123.498 2.799 . . . . 0.0 112.502 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 97' ' ' VAL . 27.5 m -96.9 157.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.458 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.421 ' O ' HG13 ' A' ' 135' ' ' ILE . 7.1 p -139.72 173.05 11.93 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 124.373 1.069 . . . . 0.0 108.542 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -92.01 128.8 37.98 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.17 -38.53 22.21 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.177 0.513 . . . . 0.0 111.624 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 132' ' ' ASN . . . 82.93 -102.78 2.41 Favored Glycine 0 N--CA 1.421 -2.355 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -176.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.78 133.06 54.25 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.717 0.77 . . . . 0.0 112.136 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 7.2 tp . . . . . 0 C--N 1.292 -1.932 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 168.05 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 N--CA 1.441 -1.598 0 N-CA-C 113.582 0.57 . . . . 0.0 113.582 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.1 m -119.54 116.79 26.79 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 51.8 t30 -115.4 163.61 15.47 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.417 -173.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 73.7 28.11 1.67 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.106 1.362 . . . . 0.0 109.36 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 91.2 mmm -88.09 158.3 18.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.745 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.485 HG23 ' HB2' ' A' ' 170' ' ' SER . 7.7 tt -116.33 138.73 45.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 122.927 0.491 . . . . 0.0 109.951 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -118.57 139.74 51.0 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.158 0.983 . . . . 0.0 111.975 -170.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -149.7 147.97 28.71 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -93.66 103.07 15.25 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -168.36 125.37 1.06 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.07 94.83 1.55 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.512 0.673 . . . . 0.0 109.769 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.0 t -80.03 176.06 10.08 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.001 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -119.94 156.36 30.96 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.7 m -76.04 114.9 15.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.01 -15.56 2.15 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.94 11.87 5.61 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.754 -0.262 . . . . 0.0 111.011 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.435 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 43.3 t -58.17 122.34 12.9 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.049 0.54 . . . . 0.0 110.083 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 86.32 10.02 75.03 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.233 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -72.16 137.17 24.78 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.437 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 25.4 t -79.08 107.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.186 0.517 . . . . 0.0 109.947 -177.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.6 tp -87.64 102.65 14.82 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 16.9 p -147.09 168.19 22.22 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.473 -173.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -137.89 -174.59 3.83 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 174.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 t -63.37 100.35 0.24 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 121.89 0.853 . . . . 0.0 112.058 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.87 10.22 85.9 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.198 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -128.91 98.28 4.91 Favored 'General case' 0 C--O 1.208 -1.118 0 O-C-N 122.491 -0.417 . . . . 0.0 109.969 -174.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 74.6 mt -99.02 117.81 44.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -90.53 -39.88 12.31 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.458 0.647 . . . . 0.0 110.365 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 164.92 -152.94 22.85 Favored Glycine 0 N--CA 1.422 -2.266 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.11 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 148' ' ' GLY . 28.1 pt -129.18 146.61 33.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.93 0.365 . . . . 0.0 110.808 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . 0.407 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 46.9 t-80 -69.48 134.48 48.95 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.446 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.1 t -99.84 -71.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.722 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.29 127.39 1.39 Allowed Glycine 0 N--CA 1.424 -2.125 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.25 153.15 20.67 Favored Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.693 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -131.7 100.57 5.16 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.75 -122.54 5.93 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -90.7 -12.16 37.51 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.041 0.448 . . . . 0.0 110.53 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -98.77 111.71 24.01 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.161 -175.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.61 119.99 5.43 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -105.97 116.65 32.3 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.573 0.701 . . . . 0.0 110.959 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.485 ' HB2' HG23 ' A' ' 135' ' ' ILE . 39.4 m -117.62 167.37 11.39 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.25 142.1 43.9 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 118.433 0.56 . . . . 0.0 110.374 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.651 ' OE1' ' HG2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -93.66 109.15 20.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.86 91.11 7.02 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.213 1.006 . . . . 0.0 111.079 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.651 ' HG2' ' OE1' ' A' ' 172' ' ' GLN . 6.8 mtpm? -65.01 148.1 52.26 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.336 -176.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -66.65 -22.46 66.1 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.024 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -68.24 -10.26 53.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.301 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -94.07 -20.62 19.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.671 0.748 . . . . 0.0 109.268 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -104.06 0.11 29.38 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.506 -173.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 66.8 t . . . . . 0 C--N 1.298 -1.632 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 175.036 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.409 ' O ' ' HB3' ' A' ' 5' ' ' GLU . 80.9 Cg_exo . . . . . 0 CA--C 1.545 1.069 0 N-CA-C 113.169 0.411 . . . . 0.0 113.169 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -60.84 -55.85 28.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.097 0.475 . . . . 0.0 110.508 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -59.25 -38.22 79.5 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.774 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 2' ' ' PRO . 31.9 tt0 -57.9 -55.46 34.56 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.604 1.161 . . . . 0.0 110.567 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.76 -46.95 86.29 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.003 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.67 -35.64 74.86 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.89 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.3 tp -71.42 -38.23 71.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.708 0.29 . . . . 0.0 110.821 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -73.1 -33.56 65.66 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.569 0.699 . . . . 0.0 109.167 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.6 tp -68.23 -41.96 80.45 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.215 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.468 ' HA ' HD12 ' A' ' 15' ' ' ILE . 58.5 tp -49.96 -54.17 21.62 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 125.076 1.351 . . . . 0.0 112.01 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.4 mtt-85 -80.32 13.35 2.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.606 -173.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -129.09 -64.25 0.92 Allowed 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.418 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -104.18 -2.87 25.13 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -173.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 11' ' ' LEU . 43.0 mt -99.93 134.75 38.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -154.38 144.85 22.22 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 122.484 0.314 . . . . 0.0 110.613 -173.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 m -80.23 118.13 21.63 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.0 mt -106.05 115.6 48.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-O 121.265 0.555 . . . . 0.0 109.569 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -83.08 97.28 8.69 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 79.1 p -91.95 -170.09 2.45 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.2 m -82.59 -13.34 56.71 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 120.706 0.289 . . . . 0.0 110.929 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -98.33 -24.08 15.36 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 110.417 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.63 -154.71 25.56 Favored Glycine 0 CA--C 1.501 -0.808 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.53 112.79 20.36 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 117.298 0.549 . . . . 0.0 109.531 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.452 ' HB3' ' O ' ' A' ' 146' ' ' CYS . 80.7 m-85 -120.66 -173.45 2.59 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 147' ' ' GLY . 5.9 t -113.93 136.91 52.37 Favored 'General case' 0 N--CA 1.406 -2.653 0 C-N-CA 118.959 -1.097 . . . . 0.0 109.934 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.02 136.89 13.64 Favored Glycine 0 N--CA 1.41 -3.092 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.5 tp -105.1 118.65 37.07 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.76 132.53 14.13 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 108.406 -1.878 . . . . 0.0 108.406 173.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.5 mm -96.08 -59.28 3.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 117.753 0.776 . . . . 0.0 109.902 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -162.12 147.37 12.87 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 55.53 -95.32 0.05 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 124.276 0.985 . . . . 0.0 111.21 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.625 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 18.9 ptp180 -132.84 10.87 4.31 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 122.044 0.926 . . . . 0.0 109.663 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -84.22 118.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.4 m -131.72 147.02 52.47 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.2 t -109.71 134.55 51.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.793 0.33 . . . . 0.0 111.727 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.428 ' HB ' ' CD2' ' A' ' 75' ' ' LEU . 6.7 mm -137.93 141.88 34.11 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 125.364 1.466 . . . . 0.0 108.358 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.06 146.57 93.86 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 121.975 1.784 . . . . 0.0 111.797 175.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.6 m -70.21 -33.35 71.58 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 123.214 0.605 . . . . 0.0 109.415 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -77.17 -4.74 46.15 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.579 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.62 -16.04 49.86 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.571 ' O ' ' HB ' ' A' ' 20' ' ' THR . 21.4 mt-30 58.14 82.67 0.23 Allowed Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.414 1.086 . . . . 0.0 112.877 176.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.08 -174.83 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.752 2.301 . . . . 0.0 111.287 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.59 179.19 18.44 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.55 -17.7 44.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.513 0.673 . . . . 0.0 110.313 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -141.71 135.92 30.31 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 12.7 p -141.6 149.98 19.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.514 -171.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -85.69 111.94 20.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.258 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.2 83.14 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.3 t30 68.65 -1.78 1.86 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.492 1.517 . . . . 0.0 111.364 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.11 -33.45 0.94 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.09 110.73 15.77 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 14.7 ptpt -78.68 137.38 37.78 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 116.819 -1.952 . . . . 0.0 109.101 174.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 78' ' ' ASP . 10.5 tp -128.99 150.69 34.85 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -91.24 142.84 27.28 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.8 t -108.73 131.19 60.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -78.29 -79.01 0.13 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.797 0.332 . . . . 0.0 111.286 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -113.75 140.17 48.5 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -104.5 93.51 4.82 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.502 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.5 m-85 -80.8 94.02 6.34 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -76.09 94.15 3.42 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.542 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 32.7 tp -85.46 103.53 14.42 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-O 121.616 0.722 . . . . 0.0 109.521 -172.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.06 178.9 2.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.71 139.29 58.24 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.2 -21.61 13.42 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 123.557 2.838 . . . . 0.0 114.542 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.3 6.1 24.23 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.2 m120 77.37 12.28 2.12 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.289 1.436 . . . . 0.0 112.747 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.0 mt -77.64 146.16 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -70.33 142.74 52.15 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 120.995 0.426 . . . . 0.0 111.622 -174.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 60.9 tp -117.38 -17.6 10.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 171.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 75.72 -17.02 0.54 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.284 1.434 . . . . 0.0 112.909 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.06 113.15 18.02 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.6 m -100.24 116.86 33.23 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 168.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 68.0 t -95.84 107.07 19.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.428 ' CD2' ' HB ' ' A' ' 37' ' ' ILE . 2.9 mm? -91.66 132.47 36.33 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.254 -178.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 m -83.68 80.3 9.17 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 171.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.625 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.7 tp -74.54 103.3 4.81 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.407 ' O ' HD12 ' A' ' 54' ' ' ILE . 12.9 t70 -73.8 84.07 1.66 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.432 0.634 . . . . 0.0 112.51 -168.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.409 ' HG3' ' CE2' ' A' ' 83' ' ' PHE . 31.4 mmt180 -99.14 125.08 44.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.197 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -74.78 -34.41 62.44 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -92.04 95.84 10.01 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -74.51 161.04 30.14 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.788 -1.096 . . . . 0.0 113.562 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.409 ' CE2' ' HG3' ' A' ' 79' ' ' ARG . 88.9 m-85 -91.27 172.57 8.45 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.042 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -73.88 137.57 43.8 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.07 95.32 1.2 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.222 0.534 . . . . 0.0 109.572 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -93.61 14.55 2.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 122.693 1.235 . . . . 0.0 109.975 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -31.13 59.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.018 -1.901 . . . . 0.0 108.764 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.07 -6.61 74.48 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 114.893 -1.048 . . . . 0.0 112.428 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -109.9 4.31 21.43 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.156 -0.614 . . . . 0.0 110.943 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.1 mt -73.22 125.95 33.06 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 CA-C-O 121.052 0.453 . . . . 0.0 110.292 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.0 t -115.24 106.8 14.46 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.428 ' OE2' ' HE3' ' A' ' 174' ' ' LYS . 7.9 pt-20 -88.53 -5.37 58.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.941 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -85.78 105.93 16.66 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 168.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.9 mt -99.98 -53.84 3.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -164.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -58.93 135.33 57.54 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.8 -38.83 3.13 Favored Glycine 0 N--CA 1.434 -1.443 0 CA-C-N 114.891 -1.05 . . . . 0.0 113.415 174.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 21.3 t -73.49 144.01 13.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 120.539 0.209 . . . . 0.0 110.906 -174.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.47 120.89 24.5 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.62 17.72 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 122.02 0.914 . . . . 0.0 111.444 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 28.1 m -127.39 131.31 50.35 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.52 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.4 tp -102.85 126.31 49.94 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.819 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.41 107.66 19.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 46.4 t -93.37 108.18 20.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.611 -178.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -133.77 124.71 27.08 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.3 t -174.98 -175.17 0.84 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -87.02 -15.29 39.11 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -94.93 -24.53 16.93 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.535 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.64 103.73 3.96 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.8 m -105.02 111.77 24.67 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 71.06 33.58 2.03 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.796 0.838 . . . . 0.0 113.238 169.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.414 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 16.2 m -93.31 109.44 20.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.512 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.0 mt -100.55 125.77 54.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.7 tp -140.69 129.36 22.89 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.942 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 4.2 mp0 -69.39 135.92 50.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.78 -19.54 6.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.21 -176.74 16.34 Favored Glycine 0 N--CA 1.433 -1.548 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.482 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 37.4 Cg_endo -68.07 129.01 18.59 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.688 2.259 . . . . 0.0 111.625 178.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.8 m -97.26 165.03 2.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.468 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.3 t -147.99 155.54 41.65 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 53.8 ttp -90.73 134.65 34.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.33 -28.52 15.52 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.308 0.575 . . . . 0.0 110.086 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.4 -87.25 1.17 Allowed Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -137.24 133.22 34.85 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.2 tp . . . . . 0 C--N 1.296 -1.724 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -176.657 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo . . . . . 0 C--O 1.254 1.294 0 CA-C-O 121.019 0.341 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 m -131.06 131.1 44.02 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -99.19 162.92 12.78 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.511 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 8.0 mpt_? 66.82 35.72 4.84 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.579 1.152 . . . . 0.0 110.749 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 95.6 mmm -94.23 139.76 30.63 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.949 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 170' ' ' SER . 3.0 tt -116.38 140.42 38.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 124.649 1.179 . . . . 0.0 109.102 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -121.53 143.83 49.05 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.054 0.542 . . . . 0.0 110.767 -171.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -152.95 152.41 31.41 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 122.95 0.5 . . . . 0.0 111.049 172.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -89.58 105.42 17.78 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.308 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -172.49 132.85 0.61 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 125.05 1.34 . . . . 0.0 108.479 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.13 100.63 5.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.353 0.597 . . . . 0.0 109.651 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.2 p -79.83 137.58 36.99 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.665 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 93.4 mttt -93.03 108.69 20.21 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.2 m -53.79 129.43 33.45 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.595 0.758 . . . . 0.0 111.692 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 134.25 -18.63 4.17 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -100.74 34.1 2.56 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.373 0.606 . . . . 0.0 112.101 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 25' ' ' PHE . 66.6 m -65.8 117.26 7.95 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.304 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 26' ' ' THR . . . 109.88 5.57 29.02 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.07 134.82 37.05 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.63 115.5 18.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.183 0.516 . . . . 0.0 111.149 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.61 108.87 21.17 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.6 p -142.0 179.25 6.99 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 120.907 0.384 . . . . 0.0 111.911 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.09 178.88 8.54 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.8 t -64.77 102.32 0.57 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.999 0.904 . . . . 0.0 111.843 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.08 73.65 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.416 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -145.27 120.6 10.25 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 81.7 mt -108.28 128.9 63.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 171.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.49 -47.56 6.21 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.413 0.625 . . . . 0.0 110.3 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.469 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 171.65 -149.37 11.95 Favored Glycine 0 N--CA 1.417 -2.61 0 C-N-CA 119.932 -1.127 . . . . 0.0 111.899 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.8 pt -130.59 142.19 44.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -73.87 125.74 28.87 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.7 m -107.81 -46.0 7.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.303 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 169' ' ' PHE . . . -157.26 136.47 4.91 Favored Glycine 0 CA--C 1.487 -1.697 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.072 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.3 140.64 11.05 Favored Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -123.95 132.15 53.67 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.79 -108.33 2.07 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.922 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 47.4 mtt180 -113.29 12.17 18.82 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -118.55 132.76 56.2 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.023 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -104.3 120.84 6.78 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 99.4 m-85 -109.11 117.08 33.22 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.19 0.995 . . . . 0.0 109.424 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 135' ' ' ILE . 18.5 m -117.6 164.28 15.17 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.079 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.08 139.61 49.74 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 3.4 pt20 -90.23 131.67 35.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.784 0.802 . . . . 0.0 110.927 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.469 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -94.26 85.06 4.53 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.305 175.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.428 ' HE3' ' OE2' ' A' ' 92' ' ' GLU . 57.2 mtpt -54.05 134.49 43.77 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.13 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.414 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 16.7 ptmt -72.17 -19.37 61.76 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.29 -174.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.463 ' HA ' HG13 ' A' ' 179' ' ' VAL . 13.4 mm100 -67.93 -9.66 47.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.281 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -89.11 -21.52 23.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.761 0.315 . . . . 0.0 110.2 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -109.68 -28.83 8.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.281 0.563 . . . . 0.0 111.839 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.463 HG13 ' HA ' ' A' ' 176' ' ' GLN . 11.0 p . . . . . 0 C--N 1.315 -0.895 0 CA-C-O 121.218 0.532 . . . . 0.0 109.996 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.94 -23.99 40.17 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.586 2.19 . . . . 0.0 111.027 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -66.92 -39.29 87.32 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.417 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 m -67.89 -44.47 76.93 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.688 0.795 . . . . 0.0 110.237 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -68.53 -36.31 78.66 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.451 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -63.17 -42.72 99.45 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.772 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.47 83.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.251 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.3 tp -69.96 -32.76 71.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.371 0.605 . . . . 0.0 110.504 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.4 m -76.9 -37.28 55.73 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.643 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.2 tp -68.44 -34.53 76.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.4 tp -54.09 -55.66 25.47 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.909 0.884 . . . . 0.0 111.568 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -72.97 -17.5 61.46 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.084 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HB2' ' HZ2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -90.23 -61.66 1.63 Allowed 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.95 -172.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -124.97 9.35 8.13 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -171.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 65.0 mt -110.81 134.72 52.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.706 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.65 167.38 23.93 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.833 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 m -92.49 125.97 37.37 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.1 mt -113.59 123.24 69.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 9.7 m -84.99 98.63 10.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.6 p -99.93 -170.25 1.86 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.457 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 30.1 t -71.53 -33.98 69.64 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.851 0.358 . . . . 0.0 110.495 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -75.59 -26.02 57.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.39 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.08 -171.3 30.06 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.493 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -91.75 104.19 16.67 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -114.02 -169.7 1.57 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.003 -174.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 10.9 m -92.05 128.9 38.07 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.965 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.94 127.23 7.71 Favored Glycine 0 N--CA 1.421 -2.312 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 174.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.4 tp -103.45 122.85 45.75 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.66 137.19 18.47 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.429 HG13 ' CE1' ' A' ' 178' ' ' PHE . 47.4 mm -97.66 -55.87 5.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -164.08 150.61 11.42 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.4 t70 58.29 -98.67 0.09 Allowed 'General case' 0 C--O 1.213 -0.839 0 O-C-N 124.21 0.944 . . . . 0.0 112.113 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 7.5 mpt_? -129.02 9.34 5.74 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.4 t -83.4 118.61 31.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.378 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.6 t -123.48 169.8 11.03 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.12 141.1 39.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.4 tp -151.15 150.59 27.65 Favored Pre-proline 0 CA--C 1.572 1.817 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.12 159.87 44.64 Favored 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 122.341 2.027 . . . . 0.0 112.771 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.8 m -82.01 -48.51 11.35 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -66.89 -8.48 29.52 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.38 -23.31 61.87 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 96.6 mt-30 58.85 84.01 0.21 Allowed Pre-proline 0 C--O 1.252 1.198 0 C-N-CA 125.601 1.561 . . . . 0.0 113.103 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -88.53 136.28 3.23 Favored 'Trans proline' 0 N--CA 1.438 -1.791 0 C-N-CA 122.816 2.344 . . . . 0.0 109.558 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.34 -176.83 51.61 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.91 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -75.03 -25.4 58.69 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.441 1.115 . . . . 0.0 108.042 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -129.5 138.38 51.35 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.89 167.28 16.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 41.8 mt -100.93 114.33 28.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.16 109.5 23.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.4 m120 61.78 23.8 14.05 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.544 0.688 . . . . 0.0 110.976 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 -13.68 63.55 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.564 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -85.15 128.21 34.57 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.442 0.697 . . . . 0.0 109.779 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.31 128.92 37.82 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.563 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.6 tp -144.53 150.24 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -105.64 147.99 27.86 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.934 0.397 . . . . 0.0 109.968 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.3 129.9 43.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -79.87 -53.17 7.02 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -132.73 133.74 43.87 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.222 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.78 110.42 12.15 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.927 -174.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -111.29 99.34 8.18 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -75.63 102.41 5.32 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 177' ' ' TYR . 41.4 tp -97.29 105.02 17.1 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 122.078 0.942 . . . . 0.0 112.415 -167.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.39 -179.85 3.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 11.8 t70 -79.87 137.34 54.07 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -42.02 -34.73 2.79 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 124.306 3.337 . . . . 0.0 114.014 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.06 22.06 1.25 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 71.43 18.14 5.58 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.186 0.994 . . . . 0.0 112.857 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 55.6 mt -84.93 132.87 30.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 131' ' ' THR . 0.8 OUTLIER -80.91 126.19 31.05 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -170.131 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.1 tp -99.06 -15.74 18.92 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 169.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 60.89 30.16 19.47 Favored 'General case' 0 C--N 1.363 1.154 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.854 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 18.7 tp -124.91 144.23 50.44 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.886 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.7 m -137.5 122.48 18.99 Favored 'General case' 0 C--N 1.286 -2.193 0 O-C-N 121.894 -0.504 . . . . 0.0 109.762 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.3 t -101.68 131.19 50.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -139.38 140.92 37.57 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.665 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.5 m -97.44 107.46 19.98 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.431 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 15.6 tp -86.45 143.14 27.92 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -175.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.563 ' O ' HD11 ' A' ' 54' ' ' ILE . 38.0 t70 -84.64 80.91 9.08 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 119.266 -0.974 . . . . 0.0 112.057 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -120.22 142.65 48.82 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -61.32 -59.88 4.61 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -70.92 149.36 46.81 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -101.01 149.85 23.51 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.967 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -81.12 145.81 30.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.3 tpt85 -70.52 128.93 37.84 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -61.47 96.72 0.06 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.469 0.652 . . . . 0.0 111.368 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -92.44 20.71 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 122.095 0.95 . . . . 0.0 109.538 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -73.95 -35.06 64.51 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.959 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.5 -5.37 85.83 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.992 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -103.55 5.74 36.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.484 0.659 . . . . 0.0 109.639 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.3 mt -74.81 133.6 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.6 t -111.03 100.62 9.27 Favored 'General case' 0 N--CA 1.396 -3.158 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -87.6 1.6 53.21 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.913 0.863 . . . . 0.0 110.131 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.82 112.27 24.17 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 168.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.2 mt -116.56 -61.11 1.77 Allowed 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.581 0.705 . . . . 0.0 112.029 -168.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 33.4 tt0 -63.69 123.2 18.27 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.355 -168.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.13 -11.66 51.95 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.13 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.9 t -95.65 142.36 13.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -77.46 128.84 34.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -122.7 151.51 41.47 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.753 0.787 . . . . 0.0 111.22 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 m -116.02 135.38 54.01 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.948 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.433 HD21 ' HB2' ' A' ' 160' ' ' HIS . 2.4 tm? -97.01 111.45 23.67 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -107.58 105.72 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.8 p -111.59 130.36 65.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-O 121.217 0.532 . . . . 0.0 110.966 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 75.3 t60 -130.92 92.19 3.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.065 0.936 . . . . 0.0 108.657 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.1 m -115.42 -175.27 2.67 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -69.69 -36.81 76.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -77.89 -60.07 2.52 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.817 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 104' ' ' HIS . 57.2 m-85 -84.9 87.06 7.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.778 -177.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.6 p -80.66 88.86 5.72 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.361 0.6 . . . . 0.0 112.347 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 58.97 70.2 0.67 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.43 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 33.1 m -97.13 108.41 21.13 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 69.2 mt -98.29 100.34 10.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.0 tp -113.63 115.25 27.61 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.728 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.53 120.89 19.75 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.9 m -102.13 -20.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.3 -158.87 14.08 Favored Glycine 0 N--CA 1.432 -1.622 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.152 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.14 127.08 9.01 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.849 2.366 . . . . 0.0 111.944 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 20.9 m -89.42 149.46 4.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.751 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.3 p -128.21 166.01 19.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.362 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.5 ttt -98.46 127.05 44.22 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.688 -0.632 . . . . 0.0 111.187 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.02 -52.13 5.61 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.09 -122.99 7.7 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.0 tt -111.29 112.02 23.5 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.05 163.0 39.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -108.57 144.67 35.96 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.5 tp -121.06 99.86 6.74 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.8 m 59.98 46.52 10.86 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.443 0.697 . . . . 0.0 111.071 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m 80.81 -12.69 1.0 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.348 1.459 . . . . 0.0 112.697 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.5 m -83.66 110.81 27.42 Favored Pre-proline 0 N--CA 1.44 -0.955 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.06 124.53 6.73 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.815 1.677 . . . . 0.0 111.371 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.526 ' HB ' ' SD ' ' A' ' 134' ' ' MET . 18.4 p -117.4 132.83 56.5 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.857 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -123.3 132.07 53.88 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -176.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 74.63 47.97 0.12 Allowed 'General case' 0 C--O 1.239 0.533 0 O-C-N 124.801 1.313 . . . . 0.0 111.825 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.526 ' SD ' ' HB ' ' A' ' 131' ' ' THR . 0.1 OUTLIER -97.64 139.28 33.77 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.253 174.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.5 HG23 ' HB3' ' A' ' 170' ' ' SER . 3.4 tt -101.43 130.07 51.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -128.09 132.13 49.01 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.343 0.592 . . . . 0.0 111.128 -171.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -120.62 134.13 55.31 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.188 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 166' ' ' ARG . 10.7 t70 -83.95 96.31 8.8 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -156.45 124.15 5.51 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.868 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.5 99.7 0.32 Allowed 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 124.175 0.922 . . . . 0.0 109.44 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.2 t -105.61 147.31 28.59 Favored 'General case' 0 N--CA 1.407 -2.576 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.365 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -87.28 94.19 9.6 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.1 t -45.76 143.83 1.92 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 124.548 1.139 . . . . 0.0 113.526 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.19 -2.27 2.31 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.079 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -90.3 40.29 1.0 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.719 0.408 . . . . 0.0 112.071 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 74.8 m -60.97 117.31 5.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.175 0.512 . . . . 0.0 110.954 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.524 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 101.45 2.28 53.56 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.68 122.96 31.43 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 112.203 -0.359 . . . . 0.0 112.203 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.571 HG12 ' SG ' ' A' ' 151' ' ' CYS . 54.3 t -74.15 108.1 5.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 124.005 0.922 . . . . 0.0 109.264 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.2 tp -88.67 104.17 16.62 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.665 ' SG ' HG13 ' A' ' 156' ' ' ILE . 84.0 m -145.49 174.92 10.73 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -173.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.31 -177.4 5.74 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.6 m -59.53 102.39 0.14 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.035 0.445 . . . . 0.0 111.819 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.91 26.64 72.18 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.18 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -141.4 105.56 4.8 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.665 HG13 ' SG ' ' A' ' 151' ' ' CYS . 2.5 mp -91.81 119.88 39.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -92.24 -34.88 14.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.974 0.892 . . . . 0.0 109.809 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.73 -156.35 27.52 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.6 pt -134.19 140.81 45.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.779 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.433 ' HB2' HD21 ' A' ' 101' ' ' LEU . 20.9 t60 -67.96 105.42 2.0 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.41 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.41 -38.39 13.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.42 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.49 87.8 0.07 OUTLIER Glycine 0 N--CA 1.426 -2.019 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.649 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.88 155.67 21.22 Favored Glycine 0 N--CA 1.428 -1.847 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -151.77 135.21 16.09 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 65.97 -133.26 34.24 Favored Glycine 0 C--N 1.313 -0.74 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 99.2 mtt180 -87.21 6.17 34.46 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -117.05 101.72 8.72 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.86 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.31 107.37 3.09 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -93.31 118.91 31.84 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.777 0.799 . . . . 0.0 111.751 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.5 ' HB3' HG23 ' A' ' 135' ' ' ILE . 30.9 t -120.12 151.09 39.57 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.398 -1.273 . . . . 0.0 107.578 176.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.3 142.72 27.45 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -80.42 105.63 11.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 123.869 0.73 . . . . 0.0 110.575 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.03 88.09 7.45 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -90.51 151.06 21.52 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -60.17 -26.61 66.45 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -50.4 -37.11 35.91 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.36 1.064 . . . . 0.0 112.094 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.446 ' CD1' HD22 ' A' ' 62' ' ' LEU . 46.7 m-85 -75.86 -17.82 59.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.991 0.424 . . . . 0.0 111.846 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.429 ' CE1' HG13 ' A' ' 30' ' ' ILE . 73.9 m-85 -109.51 8.79 25.31 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.46 -174.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 83.0 t -72.63 112.5 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -56.75 -57.05 14.12 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 123.64 0.588 . . . . 0.0 112.384 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.67 125.97 47.9 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.318 177.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.871 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.624 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.4 -32.18 93.25 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.075 2.517 . . . . 0.0 112.663 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.21 -38.83 91.66 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.256 0.55 . . . . 0.0 110.036 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 m -71.77 -41.38 68.42 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.199 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.15 -49.27 78.52 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.225 0.61 . . . . 0.0 111.207 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -63.78 -44.41 93.47 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.082 0.468 . . . . 0.0 110.845 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.07 -41.92 90.1 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.594 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.0 tp -66.79 -33.51 75.78 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.092 0.557 . . . . 0.0 111.428 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -78.51 -46.05 20.49 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 120.749 0.309 . . . . 0.0 110.299 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.7 tp -55.82 -35.67 66.61 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.952 0.901 . . . . 0.0 109.835 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.422 ' HA ' HD13 ' A' ' 15' ' ' ILE . 50.7 tp -52.68 -50.02 64.13 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.473 1.509 . . . . 0.0 112.791 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -81.05 -22.79 39.03 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.386 0.612 . . . . 0.0 110.738 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -91.0 -46.55 8.08 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.056 -169.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -128.73 3.27 5.46 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 11' ' ' LEU . 53.8 mt -115.83 137.15 50.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.464 -176.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.82 169.4 21.78 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.905 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 94.8 m -98.23 123.15 42.16 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 65.5 mt -110.56 115.52 50.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 11.4 m -88.57 103.81 16.25 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 81.6 p -89.87 -165.8 1.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.865 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -69.42 -19.69 63.79 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.221 0.534 . . . . 0.0 110.127 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -97.7 -45.07 6.5 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.83 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.31 -179.73 48.49 Favored Glycine 0 CA--C 1.497 -1.031 0 C-N-CA 119.242 -1.456 . . . . 0.0 112.592 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 2.8 mp0 -78.27 107.94 11.24 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.474 ' HB3' ' O ' ' A' ' 146' ' ' CYS . 26.5 m-85 -117.01 -177.57 3.23 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 33.0 m -97.34 138.37 34.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.14 143.23 16.02 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 tp -113.56 122.0 45.92 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.31 110.21 3.54 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 175.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.1 mm -71.77 -51.27 33.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 122.354 0.262 . . . . 0.0 110.963 -174.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -170.85 147.33 2.71 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.442 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 38.1 t70 60.53 -81.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.968 1.307 . . . . 0.0 112.943 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 14.4 ptp180 -149.85 13.19 0.8 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.769 0.795 . . . . 0.0 110.246 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.44 113.79 26.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.68 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.7 m -120.12 156.13 31.66 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -137.44 144.65 31.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 117.885 0.311 . . . . 0.0 110.544 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.409 HG23 HD21 ' A' ' 75' ' ' LEU . 14.7 tt -157.12 146.7 15.3 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 6.8 Cg_endo -51.45 141.41 41.56 Favored 'Trans proline' 0 C--N 1.363 1.304 0 C-N-CA 122.907 2.405 . . . . 0.0 113.393 177.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.3 m -57.07 -48.19 79.15 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.929 0.892 . . . . 0.0 113.123 -176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -66.75 -1.5 3.92 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.47 -25.08 60.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.661 ' O ' ' HB ' ' A' ' 20' ' ' THR . 29.4 mm-40 61.6 82.43 0.22 Allowed Pre-proline 0 N--CA 1.467 0.396 0 C-N-CA 125.462 1.505 . . . . 0.0 114.425 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -85.17 124.75 2.92 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.793 2.329 . . . . 0.0 109.984 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.96 -125.51 0.67 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.776 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -96.11 -59.77 1.77 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.616 0.722 . . . . 0.0 109.293 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 42.4 p-10 -124.19 125.5 44.53 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.449 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.84 148.18 16.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.532 -173.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.1 mt -79.93 102.14 9.02 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.938 0.399 . . . . 0.0 110.175 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 17' ' ' THR . 7.5 p -94.29 90.0 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 122.063 0.935 . . . . 0.0 109.055 176.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m120 62.39 8.1 2.64 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.934 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.43 -32.47 1.96 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.932 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -82.77 125.14 30.94 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -88.05 96.6 10.57 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.444 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.4 tp -101.31 132.65 46.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.359 -171.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -82.44 121.52 26.85 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.095 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.8 t -84.06 132.93 30.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -79.31 -48.16 14.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.968 0.413 . . . . 0.0 110.963 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.26 138.71 31.58 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -115.47 98.65 6.85 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.439 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 80.0 m-85 -84.07 129.88 34.89 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.758 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -84.42 112.15 20.1 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 173.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 53.1 tp -90.31 99.0 12.1 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.539 0.685 . . . . 0.0 109.346 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.86 148.47 16.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.378 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.26 141.26 57.39 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.57 -3.22 0.55 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 123.944 3.096 . . . . 0.0 114.546 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.88 -2.86 41.84 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.0 t30 77.89 6.45 2.75 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 125.683 1.593 . . . . 0.0 111.273 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.577 ' HB ' ' ND2' ' A' ' 132' ' ' ASN . 50.9 mm -96.43 150.44 4.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 131' ' ' THR . 52.9 t30 -70.83 126.92 30.91 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -177.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 54.1 tp -92.08 -13.22 31.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 21.1 tp10 66.96 23.95 9.71 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.566 175.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.5 mt -117.42 135.19 54.06 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.563 -0.711 . . . . 0.0 111.753 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.5 m -114.38 130.25 56.68 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 94.1 t -102.04 120.47 51.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.409 HD21 HG23 ' A' ' 37' ' ' ILE . 2.4 mm? -103.51 127.11 50.97 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.392 -175.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 m -87.53 88.91 7.8 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.4 tt -89.99 124.26 34.6 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.444 ' O ' HD11 ' A' ' 54' ' ' ILE . 32.7 t70 -74.9 80.84 2.14 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-O 121.995 0.903 . . . . 0.0 110.275 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -100.41 131.57 46.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.31 -175.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -74.77 -24.49 58.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.586 0.708 . . . . 0.0 109.82 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -88.82 119.6 29.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.153 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -77.31 113.28 14.91 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -62.67 138.68 58.56 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -74.65 142.97 44.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.515 ' OD1' ' HB2' ' A' ' 87' ' ' ARG . 10.0 t70 -67.66 99.06 0.75 Allowed 'General case' 0 C--N 1.311 -1.101 0 O-C-N 123.414 0.446 . . . . 0.0 111.535 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -90.65 19.14 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.781 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.515 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 85.3 mtm180 -71.44 -24.94 62.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.607 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.48 -19.22 79.64 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.817 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -93.54 -12.51 29.43 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.606 -0.349 . . . . 0.0 111.22 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.8 mt -64.76 120.93 12.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.318 0.58 . . . . 0.0 110.26 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 155' ' ' LYS . 5.7 p -105.67 112.56 25.69 Favored 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.712 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -84.43 -10.0 57.9 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.356 0.598 . . . . 0.0 110.316 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -85.76 117.74 24.82 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.5 mt -117.34 -53.71 2.43 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -168.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.18 115.11 5.18 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -167.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.88 1.29 58.62 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.524 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.17 160.49 2.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -73.33 155.12 39.75 Favored 'General case' 0 C--O 1.21 -0.981 0 C-N-CA 123.396 0.678 . . . . 0.0 109.605 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -159.05 152.22 22.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.759 0.79 . . . . 0.0 112.146 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 94.9 m -143.96 132.81 22.61 Favored 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 125.801 1.64 . . . . 0.0 107.916 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.2 tp -98.16 119.98 37.76 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.9 t -100.96 116.61 44.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.05 123.98 66.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.411 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 28.1 t60 -130.12 79.8 1.92 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.6 m -139.85 -165.81 1.96 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.83 -175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -71.42 -53.75 12.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -67.66 -39.6 84.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.13 0.49 . . . . 0.0 111.321 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -126.43 95.0 4.22 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.5 m -92.32 120.54 32.96 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.138 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.411 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 4.3 t30 61.97 42.89 9.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.858 0.837 . . . . 0.0 109.186 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.9 m -108.22 115.88 30.93 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.088 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 87.3 mt -90.09 109.19 20.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.3 tp -108.45 114.62 28.61 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 123.041 0.536 . . . . 0.0 109.983 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -71.38 145.77 49.17 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.834 0.349 . . . . 0.0 111.781 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.5 t -115.47 -51.43 4.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.841 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 113.0 -121.56 5.58 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -98.29 135.4 0.33 Allowed 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 122.989 2.459 . . . . 0.0 113.044 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.4 m -103.63 155.53 5.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.899 -0.501 . . . . 0.0 112.278 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.436 ' O ' HG13 ' A' ' 135' ' ' ILE . 17.5 p -131.88 178.75 6.53 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.65 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 46.5 ttm -114.2 140.32 48.65 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 121.483 -0.76 . . . . 0.0 111.165 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.463 ' HB3' ' HB2' ' A' ' 136' ' ' ARG . . . -104.75 -53.64 2.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.36 -117.69 5.95 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.798 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.9 tp -96.14 114.78 26.51 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.201 0.6 . . . . 0.0 109.892 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.0 pt -137.42 166.58 24.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -109.54 101.16 10.12 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.4 tp -117.07 134.61 54.54 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.5 t 63.43 34.56 12.78 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.5 m 63.0 21.33 12.84 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 124.429 1.092 . . . . 0.0 111.31 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.6 m -126.97 130.13 23.85 Favored Pre-proline 0 N--CA 1.43 -1.426 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -64.44 114.51 2.73 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.196 1.931 . . . . 0.0 109.823 173.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 20.8 p -127.21 128.97 46.93 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.179 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.577 ' ND2' ' HB ' ' A' ' 68' ' ' ILE . 41.8 p30 -110.25 171.07 7.67 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.715 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.51 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.9 mpt_? 67.32 23.8 9.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.813 0.845 . . . . 0.0 110.884 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.8 mmt -81.84 128.62 34.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.583 0.706 . . . . 0.0 111.687 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.44 HG23 ' HB2' ' A' ' 170' ' ' SER . 3.4 tt -96.88 136.84 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.629 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.463 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . 34.7 ttm180 -116.61 135.97 53.36 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.501 0.501 . . . . 0.0 111.097 -170.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.5 140.34 31.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.659 -0.496 . . . . 0.0 109.659 173.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.26 110.04 19.36 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -163.32 147.92 11.05 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.56 87.26 2.12 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.0 p -81.2 128.61 33.97 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.984 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -76.63 111.99 12.71 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.7 m -70.53 129.5 39.38 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.333 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 129.38 -37.38 2.2 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.601 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -75.37 52.03 0.59 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.077 0.951 . . . . 0.0 112.913 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 25' ' ' PHE . 56.9 m -63.4 147.86 50.07 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.395 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 93.53 1.25 66.37 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.749 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.98 129.56 38.35 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.6 109.2 8.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-O 121.195 0.521 . . . . 0.0 110.56 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.7 tp -89.33 99.71 12.65 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 23.4 p -126.82 -172.6 2.68 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.561 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.455 ' HB1' ' HB2' ' A' ' 155' ' ' LYS . . . -157.79 -169.57 2.89 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.4 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 20.7 p -62.79 96.02 0.08 Allowed 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.708 0.63 . . . . 0.0 110.849 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.23 25.17 76.05 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.549 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.461 ' HB3' ' OG ' ' A' ' 91' ' ' SER . 39.1 mttp -142.56 154.78 44.75 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 117.279 0.54 . . . . 0.0 109.665 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 151' ' ' CYS . 86.4 mt -137.22 128.17 40.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -100.25 -43.81 6.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.623 0.725 . . . . 0.0 110.23 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 172.92 -154.59 21.1 Favored Glycine 0 N--CA 1.416 -2.668 0 C-N-CA 120.283 -0.961 . . . . 0.0 111.14 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.6 pt -131.98 143.31 40.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 120.567 0.222 . . . . 0.0 110.628 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -58.58 126.2 26.61 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.352 1.061 . . . . 0.0 110.691 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.1 t -110.08 -63.88 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.32 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.44 108.79 0.61 Allowed Glycine 0 N--CA 1.421 -2.312 0 C-N-CA 119.901 -1.143 . . . . 0.0 112.293 -175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.94 115.0 4.37 Favored Glycine 0 N--CA 1.427 -1.954 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 175.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -114.74 97.61 6.37 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.487 0.661 . . . . 0.0 110.502 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.13 -98.49 0.64 Allowed Glycine 0 N--CA 1.425 -2.034 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.654 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.485 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 6.4 mpt_? -110.98 -0.7 16.62 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.619 -0.291 . . . . 0.0 111.055 -174.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -119.18 120.62 37.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.602 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.28 120.77 5.84 Favored Glycine 0 N--CA 1.418 -2.538 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -108.14 118.67 37.35 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.574 0.702 . . . . 0.0 109.931 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.44 ' HB2' HG23 ' A' ' 135' ' ' ILE . 28.6 m -115.83 157.5 24.33 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.693 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -98.81 132.54 44.09 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 10.8 pt20 -87.64 103.3 15.44 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.947 0.88 . . . . 0.0 110.655 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . 0.337 0.0 OUTLIER -85.11 79.79 9.47 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.18 0.991 . . . . 0.0 111.716 177.155 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -57.86 145.01 36.75 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.526 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.476 ' O ' HG22 ' A' ' 179' ' ' VAL . 20.2 ptmt -56.13 -25.41 45.96 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.358 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -58.66 -29.99 67.0 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.843 0.857 . . . . 0.0 112.311 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -74.81 -20.5 59.75 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.112 0.482 . . . . 0.0 110.78 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -101.68 11.14 39.35 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.501 0.667 . . . . 0.0 109.498 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 175' ' ' LYS . 92.5 t -97.1 134.93 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 174.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.58 -43.41 80.66 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.403 0.621 . . . . 0.0 109.638 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -104.79 90.56 3.52 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.547 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 . . . . . 0 C--N 1.31 -1.127 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.792 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.503 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -57.34 -32.26 93.34 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.197 2.598 . . . . 0.0 112.935 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -69.51 -40.64 76.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.66 -40.59 97.24 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.931 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -64.23 -40.05 95.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.857 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.18 -42.91 93.17 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.126 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.96 82.27 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.112 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.87 -35.68 80.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -82.84 -37.4 24.44 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.877 -0.514 . . . . 0.0 111.332 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.02 -41.17 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.411 HD11 ' HD1' ' A' ' 104' ' ' HIS . 54.5 tp -53.51 -51.42 62.88 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.638 1.175 . . . . 0.0 112.335 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -70.54 -12.82 61.82 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -125.38 -42.01 2.0 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -106.46 -18.06 14.09 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -169.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.5 mt -89.16 105.36 15.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.29 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.2 mtp -105.45 140.22 38.88 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.325 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 m -99.38 116.03 30.59 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.3 mt -111.02 118.48 57.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.352 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 99.8 m -85.4 109.12 18.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 73.3 p -96.02 -157.54 0.59 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.505 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.5 m -84.01 3.31 34.96 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 121.193 0.521 . . . . 0.0 109.946 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -115.66 -39.52 3.51 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.158 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.61 -153.14 23.99 Favored Glycine 0 CA--C 1.498 -1.022 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -92.76 115.58 28.24 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.263 0.554 . . . . 0.0 110.823 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -116.48 169.6 9.2 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.6 m -98.54 127.8 44.62 Favored 'General case' 0 N--CA 1.41 -2.443 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.268 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.68 129.44 9.29 Favored Glycine 0 N--CA 1.412 -2.956 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -100.08 116.43 32.09 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.023 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.6 113.98 4.66 Favored Glycine 0 C--O 1.212 -1.253 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.1 mm -90.87 -50.64 12.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 116.964 0.382 . . . . 0.0 111.593 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -156.09 121.22 4.75 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.831 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.432 ' OD1' ' HG3' ' A' ' 82' ' ' LYS . 28.9 t70 67.18 -79.98 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.148 0.905 . . . . 0.0 113.266 168.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -140.46 11.88 2.33 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.794 0.838 . . . . 0.0 109.54 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.4 t -91.95 115.22 30.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.305 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -120.78 139.22 53.43 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.4 t -114.64 135.27 55.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 120.581 0.229 . . . . 0.0 111.082 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.5 tt -146.54 145.03 21.98 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 59.9 Cg_exo -57.8 138.91 88.41 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.465 2.11 . . . . 0.0 112.415 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.668 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 21.5 m -60.94 -41.69 96.76 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -71.01 -0.27 9.03 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.91 -15.5 60.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.615 ' O ' ' HB ' ' A' ' 20' ' ' THR . 82.8 mm-40 60.44 82.0 0.23 Allowed Pre-proline 0 CA--C 1.518 -0.283 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 175.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.19 158.98 11.33 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.46 2.107 . . . . 0.0 109.579 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.36 -141.55 11.1 Favored Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.446 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -88.21 -15.22 36.53 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.02 151.77 39.07 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.13 153.98 39.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 7.2 mp -103.57 105.4 15.63 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.829 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.51 92.97 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 66.09 8.24 5.34 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.596 1.558 . . . . 0.0 110.564 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.63 -24.83 3.31 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.66 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 46.5 mt-30 -75.12 106.73 6.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.594 0.197 . . . . 0.0 111.062 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -68.9 103.53 1.83 Allowed 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.4 tp -112.06 121.46 64.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-O 121.241 0.543 . . . . 0.0 109.693 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -75.48 110.32 9.77 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.9 t -65.9 135.4 28.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.58 -63.14 1.31 Allowed 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -144.77 144.46 31.19 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -108.14 111.0 22.79 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.473 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 61.9 m-85 -96.59 113.18 24.72 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -77.15 114.18 15.68 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -88.92 94.86 10.09 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.1 t -112.33 149.29 14.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -65.48 142.08 98.22 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.56 -22.55 17.06 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.498 2.799 . . . . 0.0 114.193 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -94.83 14.45 21.39 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 122.058 0.933 . . . . 0.0 109.761 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 66.54 26.69 9.85 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.61 1.164 . . . . 0.0 111.943 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.8 mm -86.3 137.27 21.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 131' ' ' THR . 63.3 t30 -92.13 135.0 34.33 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.811 -171.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -123.01 2.45 9.33 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.701 172.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.668 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 4.9 tp10 62.84 23.35 13.94 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.179 1.392 . . . . 0.0 111.864 174.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.7 tt -95.8 120.89 36.87 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 121.666 -0.646 . . . . 0.0 110.141 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 m -114.89 127.39 55.67 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 60.8 t -99.74 107.75 21.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.5 mt -95.69 117.76 31.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.9 m -97.6 103.69 15.65 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -78.17 141.04 38.95 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.257 0.551 . . . . 0.0 111.479 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -91.32 83.25 5.45 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.566 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 11.0 mmm180 -134.06 175.14 9.75 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.806 -174.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -108.33 -28.6 9.32 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 123.325 0.391 . . . . 0.0 111.073 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.566 ' OE1' ' HB3' ' A' ' 79' ' ' ARG . 1.5 pm0 -70.4 127.25 32.11 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-O 121.281 0.562 . . . . 0.0 111.192 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.432 ' HG3' ' OD1' ' A' ' 32' ' ' ASP . 41.4 tttp -92.33 109.54 20.92 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -73.35 139.39 45.97 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.586 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -49.94 123.19 7.68 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.525 1.13 . . . . 0.0 110.001 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -81.49 114.73 20.41 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.892 178.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.9 pt -93.8 25.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.997 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -68.3 -27.02 65.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.911 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.73 -9.23 86.45 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.252 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -100.86 -8.97 22.07 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.77 124.51 22.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.5 t -113.3 114.25 26.42 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.446 ' OE2' ' HG3' ' A' ' 176' ' ' GLN . 45.8 mt-10 -84.47 -20.25 32.02 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.233 0.539 . . . . 0.0 110.186 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -90.04 123.74 34.18 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 170.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.7 mt -113.93 -56.75 2.36 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.981 0.896 . . . . 0.0 111.228 -168.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -59.68 126.53 27.98 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.618 -170.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.78 -27.1 8.07 Favored Glycine 0 N--CA 1.436 -1.304 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.117 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.02 156.82 3.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 120.834 0.349 . . . . 0.0 110.384 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -89.21 143.67 26.67 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.71 162.25 33.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.658 0.742 . . . . 0.0 112.097 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 88.3 m -124.93 141.62 52.0 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.904 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -107.88 120.87 43.5 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 111' ' ' THR . 37.8 t -116.51 111.32 34.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 120.894 0.378 . . . . 0.0 110.059 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.4 p -113.21 141.04 30.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.411 ' HD1' HD11 ' A' ' 11' ' ' LEU . 6.0 t60 -133.45 95.72 3.56 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.725 0.774 . . . . 0.0 109.37 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.2 t -104.44 -172.86 2.18 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -88.59 -42.84 11.8 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.54 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -70.44 -49.48 48.25 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -95.57 79.44 3.39 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.9 m -79.96 107.83 13.05 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.171 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.0 t30 58.77 71.82 0.56 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.016 0.926 . . . . 0.0 113.02 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 22.7 m -98.77 107.74 20.26 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.9 mt -95.62 94.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.1 tp -103.76 114.43 28.69 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.636 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.56 96.38 6.8 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.08 -35.82 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.979 -176.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 113.4 -135.17 12.38 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.579 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.95 130.01 10.15 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 123.038 2.492 . . . . 0.0 112.345 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.411 ' HB ' HD11 ' A' ' 135' ' ' ILE . 31.2 m -105.57 138.23 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-O 121.531 0.682 . . . . 0.0 111.129 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.4 m -122.59 145.52 48.27 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.019 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 57.9 ttp -83.45 122.0 27.93 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -82.36 -32.61 29.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.121 0.486 . . . . 0.0 111.364 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.78 -86.59 1.51 Allowed Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -152.03 138.27 18.38 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.9 mm -126.72 155.05 37.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -105.56 113.49 27.09 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.7 mt -114.52 85.83 2.31 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.354 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 129' ' ' THR . 27.6 m 55.88 77.03 0.25 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.463 1.105 . . . . 0.0 112.273 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.1 m 67.72 -19.68 0.13 Allowed 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.962 1.305 . . . . 0.0 113.476 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.414 ' H ' ' C ' ' A' ' 127' ' ' SER . 91.8 m -92.83 117.59 67.61 Favored Pre-proline 0 N--CA 1.427 -1.606 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -83.58 121.34 2.93 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 121.616 1.544 . . . . 0.0 109.574 174.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.52 ' HB ' ' SD ' ' A' ' 134' ' ' MET . 33.3 p -107.59 102.76 11.99 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-O 121.764 0.792 . . . . 0.0 110.226 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -103.65 164.0 11.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 67.81 38.12 2.99 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.736 0.814 . . . . 0.0 109.437 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.52 ' SD ' ' HB ' ' A' ' 131' ' ' THR . 57.1 mtt -119.24 164.23 15.94 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-O 121.798 0.809 . . . . 0.0 113.105 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.51 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 12.9 tt -123.15 151.42 27.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 124.712 1.205 . . . . 0.0 108.317 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -128.29 142.56 51.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.067 0.46 . . . . 0.0 111.889 -174.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -144.56 137.34 26.72 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.892 169.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.96 104.65 16.48 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.792 0.806 . . . . 0.0 111.662 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -162.56 138.07 7.12 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 125.808 1.643 . . . . 0.0 107.45 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.04 98.97 2.64 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.5 m -53.03 138.51 30.45 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 124.951 1.3 . . . . 0.0 112.836 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 145' ' ' GLN . 62.8 tttp -99.85 140.22 34.37 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.7 m -63.92 139.12 58.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 122.529 0.332 . . . . 0.0 110.263 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.34 33.47 9.4 Favored Glycine 0 C--O 1.219 -0.823 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 3.4 tp-100 -116.89 -6.13 11.49 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.603 0.716 . . . . 0.0 109.432 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.417 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 42.2 t -69.78 129.0 38.37 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.704 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.34 -7.66 58.39 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.095 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.75 140.28 42.22 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.526 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.34 120.67 35.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.729 0.776 . . . . 0.0 110.774 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 42.3 tp -88.2 106.04 17.93 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.0 p -140.99 168.67 19.23 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.747 0.784 . . . . 0.0 112.577 -172.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.54 -179.1 6.71 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.4 t -57.41 101.22 0.06 Allowed 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.938 0.875 . . . . 0.0 111.937 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.3 14.88 74.52 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.275 -1.33 . . . . 0.0 113.092 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -135.64 108.74 7.69 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 117.251 0.526 . . . . 0.0 111.045 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.13 126.26 57.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -97.87 -33.63 11.16 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 123.896 0.747 . . . . 0.0 110.959 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 165.54 -159.85 33.11 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 119.441 -1.361 . . . . 0.0 112.675 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.6 pt -121.86 137.75 54.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -69.34 125.96 28.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.0 p -96.69 -46.7 12.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.316 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.77 156.34 11.36 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -131.08 156.73 21.91 Favored Glycine 0 N--CA 1.428 -1.852 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.528 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -154.95 144.16 21.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.97 -122.68 5.9 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -117.84 13.21 14.03 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -121.43 136.88 54.91 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.017 0.437 . . . . 0.0 111.971 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -106.94 130.14 10.03 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -112.44 140.71 46.95 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.198 0.523 . . . . 0.0 109.96 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.51 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 18.6 m -131.15 154.7 48.07 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.41 139.56 30.56 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.67 116.35 19.8 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 123.37 0.419 . . . . 0.0 110.964 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 81.9 mt -89.02 94.38 9.93 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -84.08 140.66 31.67 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.093 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -69.16 -20.84 64.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.442 0.639 . . . . 0.0 109.6 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.446 ' HG3' ' OE2' ' A' ' 92' ' ' GLU . 69.4 mt-30 -58.21 -21.75 49.07 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.506 1.523 . . . . 0.0 112.23 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -86.99 -23.42 25.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.93 0.395 . . . . 0.0 110.726 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.4 ' CG ' HG23 ' A' ' 30' ' ' ILE . 49.2 m-85 -106.5 18.72 21.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.154 0.502 . . . . 0.0 112.017 -169.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 24.0 m -100.12 -179.81 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.629 176.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.5 -37.85 27.23 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.215 0.531 . . . . 0.0 110.127 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -91.45 106.29 18.38 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.426 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--N 1.303 -1.449 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.195 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.358 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.63 -27.6 76.31 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.012 2.474 . . . . 0.0 111.106 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -61.21 -37.27 82.39 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.057 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.4 m -64.52 -37.43 87.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.506 0.722 . . . . 0.0 109.608 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.35 -44.83 82.18 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.915 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.83 -45.98 88.75 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.944 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.48 98.75 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.02 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.84 -37.7 85.45 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 123.346 0.658 . . . . 0.0 110.438 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 m -76.41 -31.62 58.03 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.527 0.679 . . . . 0.0 110.325 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -73.69 -31.14 63.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.303 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.511 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 62.2 tp -51.68 -56.32 14.37 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.436 1.094 . . . . 0.0 112.05 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -83.02 10.26 8.41 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.221 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -117.91 -59.79 1.87 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -122.72 -6.81 8.56 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.511 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 50.5 mt -89.19 103.32 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 mmt -115.58 126.03 53.7 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.25 0.548 . . . . 0.0 111.002 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.4 m -70.2 96.82 1.13 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.864 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 58.5 mt -89.86 111.9 23.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 121.16 0.505 . . . . 0.0 109.908 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.8 m -86.5 107.6 18.17 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 80.5 p -89.74 -157.75 0.48 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.776 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 t -85.57 -9.45 57.32 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -106.3 -38.06 6.35 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.03 -160.4 27.45 Favored Glycine 0 CA--C 1.493 -1.326 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.804 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -99.86 112.27 24.54 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -112.73 159.3 19.08 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.544 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 17.9 m -86.65 116.26 24.65 Favored 'General case' 0 N--CA 1.408 -2.556 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.47 129.26 9.81 Favored Glycine 0 N--CA 1.417 -2.624 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.2 tp -105.4 115.9 31.04 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 120.839 0.352 . . . . 0.0 110.549 -178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.7 136.48 23.17 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.3 mm -100.61 -56.34 5.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 117.566 0.683 . . . . 0.0 109.537 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.595 ' NE2' ' HB3' ' A' ' 178' ' ' PHE . 0.1 OUTLIER -172.97 167.94 4.95 Favored 'General case' 0 CA--C 1.46 -2.494 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 52.06 -135.57 1.47 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.67 25.73 10.44 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -92.61 112.87 26.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.272 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 43.2 t -122.14 139.71 53.42 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.15 140.77 26.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 122.225 0.21 . . . . 0.0 110.585 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 tt -151.78 147.44 20.05 Favored Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -63.94 147.26 92.02 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.158 1.905 . . . . 0.0 112.066 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.0 m -64.44 -37.66 88.29 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -76.09 5.24 7.01 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.42 -19.65 57.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.477 ' O ' ' HB ' ' A' ' 20' ' ' THR . 78.6 mt-30 57.22 76.6 0.47 Allowed Pre-proline 0 C--O 1.251 1.158 0 C-N-CA 125.414 1.486 . . . . 0.0 113.361 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -92.29 164.8 3.02 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 122.346 2.031 . . . . 0.0 110.724 175.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.34 -152.09 10.96 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.06 -1.44 54.41 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -144.87 126.13 14.76 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.18 155.39 39.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.063 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 8.8 mp -92.26 102.06 14.56 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.3 p -87.82 105.46 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.052 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 74.03 -3.9 2.41 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.611 0.764 . . . . 0.0 110.81 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.51 -9.3 11.78 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -97.67 118.26 33.79 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 14.9 ptpt -77.19 134.63 38.59 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 118.28 -1.368 . . . . 0.0 112.738 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 77' ' ' LEU . 5.3 tp -131.49 141.12 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 114.251 -1.341 . . . . 0.0 108.346 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -86.47 139.66 30.68 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.6 t -93.01 139.93 17.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -79.68 -71.34 0.45 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -126.15 139.38 53.41 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -99.88 90.97 4.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.408 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 93.8 m-85 -79.2 109.97 14.03 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.155 0.502 . . . . 0.0 110.523 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -77.14 104.42 7.63 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.7 tp -80.26 87.89 5.53 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 122.181 0.991 . . . . 0.0 109.245 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -119.64 163.52 16.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 113.848 -1.523 . . . . 0.0 108.397 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.58 137.15 48.05 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.53 -23.9 11.55 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.667 2.911 . . . . 0.0 114.348 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -82.77 13.53 3.79 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 122.379 0.272 . . . . 0.0 111.384 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.9 m120 79.21 10.19 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 125.383 1.473 . . . . 0.0 112.347 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.5 mt -86.47 119.84 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.597 ' O ' ' HA ' ' A' ' 131' ' ' THR . 74.6 m-20 -81.07 157.67 25.32 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.882 -173.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -109.36 -0.97 18.78 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 61.72 30.05 18.29 Favored 'General case' 0 C--N 1.364 1.218 0 CA-C-O 122.83 1.3 . . . . 0.0 108.634 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.9 tp -133.01 142.89 49.07 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.584 -170.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.0 m -138.08 140.3 39.92 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.255 0.55 . . . . 0.0 110.657 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 92.7 t -105.98 122.25 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.8 mt -102.38 113.69 27.23 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.7 m -87.6 107.55 18.65 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.404 ' HB3' HG12 ' A' ' 54' ' ' ILE . 66.0 mt -80.48 141.31 35.34 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.725 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.52 74.72 10.35 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 122.045 0.926 . . . . 0.0 111.6 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -125.12 161.59 26.49 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.436 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -93.23 -49.57 5.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -66.96 148.16 52.3 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -119.27 173.18 7.1 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.388 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -82.56 179.64 7.72 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -73.75 127.93 34.13 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.01 90.16 1.15 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -92.61 20.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.755 -0.591 . . . . 0.0 112.162 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -68.69 -29.74 68.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.811 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.72 -27.54 73.77 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -85.1 -8.82 58.48 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 122.9 -0.177 . . . . 0.0 110.699 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.4 mt -66.54 131.69 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 t -124.44 111.48 15.78 Favored 'General case' 0 N--CA 1.387 -3.589 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -86.84 5.46 36.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.495 1.14 . . . . 0.0 108.935 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.83 110.57 22.02 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 169.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.5 -29.76 0.62 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -171.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -68.1 103.02 1.43 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.113 0.482 . . . . 0.0 111.747 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.38 -0.43 34.94 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.604 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.0 t -91.53 138.71 19.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -79.7 116.72 20.05 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -115.59 172.25 7.23 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.821 0.82 . . . . 0.0 112.097 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.6 m -128.79 141.25 51.37 Favored 'General case' 0 N--CA 1.422 -1.857 0 C-N-CA 124.908 1.283 . . . . 0.0 108.719 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.8 tp -106.12 122.19 45.69 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -113.96 107.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.815 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.4 m -107.85 138.91 31.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -139.28 107.99 5.93 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.325 0.583 . . . . 0.0 110.002 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.3 p -144.27 -172.58 3.81 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.46 -25.76 41.85 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.401 176.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -73.68 -51.27 17.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.419 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -115.79 84.35 2.09 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.8 m -80.14 96.32 6.49 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.355 0.597 . . . . 0.0 111.005 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.2 t30 60.15 70.71 0.61 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.755 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.3 m -101.34 108.03 19.54 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.08 108.67 24.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.0 tp -125.15 123.88 40.6 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.875 0.369 . . . . 0.0 111.563 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.86 102.65 4.8 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.1 m -78.39 -26.54 14.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.243 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 106.85 -149.53 16.6 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 119.94 -1.124 . . . . 0.0 111.1 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.95 122.25 8.63 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.745 2.297 . . . . 0.0 112.901 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.8 m -89.57 145.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.949 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.5 p -128.45 172.8 10.79 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.246 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 28.2 ttt -114.45 136.64 52.78 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.74 -26.84 12.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.335 0.588 . . . . 0.0 109.419 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.53 -88.89 1.46 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 131' ' ' THR . 4.9 mp -131.99 155.99 47.0 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 11.1 tt -144.05 128.18 13.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 130' ' ' PRO . 7.2 t30 -91.17 95.48 10.08 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.2 tp -107.13 121.99 45.6 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.5 p 50.05 49.68 19.91 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.753 0.821 . . . . 0.0 112.776 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 26.3 m 62.9 17.85 10.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.622 0.769 . . . . 0.0 112.599 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 96.1 m -129.93 106.58 16.69 Favored Pre-proline 0 N--CA 1.42 -1.949 0 CA-C-O 121.163 0.506 . . . . 0.0 109.894 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 50.7 Cg_endo -78.84 131.28 10.04 Favored 'Trans proline' 0 N--CA 1.428 -2.358 0 C-N-CA 121.451 1.434 . . . . 0.0 110.816 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.1 p -103.69 133.45 48.67 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.41 ' OD1' ' HD2' ' A' ' 133' ' ' ARG . 29.0 t-20 -108.19 159.9 16.24 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -175.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 5.5 mpt_? 65.72 38.8 5.1 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.563 1.145 . . . . 0.0 110.638 -177.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.468 ' HE3' ' HA ' ' A' ' 134' ' ' MET . 16.5 mmt -85.55 118.42 25.06 Favored 'General case' 0 C--O 1.252 1.214 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.256 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 170' ' ' SER . 5.4 tt -99.84 136.34 31.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 144.58 51.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.752 0.31 . . . . 0.0 111.311 -172.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.95 163.81 31.38 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.907 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.27 99.95 12.84 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 124.227 0.955 . . . . 0.0 108.669 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -171.34 124.35 0.6 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.485 1.114 . . . . 0.0 109.65 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -70.46 102.81 2.29 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.941 176.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.8 t -119.81 155.73 32.0 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -127.21 165.44 19.61 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.721 0.296 . . . . 0.0 110.505 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.4 m -60.74 129.38 41.22 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.287 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.27 -20.41 9.04 Favored Glycine 0 C--O 1.215 -1.049 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -93.42 23.71 4.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.183 0.992 . . . . 0.0 108.386 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.1 m -79.12 137.88 37.68 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.415 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.544 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 97.55 0.43 59.35 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.57 126.58 37.81 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 121.566 -0.349 . . . . 0.0 112.643 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -73.25 113.0 10.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 123.318 0.647 . . . . 0.0 109.465 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 52.3 tp -94.18 106.45 18.42 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.5 p -147.02 163.23 36.91 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.675 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.77 177.8 6.58 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.1 t -64.38 108.46 1.63 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.956 0.884 . . . . 0.0 110.946 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 83.27 2.37 90.36 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.262 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -136.35 108.38 7.18 Favored 'General case' 0 C--O 1.211 -0.956 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.1 mt -97.68 130.92 45.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -103.41 -31.97 9.75 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.147 0.498 . . . . 0.0 110.691 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.4 -154.84 25.91 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.283 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.9 pt -132.28 148.08 32.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 116.911 0.355 . . . . 0.0 110.597 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.409 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 23.8 t-80 -68.14 131.16 44.91 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.203 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.6 m -105.47 -59.96 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.56 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -156.93 142.89 9.06 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.019 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -131.67 143.99 15.57 Favored Glycine 0 N--CA 1.423 -2.232 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.894 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -119.76 105.99 11.68 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.638 0.732 . . . . 0.0 109.911 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 74.2 -130.76 12.75 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -177.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 34.0 ptt180 -90.14 9.09 29.67 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.961 0.41 . . . . 0.0 110.982 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -111.37 94.72 5.12 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.618 0.723 . . . . 0.0 110.063 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.9 123.93 6.9 Favored Glycine 0 N--CA 1.422 -2.283 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.55 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -104.27 127.52 51.91 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.951 0.881 . . . . 0.0 109.557 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.486 ' HB2' HG23 ' A' ' 135' ' ' ILE . 19.4 m -124.62 166.29 16.38 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.36 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -100.56 129.49 46.5 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 4.0 pt20 -85.18 115.88 23.22 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.922 0.868 . . . . 0.0 110.319 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.09 93.4 9.35 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.954 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -73.3 146.73 45.12 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -75.3 -6.3 49.12 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.334 0.588 . . . . 0.0 110.907 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.09 -33.42 74.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.077 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -75.33 -27.0 59.07 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.173 0.511 . . . . 0.0 110.899 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.595 ' HB3' ' NE2' ' A' ' 31' ' ' HIS . 82.7 m-85 -102.1 0.99 35.75 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.897 -170.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.7 p -92.74 136.37 25.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -65.79 -46.26 79.37 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.185 0.517 . . . . 0.0 110.883 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.24 146.56 45.94 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.344 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 C--N 1.285 -2.2 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.544 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.522 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.4 -27.51 71.07 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 123.048 2.499 . . . . 0.0 113.272 -176.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -76.56 -40.13 50.69 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -60.89 -46.21 91.54 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.851 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.45 -49.52 77.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.332 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -58.57 -46.8 86.15 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 123.498 0.499 . . . . 0.0 110.781 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.61 -35.14 78.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.6 tp -71.38 -42.14 68.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.049 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -70.73 -33.09 70.47 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.022 -0.423 . . . . 0.0 111.46 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.6 tp -67.27 -40.53 86.2 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.733 0.813 . . . . 0.0 108.927 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.441 HD22 HD21 ' A' ' 110' ' ' ASN . 18.5 tp -53.51 -50.49 65.3 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.742 1.217 . . . . 0.0 111.591 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -73.36 -3.61 28.3 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.783 -1.098 . . . . 0.0 113.447 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -126.42 -47.98 1.57 Allowed 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -115.84 -10.49 11.69 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -171.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 29.8 mt -99.19 115.34 39.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.101 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 mmt -127.65 146.37 50.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.465 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 22.7 m -78.56 132.41 37.15 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.7 mt -125.93 110.8 24.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 98.4 m -77.03 103.72 7.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.2 p -94.55 -168.68 1.88 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.008 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -71.12 -16.11 62.54 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 120.842 0.353 . . . . 0.0 111.047 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -110.11 9.63 24.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.84 -162.41 14.01 Favored Glycine 0 C--N 1.31 -0.869 0 C-N-CA 119.49 -1.338 . . . . 0.0 113.642 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -86.48 101.27 13.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.312 0.577 . . . . 0.0 111.738 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -106.92 -179.25 3.88 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 t -127.44 139.28 52.92 Favored 'General case' 0 N--CA 1.408 -2.571 0 C-N-CA 119.005 -1.078 . . . . 0.0 109.028 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.59 137.63 14.41 Favored Glycine 0 N--CA 1.415 -2.737 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.7 tp -101.84 118.41 36.86 Favored 'General case' 0 C--N 1.29 -2.01 0 O-C-N 123.811 0.359 . . . . 0.0 110.175 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.47 132.38 22.76 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mm -100.11 -53.03 8.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 117.624 0.712 . . . . 0.0 109.933 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -161.94 151.02 15.69 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.495 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.4 ' C ' ' HD2' ' A' ' 33' ' ' ARG . 4.6 t70 53.72 -92.24 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 125.333 1.453 . . . . 0.0 112.695 177.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.4 ' HD2' ' C ' ' A' ' 32' ' ' ASP . 9.3 mpt_? -132.0 7.74 4.36 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.398 0.618 . . . . 0.0 110.033 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.0 t -77.82 112.83 16.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.573 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.7 m -121.94 142.84 49.88 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.3 p -115.91 141.39 33.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 120.743 0.306 . . . . 0.0 110.571 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 tt -154.47 149.42 20.24 Favored Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.57 144.9 95.13 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 122.279 1.986 . . . . 0.0 112.781 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.583 ' HB ' ' OG1' ' A' ' 73' ' ' THR . 9.6 t -86.52 -10.29 54.39 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -79.02 -2.51 40.67 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.282 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.73 -27.74 20.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.001 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.424 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 13.5 mm-40 60.04 87.46 0.14 Allowed Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.653 1.181 . . . . 0.0 114.171 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.48 149.08 18.74 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.156 1.904 . . . . 0.0 109.194 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.01 -157.35 30.09 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.478 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -82.2 -30.24 31.0 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -139.58 136.29 34.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 23.9 m -136.68 157.68 36.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 120.755 0.312 . . . . 0.0 111.644 -174.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 86.6 mt -89.81 109.88 20.85 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 17' ' ' THR . 81.8 t -97.77 88.55 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.251 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 63.52 18.47 11.09 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.519 1.152 . . . . 0.0 109.934 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.18 -38.69 2.03 Favored Glycine 0 N--CA 1.436 -1.3 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.128 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -81.03 120.11 24.39 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.773 -0.251 . . . . 0.0 110.371 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 39.1 ttpt -80.59 110.41 16.04 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.2 tp -103.82 150.19 7.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -99.52 139.52 35.06 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 118.272 -1.371 . . . . 0.0 107.824 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.43 124.96 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 57.7 tttm -70.86 -52.25 21.47 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.34 0.59 . . . . 0.0 109.839 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.2 m-20 -138.71 138.25 37.55 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.602 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -115.55 112.51 22.3 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.449 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 63.9 m-85 -109.88 111.62 23.15 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.527 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -78.6 116.24 18.84 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.557 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 37.8 tp -90.73 101.97 14.72 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.1 t -123.89 140.8 46.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -81.78 130.94 58.98 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.98 5.23 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.081 3.187 . . . . 0.0 116.044 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.7 14.57 16.74 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.9 t30 70.66 40.06 1.06 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.011 1.324 . . . . 0.0 109.007 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 53.3 mt -120.06 122.02 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.62 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.627 ' O ' ' HA ' ' A' ' 131' ' ' THR . 50.4 t30 -64.54 150.29 47.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.598 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.557 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 39.1 tp -126.52 -9.58 6.26 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.716 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 72.5 -20.59 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.673 1.189 . . . . 0.0 113.108 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.67 118.69 11.99 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.583 ' OG1' ' HB ' ' A' ' 39' ' ' THR . 55.0 m -106.83 114.28 28.28 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 64.2 t -92.97 104.88 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.75 124.42 42.1 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.253 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.8 m -98.05 93.78 6.48 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -71.05 137.55 49.07 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.23 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.78 76.89 10.17 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.429 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -101.47 128.84 47.51 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.305 -1.771 . . . . 0.0 107.23 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.55 -50.74 64.04 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.365 0.415 . . . . 0.0 111.457 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -74.02 160.09 31.79 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 121.242 0.544 . . . . 0.0 110.62 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.493 ' HZ3' ' CG ' ' A' ' 85' ' ' ASP . 58.1 tttm -99.52 142.55 30.85 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.604 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -80.8 162.3 24.1 Favored 'General case' 0 C--O 1.257 1.448 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 175.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -77.18 132.48 38.79 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.493 ' CG ' ' HZ3' ' A' ' 82' ' ' LYS . 44.9 m-20 -80.24 96.17 6.52 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.785 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.4 pt -96.0 20.32 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.767 0.794 . . . . 0.0 109.523 -177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -65.32 -28.16 69.12 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.837 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.72 -5.99 89.42 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.643 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -96.16 -3.06 45.1 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.282 0.563 . . . . 0.0 110.584 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.6 mt -70.22 120.07 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.987 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 p -108.68 105.08 14.53 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.544 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 1.0 OUTLIER -80.2 -12.48 59.64 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.299 177.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.35 118.98 21.76 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.501 HD11 ' NE2' ' A' ' 172' ' ' GLN . 21.6 mt -112.65 -63.84 1.38 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.394 0.616 . . . . 0.0 112.3 -169.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 16.9 pt-20 -54.69 126.95 26.03 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -166.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.87 -38.28 3.2 Favored Glycine 0 N--CA 1.432 -1.582 0 CA-C-N 114.488 -1.233 . . . . 0.0 113.011 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.3 t -78.52 138.64 19.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.997 0.427 . . . . 0.0 110.897 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 7.4 m-20 -80.97 102.4 10.12 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 176.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.9 163.54 24.24 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.554 0.693 . . . . 0.0 111.16 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.6 m -129.28 139.04 51.94 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.5 tp -112.65 125.09 53.91 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 111' ' ' THR . 7.6 p -117.89 122.4 69.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.412 0.625 . . . . 0.0 110.832 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 t -111.72 139.13 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.743 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -126.5 79.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.258 1.028 . . . . 0.0 109.806 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.9 t -116.91 -177.82 3.29 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -71.33 -45.28 63.38 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.091 0.472 . . . . 0.0 110.374 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -82.28 -47.39 12.46 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.515 0.674 . . . . 0.0 109.885 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -88.69 76.6 8.04 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.761 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 22.5 m -94.44 101.11 13.02 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.921 0.391 . . . . 0.0 110.008 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.441 HD21 HD22 ' A' ' 11' ' ' LEU . 27.1 t-20 64.45 62.9 0.78 Allowed 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.927 1.346 . . . . 0.0 110.033 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 24.6 m -96.54 96.15 8.48 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.344 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 54.1 mt -100.99 97.03 5.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.7 tp -120.2 137.17 54.35 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -68.67 146.08 53.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.2 t -102.72 -51.4 9.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 98' ' ' ASP . . . 119.54 -168.58 13.56 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -177.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.59 116.8 4.13 Favored 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.704 2.27 . . . . 0.0 112.278 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 26.8 m -87.29 155.72 3.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.091 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.0 p -136.84 169.61 17.46 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 123.129 0.572 . . . . 0.0 109.592 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.2 ttt -87.82 142.68 27.62 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -95.84 -39.54 9.78 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.037 0.446 . . . . 0.0 110.976 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 133' ' ' ARG . . . 99.36 -111.68 4.27 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -134.94 112.19 10.43 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.284 1.04 . . . . 0.0 110.911 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 7.6 tp -162.82 156.67 2.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' A' ' 129' ' ' THR . 2.6 t-20 -159.27 -77.56 0.07 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -161.08 151.55 17.94 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 51.9 p 50.1 33.96 7.73 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.346 1.058 . . . . 0.0 113.826 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.3 m 60.53 60.59 1.93 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 122.161 0.982 . . . . 0.0 110.089 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.524 ' O ' ' HB3' ' A' ' 125' ' ' ASN . 61.2 m -142.78 128.8 10.47 Favored Pre-proline 0 N--CA 1.412 -2.367 0 N-CA-C 101.688 -3.449 . . . . 0.0 101.688 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -100.37 148.56 0.41 Allowed 'Trans proline' 0 N--CA 1.441 -1.573 0 N-CA-C 117.017 1.891 . . . . 0.0 117.017 -170.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 97.6 m -92.01 130.73 37.69 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 164.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.31 97.18 0.39 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 20.3 mtm-85 62.76 80.35 0.23 Allowed 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.255 1.026 . . . . 0.0 110.767 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.5 ttt -103.61 169.75 8.34 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.415 -172.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.419 HG21 ' HB2' ' A' ' 170' ' ' SER . 7.7 tt -117.32 142.34 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.017 0.527 . . . . 0.0 109.869 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -137.37 146.53 44.62 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 123.719 0.807 . . . . 0.0 109.659 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -151.4 159.51 44.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 120.373 0.13 . . . . 0.0 111.287 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -83.22 113.51 20.72 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -165.55 126.12 1.86 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -174.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.45 101.96 1.34 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 44.4 m -78.77 138.94 38.46 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.923 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -111.3 154.47 24.46 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.9 t -86.76 138.69 31.4 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.0 -13.87 28.94 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.124 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.31 5.72 50.93 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.376 0.607 . . . . 0.0 111.432 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 41.9 t -62.32 135.12 57.31 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.524 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 103.57 -14.53 53.82 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.848 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.71 141.9 46.24 Favored Glycine 0 C--O 1.241 0.562 0 O-C-N 123.969 0.452 . . . . 0.0 113.726 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.5 t -81.27 114.46 22.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.319 0.58 . . . . 0.0 109.771 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 39.5 tp -87.35 106.27 17.83 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.6 p -140.82 -171.71 3.3 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.205 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.16 -173.47 4.45 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.8 t -70.48 99.57 1.64 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.283 1.04 . . . . 0.0 111.297 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.99 12.58 70.91 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.595 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -137.21 140.69 41.9 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 85.9 mt -126.95 124.34 64.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -96.98 -35.45 10.85 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.131 0.491 . . . . 0.0 110.629 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.464 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 164.01 -154.32 25.14 Favored Glycine 0 N--CA 1.427 -1.925 0 C-N-CA 119.305 -1.426 . . . . 0.0 113.16 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.5 pt -125.01 134.06 67.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 122.56 0.344 . . . . 0.0 111.15 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.435 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 68.9 t60 -67.42 128.58 36.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.441 0.696 . . . . 0.0 109.828 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.49 -15.42 9.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.29 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.25 -159.63 24.44 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 176.9 -176.5 48.05 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -147.93 145.83 28.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.2 -110.62 3.35 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.024 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 46.0 mtm105 -120.27 7.71 10.78 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -110.69 129.13 55.91 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.835 0.35 . . . . 0.0 110.276 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -105.31 142.39 15.51 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.0 143.77 49.7 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.536 0.684 . . . . 0.0 110.827 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' A' ' 160' ' ' HIS . 74.1 m -138.79 159.8 41.23 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.348 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -96.58 119.15 34.54 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.501 ' NE2' HD11 ' A' ' 94' ' ' LEU . 3.0 pt20 -76.56 122.01 24.0 Favored 'General case' 0 C--O 1.253 1.274 0 CA-C-O 121.948 0.88 . . . . 0.0 111.315 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.464 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 95.4 mt -83.57 99.88 10.45 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -88.55 138.24 31.6 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.544 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 9.7 ptpp? -69.55 -13.88 62.56 Favored 'General case' 0 C--O 1.21 -0.995 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.877 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -61.35 -22.85 65.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.931 1.292 . . . . 0.0 110.562 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -85.34 -33.62 22.02 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.379 0.609 . . . . 0.0 109.428 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -91.76 3.5 54.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.016 -169.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.56 115.71 49.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -90.16 -30.83 17.37 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.641 0.734 . . . . 0.0 109.278 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -93.74 84.97 4.7 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.319 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 C--N 1.308 -1.235 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.482 -178.768 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.466 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.43 -36.96 63.2 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.528 2.152 . . . . 0.0 112.405 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -79.92 -32.39 40.15 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.588 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 19.3 m -61.48 -44.5 96.97 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.428 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -54.94 -51.55 65.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.055 0.942 . . . . 0.0 109.038 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.04 -45.19 94.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.432 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.39 75.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.331 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 4' ' ' THR . 92.8 mt -61.8 -47.67 84.06 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.058 0.456 . . . . 0.0 109.878 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 11.1 m -66.21 -49.98 65.43 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.309 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.9 tp -57.08 -45.65 83.17 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.58 0.752 . . . . 0.0 111.292 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.519 HD13 HD21 ' A' ' 110' ' ' ASN . 9.3 tt -64.59 -43.84 92.55 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -76.25 -9.39 58.6 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 9' ' ' SER . 68.0 mttm -99.93 -65.63 0.95 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.896 0.379 . . . . 0.0 111.247 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -108.71 -5.48 16.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -168.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 47.6 mt -95.82 139.7 18.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.336 -176.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.445 ' HB3' HG12 ' A' ' 49' ' ' VAL . 57.1 mtm -140.53 163.16 33.58 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.047 0.939 . . . . 0.0 109.306 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 96.5 m -103.11 119.74 39.41 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 71.1 mt -110.96 112.63 41.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.076 0.465 . . . . 0.0 110.179 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 59.9 m -80.35 107.9 13.52 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 p -97.6 -166.96 1.45 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.362 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -78.65 -2.89 41.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.348 0.594 . . . . 0.0 110.302 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -106.44 -43.09 4.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.295 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.59 -160.44 33.94 Favored Glycine 0 C--O 1.246 0.889 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.651 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -81.83 96.09 7.51 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.336 0.654 . . . . 0.0 109.422 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -99.64 159.53 14.97 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.411 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 95.0 m -94.5 127.74 40.63 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.91 121.73 7.03 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.96 113.02 26.26 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.8 134.94 21.07 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 50.8 mm -100.97 -48.85 11.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 117.298 0.549 . . . . 0.0 110.219 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.586 ' CD2' ' HB3' ' A' ' 85' ' ' ASP . 22.8 t-80 -166.66 139.81 3.82 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.131 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t70 61.21 -92.62 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.631 0 O-C-N 124.257 0.973 . . . . 0.0 112.745 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -131.86 5.75 4.26 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.406 0.622 . . . . 0.0 109.975 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.8 t -85.51 117.42 30.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.675 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.4 m -125.45 157.24 37.41 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.3 145.06 23.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 120.771 0.319 . . . . 0.0 111.67 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 tt -160.34 140.56 8.53 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.742 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 73.7 Cg_exo -57.66 134.58 63.96 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.909 2.406 . . . . 0.0 113.46 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.481 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 25.3 m -64.02 -33.58 76.06 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 124.276 1.031 . . . . 0.0 112.727 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -64.19 -12.25 38.65 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.19 -25.76 59.88 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 53.35 84.89 0.2 Allowed Pre-proline 0 C--O 1.242 0.667 0 C-N-CA 124.936 1.295 . . . . 0.0 112.816 -176.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -83.88 152.22 12.89 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 C-N-CA 121.935 1.756 . . . . 0.0 110.619 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.59 -162.35 37.07 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.162 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -93.37 10.03 33.9 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.083 0.944 . . . . 0.0 110.415 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -160.36 124.75 3.71 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.65 149.76 29.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.533 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 93.9 mt -85.48 114.11 22.26 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 17' ' ' THR . 39.2 t -102.28 102.32 13.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.217 175.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.6 m120 59.04 25.06 13.4 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.621 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.01 -7.38 44.35 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.943 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -106.83 118.62 37.17 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.542 -0.387 . . . . 0.0 110.48 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -73.44 124.69 26.29 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.68 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -119.94 122.8 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.925 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -71.52 124.69 25.22 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.309 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.7 t -84.22 139.99 16.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.48 -176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.535 ' HZ2' ' HB3' ' A' ' 57' ' ' LYS . 8.6 mtpm? -97.87 -69.77 0.75 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.032 0.92 . . . . 0.0 109.785 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -116.04 143.47 45.42 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.926 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -146.32 96.96 2.86 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -106.58 139.33 41.21 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.87 128.53 44.54 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.074 174.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.03 110.21 14.05 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.86 129.45 69.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.496 ' OD2' ' HG2' ' A' ' 66' ' ' GLU . 22.1 t70 -66.33 143.92 98.48 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -175.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.31 -17.25 0.5 Allowed 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 123.917 3.078 . . . . 0.0 115.141 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.496 ' HG2' ' OD2' ' A' ' 64' ' ' ASP . 19.0 mm-40 -83.47 3.78 30.69 Favored 'General case' 0 CA--C 1.555 1.158 0 O-C-N 121.633 -0.667 . . . . 0.0 111.178 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.7 t30 73.78 18.8 3.32 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.435 1.494 . . . . 0.0 109.343 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.0 mm -99.44 136.1 32.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 131' ' ' THR . 91.7 m-20 -73.51 148.39 43.14 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.591 0.234 . . . . 0.0 111.411 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 64' ' ' ASP . 73.0 mt -103.97 -13.22 16.41 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 172.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.481 ' OE1' ' HB ' ' A' ' 39' ' ' THR . 2.7 tp10 60.05 31.25 20.53 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 114.176 -1.374 . . . . 0.0 109.34 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.0 tp -115.82 120.58 39.73 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.881 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -104.38 130.94 52.22 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -91.86 100.28 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 171.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.6 tp -96.54 116.28 28.82 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.771 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -104.93 109.43 21.42 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.574 0.702 . . . . 0.0 109.107 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.41 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 88.7 mt -93.82 153.46 18.27 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.765 -175.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -88.22 80.08 7.67 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -118.3 115.02 23.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.756 -1.565 . . . . 0.0 108.014 -171.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -81.43 -10.13 59.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.521 0.677 . . . . 0.0 112.627 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -90.74 87.84 6.84 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -78.64 139.69 38.51 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.994 -0.683 . . . . 0.0 111.721 -172.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -77.33 147.63 36.06 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.57 -172.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -70.76 140.24 51.28 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.347 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.586 ' HB3' ' CD2' ' A' ' 31' ' ' HIS . 6.5 p-10 -70.45 107.0 3.62 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.952 0.882 . . . . 0.0 109.399 173.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.8 pt -93.47 22.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.401 ' H ' ' C ' ' A' ' 85' ' ' ASP . 35.4 ttt-85 -66.1 -30.77 71.34 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.645 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.38 -12.77 84.24 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.357 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -91.11 -10.45 41.9 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.434 -0.451 . . . . 0.0 110.227 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.5 mt -66.58 133.71 30.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.571 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.3 t -113.54 110.59 20.51 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -87.78 4.41 44.46 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.663 0.744 . . . . 0.0 110.818 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.36 119.51 37.17 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.88 -2.266 . . . . 0.0 104.88 172.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mp -120.5 -49.66 2.24 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -169.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -57.24 129.91 43.87 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.83 -1.78 78.78 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.5 173.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.483 ' O ' HG21 ' A' ' 118' ' ' VAL . 22.1 t -101.16 155.78 4.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 3.0 p-10 -95.59 148.48 22.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 118.718 0.69 . . . . 0.0 110.545 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.83 165.83 25.5 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.949 0.88 . . . . 0.0 112.823 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.507 ' OG1' ' HG2' ' A' ' 114' ' ' GLU . 26.7 m -122.86 138.56 54.62 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 125.002 1.321 . . . . 0.0 108.749 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.7 tp -99.2 117.11 32.93 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -113.27 112.06 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.85 142.75 24.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.189 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -136.6 100.48 4.35 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.704 0.764 . . . . 0.0 109.096 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.6 p -136.07 176.16 8.94 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.71 -30.73 71.45 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.849 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -77.39 -50.11 13.45 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.002 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -109.02 81.08 1.39 Allowed 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.19 98.28 9.28 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 120.793 0.33 . . . . 0.0 111.294 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.519 HD21 HD13 ' A' ' 11' ' ' LEU . 27.1 t-20 68.48 70.6 0.3 Allowed 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.175 0.988 . . . . 0.0 110.349 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 51.6 m -108.75 107.97 18.62 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 73.0 mt -108.92 102.25 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.712 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.0 tp -123.13 113.92 19.63 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.727 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.507 ' HG2' ' OG1' ' A' ' 100' ' ' THR . 45.6 mt-10 -73.88 123.41 24.18 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.7 m -91.24 -43.45 14.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.839 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.69 -152.11 19.77 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 98' ' ' ASP . 59.9 Cg_endo -71.87 144.3 43.06 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.921 2.414 . . . . 0.0 112.121 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 97' ' ' VAL . 35.5 m -106.53 137.98 34.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.24 0.543 . . . . 0.0 110.973 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.3 p -110.16 173.73 6.19 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.982 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 38.9 tpp -110.41 132.68 53.97 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.676 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -99.4 -45.02 5.98 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.302 0.572 . . . . 0.0 109.585 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.09 -79.5 0.53 Allowed Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.46 155.43 41.18 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.0 tt -163.21 152.31 3.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 120.885 0.374 . . . . 0.0 110.018 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -79.81 94.18 5.75 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -93.0 98.83 11.6 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.4 p 52.16 66.65 1.15 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.346 1.058 . . . . 0.0 113.506 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.0 m 63.36 7.54 2.98 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.212 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.2 m -120.27 105.13 42.41 Favored Pre-proline 0 N--CA 1.427 -1.583 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -61.38 110.87 0.98 Allowed 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 121.922 1.748 . . . . 0.0 110.144 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 9.6 m -120.74 138.55 53.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.332 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -119.74 168.37 11.14 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 172' ' ' GLN . 11.0 tpp180 65.62 42.84 3.48 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.673 1.589 . . . . 0.0 109.605 175.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.1 mtp -108.12 140.94 40.58 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-O 121.978 0.894 . . . . 0.0 112.301 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.524 HG21 ' HB3' ' A' ' 170' ' ' SER . 5.9 tt -105.02 146.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.894 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 23.8 ttm180 -128.97 137.23 51.25 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -173.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -131.51 131.27 43.3 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -80.88 97.0 7.2 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.773 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -156.09 134.81 11.78 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -72.78 109.41 6.36 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 13.1 t -140.03 171.29 14.4 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 143' ' ' THR . 37.9 ttpt -114.82 142.57 46.37 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 13.4 t -80.36 165.43 22.28 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 146' ' ' CYS . . . 105.69 -17.78 41.91 Favored Glycine 0 C--N 1.303 -1.298 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -94.09 28.61 2.41 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.742 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 33.7 t -76.74 141.64 40.74 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 113.14 -1.845 . . . . 0.0 109.241 -174.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.411 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 93.04 -4.26 74.44 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.62 134.35 26.03 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.6 p -76.12 119.48 24.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 122.086 0.946 . . . . 0.0 111.348 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.3 tp -90.1 102.0 14.71 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 20.3 p -147.66 174.22 11.98 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.38 0.609 . . . . 0.0 111.929 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.92 172.91 12.06 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.7 t -64.74 103.74 0.74 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.962 0.887 . . . . 0.0 111.297 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.18 6.14 66.94 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.621 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -140.56 103.02 4.45 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 117.239 0.52 . . . . 0.0 111.428 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 88.2 mt -97.28 123.8 49.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -95.93 -42.83 8.1 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.36 0.6 . . . . 0.0 110.336 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 171.78 -157.7 28.07 Favored Glycine 0 N--CA 1.425 -2.098 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.46 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 28.3 pt -127.21 145.87 34.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -63.76 129.3 39.57 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 123.502 0.721 . . . . 0.0 109.426 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.443 ' HA ' ' SG ' ' A' ' 146' ' ' CYS . 62.1 t -117.27 -48.69 4.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 O-C-N 123.212 0.32 . . . . 0.0 110.754 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -133.64 108.33 0.73 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.314 -1.422 . . . . 0.0 112.86 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.19 108.25 3.66 Favored Glycine 0 C--N 1.3 -1.437 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -120.01 90.65 3.37 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 59.65 -106.63 1.01 Allowed Glycine 0 C--O 1.229 -0.192 0 O-C-N 123.821 0.7 . . . . 0.0 113.185 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -94.81 8.2 43.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -122.29 115.8 22.97 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.102 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -97.05 115.91 5.36 Favored Glycine 0 N--CA 1.42 -2.423 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -102.0 129.28 48.25 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.159 0.504 . . . . 0.0 110.276 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.524 ' HB3' HG21 ' A' ' 135' ' ' ILE . 29.0 t -127.25 156.69 41.49 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.257 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.401 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -101.43 140.72 35.34 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 66.6 mt-30 -76.26 121.19 22.58 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 123.517 0.511 . . . . 0.0 110.974 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.58 85.27 4.47 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -83.63 144.61 29.32 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.449 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -73.68 -14.64 61.19 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.925 0.393 . . . . 0.0 110.595 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -65.58 -19.32 65.87 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.632 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -79.78 -25.4 40.97 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 121.932 -0.48 . . . . 0.0 109.917 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -101.24 50.37 0.86 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.788 0.804 . . . . 0.0 110.327 -174.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 30.7 m -103.67 169.85 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.472 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -83.86 -54.54 4.81 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -120.79 144.09 48.49 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.099 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 . . . . . 0 C--N 1.305 -1.344 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.114 -177.534 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.422 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.93 -32.51 85.8 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.19 2.594 . . . . 0.0 111.871 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -63.31 -41.94 98.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.455 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 m -63.38 -40.4 97.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.651 0.78 . . . . 0.0 109.521 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -64.31 -43.6 94.18 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.236 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -63.56 -46.26 86.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.966 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 11' ' ' LEU . . . -54.33 -50.23 67.9 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 124.074 0.859 . . . . 0.0 111.699 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -64.95 -35.38 80.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 m -72.26 -42.48 65.55 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.016 0.436 . . . . 0.0 110.699 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.8 tp -65.79 -39.94 91.45 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.779 0.832 . . . . 0.0 109.535 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 6.0 tt -56.0 -50.9 69.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.299 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -83.56 15.03 3.33 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -123.95 -56.27 1.66 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -118.09 -5.22 10.96 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -171.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.475 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 42.2 mt -96.53 121.46 47.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.935 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 19.8 ptp -140.85 153.94 45.98 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.726 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.84 111.53 20.27 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.3 mt -104.7 113.25 41.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.777 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.6 m -76.44 107.46 8.72 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.9 p -87.56 -149.88 0.16 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.3 p -52.91 -42.03 64.96 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.122 0.569 . . . . 0.0 112.094 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -129.56 -60.66 1.04 Allowed 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.25 158.5 20.55 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 119.643 -1.265 . . . . 0.0 114.467 -172.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -86.74 112.15 21.4 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -105.77 174.4 5.9 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.458 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 35.1 m -87.3 114.99 24.41 Favored 'General case' 0 N--CA 1.411 -2.399 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.595 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.59 110.8 3.9 Favored Glycine 0 N--CA 1.41 -3.036 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.6 tp -94.32 109.08 20.94 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.28 133.19 28.28 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 48.0 mm -109.82 -54.51 5.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 117.331 0.565 . . . . 0.0 111.148 -177.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -154.53 123.26 6.2 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.737 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 66.72 -86.28 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.865 0.728 . . . . 0.0 112.82 169.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 83.7 mtm180 -132.7 10.52 4.33 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.93 0.871 . . . . 0.0 109.463 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.2 t -91.65 123.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.838 -1.073 . . . . 0.0 111.184 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.9 p -127.01 148.36 50.11 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.07 130.38 57.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.264 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.7 mm -130.26 136.24 28.69 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 124.584 1.154 . . . . 0.0 108.43 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.88 142.97 95.11 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.292 1.994 . . . . 0.0 111.387 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.1 m -62.51 -47.32 84.47 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 122.145 0.178 . . . . 0.0 111.435 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -61.77 -14.83 36.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.675 0.79 . . . . 0.0 112.838 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.76 -25.19 60.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 58.09 88.0 0.13 Allowed Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 124.594 1.158 . . . . 0.0 113.863 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -83.1 149.66 13.62 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.864 1.709 . . . . 0.0 109.835 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -157.35 33.06 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.459 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.72 -17.25 27.06 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.973 0.892 . . . . 0.0 110.093 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -137.12 131.03 32.06 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 m -117.17 164.24 13.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 5.7 mp -113.49 110.59 20.52 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.146 178.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.7 t -87.75 94.24 4.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 t30 51.75 62.33 2.76 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 124.549 1.14 . . . . 0.0 109.024 -174.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.06 -34.36 3.42 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.018 -0.992 . . . . 0.0 114.03 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 24.1 mt-30 -72.21 108.89 5.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.169 0.485 . . . . 0.0 111.993 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -68.78 122.62 18.95 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.4 127.7 50.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -78.18 127.68 32.63 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.784 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.2 140.39 18.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.573 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.424 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 60.5 tttm -89.32 -59.01 2.33 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.277 0.561 . . . . 0.0 110.16 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.2 m-20 -136.34 149.78 48.55 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.357 -177.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -132.23 107.87 8.87 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -117.53 126.68 53.0 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -77.0 133.28 39.19 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.459 -0.896 . . . . 0.0 108.871 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.9 tp -91.24 104.5 17.04 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.62 0.724 . . . . 0.0 109.44 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 69' ' ' ASN . 20.5 m -119.62 160.02 20.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.406 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.01 147.42 47.98 Favored Pre-proline 0 C--N 1.289 -2.022 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -45.2 -13.95 0.08 OUTLIER 'Trans proline' 0 CA--C 1.564 1.982 0 C-N-CA 124.266 3.311 . . . . 0.0 116.074 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -77.19 -2.32 33.9 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.486 -0.759 . . . . 0.0 111.011 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 75.63 12.52 3.07 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.962 1.705 . . . . 0.0 109.998 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.5 mm -90.41 134.44 29.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 114.119 -1.4 . . . . 0.0 107.405 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 131' ' ' THR . 57.3 t30 -79.99 147.55 31.51 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.999 0.428 . . . . 0.0 111.395 -173.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.0 mt -99.32 -6.18 28.37 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 75.39 16.35 2.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 123.169 1.462 . . . . 0.0 109.823 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.25 136.27 50.58 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.669 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.0 m -116.52 128.94 55.9 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.5 t -82.99 101.18 7.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -98.08 111.88 24.04 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.2 m -94.77 110.92 22.73 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.77 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 95.8 mt -86.32 142.32 28.58 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.863 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -88.68 86.84 7.07 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -122.65 131.76 53.96 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -68.34 -34.5 76.22 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.298 0.374 . . . . 0.0 111.222 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -86.45 104.31 15.8 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -79.1 142.36 36.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.302 0.573 . . . . 0.0 110.445 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -83.63 145.48 28.79 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.31 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -57.27 120.17 7.68 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.112 -1.403 . . . . 0.0 108.69 175.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 4.6 p30 -74.85 117.7 16.98 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.234 -1.387 . . . . 0.0 109.906 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.0 pt -97.17 28.53 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.52 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.8 ttm105 -59.94 -37.14 78.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.99 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.96 -7.45 70.65 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.489 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -96.74 -10.54 26.6 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.425 0.612 . . . . 0.0 110.943 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.6 mt -66.53 123.54 19.76 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-O 121.144 0.497 . . . . 0.0 110.315 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.8 p -100.74 115.92 31.41 Favored 'General case' 0 N--CA 1.407 -2.623 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.552 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 1.3 pm0 -71.38 -29.77 65.34 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.536 175.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.12 115.44 18.79 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.1 mt -106.83 -60.77 1.63 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.875 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.93 131.53 45.66 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.157 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.02 -22.29 33.73 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.661 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.8 t -92.29 148.31 4.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.02 125.23 38.53 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.695 0.76 . . . . 0.0 109.835 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.76 154.37 18.68 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 122.08 0.943 . . . . 0.0 113.121 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.9 m -127.38 125.91 41.52 Favored 'General case' 0 N--CA 1.417 -2.079 0 C-N-CA 125.432 1.493 . . . . 0.0 107.95 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -95.48 118.85 32.95 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -111.91 112.49 40.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.475 HG12 ' NE2' ' A' ' 145' ' ' GLN . 7.4 p -114.89 135.78 53.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.6 0.714 . . . . 0.0 111.101 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -129.58 84.82 2.25 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.8 t -130.51 174.94 9.4 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.018 -174.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -70.64 -31.54 68.52 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -69.74 -51.92 29.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.952 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.562 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 79.1 m-85 -138.5 119.85 14.8 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.124 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.2 m -107.66 112.76 25.62 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 -175.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 74.06 27.16 1.61 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.457 1.103 . . . . 0.0 111.221 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.562 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 13.7 m -79.8 117.06 20.34 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.658 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.2 mt -101.59 99.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.8 tp -102.31 111.83 24.28 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.279 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -82.52 108.56 16.02 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.84 -54.61 9.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.431 -172.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 125.43 -164.12 19.13 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.32 135.94 52.77 Favored 'Trans proline' 0 C--O 1.244 0.8 0 C-N-CA 122.935 2.424 . . . . 0.0 112.771 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.1 m -110.81 160.34 10.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.273 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.7 t -143.36 159.71 41.87 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.8 ttt -89.24 131.49 35.33 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -90.91 -50.32 5.94 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.57 0.7 . . . . 0.0 109.206 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.48 -103.56 0.76 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 pp -126.58 158.18 36.92 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.563 0.22 . . . . 0.0 111.448 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.8 tt -161.27 137.56 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.502 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -113.38 113.81 25.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -133.6 139.49 46.56 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.6 t 61.64 30.61 18.63 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 76.1 p 62.76 10.86 4.5 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.783 2.033 . . . . 0.0 112.837 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m -96.28 108.86 44.32 Favored Pre-proline 0 N--CA 1.427 -1.607 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.43 112.28 3.43 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 122.099 1.866 . . . . 0.0 110.013 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 31.7 p -112.06 143.02 43.76 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.52 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -139.13 159.49 42.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.424 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 16.2 mtp180 75.98 27.25 0.94 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.604 1.562 . . . . 0.0 109.126 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 131.56 36.15 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.062 -175.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.469 HG21 ' HB3' ' A' ' 170' ' ' SER . 2.0 tt -98.91 136.54 29.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.049 -1.432 . . . . 0.0 107.764 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -121.69 142.9 49.7 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.432 0.634 . . . . 0.0 111.522 -172.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.16 140.51 46.6 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.252 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 166' ' ' ARG . 16.8 t70 -94.91 105.31 17.23 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -159.23 143.54 15.3 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.21 100.19 0.44 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.181 0.515 . . . . 0.0 109.664 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.0 p -65.39 161.02 20.66 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -133.68 137.82 45.52 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.5 m -84.39 152.15 24.23 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.01 -7.32 76.54 Favored Glycine 0 N--CA 1.459 0.209 0 C-N-CA 119.979 -1.105 . . . . 0.0 111.601 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.475 ' NE2' HG12 ' A' ' 103' ' ' VAL . 11.9 mm100 -92.1 2.69 56.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.048 0.928 . . . . 0.0 108.676 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 27.8 m -61.92 127.37 31.08 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.882 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.458 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 103.52 -11.7 54.08 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.153 -1.023 . . . . 0.0 111.192 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.12 137.93 36.33 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.4 p -77.61 123.83 34.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.743 0.782 . . . . 0.0 111.277 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 28.4 tp -91.84 100.28 12.99 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.6 p -125.57 -173.86 2.93 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.885 -173.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -155.07 -175.84 5.64 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.2 t -62.45 99.7 0.15 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.828 0.823 . . . . 0.0 111.311 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.2 20.75 79.29 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.568 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 97.4 mttt -138.44 148.06 43.99 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.648 0.379 . . . . 0.0 110.369 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 91.1 mt -132.45 126.45 55.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -96.14 -49.98 5.02 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.731 0.776 . . . . 0.0 109.637 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.465 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 178.81 -152.18 11.06 Favored Glycine 0 N--CA 1.42 -2.387 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.055 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 pt -126.46 151.97 33.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 117.121 0.461 . . . . 0.0 110.352 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -63.46 118.42 8.09 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.0 t -91.7 -62.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.33 -139.8 5.11 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.973 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.81 137.99 5.32 Favored Glycine 0 C--N 1.288 -2.128 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -110.13 130.38 55.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.24 -125.26 8.42 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.642 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 10.9 mtm180 -106.21 -7.08 18.03 Favored 'General case' 0 C--O 1.214 -0.777 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.461 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -96.31 106.24 18.43 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.611 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.66 132.02 11.07 Favored Glycine 0 N--CA 1.418 -2.562 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -115.61 127.82 55.49 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.684 0.755 . . . . 0.0 110.695 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.469 ' HB3' HG21 ' A' ' 135' ' ' ILE . 37.7 t -120.34 155.09 34.07 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.447 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -108.74 134.27 51.69 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 11.0 pt20 -78.07 117.36 19.31 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 124.015 0.822 . . . . 0.0 110.725 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.465 ' HG ' ' HA2' ' A' ' 158' ' ' GLY 0.304 0.7 OUTLIER -99.37 75.35 1.97 Allowed 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.226 1.013 . . . . 0.0 111.831 177.282 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -59.49 144.74 46.31 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.324 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -61.17 -20.21 62.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.832 0.853 . . . . 0.0 110.94 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -59.33 -29.05 67.37 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.689 1.195 . . . . 0.0 110.925 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -82.14 -8.04 59.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.715 0.293 . . . . 0.0 111.341 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -128.46 28.1 5.48 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 16.0 m -57.1 150.29 3.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-O 121.324 0.583 . . . . 0.0 112.507 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -80.75 -23.7 39.2 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.118 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -120.08 104.73 10.36 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.989 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 . . . . . 0 C--N 1.297 -1.691 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.856 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.883 0 CA-C-O 118.621 -1.099 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -37.61 -63.47 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 125.21 3.94 . . . . 0.0 116.262 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -70.03 -34.27 73.05 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.52 -174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.5 m -72.72 -33.64 66.57 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.136 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -61.9 -48.29 81.11 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.536 0.735 . . . . 0.0 109.376 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -63.81 -47.94 78.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.011 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.48 81.0 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.473 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 tp -65.62 -36.72 84.53 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 122.794 0.438 . . . . 0.0 111.232 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -71.87 -44.41 63.81 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.949 0.404 . . . . 0.0 110.414 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.9 tp -65.84 -36.97 84.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.522 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.467 ' HA ' HD12 ' A' ' 15' ' ' ILE . 37.4 tp -51.57 -56.82 11.32 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.364 1.465 . . . . 0.0 112.254 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -79.18 7.81 6.98 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -131.37 -49.98 1.0 Allowed 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -118.05 0.11 11.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 11' ' ' LEU . 50.0 mt -113.18 106.83 21.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.882 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -123.35 160.16 27.35 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.925 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.486 ' CG2' ' HB3' ' A' ' 24' ' ' GLU . 80.5 m -90.3 121.5 32.36 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 174.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.3 mt -106.5 124.48 62.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 p -79.31 98.97 6.9 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.741 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.2 p -98.59 -173.61 2.59 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.1 t -69.93 -34.82 73.97 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -84.77 -5.29 59.32 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.77 -162.82 24.48 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.081 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.486 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 40.2 mt-10 -94.53 111.13 22.88 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.893 0.378 . . . . 0.0 110.861 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -116.67 -178.77 3.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.384 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.7 m -98.11 136.81 37.82 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.7 126.47 6.63 Favored Glycine 0 N--CA 1.418 -2.549 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -96.79 119.59 35.55 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.5 121.94 5.59 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.6 mm -85.04 -53.94 9.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 117.388 0.594 . . . . 0.0 109.788 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -164.53 154.69 14.25 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 54.27 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.3 ptt180 -139.64 10.48 2.46 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.705 1.202 . . . . 0.0 108.956 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.15 114.55 31.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.125 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -125.11 156.36 38.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -117.09 135.5 57.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.405 ' O ' ' HB ' ' A' ' 73' ' ' THR . 10.1 tp -141.53 148.73 51.52 Favored Pre-proline 0 CA--C 1.559 1.309 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -76.2 145.4 27.44 Favored 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 121.964 1.776 . . . . 0.0 112.787 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.513 HG22 ' OG1' ' A' ' 73' ' ' THR . 0.2 OUTLIER -74.41 -18.56 60.64 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -73.47 -21.42 60.44 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.658 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.55 -26.15 45.61 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 63.44 90.63 0.09 OUTLIER Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.735 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.14 152.48 24.23 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 121.962 1.775 . . . . 0.0 110.203 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.61 -157.65 26.72 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 119.971 -1.109 . . . . 0.0 113.142 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.74 -34.41 30.49 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.573 0.702 . . . . 0.0 110.902 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -137.84 138.88 39.59 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.71 144.95 36.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.224 0.535 . . . . 0.0 111.311 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.74 101.26 12.07 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.5 p -96.98 94.55 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 122.033 0.92 . . . . 0.0 110.492 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.6 t30 55.97 23.42 6.67 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.134 1.374 . . . . 0.0 112.019 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.52 -49.67 0.8 Allowed Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.808 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -85.09 119.2 25.21 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.12 108.45 12.62 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.462 HD11 ' O ' ' A' ' 78' ' ' ASP . 9.4 tp -112.76 143.54 22.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.439 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -78.94 131.59 36.42 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.114 0.483 . . . . 0.0 110.783 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.5 t -89.68 125.94 42.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -78.66 -59.52 2.75 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.462 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -136.21 159.64 41.13 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -140.74 100.55 3.87 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -174.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.473 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 59.4 m-85 -97.08 113.56 25.13 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -82.56 111.19 18.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.31 104.55 6.89 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -174.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.87 133.9 62.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -71.63 145.07 89.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.73 -20.02 4.14 Favored 'Trans proline' 0 CA--C 1.552 1.39 0 C-N-CA 123.867 3.045 . . . . 0.0 115.3 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -86.58 9.12 19.49 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.752 -0.592 . . . . 0.0 111.175 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 71.78 26.38 3.04 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 123.433 1.587 . . . . 0.0 109.931 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.4 mt -97.57 127.94 49.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.516 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -89.06 155.33 19.53 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.059 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.253 0.0 OUTLIER -132.22 18.94 4.45 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.795 0.807 . . . . 0.0 110.896 173.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 70.05 -20.8 0.18 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.338 1.855 . . . . 0.0 114.593 173.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.18 119.15 5.47 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.513 ' OG1' HG22 ' A' ' 39' ' ' THR . 20.5 m -117.9 112.85 20.89 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 171.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 44.0 t -81.86 105.57 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.83 113.67 26.01 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.9 m -99.11 105.34 17.41 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 120.876 0.37 . . . . 0.0 110.035 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.9 mp -77.98 139.38 39.16 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.579 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.462 ' O ' HD11 ' A' ' 54' ' ' ILE . 36.5 t70 -89.48 96.14 10.57 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.752 177.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -155.53 152.2 28.56 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.62 0.724 . . . . 0.0 112.488 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -89.16 -12.42 41.05 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.368 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -74.07 132.82 42.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.009 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -108.35 121.82 45.7 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.729 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -76.8 144.07 39.38 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -59.66 131.11 49.92 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.83 96.76 0.14 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.876 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -93.71 18.27 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 122.204 1.002 . . . . 0.0 110.388 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -62.87 -32.22 73.42 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.166 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.14 2.48 87.65 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.923 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -103.14 -8.77 20.2 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 117.136 0.468 . . . . 0.0 110.731 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.4 mt -67.57 128.7 31.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.9 t -95.04 107.72 19.78 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -62.89 -23.13 67.19 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.778 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -106.05 111.55 24.22 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mp -102.81 -51.23 3.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.18 137.03 56.72 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -172.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.15 8.1 31.9 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.89 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.437 ' O ' HG21 ' A' ' 118' ' ' VAL . 40.4 t -122.31 150.37 25.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 O-C-N 122.183 -0.598 . . . . 0.0 109.717 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -82.18 122.63 28.14 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -115.0 160.7 19.28 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.98 0.895 . . . . 0.0 113.152 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 37.6 m -122.76 135.51 54.58 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.059 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.5 tp -100.19 124.99 46.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -113.77 117.65 56.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.454 ' HB ' ' OG1' ' A' ' 111' ' ' THR . 23.9 t -112.03 138.17 41.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -136.66 92.62 2.77 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.9 p -138.7 -169.74 2.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.127 -174.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -56.51 -59.34 5.12 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.021 0.928 . . . . 0.0 112.142 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -92.71 -35.62 13.37 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.407 0.622 . . . . 0.0 110.517 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -99.17 84.15 2.98 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.488 0.661 . . . . 0.0 109.765 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.57 111.04 22.63 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.344 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 65.17 37.16 6.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.286 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.454 ' OG1' ' HB ' ' A' ' 103' ' ' VAL . 32.5 p -79.61 94.22 5.63 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.013 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.72 103.41 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.5 tp -117.43 114.31 23.32 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.655 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 0.3 OUTLIER -77.66 143.53 38.09 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.979 177.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 36.0 m -111.43 -31.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 119.949 -0.701 . . . . 0.0 111.844 -176.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.78 -155.03 16.53 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.064 -1.065 . . . . 0.0 111.555 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.92 124.35 10.53 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.845 2.363 . . . . 0.0 111.978 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 97' ' ' VAL . 35.0 m -96.93 134.07 36.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.348 0.594 . . . . 0.0 110.895 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.6 p -128.38 163.68 24.31 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.755 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.3 ttt -84.47 133.13 34.49 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 118.551 0.614 . . . . 0.0 110.013 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -82.09 -37.82 25.77 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 121.832 0.825 . . . . 0.0 108.801 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.94 -102.83 2.21 Favored Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.97 149.4 47.52 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.4 pt -132.53 172.16 16.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.55 138.76 51.16 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -127.4 112.98 15.62 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 16.4 t 61.81 36.18 16.25 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 121.834 0.826 . . . . 0.0 108.985 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.8 m 69.37 10.08 7.58 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.137 1.375 . . . . 0.0 111.996 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.7 m -98.91 118.53 62.71 Favored Pre-proline 0 N--CA 1.425 -1.722 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.38 127.4 17.3 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.231 1.954 . . . . 0.0 112.064 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.9 t -125.17 118.63 26.51 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -106.35 156.93 18.01 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.581 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 74.22 57.02 0.09 Allowed 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.051 1.341 . . . . 0.0 111.508 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.0 mmt -113.28 143.03 45.11 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 113.064 -1.88 . . . . 0.0 108.832 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 170' ' ' SER . 18.1 tt -106.96 141.79 21.31 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.456 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 24.4 ttm-85 -118.96 132.97 56.1 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 122.634 0.374 . . . . 0.0 110.427 -173.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -136.29 134.62 38.18 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.637 172.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -87.84 91.31 8.71 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.869 0.842 . . . . 0.0 110.342 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -158.06 136.68 11.2 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.52 87.29 2.64 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.54 0.686 . . . . 0.0 111.398 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.6 p -94.48 161.09 14.36 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.798 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -118.31 136.16 53.87 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.0 m -61.22 124.98 22.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.594 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 132.45 -15.9 4.92 Favored Glycine 0 C--N 1.299 -1.517 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.547 ' HA ' HE21 ' A' ' 145' ' ' GLN . 0.0 OUTLIER -97.79 18.09 16.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.25 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.9 m -62.7 130.92 47.13 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.021 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.43 -1.21 66.47 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.62 138.99 26.87 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.65 124.72 38.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.859 0.838 . . . . 0.0 111.472 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.7 tp -92.19 108.85 20.25 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.5 p -141.75 177.57 8.07 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.172 0.51 . . . . 0.0 111.813 -173.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.96 179.52 8.61 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.9 m -54.71 101.1 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.17 0.588 . . . . 0.0 111.876 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 69.15 23.31 76.22 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.667 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -136.26 118.34 15.41 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 98.7 mt -108.14 129.24 62.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -103.45 -45.47 4.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.262 0.553 . . . . 0.0 110.899 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.447 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 176.82 -157.86 23.36 Favored Glycine 0 N--CA 1.421 -2.359 0 C-N-CA 118.968 -1.587 . . . . 0.0 112.586 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.4 pt -126.49 141.77 44.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -63.58 130.79 45.78 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.216 0.606 . . . . 0.0 110.357 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.0 t -101.14 -49.2 11.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -173.06 160.99 31.97 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.697 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -107.59 129.54 9.7 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -126.86 95.27 4.27 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.27 -125.04 17.5 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -101.44 21.5 14.1 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.318 0.58 . . . . 0.0 111.174 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -122.77 124.47 43.41 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.048 0.451 . . . . 0.0 110.146 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -102.26 131.56 10.65 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -109.12 133.63 52.76 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.512 ' O ' HG23 ' A' ' 135' ' ' ILE . 41.9 m -130.62 150.44 51.81 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.759 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -88.81 135.46 33.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -82.96 95.65 8.06 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 123.485 0.49 . . . . 0.0 110.623 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.447 ' HG ' ' HA2' ' A' ' 158' ' ' GLY 0.306 1.0 OUTLIER -83.08 76.46 9.85 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-O 122.745 1.259 . . . . 0.0 112.299 177.909 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -75.71 153.35 37.14 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.209 -1.359 . . . . 0.0 111.88 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -59.7 -23.91 63.53 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.383 1.073 . . . . 0.0 112.046 -174.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -58.87 -22.89 60.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.728 1.211 . . . . 0.0 112.052 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -96.14 -9.83 29.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.937 0.399 . . . . 0.0 111.695 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -111.59 18.48 19.02 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.416 0.627 . . . . 0.0 110.756 -175.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.81 117.94 22.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.384 -0.826 . . . . 0.0 108.818 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -71.52 -38.64 71.09 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.268 0.556 . . . . 0.0 109.741 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -86.57 79.88 8.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.349 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 C--N 1.298 -1.668 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -177.305 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.542 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.92 -44.56 46.11 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.602 2.868 . . . . 0.0 113.681 -175.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -68.44 -30.2 69.02 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.016 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 m -70.36 -41.82 72.64 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.238 0.615 . . . . 0.0 109.357 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.24 -50.11 74.95 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.808 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -65.04 -42.66 94.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.647 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.29 82.89 Favored 'General case' 0 C--O 1.216 -0.684 0 O-C-N 123.516 0.51 . . . . 0.0 110.856 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.63 -39.99 95.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.146 0.498 . . . . 0.0 110.719 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -68.48 -43.48 76.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.005 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.7 tp -68.12 -39.07 82.84 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.276 0.631 . . . . 0.0 109.913 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.433 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 7.8 tt -55.31 -47.94 74.86 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.896 0.878 . . . . 0.0 110.25 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -79.09 14.94 1.26 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.978 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 -64.36 0.96 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -116.37 4.49 13.4 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.453 ' CG2' ' HB3' ' A' ' 104' ' ' HIS . 1.7 mp -87.36 115.03 27.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.255 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.6 mmt -113.21 134.13 54.73 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.043 -174.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 89.8 m -92.8 103.58 15.92 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.7 mt -101.37 121.13 51.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 121.198 0.523 . . . . 0.0 110.544 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -87.41 108.15 18.87 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.2 p -102.92 -166.59 1.29 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.51 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.3 t -66.28 -43.15 87.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.071 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 22' ' ' LYS . 40.6 mmtm -89.39 -9.94 48.4 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -172.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.14 -165.82 33.39 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.19 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -108.59 103.33 12.42 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.406 ' CD1' ' HB3' ' A' ' 146' ' ' CYS . 83.4 m-85 -113.52 175.0 5.64 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.087 -174.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.6 m -93.78 136.33 34.18 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.84 145.31 16.75 Favored Glycine 0 N--CA 1.416 -2.691 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.4 tp -105.4 119.96 40.39 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.206 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.68 139.77 25.03 Favored Glycine 0 N--CA 1.428 -1.847 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 40.4 mm -99.31 -49.73 11.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -174.86 153.99 1.81 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.543 ' OD1' ' HG2' ' A' ' 82' ' ' LYS . 36.1 m-20 51.02 -94.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.575 1.172 . . . . 0.0 113.186 176.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 17.7 ptp180 -127.06 6.11 6.51 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.511 -176.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 64.6 t -92.77 118.71 39.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -132.45 159.92 37.93 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 m -123.27 146.6 28.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 122.155 -0.341 . . . . 0.0 111.011 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.8 tt -158.13 147.12 14.58 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 45.1 Cg_exo -60.75 142.12 96.85 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 122.496 2.131 . . . . 0.0 112.8 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.1 m -59.73 -37.9 80.2 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -71.21 -2.06 14.68 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.41 -30.29 57.39 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 60.46 89.13 0.11 Allowed Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.123 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.41 154.82 28.18 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.206 1.937 . . . . 0.0 110.507 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.32 -166.02 29.88 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.436 -0.887 . . . . 0.0 111.859 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -81.85 -18.7 42.99 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 122.104 0.954 . . . . 0.0 109.126 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -147.37 148.15 31.05 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 m -142.52 -172.81 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 1.2 pt? -138.63 127.64 23.93 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 17' ' ' THR . 5.2 p -115.85 116.1 51.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.757 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 65.56 19.85 11.56 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.051 0.94 . . . . 0.0 109.465 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.23 -15.41 59.07 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.318 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 83.1 mt-30 -78.42 121.66 24.8 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 122.461 0.304 . . . . 0.0 110.263 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -67.65 126.18 28.56 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 78' ' ' ASP . 9.3 tp -146.19 133.83 15.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.586 0.708 . . . . 0.0 110.551 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -85.37 145.4 27.5 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.585 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.77 148.31 5.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -97.82 -57.03 2.33 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -141.76 166.96 23.28 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.502 ' HZ1' ' HB2' ' A' ' 59' ' ' LYS . 10.1 mtmp? -139.89 95.25 2.87 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.463 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 84.6 m-85 -81.37 111.37 17.68 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.5 103.73 4.95 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -80.82 101.83 9.62 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.4 155.7 9.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.69 138.44 83.07 Favored Pre-proline 0 C--N 1.311 -1.068 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -47.4 -29.06 9.32 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.056 3.171 . . . . 0.0 114.442 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -93.16 16.72 12.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.704 0.288 . . . . 0.0 110.986 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 71.87 20.18 4.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.298 1.039 . . . . 0.0 112.327 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.4 mm -87.69 149.89 3.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 131' ' ' THR . 56.4 t30 -69.87 142.89 52.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.472 HD23 ' HD2' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -118.27 -29.72 5.46 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 69.06 17.39 8.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.603 1.161 . . . . 0.0 111.281 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.15 135.43 54.19 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.1 m -128.15 130.29 47.86 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 120.826 0.346 . . . . 0.0 110.13 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 46.4 t -90.46 109.68 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -91.61 121.98 33.77 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.4 m -104.86 105.5 15.59 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 91.8 mt -82.65 168.68 17.04 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.419 ' O ' HD12 ' A' ' 54' ' ' ILE . 18.7 t70 -93.64 89.88 6.4 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 171.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -129.61 116.01 18.24 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.302 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.78 -29.77 36.09 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.53 140.22 51.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.813 -1.54 . . . . 0.0 110.739 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.543 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 60.5 mttm -90.26 105.55 17.89 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -77.64 144.88 37.07 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 166.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -59.04 126.95 29.81 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 124.008 0.818 . . . . 0.0 112.376 -172.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 12.7 p-10 -69.74 102.87 2.0 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.09 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -93.12 23.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.633 -0.667 . . . . 0.0 111.794 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -62.8 -40.11 96.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.067 -175.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.35 -0.48 89.11 Favored Glycine 0 C--N 1.317 -0.511 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.606 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -98.97 -14.11 19.65 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.8 mt -64.46 122.51 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.441 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.1 m -122.89 95.58 4.68 Favored 'General case' 0 N--CA 1.397 -3.112 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.97 -14.92 57.52 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -88.48 95.17 10.12 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 171.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.404 HD11 ' N ' ' A' ' 95' ' ' GLU . 2.2 pp -125.79 -21.54 4.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 -162.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.404 ' N ' HD11 ' A' ' 94' ' ' LEU . 12.1 pt-20 -68.44 134.05 49.58 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.797 -1.161 . . . . 0.0 113.656 -172.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.35 -13.99 56.85 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.684 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 118' ' ' VAL . 16.0 t -93.45 157.02 3.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -96.22 148.96 22.18 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.8 158.87 38.98 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.034 0.921 . . . . 0.0 112.64 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.0 m -123.63 131.83 53.71 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.076 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.2 tp -94.97 115.83 27.93 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.99 109.24 27.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.435 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 47.2 t -113.97 131.89 64.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.453 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 9.7 t60 -140.85 93.71 2.63 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -121.36 179.7 4.34 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.503 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -75.63 -37.73 59.49 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.214 -0.595 . . . . 0.0 111.287 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -86.62 -22.98 25.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.178 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -125.05 76.9 1.58 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.4 m -88.56 129.39 35.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.351 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 57.38 68.03 0.9 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.902 1.281 . . . . 0.0 113.458 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.435 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 27.3 m -107.78 99.8 9.24 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.189 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.4 mt -100.76 96.61 4.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.8 tp -110.34 106.22 15.52 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.546 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.17 115.84 14.12 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.9 m -94.98 -19.63 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.19 -159.5 17.94 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.63 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.01 133.61 36.46 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.42 2.747 . . . . 0.0 112.586 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 97' ' ' VAL . 35.4 m -111.31 159.35 11.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.154 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.5 t -142.11 167.03 23.1 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.6 ttt -87.54 129.35 35.12 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.49 -26.13 18.95 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.282 0.563 . . . . 0.0 110.696 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.62 -106.99 2.59 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.51 116.73 23.66 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.2 mm -104.67 122.03 57.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.782 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -106.94 85.73 2.19 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 122.106 0.955 . . . . 0.0 110.967 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.1 tp -97.66 133.72 41.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 40.8 m 61.05 32.48 19.79 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.677 0.751 . . . . 0.0 109.43 -176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.3 m 64.23 12.96 7.55 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.749 1.22 . . . . 0.0 111.522 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 44.9 m -102.62 107.08 52.81 Favored Pre-proline 0 N--CA 1.428 -1.528 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.65 121.67 6.86 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.687 2.258 . . . . 0.0 112.602 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 24.6 m -121.96 120.46 34.49 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -98.95 158.77 15.42 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.472 ' HD2' HD23 ' A' ' 70' ' ' LEU . 98.9 mtt180 64.27 62.01 0.86 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 122.514 1.15 . . . . 0.0 110.813 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 54.8 ttm -124.78 145.57 49.67 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.566 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 170' ' ' SER . 1.4 tt -109.38 134.77 50.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -120.51 140.21 51.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.158 0.504 . . . . 0.0 111.772 -173.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.402 ' HB3' HG12 ' A' ' 118' ' ' VAL . 26.5 p90 -141.74 132.38 25.52 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.466 172.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.37 81.03 4.91 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.976 0.893 . . . . 0.0 109.634 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -144.52 127.74 16.72 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.43 105.88 4.31 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.193 0.52 . . . . 0.0 111.15 -176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.3 p -89.59 174.36 7.8 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -114.39 172.67 6.88 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.1 t -84.93 146.89 27.02 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.3 56.68 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -106.37 14.77 26.92 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.428 0.633 . . . . 0.0 110.369 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.444 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 47.2 t -71.07 129.46 39.02 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.329 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.15 2.68 62.14 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.327 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.23 131.82 38.94 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.2 t -76.92 109.53 11.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 28.7 tp -88.0 106.0 17.84 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.7 p -136.75 178.36 7.13 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.957 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.83 -178.95 6.17 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.5 m -64.92 97.24 0.22 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.193 0.52 . . . . 0.0 110.931 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.52 11.41 68.8 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.877 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.75 143.11 33.32 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 117.089 0.445 . . . . 0.0 110.749 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 75.8 mt -122.62 130.83 74.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -105.22 -34.12 8.01 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.222 0.534 . . . . 0.0 111.328 -175.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 168.9 -159.6 32.75 Favored Glycine 0 N--CA 1.426 -1.967 0 C-N-CA 119.884 -1.151 . . . . 0.0 112.1 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 27.5 pt -132.58 135.78 57.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.838 0.351 . . . . 0.0 110.663 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -64.84 118.69 9.37 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 123.62 0.768 . . . . 0.0 110.179 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.7 m -90.95 -36.05 7.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 120.87 0.367 . . . . 0.0 110.309 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.88 164.71 31.65 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -129.26 143.89 14.94 Favored Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -132.83 103.8 6.27 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.16 -108.31 2.45 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -104.58 -10.45 17.57 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -85.07 99.26 10.92 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 120.988 0.423 . . . . 0.0 111.451 -174.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.5 113.32 3.81 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -95.95 120.95 37.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 121.3 0.572 . . . . 0.0 109.614 -176.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.456 ' HB3' HG23 ' A' ' 135' ' ' ILE . 35.1 t -119.22 139.14 52.36 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.405 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -76.18 134.17 39.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -79.71 111.48 16.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.71 99.31 10.16 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -85.69 142.52 28.97 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.372 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -72.55 -19.13 61.56 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.734 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.461 ' O ' HG13 ' A' ' 179' ' ' VAL . 3.4 pt20 -75.16 -5.34 43.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.729 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -76.76 -26.03 54.09 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -106.97 1.02 24.16 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.069 -173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 176' ' ' GLN . 9.1 p -74.27 130.51 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -93.86 -16.19 24.31 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.691 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -110.79 107.72 17.33 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.957 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 . . . . . 0 C--N 1.295 -1.776 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 177.203 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.001 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.58 -62.24 0.47 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.553 2.836 . . . . 0.0 114.621 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -72.03 -41.45 67.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.241 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -62.31 -40.28 95.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.626 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.54 -36.83 71.13 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.45 0.167 . . . . 0.0 110.607 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.86 -48.88 79.8 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.47 96.35 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.357 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.4 -44.86 96.41 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.0 0.52 . . . . 0.0 110.419 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -63.03 -48.55 78.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.547 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.71 -41.73 98.0 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.279 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.423 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 26.1 tp -56.17 -58.92 5.89 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.809 1.243 . . . . 0.0 111.706 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -76.51 -2.23 31.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.819 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -109.37 -63.88 1.31 Allowed 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -108.96 -10.06 15.07 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -170.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.423 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 58.2 mt -91.77 109.89 21.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.025 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 67.6 mtm -116.39 139.93 49.9 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 120.592 0.234 . . . . 0.0 111.09 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.5 m -82.55 119.42 24.22 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.9 mt -109.11 108.3 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.2 m -81.85 104.79 12.48 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 77.1 p -91.88 -162.6 0.94 Allowed 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.937 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.7 t -81.41 -14.2 57.41 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -100.39 -34.38 9.99 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.287 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.04 -162.6 36.35 Favored Glycine 0 CA--C 1.502 -0.759 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.743 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.456 ' CD ' ' HB3' ' A' ' 106' ' ' ASN . 82.8 mt-10 -92.7 104.09 16.4 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -107.45 176.61 5.1 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.91 131.58 56.5 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-O 121.11 0.481 . . . . 0.0 109.983 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.44 131.65 10.14 Favored Glycine 0 N--CA 1.416 -2.633 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -98.51 115.72 29.19 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.86 122.35 8.2 Favored Glycine 0 N--CA 1.434 -1.482 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.0 mm -85.8 -57.51 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.315 0.578 . . . . 0.0 109.874 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -155.33 137.21 14.48 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.928 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 62.52 -85.91 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 O-C-N 124.641 1.213 . . . . 0.0 112.455 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -143.2 18.75 1.92 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.264 1.031 . . . . 0.0 109.989 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.6 t -92.51 113.56 27.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.5 p -122.19 155.49 35.7 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.423 ' HB ' HD11 ' A' ' 72' ' ' LEU . 27.1 m -117.73 145.42 23.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 120.732 0.301 . . . . 0.0 110.934 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.2 tt -146.49 141.51 16.37 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -60.4 143.44 99.48 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.724 1.616 . . . . 0.0 111.14 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.2 m -66.99 -40.15 87.31 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.124 0.487 . . . . 0.0 111.577 -174.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -70.97 -1.42 11.94 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.43 -17.5 61.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 122.073 -0.392 . . . . 0.0 110.327 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.622 ' O ' ' HB ' ' A' ' 20' ' ' THR . 16.9 mm100 63.93 74.43 0.43 Allowed Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 124.638 1.175 . . . . 0.0 113.174 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -89.15 -175.19 1.09 Allowed 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 122.67 2.247 . . . . 0.0 109.814 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.95 -160.1 8.23 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -81.67 -20.22 40.0 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.875 0.845 . . . . 0.0 109.232 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -132.41 141.64 48.95 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.76 160.37 42.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 90.5 mt -101.89 102.07 12.59 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.06 100.66 7.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 121.864 0.84 . . . . 0.0 108.894 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.8 t30 63.47 10.7 5.04 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.19 1.396 . . . . 0.0 110.355 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.9 -19.97 8.23 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.737 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -77.95 116.03 18.14 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 120.583 0.23 . . . . 0.0 110.384 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -70.29 111.93 6.24 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.656 0.741 . . . . 0.0 109.914 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.474 HD11 ' O ' ' A' ' 78' ' ' ASP . 9.5 tp -126.05 140.96 47.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.564 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -87.61 143.24 27.29 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.3 133.04 42.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -80.63 -62.78 1.57 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.09 0.472 . . . . 0.0 110.194 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -128.56 148.83 50.79 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.899 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -129.78 117.0 19.56 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.453 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.0 m-85 -111.45 117.63 33.57 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.635 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -76.31 107.72 8.76 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.3 tp -84.2 98.89 10.19 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.979 0.895 . . . . 0.0 109.123 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -127.3 160.06 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.412 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -67.89 148.3 98.45 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -32.17 -44.88 0.2 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.862 3.708 . . . . 0.0 115.072 173.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.16 16.43 2.42 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.993 -0.442 . . . . 0.0 112.122 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 t30 60.4 48.56 7.69 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 125.626 1.571 . . . . 0.0 109.753 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.0 mt -98.43 126.64 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 172.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 131' ' ' THR . 16.6 m120 -73.72 133.2 43.3 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.84 -171.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.4 tp -97.25 -2.95 41.61 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 69.54 5.65 5.29 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.452 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.423 HD11 ' HB ' ' A' ' 36' ' ' VAL . 20.0 tp -102.79 131.13 49.86 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.55 -0.719 . . . . 0.0 111.236 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.0 m -111.24 123.79 50.91 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 55.0 t -86.51 114.11 25.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.1 tp -102.3 111.94 24.43 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.654 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.5 m -87.32 100.09 12.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.79 125.54 29.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.474 ' O ' HD11 ' A' ' 54' ' ' ILE . 31.4 t70 -83.61 78.99 9.59 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.807 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.49 ' HD3' ' OE2' ' A' ' 81' ' ' GLU . 14.5 ttm180 -137.28 134.66 36.37 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -84.06 1.94 41.57 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.49 ' OE2' ' HD3' ' A' ' 79' ' ' ARG . 45.1 mt-10 -77.36 126.0 30.22 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 173.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -102.89 109.14 20.59 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.396 0.617 . . . . 0.0 109.684 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -79.47 173.1 12.93 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.32 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -72.73 143.27 48.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.196 0.522 . . . . 0.0 111.124 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.16 100.22 5.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 171.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 pt -99.15 19.01 2.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 122.559 1.171 . . . . 0.0 108.643 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -70.29 -34.98 73.41 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.421 -1.718 . . . . 0.0 112.645 -171.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.39 -12.48 82.09 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.189 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.66 -11.59 55.62 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.76 123.36 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 m -118.92 103.55 9.7 Favored 'General case' 0 N--CA 1.405 -2.675 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.14 1.52 31.51 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -89.54 119.69 30.19 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 27.3 mt -107.67 -50.41 3.07 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -166.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.66 127.67 32.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -167.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.69 16.31 52.39 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.085 -1.416 . . . . 0.0 114.083 172.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.8 t -115.48 132.81 63.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.815 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.97 113.09 4.71 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.173 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.0 150.95 26.48 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.471 0.653 . . . . 0.0 111.459 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.7 m -114.93 131.81 56.76 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 tp -96.43 119.6 35.21 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 111' ' ' THR . 40.5 t -113.15 111.8 37.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-O 121.2 0.524 . . . . 0.0 110.116 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 26.7 t -107.97 147.0 13.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -139.38 103.76 4.8 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.4 p -124.62 175.38 7.23 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.456 ' HB3' ' CD ' ' A' ' 24' ' ' GLU . 3.7 t30 -80.14 -43.6 21.36 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.78 0.324 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -68.63 -35.61 77.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.784 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -133.15 96.58 3.78 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.2 m -96.45 134.83 39.13 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.837 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 71.74 71.28 0.16 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.377 0.671 . . . . 0.0 111.488 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.618 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 7.2 m -97.68 93.68 6.53 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.1 mt -105.26 98.55 7.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.5 tp -122.75 125.49 45.61 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.443 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.04 134.95 41.28 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.2 -51.32 8.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 120.988 0.423 . . . . 0.0 111.268 -176.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.03 -162.93 22.49 Favored Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.31 123.38 8.18 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.925 2.417 . . . . 0.0 111.673 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.8 m -87.79 156.77 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.696 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.3 p -137.05 151.48 48.97 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.719 0.807 . . . . 0.0 110.257 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 56.7 ttp -89.56 126.69 35.7 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.82 -0.55 . . . . 0.0 109.604 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.32 -42.36 11.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.875 0.369 . . . . 0.0 110.436 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.12 -127.81 9.22 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 44.7 tp -95.16 115.59 27.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.244 0.545 . . . . 0.0 110.447 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.1 pt -111.4 153.79 13.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -127.83 109.46 11.64 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 121.681 0.753 . . . . 0.0 109.434 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 48.4 tp -125.68 119.03 26.9 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.378 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.7 p 49.83 64.59 1.71 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.284 1.034 . . . . 0.0 113.565 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.7 m 61.94 15.96 7.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.714 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.3 m -126.18 118.74 23.55 Favored Pre-proline 0 N--CA 1.431 -1.394 0 O-C-N 122.157 -0.34 . . . . 0.0 110.899 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -85.38 126.95 3.22 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 122.374 2.05 . . . . 0.0 110.846 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 28.6 m -129.53 117.99 21.35 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 27.4 p-10 -103.85 163.83 12.09 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.896 -173.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.57 ' HD2' ' OE1' ' A' ' 172' ' ' GLN . 20.5 mmt180 55.73 47.85 19.61 Favored 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 124.59 1.181 . . . . 0.0 112.804 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 98.2 mmm -95.57 147.73 23.27 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.597 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.448 HG21 ' HB2' ' A' ' 170' ' ' SER . 3.4 tt -117.73 134.03 62.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 42.1 ptt85 -124.48 157.85 34.26 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.96 0.886 . . . . 0.0 110.405 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.497 ' HH ' ' CD2' ' A' ' 160' ' ' HIS . 10.9 p90 -137.42 149.56 47.0 Favored 'General case' 0 C--N 1.26 -3.326 0 CA-C-N 114.0 -1.455 . . . . 0.0 107.689 173.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.02 99.82 11.76 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -164.22 144.18 7.91 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.467 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -75.36 99.23 4.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.222 0.535 . . . . 0.0 110.94 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.6 t -132.03 177.61 7.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -158.87 168.54 26.52 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 120.728 0.299 . . . . 0.0 111.111 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 54.2 m -64.28 116.85 6.43 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.013 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.72 -35.57 0.54 Allowed Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -87.97 25.59 1.53 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 34.8 m -73.22 127.6 33.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.598 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.42 5.95 63.08 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.406 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.23 137.56 17.23 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.3 126.74 37.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.792 0.806 . . . . 0.0 110.764 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 42.5 tp -96.96 103.79 15.74 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 20.8 p -145.1 162.7 36.37 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.512 0.672 . . . . 0.0 112.331 -173.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.44 -176.27 3.55 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.4 p -60.41 99.42 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.343 0.592 . . . . 0.0 111.698 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 76.77 13.7 83.3 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.835 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -135.15 108.01 7.55 Favored 'General case' 0 C--O 1.21 -0.992 0 O-C-N 122.595 -0.356 . . . . 0.0 111.041 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 88.1 mt -98.63 129.68 48.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -101.47 -33.32 10.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.688 0.756 . . . . 0.0 110.603 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 160.9 -151.92 22.45 Favored Glycine 0 N--CA 1.421 -2.31 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.6 pt -133.01 149.3 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.497 ' CD2' ' HH ' ' A' ' 137' ' ' TYR . 20.2 t-80 -70.72 135.8 48.52 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.606 0.566 . . . . 0.0 111.398 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.29 -58.35 3.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.049 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.69 157.49 22.84 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -137.75 138.21 9.46 Favored Glycine 0 N--CA 1.419 -2.487 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -105.48 84.01 2.03 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 122.304 1.049 . . . . 0.0 110.663 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 80.91 -102.22 2.12 Favored Glycine 0 N--CA 1.419 -2.494 0 CA-C-N 114.398 -1.274 . . . . 0.0 113.013 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -98.42 -0.38 43.7 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -120.97 132.27 54.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -118.83 124.46 6.03 Favored Glycine 0 CA--C 1.476 -2.356 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.018 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -108.99 125.4 52.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.328 1.061 . . . . 0.0 111.645 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.448 ' HB2' HG21 ' A' ' 135' ' ' ILE . 19.8 m -120.56 161.39 21.4 Favored 'General case' 0 C--N 1.275 -2.639 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.36 138.68 32.04 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.57 ' OE1' ' HD2' ' A' ' 133' ' ' ARG . 58.4 tt0 -82.5 105.22 13.37 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.497 0.665 . . . . 0.0 109.63 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.5 mp -86.0 94.0 9.11 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -74.16 144.31 44.89 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -70.99 -21.93 62.24 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -64.48 -19.03 65.32 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.14 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -88.42 -15.1 36.36 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.827 -0.546 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.94 15.51 22.55 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.659 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.9 128.66 75.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -72.67 -64.37 0.97 Allowed 'General case' 0 CA--C 1.487 -1.452 0 CA-C-O 121.823 0.82 . . . . 0.0 110.653 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -87.3 134.84 33.5 Favored 'General case' 0 N--CA 1.398 -3.029 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.581 -172.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 N--CA 1.419 -1.976 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 173.236 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.861 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.93 -36.61 99.2 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 123.13 2.553 . . . . 0.0 111.104 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -64.99 -45.59 84.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.483 177.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -59.34 -49.28 78.43 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.52 0.728 . . . . 0.0 109.961 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.73 -36.48 82.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.859 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -65.77 -48.41 71.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.59 95.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.814 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.5 -47.22 79.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.654 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.2 m -62.75 -36.54 83.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.346 0.594 . . . . 0.0 110.746 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.9 tp -66.5 -49.25 67.2 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.062 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.409 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 60.8 tp -51.27 -52.59 43.61 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.775 1.23 . . . . 0.0 111.419 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -56.34 -21.03 21.87 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -174.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -137.49 -29.64 0.87 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 118.841 -1.144 . . . . 0.0 113.84 -177.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -107.05 -13.9 15.07 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.435 HG22 ' CG2' ' A' ' 26' ' ' THR . 27.3 mt -90.71 110.66 22.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.875 0.845 . . . . 0.0 111.562 -177.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.8 mtp -101.6 131.76 47.63 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.216 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 6.6 m -87.3 102.71 14.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 mt -100.35 111.95 31.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 121.64 0.733 . . . . 0.0 112.034 -174.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.3 m -84.05 106.81 15.99 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.378 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 28.0 p -96.69 -167.23 1.53 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.536 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m -73.19 -22.2 60.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 120.852 0.358 . . . . 0.0 110.281 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -92.45 -46.39 7.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.683 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.29 -167.56 33.27 Favored Glycine 0 CA--C 1.503 -0.677 0 C-N-CA 118.862 -1.637 . . . . 0.0 113.401 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -100.69 99.93 10.55 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -115.05 -168.63 1.41 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.173 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.435 ' CG2' HG22 ' A' ' 15' ' ' ILE . 90.3 m -111.83 135.53 52.33 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-O 121.243 0.544 . . . . 0.0 110.542 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.73 142.22 16.13 Favored Glycine 0 N--CA 1.409 -3.122 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.1 tp -114.52 118.26 33.25 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.321 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.17 119.66 5.0 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 46.5 mm -95.46 -51.81 10.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 117.714 0.757 . . . . 0.0 111.986 -173.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.513 ' O ' HG12 ' A' ' 34' ' ' VAL . 35.4 t-80 -156.28 111.39 2.9 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.566 -173.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 61.4 -77.87 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 170.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.594 ' HB3' ' NE ' ' A' ' 79' ' ' ARG . 1.1 ppt_? -120.02 -2.17 10.29 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 31' ' ' HIS . 14.3 p -100.97 118.85 48.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.719 -176.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.5 m -120.33 164.63 16.03 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.337 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.484 ' CG1' HD11 ' A' ' 72' ' ' LEU . 46.7 t -118.63 134.5 62.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tp -148.02 143.64 17.93 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.509 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 25.4 Cg_exo -69.61 155.28 66.84 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.36 2.04 . . . . 0.0 112.858 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.9 m -74.74 -44.58 49.09 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -63.6 -13.93 46.73 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.94 -24.28 63.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.068 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.412 ' O ' ' HB ' ' A' ' 20' ' ' THR . 25.2 mt-30 62.94 84.05 0.19 Allowed Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 123.756 0.822 . . . . 0.0 110.705 -177.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.55 121.46 6.0 Favored 'Trans proline' 0 C--O 1.258 1.505 0 C-N-CA 121.898 1.732 . . . . 0.0 110.179 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.2 -169.13 31.27 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.426 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -86.18 -14.4 44.12 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.426 0.631 . . . . 0.0 109.34 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -143.47 137.25 28.43 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.1 158.46 33.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.054 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 79.0 mt -105.6 115.22 29.88 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 17' ' ' THR . 6.0 p -87.78 90.39 3.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 71.75 -10.42 0.85 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.079 1.751 . . . . 0.0 110.632 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 148.94 -22.99 1.28 Allowed Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -73.44 113.85 11.0 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.445 ' HZ1' ' HB2' ' A' ' 53' ' ' LYS . 4.0 ttmp? -75.48 121.27 22.09 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 121.062 0.458 . . . . 0.0 110.799 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.417 ' CG2' HD11 ' A' ' 77' ' ' LEU . 10.6 tp -130.29 141.34 46.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.29 149.56 33.5 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.44 0.638 . . . . 0.0 111.401 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.5 t -94.01 126.97 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 172.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.483 ' HB3' HG23 ' A' ' 76' ' ' THR . 8.0 tmtm? -89.93 -43.81 10.33 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.766 -174.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -156.18 154.09 30.28 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -134.36 127.28 31.33 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.445 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 16.5 m-85 -123.13 108.64 13.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -81.19 136.93 35.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.15 76.2 9.29 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 122.402 1.096 . . . . 0.0 111.682 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.6 p -109.0 118.54 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.271 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 21.5 t70 -62.47 143.5 96.0 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.619 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.28 -21.24 22.19 Favored 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 123.796 2.997 . . . . 0.0 114.347 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -88.38 7.6 31.79 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.483 0.659 . . . . 0.0 109.242 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.275 40.6 m-80 67.85 63.62 0.39 Allowed 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 125.72 1.608 . . . . 0.0 112.252 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 18.1 mm -123.55 126.07 72.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 131' ' ' THR . 36.2 t30 -99.75 129.6 45.88 Favored 'General case' 0 C--O 1.203 -1.387 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -170.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.589 HD11 ' O ' ' A' ' 132' ' ' ASN . 40.0 tp -94.57 -8.18 38.92 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 117.607 0.185 . . . . 0.0 111.302 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 66.73 20.77 10.65 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.509 1.147 . . . . 0.0 109.316 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.484 HD11 ' CG1' ' A' ' 36' ' ' VAL . 20.4 tp -126.63 137.08 53.25 Favored 'General case' 0 N--CA 1.426 -1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 110.63 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 46.0 m -124.34 126.28 45.74 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-O 121.506 0.669 . . . . 0.0 110.472 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 91.7 t -79.78 113.64 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 175.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.19 114.96 28.01 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.495 HG22 ' HD3' ' A' ' 33' ' ' ARG . 53.2 m -92.97 115.68 28.35 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.417 HD11 ' CG2' ' A' ' 54' ' ' ILE . 18.1 tp -85.96 142.99 28.41 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.219 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -81.77 82.27 7.52 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 172.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.594 ' NE ' ' HB3' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -91.51 121.99 33.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -166.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -92.58 -42.85 9.44 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 167.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -98.48 118.28 34.81 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -98.25 158.14 15.75 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.577 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -103.59 146.0 29.21 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.423 ' NH2' ' HB3' ' A' ' 13' ' ' LYS . 57.3 ttp180 -55.44 134.54 50.54 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.692 1.597 . . . . 0.0 111.387 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 10.8 p-10 -75.06 96.05 3.15 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.562 1.172 . . . . 0.0 112.776 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.3 pt -96.99 22.75 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 122.299 1.047 . . . . 0.0 109.068 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.472 ' O ' ' HE3' ' A' ' 175' ' ' LYS . 48.1 ttp180 -60.25 -38.34 83.17 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.844 -175.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.99 -11.31 84.84 Favored Glycine 0 C--N 1.315 -0.588 0 C-N-CA 121.166 -0.54 . . . . 0.0 113.024 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.44 -13.1 50.31 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.593 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.4 mt -67.05 130.94 32.86 Favored 'Isoleucine or valine' 0 C--O 1.25 1.116 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.1 t -118.72 113.45 21.17 Favored 'General case' 0 N--CA 1.4 -2.925 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -75.55 -20.14 58.86 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -86.32 115.65 23.99 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.458 HD11 ' CD ' ' A' ' 172' ' ' GLN . 10.5 mt -108.31 -66.73 1.02 Allowed 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.9 0.857 . . . . 0.0 110.76 -171.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -58.9 134.73 57.19 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.673 -168.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.56 2.28 24.32 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.675 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.2 167.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.11 152.57 18.42 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.45 157.09 42.95 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.714 0.769 . . . . 0.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 26.2 m -112.63 133.58 54.6 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 48.1 tp -101.57 119.71 39.2 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.69 93.96 4.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.421 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 61.9 t -79.84 119.55 29.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -148.17 151.55 35.74 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.1 p -171.62 -174.81 1.45 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -92.32 -11.34 35.36 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.363 -1.335 . . . . 0.0 107.991 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -73.32 -49.78 25.6 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.092 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -136.67 113.11 10.0 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.903 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.9 p -101.27 164.87 11.57 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.195 -176.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 55.8 t30 44.43 70.8 0.3 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.689 1.196 . . . . 0.0 113.453 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.421 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 56.3 m -131.26 92.39 3.18 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.475 -0.766 . . . . 0.0 110.242 176.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.7 mt -88.13 101.49 11.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -120.6 117.3 27.21 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.839 0.352 . . . . 0.0 110.977 -173.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 10.1 pt-20 -74.93 130.03 38.69 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.037 0.446 . . . . 0.0 110.494 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -97.67 -45.04 12.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.905 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.91 -152.93 20.48 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.082 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.82 138.68 34.97 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 122.878 2.385 . . . . 0.0 113.554 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.8 m -102.87 146.85 10.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.87 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.9 p -130.95 153.7 48.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.618 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 44.0 ttp -96.98 116.28 28.92 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.362 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -82.74 -46.09 13.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.968 -176.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.43 -130.32 9.79 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.47 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.5 mt -93.82 100.28 12.5 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 131' ' ' THR . 38.3 mm -118.33 133.02 66.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -95.33 83.91 3.94 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.507 1.146 . . . . 0.0 111.493 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 62.4 tp -79.94 120.06 23.63 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.446 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.1 t 61.36 32.86 19.05 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.6 m 70.12 8.29 6.59 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.648 1.579 . . . . 0.0 112.771 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 29.2 m -98.72 111.76 61.09 Favored Pre-proline 0 N--CA 1.438 -1.061 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.7 118.39 5.65 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 121.737 1.625 . . . . 0.0 110.59 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 14.6 t -88.77 132.2 34.73 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.22 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.589 ' O ' HD11 ' A' ' 70' ' ' LEU . 34.9 t30 -75.83 81.28 2.75 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 65.58 63.55 0.62 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.64 0.733 . . . . 0.0 112.738 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 28.3 mtt -89.14 164.11 15.15 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.52 HG22 ' HB3' ' A' ' 170' ' ' SER . 6.8 tt -107.84 138.83 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.064 175.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -122.89 140.75 52.63 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.598 ' HH ' ' CD2' ' A' ' 160' ' ' HIS . 50.5 p90 -132.43 153.46 50.81 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.019 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -89.07 93.22 9.51 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.511 0.507 . . . . 0.0 109.934 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -174.77 135.85 0.4 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 125.395 1.478 . . . . 0.0 108.015 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.09 91.57 7.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.042 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.7 m -97.06 147.84 23.62 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -99.81 172.43 7.25 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -80.17 169.62 17.55 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 175.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 146' ' ' CYS . . . 90.57 -34.38 4.21 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -173.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -85.81 33.14 0.58 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.028 1.331 . . . . 0.0 107.622 175.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.509 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 42.8 t -89.51 138.19 31.67 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.737 -175.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.432 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 94.88 -1.41 65.46 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.45 127.94 29.62 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.39 115.33 17.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.054 0.454 . . . . 0.0 111.114 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 39.4 tp -89.5 107.86 19.32 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.0 p -146.98 162.49 38.65 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.548 0.69 . . . . 0.0 112.653 -174.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -128.94 -179.07 4.89 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 175.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.2 t -60.4 103.24 0.22 Allowed 'General case' 0 CA--C 1.556 1.192 0 CA-C-O 122.404 1.097 . . . . 0.0 112.072 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 77.35 15.07 81.87 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.629 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -135.35 109.81 8.49 Favored 'General case' 0 C--O 1.207 -1.145 0 O-C-N 122.307 -0.525 . . . . 0.0 111.646 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.6 mt -100.68 129.54 51.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -105.23 -41.41 5.55 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.611 0.719 . . . . 0.0 110.776 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.458 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 173.93 -170.38 43.5 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.63 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.8 pt -119.29 143.64 30.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.598 ' CD2' ' HH ' ' A' ' 137' ' ' TYR . 30.7 t-80 -70.05 136.5 50.39 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.36 -46.49 3.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.111 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.57 153.6 23.12 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -127.8 152.46 18.95 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.56 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -116.73 96.1 5.33 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.23 -119.03 9.1 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.104 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -84.79 -8.01 58.98 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.745 0.818 . . . . 0.0 110.647 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -108.61 100.95 10.14 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.443 -0.786 . . . . 0.0 111.429 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -79.94 134.65 13.86 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -107.21 129.84 54.81 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 122.121 0.962 . . . . 0.0 110.45 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.52 ' HB3' HG22 ' A' ' 135' ' ' ILE . 30.0 t -118.2 141.31 48.63 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.999 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.37 120.45 23.83 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.458 ' CD ' HD11 ' A' ' 94' ' ' LEU . 6.1 tt0 -78.27 109.0 12.0 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 123.776 0.673 . . . . 0.0 110.393 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 173' ' ' LEU . 3.2 pp -94.05 88.54 5.7 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.265 1.031 . . . . 0.0 109.453 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -80.85 138.72 36.2 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.871 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.472 ' HE3' ' O ' ' A' ' 87' ' ' ARG . 4.1 ttmp? -50.88 -35.14 31.31 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.542 1.137 . . . . 0.0 112.267 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -56.47 -25.63 51.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.627 0.771 . . . . 0.0 112.977 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -82.39 -13.74 56.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.673 0.273 . . . . 0.0 111.299 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -96.54 -8.27 32.38 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -173.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 29.3 m -87.25 170.65 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -74.05 -48.13 32.01 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.791 0.329 . . . . 0.0 110.866 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -98.64 113.5 25.58 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.394 0.886 . . . . 0.0 113.394 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 . . . . . 0 C--O 1.254 1.319 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.122 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.784 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -62.46 -36.79 63.84 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.923 2.416 . . . . 0.0 111.266 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -67.01 -36.48 82.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.64 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -65.41 -48.77 71.66 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.727 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.05 -37.55 87.95 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.833 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -62.12 -48.48 79.97 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.802 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.14 95.05 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 123.932 0.77 . . . . 0.0 111.515 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.81 -43.35 96.53 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.868 0.365 . . . . 0.0 111.12 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 m -67.1 -31.71 72.37 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.462 0.649 . . . . 0.0 110.412 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.8 tp -74.14 -59.07 2.89 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.524 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.541 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 6.8 tt -50.21 -52.4 36.04 Favored 'General case' 0 C--O 1.247 0.957 0 C-N-CA 125.286 1.434 . . . . 0.0 113.341 -175.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -66.59 -4.03 7.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -172.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -129.07 -53.9 1.2 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -84.72 6.99 22.05 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -171.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.541 ' CG1' ' HA ' ' A' ' 11' ' ' LEU . 48.2 mm -102.4 123.63 55.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.122 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 18' ' ' ILE . 1.8 mpt? -101.71 97.06 7.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.417 ' HA ' HG22 ' A' ' 26' ' ' THR . 23.3 m -70.65 93.17 0.91 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 16' ' ' MET . 82.1 mt -93.48 118.55 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.966 -172.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 7.0 m -85.27 106.59 16.79 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.685 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 60.6 p -90.81 -163.32 1.01 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.761 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 m -79.75 -2.96 45.45 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -118.65 -33.25 4.33 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.69 -151.26 20.21 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 119.762 -1.209 . . . . 0.0 112.542 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -86.87 104.2 16.0 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.38 133.86 52.38 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.531 HG23 ' CD2' ' A' ' 104' ' ' HIS . 13.6 p -97.8 130.58 44.73 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-O 121.796 0.808 . . . . 0.0 113.078 -172.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.41 131.11 10.45 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.4 tp -89.81 114.06 25.72 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.5 103.89 1.69 Allowed Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.8 mm -71.44 -47.17 60.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 C-N-CA 123.129 0.572 . . . . 0.0 109.857 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -169.95 154.1 5.03 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.581 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t70 50.79 -95.48 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.715 1.26 . . . . 0.0 113.402 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 76' ' ' THR . 54.6 mtt180 -123.82 4.7 8.78 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 122.817 0.447 . . . . 0.0 111.073 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.05 113.91 26.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.256 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 p -126.9 137.47 53.16 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -110.75 138.49 38.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.98 149.91 26.29 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.16 149.78 83.11 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 122.248 1.966 . . . . 0.0 112.555 174.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.418 ' HB ' ' OG1' ' A' ' 73' ' ' THR . 8.9 t -79.43 -31.02 42.52 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 122.517 0.327 . . . . 0.0 110.995 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -72.66 -4.97 34.31 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.208 0.528 . . . . 0.0 111.024 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.27 -13.17 60.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.685 ' O ' ' HB ' ' A' ' 20' ' ' THR . 14.2 mm100 66.62 77.78 0.26 Allowed Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 125.145 1.378 . . . . 0.0 113.281 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.17 153.86 18.93 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.198 1.932 . . . . 0.0 110.297 176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.99 -164.32 13.93 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -83.38 -20.97 33.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.048 0.928 . . . . 0.0 108.59 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -143.72 149.6 37.41 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.8 m -143.33 170.42 10.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 73.3 mt -102.31 114.12 28.01 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.41 ' C ' ' H ' ' A' ' 51' ' ' GLY . 8.9 m -92.32 97.74 7.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.615 0.721 . . . . 0.0 109.617 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 69.53 -10.4 0.58 Allowed 'General case' 0 CA--C 1.564 1.517 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.96 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 154.84 -25.18 0.63 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 112.285 -0.326 . . . . 0.0 112.285 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -90.42 131.86 35.95 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 122.552 -0.381 . . . . 0.0 110.719 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.497 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -77.44 115.21 17.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.481 0.658 . . . . 0.0 109.677 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.8 tp -120.37 143.51 32.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.427 ' N ' ' HD2' ' A' ' 55' ' ' ARG . 2.8 mpt_? -89.87 141.07 28.98 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.685 0.755 . . . . 0.0 111.777 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.2 t -97.21 102.99 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -69.16 -62.4 1.39 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 123.675 0.609 . . . . 0.0 110.097 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -111.42 138.39 47.98 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -146.34 105.08 3.85 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-O 121.275 0.56 . . . . 0.0 109.589 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -107.92 129.67 55.08 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.276 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.45 131.43 34.19 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.5 tp -83.49 104.02 13.3 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.788 0.804 . . . . 0.0 109.997 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.53 141.51 43.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.936 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -83.49 142.46 43.17 Favored Pre-proline 0 C--N 1.279 -2.492 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.79 -11.69 7.59 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.562 2.841 . . . . 0.0 114.576 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -98.99 18.33 17.52 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.989 -0.444 . . . . 0.0 110.788 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 75.01 17.71 2.66 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.636 1.175 . . . . 0.0 112.65 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.8 mm -91.08 140.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 131' ' ' THR . 9.1 t-20 -98.1 152.49 19.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 72' ' ' LEU . 4.0 mm? -112.29 -7.27 14.01 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.55 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 67.77 -21.08 0.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.291 1.436 . . . . 0.0 112.252 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 70' ' ' LEU . 7.4 tt -79.4 133.3 36.56 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 124.067 0.947 . . . . 0.0 110.371 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.418 ' OG1' ' HB ' ' A' ' 39' ' ' THR . 20.4 m -117.45 133.44 55.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.2 t -98.47 108.79 22.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.3 mt -102.25 132.3 48.28 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 27.6 m -109.56 100.14 9.23 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.8 mt -87.04 155.62 20.07 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.768 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.92 93.52 2.68 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.511 ' NE ' ' HA ' ' A' ' 79' ' ' ARG . 2.5 mmp_? -106.55 108.47 19.99 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.393 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -83.19 -29.68 28.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -99.69 107.49 19.6 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 170.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -99.88 166.41 11.08 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.852 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -121.68 169.57 10.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -57.47 142.58 43.63 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.77 1.628 . . . . 0.0 112.117 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 14.6 t70 -75.86 96.0 3.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.885 0.85 . . . . 0.0 109.211 172.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.9 pt -84.91 10.71 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-O 121.813 0.815 . . . . 0.0 110.972 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -68.26 -24.71 64.92 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.4 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.91 -11.4 66.39 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.296 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -103.86 -4.55 23.37 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 117.138 0.469 . . . . 0.0 110.554 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -64.18 121.06 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.703 0.763 . . . . 0.0 110.708 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 m -93.32 114.99 27.57 Favored 'General case' 0 N--CA 1.391 -3.391 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.3 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -2.63 56.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 122.234 1.016 . . . . 0.0 108.958 175.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -113.34 113.72 25.65 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.58 -1.645 . . . . 0.0 107.347 176.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -115.98 -54.5 2.49 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.548 0.69 . . . . 0.0 111.674 -170.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -72.95 127.1 31.56 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.501 -168.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.93 -7.92 41.96 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.301 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 t -104.52 147.51 10.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 5.8 p-10 -89.23 145.45 25.4 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.15 155.59 45.25 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 122.156 0.979 . . . . 0.0 113.286 -175.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 27.1 m -111.27 127.83 55.74 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 113.565 -1.652 . . . . 0.0 107.387 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.9 tp -101.74 117.24 34.47 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.303 0.573 . . . . 0.0 109.933 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 t -94.01 97.14 6.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.475 ' O ' ' HB ' ' A' ' 111' ' ' THR . 15.6 m -88.34 126.63 41.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.531 ' CD2' HG23 ' A' ' 26' ' ' THR . 33.0 p-80 -153.93 153.82 32.71 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.352 0.596 . . . . 0.0 111.394 -173.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.4 p -154.58 -162.63 1.43 Allowed 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -84.91 -35.67 21.97 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 118.741 -1.183 . . . . 0.0 108.63 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -77.77 -36.37 50.66 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.417 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 104' ' ' HIS . 97.1 m-85 -115.37 93.2 4.19 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 m -112.22 150.77 30.41 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 71.76 19.15 4.99 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.687 0.795 . . . . 0.0 112.609 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 103' ' ' VAL . 43.7 m -80.47 101.13 8.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 82.5 mt -102.78 98.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.503 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.4 tp -112.72 105.89 14.13 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.669 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 6.5 pt-20 -79.67 139.65 37.32 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.821 -0.55 . . . . 0.0 111.917 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.0 m -107.63 -42.19 5.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.402 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 126.07 -158.06 20.17 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.615 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 98' ' ' ASP . 24.4 Cg_exo -64.37 126.04 16.21 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.682 2.921 . . . . 0.0 112.892 -178.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -92.08 151.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.371 0.605 . . . . 0.0 111.736 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.4 m -122.28 154.47 37.53 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -94.73 139.56 31.08 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.78 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.99 -23.62 19.49 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.06 -123.81 6.24 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.369 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -105.74 108.99 20.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.4 pt -120.7 153.17 23.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.59 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -102.9 115.62 30.95 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.304 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 98.9 mt -113.11 92.03 3.86 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.7 m 51.49 72.74 0.35 Allowed 'General case' 0 C--O 1.252 1.205 0 C-N-CA 124.095 0.958 . . . . 0.0 113.028 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.2 m 61.68 14.61 6.22 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.621 -1.172 . . . . 0.0 112.566 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.2 m -121.32 96.3 48.06 Favored Pre-proline 0 N--CA 1.414 -2.273 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.83 115.82 4.41 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 121.978 1.785 . . . . 0.0 108.228 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.4 t -103.27 125.98 50.2 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-O 121.389 0.614 . . . . 0.0 109.523 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -83.3 134.42 34.93 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.007 -176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 63.04 49.78 3.33 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 124.126 0.891 . . . . 0.0 110.166 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 8.3 tpt -85.69 143.2 28.51 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.472 HG23 ' HB2' ' A' ' 170' ' ' SER . 14.5 tt -112.66 144.97 19.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -132.96 142.62 48.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.289 0.566 . . . . 0.0 111.347 -173.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -134.74 115.96 14.34 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.43 92.56 1.1 Allowed 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -167.86 117.77 0.8 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.63 110.68 1.04 Allowed 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.545 0.688 . . . . 0.0 110.494 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.6 m -121.15 153.51 37.42 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -88.33 123.93 33.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.044 0.449 . . . . 0.0 110.977 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.4 t -78.52 151.43 32.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.9 -15.53 40.42 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -106.84 35.07 3.13 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 10.0 m -69.94 146.67 51.0 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.233 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.92 3.51 42.38 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.54 145.63 40.81 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.86 116.36 31.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 120.924 0.392 . . . . 0.0 110.226 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.2 tp -89.45 104.95 17.46 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.0 p -141.52 -173.73 3.85 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.254 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 155' ' ' LYS . . . -161.54 -175.52 4.81 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 175.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.4 m -64.23 99.12 0.26 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 118.355 0.525 . . . . 0.0 110.765 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.15 18.66 71.4 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.98 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.412 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 74.5 mmtt -132.93 134.86 45.1 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -129.11 120.97 52.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -96.8 -46.19 6.35 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.8 0.687 . . . . 0.0 111.559 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.486 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 179.54 -176.03 47.37 Favored Glycine 0 N--CA 1.419 -2.477 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.715 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 22.7 pt -109.41 134.31 51.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 O-C-N 123.69 0.288 . . . . 0.0 110.228 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.428 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 11.2 t-80 -58.52 113.47 2.01 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 124.474 1.109 . . . . 0.0 110.25 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.5 t -88.27 -41.6 14.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.599 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.47 127.61 0.95 Allowed Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 119.022 -1.561 . . . . 0.0 113.103 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.431 ' HA2' ' HA2' ' A' ' 168' ' ' GLY . . . -78.68 79.5 1.55 Allowed Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 172.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -93.33 89.01 6.19 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 100.69 -147.3 17.89 Favored Glycine 0 N--CA 1.427 -1.915 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.392 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 43.1 ttm105 -85.57 -0.9 56.38 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.487 0.66 . . . . 0.0 110.223 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -124.52 124.93 43.35 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.887 -0.508 . . . . 0.0 110.064 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.431 ' HA2' ' HA2' ' A' ' 163' ' ' GLY . . . -84.25 126.46 7.62 Favored Glycine 0 N--CA 1.414 -2.8 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -109.71 127.15 54.4 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 121.213 0.53 . . . . 0.0 109.9 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.472 ' HB2' HG23 ' A' ' 135' ' ' ILE . 49.8 m -127.83 159.65 34.2 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -100.04 132.6 45.3 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -76.21 104.15 6.6 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.486 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -80.38 70.99 7.17 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.386 1.089 . . . . 0.0 111.431 177.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -63.1 139.94 58.82 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.186 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -53.14 -30.41 36.79 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 126.513 1.925 . . . . 0.0 111.499 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -62.29 -25.27 67.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -78.13 -20.48 52.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.571 0.701 . . . . 0.0 109.34 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -104.34 21.83 15.93 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.362 -171.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 52.6 t -75.63 115.65 17.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 173.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -69.91 -30.83 68.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.262 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -80.66 125.41 29.99 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.457 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 . . . . . 0 C--N 1.293 -1.856 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 176.602 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.511 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 C--O 1.215 -1.065 0 CA-C-O 118.342 -1.254 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -35.23 -54.93 0.64 Allowed 'Trans proline' 0 C--N 1.361 1.212 1 C-N-CA 125.342 4.028 . . . . 0.0 116.163 -173.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -71.44 -38.58 71.34 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.929 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.2 m -71.25 -29.38 65.04 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.753 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 1' ' ' GLY . 4.9 mm-40 -69.07 -43.57 74.34 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -64.82 -44.0 91.3 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.424 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.77 -49.35 71.11 Favored 'General case' 0 C--O 1.204 -1.318 0 O-C-N 123.97 0.794 . . . . 0.0 110.98 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 tp -63.67 -38.73 92.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.088 0.471 . . . . 0.0 111.423 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -71.12 -37.07 72.34 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.469 0.652 . . . . 0.0 110.893 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.86 -38.76 64.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.411 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.51 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 37.2 tp -49.61 -54.73 16.7 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 125.419 1.488 . . . . 0.0 112.568 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -72.53 -3.8 26.75 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -170.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -133.48 -29.89 1.33 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -120.87 -25.25 5.45 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.51 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 33.7 mt -95.26 105.96 17.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.3 mmt -122.51 149.54 43.77 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.118 0.485 . . . . 0.0 112.123 -175.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 m -80.2 124.46 28.81 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.9 mt -113.1 108.46 25.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.2 m -87.18 104.46 16.38 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.2 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 40.9 p -95.34 -156.6 0.52 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.465 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -75.88 -28.96 58.34 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -81.57 -38.16 26.58 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.27 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.84 -156.7 27.91 Favored Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 119.949 -1.119 . . . . 0.0 111.78 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.18 105.38 16.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.015 0.436 . . . . 0.0 110.703 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -107.66 176.07 5.27 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.0 m -115.56 134.5 55.0 Favored 'General case' 0 N--CA 1.408 -2.538 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.16 139.1 13.01 Favored Glycine 0 N--CA 1.412 -2.924 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.4 tp -102.11 118.24 36.48 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.08 114.31 3.83 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mm -78.77 -50.05 19.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -167.67 145.38 4.51 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.151 176.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' HB3' ' HG3' ' A' ' 82' ' ' LYS 0.314 1.2 p30 46.8 -96.11 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 177.259 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 37.4 ptt180 -117.07 2.35 12.66 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.153 0.502 . . . . 0.0 110.882 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.6 t -91.72 106.38 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.631 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.6 m -122.49 162.18 22.21 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 p -133.17 140.81 46.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.62 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.0 tt -153.02 147.53 19.1 Favored Pre-proline 0 CA--C 1.561 1.384 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.75 147.51 94.6 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.417 2.078 . . . . 0.0 112.483 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.4 m -62.05 -44.9 95.69 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.281 0.633 . . . . 0.0 112.612 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -65.46 2.53 0.88 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.36 -23.28 54.16 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.442 ' O ' ' HB ' ' A' ' 20' ' ' THR . 13.4 mm100 64.47 77.35 0.3 Allowed Pre-proline 0 C--O 1.25 1.119 0 C-N-CA 125.228 1.411 . . . . 0.0 111.664 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.34 128.84 9.91 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.673 2.249 . . . . 0.0 110.826 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.52 -163.62 38.65 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.801 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.81 -33.64 75.2 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.657 0.741 . . . . 0.0 110.912 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -139.84 141.03 36.7 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.15 154.0 23.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 120.57 0.224 . . . . 0.0 110.918 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 8.2 mp -96.36 105.28 17.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.026 0.441 . . . . 0.0 111.173 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.59 93.53 4.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 t30 65.88 9.37 6.03 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.682 1.193 . . . . 0.0 110.732 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.69 -22.85 5.44 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.564 HE21 ' HA ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -80.59 107.67 13.59 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -80.62 111.31 16.93 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.836 0.827 . . . . 0.0 109.204 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.456 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.1 tp -113.35 135.57 52.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.316 -174.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -68.69 132.8 47.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.858 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.89 126.92 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -77.67 -63.02 1.48 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.457 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -147.22 148.96 32.02 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -112.59 104.02 12.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.496 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.8 m-85 -81.55 95.18 7.06 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -75.23 123.0 24.53 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.11 102.96 15.29 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -177.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.9 132.56 60.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.3 145.25 86.47 Favored Pre-proline 0 C--N 1.307 -1.268 0 O-C-N 123.383 0.427 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.3 -21.98 73.43 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.558 2.172 . . . . 0.0 110.798 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.49 7.81 21.47 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.391 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 71.18 21.54 4.73 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.51 1.524 . . . . 0.0 113.15 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.5 mm -92.49 152.75 3.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 131' ' ' THR . 48.3 t30 -85.5 138.4 32.24 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.411 HD21 ' HH ' ' A' ' 177' ' ' TYR . 0.2 OUTLIER -98.43 -19.73 17.53 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.195 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 66.29 21.74 10.97 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 122.989 1.376 . . . . 0.0 109.475 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.3 tp -121.16 143.72 48.97 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.373 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.1 m -138.9 126.98 22.5 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.114 0.483 . . . . 0.0 110.388 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 60.6 t -86.87 110.79 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.7 tp -91.75 116.13 28.63 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.712 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.3 m -93.24 106.42 18.38 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.1 0.476 . . . . 0.0 109.882 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 8.3 mp -81.37 153.78 26.8 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.758 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.456 ' O ' HD11 ' A' ' 54' ' ' ILE . 22.8 t70 -83.41 74.68 10.05 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.84 0.829 . . . . 0.0 109.052 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -114.78 130.71 56.9 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.45 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -95.85 -39.64 9.72 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.72 129.13 38.68 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.578 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.476 ' HG3' ' HB3' ' A' ' 32' ' ' ASP . 51.7 tttp -89.02 102.86 15.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.301 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.403 ' H ' ' HA ' ' A' ' 32' ' ' ASP . 96.5 m-85 -70.47 156.34 39.5 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 172.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -49.7 132.49 21.77 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.779 1.232 . . . . 0.0 113.436 -173.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.62 97.06 9.4 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.613 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -97.79 22.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.854 0.835 . . . . 0.0 110.921 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -60.55 -41.66 94.99 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.138 -174.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.63 1.43 66.89 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 116.11 -0.496 . . . . 0.0 113.72 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -95.83 -6.78 38.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.98 0.39 . . . . 0.0 110.51 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.3 mt -72.04 109.67 4.44 Favored 'Isoleucine or valine' 0 C--O 1.261 1.692 0 CA-C-O 121.308 0.575 . . . . 0.0 110.004 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 p -94.97 105.69 17.63 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.514 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -82.0 -13.05 57.97 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.819 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -94.28 115.62 27.89 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.7 mt -112.73 -56.97 2.35 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.188 -164.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 32.1 tt0 -60.11 112.37 1.87 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -164.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 119.25 -18.87 10.16 Favored Glycine 0 C--O 1.251 1.169 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.529 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.45 147.05 5.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.94 129.24 35.3 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -124.41 160.71 27.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.391 0.615 . . . . 0.0 111.901 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.8 m -121.16 145.02 48.26 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 124.471 1.108 . . . . 0.0 108.721 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 160' ' ' HIS . 2.3 tm? -103.65 119.37 38.77 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.5 t -123.73 130.97 73.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.964 0.412 . . . . 0.0 112.071 -175.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.41 ' CG2' ' HB ' ' A' ' 111' ' ' THR . 17.4 m -125.38 142.84 40.96 Favored 'Isoleucine or valine' 0 C--O 1.254 1.326 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -71.65 -59.38 2.78 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.9 t -153.43 106.46 2.94 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 170.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 145' ' ' GLN . 28.1 t-20 -103.9 -74.59 0.64 Allowed 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -100.11 -26.39 13.97 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.164 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -148.79 156.07 41.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.3 m -84.74 131.89 34.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.601 0.239 . . . . 0.0 111.113 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 70.12 71.32 0.22 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.812 1.245 . . . . 0.0 111.967 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.41 ' HB ' ' CG2' ' A' ' 103' ' ' VAL . 34.7 m -111.56 107.92 17.25 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.563 176.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.5 mt -117.55 103.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.0 tp -123.46 124.49 43.0 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.307 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.2 140.82 56.1 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.695 0.76 . . . . 0.0 112.894 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.84 -57.16 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.136 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.77 -152.89 17.45 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.0 123.82 11.81 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 123.007 2.472 . . . . 0.0 112.306 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 27.3 m -96.97 157.63 3.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.9 p -133.29 164.83 26.21 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.647 0.379 . . . . 0.0 111.23 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 56.5 ttp -82.04 136.0 35.27 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' A' ' 136' ' ' ARG . . . -99.58 -52.79 3.38 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.521 0.677 . . . . 0.0 110.248 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.98 -110.53 3.76 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.817 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.0 tp -110.91 118.7 36.81 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mm -123.62 121.15 61.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -100.32 109.13 21.32 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 69.0 tp -129.17 126.75 39.93 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.4 t 60.93 47.92 7.15 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.974 0.91 . . . . 0.0 109.151 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.8 m 61.55 13.28 5.05 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.117 1.367 . . . . 0.0 112.108 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.7 m -117.72 109.51 41.47 Favored Pre-proline 0 N--CA 1.425 -1.691 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.243 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.68 122.62 6.49 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.385 2.057 . . . . 0.0 110.558 176.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.5 m -122.2 127.41 49.96 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -111.51 158.96 18.56 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 111.133 0.049 . . . . 0.0 111.133 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 61.7 50.94 4.13 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 122.968 1.366 . . . . 0.0 111.334 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 90.2 mmm -113.87 157.03 22.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.029 -1.896 . . . . 0.0 110.258 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.525 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 12.4 tt -107.37 147.16 12.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 39.3 ttp85 -126.89 140.95 51.97 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.268 0.627 . . . . 0.0 110.207 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -150.31 148.77 29.24 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.488 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.92 111.48 18.83 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -164.47 146.47 8.56 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.21 93.1 1.42 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.1 t -87.96 145.29 26.09 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.141 -174.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 145' ' ' GLN . 17.8 tppt? -134.73 125.46 27.05 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.2 m -73.29 124.83 26.46 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.59 -41.46 1.28 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.505 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 3.4 pt20 -84.07 42.86 0.89 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.456 1.122 . . . . 0.0 109.604 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 33.4 m -82.82 147.06 28.58 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.835 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.19 7.18 59.67 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -68.92 119.63 9.95 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.04 108.17 6.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 37.0 tp -84.53 107.9 17.01 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.1 p -142.1 164.9 28.92 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.266 0.555 . . . . 0.0 112.049 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.39 178.17 7.61 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.5 t -60.96 102.88 0.22 Allowed 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.756 0.788 . . . . 0.0 111.669 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 84.08 6.23 86.74 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.02 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -134.02 126.55 30.44 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 117.331 0.566 . . . . 0.0 111.275 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 76.2 mt -112.81 122.12 66.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -97.48 -22.17 16.72 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.883 0.373 . . . . 0.0 111.169 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 149.75 -163.8 29.4 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.551 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 148' ' ' GLY . 27.3 pt -128.21 134.11 65.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 120.989 0.424 . . . . 0.0 111.324 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.441 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 36.4 t-80 -60.52 133.32 55.98 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 124.852 1.261 . . . . 0.0 111.925 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.33 -6.73 11.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.916 0.389 . . . . 0.0 110.884 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 123.47 -158.59 18.09 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.448 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 156.79 178.13 30.59 Favored Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -134.23 119.08 18.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 100.72 -123.04 7.81 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.433 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -113.26 6.59 17.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.891 0.377 . . . . 0.0 111.472 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -112.76 113.87 26.17 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.478 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.16 133.1 11.62 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -111.32 137.79 48.62 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.555 0.693 . . . . 0.0 109.93 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.525 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 16.2 m -135.41 153.31 51.84 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.915 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.432 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -81.43 132.94 35.34 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -64.7 -9.22 18.39 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.8 mt 49.32 29.39 2.71 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -40.49 121.4 1.41 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.546 1.139 . . . . 0.0 110.632 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -53.58 -25.71 18.47 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.411 ' O ' HG12 ' A' ' 179' ' ' VAL . 28.5 pt20 -63.56 -17.17 62.55 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 123.71 0.804 . . . . 0.0 112.672 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.411 ' HH ' HD21 ' A' ' 70' ' ' LEU . 16.3 m-30 -73.63 -23.32 59.87 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.758 -0.589 . . . . 0.0 111.012 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.41 12.05 34.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -170.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 176' ' ' GLN . 12.0 p -110.94 132.8 58.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.84 -39.27 80.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.014 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -77.02 109.5 10.9 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 . . . . . 0 C--O 1.248 1.025 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.838 -171.745 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.391 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.06 -22.78 75.78 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.754 2.303 . . . . 0.0 111.429 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -61.97 -39.5 92.36 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.13 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -69.21 -40.41 78.01 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.572 0.749 . . . . 0.0 109.462 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.76 -44.18 96.86 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.479 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -67.19 -50.26 61.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.254 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.41 84.49 Favored 'General case' 0 C--O 1.209 -1.037 0 C-N-CA 123.204 0.602 . . . . 0.0 111.845 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.01 -39.57 95.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.017 0.437 . . . . 0.0 111.101 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 m -74.86 -32.81 61.99 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.72 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.5 tp -73.38 -40.67 64.16 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.484 177.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 2.2 tm? -54.4 -52.89 60.3 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.256 1.422 . . . . 0.0 111.82 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -66.44 -7.59 20.48 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -170.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -126.29 -51.66 1.52 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -104.73 -2.87 24.33 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -170.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.525 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 56.5 mt -114.42 104.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.6 tpt -135.74 154.78 51.14 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.833 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.4 m -75.39 115.82 15.46 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.071 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 mt -99.58 99.74 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p -80.24 101.62 8.98 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.756 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 82.6 p -89.27 -166.15 1.52 Allowed 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.81 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -73.85 -20.91 60.3 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.879 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -101.18 -49.52 4.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.59 -157.12 8.52 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 118.82 -1.657 . . . . 0.0 113.537 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -109.38 94.72 5.18 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -100.69 160.77 14.09 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.9 m -99.49 123.69 43.98 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.3 123.68 7.94 Favored Glycine 0 N--CA 1.411 -2.996 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.8 tp -101.29 112.84 25.46 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.993 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.45 135.59 16.74 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.1 -50.88 6.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 117.716 0.758 . . . . 0.0 110.74 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -146.14 110.17 4.95 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.754 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.578 ' OD2' ' HG3' ' A' ' 33' ' ' ARG . 24.9 t70 56.73 -81.17 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 171.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.578 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -116.37 0.94 12.95 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.436 0.636 . . . . 0.0 111.61 179.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.0 t -88.57 114.9 27.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.914 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.1 t -125.95 144.63 50.61 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.84 139.86 29.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -148.89 143.5 17.17 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.49 154.72 73.27 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.957 1.772 . . . . 0.0 110.872 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -68.76 -42.15 77.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.563 0.697 . . . . 0.0 109.814 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -73.89 20.38 0.1 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.4 -23.36 21.08 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.319 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.563 ' O ' ' HB ' ' A' ' 20' ' ' THR . 24.6 mm-40 69.4 66.0 0.49 Allowed Pre-proline 0 N--CA 1.486 1.362 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -94.95 135.58 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 122.615 2.21 . . . . 0.0 110.816 172.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.71 -146.8 17.34 Favored Glycine 0 C--N 1.314 -0.652 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.966 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.14 -43.0 55.03 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.621 0.724 . . . . 0.0 109.258 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -123.65 139.63 53.8 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.9 p -125.95 153.04 33.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -92.35 120.41 32.85 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 51' ' ' GLY . 58.2 t -95.83 85.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 t30 70.79 -10.13 0.76 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.509 1.123 . . . . 0.0 112.085 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 156.73 -39.21 0.57 Allowed Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -78.37 126.78 31.27 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -90.91 146.89 23.52 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.497 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.5 tp -132.64 135.22 57.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -86.19 139.25 31.24 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.186 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -78.01 137.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.506 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -87.63 -48.86 7.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -164.01 151.16 11.97 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.28 101.01 7.87 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.499 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 84.4 m-85 -81.79 125.95 31.27 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.96 116.13 24.0 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -77.43 108.7 10.78 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.553 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.96 130.8 72.28 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -80.75 139.53 50.56 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -56.01 -12.25 6.96 Favored 'Trans proline' 0 CA--C 1.555 1.539 0 C-N-CA 123.725 2.95 . . . . 0.0 114.484 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -83.22 -4.07 58.04 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 121.997 0.903 . . . . 0.0 108.698 174.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.5 t30 67.73 70.29 0.34 Allowed 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.19 1.396 . . . . 0.0 110.257 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.3 mt -141.73 145.1 24.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.547 ' O ' ' HA ' ' A' ' 131' ' ' THR . 17.1 m120 -76.74 161.65 28.32 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.573 0.546 . . . . 0.0 111.264 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -129.29 -32.07 2.03 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.604 174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 71.17 4.22 4.98 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 123.052 1.406 . . . . 0.0 110.204 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.7 mt -94.96 119.05 32.84 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.045 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.7 m -110.89 117.6 33.82 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 96.7 t -79.52 109.36 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.4 tp -87.01 99.46 11.91 Favored 'General case' 0 N--CA 1.397 -3.123 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.886 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.0 m -85.39 105.5 16.07 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.7 mt -90.34 164.49 14.32 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.473 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.26 130.13 36.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -59.54 99.69 0.07 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.808 0.843 . . . . 0.0 111.878 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -115.51 -65.69 1.16 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -100.94 109.41 21.33 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HG3' ' OD1' ' A' ' 32' ' ' ASP . 53.6 tttm -69.4 116.82 10.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.041 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -70.21 145.88 51.11 Favored 'General case' 0 C--O 1.263 1.772 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -66.9 143.59 56.75 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.62 82.56 2.63 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.157 0.503 . . . . 0.0 111.22 -176.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.9 pt -89.83 11.1 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.685 0.755 . . . . 0.0 109.527 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.579 ' O ' ' HE2' ' A' ' 175' ' ' LYS . 57.4 ttp180 -66.85 -24.23 66.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.515 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.44 -24.41 75.1 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.406 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -86.46 -4.74 59.22 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 116.991 0.396 . . . . 0.0 111.167 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.3 mt -61.92 121.1 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.8 m -99.61 108.93 21.43 Favored 'General case' 0 N--CA 1.382 -3.827 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.346 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -71.45 -25.15 62.18 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.32 111.7 22.6 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.907 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.9 mt -107.91 -66.5 1.03 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.509 ' CB ' ' HA ' ' A' ' 119' ' ' THR . 16.5 pt-20 -74.96 152.67 38.78 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -162.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.03 -19.1 38.61 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 114.064 -1.426 . . . . 0.0 111.016 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.6 t -94.37 139.32 18.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.776 0.322 . . . . 0.0 110.316 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.51 119.11 20.64 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 174.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -110.78 164.52 12.68 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.03 0.919 . . . . 0.0 113.453 -174.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.4 m -122.2 140.01 53.09 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.449 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -106.71 122.6 46.68 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.47 121.25 66.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 120.861 0.362 . . . . 0.0 110.044 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.71 145.05 22.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -135.65 90.99 2.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.863 0.839 . . . . 0.0 110.433 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.7 p -120.17 -170.75 2.03 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -87.55 -31.52 19.86 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -70.85 -50.61 33.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.541 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -113.4 86.59 2.42 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.1 m -95.44 109.22 21.44 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.442 -176.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 71.37 35.01 1.6 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.864 0.727 . . . . 0.0 110.788 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.9 m -75.93 105.63 7.08 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 65.2 mt -103.54 105.93 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.795 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 tp -118.74 118.82 32.63 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 120.715 0.293 . . . . 0.0 111.537 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -74.97 119.65 19.43 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -95.39 -35.31 5.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.22 -170.61 20.79 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.022 -1.085 . . . . 0.0 111.943 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.75 119.46 6.4 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.15 2.567 . . . . 0.0 111.303 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.4 m -82.32 151.74 4.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.509 ' HA ' ' CB ' ' A' ' 95' ' ' GLU . 8.9 t -141.97 163.48 32.77 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 47.7 tpp -86.19 134.86 33.76 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.701 0.286 . . . . 0.0 110.301 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.19 -25.29 14.94 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.11 -94.4 1.58 Allowed Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.557 ' O ' HD11 ' A' ' 123' ' ' LEU . 4.1 pp -147.02 119.66 8.55 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.21 0.528 . . . . 0.0 110.383 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.3 tt 176.0 147.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 129' ' ' THR . 48.5 t-20 -158.4 -86.16 0.04 OUTLIER 'General case' 0 C--O 1.241 0.636 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -129.68 108.39 10.16 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -171.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.4 p 43.69 73.12 0.15 Allowed 'General case' 0 C--O 1.248 0.991 0 C-N-CA 124.746 1.219 . . . . 0.0 113.999 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.5 m 65.13 24.62 12.42 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.231 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 125' ' ' ASN . 32.1 m -111.46 102.9 54.31 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.88 125.74 3.23 Favored 'Trans proline' 0 N--CA 1.431 -2.199 0 C-N-CA 121.819 1.679 . . . . 0.0 112.917 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 2.0 p -100.16 130.48 46.3 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -72.04 132.95 44.94 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -172.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 172' ' ' GLN . 36.1 mmt180 58.97 50.89 7.78 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.656 1.182 . . . . 0.0 110.507 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.3 tpt -79.53 118.86 21.77 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.134 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.484 HG23 ' HB2' ' A' ' 170' ' ' SER . 12.4 tt -90.39 138.17 20.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.257 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -127.83 146.23 50.67 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.803 -169.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -147.5 136.64 22.34 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.138 0.975 . . . . 0.0 108.704 175.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -98.96 110.24 22.88 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 122.239 1.019 . . . . 0.0 110.176 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -171.81 134.13 0.78 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.53 90.1 0.25 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.906 0.86 . . . . 0.0 110.805 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 m -104.64 140.07 38.57 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -62.87 103.45 0.45 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.814 0.816 . . . . 0.0 110.741 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.0 m -74.96 116.94 16.26 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.792 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.39 -25.0 2.02 Favored Glycine 0 C--N 1.312 -0.787 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.737 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -83.1 50.7 1.79 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.248 1.023 . . . . 0.0 110.343 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 30.8 m -60.09 137.67 58.05 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.395 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 109.99 -5.17 30.5 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.358 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.2 134.94 25.35 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.658 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.8 p -76.83 126.41 37.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.522 0.677 . . . . 0.0 110.611 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 51.8 tp -94.57 108.62 20.58 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.9 p -144.7 175.61 10.04 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.239 0.542 . . . . 0.0 111.714 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 155' ' ' LYS . . . -154.86 -177.9 6.84 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 175.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.1 t -64.21 103.07 0.58 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.586 0.708 . . . . 0.0 111.386 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.37 26.37 66.01 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.741 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 152' ' ' ALA . 59.9 mmtt -143.22 114.43 7.86 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.12 0.568 . . . . 0.0 110.626 -177.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 89.2 mt -113.5 123.95 69.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 169.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -99.49 -27.6 13.64 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.503 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 149.88 -149.58 21.52 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.5 pt -131.26 149.11 32.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 117.134 0.467 . . . . 0.0 111.21 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -68.56 115.77 8.34 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.841 0.856 . . . . 0.0 109.129 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.2 t -97.81 -36.44 5.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.07 -149.66 8.96 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -177.41 163.07 31.41 Favored Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -142.58 121.88 13.08 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.19 -126.42 9.41 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -104.6 2.34 30.58 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -92.89 112.64 24.68 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.081 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.18 135.0 13.37 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -117.52 119.8 36.15 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 122.122 0.963 . . . . 0.0 110.962 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.484 ' HB2' HG23 ' A' ' 135' ' ' ILE . 20.8 m -119.7 154.53 33.96 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.415 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -104.35 144.7 31.28 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.212 -177.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 133' ' ' ARG . 0.7 OUTLIER -81.89 118.1 22.66 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.189 0.93 . . . . 0.0 108.986 -177.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 66.9 mt -93.16 74.41 4.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -67.69 146.07 54.16 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.586 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.579 ' HE2' ' O ' ' A' ' 87' ' ' ARG . 94.7 mttt -57.36 -31.0 65.31 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.807 0.813 . . . . 0.0 110.324 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -68.69 -9.01 47.76 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.743 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -92.56 -23.26 19.12 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 121.921 -0.487 . . . . 0.0 110.05 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -102.17 18.82 19.91 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.217 -174.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 27.3 m -80.71 152.17 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.048 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -89.1 -40.81 12.67 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -84.52 104.21 14.32 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.683 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 . . . . . 0 C--N 1.31 -1.133 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.072 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.714 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.71 -49.04 4.61 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.509 2.139 . . . . 0.0 112.143 -175.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -67.53 -37.01 82.11 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.064 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -62.35 -49.58 75.0 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.65 0.78 . . . . 0.0 109.789 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.09 -43.99 90.33 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.949 0.9 . . . . 0.0 110.015 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -58.46 -47.73 83.05 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.007 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.16 80.96 Favored 'General case' 0 C--O 1.206 -1.185 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.964 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.05 -41.77 88.69 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.304 0.642 . . . . 0.0 110.321 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.0 m -65.29 -43.38 91.34 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.999 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.8 tp -66.53 -43.53 84.93 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.954 0.901 . . . . 0.0 109.666 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.428 ' HA ' HD12 ' A' ' 15' ' ' ILE . 16.5 tp -49.57 -59.57 3.65 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 126.134 1.774 . . . . 0.0 112.755 -176.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -80.49 11.07 3.95 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.141 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -123.01 -56.66 1.74 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.67 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -119.3 4.63 11.24 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 11' ' ' LEU . 33.4 mt -99.66 98.16 6.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.747 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.92 144.17 30.19 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.369 -175.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 45.5 m -79.95 115.31 19.45 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 172.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.8 mt -115.14 107.46 22.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.438 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.3 m -89.78 113.25 24.76 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 76.7 p -93.87 -157.46 0.55 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.595 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -83.32 0.72 44.57 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -112.52 -52.23 2.79 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.812 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 19' ' ' THR . . . -175.15 -160.14 22.51 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 119.823 -1.179 . . . . 0.0 111.943 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.14 105.88 18.11 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.82 169.42 8.85 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.5 m -99.69 123.45 43.97 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.13 118.89 6.11 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.1 tp -98.38 113.89 26.03 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.504 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.18 112.66 3.84 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.6 mm -86.65 -52.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 116.564 0.182 . . . . 0.0 110.789 -176.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -162.19 141.65 9.62 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.34 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.422 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 16.1 t70 59.37 -90.98 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 175.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -135.6 9.08 3.37 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.278 1.037 . . . . 0.0 108.709 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.467 HG12 ' CG1' ' A' ' 74' ' ' VAL . 53.9 t -80.72 108.81 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.777 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.0 m -113.01 145.47 40.79 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -112.5 133.97 56.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 O-C-N 122.185 -0.322 . . . . 0.0 111.29 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 tt -153.88 145.17 16.43 Favored Pre-proline 0 CA--C 1.566 1.571 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.621 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 31.3 Cg_exo -65.16 150.18 87.97 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.356 2.037 . . . . 0.0 113.009 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.0 m -58.1 -43.01 86.89 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.6 0.76 . . . . 0.0 112.686 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -69.59 -1.65 9.39 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.65 -32.7 62.34 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.426 ' O ' ' HB ' ' A' ' 20' ' ' THR . 25.6 mt-30 52.15 82.48 0.24 Allowed Pre-proline 0 C--O 1.248 1.024 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.46 143.13 16.96 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.965 2.443 . . . . 0.0 110.559 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.59 -136.41 7.54 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.559 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.33 -31.03 30.1 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 5.2 p-10 -136.55 153.4 51.0 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.24 -1.345 . . . . 0.0 107.622 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.53 158.39 42.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 76.7 mt -99.48 103.08 14.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 17' ' ' THR . 72.6 t -83.45 91.73 2.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 175.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 62.78 15.81 8.48 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.079 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.01 -18.36 7.95 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.251 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -84.63 119.73 25.56 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.262 0.225 . . . . 0.0 110.772 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -71.74 119.05 15.36 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.959 0.409 . . . . 0.0 111.986 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 78' ' ' ASP . 16.7 tt -132.72 139.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 174.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 41.7 mtp180 -82.25 157.45 23.89 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.527 0.679 . . . . 0.0 112.481 -177.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.58 140.4 16.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.439 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -93.8 -54.24 3.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -146.24 165.73 28.35 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -140.38 95.1 2.82 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.492 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.0 m-85 -83.3 100.59 10.73 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.7 102.3 2.27 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 tt -83.39 102.83 12.3 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-O 122.065 0.936 . . . . 0.0 109.143 -171.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 67.3 t -109.86 139.52 32.71 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.05 141.64 86.26 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.7 -10.22 2.34 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 123.513 2.808 . . . . 0.0 114.838 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -97.5 7.24 46.86 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 121.676 0.75 . . . . 0.0 109.862 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 73.61 23.26 2.44 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.123 1.369 . . . . 0.0 114.394 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.3 mm -96.89 140.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.542 ' O ' ' HA ' ' A' ' 131' ' ' THR . 5.0 m-20 -66.24 133.32 50.36 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 120.892 0.377 . . . . 0.0 111.341 -177.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.403 ' CD1' ' HB3' ' A' ' 133' ' ' ARG . 58.7 tp -94.37 -15.36 24.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 170.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 61.58 27.28 16.8 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.986 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -125.07 140.84 52.54 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.171 -173.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.9 m -134.32 130.2 36.64 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.373 0.606 . . . . 0.0 110.264 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 51.5 t -87.02 108.7 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -89.5 113.56 24.96 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -175.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.3 m -90.66 97.46 11.19 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.6 tp -78.11 150.16 33.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' O ' HD12 ' A' ' 54' ' ' ILE . 35.5 t70 -79.91 95.77 6.18 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 119.019 -1.073 . . . . 0.0 109.765 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 79' ' ' ARG . 4.4 mmp_? -133.12 110.07 9.92 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.315 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -85.92 -28.25 24.45 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 168.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -78.2 91.02 4.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 171.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 24.3 pttm -78.53 150.81 32.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -170.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -86.82 160.46 18.76 Favored 'General case' 0 C--O 1.256 1.403 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.811 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -81.35 140.97 34.45 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 5.5 p-10 -76.32 106.74 8.12 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 122.376 1.084 . . . . 0.0 110.19 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.7 pt -88.13 17.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 122.192 0.996 . . . . 0.0 109.468 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 85' ' ' ASP . 42.2 ttp180 -63.21 -27.51 69.41 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.812 -1.54 . . . . 0.0 111.947 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.61 -16.82 78.99 Favored Glycine 0 C--N 1.317 -0.483 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.708 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -93.36 -3.4 53.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.731 0.3 . . . . 0.0 110.384 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.5 mt -66.08 135.72 27.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.155 0.502 . . . . 0.0 110.564 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.8 t -125.63 103.75 8.01 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -87.54 -8.59 56.15 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.593 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.24 123.15 36.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.404 HD13 ' CD ' ' A' ' 172' ' ' GLN . 20.1 mt -106.38 -71.06 0.76 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -164.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 11.1 pt-20 -50.45 137.09 19.62 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -165.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.34 -14.05 33.26 Favored Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.658 174.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.05 144.06 18.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 122.415 -0.462 . . . . 0.0 110.368 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.13 116.87 21.25 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.28 159.5 14.95 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.396 0.617 . . . . 0.0 110.731 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.2 m -129.39 133.52 47.41 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.37 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.7 mt -90.91 125.72 35.84 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.413 ' HB ' ' CG1' ' A' ' 149' ' ' VAL . 30.5 t -117.69 107.63 22.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.6 t -109.02 147.71 13.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.522 ' CE1' HG21 ' A' ' 109' ' ' THR . 2.6 t-80 -140.0 106.91 5.41 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.8 p -128.74 -170.47 2.27 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -89.91 -34.94 15.87 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 176.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -63.06 -45.5 91.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.788 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . 0.265 9.3 p90 -133.53 96.55 3.73 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.603 1.192 . . . . 0.0 112.509 175.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.522 HG21 ' CE1' ' A' ' 104' ' ' HIS . 90.8 m -83.43 122.58 28.69 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.943 178.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.01 71.24 0.52 Allowed 'General case' 0 C--O 1.245 0.867 0 C-N-CA 124.321 1.048 . . . . 0.0 112.867 176.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.5 m -102.15 99.15 9.25 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.998 176.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.4 mt -95.19 110.62 24.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.7 tp -128.9 108.23 10.26 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.864 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -68.28 124.9 24.77 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.0 m -99.05 -27.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.613 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.92 -164.8 12.19 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 119.81 -1.186 . . . . 0.0 112.119 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.08 129.98 19.33 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.014 2.476 . . . . 0.0 112.668 -177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 31.2 m -96.27 161.54 2.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.381 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.8 p -144.35 164.69 30.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.738 1.215 . . . . 0.0 108.683 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 52.2 ttm -86.93 139.28 30.78 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 136' ' ' ARG . . . -105.37 -40.57 5.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.739 0.305 . . . . 0.0 111.465 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.73 -113.51 3.7 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.606 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.7 mt -93.22 120.6 33.68 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.009 0.524 . . . . 0.0 110.049 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm -131.71 134.42 60.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -94.67 86.39 4.75 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp -88.04 105.84 17.74 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.862 -175.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.1 m 61.9 39.14 13.94 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.829 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.5 t 73.89 11.45 4.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.748 1.219 . . . . 0.0 112.039 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.5 m -108.81 115.97 56.55 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.24 106.97 2.27 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 121.997 1.798 . . . . 0.0 111.434 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 22.3 p -109.1 135.03 50.91 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.814 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -111.27 164.35 12.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.404 ' HG3' ' HB2' ' A' ' 172' ' ' GLN . 12.7 tpp180 66.38 27.49 9.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.577 1.151 . . . . 0.0 108.976 173.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.417 ' HE1' ' HA ' ' A' ' 134' ' ' MET . 25.2 mmt -79.57 150.44 31.08 Favored 'General case' 0 C--O 1.251 1.152 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.429 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.465 HG23 ' HB2' ' A' ' 170' ' ' SER . 8.6 tt -115.57 141.87 30.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 173.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.445 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 39.4 ttt180 -127.25 139.34 52.98 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 123.216 0.606 . . . . 0.0 111.319 -171.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -149.23 144.02 26.27 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.01 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.67 107.41 19.16 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.886 0.741 . . . . 0.0 110.171 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -173.02 138.17 0.75 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.75 92.08 2.45 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.511 0.672 . . . . 0.0 110.103 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.2 t -79.19 165.92 22.75 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.531 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -120.25 163.13 18.24 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.6 t -78.56 153.63 31.05 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.78 -9.11 63.97 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -89.32 4.5 48.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.204 0.526 . . . . 0.0 111.315 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.621 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 48.0 t -58.11 120.74 9.15 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.453 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.43 -12.52 56.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.02 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.29 131.99 27.63 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.413 ' CG1' ' HB ' ' A' ' 102' ' ' VAL . 7.4 p -70.21 124.59 26.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.699 0.761 . . . . 0.0 111.219 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.1 tp -94.2 98.71 11.14 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 22.6 p -140.07 156.44 46.58 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.312 0.577 . . . . 0.0 111.586 -174.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -121.24 -173.18 2.56 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 t -71.75 79.51 0.85 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.005 0.907 . . . . 0.0 112.952 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 105.91 8.96 33.39 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.98 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -137.31 104.44 5.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 84.4 mt -93.86 120.14 42.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -94.82 -34.06 12.62 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.577 0.703 . . . . 0.0 110.538 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 165.19 -149.08 15.15 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.309 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.443 ' O ' ' HB3' ' A' ' 170' ' ' SER . 46.0 pt -135.01 149.21 28.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -66.63 133.36 50.12 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.295 0.638 . . . . 0.0 110.71 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 86.6 t -108.46 -59.69 3.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.09 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -159.58 153.39 24.42 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.282 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -115.56 125.86 6.88 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.409 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -112.24 97.49 6.67 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.7 -113.33 5.19 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -99.91 -6.35 26.85 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.963 0.411 . . . . 0.0 110.497 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -96.18 102.35 14.13 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.343 0.592 . . . . 0.0 110.792 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.24 119.7 4.96 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -105.41 123.84 48.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.854 0.835 . . . . 0.0 110.213 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.465 ' HB2' HG23 ' A' ' 135' ' ' ILE . 14.6 m -123.94 166.17 16.14 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.908 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.504 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -98.42 131.0 45.04 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.404 ' CD ' HD13 ' A' ' 94' ' ' LEU . 46.5 mt-30 -73.39 121.54 20.64 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 123.869 0.73 . . . . 0.0 109.885 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 89.0 mt -95.44 85.0 4.1 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -72.34 146.02 47.39 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.458 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -65.7 -24.99 67.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -48.18 -39.1 19.84 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.232 1.813 . . . . 0.0 111.56 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -83.35 -9.9 58.79 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.05 -0.406 . . . . 0.0 111.477 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -122.42 18.16 10.54 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 121.126 -0.229 . . . . 0.0 111.157 -174.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.8 m -60.98 134.93 26.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-O 121.845 0.831 . . . . 0.0 111.662 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -79.28 -27.07 42.26 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.864 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.594 ' HD3' ' O ' ' A' ' 181' ' ' LYS . 0.1 OUTLIER -106.79 123.77 48.64 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.324 175.148 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 C--N 1.299 -1.603 0 CA-C-O 118.307 -0.854 . . . . 0.0 109.118 -179.36 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.544 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -63.11 -27.21 73.24 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.856 2.371 . . . . 0.0 111.304 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -66.92 -34.21 77.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.738 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.9 m -67.64 -43.68 79.76 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.672 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.54 -43.0 95.36 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.929 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -61.4 -45.48 94.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.02 82.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.01 0.433 . . . . 0.0 111.269 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.5 -44.02 75.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.986 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 p -73.78 -34.53 64.71 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 120.722 0.296 . . . . 0.0 111.594 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.35 -40.72 95.32 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.737 0.815 . . . . 0.0 109.494 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.5 tp -48.97 -61.0 2.3 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 125.209 1.403 . . . . 0.0 113.649 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -80.91 11.85 3.69 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -172.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -127.0 -53.57 1.41 Allowed 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.16 0.505 . . . . 0.0 111.512 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -107.01 -9.6 16.18 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -171.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.3 mt -105.05 125.65 60.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 120.731 0.3 . . . . 0.0 110.932 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.08 135.73 27.6 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.934 0.397 . . . . 0.0 111.131 177.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.5 m -68.1 132.78 47.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.662 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.89 113.1 31.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 121.002 0.43 . . . . 0.0 110.161 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.9 m -78.08 104.83 8.89 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.6 p -90.89 -165.11 1.28 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.412 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.1 m -84.7 -7.6 59.16 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 121.049 0.452 . . . . 0.0 111.028 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -108.98 -46.21 3.65 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.223 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -166.17 -173.08 34.25 Favored Glycine 0 CA--C 1.497 -1.07 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.198 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -98.94 97.22 8.42 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -104.91 -173.69 2.36 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.2 p -124.52 145.28 49.65 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.58 150.26 18.7 Favored Glycine 0 N--CA 1.412 -2.964 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -107.48 118.81 37.71 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.75 119.9 5.1 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mm -83.66 -49.38 16.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 117.205 0.503 . . . . 0.0 109.656 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -170.56 157.12 5.7 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.174 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 5.3 m-20 53.75 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.292 1.037 . . . . 0.0 112.974 177.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -139.16 11.77 2.6 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.672 0.749 . . . . 0.0 109.078 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.0 t -88.25 112.79 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.893 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.4 m -128.82 152.85 48.03 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.9 m -115.65 148.97 18.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.0 tp -151.96 148.62 21.87 Favored Pre-proline 0 CA--C 1.564 1.499 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -67.26 147.77 79.06 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 121.92 1.746 . . . . 0.0 111.899 174.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.8 m -66.11 -41.36 90.67 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.036 0.446 . . . . 0.0 112.202 -176.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -65.76 -13.26 59.05 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.73 -26.95 63.61 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 62.79 87.37 0.13 Allowed Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.622 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.12 151.23 15.97 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 122.325 2.017 . . . . 0.0 110.066 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.14 -168.88 24.03 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.49 -13.47 59.82 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.205 0.526 . . . . 0.0 111.885 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -148.08 138.82 23.07 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.61 160.65 42.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.2 mt -93.31 107.68 19.46 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.3 p -90.07 84.22 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-O 122.864 1.316 . . . . 0.0 109.354 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.5 t30 62.36 20.69 12.01 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.614 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.87 -47.85 0.98 Allowed Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.545 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -66.9 124.7 23.7 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -80.22 123.23 27.76 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 78' ' ' ASP . 8.6 tp -122.35 125.68 73.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -72.88 123.83 24.19 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.478 0.656 . . . . 0.0 109.379 175.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.0 t -93.66 116.23 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.489 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 28.7 ttpp -68.4 -72.09 0.19 Allowed 'General case' 0 C--N 1.293 -1.883 0 O-C-N 123.499 0.499 . . . . 0.0 111.023 -175.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.489 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.4 m-20 -108.63 146.12 33.87 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 122.039 -0.413 . . . . 0.0 110.925 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -116.69 102.7 9.66 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.509 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 91.7 m-85 -89.56 94.63 9.94 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.613 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -71.18 98.64 1.73 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 174.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 36.3 tp -77.05 108.15 9.92 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 122.252 1.025 . . . . 0.0 112.563 -167.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.84 151.09 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.796 0 CA-C-N 113.415 -1.72 . . . . 0.0 107.225 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.39 140.11 89.91 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.13 -21.36 9.06 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.496 2.798 . . . . 0.0 114.821 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.22 8.54 23.58 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.053 0.454 . . . . 0.0 110.978 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.2 t30 73.36 68.03 0.11 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.821 1.649 . . . . 0.0 112.004 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.0 mt -143.2 147.3 20.56 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -90.52 156.1 18.41 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.418 1.008 . . . . 0.0 111.987 -174.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.428 ' HG ' ' HB2' ' A' ' 133' ' ' ARG . 8.7 mp -112.33 -11.73 13.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.479 174.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 68.26 25.07 7.27 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 123.267 1.508 . . . . 0.0 108.284 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 tp -125.19 142.08 51.71 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.417 -1.719 . . . . 0.0 109.426 -174.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.0 m -135.82 134.04 38.48 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 43.2 t -102.08 125.67 56.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.37 138.19 42.99 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.106 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.2 m -98.65 99.16 10.25 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.8 mt -80.44 104.97 11.34 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.419 ' O ' HD12 ' A' ' 54' ' ' ILE . 33.9 t70 -81.36 92.82 6.47 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -146.49 175.25 10.71 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.77 -22.75 23.13 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -78.97 123.07 26.93 Favored 'General case' 0 C--O 1.247 0.969 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.012 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 20.4 pttp -100.22 139.51 35.78 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.051 -177.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -75.78 157.11 33.86 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.477 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -64.97 131.34 46.36 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.966 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.58 93.29 2.01 Favored 'General case' 0 C--O 1.2 -1.549 0 CA-C-O 122.029 0.918 . . . . 0.0 112.565 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.4 pt -96.24 21.27 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 O-C-N 120.83 -1.168 . . . . 0.0 109.584 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -69.4 -31.71 70.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.664 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -79.73 -7.37 88.56 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.129 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 64.7 m-85 -97.94 -0.8 44.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.245 0.545 . . . . 0.0 109.897 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.57 116.94 8.03 Favored 'Isoleucine or valine' 0 C--O 1.254 1.316 0 CA-C-O 121.229 0.538 . . . . 0.0 110.853 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.6 t -102.26 107.15 18.1 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 174' ' ' LYS . 32.5 mt-10 -87.95 -6.56 57.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -95.15 118.01 31.21 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 175.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.436 HD13 ' CD ' ' A' ' 172' ' ' GLN . 12.8 mt -116.11 -60.56 1.85 Allowed 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.968 0.89 . . . . 0.0 110.966 -170.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 34.5 tt0 -64.8 120.04 11.75 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.651 -167.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 112.36 -22.1 18.33 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.529 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.1 t -91.57 141.42 14.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.82 123.96 28.68 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -110.43 158.58 18.32 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.674 0.749 . . . . 0.0 111.355 -177.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.8 m -123.86 123.96 41.6 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.858 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.6 tp -95.78 116.32 28.72 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.42 104.15 14.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 93.5 t -84.21 115.51 26.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -153.17 156.6 38.9 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 78.1 p -175.49 -152.69 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -84.61 -25.87 28.28 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 119.273 0.942 . . . . 0.0 108.585 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -87.48 -48.86 7.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.98 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -94.39 144.14 25.81 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 23.4 m -148.81 124.42 10.42 Favored 'General case' 0 C--N 1.281 -2.403 0 O-C-N 121.356 -0.84 . . . . 0.0 110.311 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.63 30.86 20.51 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.068 0.855 . . . . 0.0 113.073 173.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 95.3 m -83.88 87.35 7.09 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-O 122.08 0.943 . . . . 0.0 108.741 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 75.4 mt -77.16 102.22 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.174 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.3 tp -109.51 103.83 12.78 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.104 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -76.13 121.6 23.08 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.9 m -104.19 -10.16 9.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.11 -153.12 24.23 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.632 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.29 124.87 11.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.544 2.163 . . . . 0.0 112.704 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 16.6 m -92.58 160.12 2.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.199 177.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 p -130.91 159.11 38.38 Favored 'General case' 0 C--O 1.251 1.169 0 O-C-N 123.346 0.404 . . . . 0.0 111.155 -177.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 25.3 ttt -79.65 118.06 21.13 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 136' ' ' ARG . . . -75.4 -42.17 54.43 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 176.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.2 -100.21 2.65 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.171 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 124' ' ' ILE . 7.1 tt -130.52 145.56 51.88 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.453 ' N ' HD23 ' A' ' 123' ' ' LEU . 14.8 tt -138.35 138.07 43.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -100.69 115.24 29.78 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.7 mt -112.59 89.58 3.11 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.649 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.4 p 50.13 75.78 0.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.646 1.178 . . . . 0.0 113.075 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.7 t 65.51 3.69 2.48 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.136 0.974 . . . . 0.0 112.115 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.4 m -116.51 101.94 53.53 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.43 129.13 15.39 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 121.61 1.54 . . . . 0.0 110.858 178.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.8 m -119.28 133.39 55.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 133' ' ' ARG . 3.0 t-20 -131.08 170.72 14.14 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.428 ' HB2' ' HG ' ' A' ' 70' ' ' LEU . 30.6 mmt180 64.48 41.62 5.51 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.211 1.004 . . . . 0.0 108.925 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.525 ' SD ' ' HB3' ' A' ' 169' ' ' PHE . 48.3 ttm -109.56 149.63 29.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.634 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.425 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 13.2 tt -115.19 147.61 18.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 123.765 0.826 . . . . 0.0 108.856 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.434 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . 43.7 ttp180 -127.62 143.95 51.12 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.116 0.484 . . . . 0.0 111.089 -174.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -149.14 136.23 19.9 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 171.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.97 91.01 7.07 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.867 1.317 . . . . 0.0 111.905 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -156.3 125.88 6.28 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.93 89.79 1.43 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.531 0.52 . . . . 0.0 110.624 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.0 p -79.27 170.1 17.12 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.885 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -110.14 141.8 42.52 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.346 0.593 . . . . 0.0 111.423 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.8 m -71.22 125.98 28.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 146' ' ' CYS . . . 125.52 -25.32 5.68 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -174.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -87.16 24.31 1.6 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.402 ' H ' ' C ' ' A' ' 144' ' ' GLY . 26.6 m -75.39 128.13 34.68 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.55 -177.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.74 1.4 49.43 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.264 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.79 135.8 28.74 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 86.5 t -90.32 120.09 38.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 CA-C-O 121.18 0.514 . . . . 0.0 110.58 -174.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.4 tp -92.1 106.71 18.66 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.9 p -142.22 -178.9 5.95 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.306 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.75 -175.42 5.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.3 m -61.02 101.8 0.17 Allowed 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 122.602 0.361 . . . . 0.0 111.617 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 73.11 22.7 78.79 Favored Glycine 0 C--O 1.244 0.734 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.12 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 58.2 mttp -140.81 114.17 8.66 Favored 'General case' 0 C--O 1.206 -1.213 0 O-C-N 122.887 -0.184 . . . . 0.0 111.115 -175.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.29 126.85 57.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.08 -38.07 9.89 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.719 0.771 . . . . 0.0 109.504 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 165.11 -160.22 33.48 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.849 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.74 145.29 33.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 120.704 0.288 . . . . 0.0 110.402 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -66.13 130.98 45.09 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.88 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.0 t -95.9 -56.68 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.43 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.17 164.09 29.26 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.03 125.35 8.54 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -111.16 81.75 1.49 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.93 -123.65 6.38 Favored Glycine 0 N--CA 1.422 -2.235 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -89.17 -13.94 37.21 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.208 0.527 . . . . 0.0 109.7 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -98.26 122.85 41.94 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.065 0.459 . . . . 0.0 111.424 -177.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.19 121.99 6.54 Favored Glycine 0 N--CA 1.422 -2.245 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.525 ' HB3' ' SD ' ' A' ' 134' ' ' MET . 84.3 m-85 -108.82 134.91 50.87 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.435 0.636 . . . . 0.0 110.993 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 134' ' ' MET . 18.8 m -133.11 158.99 41.4 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.966 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.491 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -92.71 140.9 29.05 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.436 ' CD ' HD13 ' A' ' 94' ' ' LEU . 78.6 mt-30 -84.58 124.49 31.48 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 121.475 0.655 . . . . 0.0 111.325 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 98.2 mt -93.63 92.78 7.7 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.469 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 68.2 mttm -87.09 150.45 23.99 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.501 ' O ' HG13 ' A' ' 179' ' ' VAL . 10.0 ptpp? -77.12 -13.68 59.91 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.958 -176.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -58.81 -22.43 58.51 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.602 1.161 . . . . 0.0 111.11 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 174' ' ' LYS . 45.5 m-85 -91.1 -8.74 47.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.196 0.522 . . . . 0.0 110.331 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -119.58 10.93 11.91 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.547 -175.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 175' ' ' LYS . 31.6 m -97.5 160.91 2.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -74.84 -43.75 52.86 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -121.16 144.89 48.34 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 . . . . . 0 C--N 1.31 -1.111 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.73 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.626 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -40.17 -56.84 1.35 Allowed 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 124.858 3.705 . . . . 0.0 115.477 -174.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -59.14 -49.84 76.32 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.7 m -64.8 -39.54 93.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.89 0.476 . . . . 0.0 111.088 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.79 -41.79 78.23 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.006 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -62.35 -43.4 98.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.66 98.45 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.114 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.06 -33.06 75.14 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-O 121.246 0.546 . . . . 0.0 111.187 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -71.32 -53.57 13.74 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.9 tp -53.86 -44.37 70.3 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.8 0.84 . . . . 0.0 109.891 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' A' ' 15' ' ' ILE . 44.4 tp -51.65 -58.46 6.29 Favored 'General case' 0 C--O 1.206 -1.191 0 C-N-CA 125.522 1.529 . . . . 0.0 112.644 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -87.73 0.2 56.06 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -172.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -112.81 -44.1 3.35 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -121.75 3.49 10.07 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 11' ' ' LEU . 59.0 mt -112.72 130.23 66.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.166 0.508 . . . . 0.0 110.52 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.75 165.51 26.25 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.398 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.7 m -98.99 118.34 35.54 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.63 120.87 55.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.462 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 24.1 m -79.9 101.39 8.55 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.352 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.2 p -104.53 -174.31 2.51 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.281 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -75.16 -35.0 61.65 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -91.03 3.54 54.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.23 -174.32 27.96 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.167 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG2' ' HA ' ' A' ' 19' ' ' THR . 38.8 mt-10 -112.51 94.3 4.85 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -92.63 179.86 5.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.504 -171.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 20.3 m -86.61 124.28 32.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.719 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.0 130.81 10.38 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 175.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.0 tp -110.16 119.09 38.17 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.964 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.08 123.5 6.23 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 174.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mm -87.52 -44.11 15.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.402 ' ND1' ' HB3' ' A' ' 85' ' ' ASP . 62.6 t60 -171.85 144.18 1.73 Allowed 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.534 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.504 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 37.1 t70 60.32 -89.24 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.657 1.223 . . . . 0.0 112.083 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.649 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 36.0 ptt180 -140.25 11.13 2.36 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.998 0.904 . . . . 0.0 109.937 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.0 t -79.88 112.97 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.237 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 m -123.29 151.69 42.15 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 124.013 0.821 . . . . 0.0 110.235 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -125.77 141.85 44.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.7 tt -157.22 150.61 18.88 Favored Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -71.6 155.31 59.31 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.019 1.812 . . . . 0.0 112.202 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.6 m -71.16 -33.14 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.266 -0.271 . . . . 0.0 110.301 -177.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -66.15 -2.76 4.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.28 -28.23 59.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 69.38 81.06 0.2 Allowed Pre-proline 0 C--O 1.232 0.144 0 C-N-CA 125.336 1.454 . . . . 0.0 112.559 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -96.96 171.2 0.86 Allowed 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.777 2.318 . . . . 0.0 111.788 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.72 -143.31 6.95 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -91.1 -29.96 17.01 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.671 0.748 . . . . 0.0 110.075 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -141.23 135.33 30.6 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.75 -172.62 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.392 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.7 mt -113.25 128.14 56.38 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.39 96.88 4.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 58.29 20.37 7.16 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.188 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.02 -36.3 2.87 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.347 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -74.54 134.45 42.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.705 0.253 . . . . 0.0 110.832 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -75.83 111.89 11.67 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.53 HD12 ' O ' ' A' ' 78' ' ' ASP . 11.1 tp -120.14 140.22 44.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.074 0.464 . . . . 0.0 111.142 -174.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.532 ' N ' ' HD2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -97.85 138.84 34.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.8 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -100.32 109.63 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -70.02 -71.77 0.22 Allowed 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.904 0.753 . . . . 0.0 110.564 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -102.98 141.36 35.92 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -126.95 96.15 4.54 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -96.1 107.59 19.93 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -93.55 116.71 29.23 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.69 115.1 17.18 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.786 0.803 . . . . 0.0 111.534 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.21 145.5 32.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.466 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 14.7 t70 -70.99 145.81 92.07 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -46.33 -31.36 9.29 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.784 2.989 . . . . 0.0 113.981 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -82.5 5.9 19.2 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.03 0.443 . . . . 0.0 111.553 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 71.24 68.58 0.17 Allowed 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 125.281 1.432 . . . . 0.0 111.122 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 67.6 mt -131.16 139.87 49.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 131' ' ' THR . 0.9 OUTLIER -73.55 137.85 44.6 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -176.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 72' ' ' LEU . 72.2 mt -111.49 -2.16 15.61 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 63.72 -21.68 0.06 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 127.222 2.209 . . . . 0.0 113.812 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 70' ' ' LEU . 82.8 mt -70.28 118.98 13.79 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.17 0.51 . . . . 0.0 111.618 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.9 m -112.71 115.93 29.33 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.0 t -100.99 121.53 51.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -113.53 133.19 55.38 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.492 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 96.0 m -86.08 82.85 7.93 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 169.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.649 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 18.8 tp -76.87 132.18 39.0 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.53 ' O ' HD12 ' A' ' 54' ' ' ILE . 27.8 t70 -76.22 77.52 3.02 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 117.669 -1.612 . . . . 0.0 112.336 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -96.37 94.89 7.7 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -68.8 -12.71 61.81 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.449 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -98.29 100.97 12.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 8.2 ptpp? -62.43 136.83 58.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -172.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -81.62 152.79 27.0 Favored 'General case' 0 C--O 1.257 1.456 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.529 175.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -69.86 144.56 52.49 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.625 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.402 ' HB3' ' ND1' ' A' ' 31' ' ' HIS . 6.6 p-10 -72.01 97.45 1.88 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.916 0.865 . . . . 0.0 111.49 177.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.3 pt -91.2 18.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 121.596 0.712 . . . . 0.0 110.403 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -69.41 -30.87 68.92 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.774 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.39 -10.82 86.02 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.44 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -97.76 -5.18 35.54 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.7 mt -70.39 113.53 6.6 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 CA-C-O 121.301 0.572 . . . . 0.0 111.317 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -104.09 93.73 5.0 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.427 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 5.6 pt-20 -90.93 1.6 56.89 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.905 0.86 . . . . 0.0 111.049 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -97.17 110.2 22.79 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 167.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.417 HD13 ' HB ' ' A' ' 135' ' ' ILE . 6.4 mt -106.38 -57.36 2.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -164.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -42.02 113.94 0.49 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.445 1.498 . . . . 0.0 114.499 -168.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 -13.22 65.53 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.858 -1.064 . . . . 0.0 113.624 174.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 40.3 t -91.23 141.86 13.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 117.143 0.472 . . . . 0.0 110.68 -177.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -75.31 146.25 41.15 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.69 0.796 . . . . 0.0 111.614 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -138.61 170.46 15.97 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.053 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.5 m -135.39 148.47 49.37 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 tp -108.98 121.11 44.44 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 109.373 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.06 105.83 19.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.5 t -105.27 127.55 59.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -136.55 87.7 2.32 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.4 p -115.87 -172.38 2.15 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -79.49 -44.86 20.45 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 117.763 -1.575 . . . . 0.0 107.414 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.64 -42.19 78.36 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.809 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -105.89 91.39 3.72 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.0 m -87.76 100.38 12.8 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.591 -175.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 70.0 71.29 0.23 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.211 1.005 . . . . 0.0 113.203 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.1 m -108.83 95.33 5.58 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.6 mt -95.78 96.02 5.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.1 tp -113.42 123.42 50.03 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.977 -173.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.91 145.04 55.87 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.69 -39.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.559 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.62 -164.02 19.81 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.71 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 51.9 Cg_exo -58.38 129.35 32.27 Favored 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 123.712 2.941 . . . . 0.0 113.163 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.9 m -104.31 163.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.188 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.423 ' O ' HG13 ' A' ' 135' ' ' ILE . 42.8 p -129.61 174.75 9.38 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -116.71 131.35 56.97 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.57 -36.42 12.41 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.816 0.341 . . . . 0.0 111.227 -175.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.8 -105.76 3.19 Favored Glycine 0 CA--C 1.486 -1.74 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.82 138.58 51.01 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.404 HG13 ' HG3' ' A' ' 134' ' ' MET . 2.8 pp -128.09 141.37 46.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -102.46 105.07 15.58 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.1 tp -112.03 109.38 19.1 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.6 m 64.02 32.98 12.57 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.859 0.838 . . . . 0.0 108.911 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.7 t 69.92 12.38 7.87 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.637 -1.62 . . . . 0.0 111.513 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.3 m -97.04 108.61 44.82 Favored Pre-proline 0 N--CA 1.428 -1.534 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.32 120.99 5.85 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.677 1.584 . . . . 0.0 111.222 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 9.9 m -119.12 129.55 55.11 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -113.52 165.36 12.56 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.154 0.582 . . . . 0.0 109.944 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? 72.03 28.44 2.53 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.309 1.444 . . . . 0.0 109.402 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.404 ' HG3' HG13 ' A' ' 124' ' ' ILE . 95.4 mmm -86.92 126.24 34.56 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.616 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.454 HG23 ' HB3' ' A' ' 170' ' ' SER . 2.8 tt -99.26 143.77 12.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -132.28 139.79 48.37 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.95 0.405 . . . . 0.0 111.138 -170.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.482 ' CE1' ' HA3' ' A' ' 168' ' ' GLY . 37.0 p90 -140.41 135.86 32.49 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -93.72 117.31 29.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -176.09 143.52 0.55 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.74 92.86 0.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.911 0.862 . . . . 0.0 110.861 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.2 m -121.25 138.38 54.26 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -108.6 152.27 25.01 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.882 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -74.06 154.47 39.2 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 109.54 -16.67 31.45 Favored Glycine 0 C--N 1.307 -1.08 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -173.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -92.22 21.65 5.0 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 37.3 m -68.22 135.73 52.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.174 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.549 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 95.94 -4.74 65.78 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.15 135.82 30.09 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.24 115.22 25.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.278 0.561 . . . . 0.0 110.664 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.3 tp -85.38 101.53 12.66 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 18.0 p -151.73 168.94 23.46 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.675 0.75 . . . . 0.0 111.958 -172.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.85 -177.9 6.05 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.9 t -60.12 105.42 0.4 Allowed 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.976 0.893 . . . . 0.0 112.03 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.17 19.1 78.39 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.555 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -141.44 92.59 2.48 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 116.826 0.313 . . . . 0.0 110.683 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.3 mt -99.56 122.8 51.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -95.74 -36.12 11.29 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.591 0.71 . . . . 0.0 110.43 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 165.2 -156.33 28.24 Favored Glycine 0 N--CA 1.424 -2.166 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.663 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.9 pt -124.02 145.09 31.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -69.9 131.11 43.93 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 123.279 0.631 . . . . 0.0 110.135 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.65 11.11 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.762 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -129.86 -119.38 2.13 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.213 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 103.68 51.09 0.98 Allowed Glycine 0 CA--C 1.494 -1.261 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -106.92 96.81 6.7 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.83 -109.43 2.83 Favored Glycine 0 C--N 1.314 -0.668 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 41.3 mtm105 -111.38 14.67 21.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.017 0.437 . . . . 0.0 109.91 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -112.26 110.12 20.18 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.129 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.482 ' HA3' ' CE1' ' A' ' 137' ' ' TYR . . . -90.99 112.16 4.08 Favored Glycine 0 N--CA 1.411 -2.989 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -101.6 130.18 47.88 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.454 ' HB3' HG23 ' A' ' 135' ' ' ILE . 29.8 t -129.94 158.9 38.26 Favored 'General case' 0 C--N 1.265 -3.096 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.53 137.18 49.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -70.67 116.6 11.17 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 123.821 0.701 . . . . 0.0 112.174 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.2 mp -85.63 81.3 8.7 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.503 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -67.53 129.4 39.79 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.427 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 7.8 ptpp? -63.3 -16.21 59.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.768 0.318 . . . . 0.0 111.485 -177.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -58.37 -29.66 66.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.4 1.08 . . . . 0.0 110.73 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -80.75 -17.33 51.29 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.331 0.586 . . . . 0.0 110.29 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -111.68 0.33 16.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.284 -173.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.18 108.6 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 CA-C-O 121.891 0.853 . . . . 0.0 109.027 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.88 -48.06 40.61 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.165 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -117.79 115.79 25.7 Favored 'General case' 0 N--CA 1.405 -2.685 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.531 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.485 ' HA ' HE21 ' A' ' 182' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.424 -1.741 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 173.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.432 ' H3 ' ' CB ' ' A' ' 4' ' ' THR . . . . . . . . 0 N--CA 1.468 0.783 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.74 -46.7 30.36 Favored 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 123.07 2.514 . . . . 0.0 112.827 -176.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -68.67 -39.66 80.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.956 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.432 ' CB ' ' H3 ' ' A' ' 1' ' ' GLY . 1.2 m -65.02 -46.71 80.23 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 122.938 0.495 . . . . 0.0 110.76 -178.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.89 -29.17 58.38 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -63.91 -49.64 71.87 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.77 86.02 Favored 'General case' 0 C--O 1.194 -1.822 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.621 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.8 tp -57.47 -52.02 67.09 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.404 0.681 . . . . 0.0 111.446 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -67.9 -31.03 70.53 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.453 0.644 . . . . 0.0 110.302 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.7 tp -70.34 -52.94 18.99 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.42 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.444 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.4 tp -53.1 -54.5 34.68 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 126.344 1.858 . . . . 0.0 113.123 -176.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.2 mtp85 -62.21 -7.16 3.76 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -171.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -137.56 -50.65 0.62 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.416 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -91.36 -7.16 51.66 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -167.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 60.1 mt -115.89 113.58 43.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 42.1 ttm -140.37 136.98 33.69 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.771 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 50.7 m -63.6 135.31 56.7 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.202 0.601 . . . . 0.0 111.394 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 75.5 mt -129.11 126.53 64.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 92.1 m -89.6 110.24 21.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 72.4 p -91.99 -162.52 0.93 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.796 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 t -83.14 -1.14 52.13 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -104.51 -55.95 2.26 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.92 -158.02 21.18 Favored Glycine 0 CA--C 1.502 -0.727 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.817 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -89.85 113.58 25.2 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 116.773 0.287 . . . . 0.0 110.928 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -122.45 -172.65 2.51 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 104' ' ' HIS . 8.8 t -128.23 138.65 52.54 Favored 'General case' 0 N--CA 1.403 -2.79 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.257 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.96 148.59 18.22 Favored Glycine 0 N--CA 1.418 -2.54 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -111.08 118.32 35.68 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.61 111.55 3.44 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.3 mm -77.46 -45.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 85' ' ' ASP . 1.5 p-80 -179.58 161.54 1.04 Allowed 'General case' 0 CA--C 1.484 -1.585 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.601 177.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 52.17 -104.94 0.2 Allowed 'General case' 0 CA--C 1.554 1.125 0 O-C-N 124.511 1.132 . . . . 0.0 112.732 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -119.43 5.48 11.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.063 0.459 . . . . 0.0 109.872 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.1 t -85.59 107.54 16.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.704 -174.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -119.13 141.72 48.56 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.429 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.1 t -117.73 140.53 40.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 122.904 0.481 . . . . 0.0 111.536 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.6 tt -156.69 147.71 16.54 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 72.1 Cg_exo -55.87 154.4 26.96 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.736 2.291 . . . . 0.0 112.503 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -79.19 -28.86 42.68 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.099 -0.376 . . . . 0.0 111.407 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -73.31 -7.13 50.27 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.068 0.461 . . . . 0.0 111.178 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.78 -19.55 60.16 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.492 ' O ' ' HB ' ' A' ' 20' ' ' THR . 27.6 mt-30 53.11 78.61 0.39 Allowed Pre-proline 0 C--O 1.247 0.942 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 177.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -84.79 146.14 10.39 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.134 1.889 . . . . 0.0 110.097 173.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.81 -143.19 14.03 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.139 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -94.43 -20.53 19.63 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.16 0.505 . . . . 0.0 110.841 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -146.19 135.13 22.52 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.51 165.76 29.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 123.508 0.505 . . . . 0.0 110.408 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 78.3 mt -97.12 104.72 16.76 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -90.28 85.85 2.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 122.372 1.082 . . . . 0.0 109.739 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 66.76 14.96 10.01 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.514 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.51 -50.48 0.82 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.86 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.07 132.59 48.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.825 0.45 . . . . 0.0 111.28 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -78.66 124.84 28.6 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.8 tp -132.39 134.91 58.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.989 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -86.21 137.69 32.45 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.968 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.61 127.3 41.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -65.92 -62.8 1.3 Allowed 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.783 0.677 . . . . 0.0 109.661 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -152.87 148.44 27.16 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -132.93 151.55 52.03 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -172.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -125.37 123.18 38.8 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.933 -176.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -81.06 104.66 11.71 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 167.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 50.0 tp -88.44 111.24 21.56 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.33 179.91 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.813 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -77.19 140.66 65.97 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.79 -28.78 13.49 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.771 2.981 . . . . 0.0 114.766 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -87.9 10.41 18.81 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.472 0.653 . . . . 0.0 110.595 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.4 t30 65.49 70.15 0.45 Allowed 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 125.379 1.472 . . . . 0.0 111.274 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.8 mt -137.7 145.98 28.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.59 ' O ' ' HA ' ' A' ' 131' ' ' THR . 58.6 t30 -65.73 132.5 48.9 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.997 0.427 . . . . 0.0 110.742 -176.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.465 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 50.6 tp -105.72 -7.11 18.6 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 14.8 tp10 62.9 28.55 16.4 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.844 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.51 125.35 47.63 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.104 -172.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.1 m -123.15 123.02 39.87 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.6 t -100.84 120.4 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.5 128.63 53.67 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.3 m -85.92 86.71 7.35 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 tp -86.34 120.3 27.54 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.445 ' O ' ' HD2' ' A' ' 79' ' ' ARG . 33.1 t70 -63.42 101.79 0.35 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.326 0.584 . . . . 0.0 111.116 -177.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 26.9 mmm180 -126.42 117.89 23.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -77.05 -37.37 54.82 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -97.11 104.89 16.95 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -93.87 154.13 17.89 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -168.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -74.82 170.21 16.35 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.287 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -85.92 143.8 28.0 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.443 ' HA ' ' HB3' ' A' ' 31' ' ' HIS . 9.6 t70 -71.43 95.78 1.4 Allowed 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.043 0.925 . . . . 0.0 110.004 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.1 pt -86.82 9.37 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.117 0.961 . . . . 0.0 109.682 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -73.2 -28.08 61.98 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.32 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.54 -18.79 68.28 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.876 174.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -100.07 2.67 43.46 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 110.549 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.5 mt -76.43 127.15 37.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -94.66 112.68 24.43 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.2 0.52 28.1 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.179 -0.609 . . . . 0.0 112.311 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -113.76 122.57 47.5 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.08 -66.93 0.98 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -166.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -69.11 148.38 50.07 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -167.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.59 48.76 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 114.794 -1.093 . . . . 0.0 112.704 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.3 136.32 30.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 122.453 -0.439 . . . . 0.0 111.223 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.97 125.0 21.97 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.887 0.875 . . . . 0.0 109.974 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -120.2 161.03 21.75 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.518 0.675 . . . . 0.0 111.88 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 25.8 m -118.95 137.1 53.72 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 124.913 1.285 . . . . 0.0 107.941 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.3 tp -102.86 120.65 40.99 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 111' ' ' THR . 25.6 m -113.21 121.48 65.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.478 0.656 . . . . 0.0 110.715 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.45 143.88 37.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.311 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.466 ' O ' ' HB ' ' A' ' 26' ' ' THR . 17.4 t60 -146.94 90.56 1.91 Allowed 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.8 m -150.8 -177.91 6.27 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -64.47 -29.42 70.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.804 0.335 . . . . 0.0 111.044 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -59.76 -32.98 71.09 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.779 0.831 . . . . 0.0 112.046 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -175.73 128.47 0.24 Allowed 'General case' 0 C--O 1.245 0.845 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 p -93.14 123.41 36.39 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.442 ' OD1' HD22 ' A' ' 11' ' ' LEU . 93.8 m-20 65.0 71.0 0.46 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 90.8 m -115.52 117.83 31.46 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 174.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 66.4 mt -119.15 90.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.6 tp -127.16 132.66 50.47 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.522 -174.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 30.5 mp0 -66.35 136.65 56.1 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 124.266 1.027 . . . . 0.0 109.636 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.28 -7.65 12.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.46 -171.72 19.66 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.914 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.47 118.65 5.42 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.063 2.509 . . . . 0.0 112.038 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.46 145.52 12.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.882 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.5 m -125.75 150.56 47.62 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 21.7 ttt -71.97 135.69 46.52 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.4 -40.76 6.93 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.2 -99.87 2.34 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tt -138.28 118.91 13.97 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 10.8 tp -130.82 158.54 43.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -114.14 114.75 26.48 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.419 173.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp -102.84 118.39 36.73 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.9 t 59.82 39.69 20.32 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.1 m 65.74 10.83 7.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.437 1.495 . . . . 0.0 112.971 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.8 m -101.74 108.03 54.28 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.49 124.66 9.53 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.096 1.864 . . . . 0.0 111.92 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 15.9 p -115.22 125.22 53.1 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.517 177.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -101.1 155.5 17.96 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 69.18 36.66 2.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.565 1.146 . . . . 0.0 107.932 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.404 ' HE2' ' HB3' ' A' ' 169' ' ' PHE . 8.4 tpt -85.21 147.58 26.52 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.515 -175.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.427 HG22 ' HB2' ' A' ' 170' ' ' SER . 14.7 tt -130.11 144.42 38.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -143.62 165.17 28.35 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.315 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -145.98 149.34 33.97 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -89.16 104.06 16.63 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.092 0.948 . . . . 0.0 110.424 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -167.89 136.17 2.38 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.92 91.21 4.17 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.528 0.68 . . . . 0.0 110.304 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -104.38 161.6 13.93 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.694 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -92.45 176.89 6.3 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.1 t -115.13 168.26 10.09 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 94.21 -4.89 71.12 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.918 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.433 ' HB2' ' CD2' ' A' ' 160' ' ' HIS . 16.8 mt-30 -95.1 15.1 19.89 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 8.1 m -59.01 118.17 5.51 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.39 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 113.95 -2.48 24.27 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -176.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.77 148.69 43.67 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 174.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.417 ' HB ' ' CG2' ' A' ' 102' ' ' VAL . 28.4 t -93.59 122.86 45.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.276 0.56 . . . . 0.0 110.745 -175.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.4 tp -94.86 105.02 16.93 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 14.3 p -145.8 170.9 15.61 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.031 0.443 . . . . 0.0 112.11 -172.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.03 178.83 6.99 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.1 t -55.62 106.22 0.23 Allowed 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 121.86 0.838 . . . . 0.0 111.959 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.8 19.08 76.51 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.238 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -143.28 106.05 4.49 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -92.46 128.1 44.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -98.66 -38.16 9.23 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.425 0.631 . . . . 0.0 110.863 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 170.58 -159.84 32.25 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.454 -1.355 . . . . 0.0 112.387 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.8 pt -118.64 144.08 27.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 120.96 0.41 . . . . 0.0 110.533 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.433 ' CD2' ' HB2' ' A' ' 145' ' ' GLN . 52.8 t60 -74.56 132.2 41.61 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.698 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.25 -6.13 11.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.278 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 149.0 -154.56 25.88 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 119.859 -1.162 . . . . 0.0 112.429 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.67 160.66 25.13 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -155.96 118.25 4.09 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.72 -117.38 4.58 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -110.62 8.31 22.71 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.061 0.458 . . . . 0.0 110.846 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -112.86 126.78 55.82 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.023 0.439 . . . . 0.0 110.416 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -99.85 138.23 13.73 Favored Glycine 0 CA--C 1.476 -2.361 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.404 ' HB3' ' HE2' ' A' ' 134' ' ' MET . 81.4 m-85 -113.5 132.81 55.54 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.773 0.797 . . . . 0.0 111.961 -173.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.427 ' HB2' HG22 ' A' ' 135' ' ' ILE . 54.3 m -141.08 164.2 30.91 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.821 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.31 138.4 47.83 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.42 ' OE1' ' HE3' ' A' ' 174' ' ' LYS . 79.5 mt-30 -74.41 116.99 15.71 Favored 'General case' 0 C--O 1.244 0.781 0 O-C-N 123.431 0.457 . . . . 0.0 111.253 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 63.6 mt -90.92 89.8 7.61 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.42 ' HE3' ' OE1' ' A' ' 172' ' ' GLN . 97.5 mttt -88.63 124.98 34.6 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.901 176.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -52.02 -17.73 1.14 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.136 1.374 . . . . 0.0 114.144 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -60.33 -27.76 67.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.406 1.082 . . . . 0.0 111.139 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -79.12 -19.27 51.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.802 0.334 . . . . 0.0 111.7 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -100.01 14.71 29.66 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.2 p -119.32 128.29 75.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -84.59 -14.36 49.0 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.086 0.469 . . . . 0.0 111.552 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -97.55 108.39 21.09 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.25 1.129 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.238 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.366 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.7 -31.87 68.93 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.652 2.235 . . . . 0.0 110.194 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -59.94 -36.33 76.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.919 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 m -70.05 -39.11 75.89 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 120.978 0.418 . . . . 0.0 110.133 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -69.94 -41.48 74.52 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.979 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -63.27 -42.74 99.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.501 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.43 -44.12 96.09 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.91 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.43 -48.53 81.35 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.096 0.559 . . . . 0.0 110.803 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 p -71.72 -37.58 70.59 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.9 tp -65.14 -45.98 82.78 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.624 0.77 . . . . 0.0 109.413 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.8 tp -48.7 -52.75 21.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.454 1.501 . . . . 0.0 112.526 -177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -76.74 -3.1 36.4 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.86 -53.86 2.61 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.849 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -104.04 -17.25 15.03 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -169.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.35 113.27 24.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.542 0.687 . . . . 0.0 110.418 -178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 90.3 mmm -116.16 153.28 32.1 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 m -101.11 121.54 41.99 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -112.61 123.8 68.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 O-C-N 121.928 -0.482 . . . . 0.0 111.603 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.5 m -80.82 102.9 10.29 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.254 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.2 p -102.31 -169.46 1.67 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -72.78 -20.54 61.15 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.997 0.427 . . . . 0.0 110.685 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -100.43 3.34 43.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.996 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.89 -175.62 16.53 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.994 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 mp0 -83.5 115.83 22.27 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.435 ' CD1' ' HB3' ' A' ' 146' ' ' CYS . 72.8 m-85 -122.36 -175.14 3.06 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 25.5 m -91.4 130.24 37.27 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.9 128.26 7.59 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -100.18 119.49 38.43 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.03 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.97 115.43 4.02 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 174.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.9 mm -84.52 -55.43 6.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 117.018 0.409 . . . . 0.0 111.169 -173.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -163.0 150.54 13.3 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.564 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 23.2 t70 54.7 -99.87 0.1 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.449 1.093 . . . . 0.0 111.98 173.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.564 ' HG2' ' OD2' ' A' ' 32' ' ' ASP . 14.1 ptp180 -126.65 14.56 7.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.697 0.76 . . . . 0.0 110.073 177.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.9 t -92.25 115.93 32.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.211 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -124.55 151.03 45.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.33 141.16 47.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 117.82 0.282 . . . . 0.0 111.752 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.3 tt -155.15 142.07 13.53 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 99.2 Cg_exo -49.03 144.17 16.42 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 123.702 2.935 . . . . 0.0 115.467 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.6 m -65.74 -37.21 85.76 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.432 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -63.61 -5.08 3.46 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.38 -18.05 29.23 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 54.94 86.77 0.16 Allowed Pre-proline 0 C--O 1.242 0.697 0 C-N-CA 124.959 1.304 . . . . 0.0 112.93 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -81.47 127.68 5.88 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.982 1.788 . . . . 0.0 110.119 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.54 -176.63 47.61 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.099 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -67.1 -37.2 83.51 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 120.855 0.36 . . . . 0.0 110.487 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -130.69 114.54 15.52 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.841 0.829 . . . . 0.0 109.716 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.94 176.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.162 -174.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 57.8 mt -113.34 112.65 24.05 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.38 89.36 2.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 59.57 30.92 20.59 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.287 1.435 . . . . 0.0 109.981 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.41 -33.71 5.0 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.045 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -71.52 118.54 14.46 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.457 0.303 . . . . 0.0 111.081 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 53' ' ' LYS . 12.1 mptt -75.25 132.92 41.41 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.441 HD13 ' HE ' ' A' ' 79' ' ' ARG . 6.6 tp -153.28 132.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.869 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -90.79 134.72 34.22 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -78.02 119.84 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.77 -66.72 0.85 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -102.66 128.47 49.34 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -106.15 118.21 36.03 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -114.78 94.45 4.77 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -75.57 118.78 18.79 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.79 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 3.5 mm? -87.4 83.77 7.27 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-O 122.842 1.305 . . . . 0.0 112.699 -177.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.51 148.71 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 172.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.46 135.45 41.08 Favored Pre-proline 0 C--N 1.269 -2.897 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.2 -25.32 4.37 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 124.034 3.156 . . . . 0.0 114.766 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -81.63 16.27 1.82 Allowed 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.976 -0.453 . . . . 0.0 111.582 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.0 m120 75.87 17.77 2.19 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.664 1.586 . . . . 0.0 112.383 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.3 mt -95.87 120.14 44.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.07 156.23 30.15 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 122.132 -0.355 . . . . 0.0 111.699 -174.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.444 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 60.4 tp -121.68 -9.96 8.83 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 13.6 tp10 65.44 20.01 11.67 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.931 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.21 144.89 41.92 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.323 -0.861 . . . . 0.0 110.577 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.4 m -124.0 117.79 25.53 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.5 t -94.61 118.51 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 CA-C-O 121.709 0.766 . . . . 0.0 108.999 177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 74.2 mt -106.08 124.0 48.9 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.268 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 m -97.24 98.34 9.92 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -70.79 136.47 48.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.227 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.518 ' HA ' ' NH1' ' A' ' 33' ' ' ARG . 38.7 t70 -84.41 73.87 10.44 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.623 1.202 . . . . 0.0 110.137 177.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.441 ' HE ' HD13 ' A' ' 54' ' ' ILE . 24.1 mmt180 -127.47 132.59 50.0 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.191 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -79.49 -20.75 46.51 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.39 109.85 9.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.281 -1.327 . . . . 0.0 107.848 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -106.78 170.73 7.77 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -113.37 169.33 9.04 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.411 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -73.5 125.7 28.55 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -72.81 104.78 4.11 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.21 1.005 . . . . 0.0 111.331 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.5 pt -94.12 21.93 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.959 0.885 . . . . 0.0 109.675 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -63.14 -32.98 74.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.602 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.49 0.42 89.17 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 116.178 -0.465 . . . . 0.0 113.507 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -103.77 -2.49 26.31 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 117.251 0.526 . . . . 0.0 110.551 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.67 126.68 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.342 0.591 . . . . 0.0 110.126 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.7 t -104.1 107.68 18.68 Favored 'General case' 0 N--CA 1.397 -3.099 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -87.03 -4.53 59.17 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.176 0.989 . . . . 0.0 108.488 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -94.17 115.82 28.15 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.422 HD22 ' CG ' ' A' ' 172' ' ' GLN . 26.3 mt -110.65 -63.32 1.41 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -169.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 17.0 pt-20 -58.26 121.99 12.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -168.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.28 -8.62 24.74 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.14 -0.936 . . . . 0.0 113.417 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 118' ' ' VAL . 21.9 t -108.81 144.65 16.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 117.34 0.57 . . . . 0.0 110.324 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.09 127.4 35.12 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -112.54 160.67 17.59 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.986 0.898 . . . . 0.0 112.042 -176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.1 m -122.73 137.65 54.85 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 tp -103.95 109.27 20.97 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.6 t -103.93 116.38 47.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.347 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.443 ' CG2' ' HB ' ' A' ' 111' ' ' THR . 28.3 m -122.0 151.91 25.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.282 0.563 . . . . 0.0 111.473 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -149.39 68.4 1.03 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 m -93.99 -150.25 0.29 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.57 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -73.18 -66.12 0.72 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.582 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -81.2 -36.85 29.58 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.48 86.09 6.68 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.392 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.5 p -97.15 117.2 30.82 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.21 42.97 5.13 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.448 1.118 . . . . 0.0 108.698 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.443 ' HB ' ' CG2' ' A' ' 103' ' ' VAL . 23.8 m -94.89 106.67 18.67 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.328 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.4 mt -97.86 98.45 7.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.5 tp -114.94 122.87 47.61 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.225 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -83.38 134.02 34.91 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 122.282 -0.261 . . . . 0.0 110.342 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 m -108.58 -14.49 9.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -175.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.97 -160.12 19.44 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.061 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.75 127.22 12.8 Favored 'Trans proline' 0 C--O 1.243 0.772 0 C-N-CA 123.498 2.799 . . . . 0.0 112.502 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 97' ' ' VAL . 27.5 m -96.9 157.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.458 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.421 ' O ' HG13 ' A' ' 135' ' ' ILE . 7.1 p -139.72 173.05 11.93 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 124.373 1.069 . . . . 0.0 108.542 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -92.01 128.8 37.98 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.17 -38.53 22.21 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.177 0.513 . . . . 0.0 111.624 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 132' ' ' ASN . . . 82.93 -102.78 2.41 Favored Glycine 0 N--CA 1.421 -2.355 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -176.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.78 133.06 54.25 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.717 0.77 . . . . 0.0 112.136 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 7.2 tp -126.84 129.4 71.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 168.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -112.99 126.54 55.61 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.707 -173.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -110.22 96.89 6.5 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.7 m 56.23 65.85 1.34 Allowed 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.823 0.849 . . . . 0.0 111.095 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.7 t 64.86 -3.78 0.54 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.752 1.221 . . . . 0.0 112.721 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.1 m -95.99 113.85 62.98 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.89 137.9 11.33 Favored 'Trans proline' 0 N--CA 1.441 -1.598 0 C-N-CA 122.591 2.194 . . . . 0.0 113.582 -175.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.1 m -119.54 116.79 26.79 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 51.8 t30 -115.4 163.61 15.47 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.417 -173.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 73.7 28.11 1.67 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.106 1.362 . . . . 0.0 109.36 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 91.2 mmm -88.09 158.3 18.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.745 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.485 HG23 ' HB2' ' A' ' 170' ' ' SER . 7.7 tt -116.33 138.73 45.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 122.927 0.491 . . . . 0.0 109.951 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -118.57 139.74 51.0 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.158 0.983 . . . . 0.0 111.975 -170.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -149.7 147.97 28.71 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -93.66 103.07 15.25 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -168.36 125.37 1.06 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.07 94.83 1.55 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.512 0.673 . . . . 0.0 109.769 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.0 t -80.03 176.06 10.08 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.001 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -119.94 156.36 30.96 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.7 m -76.04 114.9 15.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.01 -15.56 2.15 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.94 11.87 5.61 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.754 -0.262 . . . . 0.0 111.011 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.435 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 43.3 t -58.17 122.34 12.9 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.049 0.54 . . . . 0.0 110.083 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 86.32 10.02 75.03 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.233 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -72.16 137.17 24.78 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.437 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 25.4 t -79.08 107.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.186 0.517 . . . . 0.0 109.947 -177.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.6 tp -87.64 102.65 14.82 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 16.9 p -147.09 168.19 22.22 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.473 -173.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -137.89 -174.59 3.83 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 174.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 t -63.37 100.35 0.24 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 121.89 0.853 . . . . 0.0 112.058 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.87 10.22 85.9 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.198 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -128.91 98.28 4.91 Favored 'General case' 0 C--O 1.208 -1.118 0 O-C-N 122.491 -0.417 . . . . 0.0 109.969 -174.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 74.6 mt -99.02 117.81 44.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -90.53 -39.88 12.31 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.458 0.647 . . . . 0.0 110.365 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 164.92 -152.94 22.85 Favored Glycine 0 N--CA 1.422 -2.266 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.11 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 148' ' ' GLY . 28.1 pt -129.18 146.61 33.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.93 0.365 . . . . 0.0 110.808 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.407 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 46.9 t-80 -69.48 134.48 48.95 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.446 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.1 t -99.84 -71.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.722 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.29 127.39 1.39 Allowed Glycine 0 N--CA 1.424 -2.125 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.25 153.15 20.67 Favored Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.693 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -131.7 100.57 5.16 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.75 -122.54 5.93 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -90.7 -12.16 37.51 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.041 0.448 . . . . 0.0 110.53 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -98.77 111.71 24.01 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.161 -175.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.61 119.99 5.43 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -105.97 116.65 32.3 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.573 0.701 . . . . 0.0 110.959 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.485 ' HB2' HG23 ' A' ' 135' ' ' ILE . 39.4 m -117.62 167.37 11.39 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.25 142.1 43.9 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 118.433 0.56 . . . . 0.0 110.374 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.651 ' OE1' ' HG2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -93.66 109.15 20.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.86 91.11 7.02 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.213 1.006 . . . . 0.0 111.079 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.651 ' HG2' ' OE1' ' A' ' 172' ' ' GLN . 6.8 mtpm? -65.01 148.1 52.26 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.336 -176.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -66.65 -22.46 66.1 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.024 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -68.24 -10.26 53.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.301 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -94.07 -20.62 19.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.671 0.748 . . . . 0.0 109.268 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -104.06 0.11 29.38 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.506 -173.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 66.8 t -115.8 126.59 73.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -63.84 -40.29 96.22 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -83.65 118.62 23.97 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 118.405 -0.807 . . . . 0.0 108.948 -177.645 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.631 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.409 ' O ' ' HB3' ' A' ' 5' ' ' GLU . 80.9 Cg_exo -49.77 -34.61 36.4 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 123.93 3.087 . . . . 0.0 113.169 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -60.84 -55.85 28.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.097 0.475 . . . . 0.0 110.508 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -59.25 -38.22 79.5 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.774 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 2' ' ' PRO . 31.9 tt0 -57.9 -55.46 34.56 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.604 1.161 . . . . 0.0 110.567 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.76 -46.95 86.29 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.003 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.67 -35.64 74.86 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.89 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.3 tp -71.42 -38.23 71.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.708 0.29 . . . . 0.0 110.821 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -73.1 -33.56 65.66 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.569 0.699 . . . . 0.0 109.167 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.6 tp -68.23 -41.96 80.45 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.215 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.468 ' HA ' HD12 ' A' ' 15' ' ' ILE . 58.5 tp -49.96 -54.17 21.62 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 125.076 1.351 . . . . 0.0 112.01 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.4 mtt-85 -80.32 13.35 2.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.606 -173.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -129.09 -64.25 0.92 Allowed 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.418 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -104.18 -2.87 25.13 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -173.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 11' ' ' LEU . 43.0 mt -99.93 134.75 38.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -154.38 144.85 22.22 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 122.484 0.314 . . . . 0.0 110.613 -173.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 m -80.23 118.13 21.63 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.0 mt -106.05 115.6 48.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-O 121.265 0.555 . . . . 0.0 109.569 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -83.08 97.28 8.69 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 79.1 p -91.95 -170.09 2.45 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.2 m -82.59 -13.34 56.71 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 120.706 0.289 . . . . 0.0 110.929 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -98.33 -24.08 15.36 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 110.417 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.63 -154.71 25.56 Favored Glycine 0 CA--C 1.501 -0.808 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.53 112.79 20.36 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 117.298 0.549 . . . . 0.0 109.531 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.452 ' HB3' ' O ' ' A' ' 146' ' ' CYS . 80.7 m-85 -120.66 -173.45 2.59 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 147' ' ' GLY . 5.9 t -113.93 136.91 52.37 Favored 'General case' 0 N--CA 1.406 -2.653 0 C-N-CA 118.959 -1.097 . . . . 0.0 109.934 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.02 136.89 13.64 Favored Glycine 0 N--CA 1.41 -3.092 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.5 tp -105.1 118.65 37.07 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.76 132.53 14.13 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 108.406 -1.878 . . . . 0.0 108.406 173.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.5 mm -96.08 -59.28 3.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 117.753 0.776 . . . . 0.0 109.902 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -162.12 147.37 12.87 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 55.53 -95.32 0.05 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 124.276 0.985 . . . . 0.0 111.21 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.625 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 18.9 ptp180 -132.84 10.87 4.31 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 122.044 0.926 . . . . 0.0 109.663 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -84.22 118.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.4 m -131.72 147.02 52.47 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.2 t -109.71 134.55 51.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.793 0.33 . . . . 0.0 111.727 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.428 ' HB ' ' CD2' ' A' ' 75' ' ' LEU . 6.7 mm -137.93 141.88 34.11 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 125.364 1.466 . . . . 0.0 108.358 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.06 146.57 93.86 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 121.975 1.784 . . . . 0.0 111.797 175.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.6 m -70.21 -33.35 71.58 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 123.214 0.605 . . . . 0.0 109.415 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -77.17 -4.74 46.15 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.579 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.62 -16.04 49.86 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.571 ' O ' ' HB ' ' A' ' 20' ' ' THR . 21.4 mt-30 58.14 82.67 0.23 Allowed Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.414 1.086 . . . . 0.0 112.877 176.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.08 -174.83 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.752 2.301 . . . . 0.0 111.287 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.59 179.19 18.44 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.55 -17.7 44.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.513 0.673 . . . . 0.0 110.313 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -141.71 135.92 30.31 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 12.7 p -141.6 149.98 19.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.514 -171.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -85.69 111.94 20.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.258 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.2 83.14 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.3 t30 68.65 -1.78 1.86 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.492 1.517 . . . . 0.0 111.364 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.11 -33.45 0.94 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.09 110.73 15.77 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 14.7 ptpt -78.68 137.38 37.78 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 116.819 -1.952 . . . . 0.0 109.101 174.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 78' ' ' ASP . 10.5 tp -128.99 150.69 34.85 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -91.24 142.84 27.28 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.8 t -108.73 131.19 60.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -78.29 -79.01 0.13 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.797 0.332 . . . . 0.0 111.286 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -113.75 140.17 48.5 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -104.5 93.51 4.82 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.502 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.5 m-85 -80.8 94.02 6.34 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -76.09 94.15 3.42 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.542 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 32.7 tp -85.46 103.53 14.42 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-O 121.616 0.722 . . . . 0.0 109.521 -172.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.06 178.9 2.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.71 139.29 58.24 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.2 -21.61 13.42 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 123.557 2.838 . . . . 0.0 114.542 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.3 6.1 24.23 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.2 m120 77.37 12.28 2.12 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.289 1.436 . . . . 0.0 112.747 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.0 mt -77.64 146.16 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -70.33 142.74 52.15 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 120.995 0.426 . . . . 0.0 111.622 -174.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 60.9 tp -117.38 -17.6 10.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 171.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 75.72 -17.02 0.54 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.284 1.434 . . . . 0.0 112.909 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.06 113.15 18.02 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.6 m -100.24 116.86 33.23 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 168.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 68.0 t -95.84 107.07 19.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.428 ' CD2' ' HB ' ' A' ' 37' ' ' ILE . 2.9 mm? -91.66 132.47 36.33 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.254 -178.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 m -83.68 80.3 9.17 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 171.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.625 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.7 tp -74.54 103.3 4.81 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.407 ' O ' HD12 ' A' ' 54' ' ' ILE . 12.9 t70 -73.8 84.07 1.66 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.432 0.634 . . . . 0.0 112.51 -168.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.409 ' HG3' ' CE2' ' A' ' 83' ' ' PHE . 31.4 mmt180 -99.14 125.08 44.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.197 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -74.78 -34.41 62.44 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -92.04 95.84 10.01 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -74.51 161.04 30.14 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.788 -1.096 . . . . 0.0 113.562 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.409 ' CE2' ' HG3' ' A' ' 79' ' ' ARG . 88.9 m-85 -91.27 172.57 8.45 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.042 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -73.88 137.57 43.8 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.07 95.32 1.2 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.222 0.534 . . . . 0.0 109.572 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -93.61 14.55 2.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 122.693 1.235 . . . . 0.0 109.975 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -31.13 59.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.018 -1.901 . . . . 0.0 108.764 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.07 -6.61 74.48 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 114.893 -1.048 . . . . 0.0 112.428 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -109.9 4.31 21.43 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.156 -0.614 . . . . 0.0 110.943 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.1 mt -73.22 125.95 33.06 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 CA-C-O 121.052 0.453 . . . . 0.0 110.292 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.0 t -115.24 106.8 14.46 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.428 ' OE2' ' HE3' ' A' ' 174' ' ' LYS . 7.9 pt-20 -88.53 -5.37 58.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.941 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -85.78 105.93 16.66 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 168.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.9 mt -99.98 -53.84 3.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -164.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -58.93 135.33 57.54 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.8 -38.83 3.13 Favored Glycine 0 N--CA 1.434 -1.443 0 CA-C-N 114.891 -1.05 . . . . 0.0 113.415 174.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 21.3 t -73.49 144.01 13.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 120.539 0.209 . . . . 0.0 110.906 -174.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.47 120.89 24.5 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.62 17.72 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 122.02 0.914 . . . . 0.0 111.444 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 28.1 m -127.39 131.31 50.35 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.52 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.4 tp -102.85 126.31 49.94 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.819 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.41 107.66 19.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 46.4 t -93.37 108.18 20.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.611 -178.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -133.77 124.71 27.08 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.3 t -174.98 -175.17 0.84 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -87.02 -15.29 39.11 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -94.93 -24.53 16.93 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.535 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.64 103.73 3.96 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.8 m -105.02 111.77 24.67 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 71.06 33.58 2.03 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.796 0.838 . . . . 0.0 113.238 169.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.414 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 16.2 m -93.31 109.44 20.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.512 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.0 mt -100.55 125.77 54.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.7 tp -140.69 129.36 22.89 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.942 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 4.2 mp0 -69.39 135.92 50.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.78 -19.54 6.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.21 -176.74 16.34 Favored Glycine 0 N--CA 1.433 -1.548 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.482 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 37.4 Cg_endo -68.07 129.01 18.59 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.688 2.259 . . . . 0.0 111.625 178.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.8 m -97.26 165.03 2.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.468 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.3 t -147.99 155.54 41.65 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 53.8 ttp -90.73 134.65 34.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.33 -28.52 15.52 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.308 0.575 . . . . 0.0 110.086 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.4 -87.25 1.17 Allowed Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -137.24 133.22 34.85 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.2 tp -132.15 156.41 42.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -106.41 115.26 29.91 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.09 90.82 4.29 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.4 m 53.32 72.7 0.41 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.793 0.837 . . . . 0.0 111.51 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.0 m 61.85 16.61 8.13 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.365 0.666 . . . . 0.0 112.411 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.2 m -121.25 107.8 36.78 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -80.2 128.77 7.41 Favored 'Trans proline' 0 C--O 1.254 1.294 0 C-N-CA 122.332 2.021 . . . . 0.0 112.018 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 m -131.06 131.1 44.02 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -99.19 162.92 12.78 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.511 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 8.0 mpt_? 66.82 35.72 4.84 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.579 1.152 . . . . 0.0 110.749 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 95.6 mmm -94.23 139.76 30.63 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.949 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 170' ' ' SER . 3.0 tt -116.38 140.42 38.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 124.649 1.179 . . . . 0.0 109.102 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -121.53 143.83 49.05 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.054 0.542 . . . . 0.0 110.767 -171.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -152.95 152.41 31.41 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 122.95 0.5 . . . . 0.0 111.049 172.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -89.58 105.42 17.78 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.308 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -172.49 132.85 0.61 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 125.05 1.34 . . . . 0.0 108.479 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.13 100.63 5.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.353 0.597 . . . . 0.0 109.651 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.2 p -79.83 137.58 36.99 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.665 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 93.4 mttt -93.03 108.69 20.21 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.2 m -53.79 129.43 33.45 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.595 0.758 . . . . 0.0 111.692 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 134.25 -18.63 4.17 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -100.74 34.1 2.56 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.373 0.606 . . . . 0.0 112.101 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 25' ' ' PHE . 66.6 m -65.8 117.26 7.95 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.304 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 26' ' ' THR . . . 109.88 5.57 29.02 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.07 134.82 37.05 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.63 115.5 18.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.183 0.516 . . . . 0.0 111.149 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.61 108.87 21.17 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.6 p -142.0 179.25 6.99 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 120.907 0.384 . . . . 0.0 111.911 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.09 178.88 8.54 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.8 t -64.77 102.32 0.57 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.999 0.904 . . . . 0.0 111.843 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.08 73.65 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.416 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -145.27 120.6 10.25 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 81.7 mt -108.28 128.9 63.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 171.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.49 -47.56 6.21 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.413 0.625 . . . . 0.0 110.3 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.469 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 171.65 -149.37 11.95 Favored Glycine 0 N--CA 1.417 -2.61 0 C-N-CA 119.932 -1.127 . . . . 0.0 111.899 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.8 pt -130.59 142.19 44.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -73.87 125.74 28.87 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.7 m -107.81 -46.0 7.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.303 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 169' ' ' PHE . . . -157.26 136.47 4.91 Favored Glycine 0 CA--C 1.487 -1.697 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.072 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.3 140.64 11.05 Favored Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -123.95 132.15 53.67 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.79 -108.33 2.07 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.922 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 47.4 mtt180 -113.29 12.17 18.82 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -118.55 132.76 56.2 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.023 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -104.3 120.84 6.78 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 99.4 m-85 -109.11 117.08 33.22 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.19 0.995 . . . . 0.0 109.424 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 135' ' ' ILE . 18.5 m -117.6 164.28 15.17 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.079 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.08 139.61 49.74 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 3.4 pt20 -90.23 131.67 35.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.784 0.802 . . . . 0.0 110.927 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.469 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -94.26 85.06 4.53 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.305 175.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.428 ' HE3' ' OE2' ' A' ' 92' ' ' GLU . 57.2 mtpt -54.05 134.49 43.77 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.13 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.414 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 16.7 ptmt -72.17 -19.37 61.76 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.29 -174.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.463 ' HA ' HG13 ' A' ' 179' ' ' VAL . 13.4 mm100 -67.93 -9.66 47.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.281 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -89.11 -21.52 23.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.761 0.315 . . . . 0.0 110.2 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -109.68 -28.83 8.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.281 0.563 . . . . 0.0 111.839 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.463 HG13 ' HA ' ' A' ' 176' ' ' GLN . 11.0 p -75.3 167.25 2.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.218 0.532 . . . . 0.0 109.996 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -76.87 -4.41 43.61 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 124.705 1.202 . . . . 0.0 110.064 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -103.05 138.92 39.27 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.241 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 . . . . . 0 C--N 1.287 -2.133 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 174.274 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo . . . . . 0 N--CA 1.471 0.197 0 CA-C-O 121.606 0.586 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -66.92 -39.29 87.32 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.417 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 m -67.89 -44.47 76.93 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.688 0.795 . . . . 0.0 110.237 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -68.53 -36.31 78.66 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.451 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -63.17 -42.72 99.45 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.772 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.47 83.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.251 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.3 tp -69.96 -32.76 71.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.371 0.605 . . . . 0.0 110.504 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.4 m -76.9 -37.28 55.73 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.643 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.2 tp -68.44 -34.53 76.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.4 tp -54.09 -55.66 25.47 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.909 0.884 . . . . 0.0 111.568 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -72.97 -17.5 61.46 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.084 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -61.66 1.63 Allowed 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.95 -172.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -124.97 9.35 8.13 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -171.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 65.0 mt -110.81 134.72 52.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.706 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.65 167.38 23.93 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.833 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 m -92.49 125.97 37.37 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.1 mt -113.59 123.24 69.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.564 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 9.7 m -84.99 98.63 10.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.6 p -99.93 -170.25 1.86 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 30.1 t -71.53 -33.98 69.64 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.851 0.358 . . . . 0.0 110.495 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -75.59 -26.02 57.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.39 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.08 -171.3 30.06 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.493 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 19' ' ' THR . 36.2 mt-10 -91.75 104.19 16.67 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -114.02 -169.7 1.57 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.003 -174.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.54 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 10.9 m -92.05 128.9 38.07 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.965 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.94 127.23 7.71 Favored Glycine 0 N--CA 1.421 -2.312 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 174.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.4 tp -103.45 122.85 45.75 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.66 137.19 18.47 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.436 HG13 ' CE1' ' A' ' 178' ' ' PHE . 47.4 mm -97.66 -55.87 5.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -164.08 150.61 11.42 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.4 t70 58.29 -98.67 0.09 Allowed 'General case' 0 C--O 1.213 -0.839 0 O-C-N 124.21 0.944 . . . . 0.0 112.113 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.44 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 7.5 mpt_? -129.02 9.34 5.74 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.4 t -83.4 118.61 31.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.378 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.6 t -123.48 169.8 11.03 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.12 141.1 39.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.4 tp -151.15 150.59 27.65 Favored Pre-proline 0 CA--C 1.572 1.817 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.12 159.87 44.64 Favored 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 122.341 2.027 . . . . 0.0 112.771 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.8 m -82.01 -48.51 11.35 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -66.89 -8.48 29.52 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.38 -23.31 61.87 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 96.6 mt-30 58.85 84.01 0.21 Allowed Pre-proline 0 C--O 1.252 1.198 0 C-N-CA 125.601 1.561 . . . . 0.0 113.103 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -88.53 136.28 3.23 Favored 'Trans proline' 0 N--CA 1.438 -1.791 0 C-N-CA 122.816 2.344 . . . . 0.0 109.558 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.34 -176.83 51.61 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.91 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -75.03 -25.4 58.69 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.441 1.115 . . . . 0.0 108.042 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -129.5 138.38 51.35 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.89 167.28 16.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 41.8 mt -100.93 114.33 28.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.16 109.5 23.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.4 m120 61.78 23.8 14.05 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.544 0.688 . . . . 0.0 110.976 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 -13.68 63.55 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.564 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -85.15 128.21 34.57 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.442 0.697 . . . . 0.0 109.779 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.31 128.92 37.82 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.57 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.6 tp -144.53 150.24 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -105.64 147.99 27.86 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.934 0.397 . . . . 0.0 109.968 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.3 129.9 43.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -79.87 -53.17 7.02 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -132.73 133.74 43.87 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.222 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.78 110.42 12.15 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.927 -174.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -111.29 99.34 8.18 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -75.63 102.41 5.32 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.463 HD21 ' CD1' ' A' ' 177' ' ' TYR . 41.4 tp -97.29 105.02 17.1 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 122.078 0.942 . . . . 0.0 112.415 -167.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.39 -179.85 3.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.532 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 11.8 t70 -79.87 137.34 54.07 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -42.02 -34.73 2.79 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 124.306 3.337 . . . . 0.0 114.014 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.06 22.06 1.25 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 71.43 18.14 5.58 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.186 0.994 . . . . 0.0 112.857 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 55.6 mt -84.93 132.87 30.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 131' ' ' THR . 3.6 m-20 -80.91 126.19 31.05 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -170.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.1 tp -99.06 -15.74 18.92 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 169.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 60.89 30.16 19.47 Favored 'General case' 0 C--N 1.363 1.154 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.854 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 18.7 tp -124.91 144.23 50.44 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.886 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.7 m -137.5 122.48 18.99 Favored 'General case' 0 C--N 1.286 -2.193 0 O-C-N 121.894 -0.504 . . . . 0.0 109.762 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.3 t -101.68 131.19 50.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -139.38 140.92 37.57 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.665 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.5 m -97.44 107.46 19.98 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.44 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 15.6 tp -86.45 143.14 27.92 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -175.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.57 ' O ' HD11 ' A' ' 54' ' ' ILE . 38.0 t70 -84.64 80.91 9.08 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 119.266 -0.974 . . . . 0.0 112.057 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -120.22 142.65 48.82 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -61.32 -59.88 4.61 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -70.92 149.36 46.81 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -101.01 149.85 23.51 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.967 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -81.12 145.81 30.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.3 tpt85 -70.52 128.93 37.84 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -61.47 96.72 0.06 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.469 0.652 . . . . 0.0 111.368 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -92.44 20.71 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 122.095 0.95 . . . . 0.0 109.538 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -73.95 -35.06 64.51 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.959 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.5 -5.37 85.83 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.992 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -103.55 5.74 36.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.484 0.659 . . . . 0.0 109.639 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.3 mt -74.81 133.6 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.6 t -111.03 100.62 9.27 Favored 'General case' 0 N--CA 1.396 -3.158 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -87.6 1.6 53.21 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.913 0.863 . . . . 0.0 110.131 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.82 112.27 24.17 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 168.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.2 mt -116.56 -61.11 1.77 Allowed 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.581 0.705 . . . . 0.0 112.029 -168.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 33.4 tt0 -63.69 123.2 18.27 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.355 -168.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.13 -11.66 51.95 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.13 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.9 t -95.65 142.36 13.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -77.46 128.84 34.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -122.7 151.51 41.47 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.753 0.787 . . . . 0.0 111.22 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 m -116.02 135.38 54.01 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.948 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 160' ' ' HIS . 2.4 tm? -97.01 111.45 23.67 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -107.58 105.72 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.8 p -111.59 130.36 65.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-O 121.217 0.532 . . . . 0.0 110.966 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.41 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 75.3 t60 -130.92 92.19 3.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.065 0.936 . . . . 0.0 108.657 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.1 m -115.42 -175.27 2.67 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -69.69 -36.81 76.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -77.89 -60.07 2.52 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.817 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -84.9 87.06 7.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.778 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.6 p -80.66 88.86 5.72 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.361 0.6 . . . . 0.0 112.347 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.41 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 28.8 t-20 58.97 70.2 0.67 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.43 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 33.1 m -97.13 108.41 21.13 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 69.2 mt -98.29 100.34 10.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.0 tp -113.63 115.25 27.61 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.728 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.53 120.89 19.75 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.9 m -102.13 -20.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.3 -158.87 14.08 Favored Glycine 0 N--CA 1.432 -1.622 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.152 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.14 127.08 9.01 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.849 2.366 . . . . 0.0 111.944 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 20.9 m -89.42 149.46 4.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.751 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.3 p -128.21 166.01 19.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.362 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.5 ttt -98.46 127.05 44.22 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.688 -0.632 . . . . 0.0 111.187 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.02 -52.13 5.61 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.09 -122.99 7.7 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 131' ' ' THR . 6.0 tt -111.29 112.02 23.5 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 124' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.293 -1.883 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 N--CA 1.447 -1.231 0 CA-C-O 121.313 0.464 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.536 ' HB ' ' SD ' ' A' ' 134' ' ' MET . 18.4 p -117.4 132.83 56.5 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.857 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.403 ' HB2' HG21 ' A' ' 68' ' ' ILE . 50.8 t30 -123.3 132.07 53.88 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -176.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 74.63 47.97 0.12 Allowed 'General case' 0 C--O 1.239 0.533 0 O-C-N 124.801 1.313 . . . . 0.0 111.825 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.536 ' SD ' ' HB ' ' A' ' 131' ' ' THR . 0.1 OUTLIER -97.64 139.28 33.77 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.253 174.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.606 HG23 ' HB3' ' A' ' 170' ' ' SER . 3.4 tt -101.43 130.07 51.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -128.09 132.13 49.01 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.343 0.592 . . . . 0.0 111.128 -171.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.433 ' HB3' HG12 ' A' ' 118' ' ' VAL . 16.3 p90 -120.62 134.13 55.31 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.188 175.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 166' ' ' ARG . 10.7 t70 -83.95 96.31 8.8 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -156.45 124.15 5.51 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.868 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -64.5 99.7 0.32 Allowed 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 124.175 0.922 . . . . 0.0 109.44 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.2 t -105.61 147.31 28.59 Favored 'General case' 0 N--CA 1.407 -2.576 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.365 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -87.28 94.19 9.6 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.1 t -45.76 143.83 1.92 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 124.548 1.139 . . . . 0.0 113.526 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.19 -2.27 2.31 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.079 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -90.3 40.29 1.0 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.719 0.408 . . . . 0.0 112.071 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 74.8 m -60.97 117.31 5.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.175 0.512 . . . . 0.0 110.954 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.54 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 101.45 2.28 53.56 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.68 122.96 31.43 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 112.203 -0.359 . . . . 0.0 112.203 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.581 HG12 ' SG ' ' A' ' 151' ' ' CYS . 54.3 t -74.15 108.1 5.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 124.005 0.922 . . . . 0.0 109.264 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.2 tp -88.67 104.17 16.62 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.669 ' SG ' HG13 ' A' ' 156' ' ' ILE . 84.0 m -145.49 174.92 10.73 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -173.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.31 -177.4 5.74 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.6 m -59.53 102.39 0.14 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.035 0.445 . . . . 0.0 111.819 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.91 26.64 72.18 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.18 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -141.4 105.56 4.8 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.669 HG13 ' SG ' ' A' ' 151' ' ' CYS . 2.5 mp -91.81 119.88 39.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -92.24 -34.88 14.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.974 0.892 . . . . 0.0 109.809 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.73 -156.35 27.52 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.6 pt -134.19 140.81 45.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.779 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.573 ' HB2' HD21 ' A' ' 101' ' ' LEU . 20.9 t60 -67.96 105.42 2.0 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.41 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.41 -38.39 13.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.42 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.49 87.8 0.07 OUTLIER Glycine 0 N--CA 1.426 -2.019 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.649 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.88 155.67 21.22 Favored Glycine 0 N--CA 1.428 -1.847 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -151.77 135.21 16.09 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 65.97 -133.26 34.24 Favored Glycine 0 C--N 1.313 -0.74 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 99.2 mtt180 -87.21 6.17 34.46 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -117.05 101.72 8.72 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.86 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -85.31 107.37 3.09 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -93.31 118.91 31.84 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.777 0.799 . . . . 0.0 111.751 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.606 ' HB3' HG23 ' A' ' 135' ' ' ILE . 30.9 t -120.12 151.09 39.57 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.398 -1.273 . . . . 0.0 107.578 176.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.3 142.72 27.45 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -80.42 105.63 11.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 123.869 0.73 . . . . 0.0 110.575 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.03 88.09 7.45 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -90.51 151.06 21.52 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -60.17 -26.61 66.45 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -50.4 -37.11 35.91 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.36 1.064 . . . . 0.0 112.094 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.463 ' CD1' HD21 ' A' ' 62' ' ' LEU . 46.7 m-85 -75.86 -17.82 59.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.991 0.424 . . . . 0.0 111.846 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.436 ' CE1' HG13 ' A' ' 30' ' ' ILE . 73.9 m-85 -109.51 8.79 25.31 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.46 -174.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 83.0 t . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 174.619 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 N--CA 1.475 0.436 0 N-CA-C 112.663 0.217 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.21 -38.83 91.66 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.256 0.55 . . . . 0.0 110.036 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 m -71.77 -41.38 68.42 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.199 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.15 -49.27 78.52 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.225 0.61 . . . . 0.0 111.207 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -63.78 -44.41 93.47 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.082 0.468 . . . . 0.0 110.845 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.07 -41.92 90.1 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.594 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.0 tp -66.79 -33.51 75.78 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.092 0.557 . . . . 0.0 111.428 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -78.51 -46.05 20.49 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 120.749 0.309 . . . . 0.0 110.299 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.7 tp -55.82 -35.67 66.61 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.952 0.901 . . . . 0.0 109.835 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.434 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 50.7 tp -52.68 -50.02 64.13 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.473 1.509 . . . . 0.0 112.791 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -81.05 -22.79 39.03 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.386 0.612 . . . . 0.0 110.738 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -91.0 -46.55 8.08 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.056 -169.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -128.73 3.27 5.46 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 53.8 mt -115.83 137.15 50.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.464 -176.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.82 169.4 21.78 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.905 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 94.8 m -98.23 123.15 42.16 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 65.5 mt -110.56 115.52 50.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 11.4 m -88.57 103.81 16.25 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.673 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 81.6 p -89.87 -165.8 1.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.865 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -69.42 -19.69 63.79 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.221 0.534 . . . . 0.0 110.127 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -97.7 -45.07 6.5 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.83 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.31 -179.73 48.49 Favored Glycine 0 CA--C 1.497 -1.031 0 C-N-CA 119.242 -1.456 . . . . 0.0 112.592 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 2.8 mp0 -78.27 107.94 11.24 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.481 ' HB3' ' O ' ' A' ' 146' ' ' CYS . 26.5 m-85 -117.01 -177.57 3.23 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 33.0 m -97.34 138.37 34.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.14 143.23 16.02 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 tp -113.56 122.0 45.92 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.31 110.21 3.54 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 175.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.1 mm -71.77 -51.27 33.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 122.354 0.262 . . . . 0.0 110.963 -174.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -170.85 147.33 2.71 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.449 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 38.1 t70 60.53 -81.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.968 1.307 . . . . 0.0 112.943 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.57 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 14.4 ptp180 -149.85 13.19 0.8 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.769 0.795 . . . . 0.0 110.246 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.44 113.79 26.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.68 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.7 m -120.12 156.13 31.66 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -137.44 144.65 31.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 117.885 0.311 . . . . 0.0 110.544 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.521 HG22 HD21 ' A' ' 75' ' ' LEU . 14.7 tt -157.12 146.7 15.3 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 6.8 Cg_endo -51.45 141.41 41.56 Favored 'Trans proline' 0 C--N 1.363 1.304 0 C-N-CA 122.907 2.405 . . . . 0.0 113.393 177.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.3 m -57.07 -48.19 79.15 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.929 0.892 . . . . 0.0 113.123 -176.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -66.75 -1.5 3.92 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.47 -25.08 60.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.673 ' O ' ' HB ' ' A' ' 20' ' ' THR . 29.4 mm-40 61.6 82.43 0.22 Allowed Pre-proline 0 N--CA 1.467 0.396 0 C-N-CA 125.462 1.505 . . . . 0.0 114.425 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -85.17 124.75 2.92 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.793 2.329 . . . . 0.0 109.984 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.96 -125.51 0.67 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.776 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -96.11 -59.77 1.77 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.616 0.722 . . . . 0.0 109.293 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 42.4 p-10 -124.19 125.5 44.53 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.449 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.84 148.18 16.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.532 -173.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 93.1 mt -79.93 102.14 9.02 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.938 0.399 . . . . 0.0 110.175 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 17' ' ' THR . 7.5 p -94.29 90.0 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 122.063 0.935 . . . . 0.0 109.055 176.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m120 62.39 8.1 2.64 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.934 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.43 -32.47 1.96 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.932 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -82.77 125.14 30.94 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -88.05 96.6 10.57 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 46' ' ' ASP . 10.4 tp -101.31 132.65 46.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.359 -171.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -82.44 121.52 26.85 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.095 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.419 HG11 HD12 ' A' ' 75' ' ' LEU . 55.8 t -84.06 132.93 30.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -79.31 -48.16 14.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.968 0.413 . . . . 0.0 110.963 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.26 138.71 31.58 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -115.47 98.65 6.85 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.462 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 80.0 m-85 -84.07 129.88 34.89 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.758 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -84.42 112.15 20.1 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 173.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 53.1 tp -90.31 99.0 12.1 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.539 0.685 . . . . 0.0 109.346 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.86 148.47 16.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.378 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.26 141.26 57.39 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.57 -3.22 0.55 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 123.944 3.096 . . . . 0.0 114.546 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.88 -2.86 41.84 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.0 t30 77.89 6.45 2.75 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 125.683 1.593 . . . . 0.0 111.273 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.574 ' HB ' ' ND2' ' A' ' 132' ' ' ASN . 50.9 mm -96.43 150.44 4.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 131' ' ' THR . 52.9 t30 -70.83 126.92 30.91 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -177.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 54.1 tp -92.08 -13.22 31.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 21.1 tp10 66.96 23.95 9.71 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.566 175.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.5 mt -117.42 135.19 54.06 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.563 -0.711 . . . . 0.0 111.753 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.5 m -114.38 130.25 56.68 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 94.1 t -102.04 120.47 51.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.521 HD21 HG22 ' A' ' 37' ' ' ILE . 2.4 mm? -103.51 127.11 50.97 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.392 -175.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 m -87.53 88.91 7.8 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.4 tt -89.99 124.26 34.6 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.409 ' O ' HD11 ' A' ' 54' ' ' ILE . 32.7 t70 -74.9 80.84 2.14 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-O 121.995 0.903 . . . . 0.0 110.275 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -100.41 131.57 46.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.31 -175.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -74.77 -24.49 58.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.586 0.708 . . . . 0.0 109.82 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -88.82 119.6 29.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.153 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -77.31 113.28 14.91 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -62.67 138.68 58.56 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -74.65 142.97 44.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 87' ' ' ARG . 10.0 t70 -67.66 99.06 0.75 Allowed 'General case' 0 C--N 1.311 -1.101 0 O-C-N 123.414 0.446 . . . . 0.0 111.535 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -90.65 19.14 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.781 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.493 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 85.3 mtm180 -71.44 -24.94 62.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.607 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.48 -19.22 79.64 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.817 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -93.54 -12.51 29.43 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.606 -0.349 . . . . 0.0 111.22 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.8 mt -64.76 120.93 12.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.318 0.58 . . . . 0.0 110.26 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 155' ' ' LYS . 5.7 p -105.67 112.56 25.69 Favored 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.712 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -84.43 -10.0 57.9 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.356 0.598 . . . . 0.0 110.316 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -85.76 117.74 24.82 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.5 mt -117.34 -53.71 2.43 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -168.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.18 115.11 5.18 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -167.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.88 1.29 58.62 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.524 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.17 160.49 2.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -73.33 155.12 39.75 Favored 'General case' 0 C--O 1.21 -0.981 0 C-N-CA 123.396 0.678 . . . . 0.0 109.605 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -159.05 152.22 22.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.759 0.79 . . . . 0.0 112.146 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.413 HG23 ' HA ' ' A' ' 114' ' ' GLU . 94.9 m -143.96 132.81 22.61 Favored 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 125.801 1.64 . . . . 0.0 107.916 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.2 tp -98.16 119.98 37.76 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.9 t -100.96 116.61 44.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.05 123.98 66.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.489 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 28.1 t60 -130.12 79.8 1.92 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.6 m -139.85 -165.81 1.96 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.83 -175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -71.42 -53.75 12.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -67.66 -39.6 84.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.13 0.49 . . . . 0.0 111.321 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -126.43 95.0 4.22 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.5 m -92.32 120.54 32.96 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.138 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.489 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 4.3 t30 61.97 42.89 9.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.858 0.837 . . . . 0.0 109.186 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.9 m -108.22 115.88 30.93 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.088 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 87.3 mt -90.09 109.19 20.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.3 tp -108.45 114.62 28.61 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 123.041 0.536 . . . . 0.0 109.983 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.413 ' HA ' HG23 ' A' ' 100' ' ' THR . 43.8 mt-10 -71.38 145.77 49.17 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.834 0.349 . . . . 0.0 111.781 -178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.5 t -115.47 -51.43 4.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.841 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 113.0 -121.56 5.58 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -98.29 135.4 0.33 Allowed 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 122.989 2.459 . . . . 0.0 113.044 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.4 m -103.63 155.53 5.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.899 -0.501 . . . . 0.0 112.278 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.446 ' O ' HG13 ' A' ' 135' ' ' ILE . 17.5 p -131.88 178.75 6.53 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.65 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 46.5 ttm -114.2 140.32 48.65 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 121.483 -0.76 . . . . 0.0 111.165 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -104.75 -53.64 2.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.36 -117.69 5.95 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.798 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.9 tp -96.14 114.78 26.51 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.201 0.6 . . . . 0.0 109.892 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 C--N 1.31 -1.129 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo . . . . . 0 C--O 1.243 0.729 0 N-CA-C 109.823 -0.876 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 20.8 p -127.21 128.97 46.93 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.179 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.574 ' ND2' ' HB ' ' A' ' 68' ' ' ILE . 41.8 p30 -110.25 171.07 7.67 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.715 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.493 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.9 mpt_? 67.32 23.8 9.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.813 0.845 . . . . 0.0 110.884 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.8 mmt -81.84 128.62 34.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.583 0.706 . . . . 0.0 111.687 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 170' ' ' SER . 3.4 tt -96.88 136.84 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.629 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 34.7 ttm180 -116.61 135.97 53.36 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.501 0.501 . . . . 0.0 111.097 -170.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.5 140.34 31.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.659 -0.496 . . . . 0.0 109.659 173.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.26 110.04 19.36 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -163.32 147.92 11.05 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.56 87.26 2.12 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.0 p -81.2 128.61 33.97 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.984 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -76.63 111.99 12.71 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.7 m -70.53 129.5 39.38 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.333 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 129.38 -37.38 2.2 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.601 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -75.37 52.03 0.59 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.077 0.951 . . . . 0.0 112.913 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 25' ' ' PHE . 56.9 m -63.4 147.86 50.07 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.395 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 93.53 1.25 66.37 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.749 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.98 129.56 38.35 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.6 109.2 8.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-O 121.195 0.521 . . . . 0.0 110.56 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.7 tp -89.33 99.71 12.65 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 23.4 p -126.82 -172.6 2.68 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.561 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -157.79 -169.57 2.89 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.417 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 20.7 p -62.79 96.02 0.08 Allowed 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.708 0.63 . . . . 0.0 110.849 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.23 25.17 76.05 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.549 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 39.1 mttp -142.56 154.78 44.75 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 117.279 0.54 . . . . 0.0 109.665 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 151' ' ' CYS . 86.4 mt -137.22 128.17 40.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -100.25 -43.81 6.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.623 0.725 . . . . 0.0 110.23 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 172.92 -154.59 21.1 Favored Glycine 0 N--CA 1.416 -2.668 0 C-N-CA 120.283 -0.961 . . . . 0.0 111.14 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.6 pt -131.98 143.31 40.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 120.567 0.222 . . . . 0.0 110.628 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -58.58 126.2 26.61 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.352 1.061 . . . . 0.0 110.691 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.1 t -110.08 -63.88 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.32 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.44 108.79 0.61 Allowed Glycine 0 N--CA 1.421 -2.312 0 C-N-CA 119.901 -1.143 . . . . 0.0 112.293 -175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.94 115.0 4.37 Favored Glycine 0 N--CA 1.427 -1.954 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 175.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -114.74 97.61 6.37 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.487 0.661 . . . . 0.0 110.502 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.13 -98.49 0.64 Allowed Glycine 0 N--CA 1.425 -2.034 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.654 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 6.4 mpt_? -110.98 -0.7 16.62 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.619 -0.291 . . . . 0.0 111.055 -174.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -119.18 120.62 37.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.602 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.28 120.77 5.84 Favored Glycine 0 N--CA 1.418 -2.538 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -108.14 118.67 37.35 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.574 0.702 . . . . 0.0 109.931 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.546 ' HB2' HG23 ' A' ' 135' ' ' ILE . 28.6 m -115.83 157.5 24.33 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.693 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -98.81 132.54 44.09 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 10.8 pt20 -87.64 103.3 15.44 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.947 0.88 . . . . 0.0 110.655 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.434 ' H ' HD13 ' A' ' 173' ' ' LEU 0.337 0.0 OUTLIER -85.11 79.79 9.47 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.18 0.991 . . . . 0.0 111.716 177.155 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -57.86 145.01 36.75 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.526 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.486 ' O ' HG23 ' A' ' 179' ' ' VAL . 20.2 ptmt -56.13 -25.41 45.96 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.358 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -58.66 -29.99 67.0 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.843 0.857 . . . . 0.0 112.311 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -74.81 -20.5 59.75 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.112 0.482 . . . . 0.0 110.78 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -101.68 11.14 39.35 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.501 0.667 . . . . 0.0 109.498 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 175' ' ' LYS . 92.5 t . . . . . 0 N--CA 1.425 -1.708 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo . . . . . 0 CA--C 1.536 0.592 0 N-CA-C 112.935 0.321 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -69.51 -40.64 76.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.66 -40.59 97.24 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.931 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -64.23 -40.05 95.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.857 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.18 -42.91 93.17 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.126 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.96 82.27 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.112 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.87 -35.68 80.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -82.84 -37.4 24.44 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.877 -0.514 . . . . 0.0 111.332 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.02 -41.17 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.404 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 54.5 tp -53.51 -51.42 62.88 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.638 1.175 . . . . 0.0 112.335 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -70.54 -12.82 61.82 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -125.38 -42.01 2.0 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -106.46 -18.06 14.09 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -169.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.404 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 46.5 mt -89.16 105.36 15.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.29 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.2 mtp -105.45 140.22 38.88 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.325 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 m -99.38 116.03 30.59 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.3 mt -111.02 118.48 57.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.352 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 99.8 m -85.4 109.12 18.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.623 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 73.3 p -96.02 -157.54 0.59 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.505 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.5 m -84.01 3.31 34.96 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 121.193 0.521 . . . . 0.0 109.946 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -115.66 -39.52 3.51 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.158 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.61 -153.14 23.99 Favored Glycine 0 CA--C 1.498 -1.022 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -92.76 115.58 28.24 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.263 0.554 . . . . 0.0 110.823 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -116.48 169.6 9.2 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 57.6 m -98.54 127.8 44.62 Favored 'General case' 0 N--CA 1.41 -2.443 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.268 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.68 129.44 9.29 Favored Glycine 0 N--CA 1.412 -2.956 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -100.08 116.43 32.09 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.023 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.6 113.98 4.66 Favored Glycine 0 C--O 1.212 -1.253 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.536 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.1 mm -90.87 -50.64 12.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 116.964 0.382 . . . . 0.0 111.593 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -156.09 121.22 4.75 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.831 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.441 ' OD1' ' HG3' ' A' ' 82' ' ' LYS . 28.9 t70 67.18 -79.98 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.148 0.905 . . . . 0.0 113.266 168.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -140.46 11.88 2.33 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.794 0.838 . . . . 0.0 109.54 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.435 HG13 HG13 ' A' ' 74' ' ' VAL . 87.4 t -91.95 115.22 30.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.305 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -120.78 139.22 53.43 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.4 t -114.64 135.27 55.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 120.581 0.229 . . . . 0.0 111.082 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.5 tt -146.54 145.03 21.98 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 59.9 Cg_exo -57.8 138.91 88.41 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.465 2.11 . . . . 0.0 112.415 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.677 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 21.5 m -60.94 -41.69 96.76 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -71.01 -0.27 9.03 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.91 -15.5 60.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.623 ' O ' ' HB ' ' A' ' 20' ' ' THR . 82.8 mm-40 60.44 82.0 0.23 Allowed Pre-proline 0 CA--C 1.518 -0.283 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 175.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.19 158.98 11.33 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.46 2.107 . . . . 0.0 109.579 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.36 -141.55 11.1 Favored Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.446 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -88.21 -15.22 36.53 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.02 151.77 39.07 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.13 153.98 39.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 7.2 mp -103.57 105.4 15.63 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.829 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.51 92.97 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.8 t30 66.09 8.24 5.34 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.596 1.558 . . . . 0.0 110.564 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.63 -24.83 3.31 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.66 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 46.5 mt-30 -75.12 106.73 6.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.594 0.197 . . . . 0.0 111.062 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -68.9 103.53 1.83 Allowed 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.4 tp -112.06 121.46 64.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-O 121.241 0.543 . . . . 0.0 109.693 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -75.48 110.32 9.77 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.9 t -65.9 135.4 28.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.58 -63.14 1.31 Allowed 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -144.77 144.46 31.19 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -108.14 111.0 22.79 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.503 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 61.9 m-85 -96.59 113.18 24.72 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -77.15 114.18 15.68 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -88.92 94.86 10.09 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.1 t -112.33 149.29 14.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -65.48 142.08 98.22 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.56 -22.55 17.06 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.498 2.799 . . . . 0.0 114.193 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -94.83 14.45 21.39 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 122.058 0.933 . . . . 0.0 109.761 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 66.54 26.69 9.85 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.61 1.164 . . . . 0.0 111.943 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.407 HG21 ' HB2' ' A' ' 132' ' ' ASN . 34.8 mm -86.3 137.27 21.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 131' ' ' THR . 63.3 t30 -92.13 135.0 34.33 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.811 -171.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -123.01 2.45 9.33 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.701 172.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.677 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 4.9 tp10 62.84 23.35 13.94 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.179 1.392 . . . . 0.0 111.864 174.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.7 tt -95.8 120.89 36.87 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 121.666 -0.646 . . . . 0.0 110.141 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 m -114.89 127.39 55.67 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 60.8 t -99.74 107.75 21.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.5 mt -95.69 117.76 31.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.9 m -97.6 103.69 15.65 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -78.17 141.04 38.95 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.257 0.551 . . . . 0.0 111.479 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -91.32 83.25 5.45 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.574 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 11.0 mmm180 -134.06 175.14 9.75 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.806 -174.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -108.33 -28.6 9.32 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 123.325 0.391 . . . . 0.0 111.073 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.574 ' OE1' ' HB3' ' A' ' 79' ' ' ARG . 1.5 pm0 -70.4 127.25 32.11 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-O 121.281 0.562 . . . . 0.0 111.192 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.441 ' HG3' ' OD1' ' A' ' 32' ' ' ASP . 41.4 tttp -92.33 109.54 20.92 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -73.35 139.39 45.97 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.586 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -49.94 123.19 7.68 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.525 1.13 . . . . 0.0 110.001 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -81.49 114.73 20.41 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.892 178.503 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.9 pt -93.8 25.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.997 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -68.3 -27.02 65.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.911 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.73 -9.23 86.45 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.252 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -100.86 -8.97 22.07 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.77 124.51 22.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.5 t -113.3 114.25 26.42 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.452 ' OE2' ' HG3' ' A' ' 176' ' ' GLN . 45.8 mt-10 -84.47 -20.25 32.02 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.233 0.539 . . . . 0.0 110.186 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -90.04 123.74 34.18 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 170.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.469 ' HB3' HD12 ' A' ' 135' ' ' ILE . 8.7 mt -113.93 -56.75 2.36 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.981 0.896 . . . . 0.0 111.228 -168.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 119' ' ' THR . 35.1 tt0 -59.68 126.53 27.98 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.618 -170.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.78 -27.1 8.07 Favored Glycine 0 N--CA 1.436 -1.304 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.117 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.02 156.82 3.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 120.834 0.349 . . . . 0.0 110.384 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -89.21 143.67 26.67 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.71 162.25 33.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.658 0.742 . . . . 0.0 112.097 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 88.3 m -124.93 141.62 52.0 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.904 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -107.88 120.87 43.5 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 111' ' ' THR . 37.8 t -116.51 111.32 34.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 120.894 0.378 . . . . 0.0 110.059 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.4 p -113.21 141.04 30.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -133.45 95.72 3.56 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.725 0.774 . . . . 0.0 109.37 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.2 t -104.44 -172.86 2.18 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -88.59 -42.84 11.8 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.54 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -70.44 -49.48 48.25 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -95.57 79.44 3.39 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.9 m -79.96 107.83 13.05 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.171 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.0 t30 58.77 71.82 0.56 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.016 0.926 . . . . 0.0 113.02 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 22.7 m -98.77 107.74 20.26 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.9 mt -95.62 94.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.404 HD21 ' CE2' ' A' ' 139' ' ' TYR . 65.1 tp -103.76 114.43 28.69 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.636 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.56 96.38 6.8 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.08 -35.82 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.979 -176.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.419 ' HA3' ' HD3' ' A' ' 117' ' ' PRO . . . 113.4 -135.17 12.38 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.579 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.419 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 3.1 Cg_exo -77.95 130.01 10.15 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 123.038 2.492 . . . . 0.0 112.345 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.566 ' HB ' HD11 ' A' ' 135' ' ' ILE . 31.2 m -105.57 138.23 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-O 121.531 0.682 . . . . 0.0 111.129 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . 30.4 m -122.59 145.52 48.27 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.019 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 57.9 ttp -83.45 122.0 27.93 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -82.36 -32.61 29.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.121 0.486 . . . . 0.0 111.364 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.78 -86.59 1.51 Allowed Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -152.03 138.27 18.38 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.9 mm . . . . . 0 C--N 1.301 -1.504 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.753 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo . . . . . 0 N--CA 1.434 -1.998 0 N-CA-C 109.574 -0.971 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.525 ' HB ' ' SD ' ' A' ' 134' ' ' MET . 33.3 p -107.59 102.76 11.99 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-O 121.764 0.792 . . . . 0.0 110.226 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.407 ' HB2' HG21 ' A' ' 68' ' ' ILE . 46.2 t30 -103.65 164.0 11.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -178.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.402 ' HD3' ' OH ' ' A' ' 177' ' ' TYR . 46.1 mtt180 67.81 38.12 2.99 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.736 0.814 . . . . 0.0 109.437 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.525 ' SD ' ' HB ' ' A' ' 131' ' ' THR . 57.1 mtt -119.24 164.23 15.94 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-O 121.798 0.809 . . . . 0.0 113.105 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.566 HD11 ' HB ' ' A' ' 118' ' ' VAL . 12.9 tt -123.15 151.42 27.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 124.712 1.205 . . . . 0.0 108.317 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -128.29 142.56 51.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.067 0.46 . . . . 0.0 111.889 -174.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -144.56 137.34 26.72 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.892 169.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.96 104.65 16.48 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.792 0.806 . . . . 0.0 111.662 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.404 ' CE2' HD21 ' A' ' 113' ' ' LEU . 56.8 t80 -162.56 138.07 7.12 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 125.808 1.643 . . . . 0.0 107.45 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.04 98.97 2.64 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.5 m -53.03 138.51 30.45 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 124.951 1.3 . . . . 0.0 112.836 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 145' ' ' GLN . 62.8 tttp -99.85 140.22 34.37 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.7 m -63.92 139.12 58.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 122.529 0.332 . . . . 0.0 110.263 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.34 33.47 9.4 Favored Glycine 0 C--O 1.219 -0.823 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 14.8 tp60 -116.89 -6.13 11.49 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.603 0.716 . . . . 0.0 109.432 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.41 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 42.2 t -69.78 129.0 38.37 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.704 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.405 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 100.34 -7.66 58.39 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.095 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.75 140.28 42.22 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.526 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.34 120.67 35.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.729 0.776 . . . . 0.0 110.774 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 42.3 tp -88.2 106.04 17.93 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.0 p -140.99 168.67 19.23 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.747 0.784 . . . . 0.0 112.577 -172.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.54 -179.1 6.71 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.4 t -57.41 101.22 0.06 Allowed 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.938 0.875 . . . . 0.0 111.937 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.3 14.88 74.52 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.275 -1.33 . . . . 0.0 113.092 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -135.64 108.74 7.69 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 117.251 0.526 . . . . 0.0 111.045 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.13 126.26 57.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -97.87 -33.63 11.16 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 123.896 0.747 . . . . 0.0 110.959 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 165.54 -159.85 33.11 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 119.441 -1.361 . . . . 0.0 112.675 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.561 HG23 HD11 ' A' ' 173' ' ' LEU . 19.6 pt -121.86 137.75 54.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -69.34 125.96 28.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.0 p -96.69 -46.7 12.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.316 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.77 156.34 11.36 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -131.08 156.73 21.91 Favored Glycine 0 N--CA 1.428 -1.852 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.528 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -154.95 144.16 21.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.97 -122.68 5.9 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -117.84 13.21 14.03 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -121.43 136.88 54.91 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.017 0.437 . . . . 0.0 111.971 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -106.94 130.14 10.03 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -112.44 140.71 46.95 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.198 0.523 . . . . 0.0 109.96 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.528 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 18.6 m -131.15 154.7 48.07 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.41 139.56 30.56 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.67 116.35 19.8 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 123.37 0.419 . . . . 0.0 110.964 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.561 HD11 HG23 ' A' ' 159' ' ' ILE . 81.9 mt -89.02 94.38 9.93 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -84.08 140.66 31.67 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.093 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -69.16 -20.84 64.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.442 0.639 . . . . 0.0 109.6 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.452 ' HG3' ' OE2' ' A' ' 92' ' ' GLU . 69.4 mt-30 -58.21 -21.75 49.07 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.506 1.523 . . . . 0.0 112.23 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.402 ' OH ' ' HD3' ' A' ' 133' ' ' ARG . 34.6 m-85 -86.99 -23.42 25.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.93 0.395 . . . . 0.0 110.726 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.406 ' CG ' HG21 ' A' ' 30' ' ' ILE . 49.2 m-85 -106.5 18.72 21.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.154 0.502 . . . . 0.0 112.017 -169.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--N 1.296 -1.73 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.629 176.477 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo . . . . . 0 N--CA 1.483 0.903 0 CA-C-O 121.617 0.59 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -61.21 -37.27 82.39 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.057 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.4 m -64.52 -37.43 87.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.506 0.722 . . . . 0.0 109.608 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.35 -44.83 82.18 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.915 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.83 -45.98 88.75 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.944 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.424 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -62.02 -43.48 98.75 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.02 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.84 -37.7 85.45 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 123.346 0.658 . . . . 0.0 110.438 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 m -76.41 -31.62 58.03 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.527 0.679 . . . . 0.0 110.325 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -73.69 -31.14 63.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.303 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 62.2 tp -51.68 -56.32 14.37 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.436 1.094 . . . . 0.0 112.05 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -83.02 10.26 8.41 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.221 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -117.91 -59.79 1.87 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -122.72 -6.81 8.56 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 50.5 mt -89.19 103.32 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 mmt -115.58 126.03 53.7 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.25 0.548 . . . . 0.0 111.002 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 24' ' ' GLU . 2.4 m -70.2 96.82 1.13 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.864 177.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 58.5 mt -89.86 111.9 23.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 121.16 0.505 . . . . 0.0 109.908 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.8 m -86.5 107.6 18.17 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 80.5 p -89.74 -157.75 0.48 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.776 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 t -85.57 -9.45 57.32 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -106.3 -38.06 6.35 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.03 -160.4 27.45 Favored Glycine 0 CA--C 1.493 -1.326 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.804 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HB3' HG22 ' A' ' 17' ' ' THR . 7.8 mp0 -99.86 112.27 24.54 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -112.73 159.3 19.08 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 17.9 m -86.65 116.26 24.65 Favored 'General case' 0 N--CA 1.408 -2.556 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.47 129.26 9.81 Favored Glycine 0 N--CA 1.417 -2.624 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.2 tp -105.4 115.9 31.04 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 120.839 0.352 . . . . 0.0 110.549 -178.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.7 136.48 23.17 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.418 ' HA ' HD11 ' A' ' 86' ' ' ILE . 50.3 mm -100.61 -56.34 5.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 117.566 0.683 . . . . 0.0 109.537 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.601 ' NE2' ' HB3' ' A' ' 178' ' ' PHE . 0.1 OUTLIER -172.97 167.94 4.95 Favored 'General case' 0 CA--C 1.46 -2.494 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 52.06 -135.57 1.47 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.67 25.73 10.44 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -92.61 112.87 26.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.272 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 43.2 t -122.14 139.71 53.42 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.15 140.77 26.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 122.225 0.21 . . . . 0.0 110.585 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 tt -151.78 147.44 20.05 Favored Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -63.94 147.26 92.02 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.158 1.905 . . . . 0.0 112.066 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.0 m -64.44 -37.66 88.29 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -76.09 5.24 7.01 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.42 -19.65 57.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' A' ' 20' ' ' THR . 78.6 mt-30 57.22 76.6 0.47 Allowed Pre-proline 0 C--O 1.251 1.158 0 C-N-CA 125.414 1.486 . . . . 0.0 113.361 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -92.29 164.8 3.02 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 122.346 2.031 . . . . 0.0 110.724 175.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.34 -152.09 10.96 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.06 -1.44 54.41 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -144.87 126.13 14.76 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.18 155.39 39.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.063 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 8.8 mp -92.26 102.06 14.56 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.3 p -87.82 105.46 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.052 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 74.03 -3.9 2.41 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.611 0.764 . . . . 0.0 110.81 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.51 -9.3 11.78 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -97.67 118.26 33.79 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 14.9 ptpt -77.19 134.63 38.59 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 118.28 -1.368 . . . . 0.0 112.738 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.478 HG12 ' HB3' ' A' ' 77' ' ' LEU . 5.3 tp -131.49 141.12 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 114.251 -1.341 . . . . 0.0 108.346 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -86.47 139.66 30.68 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.6 t -93.01 139.93 17.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -79.68 -71.34 0.45 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -126.15 139.38 53.41 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -99.88 90.97 4.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.447 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 93.8 m-85 -79.2 109.97 14.03 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.155 0.502 . . . . 0.0 110.523 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -77.14 104.42 7.63 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.7 tp -80.26 87.89 5.53 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 122.181 0.991 . . . . 0.0 109.245 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -119.64 163.52 16.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 113.848 -1.523 . . . . 0.0 108.397 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.58 137.15 48.05 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.53 -23.9 11.55 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.667 2.911 . . . . 0.0 114.348 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -82.77 13.53 3.79 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 122.379 0.272 . . . . 0.0 111.384 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.9 m120 79.21 10.19 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 125.383 1.473 . . . . 0.0 112.347 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.5 mt -86.47 119.84 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.628 ' O ' ' HA ' ' A' ' 131' ' ' THR . 74.6 m-20 -81.07 157.67 25.32 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.882 -173.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -109.36 -0.97 18.78 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 61.72 30.05 18.29 Favored 'General case' 0 C--N 1.364 1.218 0 CA-C-O 122.83 1.3 . . . . 0.0 108.634 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.464 HD21 HD11 ' A' ' 173' ' ' LEU . 14.9 tp -133.01 142.89 49.07 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.584 -170.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.0 m -138.08 140.3 39.92 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.255 0.55 . . . . 0.0 110.657 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 92.7 t -105.98 122.25 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.8 mt -102.38 113.69 27.23 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.7 m -87.6 107.55 18.65 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.478 ' HB3' HG12 ' A' ' 54' ' ' ILE . 66.0 mt -80.48 141.31 35.34 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.725 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.52 74.72 10.35 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 122.045 0.926 . . . . 0.0 111.6 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -125.12 161.59 26.49 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.436 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -93.23 -49.57 5.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -66.96 148.16 52.3 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -119.27 173.18 7.1 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.388 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -82.56 179.64 7.72 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -73.75 127.93 34.13 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.01 90.16 1.15 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.418 HD11 ' HA ' ' A' ' 30' ' ' ILE . 2.4 pp -92.61 20.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.755 -0.591 . . . . 0.0 112.162 -176.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -68.69 -29.74 68.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.811 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.72 -27.54 73.77 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -85.1 -8.82 58.48 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 122.9 -0.177 . . . . 0.0 110.699 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.4 mt -66.54 131.69 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 t -124.44 111.48 15.78 Favored 'General case' 0 N--CA 1.387 -3.589 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -86.84 5.46 36.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.495 1.14 . . . . 0.0 108.935 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.83 110.57 22.02 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 169.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.5 -29.76 0.62 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -171.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -68.1 103.02 1.43 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.113 0.482 . . . . 0.0 111.747 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.38 -0.43 34.94 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.604 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.0 t -91.53 138.71 19.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -79.7 116.72 20.05 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -115.59 172.25 7.23 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.821 0.82 . . . . 0.0 112.097 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.6 m -128.79 141.25 51.37 Favored 'General case' 0 N--CA 1.422 -1.857 0 C-N-CA 124.908 1.283 . . . . 0.0 108.719 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.8 tp -106.12 122.19 45.69 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.424 HG21 ' HB1' ' A' ' 7' ' ' ALA . 43.5 t -113.96 107.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.815 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.4 m -107.85 138.91 31.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -139.28 107.99 5.93 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.325 0.583 . . . . 0.0 110.002 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.3 p -144.27 -172.58 3.81 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.46 -25.76 41.85 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.401 176.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -73.68 -51.27 17.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.419 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -115.79 84.35 2.09 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.8 m -80.14 96.32 6.49 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.355 0.597 . . . . 0.0 111.005 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.2 t30 60.15 70.71 0.61 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.755 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.3 m -101.34 108.03 19.54 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.08 108.67 24.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.0 tp -125.15 123.88 40.6 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.875 0.369 . . . . 0.0 111.563 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.86 102.65 4.8 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.1 m -78.39 -26.54 14.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.243 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 106.85 -149.53 16.6 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 119.94 -1.124 . . . . 0.0 111.1 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.95 122.25 8.63 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.745 2.297 . . . . 0.0 112.901 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.8 m -89.57 145.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.949 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 135' ' ' ILE . 11.5 p -128.45 172.8 10.79 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.246 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 28.2 ttt -114.45 136.64 52.78 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.74 -26.84 12.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.335 0.588 . . . . 0.0 109.419 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.53 -88.89 1.46 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 131' ' ' THR . 4.9 mp -131.99 155.99 47.0 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 11.1 tt . . . . . 0 C--N 1.304 -1.372 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 50.7 Cg_endo . . . . . 0 N--CA 1.428 -2.358 0 N-CA-C 110.816 -0.494 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.1 p -103.69 133.45 48.67 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.415 ' OD1' ' HD2' ' A' ' 133' ' ' ARG . 29.0 t-20 -108.19 159.9 16.24 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -175.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.494 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 5.5 mpt_? 65.72 38.8 5.1 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.563 1.145 . . . . 0.0 110.638 -177.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.425 ' HG3' HG22 ' A' ' 124' ' ' ILE . 16.5 mmt -85.55 118.42 25.06 Favored 'General case' 0 C--O 1.252 1.214 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.256 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.575 HG23 ' HB2' ' A' ' 170' ' ' SER . 5.4 tt -99.84 136.34 31.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 144.58 51.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.752 0.31 . . . . 0.0 111.311 -172.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.409 ' HE2' ' HG ' ' A' ' 170' ' ' SER . 6.3 p90 -138.95 163.81 31.38 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.907 176.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.27 99.95 12.84 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 124.227 0.955 . . . . 0.0 108.669 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -171.34 124.35 0.6 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.485 1.114 . . . . 0.0 109.65 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -70.46 102.81 2.29 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.941 176.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.8 t -119.81 155.73 32.0 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -127.21 165.44 19.61 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.721 0.296 . . . . 0.0 110.505 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.4 m -60.74 129.38 41.22 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.287 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.27 -20.41 9.04 Favored Glycine 0 C--O 1.215 -1.049 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -93.42 23.71 4.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.183 0.992 . . . . 0.0 108.386 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.1 m -79.12 137.88 37.68 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.415 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.566 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 97.55 0.43 59.35 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.57 126.58 37.81 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 121.566 -0.349 . . . . 0.0 112.643 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -73.25 113.0 10.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 123.318 0.647 . . . . 0.0 109.465 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 52.3 tp -94.18 106.45 18.42 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.5 p -147.02 163.23 36.91 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.675 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.77 177.8 6.58 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.1 t -64.38 108.46 1.63 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.956 0.884 . . . . 0.0 110.946 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 83.27 2.37 90.36 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.262 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -136.35 108.38 7.18 Favored 'General case' 0 C--O 1.211 -0.956 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.1 mt -97.68 130.92 45.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -103.41 -31.97 9.75 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.147 0.498 . . . . 0.0 110.691 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.4 -154.84 25.91 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.283 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.9 pt -132.28 148.08 32.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 116.911 0.355 . . . . 0.0 110.597 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.408 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 23.8 t-80 -68.14 131.16 44.91 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.203 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.6 m -105.47 -59.96 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.56 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -156.93 142.89 9.06 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.019 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -131.67 143.99 15.57 Favored Glycine 0 N--CA 1.423 -2.232 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.894 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -119.76 105.99 11.68 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.638 0.732 . . . . 0.0 109.911 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 74.2 -130.76 12.75 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -177.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 34.0 ptt180 -90.14 9.09 29.67 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.961 0.41 . . . . 0.0 110.982 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -111.37 94.72 5.12 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.618 0.723 . . . . 0.0 110.063 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.9 123.93 6.9 Favored Glycine 0 N--CA 1.422 -2.283 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.55 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -104.27 127.52 51.91 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.951 0.881 . . . . 0.0 109.557 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.575 ' HB2' HG23 ' A' ' 135' ' ' ILE . 19.4 m -124.62 166.29 16.38 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.36 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -100.56 129.49 46.5 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 4.0 pt20 -85.18 115.88 23.22 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.922 0.868 . . . . 0.0 110.319 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.464 HD11 HD21 ' A' ' 72' ' ' LEU . 4.3 mm? -87.09 93.4 9.35 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.954 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -73.3 146.73 45.12 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -75.3 -6.3 49.12 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.334 0.588 . . . . 0.0 110.907 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.09 -33.42 74.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.077 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -75.33 -27.0 59.07 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.173 0.511 . . . . 0.0 110.899 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.601 ' HB3' ' NE2' ' A' ' 31' ' ' HIS . 82.7 m-85 -102.1 0.99 35.75 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.897 -170.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--N 1.293 -1.886 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.189 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 C--O 1.242 0.716 0 N-CA-C 113.272 0.451 . . . . 0.0 113.272 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -76.56 -40.13 50.69 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -60.89 -46.21 91.54 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.851 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.45 -49.52 77.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.332 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -58.57 -46.8 86.15 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 123.498 0.499 . . . . 0.0 110.781 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.61 -35.14 78.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.6 tp -71.38 -42.14 68.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.049 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -70.73 -33.09 70.47 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.022 -0.423 . . . . 0.0 111.46 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.412 HD11 HD13 ' A' ' 86' ' ' ILE . 50.6 tp -67.27 -40.53 86.2 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.733 0.813 . . . . 0.0 108.927 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.455 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 18.5 tp -53.51 -50.49 65.3 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.742 1.217 . . . . 0.0 111.591 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -73.36 -3.61 28.3 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.783 -1.098 . . . . 0.0 113.447 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -126.42 -47.98 1.57 Allowed 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -115.84 -10.49 11.69 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -171.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 29.8 mt -99.19 115.34 39.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.101 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 mmt -127.65 146.37 50.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.465 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 22.7 m -78.56 132.41 37.15 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.7 mt -125.93 110.8 24.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 98.4 m -77.03 103.72 7.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.2 p -94.55 -168.68 1.88 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.008 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -71.12 -16.11 62.54 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 120.842 0.353 . . . . 0.0 111.047 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -110.11 9.63 24.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.84 -162.41 14.01 Favored Glycine 0 C--N 1.31 -0.869 0 C-N-CA 119.49 -1.338 . . . . 0.0 113.642 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -86.48 101.27 13.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.312 0.577 . . . . 0.0 111.738 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -106.92 -179.25 3.88 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 t -127.44 139.28 52.92 Favored 'General case' 0 N--CA 1.408 -2.571 0 C-N-CA 119.005 -1.078 . . . . 0.0 109.028 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.59 137.63 14.41 Favored Glycine 0 N--CA 1.415 -2.737 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.7 tp -101.84 118.41 36.86 Favored 'General case' 0 C--N 1.29 -2.01 0 O-C-N 123.811 0.359 . . . . 0.0 110.175 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.47 132.38 22.76 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mm -100.11 -53.03 8.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 117.624 0.712 . . . . 0.0 109.933 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -161.94 151.02 15.69 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.495 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.488 ' HA ' ' HG3' ' A' ' 82' ' ' LYS . 4.6 t70 53.72 -92.24 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 125.333 1.453 . . . . 0.0 112.695 177.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 32' ' ' ASP . 9.3 mpt_? -132.0 7.74 4.36 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.398 0.618 . . . . 0.0 110.033 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.446 HG13 HG13 ' A' ' 74' ' ' VAL . 84.0 t -77.82 112.83 16.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.573 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.7 m -121.94 142.84 49.88 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.3 p -115.91 141.39 33.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 120.743 0.306 . . . . 0.0 110.571 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 tt -154.47 149.42 20.24 Favored Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.57 144.9 95.13 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 122.279 1.986 . . . . 0.0 112.781 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.594 ' HB ' ' OG1' ' A' ' 73' ' ' THR . 9.6 t -86.52 -10.29 54.39 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -79.02 -2.51 40.67 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.282 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.73 -27.74 20.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.001 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 13.5 mm-40 60.04 87.46 0.14 Allowed Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.653 1.181 . . . . 0.0 114.171 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.48 149.08 18.74 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.156 1.904 . . . . 0.0 109.194 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.01 -157.35 30.09 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.478 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -82.2 -30.24 31.0 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.402 ' OD2' ' HD2' ' A' ' 53' ' ' LYS . 8.6 p-10 -139.58 136.29 34.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 23.9 m -136.68 157.68 36.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 120.755 0.312 . . . . 0.0 111.644 -174.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 86.6 mt -89.81 109.88 20.85 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 17' ' ' THR . 81.8 t -97.77 88.55 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.251 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 63.52 18.47 11.09 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.519 1.152 . . . . 0.0 109.934 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.18 -38.69 2.03 Favored Glycine 0 N--CA 1.436 -1.3 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.128 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -81.03 120.11 24.39 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.773 -0.251 . . . . 0.0 110.371 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 39.1 ttpt -80.59 110.41 16.04 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.2 tp -103.82 150.19 7.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -99.52 139.52 35.06 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 118.272 -1.371 . . . . 0.0 107.824 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.43 124.96 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.407 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 57.7 tttm -70.86 -52.25 21.47 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.34 0.59 . . . . 0.0 109.839 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.407 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.2 m-20 -138.71 138.25 37.55 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.602 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -115.55 112.51 22.3 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.47 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 63.9 m-85 -109.88 111.62 23.15 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.527 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -78.6 116.24 18.84 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.567 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 37.8 tp -90.73 101.97 14.72 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.1 t -123.89 140.8 46.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -81.78 130.94 58.98 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.98 5.23 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.081 3.187 . . . . 0.0 116.044 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.7 14.57 16.74 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.9 t30 70.66 40.06 1.06 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.011 1.324 . . . . 0.0 109.007 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 53.3 mt -120.06 122.02 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.62 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 131' ' ' THR . 50.4 t30 -64.54 150.29 47.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.598 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.567 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 39.1 tp -126.52 -9.58 6.26 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.716 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 72.5 -20.59 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.673 1.189 . . . . 0.0 113.108 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.67 118.69 11.99 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.594 ' OG1' ' HB ' ' A' ' 39' ' ' THR . 55.0 m -106.83 114.28 28.28 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 64.2 t -92.97 104.88 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.75 124.42 42.1 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.253 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.8 m -98.05 93.78 6.48 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -71.05 137.55 49.07 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.23 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.78 76.89 10.17 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.429 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -101.47 128.84 47.51 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.305 -1.771 . . . . 0.0 107.23 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.55 -50.74 64.04 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.365 0.415 . . . . 0.0 111.457 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -74.02 160.09 31.79 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 121.242 0.544 . . . . 0.0 110.62 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.488 ' HG3' ' HA ' ' A' ' 32' ' ' ASP . 58.1 tttm -99.52 142.55 30.85 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.604 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -80.8 162.3 24.1 Favored 'General case' 0 C--O 1.257 1.448 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 175.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -77.18 132.48 38.79 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -80.24 96.17 6.52 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.785 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.412 HD13 HD11 ' A' ' 10' ' ' LEU . 38.4 pt -96.0 20.32 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.767 0.794 . . . . 0.0 109.523 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -65.32 -28.16 69.12 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.837 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.72 -5.99 89.42 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.643 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -96.16 -3.06 45.1 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.282 0.563 . . . . 0.0 110.584 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.6 mt -70.22 120.07 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.987 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 p -108.68 105.08 14.53 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.546 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 1.0 OUTLIER -80.2 -12.48 59.64 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.299 177.519 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.35 118.98 21.76 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.427 HD13 ' HB ' ' A' ' 135' ' ' ILE . 21.6 mt -112.65 -63.84 1.38 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.394 0.616 . . . . 0.0 112.3 -169.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 16.9 pt-20 -54.69 126.95 26.03 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -166.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.87 -38.28 3.2 Favored Glycine 0 N--CA 1.432 -1.582 0 CA-C-N 114.488 -1.233 . . . . 0.0 113.011 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.3 t -78.52 138.64 19.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.997 0.427 . . . . 0.0 110.897 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -80.97 102.4 10.12 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.9 163.54 24.24 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.554 0.693 . . . . 0.0 111.16 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.6 m -129.28 139.04 51.94 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.5 tp -112.65 125.09 53.91 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 111' ' ' THR . 7.6 p -117.89 122.4 69.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.412 0.625 . . . . 0.0 110.832 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 t -111.72 139.13 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.743 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.409 ' HB3' HG22 ' A' ' 15' ' ' ILE . 76.5 t60 -126.5 79.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.258 1.028 . . . . 0.0 109.806 175.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.9 t -116.91 -177.82 3.29 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -71.33 -45.28 63.38 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.091 0.472 . . . . 0.0 110.374 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -82.28 -47.39 12.46 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.515 0.674 . . . . 0.0 109.885 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -88.69 76.6 8.04 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.761 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 22.5 m -94.44 101.11 13.02 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.921 0.391 . . . . 0.0 110.008 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.0 t30 64.45 62.9 0.78 Allowed 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.927 1.346 . . . . 0.0 110.033 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 24.6 m -96.54 96.15 8.48 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.344 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 54.1 mt -100.99 97.03 5.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.7 tp -120.2 137.17 54.35 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -68.67 146.08 53.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.2 t -102.72 -51.4 9.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 119.54 -168.58 13.56 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.59 116.8 4.13 Favored 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.704 2.27 . . . . 0.0 112.278 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 26.8 m -87.29 155.72 3.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.091 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.0 p -136.84 169.61 17.46 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 123.129 0.572 . . . . 0.0 109.592 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.2 ttt -87.82 142.68 27.62 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -95.84 -39.54 9.78 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.037 0.446 . . . . 0.0 110.976 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 133' ' ' ARG . . . 99.36 -111.68 4.27 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 130' ' ' PRO . 2.5 pt? -134.94 112.19 10.43 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.284 1.04 . . . . 0.0 110.911 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 7.6 tp . . . . . 0 C--N 1.28 -2.453 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -177.366 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.43 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 44.9 Cg_endo . . . . . 0 N--CA 1.441 -1.573 0 N-CA-C 117.017 1.891 . . . . 0.0 117.017 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 97.6 m -92.01 130.73 37.69 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 164.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.31 97.18 0.39 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 20.3 mtm-85 62.76 80.35 0.23 Allowed 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.255 1.026 . . . . 0.0 110.767 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.5 ttt -103.61 169.75 8.34 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.415 -172.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.52 HG23 ' HB2' ' A' ' 170' ' ' SER . 7.7 tt -117.32 142.34 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.017 0.527 . . . . 0.0 109.869 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.517 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 46.8 ttp180 -137.37 146.53 44.62 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 123.719 0.807 . . . . 0.0 109.659 -174.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' A' ' 118' ' ' VAL . 6.9 p90 -151.4 159.51 44.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 120.373 0.13 . . . . 0.0 111.287 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -83.22 113.51 20.72 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -165.55 126.12 1.86 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -174.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.45 101.96 1.34 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 44.4 m -78.77 138.94 38.46 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.923 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -111.3 154.47 24.46 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.9 t -86.76 138.69 31.4 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.0 -13.87 28.94 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.124 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.31 5.72 50.93 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.376 0.607 . . . . 0.0 111.432 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 41.9 t -62.32 135.12 57.31 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.524 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 103.57 -14.53 53.82 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.848 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.71 141.9 46.24 Favored Glycine 0 C--O 1.241 0.562 0 O-C-N 123.969 0.452 . . . . 0.0 113.726 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.5 t -81.27 114.46 22.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.319 0.58 . . . . 0.0 109.771 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 39.5 tp -87.35 106.27 17.83 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.6 p -140.82 -171.71 3.3 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.205 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.16 -173.47 4.45 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.8 t -70.48 99.57 1.64 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.283 1.04 . . . . 0.0 111.297 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.99 12.58 70.91 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.595 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -137.21 140.69 41.9 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 85.9 mt -126.95 124.34 64.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -96.98 -35.45 10.85 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.131 0.491 . . . . 0.0 110.629 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.527 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 164.01 -154.32 25.14 Favored Glycine 0 N--CA 1.427 -1.925 0 C-N-CA 119.305 -1.426 . . . . 0.0 113.16 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.5 pt -125.01 134.06 67.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 122.56 0.344 . . . . 0.0 111.15 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.434 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 68.9 t60 -67.42 128.58 36.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.441 0.696 . . . . 0.0 109.828 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.49 -15.42 9.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.29 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.25 -159.63 24.44 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 176.9 -176.5 48.05 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -147.93 145.83 28.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.2 -110.62 3.35 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.024 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 46.0 mtm105 -120.27 7.71 10.78 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -110.69 129.13 55.91 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.835 0.35 . . . . 0.0 110.276 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -105.31 142.39 15.51 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.0 143.77 49.7 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.536 0.684 . . . . 0.0 110.827 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.52 ' HB2' HG23 ' A' ' 135' ' ' ILE . 74.1 m -138.79 159.8 41.23 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.348 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -96.58 119.15 34.54 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -76.56 122.01 24.0 Favored 'General case' 0 C--O 1.253 1.274 0 CA-C-O 121.948 0.88 . . . . 0.0 111.315 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.527 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 95.4 mt -83.57 99.88 10.45 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -88.55 138.24 31.6 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.546 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 9.7 ptpp? -69.55 -13.88 62.56 Favored 'General case' 0 C--O 1.21 -0.995 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.877 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -61.35 -22.85 65.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.931 1.292 . . . . 0.0 110.562 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -85.34 -33.62 22.02 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.379 0.609 . . . . 0.0 109.428 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -91.76 3.5 54.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.016 -169.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--N 1.294 -1.815 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.396 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo . . . . . 0 C--O 1.241 0.637 0 CA-C-O 121.134 0.389 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -79.92 -32.39 40.15 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.602 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 19.3 m -61.48 -44.5 96.97 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.428 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -54.94 -51.55 65.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.055 0.942 . . . . 0.0 109.038 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.04 -45.19 94.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.432 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.39 75.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.331 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 4' ' ' THR . 92.8 mt -61.8 -47.67 84.06 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.058 0.456 . . . . 0.0 109.878 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 m -66.21 -49.98 65.43 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.309 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.9 tp -57.08 -45.65 83.17 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.58 0.752 . . . . 0.0 111.292 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 9.3 tt -64.59 -43.84 92.55 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -76.25 -9.39 58.6 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -99.93 -65.63 0.95 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.896 0.379 . . . . 0.0 111.247 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -108.71 -5.48 16.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -168.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.512 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 47.6 mt -95.82 139.7 18.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.336 -176.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.546 ' HB3' HG13 ' A' ' 49' ' ' VAL . 57.1 mtm -140.53 163.16 33.58 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.047 0.939 . . . . 0.0 109.306 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 96.5 m -103.11 119.74 39.41 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 71.1 mt -110.96 112.63 41.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.076 0.465 . . . . 0.0 110.179 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 59.9 m -80.35 107.9 13.52 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 p -97.6 -166.96 1.45 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.362 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -78.65 -2.89 41.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.348 0.594 . . . . 0.0 110.302 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -106.44 -43.09 4.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.295 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.59 -160.44 33.94 Favored Glycine 0 C--O 1.246 0.889 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.651 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -81.83 96.09 7.51 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.336 0.654 . . . . 0.0 109.422 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 146' ' ' CYS . 6.6 m-85 -99.64 159.53 14.97 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.43 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 95.0 m -94.5 127.74 40.63 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.91 121.73 7.03 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.96 113.02 26.26 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.8 134.94 21.07 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 50.8 mm -100.97 -48.85 11.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 117.298 0.549 . . . . 0.0 110.219 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.407 ' ND1' ' HB3' ' A' ' 85' ' ' ASP . 70.9 t60 -166.66 139.81 3.82 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.131 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.431 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 28.8 t70 61.21 -92.62 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.631 0 O-C-N 124.257 0.973 . . . . 0.0 112.745 173.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 81.0 mtt180 -131.86 5.75 4.26 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.406 0.622 . . . . 0.0 109.975 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.8 t -85.51 117.42 30.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.675 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.4 m -125.45 157.24 37.41 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.3 145.06 23.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 120.771 0.319 . . . . 0.0 111.67 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 tt -160.34 140.56 8.53 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.755 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 73.7 Cg_exo -57.66 134.58 63.96 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.909 2.406 . . . . 0.0 113.46 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.489 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 25.3 m -64.02 -33.58 76.06 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 124.276 1.031 . . . . 0.0 112.727 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -64.19 -12.25 38.65 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.19 -25.76 59.88 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 53.35 84.89 0.2 Allowed Pre-proline 0 C--O 1.242 0.667 0 C-N-CA 124.936 1.295 . . . . 0.0 112.816 -176.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -83.88 152.22 12.89 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 C-N-CA 121.935 1.756 . . . . 0.0 110.619 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.59 -162.35 37.07 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.162 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -93.37 10.03 33.9 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.083 0.944 . . . . 0.0 110.415 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -160.36 124.75 3.71 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.65 149.76 29.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.533 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 93.9 mt -85.48 114.11 22.26 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 17' ' ' THR . 39.2 t -102.28 102.32 13.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.217 175.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.6 m120 59.04 25.06 13.4 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.621 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.01 -7.38 44.35 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.943 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -106.83 118.62 37.17 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.542 -0.387 . . . . 0.0 110.48 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -73.44 124.69 26.29 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.68 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -119.94 122.8 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.925 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -71.52 124.69 25.22 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.309 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.7 t -84.22 139.99 16.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.48 -176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.439 ' NZ ' ' HB3' ' A' ' 57' ' ' LYS . 8.6 mtpm? -97.87 -69.77 0.75 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.032 0.92 . . . . 0.0 109.785 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -116.04 143.47 45.42 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.926 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -146.32 96.96 2.86 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -106.58 139.33 41.21 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.411 ' H ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -97.87 128.53 44.54 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.074 174.006 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.03 110.21 14.05 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.86 129.45 69.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.544 ' HB2' HD21 ' A' ' 70' ' ' LEU . 22.1 t70 -66.33 143.92 98.48 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -175.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.31 -17.25 0.5 Allowed 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 123.917 3.078 . . . . 0.0 115.141 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HG2' ' OD2' ' A' ' 64' ' ' ASP . 19.0 mm-40 -83.47 3.78 30.69 Favored 'General case' 0 CA--C 1.555 1.158 0 O-C-N 121.633 -0.667 . . . . 0.0 111.178 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.7 t30 73.78 18.8 3.32 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.435 1.494 . . . . 0.0 109.343 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.401 HG21 ' HB2' ' A' ' 132' ' ' ASN . 30.0 mm -99.44 136.1 32.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 131' ' ' THR . 91.7 m-20 -73.51 148.39 43.14 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.591 0.234 . . . . 0.0 111.411 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.544 HD21 ' HB2' ' A' ' 64' ' ' ASP . 73.0 mt -103.97 -13.22 16.41 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 172.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.489 ' OE1' ' HB ' ' A' ' 39' ' ' THR . 2.7 tp10 60.05 31.25 20.53 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 114.176 -1.374 . . . . 0.0 109.34 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.0 tp -115.82 120.58 39.73 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.881 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -104.38 130.94 52.22 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -91.86 100.28 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 171.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.6 tp -96.54 116.28 28.82 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.771 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -104.93 109.43 21.42 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.574 0.702 . . . . 0.0 109.107 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 88.7 mt -93.82 153.46 18.27 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.765 -175.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -88.22 80.08 7.67 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -118.3 115.02 23.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.756 -1.565 . . . . 0.0 108.014 -171.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -81.43 -10.13 59.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.521 0.677 . . . . 0.0 112.627 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -90.74 87.84 6.84 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 24.9 pttm -78.64 139.69 38.51 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.994 -0.683 . . . . 0.0 111.721 -172.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -77.33 147.63 36.06 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.57 -172.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -70.76 140.24 51.28 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.347 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 6.5 p-10 -70.45 107.0 3.62 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.952 0.882 . . . . 0.0 109.399 173.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.8 pt -93.47 22.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.4 ttt-85 -66.1 -30.77 71.34 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.645 -174.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.38 -12.77 84.24 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.357 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -91.11 -10.45 41.9 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.434 -0.451 . . . . 0.0 110.227 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.5 mt -66.58 133.71 30.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.571 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.3 t -113.54 110.59 20.51 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.4 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 42.9 mt-10 -87.78 4.41 44.46 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.663 0.744 . . . . 0.0 110.818 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.36 119.51 37.17 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.88 -2.266 . . . . 0.0 104.88 172.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.421 ' HB3' HD12 ' A' ' 135' ' ' ILE . 3.0 mp -120.5 -49.66 2.24 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -169.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -57.24 129.91 43.87 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.83 -1.78 78.78 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.5 173.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.487 ' O ' HG22 ' A' ' 118' ' ' VAL . 22.1 t -101.16 155.78 4.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 3.0 p-10 -95.59 148.48 22.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 118.718 0.69 . . . . 0.0 110.545 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.83 165.83 25.5 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.949 0.88 . . . . 0.0 112.823 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.522 ' OG1' ' HG2' ' A' ' 114' ' ' GLU . 26.7 m -122.86 138.56 54.62 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 125.002 1.321 . . . . 0.0 108.749 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.7 tp -99.2 117.11 32.93 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -113.27 112.06 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.85 142.75 24.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.189 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -136.6 100.48 4.35 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.704 0.764 . . . . 0.0 109.096 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.6 p -136.07 176.16 8.94 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.71 -30.73 71.45 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.849 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -77.39 -50.11 13.45 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.002 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -109.02 81.08 1.39 Allowed 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.19 98.28 9.28 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 120.793 0.33 . . . . 0.0 111.294 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.6 t30 68.48 70.6 0.3 Allowed 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.175 0.988 . . . . 0.0 110.349 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 51.6 m -108.75 107.97 18.62 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.445 HG21 ' HA ' ' A' ' 4' ' ' THR . 73.0 mt -108.92 102.25 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.712 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.0 tp -123.13 113.92 19.63 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.727 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.522 ' HG2' ' OG1' ' A' ' 100' ' ' THR . 45.6 mt-10 -73.88 123.41 24.18 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.7 m -91.24 -43.45 14.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.839 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.69 -152.11 19.77 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 98' ' ' ASP . 59.9 Cg_endo -71.87 144.3 43.06 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.921 2.414 . . . . 0.0 112.121 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 97' ' ' VAL . 35.5 m -106.53 137.98 34.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.24 0.543 . . . . 0.0 110.973 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.3 p -110.16 173.73 6.19 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.982 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 38.9 tpp -110.41 132.68 53.97 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.676 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.504 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -99.4 -45.02 5.98 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.302 0.572 . . . . 0.0 109.585 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.09 -79.5 0.53 Allowed Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.46 155.43 41.18 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.0 tt . . . . . 0 C--N 1.309 -1.168 0 CA-C-O 120.885 0.374 . . . . 0.0 110.018 -179.208 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 C--O 1.25 1.09 0 N-CA-C 110.144 -0.752 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 9.6 m -120.74 138.55 53.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.332 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.401 ' HB2' HG21 ' A' ' 68' ' ' ILE . 55.0 t30 -119.74 168.37 11.14 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 172' ' ' GLN . 11.0 tpp180 65.62 42.84 3.48 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.673 1.589 . . . . 0.0 109.605 175.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.1 mtp -108.12 140.94 40.58 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-O 121.978 0.894 . . . . 0.0 112.301 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.64 HG23 ' HB3' ' A' ' 170' ' ' SER . 5.9 tt -105.02 146.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.894 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.504 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 23.8 ttm180 -128.97 137.23 51.25 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -173.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -131.51 131.27 43.3 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -80.88 97.0 7.2 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.773 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -156.09 134.81 11.78 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -72.78 109.41 6.36 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 13.1 t -140.03 171.29 14.4 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 143' ' ' THR . 37.9 ttpt -114.82 142.57 46.37 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.427 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 13.4 t -80.36 165.43 22.28 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 146' ' ' CYS . . . 105.69 -17.78 41.91 Favored Glycine 0 C--N 1.303 -1.298 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -94.09 28.61 2.41 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.755 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 33.7 t -76.74 141.64 40.74 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 113.14 -1.845 . . . . 0.0 109.241 -174.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.43 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 93.04 -4.26 74.44 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.62 134.35 26.03 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.6 p -76.12 119.48 24.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 122.086 0.946 . . . . 0.0 111.348 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.3 tp -90.1 102.0 14.71 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 20.3 p -147.66 174.22 11.98 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.38 0.609 . . . . 0.0 111.929 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.92 172.91 12.06 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.7 t -64.74 103.74 0.74 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.962 0.887 . . . . 0.0 111.297 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.18 6.14 66.94 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.621 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -140.56 103.02 4.45 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 117.239 0.52 . . . . 0.0 111.428 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 88.2 mt -97.28 123.8 49.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -95.93 -42.83 8.1 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.36 0.6 . . . . 0.0 110.336 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.414 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 171.78 -157.7 28.07 Favored Glycine 0 N--CA 1.425 -2.098 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.46 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 28.3 pt -127.21 145.87 34.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -63.76 129.3 39.57 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 123.502 0.721 . . . . 0.0 109.426 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.433 ' HA ' ' SG ' ' A' ' 146' ' ' CYS . 62.1 t -117.27 -48.69 4.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 O-C-N 123.212 0.32 . . . . 0.0 110.754 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -133.64 108.33 0.73 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.314 -1.422 . . . . 0.0 112.86 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 143' ' ' THR . . . -95.19 108.25 3.66 Favored Glycine 0 C--N 1.3 -1.437 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -120.01 90.65 3.37 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 59.65 -106.63 1.01 Allowed Glycine 0 C--O 1.229 -0.192 0 O-C-N 123.821 0.7 . . . . 0.0 113.185 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 77.8 mtm180 -94.81 8.2 43.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -122.29 115.8 22.97 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.102 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -97.05 115.91 5.36 Favored Glycine 0 N--CA 1.42 -2.423 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -102.0 129.28 48.25 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.159 0.504 . . . . 0.0 110.276 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.64 ' HB3' HG23 ' A' ' 135' ' ' ILE . 29.0 t -127.25 156.69 41.49 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.257 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.412 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -101.43 140.72 35.34 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 66.6 mt-30 -76.26 121.19 22.58 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 123.517 0.511 . . . . 0.0 110.974 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.414 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 89.9 mt -94.58 85.27 4.47 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -83.63 144.61 29.32 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.449 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.4 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 10.2 ptpp? -73.68 -14.64 61.19 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.925 0.393 . . . . 0.0 110.595 -176.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -65.58 -19.32 65.87 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.632 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -79.78 -25.4 40.97 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 121.932 -0.48 . . . . 0.0 109.917 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -101.24 50.37 0.86 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.788 0.804 . . . . 0.0 110.327 -174.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--N 1.291 -1.94 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.472 174.171 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 CA--C 1.538 0.676 0 CA-C-O 121.209 0.42 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -63.31 -41.94 98.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.455 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 m -63.38 -40.4 97.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.651 0.78 . . . . 0.0 109.521 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -64.31 -43.6 94.18 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.236 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -63.56 -46.26 86.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.966 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 11' ' ' LEU . . . -54.33 -50.23 67.9 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 124.074 0.859 . . . . 0.0 111.699 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -64.95 -35.38 80.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 m -72.26 -42.48 65.55 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.016 0.436 . . . . 0.0 110.699 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.8 tp -65.79 -39.94 91.45 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.779 0.832 . . . . 0.0 109.535 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.539 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 6.0 tt -56.0 -50.9 69.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.299 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -83.56 15.03 3.33 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -123.95 -56.27 1.66 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -118.09 -5.22 10.96 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -171.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.539 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 42.2 mt -96.53 121.46 47.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.935 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 19.8 ptp -140.85 153.94 45.98 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.726 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.419 HG22 ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -85.84 111.53 20.27 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.3 mt -104.7 113.25 41.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.777 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 10.6 m -76.44 107.46 8.72 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 75.9 p -87.56 -149.88 0.16 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.3 p -52.91 -42.03 64.96 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.122 0.569 . . . . 0.0 112.094 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -129.56 -60.66 1.04 Allowed 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.25 158.5 20.55 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 119.643 -1.265 . . . . 0.0 114.467 -172.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 40.5 mt-10 -86.74 112.15 21.4 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -105.77 174.4 5.9 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.472 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 35.1 m -87.3 114.99 24.41 Favored 'General case' 0 N--CA 1.411 -2.399 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.595 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.59 110.8 3.9 Favored Glycine 0 N--CA 1.41 -3.036 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.6 tp -94.32 109.08 20.94 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.28 133.19 28.28 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 48.0 mm -109.82 -54.51 5.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 117.331 0.565 . . . . 0.0 111.148 -177.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -154.53 123.26 6.2 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.737 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 66.72 -86.28 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.865 0.728 . . . . 0.0 112.82 169.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 83.7 mtm180 -132.7 10.52 4.33 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.93 0.871 . . . . 0.0 109.463 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.562 HG13 HG13 ' A' ' 74' ' ' VAL . 50.2 t -91.65 123.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.838 -1.073 . . . . 0.0 111.184 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.9 p -127.01 148.36 50.11 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.07 130.38 57.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.264 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.7 mm -130.26 136.24 28.69 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 124.584 1.154 . . . . 0.0 108.43 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 31.4 Cg_exo -61.88 142.97 95.11 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.292 1.994 . . . . 0.0 111.387 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.1 m -62.51 -47.32 84.47 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 122.145 0.178 . . . . 0.0 111.435 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -61.77 -14.83 36.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.675 0.79 . . . . 0.0 112.838 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.76 -25.19 60.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.403 ' O ' ' HB ' ' A' ' 20' ' ' THR . 29.9 mm-40 58.09 88.0 0.13 Allowed Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 124.594 1.158 . . . . 0.0 113.863 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -83.1 149.66 13.62 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.864 1.709 . . . . 0.0 109.835 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -157.35 33.06 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.459 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.72 -17.25 27.06 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.973 0.892 . . . . 0.0 110.093 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -137.12 131.03 32.06 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 m -117.17 164.24 13.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 5.7 mp -113.49 110.59 20.52 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.146 178.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.7 t -87.75 94.24 4.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 t30 51.75 62.33 2.76 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 124.549 1.14 . . . . 0.0 109.024 -174.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.06 -34.36 3.42 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.018 -0.992 . . . . 0.0 114.03 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 75.5 mt-30 -72.21 108.89 5.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.169 0.485 . . . . 0.0 111.993 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -68.78 122.62 18.95 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.415 HD12 HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -134.4 127.7 50.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.389 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -78.18 127.68 32.63 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.784 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.2 140.39 18.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.573 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 60.5 tttm -89.32 -59.01 2.33 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.277 0.561 . . . . 0.0 110.16 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.2 m-20 -136.34 149.78 48.55 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.357 -177.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -132.23 107.87 8.87 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -117.53 126.68 53.0 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -77.0 133.28 39.19 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.459 -0.896 . . . . 0.0 108.871 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.426 ' HG ' HD12 ' A' ' 70' ' ' LEU . 31.9 tp -91.24 104.5 17.04 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.62 0.724 . . . . 0.0 109.44 -176.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 69' ' ' ASN . 20.5 m -119.62 160.02 20.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.406 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.01 147.42 47.98 Favored Pre-proline 0 C--N 1.289 -2.022 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -45.2 -13.95 0.08 OUTLIER 'Trans proline' 0 CA--C 1.564 1.982 0 C-N-CA 124.266 3.311 . . . . 0.0 116.074 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -77.19 -2.32 33.9 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.486 -0.759 . . . . 0.0 111.011 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 75.63 12.52 3.07 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.962 1.705 . . . . 0.0 109.998 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.5 mm -90.41 134.44 29.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 114.119 -1.4 . . . . 0.0 107.405 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 131' ' ' THR . 57.3 t30 -79.99 147.55 31.51 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.999 0.428 . . . . 0.0 111.395 -173.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.426 HD12 ' HG ' ' A' ' 62' ' ' LEU . 63.0 mt -99.32 -6.18 28.37 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 17.1 tp10 75.39 16.35 2.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 123.169 1.462 . . . . 0.0 109.823 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.25 136.27 50.58 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.669 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.0 m -116.52 128.94 55.9 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.562 HG13 HG13 ' A' ' 34' ' ' VAL . 59.5 t -82.99 101.18 7.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -98.08 111.88 24.04 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.2 m -94.77 110.92 22.73 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.77 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.48 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 95.8 mt -86.32 142.32 28.58 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.863 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -88.68 86.84 7.07 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -122.65 131.76 53.96 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -68.34 -34.5 76.22 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.298 0.374 . . . . 0.0 111.222 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -86.45 104.31 15.8 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -79.1 142.36 36.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.302 0.573 . . . . 0.0 110.445 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -83.63 145.48 28.79 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.31 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -57.27 120.17 7.68 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.112 -1.403 . . . . 0.0 108.69 175.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 4.6 p30 -74.85 117.7 16.98 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.234 -1.387 . . . . 0.0 109.906 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.0 pt -97.17 28.53 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.52 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.8 ttm105 -59.94 -37.14 78.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.99 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.96 -7.45 70.65 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.489 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -96.74 -10.54 26.6 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.425 0.612 . . . . 0.0 110.943 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.6 mt -66.53 123.54 19.76 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-O 121.144 0.497 . . . . 0.0 110.315 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.8 p -100.74 115.92 31.41 Favored 'General case' 0 N--CA 1.407 -2.623 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.552 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.589 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 1.3 pm0 -71.38 -29.77 65.34 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.536 175.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.12 115.44 18.79 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.429 ' HB3' HD12 ' A' ' 135' ' ' ILE . 33.1 mt -106.83 -60.77 1.63 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.875 -174.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.93 131.53 45.66 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.157 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.02 -22.29 33.73 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.661 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.8 t -92.29 148.31 4.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.02 125.23 38.53 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.695 0.76 . . . . 0.0 109.835 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.76 154.37 18.68 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 122.08 0.943 . . . . 0.0 113.121 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.9 m -127.38 125.91 41.52 Favored 'General case' 0 N--CA 1.417 -2.079 0 C-N-CA 125.432 1.493 . . . . 0.0 107.95 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -95.48 118.85 32.95 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -111.91 112.49 40.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.484 HG11 ' NE2' ' A' ' 145' ' ' GLN . 7.4 p -114.89 135.78 53.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.6 0.714 . . . . 0.0 111.101 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -129.58 84.82 2.25 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.8 t -130.51 174.94 9.4 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.018 -174.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.473 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 26.9 t-20 -70.64 -31.54 68.52 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -69.74 -51.92 29.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.952 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.573 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 79.1 m-85 -138.5 119.85 14.8 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.124 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.2 m -107.66 112.76 25.62 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 -175.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 74.06 27.16 1.61 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.457 1.103 . . . . 0.0 111.221 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.573 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 13.7 m -79.8 117.06 20.34 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.658 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.2 mt -101.59 99.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.8 tp -102.31 111.83 24.28 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.279 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -82.52 108.56 16.02 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.84 -54.61 9.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.431 -172.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 125.43 -164.12 19.13 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.32 135.94 52.77 Favored 'Trans proline' 0 C--O 1.244 0.8 0 C-N-CA 122.935 2.424 . . . . 0.0 112.771 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.419 HG12 ' HB3' ' A' ' 137' ' ' TYR . 22.1 m -110.81 160.34 10.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.273 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.7 t -143.36 159.71 41.87 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.8 ttt -89.24 131.49 35.33 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -90.91 -50.32 5.94 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.57 0.7 . . . . 0.0 109.206 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.48 -103.56 0.76 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.407 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 2.9 pp -126.58 158.18 36.92 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.563 0.22 . . . . 0.0 111.448 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.8 tt . . . . . 0 C--N 1.311 -1.099 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.502 177.341 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 N--CA 1.44 -1.666 0 N-CA-C 110.013 -0.803 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 31.7 p -112.06 143.02 43.76 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.52 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 123' ' ' LEU . 10.9 t30 -139.13 159.49 42.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -177.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 16.2 mtp180 75.98 27.25 0.94 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.604 1.562 . . . . 0.0 109.126 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 131.56 36.15 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.062 -175.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.603 HG23 ' HB3' ' A' ' 170' ' ' SER . 2.0 tt -98.91 136.54 29.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.049 -1.432 . . . . 0.0 107.764 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.408 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 49.8 ttp180 -121.69 142.9 49.7 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.432 0.634 . . . . 0.0 111.522 -172.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.419 ' HB3' HG12 ' A' ' 118' ' ' VAL . 3.5 p90 -134.16 140.51 46.6 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.252 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 166' ' ' ARG . 16.8 t70 -94.91 105.31 17.23 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -159.23 143.54 15.3 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.21 100.19 0.44 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.181 0.515 . . . . 0.0 109.664 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.0 p -65.39 161.02 20.66 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -133.68 137.82 45.52 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.5 m -84.39 152.15 24.23 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.01 -7.32 76.54 Favored Glycine 0 N--CA 1.459 0.209 0 C-N-CA 119.979 -1.105 . . . . 0.0 111.601 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.484 ' NE2' HG11 ' A' ' 103' ' ' VAL . 11.9 mm100 -92.1 2.69 56.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.048 0.928 . . . . 0.0 108.676 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 27.8 m -61.92 127.37 31.08 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.882 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.472 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 103.52 -11.7 54.08 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.153 -1.023 . . . . 0.0 111.192 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.12 137.93 36.33 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.4 p -77.61 123.83 34.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.743 0.782 . . . . 0.0 111.277 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 28.4 tp -91.84 100.28 12.99 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.6 p -125.57 -173.86 2.93 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.885 -173.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -155.07 -175.84 5.64 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.2 t -62.45 99.7 0.15 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.828 0.823 . . . . 0.0 111.311 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.2 20.75 79.29 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.568 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 97.4 mttt -138.44 148.06 43.99 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.648 0.379 . . . . 0.0 110.369 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 91.1 mt -132.45 126.45 55.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -96.14 -49.98 5.02 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.731 0.776 . . . . 0.0 109.637 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.552 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 178.81 -152.18 11.06 Favored Glycine 0 N--CA 1.42 -2.387 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.055 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 pt -126.46 151.97 33.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 117.121 0.461 . . . . 0.0 110.352 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -63.46 118.42 8.09 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.0 t -91.7 -62.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.33 -139.8 5.11 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.973 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.81 137.99 5.32 Favored Glycine 0 C--N 1.288 -2.128 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -110.13 130.38 55.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.24 -125.26 8.42 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.642 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 10.9 mtm180 -106.21 -7.08 18.03 Favored 'General case' 0 C--O 1.214 -0.777 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.461 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -96.31 106.24 18.43 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.611 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.66 132.02 11.07 Favored Glycine 0 N--CA 1.418 -2.562 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -115.61 127.82 55.49 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.684 0.755 . . . . 0.0 110.695 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.603 ' HB3' HG23 ' A' ' 135' ' ' ILE . 37.7 t -120.34 155.09 34.07 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.453 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -108.74 134.27 51.69 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 11.0 pt20 -78.07 117.36 19.31 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 124.015 0.822 . . . . 0.0 110.725 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.552 ' HG ' ' HA2' ' A' ' 158' ' ' GLY 0.304 0.7 OUTLIER -99.37 75.35 1.97 Allowed 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.226 1.013 . . . . 0.0 111.831 177.282 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -59.49 144.74 46.31 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.324 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -61.17 -20.21 62.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.832 0.853 . . . . 0.0 110.94 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -59.33 -29.05 67.37 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.689 1.195 . . . . 0.0 110.925 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -82.14 -8.04 59.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.715 0.293 . . . . 0.0 111.341 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -128.46 28.1 5.48 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.245 0.863 0 CA-C-O 121.324 0.583 . . . . 0.0 112.507 -179.723 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo . . . . . 0 CA--C 1.543 0.952 0 N-CA-C 116.262 1.601 . . . . 0.0 116.262 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -70.03 -34.27 73.05 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.52 -174.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.5 m -72.72 -33.64 66.57 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.136 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -61.9 -48.29 81.11 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.536 0.735 . . . . 0.0 109.376 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -63.81 -47.94 78.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.011 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.48 81.0 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.473 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 tp -65.62 -36.72 84.53 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 122.794 0.438 . . . . 0.0 111.232 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -71.87 -44.41 63.81 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.949 0.404 . . . . 0.0 110.414 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.9 tp -65.84 -36.97 84.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.522 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.49 ' HA ' HD12 ' A' ' 15' ' ' ILE . 37.4 tp -51.57 -56.82 11.32 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.364 1.465 . . . . 0.0 112.254 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -79.18 7.81 6.98 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -131.37 -49.98 1.0 Allowed 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -118.05 0.11 11.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 11' ' ' LEU . 50.0 mt -113.18 106.83 21.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.882 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -123.35 160.16 27.35 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.925 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.492 ' CG2' ' HB3' ' A' ' 24' ' ' GLU . 80.5 m -90.3 121.5 32.36 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 174.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.3 mt -106.5 124.48 62.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.56 HG22 ' HG2' ' A' ' 24' ' ' GLU . 6.0 p -79.31 98.97 6.9 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.741 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.2 p -98.59 -173.61 2.59 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 21.1 t -69.93 -34.82 73.97 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -84.77 -5.29 59.32 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.77 -162.82 24.48 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.081 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HG2' HG22 ' A' ' 19' ' ' THR . 40.2 mt-10 -94.53 111.13 22.88 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.893 0.378 . . . . 0.0 110.861 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -116.67 -178.77 3.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.384 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.7 m -98.11 136.81 37.82 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.7 126.47 6.63 Favored Glycine 0 N--CA 1.418 -2.549 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -96.79 119.59 35.55 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.5 121.94 5.59 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' HA ' HD11 ' A' ' 86' ' ' ILE . 44.6 mm -85.04 -53.94 9.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 117.388 0.594 . . . . 0.0 109.788 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -164.53 154.69 14.25 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 54.27 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.3 ptt180 -139.64 10.48 2.46 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.705 1.202 . . . . 0.0 108.956 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.15 114.55 31.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.125 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -125.11 156.36 38.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -117.09 135.5 57.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.1 tp -141.53 148.73 51.52 Favored Pre-proline 0 CA--C 1.559 1.309 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -76.2 145.4 27.44 Favored 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 121.964 1.776 . . . . 0.0 112.787 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.518 HG23 ' OG1' ' A' ' 73' ' ' THR . 0.2 OUTLIER -74.41 -18.56 60.64 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -73.47 -21.42 60.44 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.658 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.55 -26.15 45.61 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 96.1 mt-30 63.44 90.63 0.09 OUTLIER Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.735 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.14 152.48 24.23 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 121.962 1.775 . . . . 0.0 110.203 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.61 -157.65 26.72 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 119.971 -1.109 . . . . 0.0 113.142 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.74 -34.41 30.49 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.573 0.702 . . . . 0.0 110.902 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -137.84 138.88 39.59 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.71 144.95 36.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.224 0.535 . . . . 0.0 111.311 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 51' ' ' GLY . 6.0 tt -84.74 101.26 12.07 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 174.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.5 p -96.98 94.55 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 122.033 0.92 . . . . 0.0 110.492 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.6 t30 55.97 23.42 6.67 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.134 1.374 . . . . 0.0 112.019 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.407 ' H ' HD23 ' A' ' 48' ' ' LEU . . . 139.52 -49.67 0.8 Allowed Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.808 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -85.09 119.2 25.21 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -174.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.12 108.45 12.62 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.474 HD11 ' O ' ' A' ' 78' ' ' ASP . 9.4 tp -112.76 143.54 22.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.439 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -78.94 131.59 36.42 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.114 0.483 . . . . 0.0 110.783 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.5 t -89.68 125.94 42.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -78.66 -59.52 2.75 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.462 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -136.21 159.64 41.13 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -140.74 100.55 3.87 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -174.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.514 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 59.4 m-85 -97.08 113.56 25.13 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -82.56 111.19 18.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.31 104.55 6.89 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -174.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.87 133.9 62.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -71.63 145.07 89.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.73 -20.02 4.14 Favored 'Trans proline' 0 CA--C 1.552 1.39 0 C-N-CA 123.867 3.045 . . . . 0.0 115.3 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -86.58 9.12 19.49 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.752 -0.592 . . . . 0.0 111.175 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 71.78 26.38 3.04 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 123.433 1.587 . . . . 0.0 109.931 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.4 mt -97.57 127.94 49.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.516 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 131' ' ' THR . 21.0 m-80 -89.06 155.33 19.53 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.059 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.253 0.0 OUTLIER -132.22 18.94 4.45 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.795 0.807 . . . . 0.0 110.896 173.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 70.05 -20.8 0.18 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.338 1.855 . . . . 0.0 114.593 173.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.18 119.15 5.47 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.518 ' OG1' HG23 ' A' ' 39' ' ' THR . 20.5 m -117.9 112.85 20.89 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 171.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 44.0 t -81.86 105.57 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.83 113.67 26.01 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.9 m -99.11 105.34 17.41 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 120.876 0.37 . . . . 0.0 110.035 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.9 mp -77.98 139.38 39.16 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.579 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.474 ' O ' HD11 ' A' ' 54' ' ' ILE . 36.5 t70 -89.48 96.14 10.57 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.752 177.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -155.53 152.2 28.56 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.62 0.724 . . . . 0.0 112.488 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -89.16 -12.42 41.05 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.368 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -74.07 132.82 42.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.009 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -108.35 121.82 45.7 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.729 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -76.8 144.07 39.38 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -59.66 131.11 49.92 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.83 96.76 0.14 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.876 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.443 HD11 ' HA ' ' A' ' 30' ' ' ILE . 2.6 pp -93.71 18.27 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 122.204 1.002 . . . . 0.0 110.388 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -62.87 -32.22 73.42 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.166 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.14 2.48 87.65 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.923 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -103.14 -8.77 20.2 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 117.136 0.468 . . . . 0.0 110.731 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.4 mt -67.57 128.7 31.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.9 t -95.04 107.72 19.78 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -62.89 -23.13 67.19 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.778 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -106.05 111.55 24.22 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mp -102.81 -51.23 3.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.18 137.03 56.72 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -172.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.15 8.1 31.9 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.89 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.443 ' O ' HG22 ' A' ' 118' ' ' VAL . 40.4 t -122.31 150.37 25.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 O-C-N 122.183 -0.598 . . . . 0.0 109.717 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -82.18 122.63 28.14 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -115.0 160.7 19.28 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.98 0.895 . . . . 0.0 113.152 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 37.6 m -122.76 135.51 54.58 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.059 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.5 tp -100.19 124.99 46.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -113.77 117.65 56.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.466 ' HB ' ' OG1' ' A' ' 111' ' ' THR . 23.9 t -112.03 138.17 41.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -136.66 92.62 2.77 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.9 p -138.7 -169.74 2.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.127 -174.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -56.51 -59.34 5.12 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.021 0.928 . . . . 0.0 112.142 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -92.71 -35.62 13.37 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.407 0.622 . . . . 0.0 110.517 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -99.17 84.15 2.98 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.488 0.661 . . . . 0.0 109.765 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.57 111.04 22.63 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.344 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 65.17 37.16 6.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.286 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.466 ' OG1' ' HB ' ' A' ' 103' ' ' VAL . 32.5 p -79.61 94.22 5.63 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.013 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.72 103.41 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.5 tp -117.43 114.31 23.32 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.655 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 0.3 OUTLIER -77.66 143.53 38.09 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.979 177.528 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 36.0 m -111.43 -31.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 119.949 -0.701 . . . . 0.0 111.844 -176.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.78 -155.03 16.53 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.064 -1.065 . . . . 0.0 111.555 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.92 124.35 10.53 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.845 2.363 . . . . 0.0 111.978 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.461 ' HB ' HD11 ' A' ' 135' ' ' ILE . 35.0 m -96.93 134.07 36.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.348 0.594 . . . . 0.0 110.895 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.6 p -128.38 163.68 24.31 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.755 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.3 ttt -84.47 133.13 34.49 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 118.551 0.614 . . . . 0.0 110.013 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.639 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -82.09 -37.82 25.77 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 121.832 0.825 . . . . 0.0 108.801 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.94 -102.83 2.21 Favored Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.97 149.4 47.52 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.4 pt . . . . . 0 C--N 1.288 -2.069 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.0 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.45 -1.053 0 CA-C-O 121.727 0.636 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.9 t -125.17 118.63 26.51 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -106.35 156.93 18.01 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.581 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 74.22 57.02 0.09 Allowed 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.051 1.341 . . . . 0.0 111.508 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.0 mmt -113.28 143.03 45.11 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 113.064 -1.88 . . . . 0.0 108.832 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 18.1 tt -106.96 141.79 21.31 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.639 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 24.4 ttm-85 -118.96 132.97 56.1 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 122.634 0.374 . . . . 0.0 110.427 -173.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -136.29 134.62 38.18 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.637 172.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -87.84 91.31 8.71 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.869 0.842 . . . . 0.0 110.342 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -158.06 136.68 11.2 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.52 87.29 2.64 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.54 0.686 . . . . 0.0 111.398 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.6 p -94.48 161.09 14.36 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.798 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -118.31 136.16 53.87 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.0 m -61.22 124.98 22.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.594 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 132.45 -15.9 4.92 Favored Glycine 0 C--N 1.299 -1.517 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -97.79 18.09 16.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.9 m -62.7 130.92 47.13 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.021 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.43 -1.21 66.47 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.62 138.99 26.87 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.65 124.72 38.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.859 0.838 . . . . 0.0 111.472 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.7 tp -92.19 108.85 20.25 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.5 p -141.75 177.57 8.07 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.172 0.51 . . . . 0.0 111.813 -173.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -152.96 179.52 8.61 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 176.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.9 m -54.71 101.1 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.17 0.588 . . . . 0.0 111.876 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 69.15 23.31 76.22 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.667 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 74.8 mmtt -136.26 118.34 15.41 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 98.7 mt -108.14 129.24 62.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -103.45 -45.47 4.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.262 0.553 . . . . 0.0 110.899 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.516 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 176.82 -157.86 23.36 Favored Glycine 0 N--CA 1.421 -2.359 0 C-N-CA 118.968 -1.587 . . . . 0.0 112.586 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.4 pt -126.49 141.77 44.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -63.58 130.79 45.78 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.216 0.606 . . . . 0.0 110.357 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.0 t -101.14 -49.2 11.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -173.06 160.99 31.97 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.697 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -107.59 129.54 9.7 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -126.86 95.27 4.27 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.27 -125.04 17.5 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -101.44 21.5 14.1 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.318 0.58 . . . . 0.0 111.174 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -122.77 124.47 43.41 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.048 0.451 . . . . 0.0 110.146 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -102.26 131.56 10.65 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -109.12 133.63 52.76 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.524 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 41.9 m -130.62 150.44 51.81 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.759 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -88.81 135.46 33.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -82.96 95.65 8.06 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 123.485 0.49 . . . . 0.0 110.623 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.516 ' HG ' ' HA2' ' A' ' 158' ' ' GLY 0.306 1.0 OUTLIER -83.08 76.46 9.85 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-O 122.745 1.259 . . . . 0.0 112.299 177.909 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -75.71 153.35 37.14 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.209 -1.359 . . . . 0.0 111.88 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -59.7 -23.91 63.53 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.383 1.073 . . . . 0.0 112.046 -174.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -58.87 -22.89 60.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.728 1.211 . . . . 0.0 112.052 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -96.14 -9.83 29.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.937 0.399 . . . . 0.0 111.695 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -111.59 18.48 19.02 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.416 0.627 . . . . 0.0 110.756 -175.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.309 -1.189 0 CA-C-N 115.384 -0.826 . . . . 0.0 108.818 178.367 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--O 1.241 0.666 0 N-CA-C 113.681 0.608 . . . . 0.0 113.681 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -68.44 -30.2 69.02 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.016 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 m -70.36 -41.82 72.64 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.238 0.615 . . . . 0.0 109.357 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.24 -50.11 74.95 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.808 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -65.04 -42.66 94.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.647 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.29 82.89 Favored 'General case' 0 C--O 1.216 -0.684 0 O-C-N 123.516 0.51 . . . . 0.0 110.856 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.63 -39.99 95.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.146 0.498 . . . . 0.0 110.719 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -68.48 -43.48 76.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.005 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.7 tp -68.12 -39.07 82.84 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.276 0.631 . . . . 0.0 109.913 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 7.8 tt -55.31 -47.94 74.86 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.896 0.878 . . . . 0.0 110.25 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -79.09 14.94 1.26 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.978 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 -64.36 0.96 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -116.37 4.49 13.4 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.478 ' CG2' ' HB3' ' A' ' 104' ' ' HIS . 1.7 mp -87.36 115.03 27.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.255 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.407 ' HB3' ' CG2' ' A' ' 49' ' ' VAL . 21.6 mmt -113.21 134.13 54.73 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.043 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 89.8 m -92.8 103.58 15.92 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.7 mt -101.37 121.13 51.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 121.198 0.523 . . . . 0.0 110.544 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -87.41 108.15 18.87 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 41.2 p -102.92 -166.59 1.29 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.51 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.431 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 31.3 t -66.28 -43.15 87.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.071 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -89.39 -9.94 48.4 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -172.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.14 -165.82 33.39 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.19 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -108.59 103.33 12.42 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 146' ' ' CYS . 83.4 m-85 -113.52 175.0 5.64 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.087 -174.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.6 m -93.78 136.33 34.18 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.84 145.31 16.75 Favored Glycine 0 N--CA 1.416 -2.691 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.4 tp -105.4 119.96 40.39 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.206 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.68 139.77 25.03 Favored Glycine 0 N--CA 1.428 -1.847 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 40.4 mm -99.31 -49.73 11.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -174.86 153.99 1.81 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.56 ' OD1' ' HG2' ' A' ' 82' ' ' LYS . 36.1 m-20 51.02 -94.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.575 1.172 . . . . 0.0 113.186 176.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 17.7 ptp180 -127.06 6.11 6.51 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.511 -176.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 64.6 t -92.77 118.71 39.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -132.45 159.92 37.93 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 m -123.27 146.6 28.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 122.155 -0.341 . . . . 0.0 111.011 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.8 tt -158.13 147.12 14.58 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 45.1 Cg_exo -60.75 142.12 96.85 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 122.496 2.131 . . . . 0.0 112.8 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.1 m -59.73 -37.9 80.2 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -71.21 -2.06 14.68 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.41 -30.29 57.39 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 77.2 mt-30 60.46 89.13 0.11 Allowed Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.123 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.41 154.82 28.18 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.206 1.937 . . . . 0.0 110.507 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.32 -166.02 29.88 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.436 -0.887 . . . . 0.0 111.859 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -81.85 -18.7 42.99 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 122.104 0.954 . . . . 0.0 109.126 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 7.7 p-10 -147.37 148.15 31.05 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 m -142.52 -172.81 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 1.2 pt? -138.63 127.64 23.93 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 17' ' ' THR . 5.2 p -115.85 116.1 51.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.757 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 65.56 19.85 11.56 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.051 0.94 . . . . 0.0 109.465 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.23 -15.41 59.07 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.318 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 83.1 mt-30 -78.42 121.66 24.8 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 122.461 0.304 . . . . 0.0 110.263 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' A' ' 48' ' ' LEU . 29.4 mmmt -67.65 126.18 28.56 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.415 HD11 ' O ' ' A' ' 78' ' ' ASP . 9.3 tp -146.19 133.83 15.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.586 0.708 . . . . 0.0 110.551 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 38.7 mtm180 -85.37 145.4 27.5 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.585 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.77 148.31 5.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -97.82 -57.03 2.33 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -141.76 166.96 23.28 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -139.89 95.25 2.87 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.496 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 84.6 m-85 -81.37 111.37 17.68 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.5 103.73 4.95 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.446 HD12 ' HG ' ' A' ' 70' ' ' LEU . 1.3 tm? -80.82 101.83 9.62 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.4 155.7 9.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.69 138.44 83.07 Favored Pre-proline 0 C--N 1.311 -1.068 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -47.4 -29.06 9.32 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.056 3.171 . . . . 0.0 114.442 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -93.16 16.72 12.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.704 0.288 . . . . 0.0 110.986 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 71.87 20.18 4.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.298 1.039 . . . . 0.0 112.327 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.4 mm -87.69 149.89 3.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 131' ' ' THR . 56.4 t30 -69.87 142.89 52.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.573 HD21 ' HD2' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -118.27 -29.72 5.46 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 69.06 17.39 8.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.603 1.161 . . . . 0.0 111.281 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.15 135.43 54.19 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.1 m -128.15 130.29 47.86 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 120.826 0.346 . . . . 0.0 110.13 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 46.4 t -90.46 109.68 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -91.61 121.98 33.77 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.4 m -104.86 105.5 15.59 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 91.8 mt -82.65 168.68 17.04 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.415 ' O ' HD11 ' A' ' 54' ' ' ILE . 18.7 t70 -93.64 89.88 6.4 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 171.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -129.61 116.01 18.24 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.302 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.78 -29.77 36.09 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.53 140.22 51.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.813 -1.54 . . . . 0.0 110.739 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.56 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 60.5 mttm -90.26 105.55 17.89 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -77.64 144.88 37.07 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 166.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -59.04 126.95 29.81 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 124.008 0.818 . . . . 0.0 112.376 -172.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 12.7 p-10 -69.74 102.87 2.0 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.09 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -93.12 23.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.633 -0.667 . . . . 0.0 111.794 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -62.8 -40.11 96.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.067 -175.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.35 -0.48 89.11 Favored Glycine 0 C--N 1.317 -0.511 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.606 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -98.97 -14.11 19.65 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.8 mt -64.46 122.51 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.441 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.1 m -122.89 95.58 4.68 Favored 'General case' 0 N--CA 1.397 -3.112 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.97 -14.92 57.52 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -88.48 95.17 10.12 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 171.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.499 HD22 HD12 ' A' ' 135' ' ' ILE . 2.2 pp -125.79 -21.54 4.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 -162.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.417 ' N ' HD12 ' A' ' 94' ' ' LEU . 12.1 pt-20 -68.44 134.05 49.58 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.797 -1.161 . . . . 0.0 113.656 -172.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.35 -13.99 56.85 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.684 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 118' ' ' VAL . 16.0 t -93.45 157.02 3.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 2.6 p30 -96.22 148.96 22.18 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.8 158.87 38.98 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.034 0.921 . . . . 0.0 112.64 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.0 m -123.63 131.83 53.71 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.076 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.2 tp -94.97 115.83 27.93 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.99 109.24 27.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 47.2 t -113.97 131.89 64.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.478 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 9.7 t60 -140.85 93.71 2.63 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -121.36 179.7 4.34 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.503 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -75.63 -37.73 59.49 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.214 -0.595 . . . . 0.0 111.287 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -86.62 -22.98 25.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.178 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -125.05 76.9 1.58 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.4 m -88.56 129.39 35.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.351 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 57.38 68.03 0.9 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.902 1.281 . . . . 0.0 113.458 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.483 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 27.3 m -107.78 99.8 9.24 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.189 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.4 mt -100.76 96.61 4.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.8 tp -110.34 106.22 15.52 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.546 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.17 115.84 14.12 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.9 m -94.98 -19.63 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.19 -159.5 17.94 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.63 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 98' ' ' ASP . 24.6 Cg_exo -65.01 133.61 36.46 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.42 2.747 . . . . 0.0 112.586 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 137' ' ' TYR . 35.4 m -111.31 159.35 11.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.154 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.5 t -142.11 167.03 23.1 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.6 ttt -87.54 129.35 35.12 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -91.49 -26.13 18.95 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.282 0.563 . . . . 0.0 110.696 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.62 -106.99 2.59 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.51 116.73 23.66 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.2 mm . . . . . 0 C--N 1.302 -1.476 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.782 -179.403 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 N--CA 1.449 -1.135 0 CA-C-O 121.37 0.487 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 24.6 m -121.96 120.46 34.49 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -98.95 158.77 15.42 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.573 ' HD2' HD21 ' A' ' 70' ' ' LEU . 98.9 mtt180 64.27 62.01 0.86 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 122.514 1.15 . . . . 0.0 110.813 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 54.8 ttm -124.78 145.57 49.67 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.566 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.547 HG23 ' HB3' ' A' ' 170' ' ' SER . 1.4 tt -109.38 134.77 50.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 53.0 ttt180 -120.51 140.21 51.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.158 0.504 . . . . 0.0 111.772 -173.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.452 ' HB3' HG12 ' A' ' 118' ' ' VAL . 26.5 p90 -141.74 132.38 25.52 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.466 172.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.37 81.03 4.91 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.976 0.893 . . . . 0.0 109.634 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -144.52 127.74 16.72 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.43 105.88 4.31 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.193 0.52 . . . . 0.0 111.15 -176.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.3 p -89.59 174.36 7.8 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -114.39 172.67 6.88 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.1 t -84.93 146.89 27.02 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.3 56.68 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -106.37 14.77 26.92 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.428 0.633 . . . . 0.0 110.369 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.443 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 47.2 t -71.07 129.46 39.02 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.329 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.15 2.68 62.14 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.327 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.23 131.82 38.94 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.2 t -76.92 109.53 11.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 28.7 tp -88.0 106.0 17.84 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.7 p -136.75 178.36 7.13 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.957 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.83 -178.95 6.17 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.5 m -64.92 97.24 0.22 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.193 0.52 . . . . 0.0 110.931 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.52 11.41 68.8 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.877 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.75 143.11 33.32 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 117.089 0.445 . . . . 0.0 110.749 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 75.8 mt -122.62 130.83 74.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -105.22 -34.12 8.01 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.222 0.534 . . . . 0.0 111.328 -175.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 168.9 -159.6 32.75 Favored Glycine 0 N--CA 1.426 -1.967 0 C-N-CA 119.884 -1.151 . . . . 0.0 112.1 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 27.5 pt -132.58 135.78 57.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.838 0.351 . . . . 0.0 110.663 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -64.84 118.69 9.37 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 123.62 0.768 . . . . 0.0 110.179 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.7 m -90.95 -36.05 7.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 120.87 0.367 . . . . 0.0 110.309 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.88 164.71 31.65 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -129.26 143.89 14.94 Favored Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -132.83 103.8 6.27 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.16 -108.31 2.45 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -104.58 -10.45 17.57 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -85.07 99.26 10.92 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 120.988 0.423 . . . . 0.0 111.451 -174.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.5 113.32 3.81 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -95.95 120.95 37.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 121.3 0.572 . . . . 0.0 109.614 -176.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.547 ' HB3' HG23 ' A' ' 135' ' ' ILE . 35.1 t -119.22 139.14 52.36 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.418 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -76.18 134.17 39.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -79.71 111.48 16.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.71 99.31 10.16 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.454 ' HB3' ' HG2' ' A' ' 176' ' ' GLN . 63.5 mttm -85.69 142.52 28.97 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.372 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -72.55 -19.13 61.56 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.734 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.47 ' O ' HG12 ' A' ' 179' ' ' VAL . 14.0 pt20 -75.16 -5.34 43.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.729 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -76.76 -26.03 54.09 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -106.97 1.02 24.16 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.069 -173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 176' ' ' GLN . 9.1 p . . . . . 0 N--CA 1.434 -1.243 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo . . . . . 0 CA--C 1.54 0.824 0 N-CA-C 114.621 0.97 . . . . 0.0 114.621 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -72.03 -41.45 67.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.241 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -62.31 -40.28 95.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.626 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.54 -36.83 71.13 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.45 0.167 . . . . 0.0 110.607 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.86 -48.88 79.8 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.47 96.35 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.357 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.4 -44.86 96.41 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.0 0.52 . . . . 0.0 110.419 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -63.03 -48.55 78.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.547 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.71 -41.73 98.0 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.279 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 26.1 tp -56.17 -58.92 5.89 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.809 1.243 . . . . 0.0 111.706 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -76.51 -2.23 31.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.819 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -109.37 -63.88 1.31 Allowed 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -108.96 -10.06 15.07 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -170.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.474 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 58.2 mt -91.77 109.89 21.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.025 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 67.6 mtm -116.39 139.93 49.9 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 120.592 0.234 . . . . 0.0 111.09 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.5 m -82.55 119.42 24.22 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.9 mt -109.11 108.3 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.2 m -81.85 104.79 12.48 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.629 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 77.1 p -91.88 -162.6 0.94 Allowed 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.937 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.7 t -81.41 -14.2 57.41 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -100.39 -34.38 9.99 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.287 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.04 -162.6 36.35 Favored Glycine 0 CA--C 1.502 -0.759 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.743 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.462 ' CD ' ' HB3' ' A' ' 106' ' ' ASN . 82.8 mt-10 -92.7 104.09 16.4 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -107.45 176.61 5.1 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 104' ' ' HIS . 0.0 OUTLIER -117.91 131.58 56.5 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-O 121.11 0.481 . . . . 0.0 109.983 -179.677 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.44 131.65 10.14 Favored Glycine 0 N--CA 1.416 -2.633 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -98.51 115.72 29.19 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.86 122.35 8.2 Favored Glycine 0 N--CA 1.434 -1.482 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.0 mm -85.8 -57.51 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.315 0.578 . . . . 0.0 109.874 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -155.33 137.21 14.48 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.928 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 62.52 -85.91 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 O-C-N 124.641 1.213 . . . . 0.0 112.455 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -143.2 18.75 1.92 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.264 1.031 . . . . 0.0 109.989 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.6 t -92.51 113.56 27.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.5 p -122.19 155.49 35.7 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.569 ' HB ' HD11 ' A' ' 72' ' ' LEU . 27.1 m -117.73 145.42 23.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 120.732 0.301 . . . . 0.0 110.934 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.2 tt -146.49 141.51 16.37 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -60.4 143.44 99.48 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.724 1.616 . . . . 0.0 111.14 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.2 m -66.99 -40.15 87.31 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.124 0.487 . . . . 0.0 111.577 -174.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -70.97 -1.42 11.94 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.43 -17.5 61.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 122.073 -0.392 . . . . 0.0 110.327 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.629 ' O ' ' HB ' ' A' ' 20' ' ' THR . 88.3 mm-40 63.93 74.43 0.43 Allowed Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 124.638 1.175 . . . . 0.0 113.174 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -89.15 -175.19 1.09 Allowed 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 122.67 2.247 . . . . 0.0 109.814 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.95 -160.1 8.23 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -81.67 -20.22 40.0 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.875 0.845 . . . . 0.0 109.232 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -132.41 141.64 48.95 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.76 160.37 42.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 90.5 mt -101.89 102.07 12.59 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.06 100.66 7.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 121.864 0.84 . . . . 0.0 108.894 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.8 t30 63.47 10.7 5.04 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.19 1.396 . . . . 0.0 110.355 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.9 -19.97 8.23 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.737 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -77.95 116.03 18.14 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 120.583 0.23 . . . . 0.0 110.384 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -70.29 111.93 6.24 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.656 0.741 . . . . 0.0 109.914 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 78' ' ' ASP . 9.5 tp -126.05 140.96 47.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.564 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -87.61 143.24 27.29 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.3 133.04 42.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -80.63 -62.78 1.57 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.09 0.472 . . . . 0.0 110.194 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.464 ' H ' ' HB ' ' A' ' 76' ' ' THR . 27.8 m-20 -128.56 148.83 50.79 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.899 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -129.78 117.0 19.56 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.484 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.0 m-85 -111.45 117.63 33.57 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.635 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -76.31 107.72 8.76 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.43 HD23 HD23 ' A' ' 72' ' ' LEU . 37.3 tp -84.2 98.89 10.19 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.979 0.895 . . . . 0.0 109.123 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 69' ' ' ASN . 33.0 m -127.3 160.06 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.412 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 14.3 t70 -67.89 148.3 98.45 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -32.17 -44.88 0.2 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.862 3.708 . . . . 0.0 115.072 173.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.16 16.43 2.42 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.993 -0.442 . . . . 0.0 112.122 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 t30 60.4 48.56 7.69 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 125.626 1.571 . . . . 0.0 109.753 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 56.0 mt -98.43 126.64 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 172.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.525 ' O ' ' HA ' ' A' ' 131' ' ' THR . 16.6 m120 -73.72 133.2 43.3 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.84 -171.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.4 tp -97.25 -2.95 41.61 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 69.54 5.65 5.29 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.452 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.569 HD11 ' HB ' ' A' ' 36' ' ' VAL . 20.0 tp -102.79 131.13 49.86 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.55 -0.719 . . . . 0.0 111.236 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.0 m -111.24 123.79 50.91 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.484 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 55.0 t -86.51 114.11 25.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.1 tp -102.3 111.94 24.43 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.654 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.464 ' HB ' ' H ' ' A' ' 58' ' ' ASP . 26.5 m -87.32 100.09 12.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.408 HD11 ' CG2' ' A' ' 54' ' ' ILE . 15.3 tp -79.79 125.54 29.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.487 ' O ' HD11 ' A' ' 54' ' ' ILE . 31.4 t70 -83.61 78.99 9.59 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.807 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.489 ' HD3' ' OE2' ' A' ' 81' ' ' GLU . 14.5 ttm180 -137.28 134.66 36.37 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -84.06 1.94 41.57 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.489 ' OE2' ' HD3' ' A' ' 79' ' ' ARG . 45.1 mt-10 -77.36 126.0 30.22 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 173.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -102.89 109.14 20.59 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.396 0.617 . . . . 0.0 109.684 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -79.47 173.1 12.93 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.32 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -72.73 143.27 48.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.196 0.522 . . . . 0.0 111.124 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.16 100.22 5.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 171.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 pt -99.15 19.01 2.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 122.559 1.171 . . . . 0.0 108.643 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -70.29 -34.98 73.41 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.421 -1.718 . . . . 0.0 112.645 -171.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.39 -12.48 82.09 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.189 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.66 -11.59 55.62 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.76 123.36 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 m -118.92 103.55 9.7 Favored 'General case' 0 N--CA 1.405 -2.675 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.14 1.52 31.51 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -89.54 119.69 30.19 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.424 HD13 ' HB ' ' A' ' 135' ' ' ILE . 27.3 mt -107.67 -50.41 3.07 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -166.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.66 127.67 32.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -167.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.69 16.31 52.39 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.085 -1.416 . . . . 0.0 114.083 172.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 25.8 t -115.48 132.81 63.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.815 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.97 113.09 4.71 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.173 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.0 150.95 26.48 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.471 0.653 . . . . 0.0 111.459 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.7 m -114.93 131.81 56.76 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 tp -96.43 119.6 35.21 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 111' ' ' THR . 40.5 t -113.15 111.8 37.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-O 121.2 0.524 . . . . 0.0 110.116 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 26.7 t -107.97 147.0 13.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.41 ' O ' ' HB ' ' A' ' 26' ' ' THR . 20.7 t-160 -139.38 103.76 4.8 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.4 p -124.62 175.38 7.23 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.462 ' HB3' ' CD ' ' A' ' 24' ' ' GLU . 3.7 t30 -80.14 -43.6 21.36 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.78 0.324 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -68.63 -35.61 77.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.784 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.532 ' HD2' ' HG1' ' A' ' 111' ' ' THR . 15.3 t80 -133.15 96.58 3.78 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.2 m -96.45 134.83 39.13 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.837 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 t30 71.74 71.28 0.16 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.377 0.671 . . . . 0.0 111.488 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 7.2 m -97.68 93.68 6.53 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.1 mt -105.26 98.55 7.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.5 tp -122.75 125.49 45.61 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.443 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.04 134.95 41.28 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.2 -51.32 8.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 120.988 0.423 . . . . 0.0 111.268 -176.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.03 -162.93 22.49 Favored Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 3.0 Cg_exo -74.31 123.38 8.18 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.925 2.417 . . . . 0.0 111.673 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.8 m -87.79 156.77 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.696 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.3 p -137.05 151.48 48.97 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.719 0.807 . . . . 0.0 110.257 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 56.7 ttp -89.56 126.69 35.7 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.82 -0.55 . . . . 0.0 109.604 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.32 -42.36 11.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.875 0.369 . . . . 0.0 110.436 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.12 -127.81 9.22 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 44.7 tp -95.16 115.59 27.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.244 0.545 . . . . 0.0 110.447 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.1 pt . . . . . 0 C--N 1.297 -1.69 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.595 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 N--CA 1.443 -1.498 0 CA-C-O 121.618 0.591 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 28.6 m -129.53 117.99 21.35 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 27.4 p-10 -103.85 163.83 12.09 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.896 -173.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.583 ' HD2' ' OE1' ' A' ' 172' ' ' GLN . 20.5 mmt180 55.73 47.85 19.61 Favored 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 124.59 1.181 . . . . 0.0 112.804 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 98.2 mmm -95.57 147.73 23.27 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.597 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 170' ' ' SER . 3.4 tt -117.73 134.03 62.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 42.1 ptt85 -124.48 157.85 34.26 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.96 0.886 . . . . 0.0 110.405 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -137.42 149.56 47.0 Favored 'General case' 0 C--N 1.26 -3.326 0 CA-C-N 114.0 -1.455 . . . . 0.0 107.689 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.02 99.82 11.76 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -164.22 144.18 7.91 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.467 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -75.36 99.23 4.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.222 0.535 . . . . 0.0 110.94 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.6 t -132.03 177.61 7.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -158.87 168.54 26.52 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 120.728 0.299 . . . . 0.0 111.111 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 54.2 m -64.28 116.85 6.43 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.013 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.72 -35.57 0.54 Allowed Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -87.97 25.59 1.53 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 34.8 m -73.22 127.6 33.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.598 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.405 ' C ' HG23 ' A' ' 26' ' ' THR . . . 93.42 5.95 63.08 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.406 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.23 137.56 17.23 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.3 126.74 37.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.792 0.806 . . . . 0.0 110.764 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 42.5 tp -96.96 103.79 15.74 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 20.8 p -145.1 162.7 36.37 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.512 0.672 . . . . 0.0 112.331 -173.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.44 -176.27 3.55 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.4 p -60.41 99.42 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.343 0.592 . . . . 0.0 111.698 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 76.77 13.7 83.3 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.835 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -135.15 108.01 7.55 Favored 'General case' 0 C--O 1.21 -0.992 0 O-C-N 122.595 -0.356 . . . . 0.0 111.041 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 88.1 mt -98.63 129.68 48.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -101.47 -33.32 10.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.688 0.756 . . . . 0.0 110.603 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 160.9 -151.92 22.45 Favored Glycine 0 N--CA 1.421 -2.31 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.6 pt -133.01 149.3 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -70.72 135.8 48.52 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.606 0.566 . . . . 0.0 111.398 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.29 -58.35 3.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.049 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.69 157.49 22.84 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -137.75 138.21 9.46 Favored Glycine 0 N--CA 1.419 -2.487 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -105.48 84.01 2.03 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 122.304 1.049 . . . . 0.0 110.663 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 80.91 -102.22 2.12 Favored Glycine 0 N--CA 1.419 -2.494 0 CA-C-N 114.398 -1.274 . . . . 0.0 113.013 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -98.42 -0.38 43.7 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -120.97 132.27 54.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -118.83 124.46 6.03 Favored Glycine 0 CA--C 1.476 -2.356 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.018 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -108.99 125.4 52.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.328 1.061 . . . . 0.0 111.645 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.534 ' HB2' HG23 ' A' ' 135' ' ' ILE . 19.8 m -120.56 161.39 21.4 Favored 'General case' 0 C--N 1.275 -2.639 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.36 138.68 32.04 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.583 ' OE1' ' HD2' ' A' ' 133' ' ' ARG . 58.4 tt0 -82.5 105.22 13.37 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.497 0.665 . . . . 0.0 109.63 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.433 HD21 HG21 ' A' ' 36' ' ' VAL . 10.5 mp -86.0 94.0 9.11 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -74.16 144.31 44.89 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -70.99 -21.93 62.24 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -64.48 -19.03 65.32 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.14 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -88.42 -15.1 36.36 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.827 -0.546 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.94 15.51 22.55 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.659 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--N 1.295 -1.772 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.857 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--O 1.241 0.643 0 N-CA-C 111.104 -0.383 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -64.99 -45.59 84.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.483 177.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -59.34 -49.28 78.43 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.52 0.728 . . . . 0.0 109.961 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.73 -36.48 82.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.859 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -65.77 -48.41 71.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.59 95.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.814 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.5 -47.22 79.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.654 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.2 m -62.75 -36.54 83.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.346 0.594 . . . . 0.0 110.746 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.9 tp -66.5 -49.25 67.2 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.062 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 60.8 tp -51.27 -52.59 43.61 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.775 1.23 . . . . 0.0 111.419 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -56.34 -21.03 21.87 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -174.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -137.49 -29.64 0.87 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 118.841 -1.144 . . . . 0.0 113.84 -177.165 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -107.05 -13.9 15.07 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.499 HG23 HG23 ' A' ' 26' ' ' THR . 27.3 mt -90.71 110.66 22.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.875 0.845 . . . . 0.0 111.562 -177.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.8 mtp -101.6 131.76 47.63 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.216 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 6.6 m -87.3 102.71 14.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 mt -100.35 111.95 31.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 121.64 0.733 . . . . 0.0 112.034 -174.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.3 m -84.05 106.81 15.99 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.378 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 28.0 p -96.69 -167.23 1.53 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.536 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m -73.19 -22.2 60.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 120.852 0.358 . . . . 0.0 110.281 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -92.45 -46.39 7.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.683 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.29 -167.56 33.27 Favored Glycine 0 CA--C 1.503 -0.677 0 C-N-CA 118.862 -1.637 . . . . 0.0 113.401 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -100.69 99.93 10.55 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CD1' ' HB3' ' A' ' 146' ' ' CYS . 67.6 m-85 -115.05 -168.63 1.41 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.173 -175.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.499 HG23 HG23 ' A' ' 15' ' ' ILE . 90.3 m -111.83 135.53 52.33 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-O 121.243 0.544 . . . . 0.0 110.542 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.73 142.22 16.13 Favored Glycine 0 N--CA 1.409 -3.122 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.1 tp -114.52 118.26 33.25 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.321 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.17 119.66 5.0 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 46.5 mm -95.46 -51.81 10.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 117.714 0.757 . . . . 0.0 111.986 -173.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.524 ' O ' HG12 ' A' ' 34' ' ' VAL . 70.9 t60 -156.28 111.39 2.9 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.566 -173.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 61.4 -77.87 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 170.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.753 ' HD3' HG23 ' A' ' 76' ' ' THR . 1.1 ppt_? -120.02 -2.17 10.29 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 31' ' ' HIS . 14.3 p -100.97 118.85 48.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.719 -176.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.5 m -120.33 164.63 16.03 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.337 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.531 ' CG1' HD11 ' A' ' 72' ' ' LEU . 46.7 t -118.63 134.5 62.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tp -148.02 143.64 17.93 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 25.4 Cg_exo -69.61 155.28 66.84 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.36 2.04 . . . . 0.0 112.858 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.9 m -74.74 -44.58 49.09 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -63.6 -13.93 46.73 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.94 -24.28 63.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.068 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.421 ' O ' ' HB ' ' A' ' 20' ' ' THR . 97.4 mt-30 62.94 84.05 0.19 Allowed Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 123.756 0.822 . . . . 0.0 110.705 -177.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.55 121.46 6.0 Favored 'Trans proline' 0 C--O 1.258 1.505 0 C-N-CA 121.898 1.732 . . . . 0.0 110.179 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.2 -169.13 31.27 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.426 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -86.18 -14.4 44.12 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.426 0.631 . . . . 0.0 109.34 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -143.47 137.25 28.43 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.1 158.46 33.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.054 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 79.0 mt -105.6 115.22 29.88 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 17' ' ' THR . 6.0 p -87.78 90.39 3.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 71.75 -10.42 0.85 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.079 1.751 . . . . 0.0 110.632 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 148.94 -22.99 1.28 Allowed Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.438 ' HB2' HG13 ' A' ' 49' ' ' VAL . 79.3 mm-40 -73.44 113.85 11.0 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -75.48 121.27 22.09 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 121.062 0.458 . . . . 0.0 110.799 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.444 ' CG2' HD11 ' A' ' 77' ' ' LEU . 10.6 tp -130.29 141.34 46.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.29 149.56 33.5 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.44 0.638 . . . . 0.0 111.401 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.5 t -94.01 126.97 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 172.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.427 ' HB3' HG22 ' A' ' 76' ' ' THR . 8.0 tmtm? -89.93 -43.81 10.33 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.766 -174.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -156.18 154.09 30.28 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -134.36 127.28 31.33 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.474 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 16.5 m-85 -123.13 108.64 13.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -81.19 136.93 35.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.15 76.2 9.29 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 122.402 1.096 . . . . 0.0 111.682 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.6 p -109.0 118.54 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.271 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.561 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 21.5 t70 -62.47 143.5 96.0 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.619 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.28 -21.24 22.19 Favored 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 123.796 2.997 . . . . 0.0 114.347 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -88.38 7.6 31.79 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.483 0.659 . . . . 0.0 109.242 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.275 40.6 m-80 67.85 63.62 0.39 Allowed 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 125.72 1.608 . . . . 0.0 112.252 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.561 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 18.1 mm -123.55 126.07 72.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 131' ' ' THR . 36.2 t30 -99.75 129.6 45.88 Favored 'General case' 0 C--O 1.203 -1.387 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -170.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.597 HD13 ' O ' ' A' ' 132' ' ' ASN . 40.0 tp -94.57 -8.18 38.92 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 117.607 0.185 . . . . 0.0 111.302 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 66.73 20.77 10.65 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.509 1.147 . . . . 0.0 109.316 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.531 HD11 ' CG1' ' A' ' 36' ' ' VAL . 20.4 tp -126.63 137.08 53.25 Favored 'General case' 0 N--CA 1.426 -1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 110.63 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 46.0 m -124.34 126.28 45.74 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-O 121.506 0.669 . . . . 0.0 110.472 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 91.7 t -79.78 113.64 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 175.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.19 114.96 28.01 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.753 HG23 ' HD3' ' A' ' 33' ' ' ARG . 53.2 m -92.97 115.68 28.35 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.444 HD11 ' CG2' ' A' ' 54' ' ' ILE . 18.1 tp -85.96 142.99 28.41 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.219 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.403 ' O ' HD11 ' A' ' 54' ' ' ILE . 19.3 t70 -81.77 82.27 7.52 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 172.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.601 ' NE ' ' HB3' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -91.51 121.99 33.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -166.583 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -92.58 -42.85 9.44 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 167.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -98.48 118.28 34.81 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -98.25 158.14 15.75 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.577 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -103.59 146.0 29.21 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.433 ' NH2' ' HB3' ' A' ' 13' ' ' LYS . 57.3 ttp180 -55.44 134.54 50.54 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.692 1.597 . . . . 0.0 111.387 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 10.8 p-10 -75.06 96.05 3.15 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.562 1.172 . . . . 0.0 112.776 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.3 pt -96.99 22.75 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 122.299 1.047 . . . . 0.0 109.068 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.481 ' O ' ' HE3' ' A' ' 175' ' ' LYS . 48.1 ttp180 -60.25 -38.34 83.17 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.844 -175.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.99 -11.31 84.84 Favored Glycine 0 C--N 1.315 -0.588 0 C-N-CA 121.166 -0.54 . . . . 0.0 113.024 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.44 -13.1 50.31 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.593 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.4 mt -67.05 130.94 32.86 Favored 'Isoleucine or valine' 0 C--O 1.25 1.116 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.1 t -118.72 113.45 21.17 Favored 'General case' 0 N--CA 1.4 -2.925 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -75.55 -20.14 58.86 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -86.32 115.65 23.99 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.564 HD13 ' HB ' ' A' ' 135' ' ' ILE . 10.5 mt -108.31 -66.73 1.02 Allowed 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.9 0.857 . . . . 0.0 110.76 -171.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -58.9 134.73 57.19 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.673 -168.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.56 2.28 24.32 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.675 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.2 167.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.11 152.57 18.42 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.45 157.09 42.95 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.714 0.769 . . . . 0.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 26.2 m -112.63 133.58 54.6 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 48.1 tp -101.57 119.71 39.2 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.69 93.96 4.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.468 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 61.9 t -79.84 119.55 29.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -148.17 151.55 35.74 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.1 p -171.62 -174.81 1.45 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -92.32 -11.34 35.36 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.363 -1.335 . . . . 0.0 107.991 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -73.32 -49.78 25.6 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.092 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -136.67 113.11 10.0 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.903 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.9 p -101.27 164.87 11.57 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.195 -176.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 55.8 t30 44.43 70.8 0.3 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.689 1.196 . . . . 0.0 113.453 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.468 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 56.3 m -131.26 92.39 3.18 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.475 -0.766 . . . . 0.0 110.242 176.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.7 mt -88.13 101.49 11.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -120.6 117.3 27.21 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.839 0.352 . . . . 0.0 110.977 -173.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 10.1 pt-20 -74.93 130.03 38.69 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.037 0.446 . . . . 0.0 110.494 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -97.67 -45.04 12.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.905 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.91 -152.93 20.48 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.082 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.82 138.68 34.97 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 122.878 2.385 . . . . 0.0 113.554 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.444 HG12 ' HB3' ' A' ' 137' ' ' TYR . 35.8 m -102.87 146.85 10.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.87 177.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.9 p -130.95 153.7 48.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.618 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 44.0 ttp -96.98 116.28 28.92 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.362 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -82.74 -46.09 13.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.968 -176.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.43 -130.32 9.79 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.47 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.4 HD22 HG21 ' A' ' 68' ' ' ILE . 83.5 mt -93.82 100.28 12.5 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 131' ' ' THR . 38.3 mm . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.41 ' HB2' HG23 ' A' ' 68' ' ' ILE . 56.2 Cg_endo . . . . . 0 N--CA 1.448 -1.169 0 N-CA-C 110.59 -0.581 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 14.6 t -88.77 132.2 34.73 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.22 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.597 ' O ' HD13 ' A' ' 70' ' ' LEU . 34.9 t30 -75.83 81.28 2.75 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 65.58 63.55 0.62 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.64 0.733 . . . . 0.0 112.738 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 28.3 mtt -89.14 164.11 15.15 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.673 HG23 ' HB3' ' A' ' 170' ' ' SER . 6.8 tt -107.84 138.83 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.064 175.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -122.89 140.75 52.63 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.444 ' HB3' HG12 ' A' ' 118' ' ' VAL . 50.5 p90 -132.43 153.46 50.81 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.019 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -89.07 93.22 9.51 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.511 0.507 . . . . 0.0 109.934 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -174.77 135.85 0.4 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 125.395 1.478 . . . . 0.0 108.015 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.09 91.57 7.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.042 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.7 m -97.06 147.84 23.62 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -99.81 172.43 7.25 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -80.17 169.62 17.55 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 175.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 146' ' ' CYS . . . 90.57 -34.38 4.21 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -173.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.455 HE21 HG11 ' A' ' 103' ' ' VAL . 49.2 mt-30 -85.81 33.14 0.58 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.028 1.331 . . . . 0.0 107.622 175.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.522 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 42.8 t -89.51 138.19 31.67 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.737 -175.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 94.88 -1.41 65.46 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.45 127.94 29.62 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.39 115.33 17.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.054 0.454 . . . . 0.0 111.114 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 39.4 tp -89.5 107.86 19.32 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.0 p -146.98 162.49 38.65 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.548 0.69 . . . . 0.0 112.653 -174.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -128.94 -179.07 4.89 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 175.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.2 t -60.4 103.24 0.22 Allowed 'General case' 0 CA--C 1.556 1.192 0 CA-C-O 122.404 1.097 . . . . 0.0 112.072 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 77.35 15.07 81.87 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.629 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -135.35 109.81 8.49 Favored 'General case' 0 C--O 1.207 -1.145 0 O-C-N 122.307 -0.525 . . . . 0.0 111.646 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.6 mt -100.68 129.54 51.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -105.23 -41.41 5.55 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.611 0.719 . . . . 0.0 110.776 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.482 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 173.93 -170.38 43.5 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.63 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.8 pt -119.29 143.64 30.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -70.05 136.5 50.39 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.36 -46.49 3.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.111 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.57 153.6 23.12 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -127.8 152.46 18.95 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.56 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -116.73 96.1 5.33 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.23 -119.03 9.1 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.104 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -84.79 -8.01 58.98 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.745 0.818 . . . . 0.0 110.647 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -108.61 100.95 10.14 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.443 -0.786 . . . . 0.0 111.429 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -79.94 134.65 13.86 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -107.21 129.84 54.81 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 122.121 0.962 . . . . 0.0 110.45 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.673 ' HB3' HG23 ' A' ' 135' ' ' ILE . 30.0 t -118.2 141.31 48.63 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.999 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.37 120.45 23.83 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.466 ' CD ' HD11 ' A' ' 94' ' ' LEU . 6.1 tt0 -78.27 109.0 12.0 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 123.776 0.673 . . . . 0.0 110.393 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 173' ' ' LEU . 3.2 pp -94.05 88.54 5.7 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.265 1.031 . . . . 0.0 109.453 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -80.85 138.72 36.2 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.871 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.505 ' HB2' ' HZ2' ' A' ' 175' ' ' LYS . 4.1 ttmp? -50.88 -35.14 31.31 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.542 1.137 . . . . 0.0 112.267 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -56.47 -25.63 51.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.627 0.771 . . . . 0.0 112.977 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -82.39 -13.74 56.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.673 0.273 . . . . 0.0 111.299 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -96.54 -8.27 32.38 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -173.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 C--N 1.306 -1.303 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.701 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo . . . . . 0 C--O 1.241 0.63 0 CA-C-O 121.045 0.352 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -67.01 -36.48 82.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.64 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 3.0 m -65.41 -48.77 71.66 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.727 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.05 -37.55 87.95 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.833 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -62.12 -48.48 79.97 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.802 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.14 95.05 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 123.932 0.77 . . . . 0.0 111.515 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 4' ' ' THR . 96.0 mt -63.81 -43.35 96.53 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.868 0.365 . . . . 0.0 111.12 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 m -67.1 -31.71 72.37 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.462 0.649 . . . . 0.0 110.412 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.8 tp -74.14 -59.07 2.89 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.524 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.73 ' HA ' HG12 ' A' ' 15' ' ' ILE . 6.8 tt -50.21 -52.4 36.04 Favored 'General case' 0 C--O 1.247 0.957 0 C-N-CA 125.286 1.434 . . . . 0.0 113.341 -175.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -66.59 -4.03 7.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -172.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -129.07 -53.9 1.2 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -84.72 6.99 22.05 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -171.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.73 HG12 ' HA ' ' A' ' 11' ' ' LEU . 48.2 mm -102.4 123.63 55.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.122 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.417 ' O ' HG13 ' A' ' 18' ' ' ILE . 1.8 mpt? -101.71 97.06 7.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.566 ' HA ' HG22 ' A' ' 26' ' ' THR . 23.3 m -70.65 93.17 0.91 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.422 HG23 ' HB ' ' A' ' 47' ' ' VAL . 82.1 mt -93.48 118.55 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.966 -172.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 7.0 m -85.27 106.59 16.79 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.693 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 60.6 p -90.81 -163.32 1.01 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.761 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 m -79.75 -2.96 45.45 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -118.65 -33.25 4.33 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.69 -151.26 20.21 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 119.762 -1.209 . . . . 0.0 112.542 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -86.87 104.2 16.0 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.38 133.86 52.38 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.584 HG21 ' CD2' ' A' ' 104' ' ' HIS . 13.6 p -97.8 130.58 44.73 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-O 121.796 0.808 . . . . 0.0 113.078 -172.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.41 131.11 10.45 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 55.4 tp -89.81 114.06 25.72 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.5 103.89 1.69 Allowed Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.8 mm -71.44 -47.17 60.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 C-N-CA 123.129 0.572 . . . . 0.0 109.857 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -169.95 154.1 5.03 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.581 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t70 50.79 -95.48 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.715 1.26 . . . . 0.0 113.402 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.492 ' HG2' ' HB2' ' A' ' 79' ' ' ARG . 54.6 mtt180 -123.82 4.7 8.78 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 122.817 0.447 . . . . 0.0 111.073 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.05 113.91 26.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.256 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 13.1 p -126.9 137.47 53.16 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -110.75 138.49 38.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.98 149.91 26.29 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.16 149.78 83.11 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 122.248 1.966 . . . . 0.0 112.555 174.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.428 ' HB ' ' OG1' ' A' ' 73' ' ' THR . 8.9 t -79.43 -31.02 42.52 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 122.517 0.327 . . . . 0.0 110.995 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -72.66 -4.97 34.31 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.208 0.528 . . . . 0.0 111.024 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.27 -13.17 60.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.693 ' O ' ' HB ' ' A' ' 20' ' ' THR . 85.5 mm-40 66.62 77.78 0.26 Allowed Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 125.145 1.378 . . . . 0.0 113.281 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.17 153.86 18.93 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.198 1.932 . . . . 0.0 110.297 176.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.99 -164.32 13.93 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -83.38 -20.97 33.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.048 0.928 . . . . 0.0 108.59 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.412 ' HB3' ' HG3' ' A' ' 55' ' ' ARG . 4.6 p-10 -143.72 149.6 37.41 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.422 ' HB ' HG23 ' A' ' 18' ' ' ILE . 24.8 m -143.33 170.42 10.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.471 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 73.3 mt -102.31 114.12 28.01 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 m -92.32 97.74 7.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.615 0.721 . . . . 0.0 109.617 174.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 69.53 -10.4 0.58 Allowed 'General case' 0 CA--C 1.564 1.517 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.96 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.84 -25.18 0.63 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 112.285 -0.326 . . . . 0.0 112.285 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -90.42 131.86 35.95 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 122.552 -0.381 . . . . 0.0 110.719 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -77.44 115.21 17.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.481 0.658 . . . . 0.0 109.677 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.8 tp -120.37 143.51 32.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.431 ' N ' ' HD2' ' A' ' 55' ' ' ARG . 2.8 mpt_? -89.87 141.07 28.98 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.685 0.755 . . . . 0.0 111.777 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.404 HG22 ' CD2' ' A' ' 77' ' ' LEU . 20.2 t -97.21 102.99 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -69.16 -62.4 1.39 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 123.675 0.609 . . . . 0.0 110.097 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -111.42 138.39 47.98 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -146.34 105.08 3.85 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-O 121.275 0.56 . . . . 0.0 109.589 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -107.92 129.67 55.08 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.276 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.45 131.43 34.19 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.5 tp -83.49 104.02 13.3 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.788 0.804 . . . . 0.0 109.997 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.53 141.51 43.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.936 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 20.8 t70 -83.49 142.46 43.17 Favored Pre-proline 0 C--N 1.279 -2.492 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.79 -11.69 7.59 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.562 2.841 . . . . 0.0 114.576 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -98.99 18.33 17.52 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.989 -0.444 . . . . 0.0 110.788 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 75.01 17.71 2.66 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.636 1.175 . . . . 0.0 112.65 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 132' ' ' ASN . 34.8 mm -91.08 140.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 131' ' ' THR . 9.1 t-20 -98.1 152.49 19.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.471 ' C ' ' H ' ' A' ' 72' ' ' LEU . 4.0 mm? -112.29 -7.27 14.01 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.55 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 67.77 -21.08 0.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.291 1.436 . . . . 0.0 112.252 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.471 ' H ' ' C ' ' A' ' 70' ' ' LEU . 7.4 tt -79.4 133.3 36.56 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 124.067 0.947 . . . . 0.0 110.371 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.428 ' OG1' ' HB ' ' A' ' 39' ' ' THR . 20.4 m -117.45 133.44 55.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.2 t -98.47 108.79 22.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.3 mt -102.25 132.3 48.28 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 27.6 m -109.56 100.14 9.23 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.404 ' CD2' HG22 ' A' ' 56' ' ' VAL . 82.8 mt -87.04 155.62 20.07 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.768 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.92 93.52 2.68 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.535 ' NE ' ' HA ' ' A' ' 79' ' ' ARG . 2.5 mmp_? -106.55 108.47 19.99 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.393 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -83.19 -29.68 28.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -99.69 107.49 19.6 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 170.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -99.88 166.41 11.08 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.852 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -121.68 169.57 10.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -57.47 142.58 43.63 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.77 1.628 . . . . 0.0 112.117 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 14.6 t70 -75.86 96.0 3.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.885 0.85 . . . . 0.0 109.211 172.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.9 pt -84.91 10.71 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-O 121.813 0.815 . . . . 0.0 110.972 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -68.26 -24.71 64.92 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.4 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.91 -11.4 66.39 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.296 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -103.86 -4.55 23.37 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 117.138 0.469 . . . . 0.0 110.554 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -64.18 121.06 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.703 0.763 . . . . 0.0 110.708 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 m -93.32 114.99 27.57 Favored 'General case' 0 N--CA 1.391 -3.391 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.3 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -2.63 56.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 122.234 1.016 . . . . 0.0 108.958 175.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -113.34 113.72 25.65 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.58 -1.645 . . . . 0.0 107.347 176.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -115.98 -54.5 2.49 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.548 0.69 . . . . 0.0 111.674 -170.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -72.95 127.1 31.56 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.501 -168.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.93 -7.92 41.96 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.301 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 t -104.52 147.51 10.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 5.8 p-10 -89.23 145.45 25.4 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.15 155.59 45.25 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 122.156 0.979 . . . . 0.0 113.286 -175.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 27.1 m -111.27 127.83 55.74 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 113.565 -1.652 . . . . 0.0 107.387 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.9 tp -101.74 117.24 34.47 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.303 0.573 . . . . 0.0 109.933 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 t -94.01 97.14 6.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.481 ' O ' ' HB ' ' A' ' 111' ' ' THR . 15.6 m -88.34 126.63 41.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.584 ' CD2' HG21 ' A' ' 26' ' ' THR . 33.0 p-80 -153.93 153.82 32.71 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.352 0.596 . . . . 0.0 111.394 -173.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.4 p -154.58 -162.63 1.43 Allowed 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -84.91 -35.67 21.97 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 118.741 -1.183 . . . . 0.0 108.63 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -77.77 -36.37 50.66 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.417 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 104' ' ' HIS . 97.1 m-85 -115.37 93.2 4.19 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 m -112.22 150.77 30.41 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 71.76 19.15 4.99 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.687 0.795 . . . . 0.0 112.609 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 103' ' ' VAL . 43.7 m -80.47 101.13 8.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 82.5 mt -102.78 98.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.503 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.4 tp -112.72 105.89 14.13 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.669 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 6.5 pt-20 -79.67 139.65 37.32 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.821 -0.55 . . . . 0.0 111.917 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.0 m -107.63 -42.19 5.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.402 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 126.07 -158.06 20.17 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.615 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 98' ' ' ASP . 24.4 Cg_exo -64.37 126.04 16.21 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.682 2.921 . . . . 0.0 112.892 -178.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -92.08 151.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.371 0.605 . . . . 0.0 111.736 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.4 m -122.28 154.47 37.53 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -94.73 139.56 31.08 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.78 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 134' ' ' MET . . . -91.99 -23.62 19.49 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.06 -123.81 6.24 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.369 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -105.74 108.99 20.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.4 pt . . . . . 0 C--N 1.299 -1.611 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.59 178.677 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 N--CA 1.435 -1.914 0 N-CA-C 108.228 -1.489 . . . . 0.0 108.228 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.4 t -103.27 125.98 50.2 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-O 121.389 0.614 . . . . 0.0 109.523 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.514 ' HB2' HG21 ' A' ' 68' ' ' ILE . 27.6 t30 -83.3 134.42 34.93 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.007 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 63.04 49.78 3.33 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 124.126 0.891 . . . . 0.0 110.166 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.41 ' HB3' ' HB3' ' A' ' 121' ' ' ALA . 8.3 tpt -85.69 143.2 28.51 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 170' ' ' SER . 14.5 tt -112.66 144.97 19.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -132.96 142.62 48.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.289 0.566 . . . . 0.0 111.347 -173.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -134.74 115.96 14.34 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.43 92.56 1.1 Allowed 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -167.86 117.77 0.8 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.63 110.68 1.04 Allowed 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.545 0.688 . . . . 0.0 110.494 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.6 m -121.15 153.51 37.42 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -88.33 123.93 33.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.044 0.449 . . . . 0.0 110.977 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.4 t -78.52 151.43 32.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.9 -15.53 40.42 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -106.84 35.07 3.13 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 10.0 m -69.94 146.67 51.0 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.233 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.92 3.51 42.38 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.54 145.63 40.81 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.86 116.36 31.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 120.924 0.392 . . . . 0.0 110.226 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.2 tp -89.45 104.95 17.46 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.0 p -141.52 -173.73 3.85 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.254 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -161.54 -175.52 4.81 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 175.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.4 m -64.23 99.12 0.26 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 118.355 0.525 . . . . 0.0 110.765 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.15 18.66 71.4 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.98 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 74.5 mmtt -132.93 134.86 45.1 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -129.11 120.97 52.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -96.8 -46.19 6.35 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.8 0.687 . . . . 0.0 111.559 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.547 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 179.54 -176.03 47.37 Favored Glycine 0 N--CA 1.419 -2.477 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.715 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 22.7 pt -109.41 134.31 51.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 O-C-N 123.69 0.288 . . . . 0.0 110.228 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.421 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 11.2 t-80 -58.52 113.47 2.01 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 124.474 1.109 . . . . 0.0 110.25 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.5 t -88.27 -41.6 14.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.599 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.47 127.61 0.95 Allowed Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 119.022 -1.561 . . . . 0.0 113.103 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.462 ' HA2' ' HA2' ' A' ' 168' ' ' GLY . . . -78.68 79.5 1.55 Allowed Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 172.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -93.33 89.01 6.19 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 100.69 -147.3 17.89 Favored Glycine 0 N--CA 1.427 -1.915 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.392 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 43.1 ttm105 -85.57 -0.9 56.38 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.487 0.66 . . . . 0.0 110.223 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -124.52 124.93 43.35 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.887 -0.508 . . . . 0.0 110.064 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.462 ' HA2' ' HA2' ' A' ' 163' ' ' GLY . . . -84.25 126.46 7.62 Favored Glycine 0 N--CA 1.414 -2.8 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -109.71 127.15 54.4 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 121.213 0.53 . . . . 0.0 109.9 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.546 ' HB2' HG23 ' A' ' 135' ' ' ILE . 49.8 m -127.83 159.65 34.2 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -100.04 132.6 45.3 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -76.21 104.15 6.6 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.547 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -80.38 70.99 7.17 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.386 1.089 . . . . 0.0 111.431 177.44 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -63.1 139.94 58.82 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.186 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -53.14 -30.41 36.79 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 126.513 1.925 . . . . 0.0 111.499 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -62.29 -25.27 67.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -78.13 -20.48 52.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.571 0.701 . . . . 0.0 109.34 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -104.34 21.83 15.93 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.362 -171.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 52.6 t . . . . . 0 C--N 1.304 -1.404 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 173.554 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo . . . . . 0 N--CA 1.487 1.124 0 N-CA-C 116.163 1.563 . . . . 0.0 116.163 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -71.44 -38.58 71.34 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.929 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.443 HG23 HG21 ' A' ' 112' ' ' ILE . 54.2 m -71.25 -29.38 65.04 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.753 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.07 -43.57 74.34 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -64.82 -44.0 91.3 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.424 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -54.77 -49.35 71.11 Favored 'General case' 0 C--O 1.204 -1.318 0 O-C-N 123.97 0.794 . . . . 0.0 110.98 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 tp -63.67 -38.73 92.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.088 0.471 . . . . 0.0 111.423 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -71.12 -37.07 72.34 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.469 0.652 . . . . 0.0 110.893 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.86 -38.76 64.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.411 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.562 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 37.2 tp -49.61 -54.73 16.7 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 125.419 1.488 . . . . 0.0 112.568 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -72.53 -3.8 26.75 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -170.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -133.48 -29.89 1.33 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -120.87 -25.25 5.45 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.562 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 33.7 mt -95.26 105.96 17.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.3 mmt -122.51 149.54 43.77 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.118 0.485 . . . . 0.0 112.123 -175.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 m -80.2 124.46 28.81 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.9 mt -113.1 108.46 25.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.2 m -87.18 104.46 16.38 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.2 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 40.9 p -95.34 -156.6 0.52 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.465 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -75.88 -28.96 58.34 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -81.57 -38.16 26.58 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.27 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.84 -156.7 27.91 Favored Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 119.949 -1.119 . . . . 0.0 111.78 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.18 105.38 16.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.015 0.436 . . . . 0.0 110.703 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -107.66 176.07 5.27 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.0 m -115.56 134.5 55.0 Favored 'General case' 0 N--CA 1.408 -2.538 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.16 139.1 13.01 Favored Glycine 0 N--CA 1.412 -2.924 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.4 tp -102.11 118.24 36.48 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.08 114.31 3.83 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mm -78.77 -50.05 19.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 85' ' ' ASP . 25.0 p80 -167.67 145.38 4.51 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.151 176.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.581 ' HB3' ' HG3' ' A' ' 82' ' ' LYS 0.314 1.2 p30 46.8 -96.11 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 177.259 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 37.4 ptt180 -117.07 2.35 12.66 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.153 0.502 . . . . 0.0 110.882 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.6 t -91.72 106.38 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.631 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.6 m -122.49 162.18 22.21 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 p -133.17 140.81 46.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.62 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.0 tt -153.02 147.53 19.1 Favored Pre-proline 0 CA--C 1.561 1.384 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.75 147.51 94.6 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.417 2.078 . . . . 0.0 112.483 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.4 m -62.05 -44.9 95.69 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.281 0.633 . . . . 0.0 112.612 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -65.46 2.53 0.88 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.36 -23.28 54.16 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.455 ' O ' ' HB ' ' A' ' 20' ' ' THR . 13.4 mm100 64.47 77.35 0.3 Allowed Pre-proline 0 C--O 1.25 1.119 0 C-N-CA 125.228 1.411 . . . . 0.0 111.664 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.34 128.84 9.91 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.673 2.249 . . . . 0.0 110.826 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.52 -163.62 38.65 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.801 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.81 -33.64 75.2 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.657 0.741 . . . . 0.0 110.912 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -139.84 141.03 36.7 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.15 154.0 23.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 120.57 0.224 . . . . 0.0 110.918 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 8.2 mp -96.36 105.28 17.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.026 0.441 . . . . 0.0 111.173 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.59 93.53 4.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 t30 65.88 9.37 6.03 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.682 1.193 . . . . 0.0 110.732 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.69 -22.85 5.44 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -80.59 107.67 13.59 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -80.62 111.31 16.93 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.836 0.827 . . . . 0.0 109.204 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.1 tp -113.35 135.57 52.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.316 -174.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -68.69 132.8 47.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.858 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.89 126.92 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -77.67 -63.02 1.48 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.457 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -147.22 148.96 32.02 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -112.59 104.02 12.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.539 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.8 m-85 -81.55 95.18 7.06 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -75.23 123.0 24.53 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.11 102.96 15.29 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -177.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.9 132.56 60.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.3 145.25 86.47 Favored Pre-proline 0 C--N 1.307 -1.268 0 O-C-N 123.383 0.427 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.3 -21.98 73.43 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.558 2.172 . . . . 0.0 110.798 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.49 7.81 21.47 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.391 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 71.18 21.54 4.73 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.51 1.524 . . . . 0.0 113.15 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 132' ' ' ASN . 39.5 mm -92.49 152.75 3.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.657 ' O ' ' HA ' ' A' ' 131' ' ' THR . 48.3 t30 -85.5 138.4 32.24 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.43 -19.73 17.53 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 66.29 21.74 10.97 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 122.989 1.376 . . . . 0.0 109.475 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.3 tp -121.16 143.72 48.97 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.373 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.1 m -138.9 126.98 22.5 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.114 0.483 . . . . 0.0 110.388 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 60.6 t -86.87 110.79 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.7 tp -91.75 116.13 28.63 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.712 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.3 m -93.24 106.42 18.38 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.1 0.476 . . . . 0.0 109.882 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.54 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 8.3 mp -81.37 153.78 26.8 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.758 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.467 ' O ' HD11 ' A' ' 54' ' ' ILE . 22.8 t70 -83.41 74.68 10.05 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.84 0.829 . . . . 0.0 109.052 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -114.78 130.71 56.9 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.45 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -95.85 -39.64 9.72 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.72 129.13 38.68 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.578 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.581 ' HG3' ' HB3' ' A' ' 32' ' ' ASP . 51.7 tttp -89.02 102.86 15.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.301 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.45 ' H ' ' HA ' ' A' ' 32' ' ' ASP . 96.5 m-85 -70.47 156.34 39.5 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 172.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -49.7 132.49 21.77 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.779 1.232 . . . . 0.0 113.436 -173.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 31' ' ' HIS . 12.2 t70 -84.62 97.06 9.4 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.613 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -97.79 22.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.854 0.835 . . . . 0.0 110.921 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -60.55 -41.66 94.99 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.138 -174.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.63 1.43 66.89 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 116.11 -0.496 . . . . 0.0 113.72 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -95.83 -6.78 38.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.98 0.39 . . . . 0.0 110.51 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.3 mt -72.04 109.67 4.44 Favored 'Isoleucine or valine' 0 C--O 1.261 1.692 0 CA-C-O 121.308 0.575 . . . . 0.0 110.004 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 p -94.97 105.69 17.63 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.514 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -82.0 -13.05 57.97 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.819 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -94.28 115.62 27.89 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.7 mt -112.73 -56.97 2.35 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.188 -164.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 32.1 tt0 -60.11 112.37 1.87 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -164.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 119.25 -18.87 10.16 Favored Glycine 0 C--O 1.251 1.169 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.529 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.45 147.05 5.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.94 129.24 35.3 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -124.41 160.71 27.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.391 0.615 . . . . 0.0 111.901 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.8 m -121.16 145.02 48.26 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 124.471 1.108 . . . . 0.0 108.721 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.536 HD21 ' HB2' ' A' ' 160' ' ' HIS . 2.3 tm? -103.65 119.37 38.77 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.444 HG21 ' HB1' ' A' ' 7' ' ' ALA . 48.5 t -123.73 130.97 73.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.964 0.412 . . . . 0.0 112.071 -175.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.419 ' CG2' ' HB ' ' A' ' 111' ' ' THR . 17.4 m -125.38 142.84 40.96 Favored 'Isoleucine or valine' 0 C--O 1.254 1.326 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -71.65 -59.38 2.78 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.9 t -153.43 106.46 2.94 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 170.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.502 ' ND2' ' HA ' ' A' ' 145' ' ' GLN . 28.1 t-20 -103.9 -74.59 0.64 Allowed 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -100.11 -26.39 13.97 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.164 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -148.79 156.07 41.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.3 m -84.74 131.89 34.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.601 0.239 . . . . 0.0 111.113 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 70.12 71.32 0.22 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.812 1.245 . . . . 0.0 111.967 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.419 ' HB ' ' CG2' ' A' ' 103' ' ' VAL . 34.7 m -111.56 107.92 17.25 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.563 176.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.443 HG21 HG23 ' A' ' 4' ' ' THR . 61.5 mt -117.55 103.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.0 tp -123.46 124.49 43.0 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.307 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.2 140.82 56.1 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.695 0.76 . . . . 0.0 112.894 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.84 -57.16 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.136 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.77 -152.89 17.45 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.0 123.82 11.81 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 123.007 2.472 . . . . 0.0 112.306 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 27.3 m -96.97 157.63 3.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.9 p -133.29 164.83 26.21 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.647 0.379 . . . . 0.0 111.23 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 56.5 ttp -82.04 136.0 35.27 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -99.58 -52.79 3.38 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.521 0.677 . . . . 0.0 110.248 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.98 -110.53 3.76 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.817 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.0 tp -110.91 118.7 36.81 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mm . . . . . 0 C--N 1.302 -1.498 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.136 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.447 -1.247 0 N-CA-C 110.558 -0.593 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.5 m -122.2 127.41 49.96 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.458 ' HB2' HG21 ' A' ' 68' ' ' ILE . 64.1 t30 -111.51 158.96 18.56 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 111.133 0.049 . . . . 0.0 111.133 -174.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 61.7 50.94 4.13 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 122.968 1.366 . . . . 0.0 111.334 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 90.2 mmm -113.87 157.03 22.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.029 -1.896 . . . . 0.0 110.258 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.539 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 12.4 tt -107.37 147.16 12.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.557 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 39.3 ttp85 -126.89 140.95 51.97 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.268 0.627 . . . . 0.0 110.207 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -150.31 148.77 29.24 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.488 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.92 111.48 18.83 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -164.47 146.47 8.56 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.21 93.1 1.42 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.1 t -87.96 145.29 26.09 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.141 -174.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 145' ' ' GLN . 17.8 tppt? -134.73 125.46 27.05 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.2 m -73.29 124.83 26.46 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.59 -41.46 1.28 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.502 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 3.4 pt20 -84.07 42.86 0.89 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.456 1.122 . . . . 0.0 109.604 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 33.4 m -82.82 147.06 28.58 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.835 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.19 7.18 59.67 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -68.92 119.63 9.95 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.04 108.17 6.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 37.0 tp -84.53 107.9 17.01 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.1 p -142.1 164.9 28.92 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.266 0.555 . . . . 0.0 112.049 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.39 178.17 7.61 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.5 t -60.96 102.88 0.22 Allowed 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.756 0.788 . . . . 0.0 111.669 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 84.08 6.23 86.74 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.02 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -134.02 126.55 30.44 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 117.331 0.566 . . . . 0.0 111.275 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 76.2 mt -112.81 122.12 66.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -97.48 -22.17 16.72 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.883 0.373 . . . . 0.0 111.169 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 149.75 -163.8 29.4 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.551 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 148' ' ' GLY . 27.3 pt -128.21 134.11 65.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 120.989 0.424 . . . . 0.0 111.324 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.536 ' HB2' HD21 ' A' ' 101' ' ' LEU . 36.4 t-80 -60.52 133.32 55.98 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 124.852 1.261 . . . . 0.0 111.925 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.33 -6.73 11.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.916 0.389 . . . . 0.0 110.884 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 123.47 -158.59 18.09 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.448 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 156.79 178.13 30.59 Favored Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -134.23 119.08 18.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 100.72 -123.04 7.81 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.433 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -113.26 6.59 17.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.891 0.377 . . . . 0.0 111.472 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -112.76 113.87 26.17 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.478 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.16 133.1 11.62 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -111.32 137.79 48.62 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.555 0.693 . . . . 0.0 109.93 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.539 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 16.2 m -135.41 153.31 51.84 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.915 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.444 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -81.43 132.94 35.34 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -64.7 -9.22 18.39 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.8 mt 49.32 29.39 2.71 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -40.49 121.4 1.41 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.546 1.139 . . . . 0.0 110.632 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -53.58 -25.71 18.47 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.424 ' O ' HG12 ' A' ' 179' ' ' VAL . 28.5 pt20 -63.56 -17.17 62.55 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 123.71 0.804 . . . . 0.0 112.672 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.3 m-30 -73.63 -23.32 59.87 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.758 -0.589 . . . . 0.0 111.012 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.41 12.05 34.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -170.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 176' ' ' GLN . 12.0 p . . . . . 0 C--N 1.301 -1.513 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 CA--C 1.534 0.504 0 CA-C-O 120.979 0.324 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -61.97 -39.5 92.36 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.13 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -69.21 -40.41 78.01 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.572 0.749 . . . . 0.0 109.462 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.76 -44.18 96.86 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.479 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -67.19 -50.26 61.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.254 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.41 84.49 Favored 'General case' 0 C--O 1.209 -1.037 0 C-N-CA 123.204 0.602 . . . . 0.0 111.845 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.01 -39.57 95.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.017 0.437 . . . . 0.0 111.101 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 m -74.86 -32.81 61.99 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.72 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.417 HD11 HD13 ' A' ' 86' ' ' ILE . 57.5 tp -73.38 -40.67 64.16 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.484 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.587 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 2.2 tm? -54.4 -52.89 60.3 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.256 1.422 . . . . 0.0 111.82 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -66.44 -7.59 20.48 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -170.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -126.29 -51.66 1.52 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -104.73 -2.87 24.33 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -170.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.587 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 56.5 mt -114.42 104.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.6 tpt -135.74 154.78 51.14 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.833 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.402 HG23 ' HA ' ' A' ' 105' ' ' SER . 28.4 m -75.39 115.82 15.46 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.071 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 mt -99.58 99.74 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p -80.24 101.62 8.98 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.756 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 82.6 p -89.27 -166.15 1.52 Allowed 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.81 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -73.85 -20.91 60.3 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.879 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -101.18 -49.52 4.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.59 -157.12 8.52 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 118.82 -1.657 . . . . 0.0 113.537 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -109.38 94.72 5.18 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -100.69 160.77 14.09 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.9 m -99.49 123.69 43.98 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.3 123.68 7.94 Favored Glycine 0 N--CA 1.411 -2.996 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.8 tp -101.29 112.84 25.46 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.993 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.45 135.59 16.74 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.1 -50.88 6.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 117.716 0.758 . . . . 0.0 110.74 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -146.14 110.17 4.95 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.754 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.585 ' OD2' ' HG3' ' A' ' 33' ' ' ARG . 24.9 t70 56.73 -81.17 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 171.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.585 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -116.37 0.94 12.95 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.436 0.636 . . . . 0.0 111.61 179.478 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.0 t -88.57 114.9 27.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.914 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.1 t -125.95 144.63 50.61 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.84 139.86 29.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -148.89 143.5 17.17 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.49 154.72 73.27 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.957 1.772 . . . . 0.0 110.872 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -68.76 -42.15 77.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.563 0.697 . . . . 0.0 109.814 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -73.89 20.38 0.1 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.4 -23.36 21.08 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.319 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.568 ' O ' ' HB ' ' A' ' 20' ' ' THR . 24.6 mm-40 69.4 66.0 0.49 Allowed Pre-proline 0 N--CA 1.486 1.362 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -94.95 135.58 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 122.615 2.21 . . . . 0.0 110.816 172.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.71 -146.8 17.34 Favored Glycine 0 C--N 1.314 -0.652 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.966 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.14 -43.0 55.03 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.621 0.724 . . . . 0.0 109.258 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -123.65 139.63 53.8 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.9 p -125.95 153.04 33.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -92.35 120.41 32.85 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.83 85.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 175.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 t30 70.79 -10.13 0.76 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.509 1.123 . . . . 0.0 112.085 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.73 -39.21 0.57 Allowed Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -78.37 126.78 31.27 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -90.91 146.89 23.52 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.497 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.5 tp -132.64 135.22 57.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -86.19 139.25 31.24 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.186 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -78.01 137.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.506 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -87.63 -48.86 7.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -164.01 151.16 11.97 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.28 101.01 7.87 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.531 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 84.4 m-85 -81.79 125.95 31.27 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.96 116.13 24.0 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -77.43 108.7 10.78 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.553 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.96 130.8 72.28 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -80.75 139.53 50.56 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -56.01 -12.25 6.96 Favored 'Trans proline' 0 CA--C 1.555 1.539 0 C-N-CA 123.725 2.95 . . . . 0.0 114.484 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -83.22 -4.07 58.04 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 121.997 0.903 . . . . 0.0 108.698 174.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.5 t30 67.73 70.29 0.34 Allowed 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.19 1.396 . . . . 0.0 110.257 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.3 mt -141.73 145.1 24.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 131' ' ' THR . 17.1 m120 -76.74 161.65 28.32 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.573 0.546 . . . . 0.0 111.264 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -129.29 -32.07 2.03 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.604 174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 71.17 4.22 4.98 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 123.052 1.406 . . . . 0.0 110.204 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.428 HD13 HD23 ' A' ' 173' ' ' LEU . 70.7 mt -94.96 119.05 32.84 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.045 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.7 m -110.89 117.6 33.82 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 96.7 t -79.52 109.36 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.4 tp -87.01 99.46 11.91 Favored 'General case' 0 N--CA 1.397 -3.123 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.886 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.0 m -85.39 105.5 16.07 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.7 mt -90.34 164.49 14.32 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.473 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.26 130.13 36.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -59.54 99.69 0.07 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.808 0.843 . . . . 0.0 111.878 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -115.51 -65.69 1.16 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -100.94 109.41 21.33 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.419 ' HG3' ' OD1' ' A' ' 32' ' ' ASP . 53.6 tttm -69.4 116.82 10.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.041 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -70.21 145.88 51.11 Favored 'General case' 0 C--O 1.263 1.772 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -66.9 143.59 56.75 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.62 82.56 2.63 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.157 0.503 . . . . 0.0 111.22 -176.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.417 HD13 HD11 ' A' ' 10' ' ' LEU . 47.9 pt -89.83 11.1 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.685 0.755 . . . . 0.0 109.527 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.583 ' O ' ' HE2' ' A' ' 175' ' ' LYS . 57.4 ttp180 -66.85 -24.23 66.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.515 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.44 -24.41 75.1 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.406 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -86.46 -4.74 59.22 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 116.991 0.396 . . . . 0.0 111.167 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 173' ' ' LEU . 87.3 mt -61.92 121.1 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.8 m -99.61 108.93 21.43 Favored 'General case' 0 N--CA 1.382 -3.827 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.346 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -71.45 -25.15 62.18 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.32 111.7 22.6 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.907 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.409 HD11 ' CG ' ' A' ' 172' ' ' GLN . 72.9 mt -107.91 -66.5 1.03 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.515 ' CB ' ' HA ' ' A' ' 119' ' ' THR . 16.5 pt-20 -74.96 152.67 38.78 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -162.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.03 -19.1 38.61 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 114.064 -1.426 . . . . 0.0 111.016 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.6 t -94.37 139.32 18.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.776 0.322 . . . . 0.0 110.316 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.51 119.11 20.64 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 174.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -110.78 164.52 12.68 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.03 0.919 . . . . 0.0 113.453 -174.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.433 HG21 HG23 ' A' ' 112' ' ' ILE . 62.4 m -122.2 140.01 53.09 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.449 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -106.71 122.6 46.68 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.47 121.25 66.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 120.861 0.362 . . . . 0.0 110.044 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.71 145.05 22.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.403 ' HB3' HG22 ' A' ' 15' ' ' ILE . 65.8 t60 -135.65 90.99 2.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.863 0.839 . . . . 0.0 110.433 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.402 ' HA ' HG23 ' A' ' 17' ' ' THR . 25.7 p -120.17 -170.75 2.03 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -87.55 -31.52 19.86 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -70.85 -50.61 33.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.541 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -113.4 86.59 2.42 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.1 m -95.44 109.22 21.44 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.442 -176.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 71.37 35.01 1.6 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.864 0.727 . . . . 0.0 110.788 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.9 m -75.93 105.63 7.08 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 100' ' ' THR . 65.2 mt -103.54 105.93 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.795 -177.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 tp -118.74 118.82 32.63 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 120.715 0.293 . . . . 0.0 111.537 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -74.97 119.65 19.43 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -95.39 -35.31 5.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.22 -170.61 20.79 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.022 -1.085 . . . . 0.0 111.943 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.75 119.46 6.4 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.15 2.567 . . . . 0.0 111.303 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.4 m -82.32 151.74 4.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.515 ' HA ' ' CB ' ' A' ' 95' ' ' GLU . 8.9 t -141.97 163.48 32.77 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 47.7 tpp -86.19 134.86 33.76 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.701 0.286 . . . . 0.0 110.301 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.19 -25.29 14.94 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.11 -94.4 1.58 Allowed Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.554 ' O ' HD12 ' A' ' 123' ' ' LEU . 4.1 pp -147.02 119.66 8.55 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.21 0.528 . . . . 0.0 110.383 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.3 tt . . . . . 0 C--N 1.308 -1.196 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.917 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo . . . . . 0 N--CA 1.431 -2.199 0 CA-C-O 121.335 0.473 . . . . 0.0 112.917 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 2.0 p -100.16 130.48 46.3 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -72.04 132.95 44.94 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -172.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 172' ' ' GLN . 36.1 mmt180 58.97 50.89 7.78 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.656 1.182 . . . . 0.0 110.507 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.3 tpt -79.53 118.86 21.77 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.134 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.564 HG23 ' HB2' ' A' ' 170' ' ' SER . 12.4 tt -90.39 138.17 20.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.257 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -127.83 146.23 50.67 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.803 -169.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -147.5 136.64 22.34 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.138 0.975 . . . . 0.0 108.704 175.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -98.96 110.24 22.88 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 122.239 1.019 . . . . 0.0 110.176 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -171.81 134.13 0.78 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.53 90.1 0.25 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.906 0.86 . . . . 0.0 110.805 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 m -104.64 140.07 38.57 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -62.87 103.45 0.45 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.814 0.816 . . . . 0.0 110.741 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.0 m -74.96 116.94 16.26 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.792 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.39 -25.0 2.02 Favored Glycine 0 C--N 1.312 -0.787 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.737 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -83.1 50.7 1.79 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.248 1.023 . . . . 0.0 110.343 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 30.8 m -60.09 137.67 58.05 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.395 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 109.99 -5.17 30.5 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.358 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.2 134.94 25.35 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.658 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.8 p -76.83 126.41 37.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.522 0.677 . . . . 0.0 110.611 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 51.8 tp -94.57 108.62 20.58 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.9 p -144.7 175.61 10.04 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.239 0.542 . . . . 0.0 111.714 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -154.86 -177.9 6.84 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 175.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.1 t -64.21 103.07 0.58 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.586 0.708 . . . . 0.0 111.386 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.37 26.37 66.01 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.741 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 59.9 mmtt -143.22 114.43 7.86 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.12 0.568 . . . . 0.0 110.626 -177.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 89.2 mt -113.5 123.95 69.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 169.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -99.49 -27.6 13.64 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.503 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 149.88 -149.58 21.52 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.5 pt -131.26 149.11 32.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 117.134 0.467 . . . . 0.0 111.21 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -68.56 115.77 8.34 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.841 0.856 . . . . 0.0 109.129 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.2 t -97.81 -36.44 5.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.07 -149.66 8.96 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -177.41 163.07 31.41 Favored Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -142.58 121.88 13.08 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.19 -126.42 9.41 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -104.6 2.34 30.58 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -92.89 112.64 24.68 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.081 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.18 135.0 13.37 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -117.52 119.8 36.15 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 122.122 0.963 . . . . 0.0 110.962 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.564 ' HB2' HG23 ' A' ' 135' ' ' ILE . 20.8 m -119.7 154.53 33.96 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -104.35 144.7 31.28 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.212 -177.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 133' ' ' ARG . 0.7 OUTLIER -81.89 118.1 22.66 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.189 0.93 . . . . 0.0 108.986 -177.802 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.428 HD23 HD13 ' A' ' 72' ' ' LEU . 66.9 mt -93.16 74.41 4.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -67.69 146.07 54.16 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.586 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.583 ' HE2' ' O ' ' A' ' 87' ' ' ARG . 94.7 mttt -57.36 -31.0 65.31 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.807 0.813 . . . . 0.0 110.324 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -68.69 -9.01 47.76 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.743 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -92.56 -23.26 19.12 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 121.921 -0.487 . . . . 0.0 110.05 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -102.17 18.82 19.91 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.217 -174.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--N 1.307 -1.277 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.048 179.279 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo . . . . . 0 CA--C 1.532 0.387 0 CA-C-O 120.734 0.223 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -67.53 -37.01 82.11 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.064 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -62.35 -49.58 75.0 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.65 0.78 . . . . 0.0 109.789 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.09 -43.99 90.33 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.949 0.9 . . . . 0.0 110.015 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -58.46 -47.73 83.05 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.007 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -62.39 -48.16 80.96 Favored 'General case' 0 C--O 1.206 -1.185 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.964 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.05 -41.77 88.69 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.304 0.642 . . . . 0.0 110.321 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.0 m -65.29 -43.38 91.34 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.999 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.476 HD11 HD13 ' A' ' 86' ' ' ILE . 59.8 tp -66.53 -43.53 84.93 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.954 0.901 . . . . 0.0 109.666 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 16.5 tp -49.57 -59.57 3.65 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 126.134 1.774 . . . . 0.0 112.755 -176.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -80.49 11.07 3.95 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.141 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -123.01 -56.66 1.74 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.67 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -119.3 4.63 11.24 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 33.4 mt -99.66 98.16 6.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.747 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.92 144.17 30.19 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.369 -175.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 45.5 m -79.95 115.31 19.45 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 172.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.8 mt -115.14 107.46 22.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.438 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.3 m -89.78 113.25 24.76 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 76.7 p -93.87 -157.46 0.55 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.595 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -83.32 0.72 44.57 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -112.52 -52.23 2.79 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.812 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' THR . . . -175.15 -160.14 22.51 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 119.823 -1.179 . . . . 0.0 111.943 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.14 105.88 18.11 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.82 169.42 8.85 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.5 m -99.69 123.45 43.97 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.13 118.89 6.11 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.1 tp -98.38 113.89 26.03 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.504 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.18 112.66 3.84 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.6 mm -86.65 -52.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 116.564 0.182 . . . . 0.0 110.789 -176.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -162.19 141.65 9.62 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.34 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 16.1 t70 59.37 -90.98 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 175.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -135.6 9.08 3.37 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.278 1.037 . . . . 0.0 108.709 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.482 HG13 ' CG1' ' A' ' 74' ' ' VAL . 53.9 t -80.72 108.81 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.777 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.0 m -113.01 145.47 40.79 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.424 ' CG1' HD21 ' A' ' 72' ' ' LEU . 48.8 t -112.5 133.97 56.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 O-C-N 122.185 -0.322 . . . . 0.0 111.29 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 tt -153.88 145.17 16.43 Favored Pre-proline 0 CA--C 1.566 1.571 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.616 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 31.3 Cg_exo -65.16 150.18 87.97 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.356 2.037 . . . . 0.0 113.009 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.0 m -58.1 -43.01 86.89 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.6 0.76 . . . . 0.0 112.686 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -69.59 -1.65 9.39 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.65 -32.7 62.34 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.431 ' O ' ' HB ' ' A' ' 20' ' ' THR . 77.9 mt-30 52.15 82.48 0.24 Allowed Pre-proline 0 C--O 1.248 1.024 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.46 143.13 16.96 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.965 2.443 . . . . 0.0 110.559 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.59 -136.41 7.54 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.559 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.33 -31.03 30.1 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 5.2 p-10 -136.55 153.4 51.0 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.24 -1.345 . . . . 0.0 107.622 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.53 158.39 42.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 76.7 mt -99.48 103.08 14.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 17' ' ' THR . 72.6 t -83.45 91.73 2.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 175.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 62.78 15.81 8.48 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.079 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.01 -18.36 7.95 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.251 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -84.63 119.73 25.56 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.262 0.225 . . . . 0.0 110.772 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -71.74 119.05 15.36 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.959 0.409 . . . . 0.0 111.986 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.451 HD11 ' O ' ' A' ' 78' ' ' ASP . 16.7 tt -132.72 139.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 174.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 41.7 mtp180 -82.25 157.45 23.89 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.527 0.679 . . . . 0.0 112.481 -177.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.58 140.4 16.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.439 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -93.8 -54.24 3.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' H ' ' HB ' ' A' ' 76' ' ' THR . 7.5 t70 -146.24 165.73 28.35 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -140.38 95.1 2.82 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.0 m-85 -83.3 100.59 10.73 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.7 102.3 2.27 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 tt -83.39 102.83 12.3 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-O 122.065 0.936 . . . . 0.0 109.143 -171.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 67.3 t -109.86 139.52 32.71 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.05 141.64 86.26 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.7 -10.22 2.34 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 123.513 2.808 . . . . 0.0 114.838 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -97.5 7.24 46.86 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 121.676 0.75 . . . . 0.0 109.862 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 73.61 23.26 2.44 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.123 1.369 . . . . 0.0 114.394 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.3 mm -96.89 140.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 131' ' ' THR . 5.0 m-20 -66.24 133.32 50.36 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 120.892 0.377 . . . . 0.0 111.341 -177.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 133' ' ' ARG . 58.7 tp -94.37 -15.36 24.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 170.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 61.58 27.28 16.8 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.986 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.424 HD21 ' CG1' ' A' ' 36' ' ' VAL . 2.7 tm? -125.07 140.84 52.54 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.171 -173.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.419 ' N ' HD13 ' A' ' 72' ' ' LEU . 93.9 m -134.32 130.2 36.64 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.373 0.606 . . . . 0.0 110.264 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 51.5 t -87.02 108.7 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -89.5 113.56 24.96 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -175.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.413 ' HB ' ' H ' ' A' ' 58' ' ' ASP . 16.3 m -90.66 97.46 11.19 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.401 HD11 ' CG2' ' A' ' 54' ' ' ILE . 17.6 tp -78.11 150.16 33.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.451 ' O ' HD11 ' A' ' 54' ' ' ILE . 35.5 t70 -79.91 95.77 6.18 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 119.019 -1.073 . . . . 0.0 109.765 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' A' ' 79' ' ' ARG . 4.4 mmp_? -133.12 110.07 9.92 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.315 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -85.92 -28.25 24.45 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 168.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -78.2 91.02 4.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 171.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 24.3 pttm -78.53 150.81 32.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -170.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -86.82 160.46 18.76 Favored 'General case' 0 C--O 1.256 1.403 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.811 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -81.35 140.97 34.45 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 5.5 p-10 -76.32 106.74 8.12 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 122.376 1.084 . . . . 0.0 110.19 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.476 HD13 HD11 ' A' ' 10' ' ' LEU . 22.7 pt -88.13 17.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 122.192 0.996 . . . . 0.0 109.468 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -63.21 -27.51 69.41 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.812 -1.54 . . . . 0.0 111.947 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.61 -16.82 78.99 Favored Glycine 0 C--N 1.317 -0.483 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.708 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -93.36 -3.4 53.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.731 0.3 . . . . 0.0 110.384 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.5 mt -66.08 135.72 27.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.155 0.502 . . . . 0.0 110.564 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.8 t -125.63 103.75 8.01 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -87.54 -8.59 56.15 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.593 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.24 123.15 36.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.414 HD11 ' CD ' ' A' ' 172' ' ' GLN . 20.1 mt -106.38 -71.06 0.76 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -164.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 11.1 pt-20 -50.45 137.09 19.62 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -165.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.34 -14.05 33.26 Favored Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.658 174.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.05 144.06 18.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 122.415 -0.462 . . . . 0.0 110.368 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.13 116.87 21.25 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.28 159.5 14.95 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.396 0.617 . . . . 0.0 110.731 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.2 m -129.39 133.52 47.41 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.37 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.7 mt -90.91 125.72 35.84 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.422 ' HB ' ' CG1' ' A' ' 149' ' ' VAL . 30.5 t -117.69 107.63 22.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.414 HG22 ' HA3' ' A' ' 148' ' ' GLY . 10.6 t -109.02 147.71 13.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.534 ' CE1' HG23 ' A' ' 109' ' ' THR . 2.6 t-80 -140.0 106.91 5.41 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.41 ' HA ' HG23 ' A' ' 17' ' ' THR . 52.8 p -128.74 -170.47 2.27 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -89.91 -34.94 15.87 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 176.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -63.06 -45.5 91.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.788 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . 0.265 9.3 p90 -133.53 96.55 3.73 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.603 1.192 . . . . 0.0 112.509 175.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.534 HG23 ' CE1' ' A' ' 104' ' ' HIS . 90.8 m -83.43 122.58 28.69 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.943 178.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.01 71.24 0.52 Allowed 'General case' 0 C--O 1.245 0.867 0 C-N-CA 124.321 1.048 . . . . 0.0 112.867 176.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.5 m -102.15 99.15 9.25 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.998 176.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.4 mt -95.19 110.62 24.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.7 tp -128.9 108.23 10.26 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.864 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -68.28 124.9 24.77 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.0 m -99.05 -27.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.613 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.92 -164.8 12.19 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 119.81 -1.186 . . . . 0.0 112.119 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.08 129.98 19.33 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.014 2.476 . . . . 0.0 112.668 -177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 31.2 m -96.27 161.54 2.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.381 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.8 p -144.35 164.69 30.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.738 1.215 . . . . 0.0 108.683 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 52.2 ttm -86.93 139.28 30.78 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.637 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -105.37 -40.57 5.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.739 0.305 . . . . 0.0 111.465 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.73 -113.51 3.7 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.606 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.7 mt -93.22 120.6 33.68 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.009 0.524 . . . . 0.0 110.049 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.739 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 C--O 1.248 0.977 0 CA-C-O 121.141 0.392 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 22.3 p -109.1 135.03 50.91 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.814 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -111.27 164.35 12.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.447 ' HG3' ' HB2' ' A' ' 172' ' ' GLN . 12.7 tpp180 66.38 27.49 9.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.577 1.151 . . . . 0.0 108.976 173.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.2 mmt -79.57 150.44 31.08 Favored 'General case' 0 C--O 1.251 1.152 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.429 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.541 HG23 ' HB2' ' A' ' 170' ' ' SER . 8.6 tt -115.57 141.87 30.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 173.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.637 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 39.4 ttt180 -127.25 139.34 52.98 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 123.216 0.606 . . . . 0.0 111.319 -171.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -149.23 144.02 26.27 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.01 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.67 107.41 19.16 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.886 0.741 . . . . 0.0 110.171 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -173.02 138.17 0.75 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.75 92.08 2.45 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.511 0.672 . . . . 0.0 110.103 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.2 t -79.19 165.92 22.75 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.531 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -120.25 163.13 18.24 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.6 t -78.56 153.63 31.05 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.78 -9.11 63.97 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -89.32 4.5 48.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.204 0.526 . . . . 0.0 111.315 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.616 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 48.0 t -58.11 120.74 9.15 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.453 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.43 -12.52 56.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.02 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.414 ' HA3' HG22 ' A' ' 103' ' ' VAL . . . -68.29 131.99 27.63 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.456 ' HA ' HG22 ' A' ' 159' ' ' ILE . 7.4 p -70.21 124.59 26.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.699 0.761 . . . . 0.0 111.219 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.1 tp -94.2 98.71 11.14 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 22.6 p -140.07 156.44 46.58 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.312 0.577 . . . . 0.0 111.586 -174.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -121.24 -173.18 2.56 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 t -71.75 79.51 0.85 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.005 0.907 . . . . 0.0 112.952 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 105.91 8.96 33.39 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.98 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -137.31 104.44 5.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 84.4 mt -93.86 120.14 42.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -94.82 -34.06 12.62 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.577 0.703 . . . . 0.0 110.538 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 165.19 -149.08 15.15 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.309 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' A' ' 149' ' ' VAL . 46.0 pt -135.01 149.21 28.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -66.63 133.36 50.12 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.295 0.638 . . . . 0.0 110.71 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 86.6 t -108.46 -59.69 3.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.09 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -159.58 153.39 24.42 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.282 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -115.56 125.86 6.88 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.409 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -112.24 97.49 6.67 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.7 -113.33 5.19 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -99.91 -6.35 26.85 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.963 0.411 . . . . 0.0 110.497 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -96.18 102.35 14.13 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.343 0.592 . . . . 0.0 110.792 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.24 119.7 4.96 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -105.41 123.84 48.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.854 0.835 . . . . 0.0 110.213 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.541 ' HB2' HG23 ' A' ' 135' ' ' ILE . 14.6 m -123.94 166.17 16.14 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.908 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.517 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -98.42 131.0 45.04 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.447 ' HB2' ' HG3' ' A' ' 133' ' ' ARG . 46.5 mt-30 -73.39 121.54 20.64 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 123.869 0.73 . . . . 0.0 109.885 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.414 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 89.0 mt -95.44 85.0 4.1 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -72.34 146.02 47.39 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.458 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -65.7 -24.99 67.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -48.18 -39.1 19.84 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.232 1.813 . . . . 0.0 111.56 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -83.35 -9.9 58.79 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.05 -0.406 . . . . 0.0 111.477 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -122.42 18.16 10.54 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 121.126 -0.229 . . . . 0.0 111.157 -174.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.242 0.671 0 CA-C-O 121.845 0.831 . . . . 0.0 111.662 179.401 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo . . . . . 0 C--O 1.243 0.753 0 CA-C-O 121.42 0.508 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -66.92 -34.21 77.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.738 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.9 m -67.64 -43.68 79.76 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.672 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.54 -43.0 95.36 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.929 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -61.4 -45.48 94.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.02 82.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.01 0.433 . . . . 0.0 111.269 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.5 -44.02 75.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.986 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 p -73.78 -34.53 64.71 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 120.722 0.296 . . . . 0.0 111.594 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.35 -40.72 95.32 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.737 0.815 . . . . 0.0 109.494 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.5 tp -48.97 -61.0 2.3 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 125.209 1.403 . . . . 0.0 113.649 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -80.91 11.85 3.69 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -172.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -127.0 -53.57 1.41 Allowed 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.16 0.505 . . . . 0.0 111.512 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -107.01 -9.6 16.18 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -171.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.3 mt -105.05 125.65 60.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 120.731 0.3 . . . . 0.0 110.932 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.08 135.73 27.6 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.934 0.397 . . . . 0.0 111.131 177.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.465 ' HA ' HG22 ' A' ' 26' ' ' THR . 4.5 m -68.1 132.78 47.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.662 176.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.89 113.1 31.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 121.002 0.43 . . . . 0.0 110.161 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 24.9 m -78.08 104.83 8.89 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.6 p -90.89 -165.11 1.28 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.412 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.1 m -84.7 -7.6 59.16 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 121.049 0.452 . . . . 0.0 111.028 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -108.98 -46.21 3.65 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.223 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -166.17 -173.08 34.25 Favored Glycine 0 CA--C 1.497 -1.07 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.198 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -98.94 97.22 8.42 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -104.91 -173.69 2.36 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.55 HG23 ' HA ' ' A' ' 105' ' ' SER . 2.2 p -124.52 145.28 49.65 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.58 150.26 18.7 Favored Glycine 0 N--CA 1.412 -2.964 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -107.48 118.81 37.71 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.75 119.9 5.1 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mm -83.66 -49.38 16.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 117.205 0.503 . . . . 0.0 109.656 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -170.56 157.12 5.7 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.174 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 5.3 m-20 53.75 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.292 1.037 . . . . 0.0 112.974 177.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -139.16 11.77 2.6 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.672 0.749 . . . . 0.0 109.078 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.0 t -88.25 112.79 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.893 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.4 m -128.82 152.85 48.03 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.426 ' HB ' HD11 ' A' ' 72' ' ' LEU . 29.9 m -115.65 148.97 18.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.0 tp -151.96 148.62 21.87 Favored Pre-proline 0 CA--C 1.564 1.499 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -67.26 147.77 79.06 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 121.92 1.746 . . . . 0.0 111.899 174.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.8 m -66.11 -41.36 90.67 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.036 0.446 . . . . 0.0 112.202 -176.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -65.76 -13.26 59.05 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.73 -26.95 63.61 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 62.79 87.37 0.13 Allowed Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.622 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.12 151.23 15.97 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 122.325 2.017 . . . . 0.0 110.066 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.14 -168.88 24.03 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.49 -13.47 59.82 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.205 0.526 . . . . 0.0 111.885 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -148.08 138.82 23.07 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.61 160.65 42.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 81.2 mt -93.31 107.68 19.46 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.3 p -90.07 84.22 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-O 122.864 1.316 . . . . 0.0 109.354 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.5 t30 62.36 20.69 12.01 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.614 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.87 -47.85 0.98 Allowed Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.545 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -66.9 124.7 23.7 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -80.22 123.23 27.76 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.432 HD11 ' O ' ' A' ' 78' ' ' ASP . 8.6 tp -122.35 125.68 73.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 55' ' ' ARG . 53.5 mtt180 -72.88 123.83 24.19 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.478 0.656 . . . . 0.0 109.379 175.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.0 t -93.66 116.23 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 28.7 ttpp -68.4 -72.09 0.19 Allowed 'General case' 0 C--N 1.293 -1.883 0 O-C-N 123.499 0.499 . . . . 0.0 111.023 -175.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.487 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.4 m-20 -108.63 146.12 33.87 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 122.039 -0.413 . . . . 0.0 110.925 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -116.69 102.7 9.66 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.56 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 91.7 m-85 -89.56 94.63 9.94 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.613 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -71.18 98.64 1.73 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 174.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.526 HD23 HD23 ' A' ' 72' ' ' LEU . 36.3 tp -77.05 108.15 9.92 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 122.252 1.025 . . . . 0.0 112.563 -167.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.84 151.09 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.796 0 CA-C-N 113.415 -1.72 . . . . 0.0 107.225 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.39 140.11 89.91 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.13 -21.36 9.06 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.496 2.798 . . . . 0.0 114.821 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.22 8.54 23.58 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.053 0.454 . . . . 0.0 110.978 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.2 t30 73.36 68.03 0.11 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.821 1.649 . . . . 0.0 112.004 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.512 HG21 ' HB2' ' A' ' 132' ' ' ASN . 55.0 mt -143.2 147.3 20.56 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -90.52 156.1 18.41 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.418 1.008 . . . . 0.0 111.987 -174.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' A' ' 133' ' ' ARG . 8.7 mp -112.33 -11.73 13.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.479 174.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 68.26 25.07 7.27 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 123.267 1.508 . . . . 0.0 108.284 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.526 HD23 HD23 ' A' ' 62' ' ' LEU . 58.3 tp -125.19 142.08 51.71 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.417 -1.719 . . . . 0.0 109.426 -174.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.0 m -135.82 134.04 38.48 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 43.2 t -102.08 125.67 56.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.37 138.19 42.99 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.106 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.2 m -98.65 99.16 10.25 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.8 mt -80.44 104.97 11.34 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.432 ' O ' HD11 ' A' ' 54' ' ' ILE . 33.9 t70 -81.36 92.82 6.47 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -146.49 175.25 10.71 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.77 -22.75 23.13 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -78.97 123.07 26.93 Favored 'General case' 0 C--O 1.247 0.969 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.012 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 20.4 pttp -100.22 139.51 35.78 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.051 -177.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -75.78 157.11 33.86 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.477 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -64.97 131.34 46.36 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.966 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.58 93.29 2.01 Favored 'General case' 0 C--O 1.2 -1.549 0 CA-C-O 122.029 0.918 . . . . 0.0 112.565 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.4 pt -96.24 21.27 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 O-C-N 120.83 -1.168 . . . . 0.0 109.584 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -69.4 -31.71 70.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.664 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -79.73 -7.37 88.56 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.129 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 64.7 m-85 -97.94 -0.8 44.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.245 0.545 . . . . 0.0 109.897 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.57 116.94 8.03 Favored 'Isoleucine or valine' 0 C--O 1.254 1.316 0 CA-C-O 121.229 0.538 . . . . 0.0 110.853 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.6 t -102.26 107.15 18.1 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.53 ' HG2' ' HA ' ' A' ' 174' ' ' LYS . 32.5 mt-10 -87.95 -6.56 57.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -95.15 118.01 31.21 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 175.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.444 HD11 ' CD ' ' A' ' 172' ' ' GLN . 12.8 mt -116.11 -60.56 1.85 Allowed 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.968 0.89 . . . . 0.0 110.966 -170.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 34.5 tt0 -64.8 120.04 11.75 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.651 -167.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 112.36 -22.1 18.33 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.529 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.1 t -91.57 141.42 14.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.82 123.96 28.68 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -110.43 158.58 18.32 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.674 0.749 . . . . 0.0 111.355 -177.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.8 m -123.86 123.96 41.6 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.858 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.6 tp -95.78 116.32 28.72 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.42 104.15 14.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.513 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 93.5 t -84.21 115.51 26.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.422 ' CD2' HG21 ' A' ' 26' ' ' THR . 37.2 p-80 -153.17 156.6 38.9 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.55 ' HA ' HG23 ' A' ' 26' ' ' THR . 78.1 p -175.49 -152.69 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -84.61 -25.87 28.28 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 119.273 0.942 . . . . 0.0 108.585 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -87.48 -48.86 7.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.98 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -94.39 144.14 25.81 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 23.4 m -148.81 124.42 10.42 Favored 'General case' 0 C--N 1.281 -2.403 0 O-C-N 121.356 -0.84 . . . . 0.0 110.311 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.63 30.86 20.51 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.068 0.855 . . . . 0.0 113.073 173.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.513 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 95.3 m -83.88 87.35 7.09 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-O 122.08 0.943 . . . . 0.0 108.741 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 75.4 mt -77.16 102.22 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.174 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.3 tp -109.51 103.83 12.78 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.104 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -76.13 121.6 23.08 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.9 m -104.19 -10.16 9.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.11 -153.12 24.23 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.632 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.29 124.87 11.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.544 2.163 . . . . 0.0 112.704 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 16.6 m -92.58 160.12 2.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.199 177.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.407 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . 13.9 p -130.91 159.11 38.38 Favored 'General case' 0 C--O 1.251 1.169 0 O-C-N 123.346 0.404 . . . . 0.0 111.155 -177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 25.3 ttt -79.65 118.06 21.13 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -75.4 -42.17 54.43 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 176.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.2 -100.21 2.65 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.171 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 124' ' ' ILE . 7.1 tt -130.52 145.56 51.88 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.46 ' N ' HD23 ' A' ' 123' ' ' LEU . 14.8 tt . . . . . 0 C--N 1.291 -1.938 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 N--CA 1.442 -1.508 0 CA-C-O 121.373 0.489 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.8 m -119.28 133.39 55.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.512 ' HB2' HG21 ' A' ' 68' ' ' ILE . 57.0 t30 -131.08 170.72 14.14 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HB2' ' HG ' ' A' ' 70' ' ' LEU . 30.6 mmt180 64.48 41.62 5.51 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.211 1.004 . . . . 0.0 108.925 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.524 ' SD ' ' HB3' ' A' ' 169' ' ' PHE . 48.3 ttm -109.56 149.63 29.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.634 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 170' ' ' SER . 13.2 tt -115.19 147.61 18.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 123.765 0.826 . . . . 0.0 108.856 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.57 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 43.7 ttp180 -127.62 143.95 51.12 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.116 0.484 . . . . 0.0 111.089 -174.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -149.14 136.23 19.9 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 171.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.97 91.01 7.07 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.867 1.317 . . . . 0.0 111.905 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -156.3 125.88 6.28 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.93 89.79 1.43 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.531 0.52 . . . . 0.0 110.624 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.0 p -79.27 170.1 17.12 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.885 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -110.14 141.8 42.52 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.346 0.593 . . . . 0.0 111.423 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.8 m -71.22 125.98 28.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 125.52 -25.32 5.68 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -174.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -87.16 24.31 1.6 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.6 m -75.39 128.13 34.68 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.55 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.74 1.4 49.43 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.264 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.79 135.8 28.74 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 86.5 t -90.32 120.09 38.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 CA-C-O 121.18 0.514 . . . . 0.0 110.58 -174.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.4 tp -92.1 106.71 18.66 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.9 p -142.22 -178.9 5.95 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.306 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.75 -175.42 5.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.3 m -61.02 101.8 0.17 Allowed 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 122.602 0.361 . . . . 0.0 111.617 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 73.11 22.7 78.79 Favored Glycine 0 C--O 1.244 0.734 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.12 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 58.2 mttp -140.81 114.17 8.66 Favored 'General case' 0 C--O 1.206 -1.213 0 O-C-N 122.887 -0.184 . . . . 0.0 111.115 -175.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.29 126.85 57.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.08 -38.07 9.89 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.719 0.771 . . . . 0.0 109.504 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 165.11 -160.22 33.48 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.849 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.74 145.29 33.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 120.704 0.288 . . . . 0.0 110.402 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -66.13 130.98 45.09 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.88 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.0 t -95.9 -56.68 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.43 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.17 164.09 29.26 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.03 125.35 8.54 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -111.16 81.75 1.49 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.93 -123.65 6.38 Favored Glycine 0 N--CA 1.422 -2.235 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -89.17 -13.94 37.21 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.208 0.527 . . . . 0.0 109.7 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -98.26 122.85 41.94 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.065 0.459 . . . . 0.0 111.424 -177.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.19 121.99 6.54 Favored Glycine 0 N--CA 1.422 -2.245 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.524 ' HB3' ' SD ' ' A' ' 134' ' ' MET . 84.3 m-85 -108.82 134.91 50.87 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.435 0.636 . . . . 0.0 110.993 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.486 ' HB2' HG23 ' A' ' 135' ' ' ILE . 18.8 m -133.11 158.99 41.4 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.966 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.498 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -92.71 140.9 29.05 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.444 ' CD ' HD11 ' A' ' 94' ' ' LEU . 78.6 mt-30 -84.58 124.49 31.48 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 121.475 0.655 . . . . 0.0 111.325 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.456 HD23 HD21 ' A' ' 72' ' ' LEU . 98.2 mt -93.63 92.78 7.7 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.53 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 68.2 mttm -87.09 150.45 23.99 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.509 ' O ' HG13 ' A' ' 179' ' ' VAL . 10.0 ptpp? -77.12 -13.68 59.91 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.958 -176.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -58.81 -22.43 58.51 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.602 1.161 . . . . 0.0 111.11 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 174' ' ' LYS . 45.5 m-85 -91.1 -8.74 47.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.196 0.522 . . . . 0.0 110.331 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -119.58 10.93 11.91 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.547 -175.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 175' ' ' LYS . 31.6 m . . . . . 0 C--N 1.313 -0.981 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo . . . . . 0 N--CA 1.483 0.872 0 N-CA-C 115.477 1.299 . . . . 0.0 115.477 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -59.14 -49.84 76.32 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.7 m -64.8 -39.54 93.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.89 0.476 . . . . 0.0 111.088 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.79 -41.79 78.23 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.006 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -62.35 -43.4 98.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.66 98.45 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.114 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.06 -33.06 75.14 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-O 121.246 0.546 . . . . 0.0 111.187 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -71.32 -53.57 13.74 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.9 tp -53.86 -44.37 70.3 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.8 0.84 . . . . 0.0 109.891 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.498 ' HA ' HD12 ' A' ' 15' ' ' ILE . 44.4 tp -51.65 -58.46 6.29 Favored 'General case' 0 C--O 1.206 -1.191 0 C-N-CA 125.522 1.529 . . . . 0.0 112.644 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -87.73 0.2 56.06 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -172.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -112.81 -44.1 3.35 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -121.75 3.49 10.07 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 11' ' ' LEU . 59.0 mt -112.72 130.23 66.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.166 0.508 . . . . 0.0 110.52 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.75 165.51 26.25 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.398 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.7 m -98.99 118.34 35.54 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.63 120.87 55.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.487 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 24.1 m -79.9 101.39 8.55 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.352 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.2 p -104.53 -174.31 2.51 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.281 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -75.16 -35.0 61.65 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -91.03 3.54 54.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.23 -174.32 27.96 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.167 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 19' ' ' THR . 38.8 mt-10 -112.51 94.3 4.85 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -92.63 179.86 5.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.504 -171.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 20.3 m -86.61 124.28 32.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.719 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.0 130.81 10.38 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 175.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.0 tp -110.16 119.09 38.17 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.964 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.08 123.5 6.23 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 174.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mm -87.52 -44.11 15.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -171.85 144.18 1.73 Allowed 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.534 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.508 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 37.1 t70 60.32 -89.24 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.657 1.223 . . . . 0.0 112.083 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.652 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 36.0 ptt180 -140.25 11.13 2.36 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.998 0.904 . . . . 0.0 109.937 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.0 t -79.88 112.97 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.237 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 m -123.29 151.69 42.15 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 124.013 0.821 . . . . 0.0 110.235 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 74' ' ' VAL . 21.9 t -125.77 141.85 44.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.7 tt -157.22 150.61 18.88 Favored Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -71.6 155.31 59.31 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.019 1.812 . . . . 0.0 112.202 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.6 m -71.16 -33.14 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.266 -0.271 . . . . 0.0 110.301 -177.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -66.15 -2.76 4.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.28 -28.23 59.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 69.38 81.06 0.2 Allowed Pre-proline 0 C--O 1.232 0.144 0 C-N-CA 125.336 1.454 . . . . 0.0 112.559 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -96.96 171.2 0.86 Allowed 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.777 2.318 . . . . 0.0 111.788 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.72 -143.31 6.95 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -91.1 -29.96 17.01 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.671 0.748 . . . . 0.0 110.075 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -141.23 135.33 30.6 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.75 -172.62 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.392 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.7 mt -113.25 128.14 56.38 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.39 96.88 4.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 58.29 20.37 7.16 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.188 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.02 -36.3 2.87 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.347 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -74.54 134.45 42.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.705 0.253 . . . . 0.0 110.832 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -75.83 111.89 11.67 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.52 HD11 ' O ' ' A' ' 78' ' ' ASP . 11.1 tp -120.14 140.22 44.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.074 0.464 . . . . 0.0 111.142 -174.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.529 ' N ' ' HD2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -97.85 138.84 34.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.8 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 75' ' ' LEU . 48.4 t -100.32 109.63 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -70.02 -71.77 0.22 Allowed 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.904 0.753 . . . . 0.0 110.564 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' H ' ' HB ' ' A' ' 76' ' ' THR . 20.8 m-20 -102.98 141.36 35.92 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -126.95 96.15 4.54 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -96.1 107.59 19.93 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -93.55 116.71 29.23 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.455 ' HB3' HD12 ' A' ' 70' ' ' LEU . 4.2 mm? -77.69 115.1 17.18 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.786 0.803 . . . . 0.0 111.534 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.21 145.5 32.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.466 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 14.7 t70 -70.99 145.81 92.07 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -46.33 -31.36 9.29 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.784 2.989 . . . . 0.0 113.981 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -82.5 5.9 19.2 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.03 0.443 . . . . 0.0 111.553 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 71.24 68.58 0.17 Allowed 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 125.281 1.432 . . . . 0.0 111.122 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 67.6 mt -131.16 139.87 49.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' A' ' 131' ' ' THR . 4.5 m-20 -73.55 137.85 44.6 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -176.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' A' ' 62' ' ' LEU . 72.2 mt -111.49 -2.16 15.61 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 63.72 -21.68 0.06 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 127.222 2.209 . . . . 0.0 113.812 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 70' ' ' LEU . 82.8 mt -70.28 118.98 13.79 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.17 0.51 . . . . 0.0 111.618 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.9 m -112.71 115.93 29.33 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 36' ' ' VAL . 59.0 t -100.99 121.53 51.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.45 ' HB3' HG13 ' A' ' 56' ' ' VAL . 2.4 mm? -113.53 133.19 55.38 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.492 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.513 ' HB ' ' H ' ' A' ' 58' ' ' ASP . 96.0 m -86.08 82.85 7.93 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 169.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.652 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 18.8 tp -76.87 132.18 39.0 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.52 ' O ' HD11 ' A' ' 54' ' ' ILE . 27.8 t70 -76.22 77.52 3.02 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 117.669 -1.612 . . . . 0.0 112.336 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -96.37 94.89 7.7 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -68.8 -12.71 61.81 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.449 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -98.29 100.97 12.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.496 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 8.2 ptpp? -62.43 136.83 58.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -172.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -81.62 152.79 27.0 Favored 'General case' 0 C--O 1.257 1.456 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.529 175.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -69.86 144.56 52.49 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.625 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.01 97.45 1.88 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.916 0.865 . . . . 0.0 111.49 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.3 pt -91.2 18.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 121.596 0.712 . . . . 0.0 110.403 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -69.41 -30.87 68.92 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.774 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.39 -10.82 86.02 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.44 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -97.76 -5.18 35.54 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.7 mt -70.39 113.53 6.6 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 CA-C-O 121.301 0.572 . . . . 0.0 111.317 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -104.09 93.73 5.0 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.42 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 5.6 pt-20 -90.93 1.6 56.89 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.905 0.86 . . . . 0.0 111.049 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -97.17 110.2 22.79 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 167.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.509 HD13 ' HB ' ' A' ' 135' ' ' ILE . 6.4 mt -106.38 -57.36 2.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -164.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -42.02 113.94 0.49 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.445 1.498 . . . . 0.0 114.499 -168.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 -13.22 65.53 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.858 -1.064 . . . . 0.0 113.624 174.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 40.3 t -91.23 141.86 13.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 117.143 0.472 . . . . 0.0 110.68 -177.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -75.31 146.25 41.15 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.69 0.796 . . . . 0.0 111.614 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -138.61 170.46 15.97 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.053 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.5 m -135.39 148.47 49.37 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 tp -108.98 121.11 44.44 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 109.373 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.06 105.83 19.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.5 t -105.27 127.55 59.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -136.55 87.7 2.32 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 29.4 p -115.87 -172.38 2.15 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -79.49 -44.86 20.45 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 117.763 -1.575 . . . . 0.0 107.414 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.64 -42.19 78.36 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.809 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -105.89 91.39 3.72 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.0 m -87.76 100.38 12.8 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.591 -175.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 70.0 71.29 0.23 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.211 1.005 . . . . 0.0 113.203 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.1 m -108.83 95.33 5.58 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.6 mt -95.78 96.02 5.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.1 tp -113.42 123.42 50.03 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.977 -173.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.91 145.04 55.87 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.69 -39.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.559 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.62 -164.02 19.81 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.71 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 51.9 Cg_exo -58.38 129.35 32.27 Favored 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 123.712 2.941 . . . . 0.0 113.163 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.9 m -104.31 163.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.188 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.436 ' O ' HG13 ' A' ' 135' ' ' ILE . 42.8 p -129.61 174.75 9.38 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -116.71 131.35 56.97 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -93.57 -36.42 12.41 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.816 0.341 . . . . 0.0 111.227 -175.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.8 -105.76 3.19 Favored Glycine 0 CA--C 1.486 -1.74 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.82 138.58 51.01 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.464 HG13 ' HG3' ' A' ' 134' ' ' MET . 2.8 pp . . . . . 0 C--N 1.292 -1.901 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 N--CA 1.444 -1.41 0 CA-C-O 121.259 0.441 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 9.9 m -119.12 129.55 55.11 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -113.52 165.36 12.56 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.154 0.582 . . . . 0.0 109.944 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? 72.03 28.44 2.53 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.309 1.444 . . . . 0.0 109.402 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.464 ' HG3' HG13 ' A' ' 124' ' ' ILE . 95.4 mmm -86.92 126.24 34.56 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.616 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.585 HG23 ' HB3' ' A' ' 170' ' ' SER . 2.8 tt -99.26 143.77 12.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 43.4 ttp180 -132.28 139.79 48.37 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.95 0.405 . . . . 0.0 111.138 -170.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.485 ' CE1' ' HA3' ' A' ' 168' ' ' GLY . 37.0 p90 -140.41 135.86 32.49 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -93.72 117.31 29.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -176.09 143.52 0.55 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.74 92.86 0.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.911 0.862 . . . . 0.0 110.861 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.2 m -121.25 138.38 54.26 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -108.6 152.27 25.01 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.882 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -74.06 154.47 39.2 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 109.54 -16.67 31.45 Favored Glycine 0 C--N 1.307 -1.08 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -173.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -92.22 21.65 5.0 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 37.3 m -68.22 135.73 52.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.174 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.563 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 95.94 -4.74 65.78 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.15 135.82 30.09 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.24 115.22 25.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.278 0.561 . . . . 0.0 110.664 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.3 tp -85.38 101.53 12.66 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 18.0 p -151.73 168.94 23.46 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.675 0.75 . . . . 0.0 111.958 -172.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.85 -177.9 6.05 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.9 t -60.12 105.42 0.4 Allowed 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.976 0.893 . . . . 0.0 112.03 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.17 19.1 78.39 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.555 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -141.44 92.59 2.48 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 116.826 0.313 . . . . 0.0 110.683 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.3 mt -99.56 122.8 51.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -95.74 -36.12 11.29 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.591 0.71 . . . . 0.0 110.43 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.478 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 165.2 -156.33 28.24 Favored Glycine 0 N--CA 1.424 -2.166 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.663 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.9 pt -124.02 145.09 31.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -69.9 131.11 43.93 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 123.279 0.631 . . . . 0.0 110.135 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.65 11.11 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.762 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -129.86 -119.38 2.13 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.213 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 103.68 51.09 0.98 Allowed Glycine 0 CA--C 1.494 -1.261 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -106.92 96.81 6.7 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.83 -109.43 2.83 Favored Glycine 0 C--N 1.314 -0.668 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 41.3 mtm105 -111.38 14.67 21.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.017 0.437 . . . . 0.0 109.91 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -112.26 110.12 20.18 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.129 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' A' ' 137' ' ' TYR . . . -90.99 112.16 4.08 Favored Glycine 0 N--CA 1.411 -2.989 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -101.6 130.18 47.88 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.585 ' HB3' HG23 ' A' ' 135' ' ' ILE . 29.8 t -129.94 158.9 38.26 Favored 'General case' 0 C--N 1.265 -3.096 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.53 137.18 49.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -70.67 116.6 11.17 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 123.821 0.701 . . . . 0.0 112.174 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.478 HD13 ' HA2' ' A' ' 158' ' ' GLY . 10.2 mp -85.63 81.3 8.7 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.503 175.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -67.53 129.4 39.79 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.42 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 7.8 ptpp? -63.3 -16.21 59.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.768 0.318 . . . . 0.0 111.485 -177.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -58.37 -29.66 66.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.4 1.08 . . . . 0.0 110.73 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -80.75 -17.33 51.29 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.331 0.586 . . . . 0.0 110.29 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -111.68 0.33 16.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.284 -173.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.428 -1.539 0 CA-C-O 121.891 0.853 . . . . 0.0 109.027 177.442 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo . . . . . 0 N--CA 1.481 0.776 0 N-CA-C 112.827 0.28 . . . . 0.0 112.827 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -68.67 -39.66 80.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.956 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m -65.02 -46.71 80.23 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 122.938 0.495 . . . . 0.0 110.76 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.89 -29.17 58.38 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -63.91 -49.64 71.87 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.77 86.02 Favored 'General case' 0 C--O 1.194 -1.822 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.621 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.8 tp -57.47 -52.02 67.09 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.404 0.681 . . . . 0.0 111.446 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -67.9 -31.03 70.53 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.453 0.644 . . . . 0.0 110.302 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.7 tp -70.34 -52.94 18.99 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.42 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.487 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.4 tp -53.1 -54.5 34.68 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 126.344 1.858 . . . . 0.0 113.123 -176.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.2 mtp85 -62.21 -7.16 3.76 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -171.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -137.56 -50.65 0.62 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.416 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -91.36 -7.16 51.66 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -167.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 60.1 mt -115.89 113.58 43.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 42.1 ttm -140.37 136.98 33.69 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.771 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 50.7 m -63.6 135.31 56.7 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.202 0.601 . . . . 0.0 111.394 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 75.5 mt -129.11 126.53 64.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 92.1 m -89.6 110.24 21.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 72.4 p -91.99 -162.52 0.93 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.796 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 t -83.14 -1.14 52.13 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -104.51 -55.95 2.26 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.92 -158.02 21.18 Favored Glycine 0 CA--C 1.502 -0.727 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.817 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -89.85 113.58 25.2 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 116.773 0.287 . . . . 0.0 110.928 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -122.45 -172.65 2.51 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 104' ' ' HIS . 8.8 t -128.23 138.65 52.54 Favored 'General case' 0 N--CA 1.403 -2.79 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.257 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.96 148.59 18.22 Favored Glycine 0 N--CA 1.418 -2.54 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -111.08 118.32 35.68 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.61 111.55 3.44 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.3 mm -77.46 -45.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 85' ' ' ASP . 1.5 p-80 -179.58 161.54 1.04 Allowed 'General case' 0 CA--C 1.484 -1.585 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.601 177.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 52.17 -104.94 0.2 Allowed 'General case' 0 CA--C 1.554 1.125 0 O-C-N 124.511 1.132 . . . . 0.0 112.732 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -119.43 5.48 11.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.063 0.459 . . . . 0.0 109.872 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.1 t -85.59 107.54 16.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.704 -174.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -119.13 141.72 48.56 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.429 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.1 t -117.73 140.53 40.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 122.904 0.481 . . . . 0.0 111.536 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.424 HG22 HD21 ' A' ' 75' ' ' LEU . 15.6 tt -156.69 147.71 16.54 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 175.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 72.1 Cg_exo -55.87 154.4 26.96 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.736 2.291 . . . . 0.0 112.503 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -79.19 -28.86 42.68 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.099 -0.376 . . . . 0.0 111.407 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -73.31 -7.13 50.27 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.068 0.461 . . . . 0.0 111.178 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.78 -19.55 60.16 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.502 ' O ' ' HB ' ' A' ' 20' ' ' THR . 78.1 mt-30 53.11 78.61 0.39 Allowed Pre-proline 0 C--O 1.247 0.942 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 177.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -84.79 146.14 10.39 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.134 1.889 . . . . 0.0 110.097 173.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.81 -143.19 14.03 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.139 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -94.43 -20.53 19.63 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.16 0.505 . . . . 0.0 110.841 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -146.19 135.13 22.52 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.51 165.76 29.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 123.508 0.505 . . . . 0.0 110.408 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 78.3 mt -97.12 104.72 16.76 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -90.28 85.85 2.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 122.372 1.082 . . . . 0.0 109.739 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.8 t30 66.76 14.96 10.01 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.514 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.51 -50.48 0.82 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.86 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.07 132.59 48.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.825 0.45 . . . . 0.0 111.28 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -78.66 124.84 28.6 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 77' ' ' LEU . 9.8 tp -132.39 134.91 58.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.989 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -86.21 137.69 32.45 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.968 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.61 127.3 41.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -65.92 -62.8 1.3 Allowed 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.783 0.677 . . . . 0.0 109.661 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -152.87 148.44 27.16 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -132.93 151.55 52.03 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -172.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -125.37 123.18 38.8 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.933 -176.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -81.06 104.66 11.71 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 167.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.478 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 50.0 tp -88.44 111.24 21.56 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.33 179.91 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.813 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -77.19 140.66 65.97 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.79 -28.78 13.49 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.771 2.981 . . . . 0.0 114.766 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -87.9 10.41 18.81 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.472 0.653 . . . . 0.0 110.595 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.4 t30 65.49 70.15 0.45 Allowed 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 125.379 1.472 . . . . 0.0 111.274 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.8 mt -137.7 145.98 28.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' A' ' 131' ' ' THR . 58.6 t30 -65.73 132.5 48.9 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.997 0.427 . . . . 0.0 110.742 -176.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 50.6 tp -105.72 -7.11 18.6 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 14.8 tp10 62.9 28.55 16.4 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.844 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.51 125.35 47.63 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.104 -172.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.1 m -123.15 123.02 39.87 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.6 t -100.84 120.4 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.424 HD21 HG22 ' A' ' 37' ' ' ILE . 2.5 mm? -105.5 128.63 53.67 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.3 m -85.92 86.71 7.35 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.432 HD11 HG23 ' A' ' 54' ' ' ILE . 15.4 tp -86.34 120.3 27.54 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -175.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.451 ' O ' ' HD2' ' A' ' 79' ' ' ARG . 33.1 t70 -63.42 101.79 0.35 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.326 0.584 . . . . 0.0 111.116 -177.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 26.9 mmm180 -126.42 117.89 23.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -77.05 -37.37 54.82 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -97.11 104.89 16.95 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -93.87 154.13 17.89 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -168.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -74.82 170.21 16.35 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.287 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -85.92 143.8 28.0 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 31' ' ' HIS . 9.6 t70 -71.43 95.78 1.4 Allowed 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.043 0.925 . . . . 0.0 110.004 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.1 pt -86.82 9.37 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.117 0.961 . . . . 0.0 109.682 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -73.2 -28.08 61.98 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.32 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.54 -18.79 68.28 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.876 174.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -100.07 2.67 43.46 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 110.549 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.5 mt -76.43 127.15 37.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -94.66 112.68 24.43 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.2 0.52 28.1 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.179 -0.609 . . . . 0.0 112.311 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -113.76 122.57 47.5 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.08 -66.93 0.98 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -166.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -69.11 148.38 50.07 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -167.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.59 48.76 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 114.794 -1.093 . . . . 0.0 112.704 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.3 136.32 30.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 122.453 -0.439 . . . . 0.0 111.223 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.97 125.0 21.97 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.887 0.875 . . . . 0.0 109.974 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -120.2 161.03 21.75 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.518 0.675 . . . . 0.0 111.88 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 25.8 m -118.95 137.1 53.72 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 124.913 1.285 . . . . 0.0 107.941 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.3 tp -102.86 120.65 40.99 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 111' ' ' THR . 25.6 m -113.21 121.48 65.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.478 0.656 . . . . 0.0 110.715 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.45 143.88 37.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.311 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.465 ' O ' ' HB ' ' A' ' 26' ' ' THR . 17.4 t60 -146.94 90.56 1.91 Allowed 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.8 m -150.8 -177.91 6.27 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -64.47 -29.42 70.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.804 0.335 . . . . 0.0 111.044 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -59.76 -32.98 71.09 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.779 0.831 . . . . 0.0 112.046 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -175.73 128.47 0.24 Allowed 'General case' 0 C--O 1.245 0.845 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 p -93.14 123.41 36.39 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.45 ' OD1' HD21 ' A' ' 11' ' ' LEU . 93.8 m-20 65.0 71.0 0.46 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 90.8 m -115.52 117.83 31.46 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 174.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 66.4 mt -119.15 90.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.6 tp -127.16 132.66 50.47 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.522 -174.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 30.5 mp0 -66.35 136.65 56.1 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 124.266 1.027 . . . . 0.0 109.636 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.28 -7.65 12.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.46 -171.72 19.66 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.914 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.47 118.65 5.42 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.063 2.509 . . . . 0.0 112.038 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 150' ' ' LEU . 27.1 m -71.46 145.52 12.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.882 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.5 m -125.75 150.56 47.62 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 21.7 ttt -71.97 135.69 46.52 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.4 -40.76 6.93 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.2 -99.87 2.34 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tt -138.28 118.91 13.97 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.415 HG22 ' HG2' ' A' ' 134' ' ' MET . 10.8 tp . . . . . 0 C--N 1.295 -1.785 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.453 -0.902 0 CA-C-O 121.163 0.401 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 15.9 p -115.22 125.22 53.1 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.517 177.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -101.1 155.5 17.96 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 69.18 36.66 2.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.565 1.146 . . . . 0.0 107.932 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.415 ' HG2' HG22 ' A' ' 124' ' ' ILE . 8.4 tpt -85.21 147.58 26.52 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.515 -175.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.488 HG23 ' HB2' ' A' ' 170' ' ' SER . 14.7 tt -130.11 144.42 38.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -143.62 165.17 28.35 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.315 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -145.98 149.34 33.97 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -89.16 104.06 16.63 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.092 0.948 . . . . 0.0 110.424 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -167.89 136.17 2.38 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.92 91.21 4.17 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.528 0.68 . . . . 0.0 110.304 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -104.38 161.6 13.93 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.694 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -92.45 176.89 6.3 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.1 t -115.13 168.26 10.09 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 94.21 -4.89 71.12 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.918 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.448 ' HB2' ' CD2' ' A' ' 160' ' ' HIS . 16.8 mt-30 -95.1 15.1 19.89 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 8.1 m -59.01 118.17 5.51 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.39 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 113.95 -2.48 24.27 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -176.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.77 148.69 43.67 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 174.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.428 ' HB ' ' CG2' ' A' ' 102' ' ' VAL . 28.4 t -93.59 122.86 45.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.276 0.56 . . . . 0.0 110.745 -175.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.41 HD21 HG11 ' A' ' 118' ' ' VAL . 49.4 tp -94.86 105.02 16.93 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 14.3 p -145.8 170.9 15.61 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.031 0.443 . . . . 0.0 112.11 -172.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.03 178.83 6.99 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.1 t -55.62 106.22 0.23 Allowed 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 121.86 0.838 . . . . 0.0 111.959 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.8 19.08 76.51 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.238 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -143.28 106.05 4.49 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -92.46 128.1 44.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -98.66 -38.16 9.23 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.425 0.631 . . . . 0.0 110.863 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.416 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 170.58 -159.84 32.25 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.454 -1.355 . . . . 0.0 112.387 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.508 HG23 HD11 ' A' ' 173' ' ' LEU . 25.8 pt -118.64 144.08 27.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 120.96 0.41 . . . . 0.0 110.533 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.448 ' CD2' ' HB2' ' A' ' 145' ' ' GLN . 52.8 t60 -74.56 132.2 41.61 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.698 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.25 -6.13 11.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.278 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 149.0 -154.56 25.88 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 119.859 -1.162 . . . . 0.0 112.429 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.67 160.66 25.13 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -155.96 118.25 4.09 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.72 -117.38 4.58 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 166' ' ' ARG . 20.7 mmt180 -110.62 8.31 22.71 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.061 0.458 . . . . 0.0 110.846 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -112.86 126.78 55.82 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.023 0.439 . . . . 0.0 110.416 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -99.85 138.23 13.73 Favored Glycine 0 CA--C 1.476 -2.361 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -113.5 132.81 55.54 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.773 0.797 . . . . 0.0 111.961 -173.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.488 ' HB2' HG23 ' A' ' 135' ' ' ILE . 54.3 m -141.08 164.2 30.91 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.821 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.31 138.4 47.83 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.436 ' OE1' ' HE3' ' A' ' 174' ' ' LYS . 79.5 mt-30 -74.41 116.99 15.71 Favored 'General case' 0 C--O 1.244 0.781 0 O-C-N 123.431 0.457 . . . . 0.0 111.253 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.508 HD11 HG23 ' A' ' 159' ' ' ILE . 63.6 mt -90.92 89.8 7.61 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.436 ' HE3' ' OE1' ' A' ' 172' ' ' GLN . 97.5 mttt -88.63 124.98 34.6 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.901 176.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -52.02 -17.73 1.14 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.136 1.374 . . . . 0.0 114.144 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -60.33 -27.76 67.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.406 1.082 . . . . 0.0 111.139 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -79.12 -19.27 51.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.802 0.334 . . . . 0.0 111.7 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -100.01 14.71 29.66 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 C--N 1.293 -1.882 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.35 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo . . . . . 0 N--CA 1.472 0.243 0 N-CA-C 110.194 -0.733 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -59.94 -36.33 76.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.919 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 m -70.05 -39.11 75.89 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 120.978 0.418 . . . . 0.0 110.133 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -69.94 -41.48 74.52 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.979 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -63.27 -42.74 99.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.501 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.43 -44.12 96.09 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.91 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.43 -48.53 81.35 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.096 0.559 . . . . 0.0 110.803 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 p -71.72 -37.58 70.59 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.9 tp -65.14 -45.98 82.78 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.624 0.77 . . . . 0.0 109.413 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.461 ' HA ' HD13 ' A' ' 15' ' ' ILE . 42.8 tp -48.7 -52.75 21.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.454 1.501 . . . . 0.0 112.526 -177.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -76.74 -3.1 36.4 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.86 -53.86 2.61 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.849 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -104.04 -17.25 15.03 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -169.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 11' ' ' LEU . 1.7 mp -87.35 113.27 24.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.542 0.687 . . . . 0.0 110.418 -178.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 90.3 mmm -116.16 153.28 32.1 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 m -101.11 121.54 41.99 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -112.61 123.8 68.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 O-C-N 121.928 -0.482 . . . . 0.0 111.603 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 18.5 m -80.82 102.9 10.29 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.254 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.2 p -102.31 -169.46 1.67 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -72.78 -20.54 61.15 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.997 0.427 . . . . 0.0 110.685 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -100.43 3.34 43.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.996 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.89 -175.62 16.53 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.994 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 30.7 mp0 -83.5 115.83 22.27 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 146' ' ' CYS . 72.8 m-85 -122.36 -175.14 3.06 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 25.5 m -91.4 130.24 37.27 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.9 128.26 7.59 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -100.18 119.49 38.43 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.03 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.97 115.43 4.02 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 174.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.9 mm -84.52 -55.43 6.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 117.018 0.409 . . . . 0.0 111.169 -173.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -163.0 150.54 13.3 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.574 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 23.2 t70 54.7 -99.87 0.1 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.449 1.093 . . . . 0.0 111.98 173.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.574 ' HG2' ' OD2' ' A' ' 32' ' ' ASP . 14.1 ptp180 -126.65 14.56 7.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.697 0.76 . . . . 0.0 110.073 177.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.9 t -92.25 115.93 32.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.211 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -124.55 151.03 45.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.33 141.16 47.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 117.82 0.282 . . . . 0.0 111.752 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.3 tt -155.15 142.07 13.53 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 99.2 Cg_exo -49.03 144.17 16.42 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 123.702 2.935 . . . . 0.0 115.467 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.406 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 27.6 m -65.74 -37.21 85.76 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.432 -176.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -63.61 -5.08 3.46 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.38 -18.05 29.23 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 54.94 86.77 0.16 Allowed Pre-proline 0 C--O 1.242 0.697 0 C-N-CA 124.959 1.304 . . . . 0.0 112.93 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -81.47 127.68 5.88 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.982 1.788 . . . . 0.0 110.119 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.54 -176.63 47.61 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.099 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -67.1 -37.2 83.51 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 120.855 0.36 . . . . 0.0 110.487 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 5.5 p-10 -130.69 114.54 15.52 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.841 0.829 . . . . 0.0 109.716 175.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.94 176.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.162 -174.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 57.8 mt -113.34 112.65 24.05 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.38 89.36 2.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.2 t30 59.57 30.92 20.59 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.287 1.435 . . . . 0.0 109.981 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.41 -33.71 5.0 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.045 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -71.52 118.54 14.46 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.457 0.303 . . . . 0.0 111.081 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 53' ' ' LYS . 12.1 mptt -75.25 132.92 41.41 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.405 HD13 ' HE ' ' A' ' 79' ' ' ARG . 6.6 tp -153.28 132.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.869 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 33.7 ttt85 -90.79 134.72 34.22 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -78.02 119.84 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.77 -66.72 0.85 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -102.66 128.47 49.34 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -106.15 118.21 36.03 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.436 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.1 m-85 -114.78 94.45 4.77 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -75.57 118.78 18.79 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.79 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.448 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 3.5 mm? -87.4 83.77 7.27 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-O 122.842 1.305 . . . . 0.0 112.699 -177.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.51 148.71 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 172.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.46 135.45 41.08 Favored Pre-proline 0 C--N 1.269 -2.897 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.2 -25.32 4.37 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 124.034 3.156 . . . . 0.0 114.766 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -81.63 16.27 1.82 Allowed 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.976 -0.453 . . . . 0.0 111.582 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.0 m120 75.87 17.77 2.19 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.664 1.586 . . . . 0.0 112.383 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.3 mt -95.87 120.14 44.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -78.07 156.23 30.15 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 122.132 -0.355 . . . . 0.0 111.699 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 60.4 tp -121.68 -9.96 8.83 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 13.6 tp10 65.44 20.01 11.67 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.931 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.21 144.89 41.92 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.323 -0.861 . . . . 0.0 110.577 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.4 m -124.0 117.79 25.53 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 54.5 t -94.61 118.51 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 CA-C-O 121.709 0.766 . . . . 0.0 108.999 177.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 74.2 mt -106.08 124.0 48.9 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.268 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 m -97.24 98.34 9.92 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -70.79 136.47 48.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.227 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.541 ' HA ' ' NH1' ' A' ' 33' ' ' ARG . 38.7 t70 -84.41 73.87 10.44 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.623 1.202 . . . . 0.0 110.137 177.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.405 ' HE ' HD13 ' A' ' 54' ' ' ILE . 24.1 mmt180 -127.47 132.59 50.0 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.191 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -79.49 -20.75 46.51 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.39 109.85 9.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.281 -1.327 . . . . 0.0 107.848 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -106.78 170.73 7.77 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -113.37 169.33 9.04 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.411 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -73.5 125.7 28.55 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -72.81 104.78 4.11 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.21 1.005 . . . . 0.0 111.331 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.5 pt -94.12 21.93 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.959 0.885 . . . . 0.0 109.675 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -63.14 -32.98 74.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.602 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.49 0.42 89.17 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 116.178 -0.465 . . . . 0.0 113.507 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -103.77 -2.49 26.31 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 117.251 0.526 . . . . 0.0 110.551 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.67 126.68 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.342 0.591 . . . . 0.0 110.126 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.7 t -104.1 107.68 18.68 Favored 'General case' 0 N--CA 1.397 -3.099 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -87.03 -4.53 59.17 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.176 0.989 . . . . 0.0 108.488 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -94.17 115.82 28.15 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.445 HD21 ' CG ' ' A' ' 172' ' ' GLN . 26.3 mt -110.65 -63.32 1.41 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -169.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 17.0 pt-20 -58.26 121.99 12.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -168.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.28 -8.62 24.74 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.14 -0.936 . . . . 0.0 113.417 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.435 ' O ' HG22 ' A' ' 118' ' ' VAL . 21.9 t -108.81 144.65 16.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 117.34 0.57 . . . . 0.0 110.324 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.09 127.4 35.12 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -112.54 160.67 17.59 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.986 0.898 . . . . 0.0 112.042 -176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.1 m -122.73 137.65 54.85 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 tp -103.95 109.27 20.97 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.6 t -103.93 116.38 47.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.347 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.495 HG12 ' CA ' ' A' ' 148' ' ' GLY . 28.3 m -122.0 151.91 25.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.282 0.563 . . . . 0.0 111.473 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -149.39 68.4 1.03 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 m -93.99 -150.25 0.29 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.57 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 22.2 t-20 -73.18 -66.12 0.72 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.582 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -81.2 -36.85 29.58 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.48 86.09 6.68 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.392 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.5 p -97.15 117.2 30.82 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.21 42.97 5.13 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.448 1.118 . . . . 0.0 108.698 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.452 ' HB ' ' CG2' ' A' ' 103' ' ' VAL . 23.8 m -94.89 106.67 18.67 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.328 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.4 mt -97.86 98.45 7.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.5 tp -114.94 122.87 47.61 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.225 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -83.38 134.02 34.91 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 122.282 -0.261 . . . . 0.0 110.342 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 m -108.58 -14.49 9.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -175.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.97 -160.12 19.44 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.061 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.75 127.22 12.8 Favored 'Trans proline' 0 C--O 1.243 0.772 0 C-N-CA 123.498 2.799 . . . . 0.0 112.502 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 97' ' ' VAL . 27.5 m -96.9 157.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.458 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.434 ' O ' HG13 ' A' ' 135' ' ' ILE . 7.1 p -139.72 173.05 11.93 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 124.373 1.069 . . . . 0.0 108.542 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -92.01 128.8 37.98 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -83.17 -38.53 22.21 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.177 0.513 . . . . 0.0 111.624 -174.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 132' ' ' ASN . . . 82.93 -102.78 2.41 Favored Glycine 0 N--CA 1.421 -2.355 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -176.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.78 133.06 54.25 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.717 0.77 . . . . 0.0 112.136 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.428 HG23 ' HB ' ' A' ' 131' ' ' THR . 7.2 tp . . . . . 0 C--N 1.292 -1.932 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 168.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 N--CA 1.441 -1.598 0 N-CA-C 113.582 0.57 . . . . 0.0 113.582 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.428 ' HB ' HG23 ' A' ' 124' ' ' ILE . 25.1 m -119.54 116.79 26.79 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 171.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 51.8 t30 -115.4 163.61 15.47 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.417 -173.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 73.7 28.11 1.67 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.106 1.362 . . . . 0.0 109.36 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.421 ' HG3' HG22 ' A' ' 124' ' ' ILE . 91.2 mmm -88.09 158.3 18.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.745 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.606 HG23 ' HB2' ' A' ' 170' ' ' SER . 7.7 tt -116.33 138.73 45.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 122.927 0.491 . . . . 0.0 109.951 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 66.4 ttt180 -118.57 139.74 51.0 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.158 0.983 . . . . 0.0 111.975 -170.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.404 ' HB3' HG12 ' A' ' 118' ' ' VAL . 45.4 p90 -149.7 147.97 28.71 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -93.66 103.07 15.25 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -168.36 125.37 1.06 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.07 94.83 1.55 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.512 0.673 . . . . 0.0 109.769 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.0 t -80.03 176.06 10.08 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.001 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -119.94 156.36 30.96 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.7 m -76.04 114.9 15.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.01 -15.56 2.15 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.94 11.87 5.61 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.754 -0.262 . . . . 0.0 111.011 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 43.3 t -58.17 122.34 12.9 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.049 0.54 . . . . 0.0 110.083 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 86.32 10.02 75.03 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.233 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.495 ' CA ' HG12 ' A' ' 103' ' ' VAL . . . -72.16 137.17 24.78 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.437 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 25.4 t -79.08 107.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.186 0.517 . . . . 0.0 109.947 -177.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.6 tp -87.64 102.65 14.82 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 16.9 p -147.09 168.19 22.22 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.473 -173.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -137.89 -174.59 3.83 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 174.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 t -63.37 100.35 0.24 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 121.89 0.853 . . . . 0.0 112.058 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.87 10.22 85.9 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.198 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -128.91 98.28 4.91 Favored 'General case' 0 C--O 1.208 -1.118 0 O-C-N 122.491 -0.417 . . . . 0.0 109.969 -174.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 74.6 mt -99.02 117.81 44.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -90.53 -39.88 12.31 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.458 0.647 . . . . 0.0 110.365 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.444 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 164.92 -152.94 22.85 Favored Glycine 0 N--CA 1.422 -2.266 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.11 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 148' ' ' GLY . 28.1 pt -129.18 146.61 33.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.93 0.365 . . . . 0.0 110.808 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' HIS . . . . . 0.41 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 46.9 t-80 -69.48 134.48 48.95 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.446 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.1 t -99.84 -71.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.722 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.29 127.39 1.39 Allowed Glycine 0 N--CA 1.424 -2.125 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.25 153.15 20.67 Favored Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.693 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -131.7 100.57 5.16 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.75 -122.54 5.93 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -90.7 -12.16 37.51 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.041 0.448 . . . . 0.0 110.53 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -98.77 111.71 24.01 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.161 -175.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.61 119.99 5.43 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -105.97 116.65 32.3 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.573 0.701 . . . . 0.0 110.959 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.606 ' HB2' HG23 ' A' ' 135' ' ' ILE . 39.4 m -117.62 167.37 11.39 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.25 142.1 43.9 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 118.433 0.56 . . . . 0.0 110.374 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.666 ' OE1' ' HG2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -93.66 109.15 20.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.444 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.8 OUTLIER -82.86 91.11 7.02 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.213 1.006 . . . . 0.0 111.079 178.288 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.666 ' HG2' ' OE1' ' A' ' 172' ' ' GLN . 6.8 mtpm? -65.01 148.1 52.26 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.336 -176.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -66.65 -22.46 66.1 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.024 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -68.24 -10.26 53.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.301 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -94.07 -20.62 19.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.671 0.748 . . . . 0.0 109.268 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -104.06 0.11 29.38 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.506 -173.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 66.8 t . . . . . 0 C--N 1.298 -1.632 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 175.036 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 5' ' ' GLU . 80.9 Cg_exo . . . . . 0 CA--C 1.545 1.069 0 N-CA-C 113.169 0.411 . . . . 0.0 113.169 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -60.84 -55.85 28.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.097 0.475 . . . . 0.0 110.508 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -59.25 -38.22 79.5 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.774 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 2' ' ' PRO . 31.9 tt0 -57.9 -55.46 34.56 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.604 1.161 . . . . 0.0 110.567 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.76 -46.95 86.29 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.003 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.67 -35.64 74.86 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.89 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.3 tp -71.42 -38.23 71.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.708 0.29 . . . . 0.0 110.821 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -73.1 -33.56 65.66 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.569 0.699 . . . . 0.0 109.167 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.6 tp -68.23 -41.96 80.45 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.215 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' A' ' 15' ' ' ILE . 58.5 tp -49.96 -54.17 21.62 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 125.076 1.351 . . . . 0.0 112.01 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.4 mtt-85 -80.32 13.35 2.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.606 -173.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -129.09 -64.25 0.92 Allowed 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.418 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -104.18 -2.87 25.13 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -173.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.507 HD12 ' HA ' ' A' ' 11' ' ' LEU . 43.0 mt -99.93 134.75 38.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -154.38 144.85 22.22 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 122.484 0.314 . . . . 0.0 110.613 -173.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 m -80.23 118.13 21.63 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.0 mt -106.05 115.6 48.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-O 121.265 0.555 . . . . 0.0 109.569 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -83.08 97.28 8.69 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 79.1 p -91.95 -170.09 2.45 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.2 m -82.59 -13.34 56.71 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 120.706 0.289 . . . . 0.0 110.929 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -98.33 -24.08 15.36 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 110.417 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.63 -154.71 25.56 Favored Glycine 0 CA--C 1.501 -0.808 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.53 112.79 20.36 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 117.298 0.549 . . . . 0.0 109.531 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.455 ' HB3' ' O ' ' A' ' 146' ' ' CYS . 80.7 m-85 -120.66 -173.45 2.59 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 147' ' ' GLY . 5.9 t -113.93 136.91 52.37 Favored 'General case' 0 N--CA 1.406 -2.653 0 C-N-CA 118.959 -1.097 . . . . 0.0 109.934 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.02 136.89 13.64 Favored Glycine 0 N--CA 1.41 -3.092 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.5 tp -105.1 118.65 37.07 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.76 132.53 14.13 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 108.406 -1.878 . . . . 0.0 108.406 173.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.5 mm -96.08 -59.28 3.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 117.753 0.776 . . . . 0.0 109.902 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -162.12 147.37 12.87 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 55.53 -95.32 0.05 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 124.276 0.985 . . . . 0.0 111.21 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 18.9 ptp180 -132.84 10.87 4.31 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 122.044 0.926 . . . . 0.0 109.663 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -84.22 118.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.4 m -131.72 147.02 52.47 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.2 t -109.71 134.55 51.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.793 0.33 . . . . 0.0 111.727 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.434 ' HB ' ' CD2' ' A' ' 75' ' ' LEU . 6.7 mm -137.93 141.88 34.11 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 125.364 1.466 . . . . 0.0 108.358 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.06 146.57 93.86 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 121.975 1.784 . . . . 0.0 111.797 175.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.6 m -70.21 -33.35 71.58 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 123.214 0.605 . . . . 0.0 109.415 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -77.17 -4.74 46.15 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.579 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.62 -16.04 49.86 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.58 ' O ' ' HB ' ' A' ' 20' ' ' THR . 21.4 mt-30 58.14 82.67 0.23 Allowed Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.414 1.086 . . . . 0.0 112.877 176.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.08 -174.83 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.752 2.301 . . . . 0.0 111.287 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.59 179.19 18.44 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.55 -17.7 44.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.513 0.673 . . . . 0.0 110.313 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -141.71 135.92 30.31 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 12.7 p -141.6 149.98 19.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.514 -171.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -85.69 111.94 20.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.258 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.2 83.14 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.3 t30 68.65 -1.78 1.86 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.492 1.517 . . . . 0.0 111.364 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.11 -33.45 0.94 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.09 110.73 15.77 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 14.7 ptpt -78.68 137.38 37.78 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 116.819 -1.952 . . . . 0.0 109.101 174.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.413 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.5 tp -128.99 150.69 34.85 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -91.24 142.84 27.28 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.8 t -108.73 131.19 60.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -78.29 -79.01 0.13 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.797 0.332 . . . . 0.0 111.286 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -113.75 140.17 48.5 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -104.5 93.51 4.82 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.569 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.5 m-85 -80.8 94.02 6.34 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -76.09 94.15 3.42 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 32.7 tp -85.46 103.53 14.42 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-O 121.616 0.722 . . . . 0.0 109.521 -172.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.06 178.9 2.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.71 139.29 58.24 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.2 -21.61 13.42 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 123.557 2.838 . . . . 0.0 114.542 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.3 6.1 24.23 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.2 m120 77.37 12.28 2.12 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.289 1.436 . . . . 0.0 112.747 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.0 mt -77.64 146.16 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -70.33 142.74 52.15 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 120.995 0.426 . . . . 0.0 111.622 -174.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 60.9 tp -117.38 -17.6 10.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 171.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 75.72 -17.02 0.54 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.284 1.434 . . . . 0.0 112.909 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 173' ' ' LEU . 10.1 mp -80.06 113.15 18.02 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.6 m -100.24 116.86 33.23 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 168.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 68.0 t -95.84 107.07 19.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.434 ' CD2' ' HB ' ' A' ' 37' ' ' ILE . 2.9 mm? -91.66 132.47 36.33 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.254 -178.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 m -83.68 80.3 9.17 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 171.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.633 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.7 tp -74.54 103.3 4.81 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.413 ' O ' HD11 ' A' ' 54' ' ' ILE . 12.9 t70 -73.8 84.07 1.66 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.432 0.634 . . . . 0.0 112.51 -168.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.425 ' HG3' ' CE2' ' A' ' 83' ' ' PHE . 31.4 mmt180 -99.14 125.08 44.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.197 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -74.78 -34.41 62.44 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -92.04 95.84 10.01 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -74.51 161.04 30.14 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.788 -1.096 . . . . 0.0 113.562 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.425 ' CE2' ' HG3' ' A' ' 79' ' ' ARG . 88.9 m-85 -91.27 172.57 8.45 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.042 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -73.88 137.57 43.8 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.07 95.32 1.2 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.222 0.534 . . . . 0.0 109.572 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -93.61 14.55 2.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 122.693 1.235 . . . . 0.0 109.975 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -31.13 59.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.018 -1.901 . . . . 0.0 108.764 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.07 -6.61 74.48 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 114.893 -1.048 . . . . 0.0 112.428 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -109.9 4.31 21.43 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.156 -0.614 . . . . 0.0 110.943 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.1 mt -73.22 125.95 33.06 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 CA-C-O 121.052 0.453 . . . . 0.0 110.292 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.0 t -115.24 106.8 14.46 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE2' ' HE3' ' A' ' 174' ' ' LYS . 7.9 pt-20 -88.53 -5.37 58.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.941 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -85.78 105.93 16.66 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 168.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.433 HD13 ' HB ' ' A' ' 135' ' ' ILE . 31.9 mt -99.98 -53.84 3.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -164.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -58.93 135.33 57.54 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.8 -38.83 3.13 Favored Glycine 0 N--CA 1.434 -1.443 0 CA-C-N 114.891 -1.05 . . . . 0.0 113.415 174.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 21.3 t -73.49 144.01 13.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 120.539 0.209 . . . . 0.0 110.906 -174.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.47 120.89 24.5 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.62 17.72 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 122.02 0.914 . . . . 0.0 111.444 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 28.1 m -127.39 131.31 50.35 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.52 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.427 HD21 HE21 ' A' ' 145' ' ' GLN . 55.4 tp -102.85 126.31 49.94 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.819 -175.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.41 107.66 19.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 145' ' ' GLN . 46.4 t -93.37 108.18 20.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.611 -178.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -133.77 124.71 27.08 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.3 t -174.98 -175.17 0.84 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -87.02 -15.29 39.11 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -94.93 -24.53 16.93 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.535 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.64 103.73 3.96 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.8 m -105.02 111.77 24.67 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 71.06 33.58 2.03 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.796 0.838 . . . . 0.0 113.238 169.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.435 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 16.2 m -93.31 109.44 20.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.512 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.0 mt -100.55 125.77 54.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.7 tp -140.69 129.36 22.89 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.942 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 4.2 mp0 -69.39 135.92 50.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.78 -19.54 6.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.21 -176.74 16.34 Favored Glycine 0 N--CA 1.433 -1.548 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.482 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 37.4 Cg_endo -68.07 129.01 18.59 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.688 2.259 . . . . 0.0 111.625 178.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.8 m -97.26 165.03 2.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.468 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.3 t -147.99 155.54 41.65 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 53.8 ttp -90.73 134.65 34.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.33 -28.52 15.52 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.308 0.575 . . . . 0.0 110.086 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.4 -87.25 1.17 Allowed Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -137.24 133.22 34.85 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.2 tp . . . . . 0 C--N 1.296 -1.724 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -176.657 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo . . . . . 0 C--O 1.254 1.294 0 CA-C-O 121.019 0.341 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 m -131.06 131.1 44.02 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -99.19 162.92 12.78 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 8.0 mpt_? 66.82 35.72 4.84 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.579 1.152 . . . . 0.0 110.749 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 95.6 mmm -94.23 139.76 30.63 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.949 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.559 HG23 ' HB2' ' A' ' 170' ' ' SER . 3.0 tt -116.38 140.42 38.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 124.649 1.179 . . . . 0.0 109.102 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -121.53 143.83 49.05 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.054 0.542 . . . . 0.0 110.767 -171.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.485 ' HE2' ' HG ' ' A' ' 170' ' ' SER . 28.0 p90 -152.95 152.41 31.41 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 122.95 0.5 . . . . 0.0 111.049 172.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -89.58 105.42 17.78 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.308 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -172.49 132.85 0.61 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 125.05 1.34 . . . . 0.0 108.479 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.13 100.63 5.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.353 0.597 . . . . 0.0 109.651 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.2 p -79.83 137.58 36.99 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.665 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 93.4 mttt -93.03 108.69 20.21 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.2 m -53.79 129.43 33.45 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.595 0.758 . . . . 0.0 111.692 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 134.25 -18.63 4.17 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -100.74 34.1 2.56 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.373 0.606 . . . . 0.0 112.101 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 25' ' ' PHE . 66.6 m -65.8 117.26 7.95 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.304 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 26' ' ' THR . . . 109.88 5.57 29.02 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.07 134.82 37.05 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.63 115.5 18.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.183 0.516 . . . . 0.0 111.149 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.61 108.87 21.17 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.6 p -142.0 179.25 6.99 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 120.907 0.384 . . . . 0.0 111.911 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.09 178.88 8.54 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.8 t -64.77 102.32 0.57 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.999 0.904 . . . . 0.0 111.843 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.08 73.65 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.416 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -145.27 120.6 10.25 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 81.7 mt -108.28 128.9 63.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 171.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.49 -47.56 6.21 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.413 0.625 . . . . 0.0 110.3 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.55 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 171.65 -149.37 11.95 Favored Glycine 0 N--CA 1.417 -2.61 0 C-N-CA 119.932 -1.127 . . . . 0.0 111.899 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.8 pt -130.59 142.19 44.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -73.87 125.74 28.87 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.7 m -107.81 -46.0 7.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.303 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 169' ' ' PHE . . . -157.26 136.47 4.91 Favored Glycine 0 CA--C 1.487 -1.697 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.072 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.3 140.64 11.05 Favored Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -123.95 132.15 53.67 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.79 -108.33 2.07 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.922 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 166' ' ' ARG . 47.4 mtt180 -113.29 12.17 18.82 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -118.55 132.76 56.2 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.023 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -104.3 120.84 6.78 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 99.4 m-85 -109.11 117.08 33.22 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.19 0.995 . . . . 0.0 109.424 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.559 ' HB2' HG23 ' A' ' 135' ' ' ILE . 18.5 m -117.6 164.28 15.17 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.079 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.08 139.61 49.74 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 28.0 pt20 -90.23 131.67 35.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.784 0.802 . . . . 0.0 110.927 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.55 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -94.26 85.06 4.53 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.305 175.926 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.44 ' HE3' ' OE2' ' A' ' 92' ' ' GLU . 57.2 mtpt -54.05 134.49 43.77 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.13 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.426 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 16.7 ptmt -72.17 -19.37 61.76 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.29 -174.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.539 ' HA ' HG12 ' A' ' 179' ' ' VAL . 13.4 mm100 -67.93 -9.66 47.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.281 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -89.11 -21.52 23.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.761 0.315 . . . . 0.0 110.2 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -109.68 -28.83 8.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.281 0.563 . . . . 0.0 111.839 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 176' ' ' GLN . 11.0 p . . . . . 0 C--N 1.315 -0.895 0 CA-C-O 121.218 0.532 . . . . 0.0 109.996 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.94 -23.99 40.17 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.586 2.19 . . . . 0.0 111.027 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -66.92 -39.29 87.32 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.417 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 m -67.89 -44.47 76.93 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.688 0.795 . . . . 0.0 110.237 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -68.53 -36.31 78.66 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.451 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -63.17 -42.72 99.45 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.772 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.47 83.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.251 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.3 tp -69.96 -32.76 71.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.371 0.605 . . . . 0.0 110.504 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.4 m -76.9 -37.28 55.73 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.643 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.2 tp -68.44 -34.53 76.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.4 tp -54.09 -55.66 25.47 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.909 0.884 . . . . 0.0 111.568 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -72.97 -17.5 61.46 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.084 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -61.66 1.63 Allowed 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.95 -172.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -124.97 9.35 8.13 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -171.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 65.0 mt -110.81 134.72 52.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.706 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.65 167.38 23.93 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.833 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 m -92.49 125.97 37.37 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.1 mt -113.59 123.24 69.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.564 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 9.7 m -84.99 98.63 10.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.6 p -99.93 -170.25 1.86 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 30.1 t -71.53 -33.98 69.64 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.851 0.358 . . . . 0.0 110.495 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -75.59 -26.02 57.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.39 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.08 -171.3 30.06 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.493 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 19' ' ' THR . 36.2 mt-10 -91.75 104.19 16.67 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -114.02 -169.7 1.57 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.003 -174.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.54 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 10.9 m -92.05 128.9 38.07 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.965 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.94 127.23 7.71 Favored Glycine 0 N--CA 1.421 -2.312 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 174.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.4 tp -103.45 122.85 45.75 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.66 137.19 18.47 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.436 HG13 ' CE1' ' A' ' 178' ' ' PHE . 47.4 mm -97.66 -55.87 5.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -164.08 150.61 11.42 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.4 t70 58.29 -98.67 0.09 Allowed 'General case' 0 C--O 1.213 -0.839 0 O-C-N 124.21 0.944 . . . . 0.0 112.113 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.44 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 7.5 mpt_? -129.02 9.34 5.74 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.4 t -83.4 118.61 31.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.378 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.6 t -123.48 169.8 11.03 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.12 141.1 39.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.4 tp -151.15 150.59 27.65 Favored Pre-proline 0 CA--C 1.572 1.817 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.12 159.87 44.64 Favored 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 122.341 2.027 . . . . 0.0 112.771 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.8 m -82.01 -48.51 11.35 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -66.89 -8.48 29.52 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.38 -23.31 61.87 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 96.6 mt-30 58.85 84.01 0.21 Allowed Pre-proline 0 C--O 1.252 1.198 0 C-N-CA 125.601 1.561 . . . . 0.0 113.103 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -88.53 136.28 3.23 Favored 'Trans proline' 0 N--CA 1.438 -1.791 0 C-N-CA 122.816 2.344 . . . . 0.0 109.558 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.34 -176.83 51.61 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.91 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -75.03 -25.4 58.69 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.441 1.115 . . . . 0.0 108.042 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -129.5 138.38 51.35 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.89 167.28 16.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 41.8 mt -100.93 114.33 28.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.16 109.5 23.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.4 m120 61.78 23.8 14.05 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.544 0.688 . . . . 0.0 110.976 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 -13.68 63.55 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.564 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -85.15 128.21 34.57 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.442 0.697 . . . . 0.0 109.779 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.31 128.92 37.82 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.57 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.6 tp -144.53 150.24 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -105.64 147.99 27.86 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.934 0.397 . . . . 0.0 109.968 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.3 129.9 43.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -79.87 -53.17 7.02 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -132.73 133.74 43.87 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.222 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.78 110.42 12.15 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.927 -174.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -111.29 99.34 8.18 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -75.63 102.41 5.32 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.463 HD21 ' CD1' ' A' ' 177' ' ' TYR . 41.4 tp -97.29 105.02 17.1 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 122.078 0.942 . . . . 0.0 112.415 -167.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.39 -179.85 3.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.532 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 11.8 t70 -79.87 137.34 54.07 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -42.02 -34.73 2.79 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 124.306 3.337 . . . . 0.0 114.014 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.06 22.06 1.25 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 71.43 18.14 5.58 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.186 0.994 . . . . 0.0 112.857 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 55.6 mt -84.93 132.87 30.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 131' ' ' THR . 3.6 m-20 -80.91 126.19 31.05 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -170.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.1 tp -99.06 -15.74 18.92 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 169.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 60.89 30.16 19.47 Favored 'General case' 0 C--N 1.363 1.154 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.854 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 18.7 tp -124.91 144.23 50.44 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.886 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.7 m -137.5 122.48 18.99 Favored 'General case' 0 C--N 1.286 -2.193 0 O-C-N 121.894 -0.504 . . . . 0.0 109.762 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.3 t -101.68 131.19 50.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -139.38 140.92 37.57 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.665 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.5 m -97.44 107.46 19.98 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.44 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 15.6 tp -86.45 143.14 27.92 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -175.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.57 ' O ' HD11 ' A' ' 54' ' ' ILE . 38.0 t70 -84.64 80.91 9.08 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 119.266 -0.974 . . . . 0.0 112.057 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -120.22 142.65 48.82 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -61.32 -59.88 4.61 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -70.92 149.36 46.81 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -101.01 149.85 23.51 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.967 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -81.12 145.81 30.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.3 tpt85 -70.52 128.93 37.84 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -61.47 96.72 0.06 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.469 0.652 . . . . 0.0 111.368 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -92.44 20.71 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 122.095 0.95 . . . . 0.0 109.538 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -73.95 -35.06 64.51 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.959 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.5 -5.37 85.83 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.992 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -103.55 5.74 36.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.484 0.659 . . . . 0.0 109.639 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.3 mt -74.81 133.6 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.6 t -111.03 100.62 9.27 Favored 'General case' 0 N--CA 1.396 -3.158 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -87.6 1.6 53.21 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.913 0.863 . . . . 0.0 110.131 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.82 112.27 24.17 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 168.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.2 mt -116.56 -61.11 1.77 Allowed 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.581 0.705 . . . . 0.0 112.029 -168.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 33.4 tt0 -63.69 123.2 18.27 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.355 -168.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.13 -11.66 51.95 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.13 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.9 t -95.65 142.36 13.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -77.46 128.84 34.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -122.7 151.51 41.47 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.753 0.787 . . . . 0.0 111.22 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 m -116.02 135.38 54.01 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.948 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 160' ' ' HIS . 2.4 tm? -97.01 111.45 23.67 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -107.58 105.72 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.8 p -111.59 130.36 65.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-O 121.217 0.532 . . . . 0.0 110.966 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.41 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 75.3 t60 -130.92 92.19 3.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.065 0.936 . . . . 0.0 108.657 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.1 m -115.42 -175.27 2.67 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -69.69 -36.81 76.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -77.89 -60.07 2.52 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.817 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -84.9 87.06 7.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.778 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.6 p -80.66 88.86 5.72 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.361 0.6 . . . . 0.0 112.347 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.41 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 28.8 t-20 58.97 70.2 0.67 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.43 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 33.1 m -97.13 108.41 21.13 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 69.2 mt -98.29 100.34 10.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.0 tp -113.63 115.25 27.61 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.728 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.53 120.89 19.75 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.9 m -102.13 -20.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.3 -158.87 14.08 Favored Glycine 0 N--CA 1.432 -1.622 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.152 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.14 127.08 9.01 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.849 2.366 . . . . 0.0 111.944 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 20.9 m -89.42 149.46 4.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.751 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.3 p -128.21 166.01 19.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.362 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.5 ttt -98.46 127.05 44.22 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.688 -0.632 . . . . 0.0 111.187 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.02 -52.13 5.61 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.09 -122.99 7.7 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 131' ' ' THR . 6.0 tt -111.29 112.02 23.5 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 124' ' ' ILE . 0.2 OUTLIER -133.05 163.0 39.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -108.57 144.67 35.96 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.5 tp -121.06 99.86 6.74 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.8 m 59.98 46.52 10.86 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.443 0.697 . . . . 0.0 111.071 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m 80.81 -12.69 1.0 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.348 1.459 . . . . 0.0 112.697 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.5 m -83.66 110.81 27.42 Favored Pre-proline 0 N--CA 1.44 -0.955 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.06 124.53 6.73 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.815 1.677 . . . . 0.0 111.371 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.536 ' HB ' ' SD ' ' A' ' 134' ' ' MET . 18.4 p -117.4 132.83 56.5 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.857 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.403 ' HB2' HG21 ' A' ' 68' ' ' ILE . 50.8 t30 -123.3 132.07 53.88 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -176.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 74.63 47.97 0.12 Allowed 'General case' 0 C--O 1.239 0.533 0 O-C-N 124.801 1.313 . . . . 0.0 111.825 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.536 ' SD ' ' HB ' ' A' ' 131' ' ' THR . 0.1 OUTLIER -97.64 139.28 33.77 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.253 174.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.606 HG23 ' HB3' ' A' ' 170' ' ' SER . 3.4 tt -101.43 130.07 51.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -128.09 132.13 49.01 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.343 0.592 . . . . 0.0 111.128 -171.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.433 ' HB3' HG12 ' A' ' 118' ' ' VAL . 16.3 p90 -120.62 134.13 55.31 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.188 175.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 166' ' ' ARG . 10.7 t70 -83.95 96.31 8.8 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -156.45 124.15 5.51 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.868 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -64.5 99.7 0.32 Allowed 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 124.175 0.922 . . . . 0.0 109.44 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.2 t -105.61 147.31 28.59 Favored 'General case' 0 N--CA 1.407 -2.576 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.365 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -87.28 94.19 9.6 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.1 t -45.76 143.83 1.92 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 124.548 1.139 . . . . 0.0 113.526 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.19 -2.27 2.31 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.079 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -90.3 40.29 1.0 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.719 0.408 . . . . 0.0 112.071 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 74.8 m -60.97 117.31 5.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.175 0.512 . . . . 0.0 110.954 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.54 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 101.45 2.28 53.56 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.68 122.96 31.43 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 112.203 -0.359 . . . . 0.0 112.203 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.581 HG12 ' SG ' ' A' ' 151' ' ' CYS . 54.3 t -74.15 108.1 5.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 124.005 0.922 . . . . 0.0 109.264 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.2 tp -88.67 104.17 16.62 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.669 ' SG ' HG13 ' A' ' 156' ' ' ILE . 84.0 m -145.49 174.92 10.73 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -173.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.31 -177.4 5.74 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.6 m -59.53 102.39 0.14 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.035 0.445 . . . . 0.0 111.819 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.91 26.64 72.18 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.18 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -141.4 105.56 4.8 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.669 HG13 ' SG ' ' A' ' 151' ' ' CYS . 2.5 mp -91.81 119.88 39.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -92.24 -34.88 14.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.974 0.892 . . . . 0.0 109.809 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.73 -156.35 27.52 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.6 pt -134.19 140.81 45.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.779 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.573 ' HB2' HD21 ' A' ' 101' ' ' LEU . 20.9 t60 -67.96 105.42 2.0 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.41 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.41 -38.39 13.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.42 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.49 87.8 0.07 OUTLIER Glycine 0 N--CA 1.426 -2.019 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.649 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.88 155.67 21.22 Favored Glycine 0 N--CA 1.428 -1.847 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -151.77 135.21 16.09 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 65.97 -133.26 34.24 Favored Glycine 0 C--N 1.313 -0.74 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 99.2 mtt180 -87.21 6.17 34.46 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -117.05 101.72 8.72 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.86 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -85.31 107.37 3.09 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -93.31 118.91 31.84 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.777 0.799 . . . . 0.0 111.751 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.606 ' HB3' HG23 ' A' ' 135' ' ' ILE . 30.9 t -120.12 151.09 39.57 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.398 -1.273 . . . . 0.0 107.578 176.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.3 142.72 27.45 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -80.42 105.63 11.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 123.869 0.73 . . . . 0.0 110.575 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.03 88.09 7.45 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -90.51 151.06 21.52 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -60.17 -26.61 66.45 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -50.4 -37.11 35.91 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.36 1.064 . . . . 0.0 112.094 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.463 ' CD1' HD21 ' A' ' 62' ' ' LEU . 46.7 m-85 -75.86 -17.82 59.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.991 0.424 . . . . 0.0 111.846 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.436 ' CE1' HG13 ' A' ' 30' ' ' ILE . 73.9 m-85 -109.51 8.79 25.31 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.46 -174.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 83.0 t -72.63 112.5 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -56.75 -57.05 14.12 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 123.64 0.588 . . . . 0.0 112.384 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.67 125.97 47.9 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.318 177.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.871 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.624 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.4 -32.18 93.25 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.075 2.517 . . . . 0.0 112.663 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.21 -38.83 91.66 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.256 0.55 . . . . 0.0 110.036 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 m -71.77 -41.38 68.42 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.199 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.15 -49.27 78.52 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.225 0.61 . . . . 0.0 111.207 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -63.78 -44.41 93.47 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.082 0.468 . . . . 0.0 110.845 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.07 -41.92 90.1 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.594 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.0 tp -66.79 -33.51 75.78 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.092 0.557 . . . . 0.0 111.428 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -78.51 -46.05 20.49 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 120.749 0.309 . . . . 0.0 110.299 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.7 tp -55.82 -35.67 66.61 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.952 0.901 . . . . 0.0 109.835 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.434 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 50.7 tp -52.68 -50.02 64.13 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.473 1.509 . . . . 0.0 112.791 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -81.05 -22.79 39.03 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.386 0.612 . . . . 0.0 110.738 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -91.0 -46.55 8.08 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.056 -169.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -128.73 3.27 5.46 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 53.8 mt -115.83 137.15 50.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.464 -176.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.82 169.4 21.78 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.905 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 94.8 m -98.23 123.15 42.16 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 65.5 mt -110.56 115.52 50.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 11.4 m -88.57 103.81 16.25 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.673 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 81.6 p -89.87 -165.8 1.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.865 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -69.42 -19.69 63.79 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.221 0.534 . . . . 0.0 110.127 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -97.7 -45.07 6.5 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.83 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.31 -179.73 48.49 Favored Glycine 0 CA--C 1.497 -1.031 0 C-N-CA 119.242 -1.456 . . . . 0.0 112.592 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 2.8 mp0 -78.27 107.94 11.24 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.481 ' HB3' ' O ' ' A' ' 146' ' ' CYS . 26.5 m-85 -117.01 -177.57 3.23 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 33.0 m -97.34 138.37 34.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.14 143.23 16.02 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 tp -113.56 122.0 45.92 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.31 110.21 3.54 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 175.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.1 mm -71.77 -51.27 33.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 122.354 0.262 . . . . 0.0 110.963 -174.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -170.85 147.33 2.71 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.449 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 38.1 t70 60.53 -81.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.968 1.307 . . . . 0.0 112.943 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.57 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 14.4 ptp180 -149.85 13.19 0.8 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.769 0.795 . . . . 0.0 110.246 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.44 113.79 26.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.68 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.7 m -120.12 156.13 31.66 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -137.44 144.65 31.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 117.885 0.311 . . . . 0.0 110.544 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.521 HG22 HD21 ' A' ' 75' ' ' LEU . 14.7 tt -157.12 146.7 15.3 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 6.8 Cg_endo -51.45 141.41 41.56 Favored 'Trans proline' 0 C--N 1.363 1.304 0 C-N-CA 122.907 2.405 . . . . 0.0 113.393 177.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.3 m -57.07 -48.19 79.15 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.929 0.892 . . . . 0.0 113.123 -176.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -66.75 -1.5 3.92 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.47 -25.08 60.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.673 ' O ' ' HB ' ' A' ' 20' ' ' THR . 29.4 mm-40 61.6 82.43 0.22 Allowed Pre-proline 0 N--CA 1.467 0.396 0 C-N-CA 125.462 1.505 . . . . 0.0 114.425 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -85.17 124.75 2.92 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.793 2.329 . . . . 0.0 109.984 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.96 -125.51 0.67 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.776 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -96.11 -59.77 1.77 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.616 0.722 . . . . 0.0 109.293 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 42.4 p-10 -124.19 125.5 44.53 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.449 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.84 148.18 16.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.532 -173.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 93.1 mt -79.93 102.14 9.02 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.938 0.399 . . . . 0.0 110.175 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 17' ' ' THR . 7.5 p -94.29 90.0 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 122.063 0.935 . . . . 0.0 109.055 176.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m120 62.39 8.1 2.64 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.934 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.43 -32.47 1.96 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.932 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -82.77 125.14 30.94 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -88.05 96.6 10.57 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 46' ' ' ASP . 10.4 tp -101.31 132.65 46.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.359 -171.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -82.44 121.52 26.85 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.095 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.419 HG11 HD12 ' A' ' 75' ' ' LEU . 55.8 t -84.06 132.93 30.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -79.31 -48.16 14.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.968 0.413 . . . . 0.0 110.963 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.26 138.71 31.58 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -115.47 98.65 6.85 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.462 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 80.0 m-85 -84.07 129.88 34.89 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.758 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -84.42 112.15 20.1 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 173.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 53.1 tp -90.31 99.0 12.1 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.539 0.685 . . . . 0.0 109.346 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.86 148.47 16.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.378 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.26 141.26 57.39 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.57 -3.22 0.55 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 123.944 3.096 . . . . 0.0 114.546 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.88 -2.86 41.84 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.0 t30 77.89 6.45 2.75 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 125.683 1.593 . . . . 0.0 111.273 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.574 ' HB ' ' ND2' ' A' ' 132' ' ' ASN . 50.9 mm -96.43 150.44 4.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 131' ' ' THR . 52.9 t30 -70.83 126.92 30.91 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -177.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 54.1 tp -92.08 -13.22 31.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 21.1 tp10 66.96 23.95 9.71 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.566 175.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.5 mt -117.42 135.19 54.06 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.563 -0.711 . . . . 0.0 111.753 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.5 m -114.38 130.25 56.68 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 94.1 t -102.04 120.47 51.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.521 HD21 HG22 ' A' ' 37' ' ' ILE . 2.4 mm? -103.51 127.11 50.97 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.392 -175.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 m -87.53 88.91 7.8 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.4 tt -89.99 124.26 34.6 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.409 ' O ' HD11 ' A' ' 54' ' ' ILE . 32.7 t70 -74.9 80.84 2.14 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-O 121.995 0.903 . . . . 0.0 110.275 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -100.41 131.57 46.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.31 -175.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -74.77 -24.49 58.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.586 0.708 . . . . 0.0 109.82 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -88.82 119.6 29.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.153 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -77.31 113.28 14.91 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -62.67 138.68 58.56 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -74.65 142.97 44.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 87' ' ' ARG . 10.0 t70 -67.66 99.06 0.75 Allowed 'General case' 0 C--N 1.311 -1.101 0 O-C-N 123.414 0.446 . . . . 0.0 111.535 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -90.65 19.14 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.781 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.493 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 85.3 mtm180 -71.44 -24.94 62.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.607 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.48 -19.22 79.64 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.817 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -93.54 -12.51 29.43 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.606 -0.349 . . . . 0.0 111.22 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.8 mt -64.76 120.93 12.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.318 0.58 . . . . 0.0 110.26 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 155' ' ' LYS . 5.7 p -105.67 112.56 25.69 Favored 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.712 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -84.43 -10.0 57.9 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.356 0.598 . . . . 0.0 110.316 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -85.76 117.74 24.82 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.5 mt -117.34 -53.71 2.43 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -168.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.18 115.11 5.18 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -167.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.88 1.29 58.62 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.524 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.17 160.49 2.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -73.33 155.12 39.75 Favored 'General case' 0 C--O 1.21 -0.981 0 C-N-CA 123.396 0.678 . . . . 0.0 109.605 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -159.05 152.22 22.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.759 0.79 . . . . 0.0 112.146 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.413 HG23 ' HA ' ' A' ' 114' ' ' GLU . 94.9 m -143.96 132.81 22.61 Favored 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 125.801 1.64 . . . . 0.0 107.916 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.2 tp -98.16 119.98 37.76 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.9 t -100.96 116.61 44.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.05 123.98 66.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.489 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 28.1 t60 -130.12 79.8 1.92 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.6 m -139.85 -165.81 1.96 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.83 -175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -71.42 -53.75 12.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -67.66 -39.6 84.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.13 0.49 . . . . 0.0 111.321 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -126.43 95.0 4.22 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.5 m -92.32 120.54 32.96 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.138 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.489 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 4.3 t30 61.97 42.89 9.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.858 0.837 . . . . 0.0 109.186 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.9 m -108.22 115.88 30.93 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.088 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 87.3 mt -90.09 109.19 20.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.3 tp -108.45 114.62 28.61 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 123.041 0.536 . . . . 0.0 109.983 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.413 ' HA ' HG23 ' A' ' 100' ' ' THR . 43.8 mt-10 -71.38 145.77 49.17 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.834 0.349 . . . . 0.0 111.781 -178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.5 t -115.47 -51.43 4.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.841 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 113.0 -121.56 5.58 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -98.29 135.4 0.33 Allowed 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 122.989 2.459 . . . . 0.0 113.044 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.4 m -103.63 155.53 5.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.899 -0.501 . . . . 0.0 112.278 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.446 ' O ' HG13 ' A' ' 135' ' ' ILE . 17.5 p -131.88 178.75 6.53 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.65 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 46.5 ttm -114.2 140.32 48.65 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 121.483 -0.76 . . . . 0.0 111.165 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -104.75 -53.64 2.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.36 -117.69 5.95 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.798 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.9 tp -96.14 114.78 26.51 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.201 0.6 . . . . 0.0 109.892 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.0 pt -137.42 166.58 24.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -109.54 101.16 10.12 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.4 tp -117.07 134.61 54.54 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.5 t 63.43 34.56 12.78 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.5 m 63.0 21.33 12.84 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 124.429 1.092 . . . . 0.0 111.31 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.6 m -126.97 130.13 23.85 Favored Pre-proline 0 N--CA 1.43 -1.426 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -64.44 114.51 2.73 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.196 1.931 . . . . 0.0 109.823 173.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 20.8 p -127.21 128.97 46.93 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.179 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.574 ' ND2' ' HB ' ' A' ' 68' ' ' ILE . 41.8 p30 -110.25 171.07 7.67 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.715 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.493 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.9 mpt_? 67.32 23.8 9.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.813 0.845 . . . . 0.0 110.884 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.8 mmt -81.84 128.62 34.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.583 0.706 . . . . 0.0 111.687 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 170' ' ' SER . 3.4 tt -96.88 136.84 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.629 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 34.7 ttm180 -116.61 135.97 53.36 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.501 0.501 . . . . 0.0 111.097 -170.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.5 140.34 31.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.659 -0.496 . . . . 0.0 109.659 173.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.26 110.04 19.36 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -163.32 147.92 11.05 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.56 87.26 2.12 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.0 p -81.2 128.61 33.97 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.984 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -76.63 111.99 12.71 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.7 m -70.53 129.5 39.38 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.333 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 129.38 -37.38 2.2 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.601 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -75.37 52.03 0.59 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.077 0.951 . . . . 0.0 112.913 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 25' ' ' PHE . 56.9 m -63.4 147.86 50.07 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.395 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 93.53 1.25 66.37 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.749 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.98 129.56 38.35 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.6 109.2 8.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-O 121.195 0.521 . . . . 0.0 110.56 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.7 tp -89.33 99.71 12.65 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 23.4 p -126.82 -172.6 2.68 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.561 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -157.79 -169.57 2.89 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.417 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 20.7 p -62.79 96.02 0.08 Allowed 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.708 0.63 . . . . 0.0 110.849 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.23 25.17 76.05 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.549 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 39.1 mttp -142.56 154.78 44.75 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 117.279 0.54 . . . . 0.0 109.665 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 151' ' ' CYS . 86.4 mt -137.22 128.17 40.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -100.25 -43.81 6.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.623 0.725 . . . . 0.0 110.23 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 172.92 -154.59 21.1 Favored Glycine 0 N--CA 1.416 -2.668 0 C-N-CA 120.283 -0.961 . . . . 0.0 111.14 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.6 pt -131.98 143.31 40.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 120.567 0.222 . . . . 0.0 110.628 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -58.58 126.2 26.61 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.352 1.061 . . . . 0.0 110.691 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.1 t -110.08 -63.88 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.32 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.44 108.79 0.61 Allowed Glycine 0 N--CA 1.421 -2.312 0 C-N-CA 119.901 -1.143 . . . . 0.0 112.293 -175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.94 115.0 4.37 Favored Glycine 0 N--CA 1.427 -1.954 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 175.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -114.74 97.61 6.37 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.487 0.661 . . . . 0.0 110.502 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.13 -98.49 0.64 Allowed Glycine 0 N--CA 1.425 -2.034 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.654 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 6.4 mpt_? -110.98 -0.7 16.62 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.619 -0.291 . . . . 0.0 111.055 -174.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -119.18 120.62 37.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.602 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.28 120.77 5.84 Favored Glycine 0 N--CA 1.418 -2.538 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -108.14 118.67 37.35 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.574 0.702 . . . . 0.0 109.931 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.546 ' HB2' HG23 ' A' ' 135' ' ' ILE . 28.6 m -115.83 157.5 24.33 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.693 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -98.81 132.54 44.09 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 10.8 pt20 -87.64 103.3 15.44 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.947 0.88 . . . . 0.0 110.655 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.434 ' H ' HD13 ' A' ' 173' ' ' LEU 0.337 0.0 OUTLIER -85.11 79.79 9.47 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.18 0.991 . . . . 0.0 111.716 177.155 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -57.86 145.01 36.75 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.526 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.486 ' O ' HG23 ' A' ' 179' ' ' VAL . 20.2 ptmt -56.13 -25.41 45.96 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.358 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -58.66 -29.99 67.0 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.843 0.857 . . . . 0.0 112.311 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -74.81 -20.5 59.75 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.112 0.482 . . . . 0.0 110.78 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -101.68 11.14 39.35 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.501 0.667 . . . . 0.0 109.498 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 175' ' ' LYS . 92.5 t -97.1 134.93 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 174.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.58 -43.41 80.66 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.403 0.621 . . . . 0.0 109.638 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -104.79 90.56 3.52 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.547 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 . . . . . 0 C--N 1.31 -1.127 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.792 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.503 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -57.34 -32.26 93.34 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.197 2.598 . . . . 0.0 112.935 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -69.51 -40.64 76.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.66 -40.59 97.24 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.931 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -64.23 -40.05 95.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.857 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.18 -42.91 93.17 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.126 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.96 82.27 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.112 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.87 -35.68 80.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -82.84 -37.4 24.44 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.877 -0.514 . . . . 0.0 111.332 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.02 -41.17 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.404 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 54.5 tp -53.51 -51.42 62.88 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.638 1.175 . . . . 0.0 112.335 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -70.54 -12.82 61.82 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -125.38 -42.01 2.0 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -106.46 -18.06 14.09 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -169.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.404 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 46.5 mt -89.16 105.36 15.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.29 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.2 mtp -105.45 140.22 38.88 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.325 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 m -99.38 116.03 30.59 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.3 mt -111.02 118.48 57.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.352 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 99.8 m -85.4 109.12 18.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.623 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 73.3 p -96.02 -157.54 0.59 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.505 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.5 m -84.01 3.31 34.96 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 121.193 0.521 . . . . 0.0 109.946 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -115.66 -39.52 3.51 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.158 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.61 -153.14 23.99 Favored Glycine 0 CA--C 1.498 -1.022 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -92.76 115.58 28.24 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.263 0.554 . . . . 0.0 110.823 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -116.48 169.6 9.2 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 57.6 m -98.54 127.8 44.62 Favored 'General case' 0 N--CA 1.41 -2.443 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.268 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.68 129.44 9.29 Favored Glycine 0 N--CA 1.412 -2.956 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -100.08 116.43 32.09 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.023 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.6 113.98 4.66 Favored Glycine 0 C--O 1.212 -1.253 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.536 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.1 mm -90.87 -50.64 12.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 116.964 0.382 . . . . 0.0 111.593 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -156.09 121.22 4.75 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.831 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.441 ' OD1' ' HG3' ' A' ' 82' ' ' LYS . 28.9 t70 67.18 -79.98 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.148 0.905 . . . . 0.0 113.266 168.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -140.46 11.88 2.33 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.794 0.838 . . . . 0.0 109.54 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.435 HG13 HG13 ' A' ' 74' ' ' VAL . 87.4 t -91.95 115.22 30.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.305 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -120.78 139.22 53.43 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.4 t -114.64 135.27 55.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 120.581 0.229 . . . . 0.0 111.082 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.5 tt -146.54 145.03 21.98 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 59.9 Cg_exo -57.8 138.91 88.41 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.465 2.11 . . . . 0.0 112.415 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.677 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 21.5 m -60.94 -41.69 96.76 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -71.01 -0.27 9.03 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.91 -15.5 60.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.623 ' O ' ' HB ' ' A' ' 20' ' ' THR . 82.8 mm-40 60.44 82.0 0.23 Allowed Pre-proline 0 CA--C 1.518 -0.283 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 175.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.19 158.98 11.33 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.46 2.107 . . . . 0.0 109.579 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.36 -141.55 11.1 Favored Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.446 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -88.21 -15.22 36.53 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.02 151.77 39.07 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.13 153.98 39.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 7.2 mp -103.57 105.4 15.63 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.829 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.51 92.97 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.8 t30 66.09 8.24 5.34 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.596 1.558 . . . . 0.0 110.564 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.63 -24.83 3.31 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.66 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 46.5 mt-30 -75.12 106.73 6.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.594 0.197 . . . . 0.0 111.062 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -68.9 103.53 1.83 Allowed 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.4 tp -112.06 121.46 64.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-O 121.241 0.543 . . . . 0.0 109.693 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -75.48 110.32 9.77 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.9 t -65.9 135.4 28.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.58 -63.14 1.31 Allowed 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -144.77 144.46 31.19 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -108.14 111.0 22.79 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.503 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 61.9 m-85 -96.59 113.18 24.72 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -77.15 114.18 15.68 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -88.92 94.86 10.09 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.1 t -112.33 149.29 14.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -65.48 142.08 98.22 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.56 -22.55 17.06 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.498 2.799 . . . . 0.0 114.193 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -94.83 14.45 21.39 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 122.058 0.933 . . . . 0.0 109.761 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 66.54 26.69 9.85 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.61 1.164 . . . . 0.0 111.943 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.407 HG21 ' HB2' ' A' ' 132' ' ' ASN . 34.8 mm -86.3 137.27 21.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 131' ' ' THR . 63.3 t30 -92.13 135.0 34.33 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.811 -171.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -123.01 2.45 9.33 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.701 172.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.677 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 4.9 tp10 62.84 23.35 13.94 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.179 1.392 . . . . 0.0 111.864 174.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.7 tt -95.8 120.89 36.87 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 121.666 -0.646 . . . . 0.0 110.141 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 m -114.89 127.39 55.67 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 60.8 t -99.74 107.75 21.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.5 mt -95.69 117.76 31.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.9 m -97.6 103.69 15.65 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -78.17 141.04 38.95 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.257 0.551 . . . . 0.0 111.479 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -91.32 83.25 5.45 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.574 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 11.0 mmm180 -134.06 175.14 9.75 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.806 -174.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -108.33 -28.6 9.32 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 123.325 0.391 . . . . 0.0 111.073 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.574 ' OE1' ' HB3' ' A' ' 79' ' ' ARG . 1.5 pm0 -70.4 127.25 32.11 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-O 121.281 0.562 . . . . 0.0 111.192 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.441 ' HG3' ' OD1' ' A' ' 32' ' ' ASP . 41.4 tttp -92.33 109.54 20.92 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -73.35 139.39 45.97 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.586 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -49.94 123.19 7.68 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.525 1.13 . . . . 0.0 110.001 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -81.49 114.73 20.41 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.892 178.503 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.9 pt -93.8 25.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.997 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -68.3 -27.02 65.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.911 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.73 -9.23 86.45 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.252 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -100.86 -8.97 22.07 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.77 124.51 22.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.5 t -113.3 114.25 26.42 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.452 ' OE2' ' HG3' ' A' ' 176' ' ' GLN . 45.8 mt-10 -84.47 -20.25 32.02 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.233 0.539 . . . . 0.0 110.186 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -90.04 123.74 34.18 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 170.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.469 ' HB3' HD12 ' A' ' 135' ' ' ILE . 8.7 mt -113.93 -56.75 2.36 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.981 0.896 . . . . 0.0 111.228 -168.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 119' ' ' THR . 35.1 tt0 -59.68 126.53 27.98 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.618 -170.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.78 -27.1 8.07 Favored Glycine 0 N--CA 1.436 -1.304 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.117 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.02 156.82 3.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 120.834 0.349 . . . . 0.0 110.384 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -89.21 143.67 26.67 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.71 162.25 33.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.658 0.742 . . . . 0.0 112.097 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 88.3 m -124.93 141.62 52.0 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.904 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -107.88 120.87 43.5 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 111' ' ' THR . 37.8 t -116.51 111.32 34.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 120.894 0.378 . . . . 0.0 110.059 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.4 p -113.21 141.04 30.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -133.45 95.72 3.56 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.725 0.774 . . . . 0.0 109.37 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.2 t -104.44 -172.86 2.18 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -88.59 -42.84 11.8 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.54 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -70.44 -49.48 48.25 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -95.57 79.44 3.39 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.9 m -79.96 107.83 13.05 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.171 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.0 t30 58.77 71.82 0.56 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.016 0.926 . . . . 0.0 113.02 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 22.7 m -98.77 107.74 20.26 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.9 mt -95.62 94.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.404 HD21 ' CE2' ' A' ' 139' ' ' TYR . 65.1 tp -103.76 114.43 28.69 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.636 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.56 96.38 6.8 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.08 -35.82 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.979 -176.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.419 ' HA3' ' HD3' ' A' ' 117' ' ' PRO . . . 113.4 -135.17 12.38 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.579 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.419 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 3.1 Cg_exo -77.95 130.01 10.15 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 123.038 2.492 . . . . 0.0 112.345 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.566 ' HB ' HD11 ' A' ' 135' ' ' ILE . 31.2 m -105.57 138.23 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-O 121.531 0.682 . . . . 0.0 111.129 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . 30.4 m -122.59 145.52 48.27 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.019 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 57.9 ttp -83.45 122.0 27.93 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -82.36 -32.61 29.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.121 0.486 . . . . 0.0 111.364 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.78 -86.59 1.51 Allowed Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -152.03 138.27 18.38 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.9 mm -126.72 155.05 37.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -105.56 113.49 27.09 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.7 mt -114.52 85.83 2.31 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.354 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.6 m 55.88 77.03 0.25 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.463 1.105 . . . . 0.0 112.273 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.1 m 67.72 -19.68 0.13 Allowed 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.962 1.305 . . . . 0.0 113.476 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 91.8 m -92.83 117.59 67.61 Favored Pre-proline 0 N--CA 1.427 -1.606 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -83.58 121.34 2.93 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 121.616 1.544 . . . . 0.0 109.574 174.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.525 ' HB ' ' SD ' ' A' ' 134' ' ' MET . 33.3 p -107.59 102.76 11.99 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-O 121.764 0.792 . . . . 0.0 110.226 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.407 ' HB2' HG21 ' A' ' 68' ' ' ILE . 46.2 t30 -103.65 164.0 11.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -178.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.402 ' HD3' ' OH ' ' A' ' 177' ' ' TYR . 46.1 mtt180 67.81 38.12 2.99 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.736 0.814 . . . . 0.0 109.437 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.525 ' SD ' ' HB ' ' A' ' 131' ' ' THR . 57.1 mtt -119.24 164.23 15.94 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-O 121.798 0.809 . . . . 0.0 113.105 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.566 HD11 ' HB ' ' A' ' 118' ' ' VAL . 12.9 tt -123.15 151.42 27.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 124.712 1.205 . . . . 0.0 108.317 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -128.29 142.56 51.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.067 0.46 . . . . 0.0 111.889 -174.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -144.56 137.34 26.72 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.892 169.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.96 104.65 16.48 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.792 0.806 . . . . 0.0 111.662 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.404 ' CE2' HD21 ' A' ' 113' ' ' LEU . 56.8 t80 -162.56 138.07 7.12 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 125.808 1.643 . . . . 0.0 107.45 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.04 98.97 2.64 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.5 m -53.03 138.51 30.45 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 124.951 1.3 . . . . 0.0 112.836 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 145' ' ' GLN . 62.8 tttp -99.85 140.22 34.37 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.7 m -63.92 139.12 58.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 122.529 0.332 . . . . 0.0 110.263 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.34 33.47 9.4 Favored Glycine 0 C--O 1.219 -0.823 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 14.8 tp60 -116.89 -6.13 11.49 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.603 0.716 . . . . 0.0 109.432 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.41 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 42.2 t -69.78 129.0 38.37 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.704 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.405 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 100.34 -7.66 58.39 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.095 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.75 140.28 42.22 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.526 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.34 120.67 35.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.729 0.776 . . . . 0.0 110.774 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 42.3 tp -88.2 106.04 17.93 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.0 p -140.99 168.67 19.23 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.747 0.784 . . . . 0.0 112.577 -172.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.54 -179.1 6.71 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.4 t -57.41 101.22 0.06 Allowed 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.938 0.875 . . . . 0.0 111.937 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.3 14.88 74.52 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.275 -1.33 . . . . 0.0 113.092 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -135.64 108.74 7.69 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 117.251 0.526 . . . . 0.0 111.045 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.13 126.26 57.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -97.87 -33.63 11.16 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 123.896 0.747 . . . . 0.0 110.959 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 165.54 -159.85 33.11 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 119.441 -1.361 . . . . 0.0 112.675 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.561 HG23 HD11 ' A' ' 173' ' ' LEU . 19.6 pt -121.86 137.75 54.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -69.34 125.96 28.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.0 p -96.69 -46.7 12.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.316 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.77 156.34 11.36 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -131.08 156.73 21.91 Favored Glycine 0 N--CA 1.428 -1.852 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.528 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -154.95 144.16 21.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.97 -122.68 5.9 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -117.84 13.21 14.03 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -121.43 136.88 54.91 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.017 0.437 . . . . 0.0 111.971 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -106.94 130.14 10.03 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -112.44 140.71 46.95 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.198 0.523 . . . . 0.0 109.96 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.528 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 18.6 m -131.15 154.7 48.07 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.41 139.56 30.56 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.67 116.35 19.8 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 123.37 0.419 . . . . 0.0 110.964 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.561 HD11 HG23 ' A' ' 159' ' ' ILE . 81.9 mt -89.02 94.38 9.93 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -84.08 140.66 31.67 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.093 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -69.16 -20.84 64.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.442 0.639 . . . . 0.0 109.6 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.452 ' HG3' ' OE2' ' A' ' 92' ' ' GLU . 69.4 mt-30 -58.21 -21.75 49.07 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.506 1.523 . . . . 0.0 112.23 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.402 ' OH ' ' HD3' ' A' ' 133' ' ' ARG . 34.6 m-85 -86.99 -23.42 25.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.93 0.395 . . . . 0.0 110.726 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.406 ' CG ' HG21 ' A' ' 30' ' ' ILE . 49.2 m-85 -106.5 18.72 21.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.154 0.502 . . . . 0.0 112.017 -169.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 24.0 m -100.12 -179.81 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.629 176.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.5 -37.85 27.23 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.215 0.531 . . . . 0.0 110.127 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -91.45 106.29 18.38 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.426 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--N 1.303 -1.449 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.195 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.358 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.63 -27.6 76.31 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.012 2.474 . . . . 0.0 111.106 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -61.21 -37.27 82.39 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.057 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.4 m -64.52 -37.43 87.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.506 0.722 . . . . 0.0 109.608 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.35 -44.83 82.18 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.915 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.83 -45.98 88.75 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.944 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.424 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -62.02 -43.48 98.75 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.02 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.84 -37.7 85.45 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 123.346 0.658 . . . . 0.0 110.438 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 m -76.41 -31.62 58.03 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.527 0.679 . . . . 0.0 110.325 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -73.69 -31.14 63.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.303 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 62.2 tp -51.68 -56.32 14.37 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.436 1.094 . . . . 0.0 112.05 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -83.02 10.26 8.41 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.221 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -117.91 -59.79 1.87 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -122.72 -6.81 8.56 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 50.5 mt -89.19 103.32 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 mmt -115.58 126.03 53.7 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.25 0.548 . . . . 0.0 111.002 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 24' ' ' GLU . 2.4 m -70.2 96.82 1.13 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.864 177.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 58.5 mt -89.86 111.9 23.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 121.16 0.505 . . . . 0.0 109.908 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.8 m -86.5 107.6 18.17 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 80.5 p -89.74 -157.75 0.48 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.776 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 t -85.57 -9.45 57.32 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -106.3 -38.06 6.35 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.03 -160.4 27.45 Favored Glycine 0 CA--C 1.493 -1.326 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.804 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HB3' HG22 ' A' ' 17' ' ' THR . 7.8 mp0 -99.86 112.27 24.54 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -112.73 159.3 19.08 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 17.9 m -86.65 116.26 24.65 Favored 'General case' 0 N--CA 1.408 -2.556 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.47 129.26 9.81 Favored Glycine 0 N--CA 1.417 -2.624 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.2 tp -105.4 115.9 31.04 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 120.839 0.352 . . . . 0.0 110.549 -178.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.7 136.48 23.17 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.418 ' HA ' HD11 ' A' ' 86' ' ' ILE . 50.3 mm -100.61 -56.34 5.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 117.566 0.683 . . . . 0.0 109.537 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.601 ' NE2' ' HB3' ' A' ' 178' ' ' PHE . 0.1 OUTLIER -172.97 167.94 4.95 Favored 'General case' 0 CA--C 1.46 -2.494 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 52.06 -135.57 1.47 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.67 25.73 10.44 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -92.61 112.87 26.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.272 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 43.2 t -122.14 139.71 53.42 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.15 140.77 26.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 122.225 0.21 . . . . 0.0 110.585 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 tt -151.78 147.44 20.05 Favored Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -63.94 147.26 92.02 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.158 1.905 . . . . 0.0 112.066 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.0 m -64.44 -37.66 88.29 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -76.09 5.24 7.01 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.42 -19.65 57.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' A' ' 20' ' ' THR . 78.6 mt-30 57.22 76.6 0.47 Allowed Pre-proline 0 C--O 1.251 1.158 0 C-N-CA 125.414 1.486 . . . . 0.0 113.361 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -92.29 164.8 3.02 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 122.346 2.031 . . . . 0.0 110.724 175.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.34 -152.09 10.96 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.06 -1.44 54.41 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -144.87 126.13 14.76 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.18 155.39 39.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.063 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 8.8 mp -92.26 102.06 14.56 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.3 p -87.82 105.46 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.052 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 74.03 -3.9 2.41 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.611 0.764 . . . . 0.0 110.81 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.51 -9.3 11.78 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -97.67 118.26 33.79 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 14.9 ptpt -77.19 134.63 38.59 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 118.28 -1.368 . . . . 0.0 112.738 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.478 HG12 ' HB3' ' A' ' 77' ' ' LEU . 5.3 tp -131.49 141.12 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 114.251 -1.341 . . . . 0.0 108.346 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -86.47 139.66 30.68 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.6 t -93.01 139.93 17.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -79.68 -71.34 0.45 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -126.15 139.38 53.41 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -99.88 90.97 4.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.447 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 93.8 m-85 -79.2 109.97 14.03 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.155 0.502 . . . . 0.0 110.523 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -77.14 104.42 7.63 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.7 tp -80.26 87.89 5.53 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 122.181 0.991 . . . . 0.0 109.245 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -119.64 163.52 16.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 113.848 -1.523 . . . . 0.0 108.397 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.58 137.15 48.05 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.53 -23.9 11.55 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.667 2.911 . . . . 0.0 114.348 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -82.77 13.53 3.79 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 122.379 0.272 . . . . 0.0 111.384 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.9 m120 79.21 10.19 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 125.383 1.473 . . . . 0.0 112.347 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.5 mt -86.47 119.84 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.628 ' O ' ' HA ' ' A' ' 131' ' ' THR . 74.6 m-20 -81.07 157.67 25.32 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.882 -173.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -109.36 -0.97 18.78 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 61.72 30.05 18.29 Favored 'General case' 0 C--N 1.364 1.218 0 CA-C-O 122.83 1.3 . . . . 0.0 108.634 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.464 HD21 HD11 ' A' ' 173' ' ' LEU . 14.9 tp -133.01 142.89 49.07 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.584 -170.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.0 m -138.08 140.3 39.92 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.255 0.55 . . . . 0.0 110.657 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 92.7 t -105.98 122.25 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.8 mt -102.38 113.69 27.23 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.7 m -87.6 107.55 18.65 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.478 ' HB3' HG12 ' A' ' 54' ' ' ILE . 66.0 mt -80.48 141.31 35.34 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.725 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.52 74.72 10.35 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 122.045 0.926 . . . . 0.0 111.6 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -125.12 161.59 26.49 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.436 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -93.23 -49.57 5.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -66.96 148.16 52.3 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -119.27 173.18 7.1 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.388 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -82.56 179.64 7.72 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -73.75 127.93 34.13 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.01 90.16 1.15 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.418 HD11 ' HA ' ' A' ' 30' ' ' ILE . 2.4 pp -92.61 20.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.755 -0.591 . . . . 0.0 112.162 -176.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -68.69 -29.74 68.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.811 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.72 -27.54 73.77 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -85.1 -8.82 58.48 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 122.9 -0.177 . . . . 0.0 110.699 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.4 mt -66.54 131.69 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 t -124.44 111.48 15.78 Favored 'General case' 0 N--CA 1.387 -3.589 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -86.84 5.46 36.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.495 1.14 . . . . 0.0 108.935 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.83 110.57 22.02 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 169.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.5 -29.76 0.62 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -171.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -68.1 103.02 1.43 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.113 0.482 . . . . 0.0 111.747 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.38 -0.43 34.94 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.604 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.0 t -91.53 138.71 19.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -79.7 116.72 20.05 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -115.59 172.25 7.23 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.821 0.82 . . . . 0.0 112.097 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.6 m -128.79 141.25 51.37 Favored 'General case' 0 N--CA 1.422 -1.857 0 C-N-CA 124.908 1.283 . . . . 0.0 108.719 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.8 tp -106.12 122.19 45.69 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.424 HG21 ' HB1' ' A' ' 7' ' ' ALA . 43.5 t -113.96 107.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.815 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.4 m -107.85 138.91 31.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -139.28 107.99 5.93 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.325 0.583 . . . . 0.0 110.002 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.3 p -144.27 -172.58 3.81 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.46 -25.76 41.85 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.401 176.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -73.68 -51.27 17.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.419 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -115.79 84.35 2.09 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.8 m -80.14 96.32 6.49 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.355 0.597 . . . . 0.0 111.005 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.2 t30 60.15 70.71 0.61 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.755 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.3 m -101.34 108.03 19.54 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.08 108.67 24.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.0 tp -125.15 123.88 40.6 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.875 0.369 . . . . 0.0 111.563 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.86 102.65 4.8 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.1 m -78.39 -26.54 14.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.243 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 106.85 -149.53 16.6 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 119.94 -1.124 . . . . 0.0 111.1 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.95 122.25 8.63 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.745 2.297 . . . . 0.0 112.901 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.8 m -89.57 145.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.949 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 135' ' ' ILE . 11.5 p -128.45 172.8 10.79 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.246 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 28.2 ttt -114.45 136.64 52.78 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.74 -26.84 12.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.335 0.588 . . . . 0.0 109.419 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.53 -88.89 1.46 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 131' ' ' THR . 4.9 mp -131.99 155.99 47.0 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 11.1 tt -144.05 128.18 13.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -91.17 95.48 10.08 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.2 tp -107.13 121.99 45.6 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.5 p 50.05 49.68 19.91 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.753 0.821 . . . . 0.0 112.776 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 26.3 m 62.9 17.85 10.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.622 0.769 . . . . 0.0 112.599 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 96.1 m -129.93 106.58 16.69 Favored Pre-proline 0 N--CA 1.42 -1.949 0 CA-C-O 121.163 0.506 . . . . 0.0 109.894 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 50.7 Cg_endo -78.84 131.28 10.04 Favored 'Trans proline' 0 N--CA 1.428 -2.358 0 C-N-CA 121.451 1.434 . . . . 0.0 110.816 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.1 p -103.69 133.45 48.67 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.415 ' OD1' ' HD2' ' A' ' 133' ' ' ARG . 29.0 t-20 -108.19 159.9 16.24 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -175.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.494 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 5.5 mpt_? 65.72 38.8 5.1 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.563 1.145 . . . . 0.0 110.638 -177.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.425 ' HG3' HG22 ' A' ' 124' ' ' ILE . 16.5 mmt -85.55 118.42 25.06 Favored 'General case' 0 C--O 1.252 1.214 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.256 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.575 HG23 ' HB2' ' A' ' 170' ' ' SER . 5.4 tt -99.84 136.34 31.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 144.58 51.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.752 0.31 . . . . 0.0 111.311 -172.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.409 ' HE2' ' HG ' ' A' ' 170' ' ' SER . 6.3 p90 -138.95 163.81 31.38 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.907 176.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.27 99.95 12.84 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 124.227 0.955 . . . . 0.0 108.669 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -171.34 124.35 0.6 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.485 1.114 . . . . 0.0 109.65 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -70.46 102.81 2.29 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.941 176.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.8 t -119.81 155.73 32.0 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -127.21 165.44 19.61 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.721 0.296 . . . . 0.0 110.505 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.4 m -60.74 129.38 41.22 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.287 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.27 -20.41 9.04 Favored Glycine 0 C--O 1.215 -1.049 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -93.42 23.71 4.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.183 0.992 . . . . 0.0 108.386 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.1 m -79.12 137.88 37.68 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.415 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.566 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 97.55 0.43 59.35 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.57 126.58 37.81 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 121.566 -0.349 . . . . 0.0 112.643 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -73.25 113.0 10.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 123.318 0.647 . . . . 0.0 109.465 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 52.3 tp -94.18 106.45 18.42 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.5 p -147.02 163.23 36.91 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.675 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.77 177.8 6.58 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.1 t -64.38 108.46 1.63 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.956 0.884 . . . . 0.0 110.946 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 83.27 2.37 90.36 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.262 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -136.35 108.38 7.18 Favored 'General case' 0 C--O 1.211 -0.956 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.1 mt -97.68 130.92 45.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -103.41 -31.97 9.75 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.147 0.498 . . . . 0.0 110.691 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.4 -154.84 25.91 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.283 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.9 pt -132.28 148.08 32.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 116.911 0.355 . . . . 0.0 110.597 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.408 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 23.8 t-80 -68.14 131.16 44.91 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.203 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.6 m -105.47 -59.96 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.56 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -156.93 142.89 9.06 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.019 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -131.67 143.99 15.57 Favored Glycine 0 N--CA 1.423 -2.232 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.894 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -119.76 105.99 11.68 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.638 0.732 . . . . 0.0 109.911 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 74.2 -130.76 12.75 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -177.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 34.0 ptt180 -90.14 9.09 29.67 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.961 0.41 . . . . 0.0 110.982 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -111.37 94.72 5.12 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.618 0.723 . . . . 0.0 110.063 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.9 123.93 6.9 Favored Glycine 0 N--CA 1.422 -2.283 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.55 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -104.27 127.52 51.91 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.951 0.881 . . . . 0.0 109.557 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.575 ' HB2' HG23 ' A' ' 135' ' ' ILE . 19.4 m -124.62 166.29 16.38 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.36 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -100.56 129.49 46.5 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 4.0 pt20 -85.18 115.88 23.22 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.922 0.868 . . . . 0.0 110.319 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.464 HD11 HD21 ' A' ' 72' ' ' LEU . 4.3 mm? -87.09 93.4 9.35 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.954 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -73.3 146.73 45.12 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -75.3 -6.3 49.12 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.334 0.588 . . . . 0.0 110.907 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.09 -33.42 74.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.077 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -75.33 -27.0 59.07 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.173 0.511 . . . . 0.0 110.899 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.601 ' HB3' ' NE2' ' A' ' 31' ' ' HIS . 82.7 m-85 -102.1 0.99 35.75 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.897 -170.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.7 p -92.74 136.37 25.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -65.79 -46.26 79.37 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.185 0.517 . . . . 0.0 110.883 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.24 146.56 45.94 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.344 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 C--N 1.285 -2.2 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.544 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.522 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.4 -27.51 71.07 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 123.048 2.499 . . . . 0.0 113.272 -176.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -76.56 -40.13 50.69 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -60.89 -46.21 91.54 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.851 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.45 -49.52 77.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.332 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -58.57 -46.8 86.15 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 123.498 0.499 . . . . 0.0 110.781 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.61 -35.14 78.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.6 tp -71.38 -42.14 68.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.049 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -70.73 -33.09 70.47 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.022 -0.423 . . . . 0.0 111.46 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.412 HD11 HD13 ' A' ' 86' ' ' ILE . 50.6 tp -67.27 -40.53 86.2 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.733 0.813 . . . . 0.0 108.927 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.455 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 18.5 tp -53.51 -50.49 65.3 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.742 1.217 . . . . 0.0 111.591 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -73.36 -3.61 28.3 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.783 -1.098 . . . . 0.0 113.447 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -126.42 -47.98 1.57 Allowed 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -115.84 -10.49 11.69 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -171.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 29.8 mt -99.19 115.34 39.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.101 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 mmt -127.65 146.37 50.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.465 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 22.7 m -78.56 132.41 37.15 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.7 mt -125.93 110.8 24.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 98.4 m -77.03 103.72 7.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.2 p -94.55 -168.68 1.88 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.008 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -71.12 -16.11 62.54 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 120.842 0.353 . . . . 0.0 111.047 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -110.11 9.63 24.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.84 -162.41 14.01 Favored Glycine 0 C--N 1.31 -0.869 0 C-N-CA 119.49 -1.338 . . . . 0.0 113.642 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -86.48 101.27 13.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.312 0.577 . . . . 0.0 111.738 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -106.92 -179.25 3.88 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 t -127.44 139.28 52.92 Favored 'General case' 0 N--CA 1.408 -2.571 0 C-N-CA 119.005 -1.078 . . . . 0.0 109.028 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.59 137.63 14.41 Favored Glycine 0 N--CA 1.415 -2.737 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.7 tp -101.84 118.41 36.86 Favored 'General case' 0 C--N 1.29 -2.01 0 O-C-N 123.811 0.359 . . . . 0.0 110.175 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.47 132.38 22.76 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mm -100.11 -53.03 8.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 117.624 0.712 . . . . 0.0 109.933 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -161.94 151.02 15.69 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.495 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.488 ' HA ' ' HG3' ' A' ' 82' ' ' LYS . 4.6 t70 53.72 -92.24 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 125.333 1.453 . . . . 0.0 112.695 177.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 32' ' ' ASP . 9.3 mpt_? -132.0 7.74 4.36 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.398 0.618 . . . . 0.0 110.033 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.446 HG13 HG13 ' A' ' 74' ' ' VAL . 84.0 t -77.82 112.83 16.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.573 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.7 m -121.94 142.84 49.88 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.3 p -115.91 141.39 33.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 120.743 0.306 . . . . 0.0 110.571 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 tt -154.47 149.42 20.24 Favored Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.57 144.9 95.13 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 122.279 1.986 . . . . 0.0 112.781 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.594 ' HB ' ' OG1' ' A' ' 73' ' ' THR . 9.6 t -86.52 -10.29 54.39 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -79.02 -2.51 40.67 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.282 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.73 -27.74 20.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.001 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 13.5 mm-40 60.04 87.46 0.14 Allowed Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.653 1.181 . . . . 0.0 114.171 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.48 149.08 18.74 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.156 1.904 . . . . 0.0 109.194 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.01 -157.35 30.09 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.478 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -82.2 -30.24 31.0 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.402 ' OD2' ' HD2' ' A' ' 53' ' ' LYS . 8.6 p-10 -139.58 136.29 34.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 23.9 m -136.68 157.68 36.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 120.755 0.312 . . . . 0.0 111.644 -174.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 86.6 mt -89.81 109.88 20.85 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 17' ' ' THR . 81.8 t -97.77 88.55 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.251 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 63.52 18.47 11.09 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.519 1.152 . . . . 0.0 109.934 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.18 -38.69 2.03 Favored Glycine 0 N--CA 1.436 -1.3 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.128 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -81.03 120.11 24.39 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.773 -0.251 . . . . 0.0 110.371 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 39.1 ttpt -80.59 110.41 16.04 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.2 tp -103.82 150.19 7.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -99.52 139.52 35.06 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 118.272 -1.371 . . . . 0.0 107.824 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.43 124.96 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.407 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 57.7 tttm -70.86 -52.25 21.47 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.34 0.59 . . . . 0.0 109.839 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.2 m-20 -138.71 138.25 37.55 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.602 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -115.55 112.51 22.3 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.47 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 63.9 m-85 -109.88 111.62 23.15 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.527 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -78.6 116.24 18.84 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.567 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 37.8 tp -90.73 101.97 14.72 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.1 t -123.89 140.8 46.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -81.78 130.94 58.98 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.98 5.23 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.081 3.187 . . . . 0.0 116.044 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.7 14.57 16.74 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.9 t30 70.66 40.06 1.06 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.011 1.324 . . . . 0.0 109.007 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 53.3 mt -120.06 122.02 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.62 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 131' ' ' THR . 50.4 t30 -64.54 150.29 47.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.598 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.567 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 39.1 tp -126.52 -9.58 6.26 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.716 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 72.5 -20.59 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.673 1.189 . . . . 0.0 113.108 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.67 118.69 11.99 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.594 ' OG1' ' HB ' ' A' ' 39' ' ' THR . 55.0 m -106.83 114.28 28.28 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 64.2 t -92.97 104.88 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.75 124.42 42.1 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.253 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.8 m -98.05 93.78 6.48 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -71.05 137.55 49.07 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.23 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.78 76.89 10.17 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.429 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -101.47 128.84 47.51 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.305 -1.771 . . . . 0.0 107.23 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.55 -50.74 64.04 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.365 0.415 . . . . 0.0 111.457 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -74.02 160.09 31.79 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 121.242 0.544 . . . . 0.0 110.62 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.488 ' HG3' ' HA ' ' A' ' 32' ' ' ASP . 58.1 tttm -99.52 142.55 30.85 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.604 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -80.8 162.3 24.1 Favored 'General case' 0 C--O 1.257 1.448 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 175.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -77.18 132.48 38.79 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -80.24 96.17 6.52 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.785 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.412 HD13 HD11 ' A' ' 10' ' ' LEU . 38.4 pt -96.0 20.32 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.767 0.794 . . . . 0.0 109.523 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -65.32 -28.16 69.12 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.837 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.72 -5.99 89.42 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.643 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -96.16 -3.06 45.1 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.282 0.563 . . . . 0.0 110.584 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.6 mt -70.22 120.07 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.987 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 p -108.68 105.08 14.53 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.546 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 1.0 OUTLIER -80.2 -12.48 59.64 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.299 177.519 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.35 118.98 21.76 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.427 HD13 ' HB ' ' A' ' 135' ' ' ILE . 21.6 mt -112.65 -63.84 1.38 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.394 0.616 . . . . 0.0 112.3 -169.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 16.9 pt-20 -54.69 126.95 26.03 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -166.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.87 -38.28 3.2 Favored Glycine 0 N--CA 1.432 -1.582 0 CA-C-N 114.488 -1.233 . . . . 0.0 113.011 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.3 t -78.52 138.64 19.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.997 0.427 . . . . 0.0 110.897 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -80.97 102.4 10.12 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.9 163.54 24.24 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.554 0.693 . . . . 0.0 111.16 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.6 m -129.28 139.04 51.94 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.5 tp -112.65 125.09 53.91 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 111' ' ' THR . 7.6 p -117.89 122.4 69.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.412 0.625 . . . . 0.0 110.832 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 t -111.72 139.13 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.743 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.409 ' HB3' HG22 ' A' ' 15' ' ' ILE . 76.5 t60 -126.5 79.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.258 1.028 . . . . 0.0 109.806 175.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.9 t -116.91 -177.82 3.29 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -71.33 -45.28 63.38 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.091 0.472 . . . . 0.0 110.374 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -82.28 -47.39 12.46 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.515 0.674 . . . . 0.0 109.885 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -88.69 76.6 8.04 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.761 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 22.5 m -94.44 101.11 13.02 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.921 0.391 . . . . 0.0 110.008 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.0 t30 64.45 62.9 0.78 Allowed 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.927 1.346 . . . . 0.0 110.033 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 24.6 m -96.54 96.15 8.48 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.344 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 54.1 mt -100.99 97.03 5.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.7 tp -120.2 137.17 54.35 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -68.67 146.08 53.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.2 t -102.72 -51.4 9.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 119.54 -168.58 13.56 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.59 116.8 4.13 Favored 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.704 2.27 . . . . 0.0 112.278 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 26.8 m -87.29 155.72 3.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.091 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.0 p -136.84 169.61 17.46 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 123.129 0.572 . . . . 0.0 109.592 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.2 ttt -87.82 142.68 27.62 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -95.84 -39.54 9.78 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.037 0.446 . . . . 0.0 110.976 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 133' ' ' ARG . . . 99.36 -111.68 4.27 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 130' ' ' PRO . 2.5 pt? -134.94 112.19 10.43 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.284 1.04 . . . . 0.0 110.911 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 7.6 tp -162.82 156.67 2.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 129' ' ' THR . 2.6 t-20 -159.27 -77.56 0.07 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -161.08 151.55 17.94 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 51.9 p 50.1 33.96 7.73 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.346 1.058 . . . . 0.0 113.826 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.3 m 60.53 60.59 1.93 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 122.161 0.982 . . . . 0.0 110.089 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.531 ' O ' ' HB3' ' A' ' 125' ' ' ASN . 61.2 m -142.78 128.8 10.47 Favored Pre-proline 0 N--CA 1.412 -2.367 0 N-CA-C 101.688 -3.449 . . . . 0.0 101.688 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.43 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 44.9 Cg_endo -100.37 148.56 0.41 Allowed 'Trans proline' 0 N--CA 1.441 -1.573 0 N-CA-C 117.017 1.891 . . . . 0.0 117.017 -170.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 97.6 m -92.01 130.73 37.69 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 164.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.31 97.18 0.39 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 20.3 mtm-85 62.76 80.35 0.23 Allowed 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.255 1.026 . . . . 0.0 110.767 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.5 ttt -103.61 169.75 8.34 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.415 -172.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.52 HG23 ' HB2' ' A' ' 170' ' ' SER . 7.7 tt -117.32 142.34 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.017 0.527 . . . . 0.0 109.869 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.517 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 46.8 ttp180 -137.37 146.53 44.62 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 123.719 0.807 . . . . 0.0 109.659 -174.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' A' ' 118' ' ' VAL . 6.9 p90 -151.4 159.51 44.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 120.373 0.13 . . . . 0.0 111.287 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -83.22 113.51 20.72 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -165.55 126.12 1.86 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -174.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.45 101.96 1.34 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 44.4 m -78.77 138.94 38.46 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.923 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -111.3 154.47 24.46 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.9 t -86.76 138.69 31.4 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.0 -13.87 28.94 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.124 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.31 5.72 50.93 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.376 0.607 . . . . 0.0 111.432 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 41.9 t -62.32 135.12 57.31 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.524 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 103.57 -14.53 53.82 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.848 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.71 141.9 46.24 Favored Glycine 0 C--O 1.241 0.562 0 O-C-N 123.969 0.452 . . . . 0.0 113.726 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.5 t -81.27 114.46 22.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.319 0.58 . . . . 0.0 109.771 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 39.5 tp -87.35 106.27 17.83 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.6 p -140.82 -171.71 3.3 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.205 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.16 -173.47 4.45 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.8 t -70.48 99.57 1.64 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.283 1.04 . . . . 0.0 111.297 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.99 12.58 70.91 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.595 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -137.21 140.69 41.9 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 85.9 mt -126.95 124.34 64.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -96.98 -35.45 10.85 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.131 0.491 . . . . 0.0 110.629 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.527 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 164.01 -154.32 25.14 Favored Glycine 0 N--CA 1.427 -1.925 0 C-N-CA 119.305 -1.426 . . . . 0.0 113.16 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.5 pt -125.01 134.06 67.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 122.56 0.344 . . . . 0.0 111.15 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.434 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 68.9 t60 -67.42 128.58 36.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.441 0.696 . . . . 0.0 109.828 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.49 -15.42 9.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.29 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.25 -159.63 24.44 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 176.9 -176.5 48.05 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -147.93 145.83 28.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.2 -110.62 3.35 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.024 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 46.0 mtm105 -120.27 7.71 10.78 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -110.69 129.13 55.91 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.835 0.35 . . . . 0.0 110.276 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -105.31 142.39 15.51 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.0 143.77 49.7 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.536 0.684 . . . . 0.0 110.827 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.52 ' HB2' HG23 ' A' ' 135' ' ' ILE . 74.1 m -138.79 159.8 41.23 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.348 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -96.58 119.15 34.54 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -76.56 122.01 24.0 Favored 'General case' 0 C--O 1.253 1.274 0 CA-C-O 121.948 0.88 . . . . 0.0 111.315 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.527 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 95.4 mt -83.57 99.88 10.45 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -88.55 138.24 31.6 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.546 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 9.7 ptpp? -69.55 -13.88 62.56 Favored 'General case' 0 C--O 1.21 -0.995 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.877 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -61.35 -22.85 65.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.931 1.292 . . . . 0.0 110.562 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -85.34 -33.62 22.02 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.379 0.609 . . . . 0.0 109.428 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -91.76 3.5 54.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.016 -169.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.56 115.71 49.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -90.16 -30.83 17.37 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.641 0.734 . . . . 0.0 109.278 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -93.74 84.97 4.7 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.319 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 C--N 1.308 -1.235 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.482 -178.768 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.466 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.43 -36.96 63.2 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.528 2.152 . . . . 0.0 112.405 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -79.92 -32.39 40.15 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.602 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 19.3 m -61.48 -44.5 96.97 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.428 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -54.94 -51.55 65.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.055 0.942 . . . . 0.0 109.038 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.04 -45.19 94.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.432 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.39 75.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.331 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 4' ' ' THR . 92.8 mt -61.8 -47.67 84.06 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.058 0.456 . . . . 0.0 109.878 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 m -66.21 -49.98 65.43 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.309 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.9 tp -57.08 -45.65 83.17 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.58 0.752 . . . . 0.0 111.292 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 9.3 tt -64.59 -43.84 92.55 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -76.25 -9.39 58.6 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -99.93 -65.63 0.95 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.896 0.379 . . . . 0.0 111.247 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -108.71 -5.48 16.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -168.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.512 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 47.6 mt -95.82 139.7 18.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.336 -176.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.546 ' HB3' HG13 ' A' ' 49' ' ' VAL . 57.1 mtm -140.53 163.16 33.58 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.047 0.939 . . . . 0.0 109.306 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 96.5 m -103.11 119.74 39.41 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 71.1 mt -110.96 112.63 41.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.076 0.465 . . . . 0.0 110.179 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 59.9 m -80.35 107.9 13.52 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 p -97.6 -166.96 1.45 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.362 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -78.65 -2.89 41.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.348 0.594 . . . . 0.0 110.302 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -106.44 -43.09 4.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.295 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.59 -160.44 33.94 Favored Glycine 0 C--O 1.246 0.889 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.651 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -81.83 96.09 7.51 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.336 0.654 . . . . 0.0 109.422 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 146' ' ' CYS . 6.6 m-85 -99.64 159.53 14.97 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.43 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 95.0 m -94.5 127.74 40.63 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.91 121.73 7.03 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.96 113.02 26.26 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.8 134.94 21.07 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 50.8 mm -100.97 -48.85 11.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 117.298 0.549 . . . . 0.0 110.219 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.407 ' ND1' ' HB3' ' A' ' 85' ' ' ASP . 70.9 t60 -166.66 139.81 3.82 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.131 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.431 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 28.8 t70 61.21 -92.62 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.631 0 O-C-N 124.257 0.973 . . . . 0.0 112.745 173.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 81.0 mtt180 -131.86 5.75 4.26 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.406 0.622 . . . . 0.0 109.975 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.8 t -85.51 117.42 30.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.675 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.4 m -125.45 157.24 37.41 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.3 145.06 23.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 120.771 0.319 . . . . 0.0 111.67 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 tt -160.34 140.56 8.53 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.755 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 73.7 Cg_exo -57.66 134.58 63.96 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.909 2.406 . . . . 0.0 113.46 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.489 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 25.3 m -64.02 -33.58 76.06 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 124.276 1.031 . . . . 0.0 112.727 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -64.19 -12.25 38.65 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.19 -25.76 59.88 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 53.35 84.89 0.2 Allowed Pre-proline 0 C--O 1.242 0.667 0 C-N-CA 124.936 1.295 . . . . 0.0 112.816 -176.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -83.88 152.22 12.89 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 C-N-CA 121.935 1.756 . . . . 0.0 110.619 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.59 -162.35 37.07 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.162 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -93.37 10.03 33.9 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.083 0.944 . . . . 0.0 110.415 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -160.36 124.75 3.71 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.65 149.76 29.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.533 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 93.9 mt -85.48 114.11 22.26 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 17' ' ' THR . 39.2 t -102.28 102.32 13.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.217 175.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.6 m120 59.04 25.06 13.4 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.621 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.01 -7.38 44.35 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.943 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -106.83 118.62 37.17 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.542 -0.387 . . . . 0.0 110.48 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -73.44 124.69 26.29 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.68 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -119.94 122.8 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.925 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -71.52 124.69 25.22 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.309 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.7 t -84.22 139.99 16.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.48 -176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.439 ' NZ ' ' HB3' ' A' ' 57' ' ' LYS . 8.6 mtpm? -97.87 -69.77 0.75 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.032 0.92 . . . . 0.0 109.785 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -116.04 143.47 45.42 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.926 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -146.32 96.96 2.86 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -106.58 139.33 41.21 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.411 ' H ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -97.87 128.53 44.54 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.074 174.006 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.03 110.21 14.05 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.86 129.45 69.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.544 ' HB2' HD21 ' A' ' 70' ' ' LEU . 22.1 t70 -66.33 143.92 98.48 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -175.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.31 -17.25 0.5 Allowed 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 123.917 3.078 . . . . 0.0 115.141 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HG2' ' OD2' ' A' ' 64' ' ' ASP . 19.0 mm-40 -83.47 3.78 30.69 Favored 'General case' 0 CA--C 1.555 1.158 0 O-C-N 121.633 -0.667 . . . . 0.0 111.178 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.7 t30 73.78 18.8 3.32 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.435 1.494 . . . . 0.0 109.343 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.401 HG21 ' HB2' ' A' ' 132' ' ' ASN . 30.0 mm -99.44 136.1 32.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 131' ' ' THR . 91.7 m-20 -73.51 148.39 43.14 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.591 0.234 . . . . 0.0 111.411 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.544 HD21 ' HB2' ' A' ' 64' ' ' ASP . 73.0 mt -103.97 -13.22 16.41 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 172.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.489 ' OE1' ' HB ' ' A' ' 39' ' ' THR . 2.7 tp10 60.05 31.25 20.53 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 114.176 -1.374 . . . . 0.0 109.34 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.0 tp -115.82 120.58 39.73 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.881 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -104.38 130.94 52.22 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -91.86 100.28 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 171.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.6 tp -96.54 116.28 28.82 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.771 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -104.93 109.43 21.42 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.574 0.702 . . . . 0.0 109.107 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 88.7 mt -93.82 153.46 18.27 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.765 -175.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -88.22 80.08 7.67 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -118.3 115.02 23.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.756 -1.565 . . . . 0.0 108.014 -171.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -81.43 -10.13 59.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.521 0.677 . . . . 0.0 112.627 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -90.74 87.84 6.84 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 24.9 pttm -78.64 139.69 38.51 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.994 -0.683 . . . . 0.0 111.721 -172.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -77.33 147.63 36.06 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.57 -172.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -70.76 140.24 51.28 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.347 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 6.5 p-10 -70.45 107.0 3.62 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.952 0.882 . . . . 0.0 109.399 173.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.8 pt -93.47 22.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.4 ttt-85 -66.1 -30.77 71.34 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.645 -174.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.38 -12.77 84.24 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.357 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -91.11 -10.45 41.9 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.434 -0.451 . . . . 0.0 110.227 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.5 mt -66.58 133.71 30.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.571 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.3 t -113.54 110.59 20.51 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.4 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 42.9 mt-10 -87.78 4.41 44.46 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.663 0.744 . . . . 0.0 110.818 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.36 119.51 37.17 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.88 -2.266 . . . . 0.0 104.88 172.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.421 ' HB3' HD12 ' A' ' 135' ' ' ILE . 3.0 mp -120.5 -49.66 2.24 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -169.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -57.24 129.91 43.87 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.83 -1.78 78.78 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.5 173.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.487 ' O ' HG22 ' A' ' 118' ' ' VAL . 22.1 t -101.16 155.78 4.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 3.0 p-10 -95.59 148.48 22.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 118.718 0.69 . . . . 0.0 110.545 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.83 165.83 25.5 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.949 0.88 . . . . 0.0 112.823 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.522 ' OG1' ' HG2' ' A' ' 114' ' ' GLU . 26.7 m -122.86 138.56 54.62 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 125.002 1.321 . . . . 0.0 108.749 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.7 tp -99.2 117.11 32.93 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -113.27 112.06 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.85 142.75 24.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.189 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -136.6 100.48 4.35 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.704 0.764 . . . . 0.0 109.096 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.6 p -136.07 176.16 8.94 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.71 -30.73 71.45 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.849 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -77.39 -50.11 13.45 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.002 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -109.02 81.08 1.39 Allowed 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.19 98.28 9.28 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 120.793 0.33 . . . . 0.0 111.294 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.6 t30 68.48 70.6 0.3 Allowed 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.175 0.988 . . . . 0.0 110.349 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 51.6 m -108.75 107.97 18.62 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.445 HG21 ' HA ' ' A' ' 4' ' ' THR . 73.0 mt -108.92 102.25 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.712 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.0 tp -123.13 113.92 19.63 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.727 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.522 ' HG2' ' OG1' ' A' ' 100' ' ' THR . 45.6 mt-10 -73.88 123.41 24.18 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.7 m -91.24 -43.45 14.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.839 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.69 -152.11 19.77 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 98' ' ' ASP . 59.9 Cg_endo -71.87 144.3 43.06 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.921 2.414 . . . . 0.0 112.121 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 97' ' ' VAL . 35.5 m -106.53 137.98 34.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.24 0.543 . . . . 0.0 110.973 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.3 p -110.16 173.73 6.19 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.982 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 38.9 tpp -110.41 132.68 53.97 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.676 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.504 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -99.4 -45.02 5.98 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.302 0.572 . . . . 0.0 109.585 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.09 -79.5 0.53 Allowed Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.46 155.43 41.18 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.0 tt -163.21 152.31 3.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 120.885 0.374 . . . . 0.0 110.018 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -79.81 94.18 5.75 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -93.0 98.83 11.6 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.4 p 52.16 66.65 1.15 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.346 1.058 . . . . 0.0 113.506 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.0 m 63.36 7.54 2.98 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.212 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.2 m -120.27 105.13 42.41 Favored Pre-proline 0 N--CA 1.427 -1.583 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -61.38 110.87 0.98 Allowed 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 121.922 1.748 . . . . 0.0 110.144 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 9.6 m -120.74 138.55 53.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.332 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.401 ' HB2' HG21 ' A' ' 68' ' ' ILE . 55.0 t30 -119.74 168.37 11.14 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 172' ' ' GLN . 11.0 tpp180 65.62 42.84 3.48 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.673 1.589 . . . . 0.0 109.605 175.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.1 mtp -108.12 140.94 40.58 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-O 121.978 0.894 . . . . 0.0 112.301 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.64 HG23 ' HB3' ' A' ' 170' ' ' SER . 5.9 tt -105.02 146.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.894 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.504 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 23.8 ttm180 -128.97 137.23 51.25 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -173.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -131.51 131.27 43.3 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -80.88 97.0 7.2 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.773 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -156.09 134.81 11.78 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -72.78 109.41 6.36 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 13.1 t -140.03 171.29 14.4 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 143' ' ' THR . 37.9 ttpt -114.82 142.57 46.37 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.427 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 13.4 t -80.36 165.43 22.28 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 146' ' ' CYS . . . 105.69 -17.78 41.91 Favored Glycine 0 C--N 1.303 -1.298 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -94.09 28.61 2.41 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.755 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 33.7 t -76.74 141.64 40.74 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 113.14 -1.845 . . . . 0.0 109.241 -174.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.43 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 93.04 -4.26 74.44 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.62 134.35 26.03 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.6 p -76.12 119.48 24.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 122.086 0.946 . . . . 0.0 111.348 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.3 tp -90.1 102.0 14.71 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 20.3 p -147.66 174.22 11.98 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.38 0.609 . . . . 0.0 111.929 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.92 172.91 12.06 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.7 t -64.74 103.74 0.74 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.962 0.887 . . . . 0.0 111.297 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.18 6.14 66.94 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.621 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -140.56 103.02 4.45 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 117.239 0.52 . . . . 0.0 111.428 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 88.2 mt -97.28 123.8 49.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -95.93 -42.83 8.1 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.36 0.6 . . . . 0.0 110.336 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.414 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 171.78 -157.7 28.07 Favored Glycine 0 N--CA 1.425 -2.098 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.46 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 28.3 pt -127.21 145.87 34.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -63.76 129.3 39.57 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 123.502 0.721 . . . . 0.0 109.426 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.433 ' HA ' ' SG ' ' A' ' 146' ' ' CYS . 62.1 t -117.27 -48.69 4.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 O-C-N 123.212 0.32 . . . . 0.0 110.754 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -133.64 108.33 0.73 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.314 -1.422 . . . . 0.0 112.86 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 143' ' ' THR . . . -95.19 108.25 3.66 Favored Glycine 0 C--N 1.3 -1.437 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -120.01 90.65 3.37 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 59.65 -106.63 1.01 Allowed Glycine 0 C--O 1.229 -0.192 0 O-C-N 123.821 0.7 . . . . 0.0 113.185 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 77.8 mtm180 -94.81 8.2 43.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -122.29 115.8 22.97 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.102 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -97.05 115.91 5.36 Favored Glycine 0 N--CA 1.42 -2.423 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -102.0 129.28 48.25 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.159 0.504 . . . . 0.0 110.276 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.64 ' HB3' HG23 ' A' ' 135' ' ' ILE . 29.0 t -127.25 156.69 41.49 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.257 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.412 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -101.43 140.72 35.34 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 66.6 mt-30 -76.26 121.19 22.58 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 123.517 0.511 . . . . 0.0 110.974 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.414 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 89.9 mt -94.58 85.27 4.47 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -83.63 144.61 29.32 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.449 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.4 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 10.2 ptpp? -73.68 -14.64 61.19 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.925 0.393 . . . . 0.0 110.595 -176.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -65.58 -19.32 65.87 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.632 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -79.78 -25.4 40.97 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 121.932 -0.48 . . . . 0.0 109.917 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -101.24 50.37 0.86 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.788 0.804 . . . . 0.0 110.327 -174.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 30.7 m -103.67 169.85 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.472 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -83.86 -54.54 4.81 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -120.79 144.09 48.49 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.099 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 . . . . . 0 C--N 1.305 -1.344 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.114 -177.534 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.422 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.93 -32.51 85.8 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.19 2.594 . . . . 0.0 111.871 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -63.31 -41.94 98.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.455 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 m -63.38 -40.4 97.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.651 0.78 . . . . 0.0 109.521 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -64.31 -43.6 94.18 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.236 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -63.56 -46.26 86.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.966 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 11' ' ' LEU . . . -54.33 -50.23 67.9 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 124.074 0.859 . . . . 0.0 111.699 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -64.95 -35.38 80.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 m -72.26 -42.48 65.55 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.016 0.436 . . . . 0.0 110.699 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.8 tp -65.79 -39.94 91.45 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.779 0.832 . . . . 0.0 109.535 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.539 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 6.0 tt -56.0 -50.9 69.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.299 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -83.56 15.03 3.33 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -123.95 -56.27 1.66 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -118.09 -5.22 10.96 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -171.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.539 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 42.2 mt -96.53 121.46 47.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.935 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 19.8 ptp -140.85 153.94 45.98 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.726 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.419 HG22 ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -85.84 111.53 20.27 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.3 mt -104.7 113.25 41.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.777 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 10.6 m -76.44 107.46 8.72 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 75.9 p -87.56 -149.88 0.16 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.3 p -52.91 -42.03 64.96 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.122 0.569 . . . . 0.0 112.094 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -129.56 -60.66 1.04 Allowed 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.25 158.5 20.55 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 119.643 -1.265 . . . . 0.0 114.467 -172.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 40.5 mt-10 -86.74 112.15 21.4 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -105.77 174.4 5.9 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.472 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 35.1 m -87.3 114.99 24.41 Favored 'General case' 0 N--CA 1.411 -2.399 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.595 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.59 110.8 3.9 Favored Glycine 0 N--CA 1.41 -3.036 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.6 tp -94.32 109.08 20.94 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.28 133.19 28.28 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 48.0 mm -109.82 -54.51 5.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 117.331 0.565 . . . . 0.0 111.148 -177.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -154.53 123.26 6.2 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.737 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 66.72 -86.28 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.865 0.728 . . . . 0.0 112.82 169.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 83.7 mtm180 -132.7 10.52 4.33 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.93 0.871 . . . . 0.0 109.463 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.562 HG13 HG13 ' A' ' 74' ' ' VAL . 50.2 t -91.65 123.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.838 -1.073 . . . . 0.0 111.184 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.9 p -127.01 148.36 50.11 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.07 130.38 57.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.264 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.7 mm -130.26 136.24 28.69 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 124.584 1.154 . . . . 0.0 108.43 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 31.4 Cg_exo -61.88 142.97 95.11 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.292 1.994 . . . . 0.0 111.387 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.1 m -62.51 -47.32 84.47 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 122.145 0.178 . . . . 0.0 111.435 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -61.77 -14.83 36.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.675 0.79 . . . . 0.0 112.838 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.76 -25.19 60.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.403 ' O ' ' HB ' ' A' ' 20' ' ' THR . 29.9 mm-40 58.09 88.0 0.13 Allowed Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 124.594 1.158 . . . . 0.0 113.863 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -83.1 149.66 13.62 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.864 1.709 . . . . 0.0 109.835 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -157.35 33.06 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.459 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.72 -17.25 27.06 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.973 0.892 . . . . 0.0 110.093 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -137.12 131.03 32.06 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 m -117.17 164.24 13.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 5.7 mp -113.49 110.59 20.52 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.146 178.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.7 t -87.75 94.24 4.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 t30 51.75 62.33 2.76 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 124.549 1.14 . . . . 0.0 109.024 -174.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.06 -34.36 3.42 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.018 -0.992 . . . . 0.0 114.03 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 75.5 mt-30 -72.21 108.89 5.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.169 0.485 . . . . 0.0 111.993 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -68.78 122.62 18.95 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.415 HD12 HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -134.4 127.7 50.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.389 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -78.18 127.68 32.63 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.784 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.2 140.39 18.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.573 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 60.5 tttm -89.32 -59.01 2.33 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.277 0.561 . . . . 0.0 110.16 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.2 m-20 -136.34 149.78 48.55 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.357 -177.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -132.23 107.87 8.87 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -117.53 126.68 53.0 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -77.0 133.28 39.19 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.459 -0.896 . . . . 0.0 108.871 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.426 ' HG ' HD12 ' A' ' 70' ' ' LEU . 31.9 tp -91.24 104.5 17.04 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.62 0.724 . . . . 0.0 109.44 -176.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 69' ' ' ASN . 20.5 m -119.62 160.02 20.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.406 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.01 147.42 47.98 Favored Pre-proline 0 C--N 1.289 -2.022 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -45.2 -13.95 0.08 OUTLIER 'Trans proline' 0 CA--C 1.564 1.982 0 C-N-CA 124.266 3.311 . . . . 0.0 116.074 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -77.19 -2.32 33.9 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.486 -0.759 . . . . 0.0 111.011 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 75.63 12.52 3.07 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.962 1.705 . . . . 0.0 109.998 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.5 mm -90.41 134.44 29.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 114.119 -1.4 . . . . 0.0 107.405 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 131' ' ' THR . 57.3 t30 -79.99 147.55 31.51 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.999 0.428 . . . . 0.0 111.395 -173.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.426 HD12 ' HG ' ' A' ' 62' ' ' LEU . 63.0 mt -99.32 -6.18 28.37 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 17.1 tp10 75.39 16.35 2.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 123.169 1.462 . . . . 0.0 109.823 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.25 136.27 50.58 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.669 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.0 m -116.52 128.94 55.9 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.562 HG13 HG13 ' A' ' 34' ' ' VAL . 59.5 t -82.99 101.18 7.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -98.08 111.88 24.04 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.2 m -94.77 110.92 22.73 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.77 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.48 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 95.8 mt -86.32 142.32 28.58 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.863 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -88.68 86.84 7.07 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -122.65 131.76 53.96 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -68.34 -34.5 76.22 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.298 0.374 . . . . 0.0 111.222 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -86.45 104.31 15.8 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -79.1 142.36 36.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.302 0.573 . . . . 0.0 110.445 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -83.63 145.48 28.79 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.31 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -57.27 120.17 7.68 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.112 -1.403 . . . . 0.0 108.69 175.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 4.6 p30 -74.85 117.7 16.98 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.234 -1.387 . . . . 0.0 109.906 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.0 pt -97.17 28.53 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.52 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.8 ttm105 -59.94 -37.14 78.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.99 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.96 -7.45 70.65 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.489 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -96.74 -10.54 26.6 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.425 0.612 . . . . 0.0 110.943 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.6 mt -66.53 123.54 19.76 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-O 121.144 0.497 . . . . 0.0 110.315 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.8 p -100.74 115.92 31.41 Favored 'General case' 0 N--CA 1.407 -2.623 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.552 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.589 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 1.3 pm0 -71.38 -29.77 65.34 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.536 175.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.12 115.44 18.79 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.429 ' HB3' HD12 ' A' ' 135' ' ' ILE . 33.1 mt -106.83 -60.77 1.63 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.875 -174.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.93 131.53 45.66 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.157 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.02 -22.29 33.73 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.661 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.8 t -92.29 148.31 4.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.02 125.23 38.53 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.695 0.76 . . . . 0.0 109.835 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.76 154.37 18.68 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 122.08 0.943 . . . . 0.0 113.121 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.9 m -127.38 125.91 41.52 Favored 'General case' 0 N--CA 1.417 -2.079 0 C-N-CA 125.432 1.493 . . . . 0.0 107.95 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -95.48 118.85 32.95 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -111.91 112.49 40.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.484 HG11 ' NE2' ' A' ' 145' ' ' GLN . 7.4 p -114.89 135.78 53.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.6 0.714 . . . . 0.0 111.101 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -129.58 84.82 2.25 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.8 t -130.51 174.94 9.4 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.018 -174.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.473 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 26.9 t-20 -70.64 -31.54 68.52 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -69.74 -51.92 29.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.952 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.573 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 79.1 m-85 -138.5 119.85 14.8 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.124 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.2 m -107.66 112.76 25.62 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 -175.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 74.06 27.16 1.61 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.457 1.103 . . . . 0.0 111.221 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.573 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 13.7 m -79.8 117.06 20.34 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.658 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.2 mt -101.59 99.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.8 tp -102.31 111.83 24.28 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.279 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -82.52 108.56 16.02 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.84 -54.61 9.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.431 -172.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 125.43 -164.12 19.13 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.32 135.94 52.77 Favored 'Trans proline' 0 C--O 1.244 0.8 0 C-N-CA 122.935 2.424 . . . . 0.0 112.771 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.419 HG12 ' HB3' ' A' ' 137' ' ' TYR . 22.1 m -110.81 160.34 10.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.273 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.7 t -143.36 159.71 41.87 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.8 ttt -89.24 131.49 35.33 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -90.91 -50.32 5.94 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.57 0.7 . . . . 0.0 109.206 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.48 -103.56 0.76 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.407 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 2.9 pp -126.58 158.18 36.92 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.563 0.22 . . . . 0.0 111.448 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.8 tt -161.27 137.56 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.502 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -113.38 113.81 25.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -133.6 139.49 46.56 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.6 t 61.64 30.61 18.63 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 76.1 p 62.76 10.86 4.5 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.783 2.033 . . . . 0.0 112.837 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m -96.28 108.86 44.32 Favored Pre-proline 0 N--CA 1.427 -1.607 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.43 112.28 3.43 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 122.099 1.866 . . . . 0.0 110.013 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 31.7 p -112.06 143.02 43.76 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.52 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 123' ' ' LEU . 10.9 t30 -139.13 159.49 42.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -177.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 16.2 mtp180 75.98 27.25 0.94 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.604 1.562 . . . . 0.0 109.126 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 131.56 36.15 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.062 -175.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.603 HG23 ' HB3' ' A' ' 170' ' ' SER . 2.0 tt -98.91 136.54 29.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.049 -1.432 . . . . 0.0 107.764 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.408 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 49.8 ttp180 -121.69 142.9 49.7 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.432 0.634 . . . . 0.0 111.522 -172.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.419 ' HB3' HG12 ' A' ' 118' ' ' VAL . 3.5 p90 -134.16 140.51 46.6 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.252 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 166' ' ' ARG . 16.8 t70 -94.91 105.31 17.23 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -159.23 143.54 15.3 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.21 100.19 0.44 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.181 0.515 . . . . 0.0 109.664 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.0 p -65.39 161.02 20.66 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -133.68 137.82 45.52 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.5 m -84.39 152.15 24.23 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.01 -7.32 76.54 Favored Glycine 0 N--CA 1.459 0.209 0 C-N-CA 119.979 -1.105 . . . . 0.0 111.601 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.484 ' NE2' HG11 ' A' ' 103' ' ' VAL . 11.9 mm100 -92.1 2.69 56.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.048 0.928 . . . . 0.0 108.676 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 27.8 m -61.92 127.37 31.08 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.882 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.472 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 103.52 -11.7 54.08 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.153 -1.023 . . . . 0.0 111.192 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.12 137.93 36.33 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.4 p -77.61 123.83 34.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.743 0.782 . . . . 0.0 111.277 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 28.4 tp -91.84 100.28 12.99 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.6 p -125.57 -173.86 2.93 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.885 -173.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -155.07 -175.84 5.64 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.2 t -62.45 99.7 0.15 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.828 0.823 . . . . 0.0 111.311 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.2 20.75 79.29 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.568 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 97.4 mttt -138.44 148.06 43.99 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.648 0.379 . . . . 0.0 110.369 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 91.1 mt -132.45 126.45 55.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -96.14 -49.98 5.02 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.731 0.776 . . . . 0.0 109.637 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.552 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 178.81 -152.18 11.06 Favored Glycine 0 N--CA 1.42 -2.387 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.055 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 pt -126.46 151.97 33.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 117.121 0.461 . . . . 0.0 110.352 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -63.46 118.42 8.09 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.0 t -91.7 -62.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.33 -139.8 5.11 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.973 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.81 137.99 5.32 Favored Glycine 0 C--N 1.288 -2.128 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -110.13 130.38 55.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.24 -125.26 8.42 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.642 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 10.9 mtm180 -106.21 -7.08 18.03 Favored 'General case' 0 C--O 1.214 -0.777 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.461 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -96.31 106.24 18.43 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.611 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.66 132.02 11.07 Favored Glycine 0 N--CA 1.418 -2.562 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -115.61 127.82 55.49 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.684 0.755 . . . . 0.0 110.695 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.603 ' HB3' HG23 ' A' ' 135' ' ' ILE . 37.7 t -120.34 155.09 34.07 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.453 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -108.74 134.27 51.69 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 11.0 pt20 -78.07 117.36 19.31 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 124.015 0.822 . . . . 0.0 110.725 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.552 ' HG ' ' HA2' ' A' ' 158' ' ' GLY 0.304 0.7 OUTLIER -99.37 75.35 1.97 Allowed 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.226 1.013 . . . . 0.0 111.831 177.282 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -59.49 144.74 46.31 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.324 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -61.17 -20.21 62.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.832 0.853 . . . . 0.0 110.94 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -59.33 -29.05 67.37 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.689 1.195 . . . . 0.0 110.925 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -82.14 -8.04 59.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.715 0.293 . . . . 0.0 111.341 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -128.46 28.1 5.48 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 182' ' ' GLN . 16.0 m -57.1 150.29 3.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-O 121.324 0.583 . . . . 0.0 112.507 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -80.75 -23.7 39.2 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.118 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -120.08 104.73 10.36 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.989 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.473 ' HB2' HG23 ' A' ' 179' ' ' VAL . 23.2 tt0 . . . . . 0 C--N 1.297 -1.691 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.883 0 CA-C-O 118.621 -1.099 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -37.61 -63.47 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 125.21 3.94 . . . . 0.0 116.262 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -70.03 -34.27 73.05 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.52 -174.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.5 m -72.72 -33.64 66.57 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.136 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -61.9 -48.29 81.11 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.536 0.735 . . . . 0.0 109.376 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -63.81 -47.94 78.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.011 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.48 81.0 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.473 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 tp -65.62 -36.72 84.53 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 122.794 0.438 . . . . 0.0 111.232 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -71.87 -44.41 63.81 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.949 0.404 . . . . 0.0 110.414 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.9 tp -65.84 -36.97 84.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.522 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.49 ' HA ' HD12 ' A' ' 15' ' ' ILE . 37.4 tp -51.57 -56.82 11.32 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.364 1.465 . . . . 0.0 112.254 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -79.18 7.81 6.98 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -131.37 -49.98 1.0 Allowed 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -118.05 0.11 11.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 11' ' ' LEU . 50.0 mt -113.18 106.83 21.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.882 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -123.35 160.16 27.35 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.925 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.492 ' CG2' ' HB3' ' A' ' 24' ' ' GLU . 80.5 m -90.3 121.5 32.36 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 174.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.3 mt -106.5 124.48 62.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.56 HG22 ' HG2' ' A' ' 24' ' ' GLU . 6.0 p -79.31 98.97 6.9 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.741 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.2 p -98.59 -173.61 2.59 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 21.1 t -69.93 -34.82 73.97 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -84.77 -5.29 59.32 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.77 -162.82 24.48 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.081 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HG2' HG22 ' A' ' 19' ' ' THR . 40.2 mt-10 -94.53 111.13 22.88 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.893 0.378 . . . . 0.0 110.861 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -116.67 -178.77 3.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.384 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.7 m -98.11 136.81 37.82 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.7 126.47 6.63 Favored Glycine 0 N--CA 1.418 -2.549 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -96.79 119.59 35.55 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.5 121.94 5.59 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' HA ' HD11 ' A' ' 86' ' ' ILE . 44.6 mm -85.04 -53.94 9.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 117.388 0.594 . . . . 0.0 109.788 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -164.53 154.69 14.25 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 54.27 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.3 ptt180 -139.64 10.48 2.46 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.705 1.202 . . . . 0.0 108.956 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.15 114.55 31.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.125 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -125.11 156.36 38.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -117.09 135.5 57.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.1 tp -141.53 148.73 51.52 Favored Pre-proline 0 CA--C 1.559 1.309 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -76.2 145.4 27.44 Favored 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 121.964 1.776 . . . . 0.0 112.787 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.518 HG23 ' OG1' ' A' ' 73' ' ' THR . 0.2 OUTLIER -74.41 -18.56 60.64 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -73.47 -21.42 60.44 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.658 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.55 -26.15 45.61 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 96.1 mt-30 63.44 90.63 0.09 OUTLIER Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.735 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.14 152.48 24.23 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 121.962 1.775 . . . . 0.0 110.203 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.61 -157.65 26.72 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 119.971 -1.109 . . . . 0.0 113.142 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.74 -34.41 30.49 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.573 0.702 . . . . 0.0 110.902 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -137.84 138.88 39.59 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.71 144.95 36.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.224 0.535 . . . . 0.0 111.311 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 51' ' ' GLY . 6.0 tt -84.74 101.26 12.07 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 174.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.5 p -96.98 94.55 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 122.033 0.92 . . . . 0.0 110.492 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.6 t30 55.97 23.42 6.67 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.134 1.374 . . . . 0.0 112.019 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.407 ' H ' HD23 ' A' ' 48' ' ' LEU . . . 139.52 -49.67 0.8 Allowed Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.808 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -85.09 119.2 25.21 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -174.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.12 108.45 12.62 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.474 HD11 ' O ' ' A' ' 78' ' ' ASP . 9.4 tp -112.76 143.54 22.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.439 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -78.94 131.59 36.42 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.114 0.483 . . . . 0.0 110.783 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.5 t -89.68 125.94 42.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -78.66 -59.52 2.75 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.462 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -136.21 159.64 41.13 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -140.74 100.55 3.87 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -174.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.514 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 59.4 m-85 -97.08 113.56 25.13 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -82.56 111.19 18.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.31 104.55 6.89 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -174.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.87 133.9 62.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -71.63 145.07 89.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.73 -20.02 4.14 Favored 'Trans proline' 0 CA--C 1.552 1.39 0 C-N-CA 123.867 3.045 . . . . 0.0 115.3 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -86.58 9.12 19.49 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.752 -0.592 . . . . 0.0 111.175 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 71.78 26.38 3.04 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 123.433 1.587 . . . . 0.0 109.931 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.4 mt -97.57 127.94 49.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.516 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 131' ' ' THR . 21.0 m-80 -89.06 155.33 19.53 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.059 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.253 0.0 OUTLIER -132.22 18.94 4.45 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.795 0.807 . . . . 0.0 110.896 173.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 70.05 -20.8 0.18 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.338 1.855 . . . . 0.0 114.593 173.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.18 119.15 5.47 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.518 ' OG1' HG23 ' A' ' 39' ' ' THR . 20.5 m -117.9 112.85 20.89 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 171.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 44.0 t -81.86 105.57 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.83 113.67 26.01 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.9 m -99.11 105.34 17.41 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 120.876 0.37 . . . . 0.0 110.035 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.9 mp -77.98 139.38 39.16 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.579 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.474 ' O ' HD11 ' A' ' 54' ' ' ILE . 36.5 t70 -89.48 96.14 10.57 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.752 177.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -155.53 152.2 28.56 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.62 0.724 . . . . 0.0 112.488 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -89.16 -12.42 41.05 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.368 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -74.07 132.82 42.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.009 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -108.35 121.82 45.7 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.729 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -76.8 144.07 39.38 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -59.66 131.11 49.92 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.83 96.76 0.14 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.876 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.443 HD11 ' HA ' ' A' ' 30' ' ' ILE . 2.6 pp -93.71 18.27 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 122.204 1.002 . . . . 0.0 110.388 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -62.87 -32.22 73.42 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.166 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.14 2.48 87.65 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.923 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -103.14 -8.77 20.2 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 117.136 0.468 . . . . 0.0 110.731 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.4 mt -67.57 128.7 31.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.9 t -95.04 107.72 19.78 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -62.89 -23.13 67.19 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.778 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -106.05 111.55 24.22 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mp -102.81 -51.23 3.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.18 137.03 56.72 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -172.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.15 8.1 31.9 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.89 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.443 ' O ' HG22 ' A' ' 118' ' ' VAL . 40.4 t -122.31 150.37 25.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 O-C-N 122.183 -0.598 . . . . 0.0 109.717 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -82.18 122.63 28.14 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -115.0 160.7 19.28 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.98 0.895 . . . . 0.0 113.152 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 37.6 m -122.76 135.51 54.58 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.059 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.5 tp -100.19 124.99 46.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -113.77 117.65 56.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.466 ' HB ' ' OG1' ' A' ' 111' ' ' THR . 23.9 t -112.03 138.17 41.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -136.66 92.62 2.77 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.9 p -138.7 -169.74 2.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.127 -174.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -56.51 -59.34 5.12 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.021 0.928 . . . . 0.0 112.142 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -92.71 -35.62 13.37 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.407 0.622 . . . . 0.0 110.517 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -99.17 84.15 2.98 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.488 0.661 . . . . 0.0 109.765 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.57 111.04 22.63 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.344 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 65.17 37.16 6.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.286 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.466 ' OG1' ' HB ' ' A' ' 103' ' ' VAL . 32.5 p -79.61 94.22 5.63 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.013 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.72 103.41 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.5 tp -117.43 114.31 23.32 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.655 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 0.3 OUTLIER -77.66 143.53 38.09 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.979 177.528 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 36.0 m -111.43 -31.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 119.949 -0.701 . . . . 0.0 111.844 -176.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.78 -155.03 16.53 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.064 -1.065 . . . . 0.0 111.555 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.92 124.35 10.53 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.845 2.363 . . . . 0.0 111.978 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.461 ' HB ' HD11 ' A' ' 135' ' ' ILE . 35.0 m -96.93 134.07 36.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.348 0.594 . . . . 0.0 110.895 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.6 p -128.38 163.68 24.31 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.755 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.3 ttt -84.47 133.13 34.49 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 118.551 0.614 . . . . 0.0 110.013 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.639 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -82.09 -37.82 25.77 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 121.832 0.825 . . . . 0.0 108.801 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.94 -102.83 2.21 Favored Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.97 149.4 47.52 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.4 pt -132.53 172.16 16.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -116.55 138.76 51.16 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -127.4 112.98 15.62 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 16.4 t 61.81 36.18 16.25 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 121.834 0.826 . . . . 0.0 108.985 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.8 m 69.37 10.08 7.58 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.137 1.375 . . . . 0.0 111.996 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.7 m -98.91 118.53 62.71 Favored Pre-proline 0 N--CA 1.425 -1.722 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.38 127.4 17.3 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.231 1.954 . . . . 0.0 112.064 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.9 t -125.17 118.63 26.51 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -106.35 156.93 18.01 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.581 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 74.22 57.02 0.09 Allowed 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.051 1.341 . . . . 0.0 111.508 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.0 mmt -113.28 143.03 45.11 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 113.064 -1.88 . . . . 0.0 108.832 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 18.1 tt -106.96 141.79 21.31 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.639 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 24.4 ttm-85 -118.96 132.97 56.1 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 122.634 0.374 . . . . 0.0 110.427 -173.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -136.29 134.62 38.18 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.637 172.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -87.84 91.31 8.71 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.869 0.842 . . . . 0.0 110.342 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -158.06 136.68 11.2 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.52 87.29 2.64 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.54 0.686 . . . . 0.0 111.398 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.6 p -94.48 161.09 14.36 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.798 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -118.31 136.16 53.87 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.0 m -61.22 124.98 22.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.594 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 132.45 -15.9 4.92 Favored Glycine 0 C--N 1.299 -1.517 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -97.79 18.09 16.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.9 m -62.7 130.92 47.13 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.021 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.43 -1.21 66.47 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.62 138.99 26.87 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.65 124.72 38.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.859 0.838 . . . . 0.0 111.472 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.7 tp -92.19 108.85 20.25 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.5 p -141.75 177.57 8.07 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.172 0.51 . . . . 0.0 111.813 -173.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -152.96 179.52 8.61 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 176.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.9 m -54.71 101.1 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.17 0.588 . . . . 0.0 111.876 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 69.15 23.31 76.22 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.667 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 74.8 mmtt -136.26 118.34 15.41 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 98.7 mt -108.14 129.24 62.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -103.45 -45.47 4.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.262 0.553 . . . . 0.0 110.899 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.516 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 176.82 -157.86 23.36 Favored Glycine 0 N--CA 1.421 -2.359 0 C-N-CA 118.968 -1.587 . . . . 0.0 112.586 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.4 pt -126.49 141.77 44.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -63.58 130.79 45.78 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.216 0.606 . . . . 0.0 110.357 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.0 t -101.14 -49.2 11.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -173.06 160.99 31.97 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.697 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -107.59 129.54 9.7 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -126.86 95.27 4.27 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.27 -125.04 17.5 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -101.44 21.5 14.1 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.318 0.58 . . . . 0.0 111.174 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -122.77 124.47 43.41 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.048 0.451 . . . . 0.0 110.146 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -102.26 131.56 10.65 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -109.12 133.63 52.76 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.524 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 41.9 m -130.62 150.44 51.81 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.759 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -88.81 135.46 33.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -82.96 95.65 8.06 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 123.485 0.49 . . . . 0.0 110.623 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.516 ' HG ' ' HA2' ' A' ' 158' ' ' GLY 0.306 1.0 OUTLIER -83.08 76.46 9.85 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-O 122.745 1.259 . . . . 0.0 112.299 177.909 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -75.71 153.35 37.14 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.209 -1.359 . . . . 0.0 111.88 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -59.7 -23.91 63.53 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.383 1.073 . . . . 0.0 112.046 -174.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -58.87 -22.89 60.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.728 1.211 . . . . 0.0 112.052 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -96.14 -9.83 29.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.937 0.399 . . . . 0.0 111.695 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -111.59 18.48 19.02 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.416 0.627 . . . . 0.0 110.756 -175.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.81 117.94 22.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.384 -0.826 . . . . 0.0 108.818 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -71.52 -38.64 71.09 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.268 0.556 . . . . 0.0 109.741 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -86.57 79.88 8.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.349 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 C--N 1.298 -1.668 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -177.305 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.542 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.92 -44.56 46.11 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.602 2.868 . . . . 0.0 113.681 -175.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -68.44 -30.2 69.02 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.016 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 m -70.36 -41.82 72.64 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.238 0.615 . . . . 0.0 109.357 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.24 -50.11 74.95 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.808 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -65.04 -42.66 94.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.647 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.29 82.89 Favored 'General case' 0 C--O 1.216 -0.684 0 O-C-N 123.516 0.51 . . . . 0.0 110.856 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.63 -39.99 95.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.146 0.498 . . . . 0.0 110.719 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -68.48 -43.48 76.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.005 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.7 tp -68.12 -39.07 82.84 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.276 0.631 . . . . 0.0 109.913 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 7.8 tt -55.31 -47.94 74.86 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.896 0.878 . . . . 0.0 110.25 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -79.09 14.94 1.26 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.978 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 -64.36 0.96 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -116.37 4.49 13.4 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.478 ' CG2' ' HB3' ' A' ' 104' ' ' HIS . 1.7 mp -87.36 115.03 27.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.255 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.407 ' HB3' ' CG2' ' A' ' 49' ' ' VAL . 21.6 mmt -113.21 134.13 54.73 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.043 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 89.8 m -92.8 103.58 15.92 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.7 mt -101.37 121.13 51.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 121.198 0.523 . . . . 0.0 110.544 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -87.41 108.15 18.87 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 41.2 p -102.92 -166.59 1.29 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.51 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.431 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 31.3 t -66.28 -43.15 87.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.071 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -89.39 -9.94 48.4 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -172.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.14 -165.82 33.39 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.19 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -108.59 103.33 12.42 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 146' ' ' CYS . 83.4 m-85 -113.52 175.0 5.64 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.087 -174.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.6 m -93.78 136.33 34.18 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.84 145.31 16.75 Favored Glycine 0 N--CA 1.416 -2.691 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.4 tp -105.4 119.96 40.39 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.206 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.68 139.77 25.03 Favored Glycine 0 N--CA 1.428 -1.847 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 40.4 mm -99.31 -49.73 11.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -174.86 153.99 1.81 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.56 ' OD1' ' HG2' ' A' ' 82' ' ' LYS . 36.1 m-20 51.02 -94.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.575 1.172 . . . . 0.0 113.186 176.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 17.7 ptp180 -127.06 6.11 6.51 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.511 -176.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 64.6 t -92.77 118.71 39.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -132.45 159.92 37.93 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 m -123.27 146.6 28.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 122.155 -0.341 . . . . 0.0 111.011 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.8 tt -158.13 147.12 14.58 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 45.1 Cg_exo -60.75 142.12 96.85 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 122.496 2.131 . . . . 0.0 112.8 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.1 m -59.73 -37.9 80.2 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -71.21 -2.06 14.68 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.41 -30.29 57.39 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 77.2 mt-30 60.46 89.13 0.11 Allowed Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.123 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.41 154.82 28.18 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.206 1.937 . . . . 0.0 110.507 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.32 -166.02 29.88 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.436 -0.887 . . . . 0.0 111.859 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -81.85 -18.7 42.99 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 122.104 0.954 . . . . 0.0 109.126 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 7.7 p-10 -147.37 148.15 31.05 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 m -142.52 -172.81 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 1.2 pt? -138.63 127.64 23.93 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 17' ' ' THR . 5.2 p -115.85 116.1 51.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.757 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 65.56 19.85 11.56 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.051 0.94 . . . . 0.0 109.465 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.23 -15.41 59.07 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.318 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 83.1 mt-30 -78.42 121.66 24.8 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 122.461 0.304 . . . . 0.0 110.263 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' A' ' 48' ' ' LEU . 29.4 mmmt -67.65 126.18 28.56 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.415 HD11 ' O ' ' A' ' 78' ' ' ASP . 9.3 tp -146.19 133.83 15.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.586 0.708 . . . . 0.0 110.551 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 38.7 mtm180 -85.37 145.4 27.5 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.585 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.77 148.31 5.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -97.82 -57.03 2.33 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -141.76 166.96 23.28 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -139.89 95.25 2.87 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.496 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 84.6 m-85 -81.37 111.37 17.68 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.5 103.73 4.95 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.446 HD12 ' HG ' ' A' ' 70' ' ' LEU . 1.3 tm? -80.82 101.83 9.62 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.4 155.7 9.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.69 138.44 83.07 Favored Pre-proline 0 C--N 1.311 -1.068 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -47.4 -29.06 9.32 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.056 3.171 . . . . 0.0 114.442 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -93.16 16.72 12.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.704 0.288 . . . . 0.0 110.986 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 71.87 20.18 4.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.298 1.039 . . . . 0.0 112.327 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.4 mm -87.69 149.89 3.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 131' ' ' THR . 56.4 t30 -69.87 142.89 52.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.573 HD21 ' HD2' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -118.27 -29.72 5.46 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 69.06 17.39 8.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.603 1.161 . . . . 0.0 111.281 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.15 135.43 54.19 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.1 m -128.15 130.29 47.86 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 120.826 0.346 . . . . 0.0 110.13 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 46.4 t -90.46 109.68 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -91.61 121.98 33.77 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.4 m -104.86 105.5 15.59 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 91.8 mt -82.65 168.68 17.04 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.415 ' O ' HD11 ' A' ' 54' ' ' ILE . 18.7 t70 -93.64 89.88 6.4 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 171.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -129.61 116.01 18.24 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.302 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.78 -29.77 36.09 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.53 140.22 51.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.813 -1.54 . . . . 0.0 110.739 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.56 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 60.5 mttm -90.26 105.55 17.89 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -77.64 144.88 37.07 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 166.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -59.04 126.95 29.81 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 124.008 0.818 . . . . 0.0 112.376 -172.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 12.7 p-10 -69.74 102.87 2.0 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.09 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -93.12 23.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.633 -0.667 . . . . 0.0 111.794 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -62.8 -40.11 96.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.067 -175.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.35 -0.48 89.11 Favored Glycine 0 C--N 1.317 -0.511 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.606 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -98.97 -14.11 19.65 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.8 mt -64.46 122.51 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.441 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.1 m -122.89 95.58 4.68 Favored 'General case' 0 N--CA 1.397 -3.112 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.97 -14.92 57.52 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -88.48 95.17 10.12 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 171.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.499 HD22 HD12 ' A' ' 135' ' ' ILE . 2.2 pp -125.79 -21.54 4.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 -162.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.417 ' N ' HD12 ' A' ' 94' ' ' LEU . 12.1 pt-20 -68.44 134.05 49.58 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.797 -1.161 . . . . 0.0 113.656 -172.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.35 -13.99 56.85 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.684 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 118' ' ' VAL . 16.0 t -93.45 157.02 3.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 2.6 p30 -96.22 148.96 22.18 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.8 158.87 38.98 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.034 0.921 . . . . 0.0 112.64 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.0 m -123.63 131.83 53.71 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.076 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.2 tp -94.97 115.83 27.93 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.99 109.24 27.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 47.2 t -113.97 131.89 64.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.478 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 9.7 t60 -140.85 93.71 2.63 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -121.36 179.7 4.34 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.503 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -75.63 -37.73 59.49 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.214 -0.595 . . . . 0.0 111.287 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -86.62 -22.98 25.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.178 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -125.05 76.9 1.58 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.4 m -88.56 129.39 35.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.351 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 57.38 68.03 0.9 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.902 1.281 . . . . 0.0 113.458 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.483 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 27.3 m -107.78 99.8 9.24 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.189 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.4 mt -100.76 96.61 4.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.8 tp -110.34 106.22 15.52 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.546 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.17 115.84 14.12 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.9 m -94.98 -19.63 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.19 -159.5 17.94 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.63 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 98' ' ' ASP . 24.6 Cg_exo -65.01 133.61 36.46 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.42 2.747 . . . . 0.0 112.586 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 137' ' ' TYR . 35.4 m -111.31 159.35 11.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.154 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.5 t -142.11 167.03 23.1 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.6 ttt -87.54 129.35 35.12 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -91.49 -26.13 18.95 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.282 0.563 . . . . 0.0 110.696 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.62 -106.99 2.59 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.51 116.73 23.66 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.2 mm -104.67 122.03 57.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.782 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -106.94 85.73 2.19 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 122.106 0.955 . . . . 0.0 110.967 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.1 tp -97.66 133.72 41.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 40.8 m 61.05 32.48 19.79 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.677 0.751 . . . . 0.0 109.43 -176.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.3 m 64.23 12.96 7.55 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.749 1.22 . . . . 0.0 111.522 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 44.9 m -102.62 107.08 52.81 Favored Pre-proline 0 N--CA 1.428 -1.528 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.65 121.67 6.86 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.687 2.258 . . . . 0.0 112.602 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 24.6 m -121.96 120.46 34.49 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -98.95 158.77 15.42 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.573 ' HD2' HD21 ' A' ' 70' ' ' LEU . 98.9 mtt180 64.27 62.01 0.86 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 122.514 1.15 . . . . 0.0 110.813 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 54.8 ttm -124.78 145.57 49.67 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.566 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.547 HG23 ' HB3' ' A' ' 170' ' ' SER . 1.4 tt -109.38 134.77 50.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 53.0 ttt180 -120.51 140.21 51.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.158 0.504 . . . . 0.0 111.772 -173.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.452 ' HB3' HG12 ' A' ' 118' ' ' VAL . 26.5 p90 -141.74 132.38 25.52 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.466 172.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.37 81.03 4.91 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.976 0.893 . . . . 0.0 109.634 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -144.52 127.74 16.72 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.43 105.88 4.31 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.193 0.52 . . . . 0.0 111.15 -176.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.3 p -89.59 174.36 7.8 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -114.39 172.67 6.88 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.1 t -84.93 146.89 27.02 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.3 56.68 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -106.37 14.77 26.92 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.428 0.633 . . . . 0.0 110.369 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.443 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 47.2 t -71.07 129.46 39.02 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.329 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.15 2.68 62.14 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.327 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.23 131.82 38.94 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.2 t -76.92 109.53 11.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 28.7 tp -88.0 106.0 17.84 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.7 p -136.75 178.36 7.13 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.957 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.83 -178.95 6.17 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.5 m -64.92 97.24 0.22 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.193 0.52 . . . . 0.0 110.931 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.52 11.41 68.8 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.877 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.75 143.11 33.32 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 117.089 0.445 . . . . 0.0 110.749 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 75.8 mt -122.62 130.83 74.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -105.22 -34.12 8.01 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.222 0.534 . . . . 0.0 111.328 -175.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 168.9 -159.6 32.75 Favored Glycine 0 N--CA 1.426 -1.967 0 C-N-CA 119.884 -1.151 . . . . 0.0 112.1 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 27.5 pt -132.58 135.78 57.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.838 0.351 . . . . 0.0 110.663 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -64.84 118.69 9.37 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 123.62 0.768 . . . . 0.0 110.179 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.7 m -90.95 -36.05 7.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 120.87 0.367 . . . . 0.0 110.309 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.88 164.71 31.65 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -129.26 143.89 14.94 Favored Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -132.83 103.8 6.27 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.16 -108.31 2.45 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -104.58 -10.45 17.57 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -85.07 99.26 10.92 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 120.988 0.423 . . . . 0.0 111.451 -174.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.5 113.32 3.81 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -95.95 120.95 37.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 121.3 0.572 . . . . 0.0 109.614 -176.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.547 ' HB3' HG23 ' A' ' 135' ' ' ILE . 35.1 t -119.22 139.14 52.36 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.418 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -76.18 134.17 39.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -79.71 111.48 16.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.71 99.31 10.16 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.454 ' HB3' ' HG2' ' A' ' 176' ' ' GLN . 63.5 mttm -85.69 142.52 28.97 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.372 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -72.55 -19.13 61.56 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.734 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.47 ' O ' HG12 ' A' ' 179' ' ' VAL . 14.0 pt20 -75.16 -5.34 43.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.729 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -76.76 -26.03 54.09 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -106.97 1.02 24.16 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.069 -173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 176' ' ' GLN . 9.1 p -74.27 130.51 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -93.86 -16.19 24.31 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.691 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -110.79 107.72 17.33 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.957 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 . . . . . 0 C--N 1.295 -1.776 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 177.203 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.001 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.58 -62.24 0.47 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.553 2.836 . . . . 0.0 114.621 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -72.03 -41.45 67.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.241 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -62.31 -40.28 95.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.626 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.54 -36.83 71.13 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.45 0.167 . . . . 0.0 110.607 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.86 -48.88 79.8 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.47 96.35 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.357 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.4 -44.86 96.41 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.0 0.52 . . . . 0.0 110.419 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -63.03 -48.55 78.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.547 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.71 -41.73 98.0 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.279 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 26.1 tp -56.17 -58.92 5.89 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.809 1.243 . . . . 0.0 111.706 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -76.51 -2.23 31.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.819 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -109.37 -63.88 1.31 Allowed 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -108.96 -10.06 15.07 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -170.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.474 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 58.2 mt -91.77 109.89 21.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.025 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 67.6 mtm -116.39 139.93 49.9 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 120.592 0.234 . . . . 0.0 111.09 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.5 m -82.55 119.42 24.22 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.9 mt -109.11 108.3 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.2 m -81.85 104.79 12.48 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.629 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 77.1 p -91.88 -162.6 0.94 Allowed 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.937 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.7 t -81.41 -14.2 57.41 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -100.39 -34.38 9.99 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.287 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.04 -162.6 36.35 Favored Glycine 0 CA--C 1.502 -0.759 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.743 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' CD ' ' HB3' ' A' ' 106' ' ' ASN . 82.8 mt-10 -92.7 104.09 16.4 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -107.45 176.61 5.1 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 104' ' ' HIS . 0.0 OUTLIER -117.91 131.58 56.5 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-O 121.11 0.481 . . . . 0.0 109.983 -179.677 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.44 131.65 10.14 Favored Glycine 0 N--CA 1.416 -2.633 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -98.51 115.72 29.19 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.86 122.35 8.2 Favored Glycine 0 N--CA 1.434 -1.482 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.0 mm -85.8 -57.51 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.315 0.578 . . . . 0.0 109.874 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -155.33 137.21 14.48 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.928 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 62.52 -85.91 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 O-C-N 124.641 1.213 . . . . 0.0 112.455 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -143.2 18.75 1.92 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.264 1.031 . . . . 0.0 109.989 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.6 t -92.51 113.56 27.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.5 p -122.19 155.49 35.7 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.569 ' HB ' HD11 ' A' ' 72' ' ' LEU . 27.1 m -117.73 145.42 23.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 120.732 0.301 . . . . 0.0 110.934 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.2 tt -146.49 141.51 16.37 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -60.4 143.44 99.48 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.724 1.616 . . . . 0.0 111.14 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.2 m -66.99 -40.15 87.31 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.124 0.487 . . . . 0.0 111.577 -174.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -70.97 -1.42 11.94 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.43 -17.5 61.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 122.073 -0.392 . . . . 0.0 110.327 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.629 ' O ' ' HB ' ' A' ' 20' ' ' THR . 88.3 mm-40 63.93 74.43 0.43 Allowed Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 124.638 1.175 . . . . 0.0 113.174 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -89.15 -175.19 1.09 Allowed 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 122.67 2.247 . . . . 0.0 109.814 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.95 -160.1 8.23 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -81.67 -20.22 40.0 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.875 0.845 . . . . 0.0 109.232 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -132.41 141.64 48.95 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.76 160.37 42.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 90.5 mt -101.89 102.07 12.59 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.06 100.66 7.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 121.864 0.84 . . . . 0.0 108.894 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.8 t30 63.47 10.7 5.04 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.19 1.396 . . . . 0.0 110.355 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.9 -19.97 8.23 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.737 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -77.95 116.03 18.14 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 120.583 0.23 . . . . 0.0 110.384 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -70.29 111.93 6.24 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.656 0.741 . . . . 0.0 109.914 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 78' ' ' ASP . 9.5 tp -126.05 140.96 47.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.564 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -87.61 143.24 27.29 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.3 133.04 42.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -80.63 -62.78 1.57 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.09 0.472 . . . . 0.0 110.194 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.464 ' H ' ' HB ' ' A' ' 76' ' ' THR . 27.8 m-20 -128.56 148.83 50.79 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.899 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -129.78 117.0 19.56 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.484 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.0 m-85 -111.45 117.63 33.57 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.635 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -76.31 107.72 8.76 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.43 HD23 HD23 ' A' ' 72' ' ' LEU . 37.3 tp -84.2 98.89 10.19 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.979 0.895 . . . . 0.0 109.123 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 69' ' ' ASN . 33.0 m -127.3 160.06 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.412 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 14.3 t70 -67.89 148.3 98.45 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -32.17 -44.88 0.2 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.862 3.708 . . . . 0.0 115.072 173.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.16 16.43 2.42 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.993 -0.442 . . . . 0.0 112.122 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 t30 60.4 48.56 7.69 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 125.626 1.571 . . . . 0.0 109.753 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 56.0 mt -98.43 126.64 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 172.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.525 ' O ' ' HA ' ' A' ' 131' ' ' THR . 16.6 m120 -73.72 133.2 43.3 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.84 -171.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.4 tp -97.25 -2.95 41.61 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 69.54 5.65 5.29 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.452 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.569 HD11 ' HB ' ' A' ' 36' ' ' VAL . 20.0 tp -102.79 131.13 49.86 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.55 -0.719 . . . . 0.0 111.236 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.0 m -111.24 123.79 50.91 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.484 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 55.0 t -86.51 114.11 25.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.1 tp -102.3 111.94 24.43 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.654 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.464 ' HB ' ' H ' ' A' ' 58' ' ' ASP . 26.5 m -87.32 100.09 12.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.408 HD11 ' CG2' ' A' ' 54' ' ' ILE . 15.3 tp -79.79 125.54 29.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.487 ' O ' HD11 ' A' ' 54' ' ' ILE . 31.4 t70 -83.61 78.99 9.59 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.807 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.489 ' HD3' ' OE2' ' A' ' 81' ' ' GLU . 14.5 ttm180 -137.28 134.66 36.37 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -84.06 1.94 41.57 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.489 ' OE2' ' HD3' ' A' ' 79' ' ' ARG . 45.1 mt-10 -77.36 126.0 30.22 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 173.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -102.89 109.14 20.59 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.396 0.617 . . . . 0.0 109.684 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -79.47 173.1 12.93 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.32 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -72.73 143.27 48.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.196 0.522 . . . . 0.0 111.124 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.16 100.22 5.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 171.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 pt -99.15 19.01 2.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 122.559 1.171 . . . . 0.0 108.643 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -70.29 -34.98 73.41 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.421 -1.718 . . . . 0.0 112.645 -171.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.39 -12.48 82.09 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.189 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.66 -11.59 55.62 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.76 123.36 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 m -118.92 103.55 9.7 Favored 'General case' 0 N--CA 1.405 -2.675 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.14 1.52 31.51 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -89.54 119.69 30.19 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.424 HD13 ' HB ' ' A' ' 135' ' ' ILE . 27.3 mt -107.67 -50.41 3.07 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -166.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.66 127.67 32.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -167.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.69 16.31 52.39 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.085 -1.416 . . . . 0.0 114.083 172.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 25.8 t -115.48 132.81 63.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.815 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.97 113.09 4.71 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.173 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.0 150.95 26.48 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.471 0.653 . . . . 0.0 111.459 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.7 m -114.93 131.81 56.76 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 tp -96.43 119.6 35.21 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 111' ' ' THR . 40.5 t -113.15 111.8 37.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-O 121.2 0.524 . . . . 0.0 110.116 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 26.7 t -107.97 147.0 13.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.41 ' O ' ' HB ' ' A' ' 26' ' ' THR . 20.7 t-160 -139.38 103.76 4.8 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.4 p -124.62 175.38 7.23 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.462 ' HB3' ' CD ' ' A' ' 24' ' ' GLU . 3.7 t30 -80.14 -43.6 21.36 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.78 0.324 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -68.63 -35.61 77.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.784 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.532 ' HD2' ' HG1' ' A' ' 111' ' ' THR . 15.3 t80 -133.15 96.58 3.78 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.2 m -96.45 134.83 39.13 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.837 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 t30 71.74 71.28 0.16 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.377 0.671 . . . . 0.0 111.488 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 7.2 m -97.68 93.68 6.53 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.1 mt -105.26 98.55 7.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.5 tp -122.75 125.49 45.61 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.443 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.04 134.95 41.28 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.2 -51.32 8.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 120.988 0.423 . . . . 0.0 111.268 -176.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.03 -162.93 22.49 Favored Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 3.0 Cg_exo -74.31 123.38 8.18 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.925 2.417 . . . . 0.0 111.673 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.8 m -87.79 156.77 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.696 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.3 p -137.05 151.48 48.97 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.719 0.807 . . . . 0.0 110.257 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 56.7 ttp -89.56 126.69 35.7 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.82 -0.55 . . . . 0.0 109.604 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.32 -42.36 11.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.875 0.369 . . . . 0.0 110.436 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.12 -127.81 9.22 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 44.7 tp -95.16 115.59 27.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.244 0.545 . . . . 0.0 110.447 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.1 pt -111.4 153.79 13.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.83 109.46 11.64 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 121.681 0.753 . . . . 0.0 109.434 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 48.4 tp -125.68 119.03 26.9 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.378 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.7 p 49.83 64.59 1.71 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.284 1.034 . . . . 0.0 113.565 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.7 m 61.94 15.96 7.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.714 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.3 m -126.18 118.74 23.55 Favored Pre-proline 0 N--CA 1.431 -1.394 0 O-C-N 122.157 -0.34 . . . . 0.0 110.899 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -85.38 126.95 3.22 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 122.374 2.05 . . . . 0.0 110.846 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 28.6 m -129.53 117.99 21.35 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 27.4 p-10 -103.85 163.83 12.09 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.896 -173.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.583 ' HD2' ' OE1' ' A' ' 172' ' ' GLN . 20.5 mmt180 55.73 47.85 19.61 Favored 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 124.59 1.181 . . . . 0.0 112.804 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 98.2 mmm -95.57 147.73 23.27 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.597 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 170' ' ' SER . 3.4 tt -117.73 134.03 62.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 42.1 ptt85 -124.48 157.85 34.26 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.96 0.886 . . . . 0.0 110.405 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -137.42 149.56 47.0 Favored 'General case' 0 C--N 1.26 -3.326 0 CA-C-N 114.0 -1.455 . . . . 0.0 107.689 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.02 99.82 11.76 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -164.22 144.18 7.91 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.467 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -75.36 99.23 4.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.222 0.535 . . . . 0.0 110.94 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.6 t -132.03 177.61 7.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -158.87 168.54 26.52 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 120.728 0.299 . . . . 0.0 111.111 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 54.2 m -64.28 116.85 6.43 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.013 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.72 -35.57 0.54 Allowed Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -87.97 25.59 1.53 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 34.8 m -73.22 127.6 33.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.598 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.405 ' C ' HG23 ' A' ' 26' ' ' THR . . . 93.42 5.95 63.08 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.406 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.23 137.56 17.23 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.3 126.74 37.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.792 0.806 . . . . 0.0 110.764 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 42.5 tp -96.96 103.79 15.74 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 20.8 p -145.1 162.7 36.37 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.512 0.672 . . . . 0.0 112.331 -173.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.44 -176.27 3.55 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.4 p -60.41 99.42 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.343 0.592 . . . . 0.0 111.698 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 76.77 13.7 83.3 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.835 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -135.15 108.01 7.55 Favored 'General case' 0 C--O 1.21 -0.992 0 O-C-N 122.595 -0.356 . . . . 0.0 111.041 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 88.1 mt -98.63 129.68 48.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -101.47 -33.32 10.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.688 0.756 . . . . 0.0 110.603 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 160.9 -151.92 22.45 Favored Glycine 0 N--CA 1.421 -2.31 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.6 pt -133.01 149.3 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -70.72 135.8 48.52 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.606 0.566 . . . . 0.0 111.398 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.29 -58.35 3.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.049 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.69 157.49 22.84 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -137.75 138.21 9.46 Favored Glycine 0 N--CA 1.419 -2.487 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -105.48 84.01 2.03 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 122.304 1.049 . . . . 0.0 110.663 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 80.91 -102.22 2.12 Favored Glycine 0 N--CA 1.419 -2.494 0 CA-C-N 114.398 -1.274 . . . . 0.0 113.013 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -98.42 -0.38 43.7 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -120.97 132.27 54.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -118.83 124.46 6.03 Favored Glycine 0 CA--C 1.476 -2.356 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.018 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -108.99 125.4 52.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.328 1.061 . . . . 0.0 111.645 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.534 ' HB2' HG23 ' A' ' 135' ' ' ILE . 19.8 m -120.56 161.39 21.4 Favored 'General case' 0 C--N 1.275 -2.639 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.36 138.68 32.04 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.583 ' OE1' ' HD2' ' A' ' 133' ' ' ARG . 58.4 tt0 -82.5 105.22 13.37 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.497 0.665 . . . . 0.0 109.63 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.433 HD21 HG21 ' A' ' 36' ' ' VAL . 10.5 mp -86.0 94.0 9.11 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -74.16 144.31 44.89 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -70.99 -21.93 62.24 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -64.48 -19.03 65.32 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.14 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -88.42 -15.1 36.36 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.827 -0.546 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.94 15.51 22.55 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.659 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.9 128.66 75.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -72.67 -64.37 0.97 Allowed 'General case' 0 CA--C 1.487 -1.452 0 CA-C-O 121.823 0.82 . . . . 0.0 110.653 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -87.3 134.84 33.5 Favored 'General case' 0 N--CA 1.398 -3.029 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.581 -172.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 . . . . . 0 N--CA 1.419 -1.976 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 173.236 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.861 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.93 -36.61 99.2 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 123.13 2.553 . . . . 0.0 111.104 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -64.99 -45.59 84.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.483 177.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -59.34 -49.28 78.43 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.52 0.728 . . . . 0.0 109.961 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.73 -36.48 82.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.859 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -65.77 -48.41 71.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.59 95.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.814 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.5 -47.22 79.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.654 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.2 m -62.75 -36.54 83.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.346 0.594 . . . . 0.0 110.746 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.9 tp -66.5 -49.25 67.2 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.062 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 60.8 tp -51.27 -52.59 43.61 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.775 1.23 . . . . 0.0 111.419 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -56.34 -21.03 21.87 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -174.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -137.49 -29.64 0.87 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 118.841 -1.144 . . . . 0.0 113.84 -177.165 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -107.05 -13.9 15.07 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.499 HG23 HG23 ' A' ' 26' ' ' THR . 27.3 mt -90.71 110.66 22.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.875 0.845 . . . . 0.0 111.562 -177.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.8 mtp -101.6 131.76 47.63 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.216 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 6.6 m -87.3 102.71 14.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 mt -100.35 111.95 31.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 121.64 0.733 . . . . 0.0 112.034 -174.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.3 m -84.05 106.81 15.99 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.378 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 28.0 p -96.69 -167.23 1.53 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.536 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m -73.19 -22.2 60.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 120.852 0.358 . . . . 0.0 110.281 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -92.45 -46.39 7.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.683 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.29 -167.56 33.27 Favored Glycine 0 CA--C 1.503 -0.677 0 C-N-CA 118.862 -1.637 . . . . 0.0 113.401 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -100.69 99.93 10.55 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CD1' ' HB3' ' A' ' 146' ' ' CYS . 67.6 m-85 -115.05 -168.63 1.41 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.173 -175.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.499 HG23 HG23 ' A' ' 15' ' ' ILE . 90.3 m -111.83 135.53 52.33 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-O 121.243 0.544 . . . . 0.0 110.542 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.73 142.22 16.13 Favored Glycine 0 N--CA 1.409 -3.122 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.1 tp -114.52 118.26 33.25 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.321 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.17 119.66 5.0 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 46.5 mm -95.46 -51.81 10.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 117.714 0.757 . . . . 0.0 111.986 -173.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.524 ' O ' HG12 ' A' ' 34' ' ' VAL . 70.9 t60 -156.28 111.39 2.9 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.566 -173.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 61.4 -77.87 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 170.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.753 ' HD3' HG23 ' A' ' 76' ' ' THR . 1.1 ppt_? -120.02 -2.17 10.29 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 31' ' ' HIS . 14.3 p -100.97 118.85 48.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.719 -176.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.5 m -120.33 164.63 16.03 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.337 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.531 ' CG1' HD11 ' A' ' 72' ' ' LEU . 46.7 t -118.63 134.5 62.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tp -148.02 143.64 17.93 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 25.4 Cg_exo -69.61 155.28 66.84 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.36 2.04 . . . . 0.0 112.858 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.9 m -74.74 -44.58 49.09 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -63.6 -13.93 46.73 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.94 -24.28 63.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.068 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.421 ' O ' ' HB ' ' A' ' 20' ' ' THR . 97.4 mt-30 62.94 84.05 0.19 Allowed Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 123.756 0.822 . . . . 0.0 110.705 -177.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.55 121.46 6.0 Favored 'Trans proline' 0 C--O 1.258 1.505 0 C-N-CA 121.898 1.732 . . . . 0.0 110.179 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.2 -169.13 31.27 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.426 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -86.18 -14.4 44.12 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.426 0.631 . . . . 0.0 109.34 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -143.47 137.25 28.43 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.1 158.46 33.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.054 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 79.0 mt -105.6 115.22 29.88 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 17' ' ' THR . 6.0 p -87.78 90.39 3.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 71.75 -10.42 0.85 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.079 1.751 . . . . 0.0 110.632 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 148.94 -22.99 1.28 Allowed Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.438 ' HB2' HG13 ' A' ' 49' ' ' VAL . 79.3 mm-40 -73.44 113.85 11.0 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -75.48 121.27 22.09 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 121.062 0.458 . . . . 0.0 110.799 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.444 ' CG2' HD11 ' A' ' 77' ' ' LEU . 10.6 tp -130.29 141.34 46.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.29 149.56 33.5 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.44 0.638 . . . . 0.0 111.401 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.5 t -94.01 126.97 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 172.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.427 ' HB3' HG22 ' A' ' 76' ' ' THR . 8.0 tmtm? -89.93 -43.81 10.33 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.766 -174.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -156.18 154.09 30.28 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -134.36 127.28 31.33 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.474 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 16.5 m-85 -123.13 108.64 13.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -81.19 136.93 35.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.15 76.2 9.29 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 122.402 1.096 . . . . 0.0 111.682 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.6 p -109.0 118.54 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.271 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.561 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 21.5 t70 -62.47 143.5 96.0 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.619 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.28 -21.24 22.19 Favored 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 123.796 2.997 . . . . 0.0 114.347 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -88.38 7.6 31.79 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.483 0.659 . . . . 0.0 109.242 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.275 40.6 m-80 67.85 63.62 0.39 Allowed 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 125.72 1.608 . . . . 0.0 112.252 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.561 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 18.1 mm -123.55 126.07 72.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 131' ' ' THR . 36.2 t30 -99.75 129.6 45.88 Favored 'General case' 0 C--O 1.203 -1.387 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -170.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.597 HD13 ' O ' ' A' ' 132' ' ' ASN . 40.0 tp -94.57 -8.18 38.92 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 117.607 0.185 . . . . 0.0 111.302 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 66.73 20.77 10.65 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.509 1.147 . . . . 0.0 109.316 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.531 HD11 ' CG1' ' A' ' 36' ' ' VAL . 20.4 tp -126.63 137.08 53.25 Favored 'General case' 0 N--CA 1.426 -1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 110.63 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 46.0 m -124.34 126.28 45.74 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-O 121.506 0.669 . . . . 0.0 110.472 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 91.7 t -79.78 113.64 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 175.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.19 114.96 28.01 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.753 HG23 ' HD3' ' A' ' 33' ' ' ARG . 53.2 m -92.97 115.68 28.35 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.444 HD11 ' CG2' ' A' ' 54' ' ' ILE . 18.1 tp -85.96 142.99 28.41 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.219 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.403 ' O ' HD11 ' A' ' 54' ' ' ILE . 19.3 t70 -81.77 82.27 7.52 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 172.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.601 ' NE ' ' HB3' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -91.51 121.99 33.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -166.583 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -92.58 -42.85 9.44 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 167.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -98.48 118.28 34.81 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -98.25 158.14 15.75 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.577 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -103.59 146.0 29.21 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.433 ' NH2' ' HB3' ' A' ' 13' ' ' LYS . 57.3 ttp180 -55.44 134.54 50.54 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.692 1.597 . . . . 0.0 111.387 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 10.8 p-10 -75.06 96.05 3.15 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.562 1.172 . . . . 0.0 112.776 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.3 pt -96.99 22.75 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 122.299 1.047 . . . . 0.0 109.068 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.481 ' O ' ' HE3' ' A' ' 175' ' ' LYS . 48.1 ttp180 -60.25 -38.34 83.17 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.844 -175.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.99 -11.31 84.84 Favored Glycine 0 C--N 1.315 -0.588 0 C-N-CA 121.166 -0.54 . . . . 0.0 113.024 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.44 -13.1 50.31 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.593 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.4 mt -67.05 130.94 32.86 Favored 'Isoleucine or valine' 0 C--O 1.25 1.116 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.1 t -118.72 113.45 21.17 Favored 'General case' 0 N--CA 1.4 -2.925 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -75.55 -20.14 58.86 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -86.32 115.65 23.99 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.564 HD13 ' HB ' ' A' ' 135' ' ' ILE . 10.5 mt -108.31 -66.73 1.02 Allowed 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.9 0.857 . . . . 0.0 110.76 -171.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -58.9 134.73 57.19 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.673 -168.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.56 2.28 24.32 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.675 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.2 167.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.11 152.57 18.42 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.45 157.09 42.95 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.714 0.769 . . . . 0.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 26.2 m -112.63 133.58 54.6 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 48.1 tp -101.57 119.71 39.2 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.69 93.96 4.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.468 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 61.9 t -79.84 119.55 29.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -148.17 151.55 35.74 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.1 p -171.62 -174.81 1.45 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -92.32 -11.34 35.36 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.363 -1.335 . . . . 0.0 107.991 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -73.32 -49.78 25.6 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.092 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -136.67 113.11 10.0 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.903 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.9 p -101.27 164.87 11.57 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.195 -176.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 55.8 t30 44.43 70.8 0.3 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.689 1.196 . . . . 0.0 113.453 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.468 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 56.3 m -131.26 92.39 3.18 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.475 -0.766 . . . . 0.0 110.242 176.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.7 mt -88.13 101.49 11.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -120.6 117.3 27.21 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.839 0.352 . . . . 0.0 110.977 -173.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 10.1 pt-20 -74.93 130.03 38.69 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.037 0.446 . . . . 0.0 110.494 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -97.67 -45.04 12.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.905 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.91 -152.93 20.48 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.082 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.82 138.68 34.97 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 122.878 2.385 . . . . 0.0 113.554 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.444 HG12 ' HB3' ' A' ' 137' ' ' TYR . 35.8 m -102.87 146.85 10.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.87 177.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.9 p -130.95 153.7 48.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.618 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 44.0 ttp -96.98 116.28 28.92 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.362 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -82.74 -46.09 13.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.968 -176.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.43 -130.32 9.79 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.47 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.4 HD22 HG21 ' A' ' 68' ' ' ILE . 83.5 mt -93.82 100.28 12.5 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 131' ' ' THR . 38.3 mm -118.33 133.02 66.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -95.33 83.91 3.94 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.507 1.146 . . . . 0.0 111.493 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 62.4 tp -79.94 120.06 23.63 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.446 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.1 t 61.36 32.86 19.05 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.6 m 70.12 8.29 6.59 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.648 1.579 . . . . 0.0 112.771 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 29.2 m -98.72 111.76 61.09 Favored Pre-proline 0 N--CA 1.438 -1.061 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.41 ' HB2' HG23 ' A' ' 68' ' ' ILE . 56.2 Cg_endo -69.7 118.39 5.65 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 121.737 1.625 . . . . 0.0 110.59 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 14.6 t -88.77 132.2 34.73 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.22 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.597 ' O ' HD13 ' A' ' 70' ' ' LEU . 34.9 t30 -75.83 81.28 2.75 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 65.58 63.55 0.62 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.64 0.733 . . . . 0.0 112.738 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 28.3 mtt -89.14 164.11 15.15 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.673 HG23 ' HB3' ' A' ' 170' ' ' SER . 6.8 tt -107.84 138.83 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.064 175.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -122.89 140.75 52.63 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.444 ' HB3' HG12 ' A' ' 118' ' ' VAL . 50.5 p90 -132.43 153.46 50.81 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.019 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -89.07 93.22 9.51 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.511 0.507 . . . . 0.0 109.934 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -174.77 135.85 0.4 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 125.395 1.478 . . . . 0.0 108.015 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.09 91.57 7.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.042 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.7 m -97.06 147.84 23.62 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -99.81 172.43 7.25 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -80.17 169.62 17.55 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 175.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 146' ' ' CYS . . . 90.57 -34.38 4.21 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -173.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.455 HE21 HG11 ' A' ' 103' ' ' VAL . 49.2 mt-30 -85.81 33.14 0.58 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.028 1.331 . . . . 0.0 107.622 175.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.522 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 42.8 t -89.51 138.19 31.67 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.737 -175.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 94.88 -1.41 65.46 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.45 127.94 29.62 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.39 115.33 17.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.054 0.454 . . . . 0.0 111.114 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 39.4 tp -89.5 107.86 19.32 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.0 p -146.98 162.49 38.65 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.548 0.69 . . . . 0.0 112.653 -174.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -128.94 -179.07 4.89 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 175.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.2 t -60.4 103.24 0.22 Allowed 'General case' 0 CA--C 1.556 1.192 0 CA-C-O 122.404 1.097 . . . . 0.0 112.072 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 77.35 15.07 81.87 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.629 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -135.35 109.81 8.49 Favored 'General case' 0 C--O 1.207 -1.145 0 O-C-N 122.307 -0.525 . . . . 0.0 111.646 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.6 mt -100.68 129.54 51.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -105.23 -41.41 5.55 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.611 0.719 . . . . 0.0 110.776 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.482 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 173.93 -170.38 43.5 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.63 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.8 pt -119.29 143.64 30.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -70.05 136.5 50.39 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.36 -46.49 3.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.111 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.57 153.6 23.12 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -127.8 152.46 18.95 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.56 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -116.73 96.1 5.33 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.23 -119.03 9.1 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.104 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -84.79 -8.01 58.98 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.745 0.818 . . . . 0.0 110.647 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -108.61 100.95 10.14 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.443 -0.786 . . . . 0.0 111.429 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -79.94 134.65 13.86 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -107.21 129.84 54.81 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 122.121 0.962 . . . . 0.0 110.45 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.673 ' HB3' HG23 ' A' ' 135' ' ' ILE . 30.0 t -118.2 141.31 48.63 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.999 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.37 120.45 23.83 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.466 ' CD ' HD11 ' A' ' 94' ' ' LEU . 6.1 tt0 -78.27 109.0 12.0 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 123.776 0.673 . . . . 0.0 110.393 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 173' ' ' LEU . 3.2 pp -94.05 88.54 5.7 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.265 1.031 . . . . 0.0 109.453 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -80.85 138.72 36.2 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.871 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.505 ' HB2' ' HZ2' ' A' ' 175' ' ' LYS . 4.1 ttmp? -50.88 -35.14 31.31 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.542 1.137 . . . . 0.0 112.267 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -56.47 -25.63 51.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.627 0.771 . . . . 0.0 112.977 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -82.39 -13.74 56.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.673 0.273 . . . . 0.0 111.299 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -96.54 -8.27 32.38 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -173.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 29.3 m -87.25 170.65 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -74.05 -48.13 32.01 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.791 0.329 . . . . 0.0 110.866 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -98.64 113.5 25.58 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.394 0.886 . . . . 0.0 113.394 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 . . . . . 0 C--O 1.254 1.319 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.122 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.784 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -62.46 -36.79 63.84 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.923 2.416 . . . . 0.0 111.266 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -67.01 -36.48 82.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.64 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 3.0 m -65.41 -48.77 71.66 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.727 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.05 -37.55 87.95 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.833 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -62.12 -48.48 79.97 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.802 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.14 95.05 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 123.932 0.77 . . . . 0.0 111.515 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 4' ' ' THR . 96.0 mt -63.81 -43.35 96.53 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.868 0.365 . . . . 0.0 111.12 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 m -67.1 -31.71 72.37 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.462 0.649 . . . . 0.0 110.412 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.8 tp -74.14 -59.07 2.89 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.524 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.73 ' HA ' HG12 ' A' ' 15' ' ' ILE . 6.8 tt -50.21 -52.4 36.04 Favored 'General case' 0 C--O 1.247 0.957 0 C-N-CA 125.286 1.434 . . . . 0.0 113.341 -175.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -66.59 -4.03 7.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -172.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -129.07 -53.9 1.2 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -84.72 6.99 22.05 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -171.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.73 HG12 ' HA ' ' A' ' 11' ' ' LEU . 48.2 mm -102.4 123.63 55.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.122 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.417 ' O ' HG13 ' A' ' 18' ' ' ILE . 1.8 mpt? -101.71 97.06 7.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.566 ' HA ' HG22 ' A' ' 26' ' ' THR . 23.3 m -70.65 93.17 0.91 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.422 HG23 ' HB ' ' A' ' 47' ' ' VAL . 82.1 mt -93.48 118.55 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.966 -172.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 7.0 m -85.27 106.59 16.79 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.693 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 60.6 p -90.81 -163.32 1.01 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.761 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 m -79.75 -2.96 45.45 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -118.65 -33.25 4.33 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.69 -151.26 20.21 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 119.762 -1.209 . . . . 0.0 112.542 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -86.87 104.2 16.0 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.38 133.86 52.38 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.584 HG21 ' CD2' ' A' ' 104' ' ' HIS . 13.6 p -97.8 130.58 44.73 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-O 121.796 0.808 . . . . 0.0 113.078 -172.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.41 131.11 10.45 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 55.4 tp -89.81 114.06 25.72 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.5 103.89 1.69 Allowed Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.8 mm -71.44 -47.17 60.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 C-N-CA 123.129 0.572 . . . . 0.0 109.857 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -169.95 154.1 5.03 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.581 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t70 50.79 -95.48 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.715 1.26 . . . . 0.0 113.402 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.492 ' HG2' ' HB2' ' A' ' 79' ' ' ARG . 54.6 mtt180 -123.82 4.7 8.78 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 122.817 0.447 . . . . 0.0 111.073 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.05 113.91 26.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.256 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 13.1 p -126.9 137.47 53.16 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -110.75 138.49 38.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.98 149.91 26.29 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.16 149.78 83.11 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 122.248 1.966 . . . . 0.0 112.555 174.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.428 ' HB ' ' OG1' ' A' ' 73' ' ' THR . 8.9 t -79.43 -31.02 42.52 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 122.517 0.327 . . . . 0.0 110.995 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -72.66 -4.97 34.31 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.208 0.528 . . . . 0.0 111.024 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.27 -13.17 60.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.693 ' O ' ' HB ' ' A' ' 20' ' ' THR . 85.5 mm-40 66.62 77.78 0.26 Allowed Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 125.145 1.378 . . . . 0.0 113.281 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.17 153.86 18.93 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.198 1.932 . . . . 0.0 110.297 176.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.99 -164.32 13.93 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -83.38 -20.97 33.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.048 0.928 . . . . 0.0 108.59 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.412 ' HB3' ' HG3' ' A' ' 55' ' ' ARG . 4.6 p-10 -143.72 149.6 37.41 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.422 ' HB ' HG23 ' A' ' 18' ' ' ILE . 24.8 m -143.33 170.42 10.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.471 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 73.3 mt -102.31 114.12 28.01 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 m -92.32 97.74 7.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.615 0.721 . . . . 0.0 109.617 174.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 69.53 -10.4 0.58 Allowed 'General case' 0 CA--C 1.564 1.517 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.96 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.84 -25.18 0.63 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 112.285 -0.326 . . . . 0.0 112.285 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -90.42 131.86 35.95 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 122.552 -0.381 . . . . 0.0 110.719 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -77.44 115.21 17.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.481 0.658 . . . . 0.0 109.677 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.8 tp -120.37 143.51 32.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.431 ' N ' ' HD2' ' A' ' 55' ' ' ARG . 2.8 mpt_? -89.87 141.07 28.98 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.685 0.755 . . . . 0.0 111.777 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.404 HG22 ' CD2' ' A' ' 77' ' ' LEU . 20.2 t -97.21 102.99 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -69.16 -62.4 1.39 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 123.675 0.609 . . . . 0.0 110.097 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -111.42 138.39 47.98 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -146.34 105.08 3.85 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-O 121.275 0.56 . . . . 0.0 109.589 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -107.92 129.67 55.08 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.276 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.45 131.43 34.19 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.5 tp -83.49 104.02 13.3 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.788 0.804 . . . . 0.0 109.997 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.53 141.51 43.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.936 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 20.8 t70 -83.49 142.46 43.17 Favored Pre-proline 0 C--N 1.279 -2.492 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.79 -11.69 7.59 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.562 2.841 . . . . 0.0 114.576 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -98.99 18.33 17.52 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.989 -0.444 . . . . 0.0 110.788 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 75.01 17.71 2.66 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.636 1.175 . . . . 0.0 112.65 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 132' ' ' ASN . 34.8 mm -91.08 140.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 131' ' ' THR . 9.1 t-20 -98.1 152.49 19.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.471 ' C ' ' H ' ' A' ' 72' ' ' LEU . 4.0 mm? -112.29 -7.27 14.01 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.55 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 67.77 -21.08 0.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.291 1.436 . . . . 0.0 112.252 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.471 ' H ' ' C ' ' A' ' 70' ' ' LEU . 7.4 tt -79.4 133.3 36.56 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 124.067 0.947 . . . . 0.0 110.371 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.428 ' OG1' ' HB ' ' A' ' 39' ' ' THR . 20.4 m -117.45 133.44 55.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.2 t -98.47 108.79 22.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.3 mt -102.25 132.3 48.28 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 27.6 m -109.56 100.14 9.23 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.404 ' CD2' HG22 ' A' ' 56' ' ' VAL . 82.8 mt -87.04 155.62 20.07 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.768 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.92 93.52 2.68 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.535 ' NE ' ' HA ' ' A' ' 79' ' ' ARG . 2.5 mmp_? -106.55 108.47 19.99 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.393 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -83.19 -29.68 28.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -99.69 107.49 19.6 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 170.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -99.88 166.41 11.08 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.852 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -121.68 169.57 10.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -57.47 142.58 43.63 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.77 1.628 . . . . 0.0 112.117 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 14.6 t70 -75.86 96.0 3.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.885 0.85 . . . . 0.0 109.211 172.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.9 pt -84.91 10.71 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-O 121.813 0.815 . . . . 0.0 110.972 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -68.26 -24.71 64.92 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.4 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.91 -11.4 66.39 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.296 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -103.86 -4.55 23.37 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 117.138 0.469 . . . . 0.0 110.554 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -64.18 121.06 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.703 0.763 . . . . 0.0 110.708 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 m -93.32 114.99 27.57 Favored 'General case' 0 N--CA 1.391 -3.391 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.3 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -2.63 56.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 122.234 1.016 . . . . 0.0 108.958 175.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -113.34 113.72 25.65 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.58 -1.645 . . . . 0.0 107.347 176.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -115.98 -54.5 2.49 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.548 0.69 . . . . 0.0 111.674 -170.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -72.95 127.1 31.56 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.501 -168.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.93 -7.92 41.96 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.301 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 t -104.52 147.51 10.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 5.8 p-10 -89.23 145.45 25.4 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.15 155.59 45.25 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 122.156 0.979 . . . . 0.0 113.286 -175.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 27.1 m -111.27 127.83 55.74 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 113.565 -1.652 . . . . 0.0 107.387 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.9 tp -101.74 117.24 34.47 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.303 0.573 . . . . 0.0 109.933 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 t -94.01 97.14 6.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.481 ' O ' ' HB ' ' A' ' 111' ' ' THR . 15.6 m -88.34 126.63 41.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.584 ' CD2' HG21 ' A' ' 26' ' ' THR . 33.0 p-80 -153.93 153.82 32.71 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.352 0.596 . . . . 0.0 111.394 -173.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.4 p -154.58 -162.63 1.43 Allowed 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -84.91 -35.67 21.97 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 118.741 -1.183 . . . . 0.0 108.63 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -77.77 -36.37 50.66 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.417 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 104' ' ' HIS . 97.1 m-85 -115.37 93.2 4.19 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 m -112.22 150.77 30.41 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 71.76 19.15 4.99 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.687 0.795 . . . . 0.0 112.609 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 103' ' ' VAL . 43.7 m -80.47 101.13 8.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 82.5 mt -102.78 98.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.503 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.4 tp -112.72 105.89 14.13 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.669 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 6.5 pt-20 -79.67 139.65 37.32 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.821 -0.55 . . . . 0.0 111.917 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.0 m -107.63 -42.19 5.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.402 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 126.07 -158.06 20.17 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.615 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 98' ' ' ASP . 24.4 Cg_exo -64.37 126.04 16.21 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.682 2.921 . . . . 0.0 112.892 -178.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -92.08 151.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.371 0.605 . . . . 0.0 111.736 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.4 m -122.28 154.47 37.53 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -94.73 139.56 31.08 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.78 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 134' ' ' MET . . . -91.99 -23.62 19.49 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.06 -123.81 6.24 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.369 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -105.74 108.99 20.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.4 pt -120.7 153.17 23.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.59 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -102.9 115.62 30.95 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.304 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 98.9 mt -113.11 92.03 3.86 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.7 m 51.49 72.74 0.35 Allowed 'General case' 0 C--O 1.252 1.205 0 C-N-CA 124.095 0.958 . . . . 0.0 113.028 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.2 m 61.68 14.61 6.22 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.621 -1.172 . . . . 0.0 112.566 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.2 m -121.32 96.3 48.06 Favored Pre-proline 0 N--CA 1.414 -2.273 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.83 115.82 4.41 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 121.978 1.785 . . . . 0.0 108.228 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.4 t -103.27 125.98 50.2 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-O 121.389 0.614 . . . . 0.0 109.523 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.514 ' HB2' HG21 ' A' ' 68' ' ' ILE . 27.6 t30 -83.3 134.42 34.93 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.007 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 63.04 49.78 3.33 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 124.126 0.891 . . . . 0.0 110.166 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.41 ' HB3' ' HB3' ' A' ' 121' ' ' ALA . 8.3 tpt -85.69 143.2 28.51 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 170' ' ' SER . 14.5 tt -112.66 144.97 19.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -132.96 142.62 48.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.289 0.566 . . . . 0.0 111.347 -173.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -134.74 115.96 14.34 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.43 92.56 1.1 Allowed 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -167.86 117.77 0.8 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.63 110.68 1.04 Allowed 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.545 0.688 . . . . 0.0 110.494 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.6 m -121.15 153.51 37.42 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -88.33 123.93 33.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.044 0.449 . . . . 0.0 110.977 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.4 t -78.52 151.43 32.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.9 -15.53 40.42 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -106.84 35.07 3.13 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 10.0 m -69.94 146.67 51.0 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.233 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.92 3.51 42.38 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.54 145.63 40.81 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.86 116.36 31.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 120.924 0.392 . . . . 0.0 110.226 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.2 tp -89.45 104.95 17.46 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.0 p -141.52 -173.73 3.85 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.254 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -161.54 -175.52 4.81 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 175.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.4 m -64.23 99.12 0.26 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 118.355 0.525 . . . . 0.0 110.765 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.15 18.66 71.4 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.98 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 74.5 mmtt -132.93 134.86 45.1 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -129.11 120.97 52.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -96.8 -46.19 6.35 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.8 0.687 . . . . 0.0 111.559 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.547 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 179.54 -176.03 47.37 Favored Glycine 0 N--CA 1.419 -2.477 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.715 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 22.7 pt -109.41 134.31 51.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 O-C-N 123.69 0.288 . . . . 0.0 110.228 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.421 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 11.2 t-80 -58.52 113.47 2.01 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 124.474 1.109 . . . . 0.0 110.25 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.5 t -88.27 -41.6 14.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.599 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.47 127.61 0.95 Allowed Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 119.022 -1.561 . . . . 0.0 113.103 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.462 ' HA2' ' HA2' ' A' ' 168' ' ' GLY . . . -78.68 79.5 1.55 Allowed Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 172.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -93.33 89.01 6.19 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 100.69 -147.3 17.89 Favored Glycine 0 N--CA 1.427 -1.915 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.392 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 43.1 ttm105 -85.57 -0.9 56.38 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.487 0.66 . . . . 0.0 110.223 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -124.52 124.93 43.35 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.887 -0.508 . . . . 0.0 110.064 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.462 ' HA2' ' HA2' ' A' ' 163' ' ' GLY . . . -84.25 126.46 7.62 Favored Glycine 0 N--CA 1.414 -2.8 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -109.71 127.15 54.4 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 121.213 0.53 . . . . 0.0 109.9 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.546 ' HB2' HG23 ' A' ' 135' ' ' ILE . 49.8 m -127.83 159.65 34.2 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -100.04 132.6 45.3 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -76.21 104.15 6.6 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.547 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -80.38 70.99 7.17 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.386 1.089 . . . . 0.0 111.431 177.44 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -63.1 139.94 58.82 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.186 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -53.14 -30.41 36.79 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 126.513 1.925 . . . . 0.0 111.499 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -62.29 -25.27 67.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -78.13 -20.48 52.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.571 0.701 . . . . 0.0 109.34 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -104.34 21.83 15.93 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.362 -171.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 52.6 t -75.63 115.65 17.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 173.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -69.91 -30.83 68.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.262 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -80.66 125.41 29.99 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.457 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 . . . . . 0 C--N 1.293 -1.856 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 176.602 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.504 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 C--O 1.215 -1.065 0 CA-C-O 118.342 -1.254 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -35.23 -54.93 0.64 Allowed 'Trans proline' 0 C--N 1.361 1.212 1 C-N-CA 125.342 4.028 . . . . 0.0 116.163 -173.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -71.44 -38.58 71.34 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.929 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.443 HG23 HG21 ' A' ' 112' ' ' ILE . 54.2 m -71.25 -29.38 65.04 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.753 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 1' ' ' GLY . 4.9 mm-40 -69.07 -43.57 74.34 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -64.82 -44.0 91.3 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.424 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -54.77 -49.35 71.11 Favored 'General case' 0 C--O 1.204 -1.318 0 O-C-N 123.97 0.794 . . . . 0.0 110.98 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 tp -63.67 -38.73 92.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.088 0.471 . . . . 0.0 111.423 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -71.12 -37.07 72.34 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.469 0.652 . . . . 0.0 110.893 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.86 -38.76 64.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.411 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.562 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 37.2 tp -49.61 -54.73 16.7 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 125.419 1.488 . . . . 0.0 112.568 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -72.53 -3.8 26.75 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -170.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -133.48 -29.89 1.33 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -120.87 -25.25 5.45 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.562 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 33.7 mt -95.26 105.96 17.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.3 mmt -122.51 149.54 43.77 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.118 0.485 . . . . 0.0 112.123 -175.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 m -80.2 124.46 28.81 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.9 mt -113.1 108.46 25.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.2 m -87.18 104.46 16.38 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.2 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 40.9 p -95.34 -156.6 0.52 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.465 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -75.88 -28.96 58.34 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -81.57 -38.16 26.58 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.27 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.84 -156.7 27.91 Favored Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 119.949 -1.119 . . . . 0.0 111.78 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.18 105.38 16.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.015 0.436 . . . . 0.0 110.703 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -107.66 176.07 5.27 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.0 m -115.56 134.5 55.0 Favored 'General case' 0 N--CA 1.408 -2.538 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.16 139.1 13.01 Favored Glycine 0 N--CA 1.412 -2.924 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.4 tp -102.11 118.24 36.48 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.08 114.31 3.83 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mm -78.77 -50.05 19.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 85' ' ' ASP . 25.0 p80 -167.67 145.38 4.51 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.151 176.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.581 ' HB3' ' HG3' ' A' ' 82' ' ' LYS 0.314 1.2 p30 46.8 -96.11 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 177.259 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 37.4 ptt180 -117.07 2.35 12.66 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.153 0.502 . . . . 0.0 110.882 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.6 t -91.72 106.38 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.631 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.6 m -122.49 162.18 22.21 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 p -133.17 140.81 46.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.62 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.0 tt -153.02 147.53 19.1 Favored Pre-proline 0 CA--C 1.561 1.384 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.75 147.51 94.6 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.417 2.078 . . . . 0.0 112.483 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.4 m -62.05 -44.9 95.69 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.281 0.633 . . . . 0.0 112.612 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -65.46 2.53 0.88 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.36 -23.28 54.16 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.455 ' O ' ' HB ' ' A' ' 20' ' ' THR . 13.4 mm100 64.47 77.35 0.3 Allowed Pre-proline 0 C--O 1.25 1.119 0 C-N-CA 125.228 1.411 . . . . 0.0 111.664 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.34 128.84 9.91 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.673 2.249 . . . . 0.0 110.826 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.52 -163.62 38.65 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.801 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.81 -33.64 75.2 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.657 0.741 . . . . 0.0 110.912 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -139.84 141.03 36.7 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.15 154.0 23.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 120.57 0.224 . . . . 0.0 110.918 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 8.2 mp -96.36 105.28 17.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.026 0.441 . . . . 0.0 111.173 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.59 93.53 4.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 t30 65.88 9.37 6.03 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.682 1.193 . . . . 0.0 110.732 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.69 -22.85 5.44 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -80.59 107.67 13.59 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -80.62 111.31 16.93 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.836 0.827 . . . . 0.0 109.204 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.1 tp -113.35 135.57 52.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.316 -174.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -68.69 132.8 47.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.858 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.89 126.92 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -77.67 -63.02 1.48 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.457 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -147.22 148.96 32.02 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -112.59 104.02 12.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.539 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.8 m-85 -81.55 95.18 7.06 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -75.23 123.0 24.53 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.11 102.96 15.29 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -177.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.9 132.56 60.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.3 145.25 86.47 Favored Pre-proline 0 C--N 1.307 -1.268 0 O-C-N 123.383 0.427 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.3 -21.98 73.43 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.558 2.172 . . . . 0.0 110.798 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.49 7.81 21.47 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.391 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 71.18 21.54 4.73 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.51 1.524 . . . . 0.0 113.15 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 132' ' ' ASN . 39.5 mm -92.49 152.75 3.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.657 ' O ' ' HA ' ' A' ' 131' ' ' THR . 48.3 t30 -85.5 138.4 32.24 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.43 -19.73 17.53 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 66.29 21.74 10.97 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 122.989 1.376 . . . . 0.0 109.475 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.3 tp -121.16 143.72 48.97 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.373 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.1 m -138.9 126.98 22.5 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.114 0.483 . . . . 0.0 110.388 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 60.6 t -86.87 110.79 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.7 tp -91.75 116.13 28.63 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.712 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.3 m -93.24 106.42 18.38 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.1 0.476 . . . . 0.0 109.882 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.54 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 8.3 mp -81.37 153.78 26.8 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.758 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.467 ' O ' HD11 ' A' ' 54' ' ' ILE . 22.8 t70 -83.41 74.68 10.05 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.84 0.829 . . . . 0.0 109.052 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -114.78 130.71 56.9 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.45 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -95.85 -39.64 9.72 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.72 129.13 38.68 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.578 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.581 ' HG3' ' HB3' ' A' ' 32' ' ' ASP . 51.7 tttp -89.02 102.86 15.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.301 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.45 ' H ' ' HA ' ' A' ' 32' ' ' ASP . 96.5 m-85 -70.47 156.34 39.5 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 172.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -49.7 132.49 21.77 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.779 1.232 . . . . 0.0 113.436 -173.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 31' ' ' HIS . 12.2 t70 -84.62 97.06 9.4 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.613 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -97.79 22.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.854 0.835 . . . . 0.0 110.921 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -60.55 -41.66 94.99 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.138 -174.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.63 1.43 66.89 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 116.11 -0.496 . . . . 0.0 113.72 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -95.83 -6.78 38.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.98 0.39 . . . . 0.0 110.51 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.3 mt -72.04 109.67 4.44 Favored 'Isoleucine or valine' 0 C--O 1.261 1.692 0 CA-C-O 121.308 0.575 . . . . 0.0 110.004 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 p -94.97 105.69 17.63 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.514 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -82.0 -13.05 57.97 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.819 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -94.28 115.62 27.89 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.7 mt -112.73 -56.97 2.35 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.188 -164.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 32.1 tt0 -60.11 112.37 1.87 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -164.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 119.25 -18.87 10.16 Favored Glycine 0 C--O 1.251 1.169 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.529 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.45 147.05 5.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.94 129.24 35.3 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -124.41 160.71 27.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.391 0.615 . . . . 0.0 111.901 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.8 m -121.16 145.02 48.26 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 124.471 1.108 . . . . 0.0 108.721 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.536 HD21 ' HB2' ' A' ' 160' ' ' HIS . 2.3 tm? -103.65 119.37 38.77 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.444 HG21 ' HB1' ' A' ' 7' ' ' ALA . 48.5 t -123.73 130.97 73.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.964 0.412 . . . . 0.0 112.071 -175.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.419 ' CG2' ' HB ' ' A' ' 111' ' ' THR . 17.4 m -125.38 142.84 40.96 Favored 'Isoleucine or valine' 0 C--O 1.254 1.326 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -71.65 -59.38 2.78 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.9 t -153.43 106.46 2.94 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 170.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.502 ' ND2' ' HA ' ' A' ' 145' ' ' GLN . 28.1 t-20 -103.9 -74.59 0.64 Allowed 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -100.11 -26.39 13.97 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.164 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -148.79 156.07 41.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.3 m -84.74 131.89 34.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.601 0.239 . . . . 0.0 111.113 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 70.12 71.32 0.22 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.812 1.245 . . . . 0.0 111.967 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.419 ' HB ' ' CG2' ' A' ' 103' ' ' VAL . 34.7 m -111.56 107.92 17.25 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.563 176.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.443 HG21 HG23 ' A' ' 4' ' ' THR . 61.5 mt -117.55 103.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.0 tp -123.46 124.49 43.0 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.307 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.2 140.82 56.1 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.695 0.76 . . . . 0.0 112.894 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.84 -57.16 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.136 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.77 -152.89 17.45 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.0 123.82 11.81 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 123.007 2.472 . . . . 0.0 112.306 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 27.3 m -96.97 157.63 3.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.9 p -133.29 164.83 26.21 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.647 0.379 . . . . 0.0 111.23 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 56.5 ttp -82.04 136.0 35.27 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -99.58 -52.79 3.38 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.521 0.677 . . . . 0.0 110.248 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.98 -110.53 3.76 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.817 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.0 tp -110.91 118.7 36.81 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mm -123.62 121.15 61.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 130' ' ' PRO . 47.2 t-20 -100.32 109.13 21.32 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 69.0 tp -129.17 126.75 39.93 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.4 t 60.93 47.92 7.15 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.974 0.91 . . . . 0.0 109.151 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.8 m 61.55 13.28 5.05 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.117 1.367 . . . . 0.0 112.108 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.7 m -117.72 109.51 41.47 Favored Pre-proline 0 N--CA 1.425 -1.691 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.243 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 125' ' ' ASN . 60.8 Cg_endo -76.68 122.62 6.49 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.385 2.057 . . . . 0.0 110.558 176.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.5 m -122.2 127.41 49.96 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.458 ' HB2' HG21 ' A' ' 68' ' ' ILE . 64.1 t30 -111.51 158.96 18.56 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 111.133 0.049 . . . . 0.0 111.133 -174.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 61.7 50.94 4.13 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 122.968 1.366 . . . . 0.0 111.334 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 90.2 mmm -113.87 157.03 22.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.029 -1.896 . . . . 0.0 110.258 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.539 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 12.4 tt -107.37 147.16 12.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.557 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 39.3 ttp85 -126.89 140.95 51.97 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.268 0.627 . . . . 0.0 110.207 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -150.31 148.77 29.24 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.488 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.92 111.48 18.83 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -164.47 146.47 8.56 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.21 93.1 1.42 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.1 t -87.96 145.29 26.09 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.141 -174.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 145' ' ' GLN . 17.8 tppt? -134.73 125.46 27.05 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.2 m -73.29 124.83 26.46 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.59 -41.46 1.28 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.502 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 3.4 pt20 -84.07 42.86 0.89 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.456 1.122 . . . . 0.0 109.604 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 33.4 m -82.82 147.06 28.58 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.835 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.19 7.18 59.67 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -68.92 119.63 9.95 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.04 108.17 6.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 37.0 tp -84.53 107.9 17.01 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.1 p -142.1 164.9 28.92 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.266 0.555 . . . . 0.0 112.049 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.39 178.17 7.61 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.5 t -60.96 102.88 0.22 Allowed 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.756 0.788 . . . . 0.0 111.669 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 84.08 6.23 86.74 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.02 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -134.02 126.55 30.44 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 117.331 0.566 . . . . 0.0 111.275 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 76.2 mt -112.81 122.12 66.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -97.48 -22.17 16.72 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.883 0.373 . . . . 0.0 111.169 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 149.75 -163.8 29.4 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.551 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 148' ' ' GLY . 27.3 pt -128.21 134.11 65.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 120.989 0.424 . . . . 0.0 111.324 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.536 ' HB2' HD21 ' A' ' 101' ' ' LEU . 36.4 t-80 -60.52 133.32 55.98 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 124.852 1.261 . . . . 0.0 111.925 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.33 -6.73 11.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.916 0.389 . . . . 0.0 110.884 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 123.47 -158.59 18.09 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.448 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 156.79 178.13 30.59 Favored Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -134.23 119.08 18.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 100.72 -123.04 7.81 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.433 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -113.26 6.59 17.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.891 0.377 . . . . 0.0 111.472 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -112.76 113.87 26.17 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.478 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.16 133.1 11.62 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -111.32 137.79 48.62 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.555 0.693 . . . . 0.0 109.93 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.539 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 16.2 m -135.41 153.31 51.84 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.915 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.444 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -81.43 132.94 35.34 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -64.7 -9.22 18.39 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.8 mt 49.32 29.39 2.71 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -40.49 121.4 1.41 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.546 1.139 . . . . 0.0 110.632 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -53.58 -25.71 18.47 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.424 ' O ' HG12 ' A' ' 179' ' ' VAL . 28.5 pt20 -63.56 -17.17 62.55 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 123.71 0.804 . . . . 0.0 112.672 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.3 m-30 -73.63 -23.32 59.87 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.758 -0.589 . . . . 0.0 111.012 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.41 12.05 34.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -170.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 176' ' ' GLN . 12.0 p -110.94 132.8 58.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.84 -39.27 80.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.014 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -77.02 109.5 10.9 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 . . . . . 0 C--O 1.248 1.025 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.838 -171.745 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.391 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.06 -22.78 75.78 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.754 2.303 . . . . 0.0 111.429 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -61.97 -39.5 92.36 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.13 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -69.21 -40.41 78.01 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.572 0.749 . . . . 0.0 109.462 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.76 -44.18 96.86 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.479 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -67.19 -50.26 61.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.254 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.41 84.49 Favored 'General case' 0 C--O 1.209 -1.037 0 C-N-CA 123.204 0.602 . . . . 0.0 111.845 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.01 -39.57 95.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.017 0.437 . . . . 0.0 111.101 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 m -74.86 -32.81 61.99 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.72 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.417 HD11 HD13 ' A' ' 86' ' ' ILE . 57.5 tp -73.38 -40.67 64.16 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.484 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.587 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 2.2 tm? -54.4 -52.89 60.3 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.256 1.422 . . . . 0.0 111.82 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -66.44 -7.59 20.48 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -170.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -126.29 -51.66 1.52 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -104.73 -2.87 24.33 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -170.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.587 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 56.5 mt -114.42 104.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.6 tpt -135.74 154.78 51.14 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.833 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.402 HG23 ' HA ' ' A' ' 105' ' ' SER . 28.4 m -75.39 115.82 15.46 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.071 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 mt -99.58 99.74 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p -80.24 101.62 8.98 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.756 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 82.6 p -89.27 -166.15 1.52 Allowed 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.81 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -73.85 -20.91 60.3 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.879 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -101.18 -49.52 4.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.59 -157.12 8.52 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 118.82 -1.657 . . . . 0.0 113.537 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -109.38 94.72 5.18 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -100.69 160.77 14.09 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.9 m -99.49 123.69 43.98 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.3 123.68 7.94 Favored Glycine 0 N--CA 1.411 -2.996 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.8 tp -101.29 112.84 25.46 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.993 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.45 135.59 16.74 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.1 -50.88 6.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 117.716 0.758 . . . . 0.0 110.74 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -146.14 110.17 4.95 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.754 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.585 ' OD2' ' HG3' ' A' ' 33' ' ' ARG . 24.9 t70 56.73 -81.17 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 171.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.585 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -116.37 0.94 12.95 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.436 0.636 . . . . 0.0 111.61 179.478 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.0 t -88.57 114.9 27.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.914 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.1 t -125.95 144.63 50.61 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.84 139.86 29.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -148.89 143.5 17.17 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.49 154.72 73.27 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.957 1.772 . . . . 0.0 110.872 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -68.76 -42.15 77.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.563 0.697 . . . . 0.0 109.814 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -73.89 20.38 0.1 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.4 -23.36 21.08 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.319 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.568 ' O ' ' HB ' ' A' ' 20' ' ' THR . 24.6 mm-40 69.4 66.0 0.49 Allowed Pre-proline 0 N--CA 1.486 1.362 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -94.95 135.58 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 122.615 2.21 . . . . 0.0 110.816 172.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.71 -146.8 17.34 Favored Glycine 0 C--N 1.314 -0.652 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.966 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.14 -43.0 55.03 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.621 0.724 . . . . 0.0 109.258 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -123.65 139.63 53.8 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.9 p -125.95 153.04 33.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -92.35 120.41 32.85 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.83 85.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 175.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 t30 70.79 -10.13 0.76 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.509 1.123 . . . . 0.0 112.085 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.73 -39.21 0.57 Allowed Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -78.37 126.78 31.27 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -90.91 146.89 23.52 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.497 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.5 tp -132.64 135.22 57.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -86.19 139.25 31.24 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.186 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -78.01 137.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.506 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -87.63 -48.86 7.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -164.01 151.16 11.97 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.28 101.01 7.87 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.531 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 84.4 m-85 -81.79 125.95 31.27 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.96 116.13 24.0 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -77.43 108.7 10.78 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.553 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.96 130.8 72.28 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -80.75 139.53 50.56 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -56.01 -12.25 6.96 Favored 'Trans proline' 0 CA--C 1.555 1.539 0 C-N-CA 123.725 2.95 . . . . 0.0 114.484 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -83.22 -4.07 58.04 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 121.997 0.903 . . . . 0.0 108.698 174.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.5 t30 67.73 70.29 0.34 Allowed 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.19 1.396 . . . . 0.0 110.257 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.3 mt -141.73 145.1 24.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 131' ' ' THR . 17.1 m120 -76.74 161.65 28.32 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.573 0.546 . . . . 0.0 111.264 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -129.29 -32.07 2.03 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.604 174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 71.17 4.22 4.98 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 123.052 1.406 . . . . 0.0 110.204 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.428 HD13 HD23 ' A' ' 173' ' ' LEU . 70.7 mt -94.96 119.05 32.84 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.045 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.7 m -110.89 117.6 33.82 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 96.7 t -79.52 109.36 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.4 tp -87.01 99.46 11.91 Favored 'General case' 0 N--CA 1.397 -3.123 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.886 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.0 m -85.39 105.5 16.07 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.7 mt -90.34 164.49 14.32 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.473 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.26 130.13 36.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -59.54 99.69 0.07 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.808 0.843 . . . . 0.0 111.878 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -115.51 -65.69 1.16 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -100.94 109.41 21.33 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.419 ' HG3' ' OD1' ' A' ' 32' ' ' ASP . 53.6 tttm -69.4 116.82 10.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.041 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -70.21 145.88 51.11 Favored 'General case' 0 C--O 1.263 1.772 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -66.9 143.59 56.75 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.62 82.56 2.63 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.157 0.503 . . . . 0.0 111.22 -176.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.417 HD13 HD11 ' A' ' 10' ' ' LEU . 47.9 pt -89.83 11.1 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.685 0.755 . . . . 0.0 109.527 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.583 ' O ' ' HE2' ' A' ' 175' ' ' LYS . 57.4 ttp180 -66.85 -24.23 66.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.515 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.44 -24.41 75.1 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.406 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -86.46 -4.74 59.22 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 116.991 0.396 . . . . 0.0 111.167 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 173' ' ' LEU . 87.3 mt -61.92 121.1 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.8 m -99.61 108.93 21.43 Favored 'General case' 0 N--CA 1.382 -3.827 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.346 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -71.45 -25.15 62.18 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.32 111.7 22.6 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.907 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.409 HD11 ' CG ' ' A' ' 172' ' ' GLN . 72.9 mt -107.91 -66.5 1.03 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.515 ' CB ' ' HA ' ' A' ' 119' ' ' THR . 16.5 pt-20 -74.96 152.67 38.78 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -162.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.03 -19.1 38.61 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 114.064 -1.426 . . . . 0.0 111.016 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.6 t -94.37 139.32 18.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.776 0.322 . . . . 0.0 110.316 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.51 119.11 20.64 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 174.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -110.78 164.52 12.68 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.03 0.919 . . . . 0.0 113.453 -174.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.433 HG21 HG23 ' A' ' 112' ' ' ILE . 62.4 m -122.2 140.01 53.09 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.449 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -106.71 122.6 46.68 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.47 121.25 66.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 120.861 0.362 . . . . 0.0 110.044 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.71 145.05 22.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.403 ' HB3' HG22 ' A' ' 15' ' ' ILE . 65.8 t60 -135.65 90.99 2.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.863 0.839 . . . . 0.0 110.433 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.402 ' HA ' HG23 ' A' ' 17' ' ' THR . 25.7 p -120.17 -170.75 2.03 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -87.55 -31.52 19.86 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -70.85 -50.61 33.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.541 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -113.4 86.59 2.42 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.1 m -95.44 109.22 21.44 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.442 -176.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 71.37 35.01 1.6 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.864 0.727 . . . . 0.0 110.788 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.9 m -75.93 105.63 7.08 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 100' ' ' THR . 65.2 mt -103.54 105.93 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.795 -177.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 tp -118.74 118.82 32.63 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 120.715 0.293 . . . . 0.0 111.537 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -74.97 119.65 19.43 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -95.39 -35.31 5.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.22 -170.61 20.79 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.022 -1.085 . . . . 0.0 111.943 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.75 119.46 6.4 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.15 2.567 . . . . 0.0 111.303 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.4 m -82.32 151.74 4.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.515 ' HA ' ' CB ' ' A' ' 95' ' ' GLU . 8.9 t -141.97 163.48 32.77 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 47.7 tpp -86.19 134.86 33.76 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.701 0.286 . . . . 0.0 110.301 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.19 -25.29 14.94 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.11 -94.4 1.58 Allowed Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.554 ' O ' HD12 ' A' ' 123' ' ' LEU . 4.1 pp -147.02 119.66 8.55 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.21 0.528 . . . . 0.0 110.383 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.3 tt 176.0 147.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 129' ' ' THR . 48.5 t-20 -158.4 -86.16 0.04 OUTLIER 'General case' 0 C--O 1.241 0.636 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -129.68 108.39 10.16 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -171.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.4 p 43.69 73.12 0.15 Allowed 'General case' 0 C--O 1.248 0.991 0 C-N-CA 124.746 1.219 . . . . 0.0 113.999 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.5 m 65.13 24.62 12.42 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.231 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.432 ' O ' ' HB3' ' A' ' 125' ' ' ASN . 32.1 m -111.46 102.9 54.31 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.88 125.74 3.23 Favored 'Trans proline' 0 N--CA 1.431 -2.199 0 C-N-CA 121.819 1.679 . . . . 0.0 112.917 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 2.0 p -100.16 130.48 46.3 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -72.04 132.95 44.94 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -172.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 172' ' ' GLN . 36.1 mmt180 58.97 50.89 7.78 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.656 1.182 . . . . 0.0 110.507 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.3 tpt -79.53 118.86 21.77 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.134 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.564 HG23 ' HB2' ' A' ' 170' ' ' SER . 12.4 tt -90.39 138.17 20.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.257 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -127.83 146.23 50.67 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.803 -169.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -147.5 136.64 22.34 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.138 0.975 . . . . 0.0 108.704 175.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -98.96 110.24 22.88 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 122.239 1.019 . . . . 0.0 110.176 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -171.81 134.13 0.78 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.53 90.1 0.25 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.906 0.86 . . . . 0.0 110.805 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 m -104.64 140.07 38.57 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -62.87 103.45 0.45 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.814 0.816 . . . . 0.0 110.741 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.0 m -74.96 116.94 16.26 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.792 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.39 -25.0 2.02 Favored Glycine 0 C--N 1.312 -0.787 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.737 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -83.1 50.7 1.79 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.248 1.023 . . . . 0.0 110.343 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 30.8 m -60.09 137.67 58.05 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.395 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 109.99 -5.17 30.5 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.358 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.2 134.94 25.35 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.658 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.8 p -76.83 126.41 37.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.522 0.677 . . . . 0.0 110.611 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 51.8 tp -94.57 108.62 20.58 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.9 p -144.7 175.61 10.04 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.239 0.542 . . . . 0.0 111.714 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -154.86 -177.9 6.84 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 175.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.1 t -64.21 103.07 0.58 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.586 0.708 . . . . 0.0 111.386 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.37 26.37 66.01 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.741 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 59.9 mmtt -143.22 114.43 7.86 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.12 0.568 . . . . 0.0 110.626 -177.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 89.2 mt -113.5 123.95 69.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 169.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -99.49 -27.6 13.64 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.503 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 149.88 -149.58 21.52 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.5 pt -131.26 149.11 32.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 117.134 0.467 . . . . 0.0 111.21 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -68.56 115.77 8.34 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.841 0.856 . . . . 0.0 109.129 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.2 t -97.81 -36.44 5.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.07 -149.66 8.96 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -177.41 163.07 31.41 Favored Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -142.58 121.88 13.08 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.19 -126.42 9.41 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -104.6 2.34 30.58 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -92.89 112.64 24.68 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.081 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.18 135.0 13.37 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -117.52 119.8 36.15 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 122.122 0.963 . . . . 0.0 110.962 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.564 ' HB2' HG23 ' A' ' 135' ' ' ILE . 20.8 m -119.7 154.53 33.96 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -104.35 144.7 31.28 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.212 -177.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 133' ' ' ARG . 0.7 OUTLIER -81.89 118.1 22.66 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.189 0.93 . . . . 0.0 108.986 -177.802 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.428 HD23 HD13 ' A' ' 72' ' ' LEU . 66.9 mt -93.16 74.41 4.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -67.69 146.07 54.16 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.586 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.583 ' HE2' ' O ' ' A' ' 87' ' ' ARG . 94.7 mttt -57.36 -31.0 65.31 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.807 0.813 . . . . 0.0 110.324 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -68.69 -9.01 47.76 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.743 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -92.56 -23.26 19.12 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 121.921 -0.487 . . . . 0.0 110.05 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -102.17 18.82 19.91 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.217 -174.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 27.3 m -80.71 152.17 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.048 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -89.1 -40.81 12.67 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -84.52 104.21 14.32 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.683 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 . . . . . 0 C--N 1.31 -1.133 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.072 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.714 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.71 -49.04 4.61 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.509 2.139 . . . . 0.0 112.143 -175.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -67.53 -37.01 82.11 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.064 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -62.35 -49.58 75.0 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.65 0.78 . . . . 0.0 109.789 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.09 -43.99 90.33 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.949 0.9 . . . . 0.0 110.015 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -58.46 -47.73 83.05 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.007 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -62.39 -48.16 80.96 Favored 'General case' 0 C--O 1.206 -1.185 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.964 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.05 -41.77 88.69 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.304 0.642 . . . . 0.0 110.321 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.0 m -65.29 -43.38 91.34 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.999 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.476 HD11 HD13 ' A' ' 86' ' ' ILE . 59.8 tp -66.53 -43.53 84.93 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.954 0.901 . . . . 0.0 109.666 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 16.5 tp -49.57 -59.57 3.65 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 126.134 1.774 . . . . 0.0 112.755 -176.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -80.49 11.07 3.95 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.141 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -123.01 -56.66 1.74 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.67 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -119.3 4.63 11.24 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 33.4 mt -99.66 98.16 6.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.747 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.92 144.17 30.19 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.369 -175.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 45.5 m -79.95 115.31 19.45 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 172.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.8 mt -115.14 107.46 22.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.438 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.3 m -89.78 113.25 24.76 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 76.7 p -93.87 -157.46 0.55 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.595 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -83.32 0.72 44.57 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -112.52 -52.23 2.79 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.812 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' THR . . . -175.15 -160.14 22.51 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 119.823 -1.179 . . . . 0.0 111.943 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.14 105.88 18.11 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.82 169.42 8.85 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.5 m -99.69 123.45 43.97 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.13 118.89 6.11 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.1 tp -98.38 113.89 26.03 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.504 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.18 112.66 3.84 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.6 mm -86.65 -52.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 116.564 0.182 . . . . 0.0 110.789 -176.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -162.19 141.65 9.62 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.34 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 16.1 t70 59.37 -90.98 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 175.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -135.6 9.08 3.37 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.278 1.037 . . . . 0.0 108.709 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.482 HG13 ' CG1' ' A' ' 74' ' ' VAL . 53.9 t -80.72 108.81 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.777 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.0 m -113.01 145.47 40.79 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.424 ' CG1' HD21 ' A' ' 72' ' ' LEU . 48.8 t -112.5 133.97 56.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 O-C-N 122.185 -0.322 . . . . 0.0 111.29 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 tt -153.88 145.17 16.43 Favored Pre-proline 0 CA--C 1.566 1.571 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.616 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 31.3 Cg_exo -65.16 150.18 87.97 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.356 2.037 . . . . 0.0 113.009 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.0 m -58.1 -43.01 86.89 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.6 0.76 . . . . 0.0 112.686 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -69.59 -1.65 9.39 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.65 -32.7 62.34 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.431 ' O ' ' HB ' ' A' ' 20' ' ' THR . 77.9 mt-30 52.15 82.48 0.24 Allowed Pre-proline 0 C--O 1.248 1.024 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.46 143.13 16.96 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.965 2.443 . . . . 0.0 110.559 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.59 -136.41 7.54 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.559 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.33 -31.03 30.1 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 5.2 p-10 -136.55 153.4 51.0 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.24 -1.345 . . . . 0.0 107.622 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.53 158.39 42.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 76.7 mt -99.48 103.08 14.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 17' ' ' THR . 72.6 t -83.45 91.73 2.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 175.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 62.78 15.81 8.48 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.079 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.01 -18.36 7.95 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.251 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -84.63 119.73 25.56 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.262 0.225 . . . . 0.0 110.772 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -71.74 119.05 15.36 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.959 0.409 . . . . 0.0 111.986 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.451 HD11 ' O ' ' A' ' 78' ' ' ASP . 16.7 tt -132.72 139.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 174.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 41.7 mtp180 -82.25 157.45 23.89 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.527 0.679 . . . . 0.0 112.481 -177.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.58 140.4 16.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.439 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -93.8 -54.24 3.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' H ' ' HB ' ' A' ' 76' ' ' THR . 7.5 t70 -146.24 165.73 28.35 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -140.38 95.1 2.82 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.0 m-85 -83.3 100.59 10.73 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.7 102.3 2.27 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 tt -83.39 102.83 12.3 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-O 122.065 0.936 . . . . 0.0 109.143 -171.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 67.3 t -109.86 139.52 32.71 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.05 141.64 86.26 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.7 -10.22 2.34 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 123.513 2.808 . . . . 0.0 114.838 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -97.5 7.24 46.86 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 121.676 0.75 . . . . 0.0 109.862 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 73.61 23.26 2.44 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.123 1.369 . . . . 0.0 114.394 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.3 mm -96.89 140.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 131' ' ' THR . 5.0 m-20 -66.24 133.32 50.36 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 120.892 0.377 . . . . 0.0 111.341 -177.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 133' ' ' ARG . 58.7 tp -94.37 -15.36 24.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 170.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 61.58 27.28 16.8 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.986 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.424 HD21 ' CG1' ' A' ' 36' ' ' VAL . 2.7 tm? -125.07 140.84 52.54 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.171 -173.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.419 ' N ' HD13 ' A' ' 72' ' ' LEU . 93.9 m -134.32 130.2 36.64 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.373 0.606 . . . . 0.0 110.264 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 51.5 t -87.02 108.7 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -89.5 113.56 24.96 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -175.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.413 ' HB ' ' H ' ' A' ' 58' ' ' ASP . 16.3 m -90.66 97.46 11.19 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.401 HD11 ' CG2' ' A' ' 54' ' ' ILE . 17.6 tp -78.11 150.16 33.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.451 ' O ' HD11 ' A' ' 54' ' ' ILE . 35.5 t70 -79.91 95.77 6.18 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 119.019 -1.073 . . . . 0.0 109.765 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' A' ' 79' ' ' ARG . 4.4 mmp_? -133.12 110.07 9.92 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.315 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -85.92 -28.25 24.45 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 168.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -78.2 91.02 4.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 171.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 24.3 pttm -78.53 150.81 32.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -170.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -86.82 160.46 18.76 Favored 'General case' 0 C--O 1.256 1.403 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.811 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -81.35 140.97 34.45 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 5.5 p-10 -76.32 106.74 8.12 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 122.376 1.084 . . . . 0.0 110.19 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.476 HD13 HD11 ' A' ' 10' ' ' LEU . 22.7 pt -88.13 17.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 122.192 0.996 . . . . 0.0 109.468 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -63.21 -27.51 69.41 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.812 -1.54 . . . . 0.0 111.947 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.61 -16.82 78.99 Favored Glycine 0 C--N 1.317 -0.483 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.708 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -93.36 -3.4 53.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.731 0.3 . . . . 0.0 110.384 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.5 mt -66.08 135.72 27.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.155 0.502 . . . . 0.0 110.564 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.8 t -125.63 103.75 8.01 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -87.54 -8.59 56.15 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.593 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.24 123.15 36.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.414 HD11 ' CD ' ' A' ' 172' ' ' GLN . 20.1 mt -106.38 -71.06 0.76 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -164.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 11.1 pt-20 -50.45 137.09 19.62 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -165.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.34 -14.05 33.26 Favored Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.658 174.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.05 144.06 18.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 122.415 -0.462 . . . . 0.0 110.368 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.13 116.87 21.25 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.28 159.5 14.95 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.396 0.617 . . . . 0.0 110.731 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.2 m -129.39 133.52 47.41 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.37 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.7 mt -90.91 125.72 35.84 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.422 ' HB ' ' CG1' ' A' ' 149' ' ' VAL . 30.5 t -117.69 107.63 22.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.414 HG22 ' HA3' ' A' ' 148' ' ' GLY . 10.6 t -109.02 147.71 13.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.534 ' CE1' HG23 ' A' ' 109' ' ' THR . 2.6 t-80 -140.0 106.91 5.41 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.41 ' HA ' HG23 ' A' ' 17' ' ' THR . 52.8 p -128.74 -170.47 2.27 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -89.91 -34.94 15.87 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 176.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -63.06 -45.5 91.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.788 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . 0.265 9.3 p90 -133.53 96.55 3.73 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.603 1.192 . . . . 0.0 112.509 175.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.534 HG23 ' CE1' ' A' ' 104' ' ' HIS . 90.8 m -83.43 122.58 28.69 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.943 178.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.01 71.24 0.52 Allowed 'General case' 0 C--O 1.245 0.867 0 C-N-CA 124.321 1.048 . . . . 0.0 112.867 176.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.5 m -102.15 99.15 9.25 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.998 176.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.4 mt -95.19 110.62 24.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.7 tp -128.9 108.23 10.26 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.864 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -68.28 124.9 24.77 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.0 m -99.05 -27.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.613 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.92 -164.8 12.19 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 119.81 -1.186 . . . . 0.0 112.119 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.08 129.98 19.33 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.014 2.476 . . . . 0.0 112.668 -177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 31.2 m -96.27 161.54 2.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.381 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.8 p -144.35 164.69 30.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.738 1.215 . . . . 0.0 108.683 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 52.2 ttm -86.93 139.28 30.78 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.637 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -105.37 -40.57 5.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.739 0.305 . . . . 0.0 111.465 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.73 -113.51 3.7 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.606 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.7 mt -93.22 120.6 33.68 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.009 0.524 . . . . 0.0 110.049 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm -131.71 134.42 60.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -94.67 86.39 4.75 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp -88.04 105.84 17.74 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.862 -175.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.1 m 61.9 39.14 13.94 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.829 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.5 t 73.89 11.45 4.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.748 1.219 . . . . 0.0 112.039 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.5 m -108.81 115.97 56.55 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.24 106.97 2.27 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 121.997 1.798 . . . . 0.0 111.434 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 22.3 p -109.1 135.03 50.91 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.814 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -111.27 164.35 12.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.447 ' HG3' ' HB2' ' A' ' 172' ' ' GLN . 12.7 tpp180 66.38 27.49 9.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.577 1.151 . . . . 0.0 108.976 173.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.2 mmt -79.57 150.44 31.08 Favored 'General case' 0 C--O 1.251 1.152 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.429 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.541 HG23 ' HB2' ' A' ' 170' ' ' SER . 8.6 tt -115.57 141.87 30.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 173.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.637 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 39.4 ttt180 -127.25 139.34 52.98 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 123.216 0.606 . . . . 0.0 111.319 -171.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -149.23 144.02 26.27 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.01 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.67 107.41 19.16 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.886 0.741 . . . . 0.0 110.171 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -173.02 138.17 0.75 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.75 92.08 2.45 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.511 0.672 . . . . 0.0 110.103 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.2 t -79.19 165.92 22.75 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.531 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -120.25 163.13 18.24 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.6 t -78.56 153.63 31.05 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.78 -9.11 63.97 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -89.32 4.5 48.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.204 0.526 . . . . 0.0 111.315 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.616 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 48.0 t -58.11 120.74 9.15 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.453 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.43 -12.52 56.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.02 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.414 ' HA3' HG22 ' A' ' 103' ' ' VAL . . . -68.29 131.99 27.63 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.456 ' HA ' HG22 ' A' ' 159' ' ' ILE . 7.4 p -70.21 124.59 26.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.699 0.761 . . . . 0.0 111.219 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.1 tp -94.2 98.71 11.14 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 22.6 p -140.07 156.44 46.58 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.312 0.577 . . . . 0.0 111.586 -174.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -121.24 -173.18 2.56 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 t -71.75 79.51 0.85 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.005 0.907 . . . . 0.0 112.952 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 105.91 8.96 33.39 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.98 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -137.31 104.44 5.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 84.4 mt -93.86 120.14 42.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -94.82 -34.06 12.62 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.577 0.703 . . . . 0.0 110.538 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 165.19 -149.08 15.15 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.309 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' A' ' 149' ' ' VAL . 46.0 pt -135.01 149.21 28.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -66.63 133.36 50.12 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.295 0.638 . . . . 0.0 110.71 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 86.6 t -108.46 -59.69 3.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.09 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -159.58 153.39 24.42 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.282 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -115.56 125.86 6.88 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.409 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -112.24 97.49 6.67 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.7 -113.33 5.19 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -99.91 -6.35 26.85 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.963 0.411 . . . . 0.0 110.497 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -96.18 102.35 14.13 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.343 0.592 . . . . 0.0 110.792 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.24 119.7 4.96 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -105.41 123.84 48.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.854 0.835 . . . . 0.0 110.213 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.541 ' HB2' HG23 ' A' ' 135' ' ' ILE . 14.6 m -123.94 166.17 16.14 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.908 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.517 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -98.42 131.0 45.04 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.447 ' HB2' ' HG3' ' A' ' 133' ' ' ARG . 46.5 mt-30 -73.39 121.54 20.64 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 123.869 0.73 . . . . 0.0 109.885 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.414 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 89.0 mt -95.44 85.0 4.1 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -72.34 146.02 47.39 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.458 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -65.7 -24.99 67.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -48.18 -39.1 19.84 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.232 1.813 . . . . 0.0 111.56 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -83.35 -9.9 58.79 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.05 -0.406 . . . . 0.0 111.477 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -122.42 18.16 10.54 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 121.126 -0.229 . . . . 0.0 111.157 -174.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.8 m -60.98 134.93 26.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-O 121.845 0.831 . . . . 0.0 111.662 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -79.28 -27.07 42.26 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.864 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 181' ' ' LYS . 0.1 OUTLIER -106.79 123.77 48.64 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.324 175.148 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 C--N 1.299 -1.603 0 CA-C-O 118.307 -0.854 . . . . 0.0 109.118 -179.36 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.544 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -63.11 -27.21 73.24 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.856 2.371 . . . . 0.0 111.304 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -66.92 -34.21 77.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.738 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.9 m -67.64 -43.68 79.76 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.672 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.54 -43.0 95.36 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.929 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -61.4 -45.48 94.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.02 82.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.01 0.433 . . . . 0.0 111.269 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.5 -44.02 75.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.986 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 p -73.78 -34.53 64.71 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 120.722 0.296 . . . . 0.0 111.594 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.35 -40.72 95.32 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.737 0.815 . . . . 0.0 109.494 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.5 tp -48.97 -61.0 2.3 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 125.209 1.403 . . . . 0.0 113.649 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -80.91 11.85 3.69 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -172.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -127.0 -53.57 1.41 Allowed 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.16 0.505 . . . . 0.0 111.512 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -107.01 -9.6 16.18 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -171.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.3 mt -105.05 125.65 60.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 120.731 0.3 . . . . 0.0 110.932 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.08 135.73 27.6 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.934 0.397 . . . . 0.0 111.131 177.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.465 ' HA ' HG22 ' A' ' 26' ' ' THR . 4.5 m -68.1 132.78 47.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.662 176.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.89 113.1 31.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 121.002 0.43 . . . . 0.0 110.161 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 24.9 m -78.08 104.83 8.89 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.6 p -90.89 -165.11 1.28 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.412 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.1 m -84.7 -7.6 59.16 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 121.049 0.452 . . . . 0.0 111.028 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -108.98 -46.21 3.65 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.223 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -166.17 -173.08 34.25 Favored Glycine 0 CA--C 1.497 -1.07 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.198 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -98.94 97.22 8.42 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -104.91 -173.69 2.36 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.55 HG23 ' HA ' ' A' ' 105' ' ' SER . 2.2 p -124.52 145.28 49.65 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.58 150.26 18.7 Favored Glycine 0 N--CA 1.412 -2.964 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -107.48 118.81 37.71 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.75 119.9 5.1 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mm -83.66 -49.38 16.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 117.205 0.503 . . . . 0.0 109.656 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -170.56 157.12 5.7 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.174 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 5.3 m-20 53.75 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.292 1.037 . . . . 0.0 112.974 177.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -139.16 11.77 2.6 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.672 0.749 . . . . 0.0 109.078 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.0 t -88.25 112.79 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.893 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.4 m -128.82 152.85 48.03 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.426 ' HB ' HD11 ' A' ' 72' ' ' LEU . 29.9 m -115.65 148.97 18.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.0 tp -151.96 148.62 21.87 Favored Pre-proline 0 CA--C 1.564 1.499 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -67.26 147.77 79.06 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 121.92 1.746 . . . . 0.0 111.899 174.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.8 m -66.11 -41.36 90.67 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.036 0.446 . . . . 0.0 112.202 -176.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -65.76 -13.26 59.05 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.73 -26.95 63.61 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 62.79 87.37 0.13 Allowed Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.622 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.12 151.23 15.97 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 122.325 2.017 . . . . 0.0 110.066 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.14 -168.88 24.03 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.49 -13.47 59.82 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.205 0.526 . . . . 0.0 111.885 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -148.08 138.82 23.07 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.61 160.65 42.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 81.2 mt -93.31 107.68 19.46 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.3 p -90.07 84.22 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-O 122.864 1.316 . . . . 0.0 109.354 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.5 t30 62.36 20.69 12.01 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.614 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.87 -47.85 0.98 Allowed Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.545 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -66.9 124.7 23.7 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -80.22 123.23 27.76 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.432 HD11 ' O ' ' A' ' 78' ' ' ASP . 8.6 tp -122.35 125.68 73.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 55' ' ' ARG . 53.5 mtt180 -72.88 123.83 24.19 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.478 0.656 . . . . 0.0 109.379 175.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.0 t -93.66 116.23 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 28.7 ttpp -68.4 -72.09 0.19 Allowed 'General case' 0 C--N 1.293 -1.883 0 O-C-N 123.499 0.499 . . . . 0.0 111.023 -175.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.4 m-20 -108.63 146.12 33.87 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 122.039 -0.413 . . . . 0.0 110.925 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -116.69 102.7 9.66 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.56 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 91.7 m-85 -89.56 94.63 9.94 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.613 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -71.18 98.64 1.73 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 174.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.526 HD23 HD23 ' A' ' 72' ' ' LEU . 36.3 tp -77.05 108.15 9.92 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 122.252 1.025 . . . . 0.0 112.563 -167.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.84 151.09 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.796 0 CA-C-N 113.415 -1.72 . . . . 0.0 107.225 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.39 140.11 89.91 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.13 -21.36 9.06 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.496 2.798 . . . . 0.0 114.821 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.22 8.54 23.58 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.053 0.454 . . . . 0.0 110.978 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.2 t30 73.36 68.03 0.11 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.821 1.649 . . . . 0.0 112.004 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.512 HG21 ' HB2' ' A' ' 132' ' ' ASN . 55.0 mt -143.2 147.3 20.56 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -90.52 156.1 18.41 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.418 1.008 . . . . 0.0 111.987 -174.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' A' ' 133' ' ' ARG . 8.7 mp -112.33 -11.73 13.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.479 174.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 68.26 25.07 7.27 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 123.267 1.508 . . . . 0.0 108.284 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.526 HD23 HD23 ' A' ' 62' ' ' LEU . 58.3 tp -125.19 142.08 51.71 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.417 -1.719 . . . . 0.0 109.426 -174.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.0 m -135.82 134.04 38.48 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 43.2 t -102.08 125.67 56.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.37 138.19 42.99 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.106 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.2 m -98.65 99.16 10.25 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.8 mt -80.44 104.97 11.34 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.432 ' O ' HD11 ' A' ' 54' ' ' ILE . 33.9 t70 -81.36 92.82 6.47 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -146.49 175.25 10.71 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.77 -22.75 23.13 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -78.97 123.07 26.93 Favored 'General case' 0 C--O 1.247 0.969 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.012 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 20.4 pttp -100.22 139.51 35.78 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.051 -177.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -75.78 157.11 33.86 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.477 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -64.97 131.34 46.36 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.966 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.58 93.29 2.01 Favored 'General case' 0 C--O 1.2 -1.549 0 CA-C-O 122.029 0.918 . . . . 0.0 112.565 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.4 pt -96.24 21.27 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 O-C-N 120.83 -1.168 . . . . 0.0 109.584 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -69.4 -31.71 70.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.664 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -79.73 -7.37 88.56 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.129 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 64.7 m-85 -97.94 -0.8 44.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.245 0.545 . . . . 0.0 109.897 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.57 116.94 8.03 Favored 'Isoleucine or valine' 0 C--O 1.254 1.316 0 CA-C-O 121.229 0.538 . . . . 0.0 110.853 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.6 t -102.26 107.15 18.1 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.53 ' HG2' ' HA ' ' A' ' 174' ' ' LYS . 32.5 mt-10 -87.95 -6.56 57.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -95.15 118.01 31.21 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 175.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.444 HD11 ' CD ' ' A' ' 172' ' ' GLN . 12.8 mt -116.11 -60.56 1.85 Allowed 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.968 0.89 . . . . 0.0 110.966 -170.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 34.5 tt0 -64.8 120.04 11.75 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.651 -167.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 112.36 -22.1 18.33 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.529 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.1 t -91.57 141.42 14.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.82 123.96 28.68 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -110.43 158.58 18.32 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.674 0.749 . . . . 0.0 111.355 -177.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.8 m -123.86 123.96 41.6 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.858 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.6 tp -95.78 116.32 28.72 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.42 104.15 14.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.513 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 93.5 t -84.21 115.51 26.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.422 ' CD2' HG21 ' A' ' 26' ' ' THR . 37.2 p-80 -153.17 156.6 38.9 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.55 ' HA ' HG23 ' A' ' 26' ' ' THR . 78.1 p -175.49 -152.69 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -84.61 -25.87 28.28 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 119.273 0.942 . . . . 0.0 108.585 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -87.48 -48.86 7.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.98 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -94.39 144.14 25.81 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 23.4 m -148.81 124.42 10.42 Favored 'General case' 0 C--N 1.281 -2.403 0 O-C-N 121.356 -0.84 . . . . 0.0 110.311 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.63 30.86 20.51 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.068 0.855 . . . . 0.0 113.073 173.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.513 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 95.3 m -83.88 87.35 7.09 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-O 122.08 0.943 . . . . 0.0 108.741 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 75.4 mt -77.16 102.22 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.174 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.3 tp -109.51 103.83 12.78 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.104 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -76.13 121.6 23.08 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.9 m -104.19 -10.16 9.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.11 -153.12 24.23 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.632 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.29 124.87 11.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.544 2.163 . . . . 0.0 112.704 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 16.6 m -92.58 160.12 2.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.199 177.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.407 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . 13.9 p -130.91 159.11 38.38 Favored 'General case' 0 C--O 1.251 1.169 0 O-C-N 123.346 0.404 . . . . 0.0 111.155 -177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 25.3 ttt -79.65 118.06 21.13 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -75.4 -42.17 54.43 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 176.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.2 -100.21 2.65 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.171 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 124' ' ' ILE . 7.1 tt -130.52 145.56 51.88 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.46 ' N ' HD23 ' A' ' 123' ' ' LEU . 14.8 tt -138.35 138.07 43.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -100.69 115.24 29.78 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.7 mt -112.59 89.58 3.11 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.649 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.4 p 50.13 75.78 0.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.646 1.178 . . . . 0.0 113.075 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.7 t 65.51 3.69 2.48 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.136 0.974 . . . . 0.0 112.115 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.4 m -116.51 101.94 53.53 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.43 129.13 15.39 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 121.61 1.54 . . . . 0.0 110.858 178.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.8 m -119.28 133.39 55.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.512 ' HB2' HG21 ' A' ' 68' ' ' ILE . 57.0 t30 -131.08 170.72 14.14 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HB2' ' HG ' ' A' ' 70' ' ' LEU . 30.6 mmt180 64.48 41.62 5.51 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.211 1.004 . . . . 0.0 108.925 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.524 ' SD ' ' HB3' ' A' ' 169' ' ' PHE . 48.3 ttm -109.56 149.63 29.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.634 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 170' ' ' SER . 13.2 tt -115.19 147.61 18.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 123.765 0.826 . . . . 0.0 108.856 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.57 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 43.7 ttp180 -127.62 143.95 51.12 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.116 0.484 . . . . 0.0 111.089 -174.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -149.14 136.23 19.9 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 171.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.97 91.01 7.07 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.867 1.317 . . . . 0.0 111.905 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -156.3 125.88 6.28 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.93 89.79 1.43 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.531 0.52 . . . . 0.0 110.624 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.0 p -79.27 170.1 17.12 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.885 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -110.14 141.8 42.52 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.346 0.593 . . . . 0.0 111.423 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.8 m -71.22 125.98 28.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 125.52 -25.32 5.68 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -174.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -87.16 24.31 1.6 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.6 m -75.39 128.13 34.68 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.55 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.74 1.4 49.43 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.264 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.79 135.8 28.74 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 86.5 t -90.32 120.09 38.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 CA-C-O 121.18 0.514 . . . . 0.0 110.58 -174.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.4 tp -92.1 106.71 18.66 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.9 p -142.22 -178.9 5.95 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.306 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.75 -175.42 5.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.3 m -61.02 101.8 0.17 Allowed 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 122.602 0.361 . . . . 0.0 111.617 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 73.11 22.7 78.79 Favored Glycine 0 C--O 1.244 0.734 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.12 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 58.2 mttp -140.81 114.17 8.66 Favored 'General case' 0 C--O 1.206 -1.213 0 O-C-N 122.887 -0.184 . . . . 0.0 111.115 -175.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.29 126.85 57.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.08 -38.07 9.89 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.719 0.771 . . . . 0.0 109.504 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 165.11 -160.22 33.48 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.849 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.74 145.29 33.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 120.704 0.288 . . . . 0.0 110.402 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -66.13 130.98 45.09 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.88 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.0 t -95.9 -56.68 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.43 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.17 164.09 29.26 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.03 125.35 8.54 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -111.16 81.75 1.49 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.93 -123.65 6.38 Favored Glycine 0 N--CA 1.422 -2.235 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -89.17 -13.94 37.21 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.208 0.527 . . . . 0.0 109.7 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -98.26 122.85 41.94 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.065 0.459 . . . . 0.0 111.424 -177.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.19 121.99 6.54 Favored Glycine 0 N--CA 1.422 -2.245 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.524 ' HB3' ' SD ' ' A' ' 134' ' ' MET . 84.3 m-85 -108.82 134.91 50.87 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.435 0.636 . . . . 0.0 110.993 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.486 ' HB2' HG23 ' A' ' 135' ' ' ILE . 18.8 m -133.11 158.99 41.4 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.966 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.498 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -92.71 140.9 29.05 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.444 ' CD ' HD11 ' A' ' 94' ' ' LEU . 78.6 mt-30 -84.58 124.49 31.48 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 121.475 0.655 . . . . 0.0 111.325 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.456 HD23 HD21 ' A' ' 72' ' ' LEU . 98.2 mt -93.63 92.78 7.7 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.53 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 68.2 mttm -87.09 150.45 23.99 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.509 ' O ' HG13 ' A' ' 179' ' ' VAL . 10.0 ptpp? -77.12 -13.68 59.91 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.958 -176.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -58.81 -22.43 58.51 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.602 1.161 . . . . 0.0 111.11 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 174' ' ' LYS . 45.5 m-85 -91.1 -8.74 47.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.196 0.522 . . . . 0.0 110.331 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -119.58 10.93 11.91 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.547 -175.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 175' ' ' LYS . 31.6 m -97.5 160.91 2.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -74.84 -43.75 52.86 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -121.16 144.89 48.34 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 . . . . . 0 C--N 1.31 -1.111 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.73 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.626 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -40.17 -56.84 1.35 Allowed 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 124.858 3.705 . . . . 0.0 115.477 -174.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -59.14 -49.84 76.32 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.7 m -64.8 -39.54 93.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.89 0.476 . . . . 0.0 111.088 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.79 -41.79 78.23 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.006 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -62.35 -43.4 98.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.66 98.45 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.114 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.06 -33.06 75.14 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-O 121.246 0.546 . . . . 0.0 111.187 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -71.32 -53.57 13.74 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.9 tp -53.86 -44.37 70.3 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.8 0.84 . . . . 0.0 109.891 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.498 ' HA ' HD12 ' A' ' 15' ' ' ILE . 44.4 tp -51.65 -58.46 6.29 Favored 'General case' 0 C--O 1.206 -1.191 0 C-N-CA 125.522 1.529 . . . . 0.0 112.644 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -87.73 0.2 56.06 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -172.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -112.81 -44.1 3.35 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -121.75 3.49 10.07 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 11' ' ' LEU . 59.0 mt -112.72 130.23 66.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.166 0.508 . . . . 0.0 110.52 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.75 165.51 26.25 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.398 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.7 m -98.99 118.34 35.54 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.63 120.87 55.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.487 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 24.1 m -79.9 101.39 8.55 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.352 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.2 p -104.53 -174.31 2.51 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.281 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -75.16 -35.0 61.65 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -91.03 3.54 54.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.23 -174.32 27.96 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.167 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 19' ' ' THR . 38.8 mt-10 -112.51 94.3 4.85 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -92.63 179.86 5.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.504 -171.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 20.3 m -86.61 124.28 32.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.719 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.0 130.81 10.38 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 175.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.0 tp -110.16 119.09 38.17 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.964 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.08 123.5 6.23 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 174.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mm -87.52 -44.11 15.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -171.85 144.18 1.73 Allowed 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.534 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.508 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 37.1 t70 60.32 -89.24 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.657 1.223 . . . . 0.0 112.083 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.652 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 36.0 ptt180 -140.25 11.13 2.36 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.998 0.904 . . . . 0.0 109.937 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.0 t -79.88 112.97 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.237 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 m -123.29 151.69 42.15 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 124.013 0.821 . . . . 0.0 110.235 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 74' ' ' VAL . 21.9 t -125.77 141.85 44.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.7 tt -157.22 150.61 18.88 Favored Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -71.6 155.31 59.31 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.019 1.812 . . . . 0.0 112.202 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.6 m -71.16 -33.14 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.266 -0.271 . . . . 0.0 110.301 -177.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -66.15 -2.76 4.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.28 -28.23 59.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 69.38 81.06 0.2 Allowed Pre-proline 0 C--O 1.232 0.144 0 C-N-CA 125.336 1.454 . . . . 0.0 112.559 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -96.96 171.2 0.86 Allowed 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.777 2.318 . . . . 0.0 111.788 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.72 -143.31 6.95 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -91.1 -29.96 17.01 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.671 0.748 . . . . 0.0 110.075 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -141.23 135.33 30.6 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.75 -172.62 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.392 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.7 mt -113.25 128.14 56.38 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.39 96.88 4.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 58.29 20.37 7.16 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.188 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.02 -36.3 2.87 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.347 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -74.54 134.45 42.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.705 0.253 . . . . 0.0 110.832 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -75.83 111.89 11.67 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.52 HD11 ' O ' ' A' ' 78' ' ' ASP . 11.1 tp -120.14 140.22 44.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.074 0.464 . . . . 0.0 111.142 -174.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.529 ' N ' ' HD2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -97.85 138.84 34.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.8 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 75' ' ' LEU . 48.4 t -100.32 109.63 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -70.02 -71.77 0.22 Allowed 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.904 0.753 . . . . 0.0 110.564 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' H ' ' HB ' ' A' ' 76' ' ' THR . 20.8 m-20 -102.98 141.36 35.92 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -126.95 96.15 4.54 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -96.1 107.59 19.93 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -93.55 116.71 29.23 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' HB3' HD12 ' A' ' 70' ' ' LEU . 4.2 mm? -77.69 115.1 17.18 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.786 0.803 . . . . 0.0 111.534 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.21 145.5 32.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.466 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 14.7 t70 -70.99 145.81 92.07 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -46.33 -31.36 9.29 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.784 2.989 . . . . 0.0 113.981 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -82.5 5.9 19.2 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.03 0.443 . . . . 0.0 111.553 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 71.24 68.58 0.17 Allowed 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 125.281 1.432 . . . . 0.0 111.122 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 67.6 mt -131.16 139.87 49.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' A' ' 131' ' ' THR . 4.5 m-20 -73.55 137.85 44.6 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -176.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' A' ' 62' ' ' LEU . 72.2 mt -111.49 -2.16 15.61 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 63.72 -21.68 0.06 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 127.222 2.209 . . . . 0.0 113.812 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 70' ' ' LEU . 82.8 mt -70.28 118.98 13.79 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.17 0.51 . . . . 0.0 111.618 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.9 m -112.71 115.93 29.33 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 36' ' ' VAL . 59.0 t -100.99 121.53 51.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.45 ' HB3' HG13 ' A' ' 56' ' ' VAL . 2.4 mm? -113.53 133.19 55.38 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.492 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.513 ' HB ' ' H ' ' A' ' 58' ' ' ASP . 96.0 m -86.08 82.85 7.93 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 169.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.652 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 18.8 tp -76.87 132.18 39.0 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.52 ' O ' HD11 ' A' ' 54' ' ' ILE . 27.8 t70 -76.22 77.52 3.02 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 117.669 -1.612 . . . . 0.0 112.336 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -96.37 94.89 7.7 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -68.8 -12.71 61.81 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.449 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -98.29 100.97 12.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.496 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 8.2 ptpp? -62.43 136.83 58.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -172.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -81.62 152.79 27.0 Favored 'General case' 0 C--O 1.257 1.456 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.529 175.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -69.86 144.56 52.49 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.625 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.01 97.45 1.88 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.916 0.865 . . . . 0.0 111.49 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.3 pt -91.2 18.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 121.596 0.712 . . . . 0.0 110.403 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -69.41 -30.87 68.92 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.774 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.39 -10.82 86.02 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.44 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -97.76 -5.18 35.54 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.7 mt -70.39 113.53 6.6 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 CA-C-O 121.301 0.572 . . . . 0.0 111.317 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -104.09 93.73 5.0 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.42 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 5.6 pt-20 -90.93 1.6 56.89 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.905 0.86 . . . . 0.0 111.049 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -97.17 110.2 22.79 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 167.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.509 HD13 ' HB ' ' A' ' 135' ' ' ILE . 6.4 mt -106.38 -57.36 2.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -164.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -42.02 113.94 0.49 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.445 1.498 . . . . 0.0 114.499 -168.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 -13.22 65.53 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.858 -1.064 . . . . 0.0 113.624 174.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 40.3 t -91.23 141.86 13.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 117.143 0.472 . . . . 0.0 110.68 -177.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -75.31 146.25 41.15 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.69 0.796 . . . . 0.0 111.614 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -138.61 170.46 15.97 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.053 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.5 m -135.39 148.47 49.37 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 tp -108.98 121.11 44.44 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 109.373 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.06 105.83 19.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.5 t -105.27 127.55 59.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -136.55 87.7 2.32 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 29.4 p -115.87 -172.38 2.15 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -79.49 -44.86 20.45 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 117.763 -1.575 . . . . 0.0 107.414 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.64 -42.19 78.36 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.809 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -105.89 91.39 3.72 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.0 m -87.76 100.38 12.8 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.591 -175.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 70.0 71.29 0.23 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.211 1.005 . . . . 0.0 113.203 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.1 m -108.83 95.33 5.58 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.6 mt -95.78 96.02 5.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.1 tp -113.42 123.42 50.03 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.977 -173.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.91 145.04 55.87 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.69 -39.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.559 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.62 -164.02 19.81 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.71 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 51.9 Cg_exo -58.38 129.35 32.27 Favored 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 123.712 2.941 . . . . 0.0 113.163 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.9 m -104.31 163.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.188 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.436 ' O ' HG13 ' A' ' 135' ' ' ILE . 42.8 p -129.61 174.75 9.38 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -116.71 131.35 56.97 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -93.57 -36.42 12.41 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.816 0.341 . . . . 0.0 111.227 -175.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.8 -105.76 3.19 Favored Glycine 0 CA--C 1.486 -1.74 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.82 138.58 51.01 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.464 HG13 ' HG3' ' A' ' 134' ' ' MET . 2.8 pp -128.09 141.37 46.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -102.46 105.07 15.58 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.1 tp -112.03 109.38 19.1 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.6 m 64.02 32.98 12.57 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.859 0.838 . . . . 0.0 108.911 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.7 t 69.92 12.38 7.87 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.637 -1.62 . . . . 0.0 111.513 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.3 m -97.04 108.61 44.82 Favored Pre-proline 0 N--CA 1.428 -1.534 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.32 120.99 5.85 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.677 1.584 . . . . 0.0 111.222 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 9.9 m -119.12 129.55 55.11 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -113.52 165.36 12.56 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.154 0.582 . . . . 0.0 109.944 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? 72.03 28.44 2.53 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.309 1.444 . . . . 0.0 109.402 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.464 ' HG3' HG13 ' A' ' 124' ' ' ILE . 95.4 mmm -86.92 126.24 34.56 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.616 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.585 HG23 ' HB3' ' A' ' 170' ' ' SER . 2.8 tt -99.26 143.77 12.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 43.4 ttp180 -132.28 139.79 48.37 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.95 0.405 . . . . 0.0 111.138 -170.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.485 ' CE1' ' HA3' ' A' ' 168' ' ' GLY . 37.0 p90 -140.41 135.86 32.49 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -93.72 117.31 29.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -176.09 143.52 0.55 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.74 92.86 0.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.911 0.862 . . . . 0.0 110.861 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.2 m -121.25 138.38 54.26 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -108.6 152.27 25.01 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.882 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -74.06 154.47 39.2 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 109.54 -16.67 31.45 Favored Glycine 0 C--N 1.307 -1.08 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -173.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -92.22 21.65 5.0 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 37.3 m -68.22 135.73 52.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.174 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.563 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 95.94 -4.74 65.78 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.15 135.82 30.09 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.24 115.22 25.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.278 0.561 . . . . 0.0 110.664 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.3 tp -85.38 101.53 12.66 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 18.0 p -151.73 168.94 23.46 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.675 0.75 . . . . 0.0 111.958 -172.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.85 -177.9 6.05 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.9 t -60.12 105.42 0.4 Allowed 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.976 0.893 . . . . 0.0 112.03 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.17 19.1 78.39 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.555 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -141.44 92.59 2.48 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 116.826 0.313 . . . . 0.0 110.683 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.3 mt -99.56 122.8 51.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -95.74 -36.12 11.29 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.591 0.71 . . . . 0.0 110.43 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.478 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 165.2 -156.33 28.24 Favored Glycine 0 N--CA 1.424 -2.166 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.663 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.9 pt -124.02 145.09 31.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -69.9 131.11 43.93 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 123.279 0.631 . . . . 0.0 110.135 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.65 11.11 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.762 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -129.86 -119.38 2.13 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.213 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 103.68 51.09 0.98 Allowed Glycine 0 CA--C 1.494 -1.261 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -106.92 96.81 6.7 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.83 -109.43 2.83 Favored Glycine 0 C--N 1.314 -0.668 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 41.3 mtm105 -111.38 14.67 21.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.017 0.437 . . . . 0.0 109.91 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -112.26 110.12 20.18 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.129 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' A' ' 137' ' ' TYR . . . -90.99 112.16 4.08 Favored Glycine 0 N--CA 1.411 -2.989 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -101.6 130.18 47.88 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.585 ' HB3' HG23 ' A' ' 135' ' ' ILE . 29.8 t -129.94 158.9 38.26 Favored 'General case' 0 C--N 1.265 -3.096 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.53 137.18 49.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -70.67 116.6 11.17 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 123.821 0.701 . . . . 0.0 112.174 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.478 HD13 ' HA2' ' A' ' 158' ' ' GLY . 10.2 mp -85.63 81.3 8.7 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.503 175.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -67.53 129.4 39.79 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.42 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 7.8 ptpp? -63.3 -16.21 59.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.768 0.318 . . . . 0.0 111.485 -177.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -58.37 -29.66 66.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.4 1.08 . . . . 0.0 110.73 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -80.75 -17.33 51.29 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.331 0.586 . . . . 0.0 110.29 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -111.68 0.33 16.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.284 -173.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.18 108.6 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 CA-C-O 121.891 0.853 . . . . 0.0 109.027 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.88 -48.06 40.61 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.165 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -117.79 115.79 25.7 Favored 'General case' 0 N--CA 1.405 -2.685 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.531 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 . . . . . 0 N--CA 1.424 -1.741 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 173.19 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.783 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.74 -46.7 30.36 Favored 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 123.07 2.514 . . . . 0.0 112.827 -176.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -68.67 -39.66 80.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.956 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m -65.02 -46.71 80.23 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 122.938 0.495 . . . . 0.0 110.76 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.89 -29.17 58.38 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -63.91 -49.64 71.87 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.77 86.02 Favored 'General case' 0 C--O 1.194 -1.822 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.621 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.8 tp -57.47 -52.02 67.09 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.404 0.681 . . . . 0.0 111.446 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -67.9 -31.03 70.53 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.453 0.644 . . . . 0.0 110.302 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.7 tp -70.34 -52.94 18.99 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.42 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.487 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.4 tp -53.1 -54.5 34.68 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 126.344 1.858 . . . . 0.0 113.123 -176.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.2 mtp85 -62.21 -7.16 3.76 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -171.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -137.56 -50.65 0.62 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.416 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -91.36 -7.16 51.66 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -167.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 60.1 mt -115.89 113.58 43.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 42.1 ttm -140.37 136.98 33.69 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.771 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 50.7 m -63.6 135.31 56.7 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.202 0.601 . . . . 0.0 111.394 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 75.5 mt -129.11 126.53 64.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 92.1 m -89.6 110.24 21.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 72.4 p -91.99 -162.52 0.93 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.796 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 t -83.14 -1.14 52.13 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -104.51 -55.95 2.26 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.92 -158.02 21.18 Favored Glycine 0 CA--C 1.502 -0.727 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.817 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -89.85 113.58 25.2 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 116.773 0.287 . . . . 0.0 110.928 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -122.45 -172.65 2.51 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 104' ' ' HIS . 8.8 t -128.23 138.65 52.54 Favored 'General case' 0 N--CA 1.403 -2.79 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.257 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.96 148.59 18.22 Favored Glycine 0 N--CA 1.418 -2.54 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -111.08 118.32 35.68 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.61 111.55 3.44 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.3 mm -77.46 -45.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 85' ' ' ASP . 1.5 p-80 -179.58 161.54 1.04 Allowed 'General case' 0 CA--C 1.484 -1.585 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.601 177.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 52.17 -104.94 0.2 Allowed 'General case' 0 CA--C 1.554 1.125 0 O-C-N 124.511 1.132 . . . . 0.0 112.732 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -119.43 5.48 11.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.063 0.459 . . . . 0.0 109.872 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.1 t -85.59 107.54 16.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.704 -174.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -119.13 141.72 48.56 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.429 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.1 t -117.73 140.53 40.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 122.904 0.481 . . . . 0.0 111.536 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.424 HG22 HD21 ' A' ' 75' ' ' LEU . 15.6 tt -156.69 147.71 16.54 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 175.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 72.1 Cg_exo -55.87 154.4 26.96 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.736 2.291 . . . . 0.0 112.503 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -79.19 -28.86 42.68 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.099 -0.376 . . . . 0.0 111.407 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -73.31 -7.13 50.27 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.068 0.461 . . . . 0.0 111.178 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.78 -19.55 60.16 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.502 ' O ' ' HB ' ' A' ' 20' ' ' THR . 78.1 mt-30 53.11 78.61 0.39 Allowed Pre-proline 0 C--O 1.247 0.942 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 177.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -84.79 146.14 10.39 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.134 1.889 . . . . 0.0 110.097 173.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.81 -143.19 14.03 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.139 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -94.43 -20.53 19.63 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.16 0.505 . . . . 0.0 110.841 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -146.19 135.13 22.52 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.51 165.76 29.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 123.508 0.505 . . . . 0.0 110.408 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 78.3 mt -97.12 104.72 16.76 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -90.28 85.85 2.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 122.372 1.082 . . . . 0.0 109.739 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.8 t30 66.76 14.96 10.01 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.514 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.51 -50.48 0.82 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.86 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.07 132.59 48.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.825 0.45 . . . . 0.0 111.28 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -78.66 124.84 28.6 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 77' ' ' LEU . 9.8 tp -132.39 134.91 58.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.989 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -86.21 137.69 32.45 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.968 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.61 127.3 41.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -65.92 -62.8 1.3 Allowed 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.783 0.677 . . . . 0.0 109.661 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -152.87 148.44 27.16 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -132.93 151.55 52.03 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -172.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -125.37 123.18 38.8 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.933 -176.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -81.06 104.66 11.71 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 167.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.478 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 50.0 tp -88.44 111.24 21.56 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.33 179.91 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.813 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -77.19 140.66 65.97 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.79 -28.78 13.49 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.771 2.981 . . . . 0.0 114.766 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -87.9 10.41 18.81 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.472 0.653 . . . . 0.0 110.595 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.4 t30 65.49 70.15 0.45 Allowed 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 125.379 1.472 . . . . 0.0 111.274 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.8 mt -137.7 145.98 28.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' A' ' 131' ' ' THR . 58.6 t30 -65.73 132.5 48.9 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.997 0.427 . . . . 0.0 110.742 -176.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 50.6 tp -105.72 -7.11 18.6 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 14.8 tp10 62.9 28.55 16.4 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.844 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.51 125.35 47.63 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.104 -172.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.1 m -123.15 123.02 39.87 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.6 t -100.84 120.4 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.424 HD21 HG22 ' A' ' 37' ' ' ILE . 2.5 mm? -105.5 128.63 53.67 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.3 m -85.92 86.71 7.35 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.432 HD11 HG23 ' A' ' 54' ' ' ILE . 15.4 tp -86.34 120.3 27.54 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -175.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.451 ' O ' ' HD2' ' A' ' 79' ' ' ARG . 33.1 t70 -63.42 101.79 0.35 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.326 0.584 . . . . 0.0 111.116 -177.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 26.9 mmm180 -126.42 117.89 23.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -77.05 -37.37 54.82 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -97.11 104.89 16.95 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -93.87 154.13 17.89 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -168.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -74.82 170.21 16.35 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.287 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -85.92 143.8 28.0 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 31' ' ' HIS . 9.6 t70 -71.43 95.78 1.4 Allowed 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.043 0.925 . . . . 0.0 110.004 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.1 pt -86.82 9.37 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.117 0.961 . . . . 0.0 109.682 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -73.2 -28.08 61.98 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.32 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.54 -18.79 68.28 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.876 174.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -100.07 2.67 43.46 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 110.549 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.5 mt -76.43 127.15 37.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -94.66 112.68 24.43 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.2 0.52 28.1 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.179 -0.609 . . . . 0.0 112.311 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -113.76 122.57 47.5 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.08 -66.93 0.98 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -166.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -69.11 148.38 50.07 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -167.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.59 48.76 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 114.794 -1.093 . . . . 0.0 112.704 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.3 136.32 30.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 122.453 -0.439 . . . . 0.0 111.223 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.97 125.0 21.97 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.887 0.875 . . . . 0.0 109.974 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -120.2 161.03 21.75 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.518 0.675 . . . . 0.0 111.88 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 25.8 m -118.95 137.1 53.72 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 124.913 1.285 . . . . 0.0 107.941 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.3 tp -102.86 120.65 40.99 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 111' ' ' THR . 25.6 m -113.21 121.48 65.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.478 0.656 . . . . 0.0 110.715 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.45 143.88 37.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.311 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.465 ' O ' ' HB ' ' A' ' 26' ' ' THR . 17.4 t60 -146.94 90.56 1.91 Allowed 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.8 m -150.8 -177.91 6.27 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -64.47 -29.42 70.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.804 0.335 . . . . 0.0 111.044 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -59.76 -32.98 71.09 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.779 0.831 . . . . 0.0 112.046 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -175.73 128.47 0.24 Allowed 'General case' 0 C--O 1.245 0.845 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 p -93.14 123.41 36.39 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.45 ' OD1' HD21 ' A' ' 11' ' ' LEU . 93.8 m-20 65.0 71.0 0.46 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 90.8 m -115.52 117.83 31.46 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 174.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 66.4 mt -119.15 90.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.6 tp -127.16 132.66 50.47 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.522 -174.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 30.5 mp0 -66.35 136.65 56.1 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 124.266 1.027 . . . . 0.0 109.636 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.28 -7.65 12.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.46 -171.72 19.66 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.914 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.47 118.65 5.42 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.063 2.509 . . . . 0.0 112.038 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 150' ' ' LEU . 27.1 m -71.46 145.52 12.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.882 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.5 m -125.75 150.56 47.62 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 21.7 ttt -71.97 135.69 46.52 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.4 -40.76 6.93 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.2 -99.87 2.34 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tt -138.28 118.91 13.97 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.415 HG22 ' HG2' ' A' ' 134' ' ' MET . 10.8 tp -130.82 158.54 43.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 130' ' ' PRO . 10.1 p30 -114.14 114.75 26.48 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.419 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp -102.84 118.39 36.73 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.9 t 59.82 39.69 20.32 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.1 m 65.74 10.83 7.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.437 1.495 . . . . 0.0 112.971 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.8 m -101.74 108.03 54.28 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 125' ' ' ASN . 60.5 Cg_endo -73.49 124.66 9.53 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.096 1.864 . . . . 0.0 111.92 -178.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 15.9 p -115.22 125.22 53.1 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.517 177.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -101.1 155.5 17.96 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 69.18 36.66 2.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.565 1.146 . . . . 0.0 107.932 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.415 ' HG2' HG22 ' A' ' 124' ' ' ILE . 8.4 tpt -85.21 147.58 26.52 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.515 -175.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.488 HG23 ' HB2' ' A' ' 170' ' ' SER . 14.7 tt -130.11 144.42 38.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -143.62 165.17 28.35 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.315 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -145.98 149.34 33.97 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -89.16 104.06 16.63 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.092 0.948 . . . . 0.0 110.424 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -167.89 136.17 2.38 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.92 91.21 4.17 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.528 0.68 . . . . 0.0 110.304 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -104.38 161.6 13.93 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.694 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -92.45 176.89 6.3 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.1 t -115.13 168.26 10.09 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 94.21 -4.89 71.12 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.918 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.448 ' HB2' ' CD2' ' A' ' 160' ' ' HIS . 16.8 mt-30 -95.1 15.1 19.89 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 8.1 m -59.01 118.17 5.51 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.39 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 113.95 -2.48 24.27 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -176.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.77 148.69 43.67 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 174.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.428 ' HB ' ' CG2' ' A' ' 102' ' ' VAL . 28.4 t -93.59 122.86 45.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.276 0.56 . . . . 0.0 110.745 -175.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.41 HD21 HG11 ' A' ' 118' ' ' VAL . 49.4 tp -94.86 105.02 16.93 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 14.3 p -145.8 170.9 15.61 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.031 0.443 . . . . 0.0 112.11 -172.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.03 178.83 6.99 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.1 t -55.62 106.22 0.23 Allowed 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 121.86 0.838 . . . . 0.0 111.959 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.8 19.08 76.51 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.238 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -143.28 106.05 4.49 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -92.46 128.1 44.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -98.66 -38.16 9.23 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.425 0.631 . . . . 0.0 110.863 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.416 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 170.58 -159.84 32.25 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.454 -1.355 . . . . 0.0 112.387 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.508 HG23 HD11 ' A' ' 173' ' ' LEU . 25.8 pt -118.64 144.08 27.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 120.96 0.41 . . . . 0.0 110.533 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.448 ' CD2' ' HB2' ' A' ' 145' ' ' GLN . 52.8 t60 -74.56 132.2 41.61 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.698 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.25 -6.13 11.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.278 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 149.0 -154.56 25.88 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 119.859 -1.162 . . . . 0.0 112.429 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.67 160.66 25.13 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -155.96 118.25 4.09 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.72 -117.38 4.58 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 166' ' ' ARG . 20.7 mmt180 -110.62 8.31 22.71 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.061 0.458 . . . . 0.0 110.846 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -112.86 126.78 55.82 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.023 0.439 . . . . 0.0 110.416 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -99.85 138.23 13.73 Favored Glycine 0 CA--C 1.476 -2.361 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -113.5 132.81 55.54 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.773 0.797 . . . . 0.0 111.961 -173.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.488 ' HB2' HG23 ' A' ' 135' ' ' ILE . 54.3 m -141.08 164.2 30.91 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.821 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.31 138.4 47.83 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.436 ' OE1' ' HE3' ' A' ' 174' ' ' LYS . 79.5 mt-30 -74.41 116.99 15.71 Favored 'General case' 0 C--O 1.244 0.781 0 O-C-N 123.431 0.457 . . . . 0.0 111.253 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.508 HD11 HG23 ' A' ' 159' ' ' ILE . 63.6 mt -90.92 89.8 7.61 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.436 ' HE3' ' OE1' ' A' ' 172' ' ' GLN . 97.5 mttt -88.63 124.98 34.6 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.901 176.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -52.02 -17.73 1.14 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.136 1.374 . . . . 0.0 114.144 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -60.33 -27.76 67.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.406 1.082 . . . . 0.0 111.139 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -79.12 -19.27 51.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.802 0.334 . . . . 0.0 111.7 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -100.01 14.71 29.66 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.2 p -119.32 128.29 75.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -84.59 -14.36 49.0 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.086 0.469 . . . . 0.0 111.552 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -97.55 108.39 21.09 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.25 1.129 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.238 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.366 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.7 -31.87 68.93 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.652 2.235 . . . . 0.0 110.194 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -59.94 -36.33 76.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.919 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 m -70.05 -39.11 75.89 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 120.978 0.418 . . . . 0.0 110.133 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -69.94 -41.48 74.52 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.979 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -63.27 -42.74 99.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.501 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.43 -44.12 96.09 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.91 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.43 -48.53 81.35 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.096 0.559 . . . . 0.0 110.803 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 p -71.72 -37.58 70.59 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.9 tp -65.14 -45.98 82.78 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.624 0.77 . . . . 0.0 109.413 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.461 ' HA ' HD13 ' A' ' 15' ' ' ILE . 42.8 tp -48.7 -52.75 21.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.454 1.501 . . . . 0.0 112.526 -177.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -76.74 -3.1 36.4 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.86 -53.86 2.61 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.849 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -104.04 -17.25 15.03 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -169.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 11' ' ' LEU . 1.7 mp -87.35 113.27 24.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.542 0.687 . . . . 0.0 110.418 -178.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 90.3 mmm -116.16 153.28 32.1 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 m -101.11 121.54 41.99 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -112.61 123.8 68.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 O-C-N 121.928 -0.482 . . . . 0.0 111.603 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 18.5 m -80.82 102.9 10.29 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.254 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.2 p -102.31 -169.46 1.67 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -72.78 -20.54 61.15 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.997 0.427 . . . . 0.0 110.685 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -100.43 3.34 43.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.996 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.89 -175.62 16.53 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.994 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 30.7 mp0 -83.5 115.83 22.27 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 146' ' ' CYS . 72.8 m-85 -122.36 -175.14 3.06 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 25.5 m -91.4 130.24 37.27 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.9 128.26 7.59 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -100.18 119.49 38.43 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.03 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.97 115.43 4.02 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 174.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.9 mm -84.52 -55.43 6.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 117.018 0.409 . . . . 0.0 111.169 -173.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -163.0 150.54 13.3 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.574 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 23.2 t70 54.7 -99.87 0.1 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.449 1.093 . . . . 0.0 111.98 173.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.574 ' HG2' ' OD2' ' A' ' 32' ' ' ASP . 14.1 ptp180 -126.65 14.56 7.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.697 0.76 . . . . 0.0 110.073 177.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.9 t -92.25 115.93 32.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.211 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -124.55 151.03 45.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.33 141.16 47.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 117.82 0.282 . . . . 0.0 111.752 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.3 tt -155.15 142.07 13.53 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 99.2 Cg_exo -49.03 144.17 16.42 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 123.702 2.935 . . . . 0.0 115.467 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.406 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 27.6 m -65.74 -37.21 85.76 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.432 -176.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -63.61 -5.08 3.46 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.38 -18.05 29.23 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 54.94 86.77 0.16 Allowed Pre-proline 0 C--O 1.242 0.697 0 C-N-CA 124.959 1.304 . . . . 0.0 112.93 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -81.47 127.68 5.88 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.982 1.788 . . . . 0.0 110.119 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.54 -176.63 47.61 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.099 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -67.1 -37.2 83.51 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 120.855 0.36 . . . . 0.0 110.487 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 5.5 p-10 -130.69 114.54 15.52 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.841 0.829 . . . . 0.0 109.716 175.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.94 176.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.162 -174.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 57.8 mt -113.34 112.65 24.05 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.38 89.36 2.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.2 t30 59.57 30.92 20.59 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.287 1.435 . . . . 0.0 109.981 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.41 -33.71 5.0 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.045 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -71.52 118.54 14.46 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.457 0.303 . . . . 0.0 111.081 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 53' ' ' LYS . 12.1 mptt -75.25 132.92 41.41 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.405 HD13 ' HE ' ' A' ' 79' ' ' ARG . 6.6 tp -153.28 132.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.869 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 33.7 ttt85 -90.79 134.72 34.22 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -78.02 119.84 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.77 -66.72 0.85 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -102.66 128.47 49.34 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -106.15 118.21 36.03 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.436 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.1 m-85 -114.78 94.45 4.77 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -75.57 118.78 18.79 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.79 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.448 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 3.5 mm? -87.4 83.77 7.27 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-O 122.842 1.305 . . . . 0.0 112.699 -177.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.51 148.71 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 172.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.46 135.45 41.08 Favored Pre-proline 0 C--N 1.269 -2.897 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.2 -25.32 4.37 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 124.034 3.156 . . . . 0.0 114.766 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -81.63 16.27 1.82 Allowed 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.976 -0.453 . . . . 0.0 111.582 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.0 m120 75.87 17.77 2.19 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.664 1.586 . . . . 0.0 112.383 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.3 mt -95.87 120.14 44.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -78.07 156.23 30.15 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 122.132 -0.355 . . . . 0.0 111.699 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 60.4 tp -121.68 -9.96 8.83 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 13.6 tp10 65.44 20.01 11.67 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.931 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.21 144.89 41.92 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.323 -0.861 . . . . 0.0 110.577 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.4 m -124.0 117.79 25.53 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 54.5 t -94.61 118.51 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 CA-C-O 121.709 0.766 . . . . 0.0 108.999 177.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 74.2 mt -106.08 124.0 48.9 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.268 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 m -97.24 98.34 9.92 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -70.79 136.47 48.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.227 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.541 ' HA ' ' NH1' ' A' ' 33' ' ' ARG . 38.7 t70 -84.41 73.87 10.44 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.623 1.202 . . . . 0.0 110.137 177.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.405 ' HE ' HD13 ' A' ' 54' ' ' ILE . 24.1 mmt180 -127.47 132.59 50.0 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.191 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -79.49 -20.75 46.51 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.39 109.85 9.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.281 -1.327 . . . . 0.0 107.848 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -106.78 170.73 7.77 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -113.37 169.33 9.04 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.411 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -73.5 125.7 28.55 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -72.81 104.78 4.11 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.21 1.005 . . . . 0.0 111.331 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.5 pt -94.12 21.93 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.959 0.885 . . . . 0.0 109.675 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -63.14 -32.98 74.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.602 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.49 0.42 89.17 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 116.178 -0.465 . . . . 0.0 113.507 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -103.77 -2.49 26.31 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 117.251 0.526 . . . . 0.0 110.551 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.67 126.68 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.342 0.591 . . . . 0.0 110.126 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.7 t -104.1 107.68 18.68 Favored 'General case' 0 N--CA 1.397 -3.099 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -87.03 -4.53 59.17 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.176 0.989 . . . . 0.0 108.488 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -94.17 115.82 28.15 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.445 HD21 ' CG ' ' A' ' 172' ' ' GLN . 26.3 mt -110.65 -63.32 1.41 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -169.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 17.0 pt-20 -58.26 121.99 12.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -168.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.28 -8.62 24.74 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.14 -0.936 . . . . 0.0 113.417 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.435 ' O ' HG22 ' A' ' 118' ' ' VAL . 21.9 t -108.81 144.65 16.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 117.34 0.57 . . . . 0.0 110.324 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.09 127.4 35.12 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -112.54 160.67 17.59 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.986 0.898 . . . . 0.0 112.042 -176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.1 m -122.73 137.65 54.85 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 tp -103.95 109.27 20.97 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.6 t -103.93 116.38 47.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.347 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.495 HG12 ' CA ' ' A' ' 148' ' ' GLY . 28.3 m -122.0 151.91 25.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.282 0.563 . . . . 0.0 111.473 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -149.39 68.4 1.03 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 m -93.99 -150.25 0.29 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.57 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 22.2 t-20 -73.18 -66.12 0.72 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.582 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -81.2 -36.85 29.58 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.48 86.09 6.68 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.392 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.5 p -97.15 117.2 30.82 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.21 42.97 5.13 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.448 1.118 . . . . 0.0 108.698 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.452 ' HB ' ' CG2' ' A' ' 103' ' ' VAL . 23.8 m -94.89 106.67 18.67 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.328 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.4 mt -97.86 98.45 7.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.5 tp -114.94 122.87 47.61 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.225 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -83.38 134.02 34.91 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 122.282 -0.261 . . . . 0.0 110.342 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 m -108.58 -14.49 9.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -175.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.97 -160.12 19.44 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.061 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.75 127.22 12.8 Favored 'Trans proline' 0 C--O 1.243 0.772 0 C-N-CA 123.498 2.799 . . . . 0.0 112.502 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 97' ' ' VAL . 27.5 m -96.9 157.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.458 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.434 ' O ' HG13 ' A' ' 135' ' ' ILE . 7.1 p -139.72 173.05 11.93 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 124.373 1.069 . . . . 0.0 108.542 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -92.01 128.8 37.98 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -83.17 -38.53 22.21 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.177 0.513 . . . . 0.0 111.624 -174.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 132' ' ' ASN . . . 82.93 -102.78 2.41 Favored Glycine 0 N--CA 1.421 -2.355 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -176.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.78 133.06 54.25 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.717 0.77 . . . . 0.0 112.136 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.428 HG23 ' HB ' ' A' ' 131' ' ' THR . 7.2 tp -126.84 129.4 71.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 168.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -112.99 126.54 55.61 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.707 -173.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -110.22 96.89 6.5 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.7 m 56.23 65.85 1.34 Allowed 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.823 0.849 . . . . 0.0 111.095 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.7 t 64.86 -3.78 0.54 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.752 1.221 . . . . 0.0 112.721 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.1 m -95.99 113.85 62.98 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.89 137.9 11.33 Favored 'Trans proline' 0 N--CA 1.441 -1.598 0 C-N-CA 122.591 2.194 . . . . 0.0 113.582 -175.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.428 ' HB ' HG23 ' A' ' 124' ' ' ILE . 25.1 m -119.54 116.79 26.79 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 171.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 51.8 t30 -115.4 163.61 15.47 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.417 -173.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 73.7 28.11 1.67 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.106 1.362 . . . . 0.0 109.36 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.421 ' HG3' HG22 ' A' ' 124' ' ' ILE . 91.2 mmm -88.09 158.3 18.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.745 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.606 HG23 ' HB2' ' A' ' 170' ' ' SER . 7.7 tt -116.33 138.73 45.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 122.927 0.491 . . . . 0.0 109.951 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 66.4 ttt180 -118.57 139.74 51.0 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.158 0.983 . . . . 0.0 111.975 -170.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.404 ' HB3' HG12 ' A' ' 118' ' ' VAL . 45.4 p90 -149.7 147.97 28.71 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -93.66 103.07 15.25 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -168.36 125.37 1.06 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.07 94.83 1.55 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.512 0.673 . . . . 0.0 109.769 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.0 t -80.03 176.06 10.08 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.001 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -119.94 156.36 30.96 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.7 m -76.04 114.9 15.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.01 -15.56 2.15 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.94 11.87 5.61 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.754 -0.262 . . . . 0.0 111.011 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 43.3 t -58.17 122.34 12.9 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.049 0.54 . . . . 0.0 110.083 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 86.32 10.02 75.03 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.233 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.495 ' CA ' HG12 ' A' ' 103' ' ' VAL . . . -72.16 137.17 24.78 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.437 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 25.4 t -79.08 107.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.186 0.517 . . . . 0.0 109.947 -177.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.6 tp -87.64 102.65 14.82 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 16.9 p -147.09 168.19 22.22 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.473 -173.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -137.89 -174.59 3.83 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 174.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 t -63.37 100.35 0.24 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 121.89 0.853 . . . . 0.0 112.058 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.87 10.22 85.9 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.198 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -128.91 98.28 4.91 Favored 'General case' 0 C--O 1.208 -1.118 0 O-C-N 122.491 -0.417 . . . . 0.0 109.969 -174.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 74.6 mt -99.02 117.81 44.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -90.53 -39.88 12.31 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.458 0.647 . . . . 0.0 110.365 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.444 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 164.92 -152.94 22.85 Favored Glycine 0 N--CA 1.422 -2.266 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.11 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 148' ' ' GLY . 28.1 pt -129.18 146.61 33.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.93 0.365 . . . . 0.0 110.808 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.41 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 46.9 t-80 -69.48 134.48 48.95 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.446 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.1 t -99.84 -71.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.722 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.29 127.39 1.39 Allowed Glycine 0 N--CA 1.424 -2.125 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.25 153.15 20.67 Favored Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.693 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -131.7 100.57 5.16 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.75 -122.54 5.93 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -90.7 -12.16 37.51 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.041 0.448 . . . . 0.0 110.53 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -98.77 111.71 24.01 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.161 -175.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.61 119.99 5.43 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -105.97 116.65 32.3 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.573 0.701 . . . . 0.0 110.959 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.606 ' HB2' HG23 ' A' ' 135' ' ' ILE . 39.4 m -117.62 167.37 11.39 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.25 142.1 43.9 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 118.433 0.56 . . . . 0.0 110.374 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.666 ' OE1' ' HG2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -93.66 109.15 20.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.444 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.8 OUTLIER -82.86 91.11 7.02 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.213 1.006 . . . . 0.0 111.079 178.288 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.666 ' HG2' ' OE1' ' A' ' 172' ' ' GLN . 6.8 mtpm? -65.01 148.1 52.26 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.336 -176.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -66.65 -22.46 66.1 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.024 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -68.24 -10.26 53.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.301 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -94.07 -20.62 19.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.671 0.748 . . . . 0.0 109.268 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -104.06 0.11 29.38 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.506 -173.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 66.8 t -115.8 126.59 73.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -63.84 -40.29 96.22 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -83.65 118.62 23.97 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 118.405 -0.807 . . . . 0.0 108.948 -177.645 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.631 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 5' ' ' GLU . 80.9 Cg_exo -49.77 -34.61 36.4 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 123.93 3.087 . . . . 0.0 113.169 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -60.84 -55.85 28.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.097 0.475 . . . . 0.0 110.508 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -59.25 -38.22 79.5 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.774 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 2' ' ' PRO . 31.9 tt0 -57.9 -55.46 34.56 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.604 1.161 . . . . 0.0 110.567 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.76 -46.95 86.29 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.003 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.67 -35.64 74.86 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.89 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.3 tp -71.42 -38.23 71.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.708 0.29 . . . . 0.0 110.821 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -73.1 -33.56 65.66 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.569 0.699 . . . . 0.0 109.167 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.6 tp -68.23 -41.96 80.45 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.215 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' A' ' 15' ' ' ILE . 58.5 tp -49.96 -54.17 21.62 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 125.076 1.351 . . . . 0.0 112.01 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.4 mtt-85 -80.32 13.35 2.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.606 -173.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -129.09 -64.25 0.92 Allowed 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.418 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -104.18 -2.87 25.13 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -173.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.507 HD12 ' HA ' ' A' ' 11' ' ' LEU . 43.0 mt -99.93 134.75 38.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -154.38 144.85 22.22 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 122.484 0.314 . . . . 0.0 110.613 -173.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 m -80.23 118.13 21.63 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.0 mt -106.05 115.6 48.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-O 121.265 0.555 . . . . 0.0 109.569 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -83.08 97.28 8.69 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 79.1 p -91.95 -170.09 2.45 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.2 m -82.59 -13.34 56.71 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 120.706 0.289 . . . . 0.0 110.929 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -98.33 -24.08 15.36 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 110.417 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.63 -154.71 25.56 Favored Glycine 0 CA--C 1.501 -0.808 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.53 112.79 20.36 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 117.298 0.549 . . . . 0.0 109.531 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.455 ' HB3' ' O ' ' A' ' 146' ' ' CYS . 80.7 m-85 -120.66 -173.45 2.59 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 147' ' ' GLY . 5.9 t -113.93 136.91 52.37 Favored 'General case' 0 N--CA 1.406 -2.653 0 C-N-CA 118.959 -1.097 . . . . 0.0 109.934 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.02 136.89 13.64 Favored Glycine 0 N--CA 1.41 -3.092 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.5 tp -105.1 118.65 37.07 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.76 132.53 14.13 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 108.406 -1.878 . . . . 0.0 108.406 173.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.5 mm -96.08 -59.28 3.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 117.753 0.776 . . . . 0.0 109.902 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -162.12 147.37 12.87 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 55.53 -95.32 0.05 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 124.276 0.985 . . . . 0.0 111.21 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 18.9 ptp180 -132.84 10.87 4.31 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 122.044 0.926 . . . . 0.0 109.663 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -84.22 118.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.4 m -131.72 147.02 52.47 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.2 t -109.71 134.55 51.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.793 0.33 . . . . 0.0 111.727 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.434 ' HB ' ' CD2' ' A' ' 75' ' ' LEU . 6.7 mm -137.93 141.88 34.11 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 125.364 1.466 . . . . 0.0 108.358 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.06 146.57 93.86 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 121.975 1.784 . . . . 0.0 111.797 175.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.6 m -70.21 -33.35 71.58 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 123.214 0.605 . . . . 0.0 109.415 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -77.17 -4.74 46.15 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.579 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.62 -16.04 49.86 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.58 ' O ' ' HB ' ' A' ' 20' ' ' THR . 21.4 mt-30 58.14 82.67 0.23 Allowed Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.414 1.086 . . . . 0.0 112.877 176.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.08 -174.83 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.752 2.301 . . . . 0.0 111.287 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.59 179.19 18.44 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.55 -17.7 44.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.513 0.673 . . . . 0.0 110.313 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -141.71 135.92 30.31 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 12.7 p -141.6 149.98 19.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.514 -171.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -85.69 111.94 20.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.258 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.2 83.14 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.3 t30 68.65 -1.78 1.86 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.492 1.517 . . . . 0.0 111.364 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.11 -33.45 0.94 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.09 110.73 15.77 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 14.7 ptpt -78.68 137.38 37.78 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 116.819 -1.952 . . . . 0.0 109.101 174.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.413 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.5 tp -128.99 150.69 34.85 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -91.24 142.84 27.28 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.8 t -108.73 131.19 60.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -78.29 -79.01 0.13 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.797 0.332 . . . . 0.0 111.286 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -113.75 140.17 48.5 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -104.5 93.51 4.82 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.569 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.5 m-85 -80.8 94.02 6.34 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -76.09 94.15 3.42 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 32.7 tp -85.46 103.53 14.42 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-O 121.616 0.722 . . . . 0.0 109.521 -172.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.06 178.9 2.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.71 139.29 58.24 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.2 -21.61 13.42 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 123.557 2.838 . . . . 0.0 114.542 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.3 6.1 24.23 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.2 m120 77.37 12.28 2.12 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.289 1.436 . . . . 0.0 112.747 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.0 mt -77.64 146.16 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -70.33 142.74 52.15 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 120.995 0.426 . . . . 0.0 111.622 -174.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 60.9 tp -117.38 -17.6 10.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 171.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 75.72 -17.02 0.54 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.284 1.434 . . . . 0.0 112.909 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 173' ' ' LEU . 10.1 mp -80.06 113.15 18.02 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.6 m -100.24 116.86 33.23 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 168.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 68.0 t -95.84 107.07 19.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.434 ' CD2' ' HB ' ' A' ' 37' ' ' ILE . 2.9 mm? -91.66 132.47 36.33 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.254 -178.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 m -83.68 80.3 9.17 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 171.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.633 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.7 tp -74.54 103.3 4.81 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.413 ' O ' HD11 ' A' ' 54' ' ' ILE . 12.9 t70 -73.8 84.07 1.66 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.432 0.634 . . . . 0.0 112.51 -168.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.425 ' HG3' ' CE2' ' A' ' 83' ' ' PHE . 31.4 mmt180 -99.14 125.08 44.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.197 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -74.78 -34.41 62.44 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -92.04 95.84 10.01 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -74.51 161.04 30.14 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.788 -1.096 . . . . 0.0 113.562 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.425 ' CE2' ' HG3' ' A' ' 79' ' ' ARG . 88.9 m-85 -91.27 172.57 8.45 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.042 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -73.88 137.57 43.8 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.07 95.32 1.2 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.222 0.534 . . . . 0.0 109.572 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -93.61 14.55 2.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 122.693 1.235 . . . . 0.0 109.975 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -31.13 59.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.018 -1.901 . . . . 0.0 108.764 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.07 -6.61 74.48 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 114.893 -1.048 . . . . 0.0 112.428 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -109.9 4.31 21.43 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.156 -0.614 . . . . 0.0 110.943 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.1 mt -73.22 125.95 33.06 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 CA-C-O 121.052 0.453 . . . . 0.0 110.292 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.0 t -115.24 106.8 14.46 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE2' ' HE3' ' A' ' 174' ' ' LYS . 7.9 pt-20 -88.53 -5.37 58.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.941 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -85.78 105.93 16.66 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 168.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.433 HD13 ' HB ' ' A' ' 135' ' ' ILE . 31.9 mt -99.98 -53.84 3.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -164.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -58.93 135.33 57.54 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.8 -38.83 3.13 Favored Glycine 0 N--CA 1.434 -1.443 0 CA-C-N 114.891 -1.05 . . . . 0.0 113.415 174.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 21.3 t -73.49 144.01 13.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 120.539 0.209 . . . . 0.0 110.906 -174.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.47 120.89 24.5 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.62 17.72 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 122.02 0.914 . . . . 0.0 111.444 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 28.1 m -127.39 131.31 50.35 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.52 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.427 HD21 HE21 ' A' ' 145' ' ' GLN . 55.4 tp -102.85 126.31 49.94 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.819 -175.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.41 107.66 19.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 145' ' ' GLN . 46.4 t -93.37 108.18 20.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.611 -178.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -133.77 124.71 27.08 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.3 t -174.98 -175.17 0.84 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -87.02 -15.29 39.11 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -94.93 -24.53 16.93 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.535 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.64 103.73 3.96 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.8 m -105.02 111.77 24.67 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 71.06 33.58 2.03 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.796 0.838 . . . . 0.0 113.238 169.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.435 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 16.2 m -93.31 109.44 20.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.512 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.0 mt -100.55 125.77 54.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.7 tp -140.69 129.36 22.89 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.942 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 4.2 mp0 -69.39 135.92 50.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.78 -19.54 6.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.21 -176.74 16.34 Favored Glycine 0 N--CA 1.433 -1.548 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.482 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 37.4 Cg_endo -68.07 129.01 18.59 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.688 2.259 . . . . 0.0 111.625 178.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.8 m -97.26 165.03 2.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.468 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.3 t -147.99 155.54 41.65 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 53.8 ttp -90.73 134.65 34.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.33 -28.52 15.52 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.308 0.575 . . . . 0.0 110.086 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.4 -87.25 1.17 Allowed Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -137.24 133.22 34.85 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.2 tp -132.15 156.41 42.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -106.41 115.26 29.91 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.09 90.82 4.29 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.4 m 53.32 72.7 0.41 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.793 0.837 . . . . 0.0 111.51 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.0 m 61.85 16.61 8.13 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.365 0.666 . . . . 0.0 112.411 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.2 m -121.25 107.8 36.78 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -80.2 128.77 7.41 Favored 'Trans proline' 0 C--O 1.254 1.294 0 C-N-CA 122.332 2.021 . . . . 0.0 112.018 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 m -131.06 131.1 44.02 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -99.19 162.92 12.78 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 8.0 mpt_? 66.82 35.72 4.84 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.579 1.152 . . . . 0.0 110.749 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 95.6 mmm -94.23 139.76 30.63 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.949 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.559 HG23 ' HB2' ' A' ' 170' ' ' SER . 3.0 tt -116.38 140.42 38.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 124.649 1.179 . . . . 0.0 109.102 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -121.53 143.83 49.05 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.054 0.542 . . . . 0.0 110.767 -171.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.485 ' HE2' ' HG ' ' A' ' 170' ' ' SER . 28.0 p90 -152.95 152.41 31.41 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 122.95 0.5 . . . . 0.0 111.049 172.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -89.58 105.42 17.78 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.308 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -172.49 132.85 0.61 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 125.05 1.34 . . . . 0.0 108.479 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.13 100.63 5.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.353 0.597 . . . . 0.0 109.651 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.2 p -79.83 137.58 36.99 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.665 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 93.4 mttt -93.03 108.69 20.21 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.2 m -53.79 129.43 33.45 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.595 0.758 . . . . 0.0 111.692 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 134.25 -18.63 4.17 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -100.74 34.1 2.56 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.373 0.606 . . . . 0.0 112.101 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 25' ' ' PHE . 66.6 m -65.8 117.26 7.95 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.304 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 26' ' ' THR . . . 109.88 5.57 29.02 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.07 134.82 37.05 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.63 115.5 18.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.183 0.516 . . . . 0.0 111.149 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.61 108.87 21.17 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.6 p -142.0 179.25 6.99 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 120.907 0.384 . . . . 0.0 111.911 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.09 178.88 8.54 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.8 t -64.77 102.32 0.57 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.999 0.904 . . . . 0.0 111.843 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.08 73.65 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.416 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -145.27 120.6 10.25 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 81.7 mt -108.28 128.9 63.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 171.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.49 -47.56 6.21 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.413 0.625 . . . . 0.0 110.3 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.55 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 171.65 -149.37 11.95 Favored Glycine 0 N--CA 1.417 -2.61 0 C-N-CA 119.932 -1.127 . . . . 0.0 111.899 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.8 pt -130.59 142.19 44.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -73.87 125.74 28.87 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.7 m -107.81 -46.0 7.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.303 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 169' ' ' PHE . . . -157.26 136.47 4.91 Favored Glycine 0 CA--C 1.487 -1.697 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.072 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.3 140.64 11.05 Favored Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -123.95 132.15 53.67 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.79 -108.33 2.07 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.922 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 166' ' ' ARG . 47.4 mtt180 -113.29 12.17 18.82 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -118.55 132.76 56.2 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.023 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -104.3 120.84 6.78 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 99.4 m-85 -109.11 117.08 33.22 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.19 0.995 . . . . 0.0 109.424 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.559 ' HB2' HG23 ' A' ' 135' ' ' ILE . 18.5 m -117.6 164.28 15.17 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.079 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.08 139.61 49.74 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 28.0 pt20 -90.23 131.67 35.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.784 0.802 . . . . 0.0 110.927 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.55 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -94.26 85.06 4.53 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.305 175.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.44 ' HE3' ' OE2' ' A' ' 92' ' ' GLU . 57.2 mtpt -54.05 134.49 43.77 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.13 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.426 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 16.7 ptmt -72.17 -19.37 61.76 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.29 -174.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.539 ' HA ' HG12 ' A' ' 179' ' ' VAL . 13.4 mm100 -67.93 -9.66 47.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.281 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -89.11 -21.52 23.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.761 0.315 . . . . 0.0 110.2 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -109.68 -28.83 8.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.281 0.563 . . . . 0.0 111.839 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 176' ' ' GLN . 11.0 p -75.3 167.25 2.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.218 0.532 . . . . 0.0 109.996 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -76.87 -4.41 43.61 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 124.705 1.202 . . . . 0.0 110.064 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.447 ' H ' HG13 ' A' ' 179' ' ' VAL . 55.9 mtpt -103.05 138.92 39.27 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.241 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 . . . . . 0 C--N 1.287 -2.133 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 174.274 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo . . . . . 0 N--CA 1.471 0.197 0 CA-C-O 121.606 0.586 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -66.92 -39.29 87.32 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.417 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 m -67.89 -44.47 76.93 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.688 0.795 . . . . 0.0 110.237 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -68.53 -36.31 78.66 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.451 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -63.17 -42.72 99.45 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.772 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.47 83.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.251 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.3 tp -69.96 -32.76 71.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.371 0.605 . . . . 0.0 110.504 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.4 m -76.9 -37.28 55.73 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.643 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.2 tp -68.44 -34.53 76.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.4 tp -54.09 -55.66 25.47 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.909 0.884 . . . . 0.0 111.568 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -72.97 -17.5 61.46 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.084 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -61.66 1.63 Allowed 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.95 -172.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -124.97 9.35 8.13 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -171.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 65.0 mt -110.81 134.72 52.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.706 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.65 167.38 23.93 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.833 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 m -92.49 125.97 37.37 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.1 mt -113.59 123.24 69.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.564 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 9.7 m -84.99 98.63 10.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.6 p -99.93 -170.25 1.86 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 30.1 t -71.53 -33.98 69.64 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.851 0.358 . . . . 0.0 110.495 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -75.59 -26.02 57.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.39 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.08 -171.3 30.06 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.493 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 19' ' ' THR . 36.2 mt-10 -91.75 104.19 16.67 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -114.02 -169.7 1.57 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.003 -174.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.54 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 10.9 m -92.05 128.9 38.07 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.965 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.94 127.23 7.71 Favored Glycine 0 N--CA 1.421 -2.312 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 174.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.4 tp -103.45 122.85 45.75 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.66 137.19 18.47 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.436 HG13 ' CE1' ' A' ' 178' ' ' PHE . 47.4 mm -97.66 -55.87 5.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -164.08 150.61 11.42 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.4 t70 58.29 -98.67 0.09 Allowed 'General case' 0 C--O 1.213 -0.839 0 O-C-N 124.21 0.944 . . . . 0.0 112.113 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.44 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 7.5 mpt_? -129.02 9.34 5.74 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.4 t -83.4 118.61 31.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.378 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.6 t -123.48 169.8 11.03 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.12 141.1 39.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.4 tp -151.15 150.59 27.65 Favored Pre-proline 0 CA--C 1.572 1.817 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.12 159.87 44.64 Favored 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 122.341 2.027 . . . . 0.0 112.771 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.8 m -82.01 -48.51 11.35 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -66.89 -8.48 29.52 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.38 -23.31 61.87 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 96.6 mt-30 58.85 84.01 0.21 Allowed Pre-proline 0 C--O 1.252 1.198 0 C-N-CA 125.601 1.561 . . . . 0.0 113.103 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -88.53 136.28 3.23 Favored 'Trans proline' 0 N--CA 1.438 -1.791 0 C-N-CA 122.816 2.344 . . . . 0.0 109.558 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.34 -176.83 51.61 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.91 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -75.03 -25.4 58.69 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.441 1.115 . . . . 0.0 108.042 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -129.5 138.38 51.35 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.89 167.28 16.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 41.8 mt -100.93 114.33 28.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.16 109.5 23.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.4 m120 61.78 23.8 14.05 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.544 0.688 . . . . 0.0 110.976 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 -13.68 63.55 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.564 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.404 HE21 ' HB2' ' A' ' 52' ' ' GLN . 14.4 mt-30 -85.15 128.21 34.57 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.442 0.697 . . . . 0.0 109.779 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.31 128.92 37.82 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.57 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.6 tp -144.53 150.24 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -105.64 147.99 27.86 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.934 0.397 . . . . 0.0 109.968 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.3 129.9 43.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -79.87 -53.17 7.02 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -132.73 133.74 43.87 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.222 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.78 110.42 12.15 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.927 -174.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -111.29 99.34 8.18 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -75.63 102.41 5.32 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.463 HD21 ' CD1' ' A' ' 177' ' ' TYR . 41.4 tp -97.29 105.02 17.1 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 122.078 0.942 . . . . 0.0 112.415 -167.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.39 -179.85 3.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.532 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 11.8 t70 -79.87 137.34 54.07 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -42.02 -34.73 2.79 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 124.306 3.337 . . . . 0.0 114.014 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.06 22.06 1.25 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 71.43 18.14 5.58 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.186 0.994 . . . . 0.0 112.857 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 55.6 mt -84.93 132.87 30.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 131' ' ' THR . 0.8 OUTLIER -80.91 126.19 31.05 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -170.131 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.1 tp -99.06 -15.74 18.92 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 169.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 60.89 30.16 19.47 Favored 'General case' 0 C--N 1.363 1.154 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.854 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 18.7 tp -124.91 144.23 50.44 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.886 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.7 m -137.5 122.48 18.99 Favored 'General case' 0 C--N 1.286 -2.193 0 O-C-N 121.894 -0.504 . . . . 0.0 109.762 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.3 t -101.68 131.19 50.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -139.38 140.92 37.57 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.665 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.5 m -97.44 107.46 19.98 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.44 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 15.6 tp -86.45 143.14 27.92 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -175.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.57 ' O ' HD11 ' A' ' 54' ' ' ILE . 38.0 t70 -84.64 80.91 9.08 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 119.266 -0.974 . . . . 0.0 112.057 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -120.22 142.65 48.82 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -61.32 -59.88 4.61 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -70.92 149.36 46.81 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -101.01 149.85 23.51 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.967 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -81.12 145.81 30.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.3 tpt85 -70.52 128.93 37.84 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -61.47 96.72 0.06 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.469 0.652 . . . . 0.0 111.368 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -92.44 20.71 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 122.095 0.95 . . . . 0.0 109.538 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -73.95 -35.06 64.51 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.959 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.5 -5.37 85.83 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.992 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -103.55 5.74 36.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.484 0.659 . . . . 0.0 109.639 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.3 mt -74.81 133.6 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.6 t -111.03 100.62 9.27 Favored 'General case' 0 N--CA 1.396 -3.158 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -87.6 1.6 53.21 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.913 0.863 . . . . 0.0 110.131 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.82 112.27 24.17 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 168.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.2 mt -116.56 -61.11 1.77 Allowed 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.581 0.705 . . . . 0.0 112.029 -168.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 33.4 tt0 -63.69 123.2 18.27 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.355 -168.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.13 -11.66 51.95 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.13 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.9 t -95.65 142.36 13.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -77.46 128.84 34.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -122.7 151.51 41.47 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.753 0.787 . . . . 0.0 111.22 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 m -116.02 135.38 54.01 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.948 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 160' ' ' HIS . 2.4 tm? -97.01 111.45 23.67 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -107.58 105.72 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.8 p -111.59 130.36 65.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-O 121.217 0.532 . . . . 0.0 110.966 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.41 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 75.3 t60 -130.92 92.19 3.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.065 0.936 . . . . 0.0 108.657 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.1 m -115.42 -175.27 2.67 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -69.69 -36.81 76.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -77.89 -60.07 2.52 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.817 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -84.9 87.06 7.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.778 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.6 p -80.66 88.86 5.72 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.361 0.6 . . . . 0.0 112.347 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.41 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 28.8 t-20 58.97 70.2 0.67 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.43 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 33.1 m -97.13 108.41 21.13 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 69.2 mt -98.29 100.34 10.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.0 tp -113.63 115.25 27.61 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.728 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.53 120.89 19.75 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.9 m -102.13 -20.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.3 -158.87 14.08 Favored Glycine 0 N--CA 1.432 -1.622 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.152 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.14 127.08 9.01 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.849 2.366 . . . . 0.0 111.944 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 20.9 m -89.42 149.46 4.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.751 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.3 p -128.21 166.01 19.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.362 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.5 ttt -98.46 127.05 44.22 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.688 -0.632 . . . . 0.0 111.187 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.02 -52.13 5.61 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.09 -122.99 7.7 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 131' ' ' THR . 6.0 tt -111.29 112.02 23.5 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 124' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.293 -1.883 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 N--CA 1.447 -1.231 0 CA-C-O 121.313 0.464 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.536 ' HB ' ' SD ' ' A' ' 134' ' ' MET . 18.4 p -117.4 132.83 56.5 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.857 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.403 ' HB2' HG21 ' A' ' 68' ' ' ILE . 50.8 t30 -123.3 132.07 53.88 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -176.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 74.63 47.97 0.12 Allowed 'General case' 0 C--O 1.239 0.533 0 O-C-N 124.801 1.313 . . . . 0.0 111.825 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.536 ' SD ' ' HB ' ' A' ' 131' ' ' THR . 0.1 OUTLIER -97.64 139.28 33.77 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.253 174.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.606 HG23 ' HB3' ' A' ' 170' ' ' SER . 3.4 tt -101.43 130.07 51.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -128.09 132.13 49.01 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.343 0.592 . . . . 0.0 111.128 -171.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.433 ' HB3' HG12 ' A' ' 118' ' ' VAL . 16.3 p90 -120.62 134.13 55.31 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.188 175.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 166' ' ' ARG . 10.7 t70 -83.95 96.31 8.8 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -156.45 124.15 5.51 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.868 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -64.5 99.7 0.32 Allowed 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 124.175 0.922 . . . . 0.0 109.44 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.2 t -105.61 147.31 28.59 Favored 'General case' 0 N--CA 1.407 -2.576 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.365 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -87.28 94.19 9.6 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.1 t -45.76 143.83 1.92 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 124.548 1.139 . . . . 0.0 113.526 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.19 -2.27 2.31 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.079 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -90.3 40.29 1.0 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.719 0.408 . . . . 0.0 112.071 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 74.8 m -60.97 117.31 5.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.175 0.512 . . . . 0.0 110.954 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.54 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 101.45 2.28 53.56 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.68 122.96 31.43 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 112.203 -0.359 . . . . 0.0 112.203 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.581 HG12 ' SG ' ' A' ' 151' ' ' CYS . 54.3 t -74.15 108.1 5.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 124.005 0.922 . . . . 0.0 109.264 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.2 tp -88.67 104.17 16.62 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.669 ' SG ' HG13 ' A' ' 156' ' ' ILE . 84.0 m -145.49 174.92 10.73 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -173.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.31 -177.4 5.74 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.6 m -59.53 102.39 0.14 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.035 0.445 . . . . 0.0 111.819 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.91 26.64 72.18 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.18 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -141.4 105.56 4.8 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.669 HG13 ' SG ' ' A' ' 151' ' ' CYS . 2.5 mp -91.81 119.88 39.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -92.24 -34.88 14.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.974 0.892 . . . . 0.0 109.809 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.73 -156.35 27.52 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.6 pt -134.19 140.81 45.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.779 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.573 ' HB2' HD21 ' A' ' 101' ' ' LEU . 20.9 t60 -67.96 105.42 2.0 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.41 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.41 -38.39 13.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.42 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.49 87.8 0.07 OUTLIER Glycine 0 N--CA 1.426 -2.019 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.649 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.88 155.67 21.22 Favored Glycine 0 N--CA 1.428 -1.847 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -151.77 135.21 16.09 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 65.97 -133.26 34.24 Favored Glycine 0 C--N 1.313 -0.74 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 99.2 mtt180 -87.21 6.17 34.46 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -117.05 101.72 8.72 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.86 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -85.31 107.37 3.09 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -93.31 118.91 31.84 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.777 0.799 . . . . 0.0 111.751 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.606 ' HB3' HG23 ' A' ' 135' ' ' ILE . 30.9 t -120.12 151.09 39.57 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.398 -1.273 . . . . 0.0 107.578 176.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.3 142.72 27.45 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -80.42 105.63 11.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 123.869 0.73 . . . . 0.0 110.575 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.03 88.09 7.45 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -90.51 151.06 21.52 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -60.17 -26.61 66.45 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -50.4 -37.11 35.91 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.36 1.064 . . . . 0.0 112.094 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.463 ' CD1' HD21 ' A' ' 62' ' ' LEU . 46.7 m-85 -75.86 -17.82 59.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.991 0.424 . . . . 0.0 111.846 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.436 ' CE1' HG13 ' A' ' 30' ' ' ILE . 73.9 m-85 -109.51 8.79 25.31 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.46 -174.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 83.0 t . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 174.619 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 N--CA 1.475 0.436 0 N-CA-C 112.663 0.217 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.21 -38.83 91.66 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.256 0.55 . . . . 0.0 110.036 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 m -71.77 -41.38 68.42 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.199 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.15 -49.27 78.52 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.225 0.61 . . . . 0.0 111.207 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -63.78 -44.41 93.47 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.082 0.468 . . . . 0.0 110.845 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.07 -41.92 90.1 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.594 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.0 tp -66.79 -33.51 75.78 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.092 0.557 . . . . 0.0 111.428 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -78.51 -46.05 20.49 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 120.749 0.309 . . . . 0.0 110.299 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.7 tp -55.82 -35.67 66.61 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.952 0.901 . . . . 0.0 109.835 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.434 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 50.7 tp -52.68 -50.02 64.13 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.473 1.509 . . . . 0.0 112.791 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -81.05 -22.79 39.03 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.386 0.612 . . . . 0.0 110.738 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -91.0 -46.55 8.08 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.056 -169.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -128.73 3.27 5.46 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 53.8 mt -115.83 137.15 50.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.464 -176.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.82 169.4 21.78 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.905 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 94.8 m -98.23 123.15 42.16 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 65.5 mt -110.56 115.52 50.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 11.4 m -88.57 103.81 16.25 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.673 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 81.6 p -89.87 -165.8 1.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.865 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -69.42 -19.69 63.79 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.221 0.534 . . . . 0.0 110.127 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -97.7 -45.07 6.5 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.83 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.31 -179.73 48.49 Favored Glycine 0 CA--C 1.497 -1.031 0 C-N-CA 119.242 -1.456 . . . . 0.0 112.592 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 2.8 mp0 -78.27 107.94 11.24 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.481 ' HB3' ' O ' ' A' ' 146' ' ' CYS . 26.5 m-85 -117.01 -177.57 3.23 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 33.0 m -97.34 138.37 34.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.14 143.23 16.02 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 tp -113.56 122.0 45.92 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.31 110.21 3.54 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 175.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.1 mm -71.77 -51.27 33.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 122.354 0.262 . . . . 0.0 110.963 -174.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -170.85 147.33 2.71 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.449 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 38.1 t70 60.53 -81.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.968 1.307 . . . . 0.0 112.943 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.57 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 14.4 ptp180 -149.85 13.19 0.8 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.769 0.795 . . . . 0.0 110.246 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.44 113.79 26.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.68 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.7 m -120.12 156.13 31.66 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -137.44 144.65 31.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 117.885 0.311 . . . . 0.0 110.544 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.521 HG22 HD21 ' A' ' 75' ' ' LEU . 14.7 tt -157.12 146.7 15.3 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 6.8 Cg_endo -51.45 141.41 41.56 Favored 'Trans proline' 0 C--N 1.363 1.304 0 C-N-CA 122.907 2.405 . . . . 0.0 113.393 177.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.3 m -57.07 -48.19 79.15 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.929 0.892 . . . . 0.0 113.123 -176.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -66.75 -1.5 3.92 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.47 -25.08 60.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.673 ' O ' ' HB ' ' A' ' 20' ' ' THR . 29.4 mm-40 61.6 82.43 0.22 Allowed Pre-proline 0 N--CA 1.467 0.396 0 C-N-CA 125.462 1.505 . . . . 0.0 114.425 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -85.17 124.75 2.92 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.793 2.329 . . . . 0.0 109.984 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.96 -125.51 0.67 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.776 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -96.11 -59.77 1.77 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.616 0.722 . . . . 0.0 109.293 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 42.4 p-10 -124.19 125.5 44.53 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.449 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.84 148.18 16.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.532 -173.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 93.1 mt -79.93 102.14 9.02 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.938 0.399 . . . . 0.0 110.175 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 17' ' ' THR . 7.5 p -94.29 90.0 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 122.063 0.935 . . . . 0.0 109.055 176.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m120 62.39 8.1 2.64 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.934 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.43 -32.47 1.96 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.932 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -82.77 125.14 30.94 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -88.05 96.6 10.57 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 46' ' ' ASP . 10.4 tp -101.31 132.65 46.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.359 -171.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -82.44 121.52 26.85 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.095 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.419 HG11 HD12 ' A' ' 75' ' ' LEU . 55.8 t -84.06 132.93 30.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -79.31 -48.16 14.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.968 0.413 . . . . 0.0 110.963 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.26 138.71 31.58 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -115.47 98.65 6.85 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.462 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 80.0 m-85 -84.07 129.88 34.89 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.758 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -84.42 112.15 20.1 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 173.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 53.1 tp -90.31 99.0 12.1 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.539 0.685 . . . . 0.0 109.346 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.86 148.47 16.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.378 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.26 141.26 57.39 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.57 -3.22 0.55 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 123.944 3.096 . . . . 0.0 114.546 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.88 -2.86 41.84 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.0 t30 77.89 6.45 2.75 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 125.683 1.593 . . . . 0.0 111.273 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.574 ' HB ' ' ND2' ' A' ' 132' ' ' ASN . 50.9 mm -96.43 150.44 4.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 131' ' ' THR . 52.9 t30 -70.83 126.92 30.91 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -177.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 54.1 tp -92.08 -13.22 31.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 21.1 tp10 66.96 23.95 9.71 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.566 175.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.5 mt -117.42 135.19 54.06 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.563 -0.711 . . . . 0.0 111.753 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.5 m -114.38 130.25 56.68 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 94.1 t -102.04 120.47 51.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.521 HD21 HG22 ' A' ' 37' ' ' ILE . 2.4 mm? -103.51 127.11 50.97 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.392 -175.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 m -87.53 88.91 7.8 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.4 tt -89.99 124.26 34.6 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.409 ' O ' HD11 ' A' ' 54' ' ' ILE . 32.7 t70 -74.9 80.84 2.14 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-O 121.995 0.903 . . . . 0.0 110.275 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -100.41 131.57 46.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.31 -175.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -74.77 -24.49 58.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.586 0.708 . . . . 0.0 109.82 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -88.82 119.6 29.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.153 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -77.31 113.28 14.91 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -62.67 138.68 58.56 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -74.65 142.97 44.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 87' ' ' ARG . 10.0 t70 -67.66 99.06 0.75 Allowed 'General case' 0 C--N 1.311 -1.101 0 O-C-N 123.414 0.446 . . . . 0.0 111.535 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -90.65 19.14 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.781 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.493 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 85.3 mtm180 -71.44 -24.94 62.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.607 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.48 -19.22 79.64 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.817 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -93.54 -12.51 29.43 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.606 -0.349 . . . . 0.0 111.22 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.8 mt -64.76 120.93 12.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.318 0.58 . . . . 0.0 110.26 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 155' ' ' LYS . 5.7 p -105.67 112.56 25.69 Favored 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.712 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -84.43 -10.0 57.9 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.356 0.598 . . . . 0.0 110.316 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -85.76 117.74 24.82 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.5 mt -117.34 -53.71 2.43 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -168.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.18 115.11 5.18 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -167.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.88 1.29 58.62 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.524 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.17 160.49 2.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -73.33 155.12 39.75 Favored 'General case' 0 C--O 1.21 -0.981 0 C-N-CA 123.396 0.678 . . . . 0.0 109.605 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -159.05 152.22 22.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.759 0.79 . . . . 0.0 112.146 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.413 HG23 ' HA ' ' A' ' 114' ' ' GLU . 94.9 m -143.96 132.81 22.61 Favored 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 125.801 1.64 . . . . 0.0 107.916 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.2 tp -98.16 119.98 37.76 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.9 t -100.96 116.61 44.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.05 123.98 66.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.489 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 28.1 t60 -130.12 79.8 1.92 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.6 m -139.85 -165.81 1.96 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.83 -175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -71.42 -53.75 12.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -67.66 -39.6 84.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.13 0.49 . . . . 0.0 111.321 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -126.43 95.0 4.22 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.5 m -92.32 120.54 32.96 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.138 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.489 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 4.3 t30 61.97 42.89 9.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.858 0.837 . . . . 0.0 109.186 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.9 m -108.22 115.88 30.93 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.088 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 87.3 mt -90.09 109.19 20.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.3 tp -108.45 114.62 28.61 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 123.041 0.536 . . . . 0.0 109.983 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.413 ' HA ' HG23 ' A' ' 100' ' ' THR . 43.8 mt-10 -71.38 145.77 49.17 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.834 0.349 . . . . 0.0 111.781 -178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.5 t -115.47 -51.43 4.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.841 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 113.0 -121.56 5.58 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -98.29 135.4 0.33 Allowed 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 122.989 2.459 . . . . 0.0 113.044 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.4 m -103.63 155.53 5.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.899 -0.501 . . . . 0.0 112.278 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.446 ' O ' HG13 ' A' ' 135' ' ' ILE . 17.5 p -131.88 178.75 6.53 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.65 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 46.5 ttm -114.2 140.32 48.65 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 121.483 -0.76 . . . . 0.0 111.165 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -104.75 -53.64 2.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.36 -117.69 5.95 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.798 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.9 tp -96.14 114.78 26.51 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.201 0.6 . . . . 0.0 109.892 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 C--N 1.31 -1.129 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo . . . . . 0 C--O 1.243 0.729 0 N-CA-C 109.823 -0.876 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 20.8 p -127.21 128.97 46.93 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.179 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.574 ' ND2' ' HB ' ' A' ' 68' ' ' ILE . 41.8 p30 -110.25 171.07 7.67 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.715 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.493 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.9 mpt_? 67.32 23.8 9.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.813 0.845 . . . . 0.0 110.884 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.8 mmt -81.84 128.62 34.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.583 0.706 . . . . 0.0 111.687 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 170' ' ' SER . 3.4 tt -96.88 136.84 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.629 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 34.7 ttm180 -116.61 135.97 53.36 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.501 0.501 . . . . 0.0 111.097 -170.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.5 140.34 31.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.659 -0.496 . . . . 0.0 109.659 173.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.26 110.04 19.36 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -163.32 147.92 11.05 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.56 87.26 2.12 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.0 p -81.2 128.61 33.97 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.984 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -76.63 111.99 12.71 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.7 m -70.53 129.5 39.38 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.333 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 129.38 -37.38 2.2 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.601 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -75.37 52.03 0.59 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.077 0.951 . . . . 0.0 112.913 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 25' ' ' PHE . 56.9 m -63.4 147.86 50.07 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.395 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 93.53 1.25 66.37 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.749 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.98 129.56 38.35 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.6 109.2 8.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-O 121.195 0.521 . . . . 0.0 110.56 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.7 tp -89.33 99.71 12.65 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 23.4 p -126.82 -172.6 2.68 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.561 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -157.79 -169.57 2.89 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.417 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 20.7 p -62.79 96.02 0.08 Allowed 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.708 0.63 . . . . 0.0 110.849 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.23 25.17 76.05 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.549 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 39.1 mttp -142.56 154.78 44.75 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 117.279 0.54 . . . . 0.0 109.665 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 151' ' ' CYS . 86.4 mt -137.22 128.17 40.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -100.25 -43.81 6.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.623 0.725 . . . . 0.0 110.23 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 172.92 -154.59 21.1 Favored Glycine 0 N--CA 1.416 -2.668 0 C-N-CA 120.283 -0.961 . . . . 0.0 111.14 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.6 pt -131.98 143.31 40.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 120.567 0.222 . . . . 0.0 110.628 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -58.58 126.2 26.61 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.352 1.061 . . . . 0.0 110.691 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.1 t -110.08 -63.88 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.32 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.44 108.79 0.61 Allowed Glycine 0 N--CA 1.421 -2.312 0 C-N-CA 119.901 -1.143 . . . . 0.0 112.293 -175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.94 115.0 4.37 Favored Glycine 0 N--CA 1.427 -1.954 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 175.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -114.74 97.61 6.37 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.487 0.661 . . . . 0.0 110.502 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.13 -98.49 0.64 Allowed Glycine 0 N--CA 1.425 -2.034 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.654 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 6.4 mpt_? -110.98 -0.7 16.62 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.619 -0.291 . . . . 0.0 111.055 -174.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -119.18 120.62 37.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.602 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.28 120.77 5.84 Favored Glycine 0 N--CA 1.418 -2.538 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -108.14 118.67 37.35 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.574 0.702 . . . . 0.0 109.931 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.546 ' HB2' HG23 ' A' ' 135' ' ' ILE . 28.6 m -115.83 157.5 24.33 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.693 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -98.81 132.54 44.09 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 10.8 pt20 -87.64 103.3 15.44 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.947 0.88 . . . . 0.0 110.655 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.434 ' H ' HD13 ' A' ' 173' ' ' LEU 0.337 0.0 OUTLIER -85.11 79.79 9.47 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.18 0.991 . . . . 0.0 111.716 177.155 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -57.86 145.01 36.75 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.526 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.486 ' O ' HG23 ' A' ' 179' ' ' VAL . 20.2 ptmt -56.13 -25.41 45.96 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.358 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -58.66 -29.99 67.0 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.843 0.857 . . . . 0.0 112.311 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -74.81 -20.5 59.75 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.112 0.482 . . . . 0.0 110.78 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -101.68 11.14 39.35 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.501 0.667 . . . . 0.0 109.498 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 175' ' ' LYS . 92.5 t . . . . . 0 N--CA 1.425 -1.708 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo . . . . . 0 CA--C 1.536 0.592 0 N-CA-C 112.935 0.321 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -69.51 -40.64 76.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.66 -40.59 97.24 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.931 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -64.23 -40.05 95.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.857 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.18 -42.91 93.17 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.126 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.96 82.27 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.112 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.87 -35.68 80.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -82.84 -37.4 24.44 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.877 -0.514 . . . . 0.0 111.332 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.02 -41.17 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.404 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 54.5 tp -53.51 -51.42 62.88 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.638 1.175 . . . . 0.0 112.335 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -70.54 -12.82 61.82 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -125.38 -42.01 2.0 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -106.46 -18.06 14.09 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -169.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.404 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 46.5 mt -89.16 105.36 15.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.29 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.2 mtp -105.45 140.22 38.88 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.325 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 m -99.38 116.03 30.59 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.3 mt -111.02 118.48 57.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.352 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 99.8 m -85.4 109.12 18.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.623 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 73.3 p -96.02 -157.54 0.59 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.505 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.5 m -84.01 3.31 34.96 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 121.193 0.521 . . . . 0.0 109.946 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -115.66 -39.52 3.51 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.158 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.61 -153.14 23.99 Favored Glycine 0 CA--C 1.498 -1.022 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -92.76 115.58 28.24 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.263 0.554 . . . . 0.0 110.823 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -116.48 169.6 9.2 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 57.6 m -98.54 127.8 44.62 Favored 'General case' 0 N--CA 1.41 -2.443 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.268 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.68 129.44 9.29 Favored Glycine 0 N--CA 1.412 -2.956 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -100.08 116.43 32.09 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.023 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.6 113.98 4.66 Favored Glycine 0 C--O 1.212 -1.253 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.536 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.1 mm -90.87 -50.64 12.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 116.964 0.382 . . . . 0.0 111.593 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -156.09 121.22 4.75 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.831 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.441 ' OD1' ' HG3' ' A' ' 82' ' ' LYS . 28.9 t70 67.18 -79.98 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.148 0.905 . . . . 0.0 113.266 168.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -140.46 11.88 2.33 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.794 0.838 . . . . 0.0 109.54 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.435 HG13 HG13 ' A' ' 74' ' ' VAL . 87.4 t -91.95 115.22 30.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.305 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -120.78 139.22 53.43 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.4 t -114.64 135.27 55.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 120.581 0.229 . . . . 0.0 111.082 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.5 tt -146.54 145.03 21.98 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 59.9 Cg_exo -57.8 138.91 88.41 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.465 2.11 . . . . 0.0 112.415 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.677 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 21.5 m -60.94 -41.69 96.76 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -71.01 -0.27 9.03 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.91 -15.5 60.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.623 ' O ' ' HB ' ' A' ' 20' ' ' THR . 82.8 mm-40 60.44 82.0 0.23 Allowed Pre-proline 0 CA--C 1.518 -0.283 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 175.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.19 158.98 11.33 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.46 2.107 . . . . 0.0 109.579 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.36 -141.55 11.1 Favored Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.446 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -88.21 -15.22 36.53 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.02 151.77 39.07 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.13 153.98 39.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 7.2 mp -103.57 105.4 15.63 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.829 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.51 92.97 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 66.09 8.24 5.34 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.596 1.558 . . . . 0.0 110.564 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.63 -24.83 3.31 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.66 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 46.5 mt-30 -75.12 106.73 6.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.594 0.197 . . . . 0.0 111.062 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -68.9 103.53 1.83 Allowed 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.4 tp -112.06 121.46 64.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-O 121.241 0.543 . . . . 0.0 109.693 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -75.48 110.32 9.77 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.9 t -65.9 135.4 28.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.58 -63.14 1.31 Allowed 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -144.77 144.46 31.19 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -108.14 111.0 22.79 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.503 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 61.9 m-85 -96.59 113.18 24.72 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -77.15 114.18 15.68 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -88.92 94.86 10.09 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.1 t -112.33 149.29 14.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -65.48 142.08 98.22 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.56 -22.55 17.06 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.498 2.799 . . . . 0.0 114.193 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -94.83 14.45 21.39 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 122.058 0.933 . . . . 0.0 109.761 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 66.54 26.69 9.85 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.61 1.164 . . . . 0.0 111.943 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.407 HG21 ' HB2' ' A' ' 132' ' ' ASN . 34.8 mm -86.3 137.27 21.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 131' ' ' THR . 63.3 t30 -92.13 135.0 34.33 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.811 -171.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -123.01 2.45 9.33 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.701 172.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.677 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 4.9 tp10 62.84 23.35 13.94 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.179 1.392 . . . . 0.0 111.864 174.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.7 tt -95.8 120.89 36.87 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 121.666 -0.646 . . . . 0.0 110.141 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 m -114.89 127.39 55.67 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 60.8 t -99.74 107.75 21.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.5 mt -95.69 117.76 31.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.9 m -97.6 103.69 15.65 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -78.17 141.04 38.95 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.257 0.551 . . . . 0.0 111.479 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -91.32 83.25 5.45 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.574 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 11.0 mmm180 -134.06 175.14 9.75 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.806 -174.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -108.33 -28.6 9.32 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 123.325 0.391 . . . . 0.0 111.073 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.574 ' OE1' ' HB3' ' A' ' 79' ' ' ARG . 1.5 pm0 -70.4 127.25 32.11 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-O 121.281 0.562 . . . . 0.0 111.192 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.441 ' HG3' ' OD1' ' A' ' 32' ' ' ASP . 41.4 tttp -92.33 109.54 20.92 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -73.35 139.39 45.97 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.586 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -49.94 123.19 7.68 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.525 1.13 . . . . 0.0 110.001 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -81.49 114.73 20.41 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.892 178.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.9 pt -93.8 25.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.997 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -68.3 -27.02 65.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.911 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.73 -9.23 86.45 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.252 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -100.86 -8.97 22.07 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.77 124.51 22.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.5 t -113.3 114.25 26.42 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.452 ' OE2' ' HG3' ' A' ' 176' ' ' GLN . 45.8 mt-10 -84.47 -20.25 32.02 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.233 0.539 . . . . 0.0 110.186 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -90.04 123.74 34.18 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 170.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.469 ' HB3' HD12 ' A' ' 135' ' ' ILE . 8.7 mt -113.93 -56.75 2.36 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.981 0.896 . . . . 0.0 111.228 -168.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 119' ' ' THR . 35.1 tt0 -59.68 126.53 27.98 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.618 -170.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.78 -27.1 8.07 Favored Glycine 0 N--CA 1.436 -1.304 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.117 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.02 156.82 3.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 120.834 0.349 . . . . 0.0 110.384 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -89.21 143.67 26.67 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.71 162.25 33.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.658 0.742 . . . . 0.0 112.097 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 88.3 m -124.93 141.62 52.0 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.904 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -107.88 120.87 43.5 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 111' ' ' THR . 37.8 t -116.51 111.32 34.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 120.894 0.378 . . . . 0.0 110.059 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.4 p -113.21 141.04 30.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -133.45 95.72 3.56 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.725 0.774 . . . . 0.0 109.37 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.2 t -104.44 -172.86 2.18 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -88.59 -42.84 11.8 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.54 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -70.44 -49.48 48.25 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -95.57 79.44 3.39 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.9 m -79.96 107.83 13.05 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.171 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.0 t30 58.77 71.82 0.56 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.016 0.926 . . . . 0.0 113.02 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 22.7 m -98.77 107.74 20.26 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.9 mt -95.62 94.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.404 HD21 ' CE2' ' A' ' 139' ' ' TYR . 65.1 tp -103.76 114.43 28.69 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.636 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.56 96.38 6.8 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.08 -35.82 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.979 -176.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.419 ' HA3' ' HD3' ' A' ' 117' ' ' PRO . . . 113.4 -135.17 12.38 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.579 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.419 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 3.1 Cg_exo -77.95 130.01 10.15 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 123.038 2.492 . . . . 0.0 112.345 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.566 ' HB ' HD11 ' A' ' 135' ' ' ILE . 31.2 m -105.57 138.23 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-O 121.531 0.682 . . . . 0.0 111.129 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . 30.4 m -122.59 145.52 48.27 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.019 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 57.9 ttp -83.45 122.0 27.93 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -82.36 -32.61 29.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.121 0.486 . . . . 0.0 111.364 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.78 -86.59 1.51 Allowed Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -152.03 138.27 18.38 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.9 mm . . . . . 0 C--N 1.301 -1.504 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.753 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo . . . . . 0 N--CA 1.434 -1.998 0 N-CA-C 109.574 -0.971 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.525 ' HB ' ' SD ' ' A' ' 134' ' ' MET . 33.3 p -107.59 102.76 11.99 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-O 121.764 0.792 . . . . 0.0 110.226 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.407 ' HB2' HG21 ' A' ' 68' ' ' ILE . 46.2 t30 -103.65 164.0 11.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -178.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.402 ' HD3' ' OH ' ' A' ' 177' ' ' TYR . 46.1 mtt180 67.81 38.12 2.99 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.736 0.814 . . . . 0.0 109.437 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.525 ' SD ' ' HB ' ' A' ' 131' ' ' THR . 57.1 mtt -119.24 164.23 15.94 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-O 121.798 0.809 . . . . 0.0 113.105 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.566 HD11 ' HB ' ' A' ' 118' ' ' VAL . 12.9 tt -123.15 151.42 27.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 124.712 1.205 . . . . 0.0 108.317 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -128.29 142.56 51.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.067 0.46 . . . . 0.0 111.889 -174.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -144.56 137.34 26.72 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.892 169.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.96 104.65 16.48 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.792 0.806 . . . . 0.0 111.662 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.404 ' CE2' HD21 ' A' ' 113' ' ' LEU . 56.8 t80 -162.56 138.07 7.12 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 125.808 1.643 . . . . 0.0 107.45 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.04 98.97 2.64 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.5 m -53.03 138.51 30.45 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 124.951 1.3 . . . . 0.0 112.836 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 145' ' ' GLN . 62.8 tttp -99.85 140.22 34.37 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.7 m -63.92 139.12 58.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 122.529 0.332 . . . . 0.0 110.263 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.34 33.47 9.4 Favored Glycine 0 C--O 1.219 -0.823 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 3.4 tp-100 -116.89 -6.13 11.49 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.603 0.716 . . . . 0.0 109.432 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.41 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 42.2 t -69.78 129.0 38.37 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.704 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.405 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 100.34 -7.66 58.39 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.095 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.75 140.28 42.22 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.526 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.34 120.67 35.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.729 0.776 . . . . 0.0 110.774 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 42.3 tp -88.2 106.04 17.93 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.0 p -140.99 168.67 19.23 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.747 0.784 . . . . 0.0 112.577 -172.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.54 -179.1 6.71 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.4 t -57.41 101.22 0.06 Allowed 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.938 0.875 . . . . 0.0 111.937 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.3 14.88 74.52 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.275 -1.33 . . . . 0.0 113.092 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -135.64 108.74 7.69 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 117.251 0.526 . . . . 0.0 111.045 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.13 126.26 57.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -97.87 -33.63 11.16 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 123.896 0.747 . . . . 0.0 110.959 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 165.54 -159.85 33.11 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 119.441 -1.361 . . . . 0.0 112.675 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.561 HG23 HD11 ' A' ' 173' ' ' LEU . 19.6 pt -121.86 137.75 54.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -69.34 125.96 28.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.0 p -96.69 -46.7 12.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.316 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.77 156.34 11.36 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -131.08 156.73 21.91 Favored Glycine 0 N--CA 1.428 -1.852 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.528 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -154.95 144.16 21.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.97 -122.68 5.9 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -117.84 13.21 14.03 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -121.43 136.88 54.91 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.017 0.437 . . . . 0.0 111.971 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -106.94 130.14 10.03 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -112.44 140.71 46.95 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.198 0.523 . . . . 0.0 109.96 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.528 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 18.6 m -131.15 154.7 48.07 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.41 139.56 30.56 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.67 116.35 19.8 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 123.37 0.419 . . . . 0.0 110.964 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.561 HD11 HG23 ' A' ' 159' ' ' ILE . 81.9 mt -89.02 94.38 9.93 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -84.08 140.66 31.67 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.093 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -69.16 -20.84 64.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.442 0.639 . . . . 0.0 109.6 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.452 ' HG3' ' OE2' ' A' ' 92' ' ' GLU . 69.4 mt-30 -58.21 -21.75 49.07 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.506 1.523 . . . . 0.0 112.23 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.402 ' OH ' ' HD3' ' A' ' 133' ' ' ARG . 34.6 m-85 -86.99 -23.42 25.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.93 0.395 . . . . 0.0 110.726 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.406 ' CG ' HG21 ' A' ' 30' ' ' ILE . 49.2 m-85 -106.5 18.72 21.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.154 0.502 . . . . 0.0 112.017 -169.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--N 1.296 -1.73 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.629 176.477 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo . . . . . 0 N--CA 1.483 0.903 0 CA-C-O 121.617 0.59 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -61.21 -37.27 82.39 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.057 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.4 m -64.52 -37.43 87.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.506 0.722 . . . . 0.0 109.608 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.35 -44.83 82.18 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.915 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.83 -45.98 88.75 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.944 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.424 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -62.02 -43.48 98.75 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.02 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.84 -37.7 85.45 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 123.346 0.658 . . . . 0.0 110.438 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 m -76.41 -31.62 58.03 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.527 0.679 . . . . 0.0 110.325 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -73.69 -31.14 63.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.303 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 62.2 tp -51.68 -56.32 14.37 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.436 1.094 . . . . 0.0 112.05 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -83.02 10.26 8.41 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.221 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -117.91 -59.79 1.87 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -122.72 -6.81 8.56 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 50.5 mt -89.19 103.32 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 mmt -115.58 126.03 53.7 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.25 0.548 . . . . 0.0 111.002 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 24' ' ' GLU . 2.4 m -70.2 96.82 1.13 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.864 177.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 58.5 mt -89.86 111.9 23.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 121.16 0.505 . . . . 0.0 109.908 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.8 m -86.5 107.6 18.17 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 80.5 p -89.74 -157.75 0.48 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.776 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 t -85.57 -9.45 57.32 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -106.3 -38.06 6.35 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.03 -160.4 27.45 Favored Glycine 0 CA--C 1.493 -1.326 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.804 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HB3' HG22 ' A' ' 17' ' ' THR . 7.8 mp0 -99.86 112.27 24.54 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -112.73 159.3 19.08 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 17.9 m -86.65 116.26 24.65 Favored 'General case' 0 N--CA 1.408 -2.556 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.47 129.26 9.81 Favored Glycine 0 N--CA 1.417 -2.624 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.2 tp -105.4 115.9 31.04 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 120.839 0.352 . . . . 0.0 110.549 -178.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.7 136.48 23.17 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.418 ' HA ' HD11 ' A' ' 86' ' ' ILE . 50.3 mm -100.61 -56.34 5.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 117.566 0.683 . . . . 0.0 109.537 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.601 ' NE2' ' HB3' ' A' ' 178' ' ' PHE . 0.1 OUTLIER -172.97 167.94 4.95 Favored 'General case' 0 CA--C 1.46 -2.494 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 52.06 -135.57 1.47 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.67 25.73 10.44 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -92.61 112.87 26.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.272 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 43.2 t -122.14 139.71 53.42 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.15 140.77 26.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 122.225 0.21 . . . . 0.0 110.585 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 tt -151.78 147.44 20.05 Favored Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -63.94 147.26 92.02 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.158 1.905 . . . . 0.0 112.066 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.0 m -64.44 -37.66 88.29 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -76.09 5.24 7.01 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.42 -19.65 57.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' A' ' 20' ' ' THR . 78.6 mt-30 57.22 76.6 0.47 Allowed Pre-proline 0 C--O 1.251 1.158 0 C-N-CA 125.414 1.486 . . . . 0.0 113.361 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -92.29 164.8 3.02 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 122.346 2.031 . . . . 0.0 110.724 175.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.34 -152.09 10.96 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.06 -1.44 54.41 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -144.87 126.13 14.76 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.18 155.39 39.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.063 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 8.8 mp -92.26 102.06 14.56 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.3 p -87.82 105.46 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.052 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 74.03 -3.9 2.41 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.611 0.764 . . . . 0.0 110.81 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.51 -9.3 11.78 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -97.67 118.26 33.79 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 14.9 ptpt -77.19 134.63 38.59 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 118.28 -1.368 . . . . 0.0 112.738 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.478 HG12 ' HB3' ' A' ' 77' ' ' LEU . 5.3 tp -131.49 141.12 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 114.251 -1.341 . . . . 0.0 108.346 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -86.47 139.66 30.68 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.6 t -93.01 139.93 17.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -79.68 -71.34 0.45 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -126.15 139.38 53.41 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -99.88 90.97 4.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.447 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 93.8 m-85 -79.2 109.97 14.03 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.155 0.502 . . . . 0.0 110.523 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -77.14 104.42 7.63 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.7 tp -80.26 87.89 5.53 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 122.181 0.991 . . . . 0.0 109.245 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -119.64 163.52 16.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 113.848 -1.523 . . . . 0.0 108.397 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.58 137.15 48.05 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.53 -23.9 11.55 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.667 2.911 . . . . 0.0 114.348 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -82.77 13.53 3.79 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 122.379 0.272 . . . . 0.0 111.384 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.9 m120 79.21 10.19 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 125.383 1.473 . . . . 0.0 112.347 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.5 mt -86.47 119.84 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.628 ' O ' ' HA ' ' A' ' 131' ' ' THR . 74.6 m-20 -81.07 157.67 25.32 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.882 -173.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -109.36 -0.97 18.78 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 61.72 30.05 18.29 Favored 'General case' 0 C--N 1.364 1.218 0 CA-C-O 122.83 1.3 . . . . 0.0 108.634 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.464 HD21 HD11 ' A' ' 173' ' ' LEU . 14.9 tp -133.01 142.89 49.07 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.584 -170.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.0 m -138.08 140.3 39.92 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.255 0.55 . . . . 0.0 110.657 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 92.7 t -105.98 122.25 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.8 mt -102.38 113.69 27.23 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.7 m -87.6 107.55 18.65 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.478 ' HB3' HG12 ' A' ' 54' ' ' ILE . 66.0 mt -80.48 141.31 35.34 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.725 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.52 74.72 10.35 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 122.045 0.926 . . . . 0.0 111.6 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -125.12 161.59 26.49 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.436 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -93.23 -49.57 5.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -66.96 148.16 52.3 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -119.27 173.18 7.1 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.388 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -82.56 179.64 7.72 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -73.75 127.93 34.13 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.01 90.16 1.15 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.418 HD11 ' HA ' ' A' ' 30' ' ' ILE . 2.4 pp -92.61 20.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.755 -0.591 . . . . 0.0 112.162 -176.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -68.69 -29.74 68.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.811 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.72 -27.54 73.77 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -85.1 -8.82 58.48 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 122.9 -0.177 . . . . 0.0 110.699 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.4 mt -66.54 131.69 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 t -124.44 111.48 15.78 Favored 'General case' 0 N--CA 1.387 -3.589 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -86.84 5.46 36.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.495 1.14 . . . . 0.0 108.935 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.83 110.57 22.02 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 169.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.5 -29.76 0.62 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -171.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -68.1 103.02 1.43 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.113 0.482 . . . . 0.0 111.747 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.38 -0.43 34.94 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.604 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.0 t -91.53 138.71 19.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -79.7 116.72 20.05 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -115.59 172.25 7.23 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.821 0.82 . . . . 0.0 112.097 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.6 m -128.79 141.25 51.37 Favored 'General case' 0 N--CA 1.422 -1.857 0 C-N-CA 124.908 1.283 . . . . 0.0 108.719 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.8 tp -106.12 122.19 45.69 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.424 HG21 ' HB1' ' A' ' 7' ' ' ALA . 43.5 t -113.96 107.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.815 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.4 m -107.85 138.91 31.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -139.28 107.99 5.93 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.325 0.583 . . . . 0.0 110.002 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.3 p -144.27 -172.58 3.81 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.46 -25.76 41.85 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.401 176.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -73.68 -51.27 17.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.419 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -115.79 84.35 2.09 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.8 m -80.14 96.32 6.49 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.355 0.597 . . . . 0.0 111.005 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.2 t30 60.15 70.71 0.61 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.755 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.3 m -101.34 108.03 19.54 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.08 108.67 24.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.0 tp -125.15 123.88 40.6 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.875 0.369 . . . . 0.0 111.563 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.86 102.65 4.8 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.1 m -78.39 -26.54 14.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.243 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 106.85 -149.53 16.6 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 119.94 -1.124 . . . . 0.0 111.1 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.95 122.25 8.63 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.745 2.297 . . . . 0.0 112.901 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.8 m -89.57 145.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.949 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 135' ' ' ILE . 11.5 p -128.45 172.8 10.79 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.246 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 28.2 ttt -114.45 136.64 52.78 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.74 -26.84 12.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.335 0.588 . . . . 0.0 109.419 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.53 -88.89 1.46 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 131' ' ' THR . 4.9 mp -131.99 155.99 47.0 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 11.1 tt . . . . . 0 C--N 1.304 -1.372 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 50.7 Cg_endo . . . . . 0 N--CA 1.428 -2.358 0 N-CA-C 110.816 -0.494 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.1 p -103.69 133.45 48.67 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.415 ' OD1' ' HD2' ' A' ' 133' ' ' ARG . 29.0 t-20 -108.19 159.9 16.24 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -175.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.494 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 5.5 mpt_? 65.72 38.8 5.1 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.563 1.145 . . . . 0.0 110.638 -177.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.425 ' HG3' HG22 ' A' ' 124' ' ' ILE . 16.5 mmt -85.55 118.42 25.06 Favored 'General case' 0 C--O 1.252 1.214 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.256 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.575 HG23 ' HB2' ' A' ' 170' ' ' SER . 5.4 tt -99.84 136.34 31.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 144.58 51.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.752 0.31 . . . . 0.0 111.311 -172.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.409 ' HE2' ' HG ' ' A' ' 170' ' ' SER . 6.3 p90 -138.95 163.81 31.38 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.907 176.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.27 99.95 12.84 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 124.227 0.955 . . . . 0.0 108.669 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -171.34 124.35 0.6 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.485 1.114 . . . . 0.0 109.65 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -70.46 102.81 2.29 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.941 176.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.8 t -119.81 155.73 32.0 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -127.21 165.44 19.61 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.721 0.296 . . . . 0.0 110.505 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.4 m -60.74 129.38 41.22 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.287 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.27 -20.41 9.04 Favored Glycine 0 C--O 1.215 -1.049 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -93.42 23.71 4.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.183 0.992 . . . . 0.0 108.386 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.1 m -79.12 137.88 37.68 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.415 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.566 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 97.55 0.43 59.35 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.57 126.58 37.81 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 121.566 -0.349 . . . . 0.0 112.643 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -73.25 113.0 10.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 123.318 0.647 . . . . 0.0 109.465 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 52.3 tp -94.18 106.45 18.42 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.5 p -147.02 163.23 36.91 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.675 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.77 177.8 6.58 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.1 t -64.38 108.46 1.63 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.956 0.884 . . . . 0.0 110.946 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 83.27 2.37 90.36 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.262 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -136.35 108.38 7.18 Favored 'General case' 0 C--O 1.211 -0.956 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.1 mt -97.68 130.92 45.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -103.41 -31.97 9.75 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.147 0.498 . . . . 0.0 110.691 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.4 -154.84 25.91 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.283 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.9 pt -132.28 148.08 32.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 116.911 0.355 . . . . 0.0 110.597 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.408 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 23.8 t-80 -68.14 131.16 44.91 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.203 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.6 m -105.47 -59.96 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.56 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -156.93 142.89 9.06 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.019 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -131.67 143.99 15.57 Favored Glycine 0 N--CA 1.423 -2.232 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.894 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -119.76 105.99 11.68 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.638 0.732 . . . . 0.0 109.911 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 74.2 -130.76 12.75 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -177.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 34.0 ptt180 -90.14 9.09 29.67 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.961 0.41 . . . . 0.0 110.982 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -111.37 94.72 5.12 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.618 0.723 . . . . 0.0 110.063 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.9 123.93 6.9 Favored Glycine 0 N--CA 1.422 -2.283 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.55 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -104.27 127.52 51.91 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.951 0.881 . . . . 0.0 109.557 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.575 ' HB2' HG23 ' A' ' 135' ' ' ILE . 19.4 m -124.62 166.29 16.38 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.36 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -100.56 129.49 46.5 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 4.0 pt20 -85.18 115.88 23.22 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.922 0.868 . . . . 0.0 110.319 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.464 HD11 HD21 ' A' ' 72' ' ' LEU . 4.3 mm? -87.09 93.4 9.35 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.954 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -73.3 146.73 45.12 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -75.3 -6.3 49.12 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.334 0.588 . . . . 0.0 110.907 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.09 -33.42 74.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.077 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -75.33 -27.0 59.07 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.173 0.511 . . . . 0.0 110.899 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.601 ' HB3' ' NE2' ' A' ' 31' ' ' HIS . 82.7 m-85 -102.1 0.99 35.75 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.897 -170.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--N 1.293 -1.886 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.189 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 C--O 1.242 0.716 0 N-CA-C 113.272 0.451 . . . . 0.0 113.272 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -76.56 -40.13 50.69 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -60.89 -46.21 91.54 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.851 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.45 -49.52 77.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.332 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -58.57 -46.8 86.15 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 123.498 0.499 . . . . 0.0 110.781 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.61 -35.14 78.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.6 tp -71.38 -42.14 68.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.049 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -70.73 -33.09 70.47 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.022 -0.423 . . . . 0.0 111.46 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.412 HD11 HD13 ' A' ' 86' ' ' ILE . 50.6 tp -67.27 -40.53 86.2 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.733 0.813 . . . . 0.0 108.927 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.511 HD22 HD22 ' A' ' 110' ' ' ASN . 18.5 tp -53.51 -50.49 65.3 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.742 1.217 . . . . 0.0 111.591 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -73.36 -3.61 28.3 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.783 -1.098 . . . . 0.0 113.447 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -126.42 -47.98 1.57 Allowed 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -115.84 -10.49 11.69 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -171.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 29.8 mt -99.19 115.34 39.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.101 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 mmt -127.65 146.37 50.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.465 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 22.7 m -78.56 132.41 37.15 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.7 mt -125.93 110.8 24.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 98.4 m -77.03 103.72 7.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.2 p -94.55 -168.68 1.88 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.008 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -71.12 -16.11 62.54 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 120.842 0.353 . . . . 0.0 111.047 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -110.11 9.63 24.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.84 -162.41 14.01 Favored Glycine 0 C--N 1.31 -0.869 0 C-N-CA 119.49 -1.338 . . . . 0.0 113.642 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -86.48 101.27 13.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.312 0.577 . . . . 0.0 111.738 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -106.92 -179.25 3.88 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 t -127.44 139.28 52.92 Favored 'General case' 0 N--CA 1.408 -2.571 0 C-N-CA 119.005 -1.078 . . . . 0.0 109.028 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.59 137.63 14.41 Favored Glycine 0 N--CA 1.415 -2.737 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.7 tp -101.84 118.41 36.86 Favored 'General case' 0 C--N 1.29 -2.01 0 O-C-N 123.811 0.359 . . . . 0.0 110.175 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.47 132.38 22.76 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mm -100.11 -53.03 8.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 117.624 0.712 . . . . 0.0 109.933 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -161.94 151.02 15.69 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.495 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.488 ' HA ' ' HG3' ' A' ' 82' ' ' LYS . 4.6 t70 53.72 -92.24 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 125.333 1.453 . . . . 0.0 112.695 177.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 32' ' ' ASP . 9.3 mpt_? -132.0 7.74 4.36 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.398 0.618 . . . . 0.0 110.033 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.446 HG13 HG13 ' A' ' 74' ' ' VAL . 84.0 t -77.82 112.83 16.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.573 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.7 m -121.94 142.84 49.88 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.3 p -115.91 141.39 33.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 120.743 0.306 . . . . 0.0 110.571 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 tt -154.47 149.42 20.24 Favored Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.57 144.9 95.13 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 122.279 1.986 . . . . 0.0 112.781 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.594 ' HB ' ' OG1' ' A' ' 73' ' ' THR . 9.6 t -86.52 -10.29 54.39 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -79.02 -2.51 40.67 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.282 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.73 -27.74 20.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.001 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 13.5 mm-40 60.04 87.46 0.14 Allowed Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.653 1.181 . . . . 0.0 114.171 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.48 149.08 18.74 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.156 1.904 . . . . 0.0 109.194 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.01 -157.35 30.09 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.478 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -82.2 -30.24 31.0 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.402 ' OD2' ' HD2' ' A' ' 53' ' ' LYS . 8.6 p-10 -139.58 136.29 34.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 23.9 m -136.68 157.68 36.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 120.755 0.312 . . . . 0.0 111.644 -174.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 86.6 mt -89.81 109.88 20.85 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 17' ' ' THR . 81.8 t -97.77 88.55 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.251 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 63.52 18.47 11.09 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.519 1.152 . . . . 0.0 109.934 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.18 -38.69 2.03 Favored Glycine 0 N--CA 1.436 -1.3 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.128 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -81.03 120.11 24.39 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.773 -0.251 . . . . 0.0 110.371 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 39.1 ttpt -80.59 110.41 16.04 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.2 tp -103.82 150.19 7.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -99.52 139.52 35.06 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 118.272 -1.371 . . . . 0.0 107.824 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.43 124.96 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.407 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 57.7 tttm -70.86 -52.25 21.47 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.34 0.59 . . . . 0.0 109.839 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.407 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.2 m-20 -138.71 138.25 37.55 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.602 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -115.55 112.51 22.3 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.47 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 63.9 m-85 -109.88 111.62 23.15 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.527 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -78.6 116.24 18.84 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.567 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 37.8 tp -90.73 101.97 14.72 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.1 t -123.89 140.8 46.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -81.78 130.94 58.98 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.98 5.23 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.081 3.187 . . . . 0.0 116.044 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.7 14.57 16.74 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.9 t30 70.66 40.06 1.06 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.011 1.324 . . . . 0.0 109.007 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 53.3 mt -120.06 122.02 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.62 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 131' ' ' THR . 50.4 t30 -64.54 150.29 47.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.598 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.567 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 39.1 tp -126.52 -9.58 6.26 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.716 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 72.5 -20.59 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.673 1.189 . . . . 0.0 113.108 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.67 118.69 11.99 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.594 ' OG1' ' HB ' ' A' ' 39' ' ' THR . 55.0 m -106.83 114.28 28.28 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 64.2 t -92.97 104.88 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.75 124.42 42.1 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.253 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.8 m -98.05 93.78 6.48 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -71.05 137.55 49.07 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.23 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.78 76.89 10.17 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.429 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -101.47 128.84 47.51 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.305 -1.771 . . . . 0.0 107.23 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.55 -50.74 64.04 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.365 0.415 . . . . 0.0 111.457 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -74.02 160.09 31.79 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 121.242 0.544 . . . . 0.0 110.62 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.488 ' HG3' ' HA ' ' A' ' 32' ' ' ASP . 58.1 tttm -99.52 142.55 30.85 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.604 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -80.8 162.3 24.1 Favored 'General case' 0 C--O 1.257 1.448 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 175.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -77.18 132.48 38.79 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -80.24 96.17 6.52 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.785 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.412 HD13 HD11 ' A' ' 10' ' ' LEU . 38.4 pt -96.0 20.32 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.767 0.794 . . . . 0.0 109.523 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -65.32 -28.16 69.12 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.837 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.72 -5.99 89.42 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.643 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -96.16 -3.06 45.1 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.282 0.563 . . . . 0.0 110.584 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.6 mt -70.22 120.07 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.987 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 p -108.68 105.08 14.53 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.546 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 1.0 OUTLIER -80.2 -12.48 59.64 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.299 177.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.35 118.98 21.76 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.526 HD11 ' NE2' ' A' ' 172' ' ' GLN . 21.6 mt -112.65 -63.84 1.38 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.394 0.616 . . . . 0.0 112.3 -169.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 16.9 pt-20 -54.69 126.95 26.03 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -166.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.87 -38.28 3.2 Favored Glycine 0 N--CA 1.432 -1.582 0 CA-C-N 114.488 -1.233 . . . . 0.0 113.011 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.3 t -78.52 138.64 19.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.997 0.427 . . . . 0.0 110.897 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -80.97 102.4 10.12 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.9 163.54 24.24 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.554 0.693 . . . . 0.0 111.16 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.6 m -129.28 139.04 51.94 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.5 tp -112.65 125.09 53.91 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 111' ' ' THR . 7.6 p -117.89 122.4 69.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.412 0.625 . . . . 0.0 110.832 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 t -111.72 139.13 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.743 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.409 ' HB3' HG22 ' A' ' 15' ' ' ILE . 76.5 t60 -126.5 79.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.258 1.028 . . . . 0.0 109.806 175.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.9 t -116.91 -177.82 3.29 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -71.33 -45.28 63.38 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.091 0.472 . . . . 0.0 110.374 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -82.28 -47.39 12.46 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.515 0.674 . . . . 0.0 109.885 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -88.69 76.6 8.04 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.761 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 22.5 m -94.44 101.11 13.02 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.921 0.391 . . . . 0.0 110.008 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.511 HD22 HD22 ' A' ' 11' ' ' LEU . 27.1 t-20 64.45 62.9 0.78 Allowed 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.927 1.346 . . . . 0.0 110.033 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 24.6 m -96.54 96.15 8.48 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.344 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.417 HD11 HD21 ' A' ' 110' ' ' ASN . 54.1 mt -100.99 97.03 5.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.7 tp -120.2 137.17 54.35 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -68.67 146.08 53.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.2 t -102.72 -51.4 9.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 119.54 -168.58 13.56 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.59 116.8 4.13 Favored 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.704 2.27 . . . . 0.0 112.278 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 26.8 m -87.29 155.72 3.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.091 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.0 p -136.84 169.61 17.46 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 123.129 0.572 . . . . 0.0 109.592 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.2 ttt -87.82 142.68 27.62 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -95.84 -39.54 9.78 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.037 0.446 . . . . 0.0 110.976 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 133' ' ' ARG . . . 99.36 -111.68 4.27 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 130' ' ' PRO . 2.5 pt? -134.94 112.19 10.43 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.284 1.04 . . . . 0.0 110.911 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 7.6 tp . . . . . 0 C--N 1.28 -2.453 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -177.366 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.43 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 44.9 Cg_endo . . . . . 0 N--CA 1.441 -1.573 0 N-CA-C 117.017 1.891 . . . . 0.0 117.017 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 97.6 m -92.01 130.73 37.69 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 164.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.31 97.18 0.39 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 20.3 mtm-85 62.76 80.35 0.23 Allowed 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.255 1.026 . . . . 0.0 110.767 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.5 ttt -103.61 169.75 8.34 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.415 -172.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.52 HG23 ' HB2' ' A' ' 170' ' ' SER . 7.7 tt -117.32 142.34 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.017 0.527 . . . . 0.0 109.869 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.517 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 46.8 ttp180 -137.37 146.53 44.62 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 123.719 0.807 . . . . 0.0 109.659 -174.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' A' ' 118' ' ' VAL . 6.9 p90 -151.4 159.51 44.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 120.373 0.13 . . . . 0.0 111.287 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -83.22 113.51 20.72 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -165.55 126.12 1.86 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -174.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.45 101.96 1.34 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 44.4 m -78.77 138.94 38.46 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.923 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -111.3 154.47 24.46 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.9 t -86.76 138.69 31.4 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.0 -13.87 28.94 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.124 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.31 5.72 50.93 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.376 0.607 . . . . 0.0 111.432 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 41.9 t -62.32 135.12 57.31 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.524 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 103.57 -14.53 53.82 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.848 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.71 141.9 46.24 Favored Glycine 0 C--O 1.241 0.562 0 O-C-N 123.969 0.452 . . . . 0.0 113.726 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.5 t -81.27 114.46 22.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.319 0.58 . . . . 0.0 109.771 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 39.5 tp -87.35 106.27 17.83 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.6 p -140.82 -171.71 3.3 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.205 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.16 -173.47 4.45 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.8 t -70.48 99.57 1.64 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.283 1.04 . . . . 0.0 111.297 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.99 12.58 70.91 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.595 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -137.21 140.69 41.9 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 85.9 mt -126.95 124.34 64.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -96.98 -35.45 10.85 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.131 0.491 . . . . 0.0 110.629 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.527 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 164.01 -154.32 25.14 Favored Glycine 0 N--CA 1.427 -1.925 0 C-N-CA 119.305 -1.426 . . . . 0.0 113.16 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.5 pt -125.01 134.06 67.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 122.56 0.344 . . . . 0.0 111.15 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.434 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 68.9 t60 -67.42 128.58 36.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.441 0.696 . . . . 0.0 109.828 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.49 -15.42 9.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.29 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.25 -159.63 24.44 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 176.9 -176.5 48.05 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -147.93 145.83 28.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.2 -110.62 3.35 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.024 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 46.0 mtm105 -120.27 7.71 10.78 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -110.69 129.13 55.91 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.835 0.35 . . . . 0.0 110.276 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -105.31 142.39 15.51 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.0 143.77 49.7 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.536 0.684 . . . . 0.0 110.827 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.52 ' HB2' HG23 ' A' ' 135' ' ' ILE . 74.1 m -138.79 159.8 41.23 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.348 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -96.58 119.15 34.54 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.526 ' NE2' HD11 ' A' ' 94' ' ' LEU . 3.0 pt20 -76.56 122.01 24.0 Favored 'General case' 0 C--O 1.253 1.274 0 CA-C-O 121.948 0.88 . . . . 0.0 111.315 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.527 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 95.4 mt -83.57 99.88 10.45 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -88.55 138.24 31.6 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.546 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 9.7 ptpp? -69.55 -13.88 62.56 Favored 'General case' 0 C--O 1.21 -0.995 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.877 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -61.35 -22.85 65.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.931 1.292 . . . . 0.0 110.562 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -85.34 -33.62 22.02 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.379 0.609 . . . . 0.0 109.428 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -91.76 3.5 54.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.016 -169.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 C--N 1.294 -1.815 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.396 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo . . . . . 0 C--O 1.241 0.637 0 CA-C-O 121.134 0.389 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -79.92 -32.39 40.15 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.602 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 19.3 m -61.48 -44.5 96.97 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.428 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -54.94 -51.55 65.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.055 0.942 . . . . 0.0 109.038 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.04 -45.19 94.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.432 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.39 75.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.331 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 4' ' ' THR . 92.8 mt -61.8 -47.67 84.06 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.058 0.456 . . . . 0.0 109.878 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 m -66.21 -49.98 65.43 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.309 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.9 tp -57.08 -45.65 83.17 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.58 0.752 . . . . 0.0 111.292 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.587 HD13 HD22 ' A' ' 110' ' ' ASN . 9.3 tt -64.59 -43.84 92.55 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -76.25 -9.39 58.6 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -99.93 -65.63 0.95 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.896 0.379 . . . . 0.0 111.247 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -108.71 -5.48 16.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -168.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.512 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 47.6 mt -95.82 139.7 18.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.336 -176.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.546 ' HB3' HG13 ' A' ' 49' ' ' VAL . 57.1 mtm -140.53 163.16 33.58 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.047 0.939 . . . . 0.0 109.306 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 96.5 m -103.11 119.74 39.41 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 71.1 mt -110.96 112.63 41.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.076 0.465 . . . . 0.0 110.179 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 59.9 m -80.35 107.9 13.52 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 p -97.6 -166.96 1.45 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.362 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -78.65 -2.89 41.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.348 0.594 . . . . 0.0 110.302 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -106.44 -43.09 4.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.295 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.59 -160.44 33.94 Favored Glycine 0 C--O 1.246 0.889 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.651 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -81.83 96.09 7.51 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.336 0.654 . . . . 0.0 109.422 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 146' ' ' CYS . 6.6 m-85 -99.64 159.53 14.97 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.43 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 95.0 m -94.5 127.74 40.63 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.91 121.73 7.03 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.96 113.02 26.26 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.8 134.94 21.07 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 50.8 mm -100.97 -48.85 11.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 117.298 0.549 . . . . 0.0 110.219 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.601 ' CD2' ' HB3' ' A' ' 85' ' ' ASP . 22.8 t-80 -166.66 139.81 3.82 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.131 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.431 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 28.8 t70 61.21 -92.62 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.631 0 O-C-N 124.257 0.973 . . . . 0.0 112.745 173.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 81.0 mtt180 -131.86 5.75 4.26 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.406 0.622 . . . . 0.0 109.975 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.8 t -85.51 117.42 30.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.675 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.4 m -125.45 157.24 37.41 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.3 145.06 23.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 120.771 0.319 . . . . 0.0 111.67 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 tt -160.34 140.56 8.53 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.755 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 73.7 Cg_exo -57.66 134.58 63.96 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.909 2.406 . . . . 0.0 113.46 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.489 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 25.3 m -64.02 -33.58 76.06 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 124.276 1.031 . . . . 0.0 112.727 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -64.19 -12.25 38.65 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.19 -25.76 59.88 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 53.35 84.89 0.2 Allowed Pre-proline 0 C--O 1.242 0.667 0 C-N-CA 124.936 1.295 . . . . 0.0 112.816 -176.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -83.88 152.22 12.89 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 C-N-CA 121.935 1.756 . . . . 0.0 110.619 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.59 -162.35 37.07 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.162 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -93.37 10.03 33.9 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.083 0.944 . . . . 0.0 110.415 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -160.36 124.75 3.71 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.65 149.76 29.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.533 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 93.9 mt -85.48 114.11 22.26 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 17' ' ' THR . 39.2 t -102.28 102.32 13.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.217 175.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.6 m120 59.04 25.06 13.4 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.621 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.01 -7.38 44.35 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.943 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -106.83 118.62 37.17 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.542 -0.387 . . . . 0.0 110.48 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -73.44 124.69 26.29 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.68 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -119.94 122.8 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.925 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -71.52 124.69 25.22 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.309 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.7 t -84.22 139.99 16.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.48 -176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.439 ' NZ ' ' HB3' ' A' ' 57' ' ' LYS . 8.6 mtpm? -97.87 -69.77 0.75 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.032 0.92 . . . . 0.0 109.785 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -116.04 143.47 45.42 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.926 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -146.32 96.96 2.86 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -106.58 139.33 41.21 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.411 ' H ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -97.87 128.53 44.54 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.074 174.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.03 110.21 14.05 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.86 129.45 69.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.544 ' HB2' HD21 ' A' ' 70' ' ' LEU . 22.1 t70 -66.33 143.92 98.48 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -175.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.31 -17.25 0.5 Allowed 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 123.917 3.078 . . . . 0.0 115.141 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HG2' ' OD2' ' A' ' 64' ' ' ASP . 19.0 mm-40 -83.47 3.78 30.69 Favored 'General case' 0 CA--C 1.555 1.158 0 O-C-N 121.633 -0.667 . . . . 0.0 111.178 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.7 t30 73.78 18.8 3.32 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.435 1.494 . . . . 0.0 109.343 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.401 HG21 ' HB2' ' A' ' 132' ' ' ASN . 30.0 mm -99.44 136.1 32.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 131' ' ' THR . 91.7 m-20 -73.51 148.39 43.14 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.591 0.234 . . . . 0.0 111.411 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.544 HD21 ' HB2' ' A' ' 64' ' ' ASP . 73.0 mt -103.97 -13.22 16.41 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 172.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.489 ' OE1' ' HB ' ' A' ' 39' ' ' THR . 2.7 tp10 60.05 31.25 20.53 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 114.176 -1.374 . . . . 0.0 109.34 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.0 tp -115.82 120.58 39.73 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.881 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -104.38 130.94 52.22 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -91.86 100.28 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 171.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.6 tp -96.54 116.28 28.82 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.771 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -104.93 109.43 21.42 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.574 0.702 . . . . 0.0 109.107 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 88.7 mt -93.82 153.46 18.27 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.765 -175.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -88.22 80.08 7.67 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -118.3 115.02 23.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.756 -1.565 . . . . 0.0 108.014 -171.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -81.43 -10.13 59.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.521 0.677 . . . . 0.0 112.627 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -90.74 87.84 6.84 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 24.9 pttm -78.64 139.69 38.51 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.994 -0.683 . . . . 0.0 111.721 -172.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -77.33 147.63 36.06 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.57 -172.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -70.76 140.24 51.28 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.347 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.601 ' HB3' ' CD2' ' A' ' 31' ' ' HIS . 6.5 p-10 -70.45 107.0 3.62 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.952 0.882 . . . . 0.0 109.399 173.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.8 pt -93.47 22.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.4 ttt-85 -66.1 -30.77 71.34 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.645 -174.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.38 -12.77 84.24 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.357 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -91.11 -10.45 41.9 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.434 -0.451 . . . . 0.0 110.227 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.5 mt -66.58 133.71 30.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.571 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.3 t -113.54 110.59 20.51 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.4 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 42.9 mt-10 -87.78 4.41 44.46 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.663 0.744 . . . . 0.0 110.818 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.36 119.51 37.17 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.88 -2.266 . . . . 0.0 104.88 172.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.421 ' HB3' HD12 ' A' ' 135' ' ' ILE . 3.0 mp -120.5 -49.66 2.24 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -169.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -57.24 129.91 43.87 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.83 -1.78 78.78 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.5 173.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.487 ' O ' HG22 ' A' ' 118' ' ' VAL . 22.1 t -101.16 155.78 4.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 3.0 p-10 -95.59 148.48 22.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 118.718 0.69 . . . . 0.0 110.545 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.83 165.83 25.5 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.949 0.88 . . . . 0.0 112.823 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.522 ' OG1' ' HG2' ' A' ' 114' ' ' GLU . 26.7 m -122.86 138.56 54.62 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 125.002 1.321 . . . . 0.0 108.749 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.7 tp -99.2 117.11 32.93 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -113.27 112.06 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.85 142.75 24.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.189 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -136.6 100.48 4.35 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.704 0.764 . . . . 0.0 109.096 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.6 p -136.07 176.16 8.94 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.71 -30.73 71.45 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.849 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -77.39 -50.11 13.45 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.002 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -109.02 81.08 1.39 Allowed 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.19 98.28 9.28 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 120.793 0.33 . . . . 0.0 111.294 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.587 HD22 HD13 ' A' ' 11' ' ' LEU . 27.1 t-20 68.48 70.6 0.3 Allowed 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.175 0.988 . . . . 0.0 110.349 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 51.6 m -108.75 107.97 18.62 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.445 HG21 ' HA ' ' A' ' 4' ' ' THR . 73.0 mt -108.92 102.25 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.712 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.0 tp -123.13 113.92 19.63 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.727 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.522 ' HG2' ' OG1' ' A' ' 100' ' ' THR . 45.6 mt-10 -73.88 123.41 24.18 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.7 m -91.24 -43.45 14.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.839 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.69 -152.11 19.77 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 98' ' ' ASP . 59.9 Cg_endo -71.87 144.3 43.06 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.921 2.414 . . . . 0.0 112.121 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 97' ' ' VAL . 35.5 m -106.53 137.98 34.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.24 0.543 . . . . 0.0 110.973 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.3 p -110.16 173.73 6.19 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.982 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 38.9 tpp -110.41 132.68 53.97 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.676 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.504 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -99.4 -45.02 5.98 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.302 0.572 . . . . 0.0 109.585 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.09 -79.5 0.53 Allowed Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.46 155.43 41.18 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.0 tt . . . . . 0 C--N 1.309 -1.168 0 CA-C-O 120.885 0.374 . . . . 0.0 110.018 -179.208 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo . . . . . 0 C--O 1.25 1.09 0 N-CA-C 110.144 -0.752 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 9.6 m -120.74 138.55 53.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.332 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.401 ' HB2' HG21 ' A' ' 68' ' ' ILE . 55.0 t30 -119.74 168.37 11.14 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 172' ' ' GLN . 11.0 tpp180 65.62 42.84 3.48 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.673 1.589 . . . . 0.0 109.605 175.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.1 mtp -108.12 140.94 40.58 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-O 121.978 0.894 . . . . 0.0 112.301 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.64 HG23 ' HB3' ' A' ' 170' ' ' SER . 5.9 tt -105.02 146.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.894 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.504 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 23.8 ttm180 -128.97 137.23 51.25 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -173.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -131.51 131.27 43.3 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -80.88 97.0 7.2 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.773 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -156.09 134.81 11.78 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -72.78 109.41 6.36 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 13.1 t -140.03 171.29 14.4 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 143' ' ' THR . 37.9 ttpt -114.82 142.57 46.37 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.427 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 13.4 t -80.36 165.43 22.28 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 146' ' ' CYS . . . 105.69 -17.78 41.91 Favored Glycine 0 C--N 1.303 -1.298 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -94.09 28.61 2.41 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.755 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 33.7 t -76.74 141.64 40.74 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 113.14 -1.845 . . . . 0.0 109.241 -174.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.43 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 93.04 -4.26 74.44 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.62 134.35 26.03 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.6 p -76.12 119.48 24.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 122.086 0.946 . . . . 0.0 111.348 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.3 tp -90.1 102.0 14.71 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 20.3 p -147.66 174.22 11.98 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.38 0.609 . . . . 0.0 111.929 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.92 172.91 12.06 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.7 t -64.74 103.74 0.74 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.962 0.887 . . . . 0.0 111.297 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.18 6.14 66.94 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.621 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -140.56 103.02 4.45 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 117.239 0.52 . . . . 0.0 111.428 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 88.2 mt -97.28 123.8 49.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -95.93 -42.83 8.1 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.36 0.6 . . . . 0.0 110.336 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.414 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 171.78 -157.7 28.07 Favored Glycine 0 N--CA 1.425 -2.098 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.46 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 28.3 pt -127.21 145.87 34.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -63.76 129.3 39.57 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 123.502 0.721 . . . . 0.0 109.426 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.433 ' HA ' ' SG ' ' A' ' 146' ' ' CYS . 62.1 t -117.27 -48.69 4.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 O-C-N 123.212 0.32 . . . . 0.0 110.754 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -133.64 108.33 0.73 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.314 -1.422 . . . . 0.0 112.86 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 143' ' ' THR . . . -95.19 108.25 3.66 Favored Glycine 0 C--N 1.3 -1.437 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -120.01 90.65 3.37 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 59.65 -106.63 1.01 Allowed Glycine 0 C--O 1.229 -0.192 0 O-C-N 123.821 0.7 . . . . 0.0 113.185 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 77.8 mtm180 -94.81 8.2 43.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -122.29 115.8 22.97 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.102 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -97.05 115.91 5.36 Favored Glycine 0 N--CA 1.42 -2.423 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -102.0 129.28 48.25 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.159 0.504 . . . . 0.0 110.276 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.64 ' HB3' HG23 ' A' ' 135' ' ' ILE . 29.0 t -127.25 156.69 41.49 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.257 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.412 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -101.43 140.72 35.34 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 66.6 mt-30 -76.26 121.19 22.58 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 123.517 0.511 . . . . 0.0 110.974 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.414 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 89.9 mt -94.58 85.27 4.47 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -83.63 144.61 29.32 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.449 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.4 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 10.2 ptpp? -73.68 -14.64 61.19 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.925 0.393 . . . . 0.0 110.595 -176.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -65.58 -19.32 65.87 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.632 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -79.78 -25.4 40.97 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 121.932 -0.48 . . . . 0.0 109.917 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -101.24 50.37 0.86 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.788 0.804 . . . . 0.0 110.327 -174.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--N 1.291 -1.94 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.472 174.171 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 CA--C 1.538 0.676 0 CA-C-O 121.209 0.42 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -63.31 -41.94 98.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.455 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 m -63.38 -40.4 97.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.651 0.78 . . . . 0.0 109.521 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -64.31 -43.6 94.18 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.236 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -63.56 -46.26 86.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.966 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 11' ' ' LEU . . . -54.33 -50.23 67.9 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 124.074 0.859 . . . . 0.0 111.699 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -64.95 -35.38 80.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 m -72.26 -42.48 65.55 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.016 0.436 . . . . 0.0 110.699 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.8 tp -65.79 -39.94 91.45 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.779 0.832 . . . . 0.0 109.535 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.539 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 6.0 tt -56.0 -50.9 69.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.299 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -83.56 15.03 3.33 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -123.95 -56.27 1.66 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -118.09 -5.22 10.96 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -171.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.539 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 42.2 mt -96.53 121.46 47.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.935 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 19.8 ptp -140.85 153.94 45.98 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.726 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.419 HG22 ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -85.84 111.53 20.27 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.3 mt -104.7 113.25 41.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.777 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 10.6 m -76.44 107.46 8.72 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 75.9 p -87.56 -149.88 0.16 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.3 p -52.91 -42.03 64.96 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.122 0.569 . . . . 0.0 112.094 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -129.56 -60.66 1.04 Allowed 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.25 158.5 20.55 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 119.643 -1.265 . . . . 0.0 114.467 -172.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 40.5 mt-10 -86.74 112.15 21.4 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -105.77 174.4 5.9 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.472 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 35.1 m -87.3 114.99 24.41 Favored 'General case' 0 N--CA 1.411 -2.399 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.595 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.59 110.8 3.9 Favored Glycine 0 N--CA 1.41 -3.036 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.6 tp -94.32 109.08 20.94 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.28 133.19 28.28 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 48.0 mm -109.82 -54.51 5.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 117.331 0.565 . . . . 0.0 111.148 -177.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -154.53 123.26 6.2 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.737 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 66.72 -86.28 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.865 0.728 . . . . 0.0 112.82 169.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 83.7 mtm180 -132.7 10.52 4.33 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.93 0.871 . . . . 0.0 109.463 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.562 HG13 HG13 ' A' ' 74' ' ' VAL . 50.2 t -91.65 123.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.838 -1.073 . . . . 0.0 111.184 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.9 p -127.01 148.36 50.11 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.07 130.38 57.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.264 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.7 mm -130.26 136.24 28.69 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 124.584 1.154 . . . . 0.0 108.43 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 31.4 Cg_exo -61.88 142.97 95.11 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.292 1.994 . . . . 0.0 111.387 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.1 m -62.51 -47.32 84.47 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 122.145 0.178 . . . . 0.0 111.435 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -61.77 -14.83 36.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.675 0.79 . . . . 0.0 112.838 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.76 -25.19 60.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.403 ' O ' ' HB ' ' A' ' 20' ' ' THR . 29.9 mm-40 58.09 88.0 0.13 Allowed Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 124.594 1.158 . . . . 0.0 113.863 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -83.1 149.66 13.62 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.864 1.709 . . . . 0.0 109.835 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -157.35 33.06 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.459 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.72 -17.25 27.06 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.973 0.892 . . . . 0.0 110.093 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -137.12 131.03 32.06 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 m -117.17 164.24 13.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 5.7 mp -113.49 110.59 20.52 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.146 178.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.7 t -87.75 94.24 4.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 t30 51.75 62.33 2.76 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 124.549 1.14 . . . . 0.0 109.024 -174.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.06 -34.36 3.42 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.018 -0.992 . . . . 0.0 114.03 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 24.1 mt-30 -72.21 108.89 5.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.169 0.485 . . . . 0.0 111.993 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -68.78 122.62 18.95 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.415 HD12 HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -134.4 127.7 50.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -78.18 127.68 32.63 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.784 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.2 140.39 18.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.573 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 60.5 tttm -89.32 -59.01 2.33 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.277 0.561 . . . . 0.0 110.16 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.2 m-20 -136.34 149.78 48.55 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.357 -177.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -132.23 107.87 8.87 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -117.53 126.68 53.0 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -77.0 133.28 39.19 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.459 -0.896 . . . . 0.0 108.871 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.426 ' HG ' HD12 ' A' ' 70' ' ' LEU . 31.9 tp -91.24 104.5 17.04 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.62 0.724 . . . . 0.0 109.44 -176.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 69' ' ' ASN . 20.5 m -119.62 160.02 20.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.406 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.01 147.42 47.98 Favored Pre-proline 0 C--N 1.289 -2.022 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -45.2 -13.95 0.08 OUTLIER 'Trans proline' 0 CA--C 1.564 1.982 0 C-N-CA 124.266 3.311 . . . . 0.0 116.074 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -77.19 -2.32 33.9 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.486 -0.759 . . . . 0.0 111.011 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 75.63 12.52 3.07 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.962 1.705 . . . . 0.0 109.998 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.5 mm -90.41 134.44 29.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 114.119 -1.4 . . . . 0.0 107.405 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 131' ' ' THR . 57.3 t30 -79.99 147.55 31.51 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.999 0.428 . . . . 0.0 111.395 -173.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.426 HD12 ' HG ' ' A' ' 62' ' ' LEU . 63.0 mt -99.32 -6.18 28.37 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 17.1 tp10 75.39 16.35 2.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 123.169 1.462 . . . . 0.0 109.823 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.25 136.27 50.58 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.669 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.0 m -116.52 128.94 55.9 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.562 HG13 HG13 ' A' ' 34' ' ' VAL . 59.5 t -82.99 101.18 7.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -98.08 111.88 24.04 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.2 m -94.77 110.92 22.73 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.77 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.48 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 95.8 mt -86.32 142.32 28.58 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.863 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -88.68 86.84 7.07 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -122.65 131.76 53.96 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -68.34 -34.5 76.22 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.298 0.374 . . . . 0.0 111.222 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -86.45 104.31 15.8 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -79.1 142.36 36.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.302 0.573 . . . . 0.0 110.445 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -83.63 145.48 28.79 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.31 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -57.27 120.17 7.68 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.112 -1.403 . . . . 0.0 108.69 175.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 4.6 p30 -74.85 117.7 16.98 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.234 -1.387 . . . . 0.0 109.906 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.0 pt -97.17 28.53 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.52 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.8 ttm105 -59.94 -37.14 78.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.99 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.96 -7.45 70.65 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.489 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -96.74 -10.54 26.6 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.425 0.612 . . . . 0.0 110.943 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.6 mt -66.53 123.54 19.76 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-O 121.144 0.497 . . . . 0.0 110.315 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.8 p -100.74 115.92 31.41 Favored 'General case' 0 N--CA 1.407 -2.623 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.552 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.589 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 1.3 pm0 -71.38 -29.77 65.34 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.536 175.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.12 115.44 18.79 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.429 ' HB3' HD12 ' A' ' 135' ' ' ILE . 33.1 mt -106.83 -60.77 1.63 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.875 -174.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.93 131.53 45.66 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.157 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.02 -22.29 33.73 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.661 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.8 t -92.29 148.31 4.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.02 125.23 38.53 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.695 0.76 . . . . 0.0 109.835 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.76 154.37 18.68 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 122.08 0.943 . . . . 0.0 113.121 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.9 m -127.38 125.91 41.52 Favored 'General case' 0 N--CA 1.417 -2.079 0 C-N-CA 125.432 1.493 . . . . 0.0 107.95 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -95.48 118.85 32.95 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -111.91 112.49 40.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.484 HG11 ' NE2' ' A' ' 145' ' ' GLN . 7.4 p -114.89 135.78 53.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.6 0.714 . . . . 0.0 111.101 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -129.58 84.82 2.25 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.8 t -130.51 174.94 9.4 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.018 -174.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.473 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 26.9 t-20 -70.64 -31.54 68.52 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -69.74 -51.92 29.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.952 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.573 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 79.1 m-85 -138.5 119.85 14.8 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.124 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.2 m -107.66 112.76 25.62 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 -175.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 74.06 27.16 1.61 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.457 1.103 . . . . 0.0 111.221 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.573 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 13.7 m -79.8 117.06 20.34 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.658 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.2 mt -101.59 99.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.8 tp -102.31 111.83 24.28 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.279 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -82.52 108.56 16.02 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.84 -54.61 9.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.431 -172.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 125.43 -164.12 19.13 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.32 135.94 52.77 Favored 'Trans proline' 0 C--O 1.244 0.8 0 C-N-CA 122.935 2.424 . . . . 0.0 112.771 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.419 HG12 ' HB3' ' A' ' 137' ' ' TYR . 22.1 m -110.81 160.34 10.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.273 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.7 t -143.36 159.71 41.87 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.8 ttt -89.24 131.49 35.33 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -90.91 -50.32 5.94 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.57 0.7 . . . . 0.0 109.206 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.48 -103.56 0.76 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.407 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 2.9 pp -126.58 158.18 36.92 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.563 0.22 . . . . 0.0 111.448 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.8 tt . . . . . 0 C--N 1.311 -1.099 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.502 177.341 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 N--CA 1.44 -1.666 0 N-CA-C 110.013 -0.803 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 31.7 p -112.06 143.02 43.76 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.52 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 123' ' ' LEU . 10.9 t30 -139.13 159.49 42.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -177.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 16.2 mtp180 75.98 27.25 0.94 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.604 1.562 . . . . 0.0 109.126 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 131.56 36.15 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.062 -175.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.603 HG23 ' HB3' ' A' ' 170' ' ' SER . 2.0 tt -98.91 136.54 29.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.049 -1.432 . . . . 0.0 107.764 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.408 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 49.8 ttp180 -121.69 142.9 49.7 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.432 0.634 . . . . 0.0 111.522 -172.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.419 ' HB3' HG12 ' A' ' 118' ' ' VAL . 3.5 p90 -134.16 140.51 46.6 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.252 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 166' ' ' ARG . 16.8 t70 -94.91 105.31 17.23 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -159.23 143.54 15.3 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.21 100.19 0.44 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.181 0.515 . . . . 0.0 109.664 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.0 p -65.39 161.02 20.66 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -133.68 137.82 45.52 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.5 m -84.39 152.15 24.23 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.01 -7.32 76.54 Favored Glycine 0 N--CA 1.459 0.209 0 C-N-CA 119.979 -1.105 . . . . 0.0 111.601 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.484 ' NE2' HG11 ' A' ' 103' ' ' VAL . 11.9 mm100 -92.1 2.69 56.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.048 0.928 . . . . 0.0 108.676 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 27.8 m -61.92 127.37 31.08 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.882 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.472 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 103.52 -11.7 54.08 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.153 -1.023 . . . . 0.0 111.192 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.12 137.93 36.33 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.4 p -77.61 123.83 34.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.743 0.782 . . . . 0.0 111.277 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 28.4 tp -91.84 100.28 12.99 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.6 p -125.57 -173.86 2.93 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.885 -173.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -155.07 -175.84 5.64 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.2 t -62.45 99.7 0.15 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.828 0.823 . . . . 0.0 111.311 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.2 20.75 79.29 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.568 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 97.4 mttt -138.44 148.06 43.99 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.648 0.379 . . . . 0.0 110.369 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 91.1 mt -132.45 126.45 55.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -96.14 -49.98 5.02 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.731 0.776 . . . . 0.0 109.637 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.552 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 178.81 -152.18 11.06 Favored Glycine 0 N--CA 1.42 -2.387 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.055 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 pt -126.46 151.97 33.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 117.121 0.461 . . . . 0.0 110.352 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -63.46 118.42 8.09 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.0 t -91.7 -62.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.33 -139.8 5.11 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.973 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.81 137.99 5.32 Favored Glycine 0 C--N 1.288 -2.128 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -110.13 130.38 55.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.24 -125.26 8.42 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.642 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 10.9 mtm180 -106.21 -7.08 18.03 Favored 'General case' 0 C--O 1.214 -0.777 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.461 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -96.31 106.24 18.43 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.611 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.66 132.02 11.07 Favored Glycine 0 N--CA 1.418 -2.562 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -115.61 127.82 55.49 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.684 0.755 . . . . 0.0 110.695 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.603 ' HB3' HG23 ' A' ' 135' ' ' ILE . 37.7 t -120.34 155.09 34.07 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.453 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -108.74 134.27 51.69 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 11.0 pt20 -78.07 117.36 19.31 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 124.015 0.822 . . . . 0.0 110.725 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.552 ' HG ' ' HA2' ' A' ' 158' ' ' GLY 0.304 0.7 OUTLIER -99.37 75.35 1.97 Allowed 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.226 1.013 . . . . 0.0 111.831 177.282 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -59.49 144.74 46.31 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.324 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -61.17 -20.21 62.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.832 0.853 . . . . 0.0 110.94 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -59.33 -29.05 67.37 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.689 1.195 . . . . 0.0 110.925 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -82.14 -8.04 59.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.715 0.293 . . . . 0.0 111.341 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -128.46 28.1 5.48 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.245 0.863 0 CA-C-O 121.324 0.583 . . . . 0.0 112.507 -179.723 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo . . . . . 0 CA--C 1.543 0.952 0 N-CA-C 116.262 1.601 . . . . 0.0 116.262 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -70.03 -34.27 73.05 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.52 -174.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.5 m -72.72 -33.64 66.57 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.136 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -61.9 -48.29 81.11 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.536 0.735 . . . . 0.0 109.376 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -63.81 -47.94 78.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.011 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.48 81.0 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.473 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 tp -65.62 -36.72 84.53 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 122.794 0.438 . . . . 0.0 111.232 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -71.87 -44.41 63.81 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.949 0.404 . . . . 0.0 110.414 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.9 tp -65.84 -36.97 84.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.522 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.49 ' HA ' HD12 ' A' ' 15' ' ' ILE . 37.4 tp -51.57 -56.82 11.32 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.364 1.465 . . . . 0.0 112.254 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -79.18 7.81 6.98 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -131.37 -49.98 1.0 Allowed 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -118.05 0.11 11.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 11' ' ' LEU . 50.0 mt -113.18 106.83 21.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.882 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -123.35 160.16 27.35 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.925 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.492 ' CG2' ' HB3' ' A' ' 24' ' ' GLU . 80.5 m -90.3 121.5 32.36 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 174.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.3 mt -106.5 124.48 62.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.56 HG22 ' HG2' ' A' ' 24' ' ' GLU . 6.0 p -79.31 98.97 6.9 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.741 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.2 p -98.59 -173.61 2.59 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 21.1 t -69.93 -34.82 73.97 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -84.77 -5.29 59.32 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.77 -162.82 24.48 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.081 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HG2' HG22 ' A' ' 19' ' ' THR . 40.2 mt-10 -94.53 111.13 22.88 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.893 0.378 . . . . 0.0 110.861 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -116.67 -178.77 3.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.384 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.7 m -98.11 136.81 37.82 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.7 126.47 6.63 Favored Glycine 0 N--CA 1.418 -2.549 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -96.79 119.59 35.55 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.5 121.94 5.59 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' HA ' HD11 ' A' ' 86' ' ' ILE . 44.6 mm -85.04 -53.94 9.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 117.388 0.594 . . . . 0.0 109.788 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -164.53 154.69 14.25 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 54.27 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.3 ptt180 -139.64 10.48 2.46 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.705 1.202 . . . . 0.0 108.956 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.15 114.55 31.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.125 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -125.11 156.36 38.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -117.09 135.5 57.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.1 tp -141.53 148.73 51.52 Favored Pre-proline 0 CA--C 1.559 1.309 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -76.2 145.4 27.44 Favored 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 121.964 1.776 . . . . 0.0 112.787 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.518 HG23 ' OG1' ' A' ' 73' ' ' THR . 0.2 OUTLIER -74.41 -18.56 60.64 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -73.47 -21.42 60.44 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.658 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.55 -26.15 45.61 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 96.1 mt-30 63.44 90.63 0.09 OUTLIER Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.735 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.14 152.48 24.23 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 121.962 1.775 . . . . 0.0 110.203 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.61 -157.65 26.72 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 119.971 -1.109 . . . . 0.0 113.142 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.74 -34.41 30.49 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.573 0.702 . . . . 0.0 110.902 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -137.84 138.88 39.59 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.71 144.95 36.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.224 0.535 . . . . 0.0 111.311 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 51' ' ' GLY . 6.0 tt -84.74 101.26 12.07 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 174.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.5 p -96.98 94.55 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 122.033 0.92 . . . . 0.0 110.492 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.6 t30 55.97 23.42 6.67 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.134 1.374 . . . . 0.0 112.019 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.407 ' H ' HD23 ' A' ' 48' ' ' LEU . . . 139.52 -49.67 0.8 Allowed Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.808 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -85.09 119.2 25.21 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -174.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.12 108.45 12.62 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.474 HD11 ' O ' ' A' ' 78' ' ' ASP . 9.4 tp -112.76 143.54 22.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.439 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -78.94 131.59 36.42 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.114 0.483 . . . . 0.0 110.783 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.5 t -89.68 125.94 42.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -78.66 -59.52 2.75 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.462 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -136.21 159.64 41.13 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -140.74 100.55 3.87 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -174.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.514 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 59.4 m-85 -97.08 113.56 25.13 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -82.56 111.19 18.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.31 104.55 6.89 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -174.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.87 133.9 62.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -71.63 145.07 89.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.73 -20.02 4.14 Favored 'Trans proline' 0 CA--C 1.552 1.39 0 C-N-CA 123.867 3.045 . . . . 0.0 115.3 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -86.58 9.12 19.49 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.752 -0.592 . . . . 0.0 111.175 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 71.78 26.38 3.04 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 123.433 1.587 . . . . 0.0 109.931 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.4 mt -97.57 127.94 49.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.516 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 131' ' ' THR . 21.0 m-80 -89.06 155.33 19.53 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.059 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.253 0.0 OUTLIER -132.22 18.94 4.45 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.795 0.807 . . . . 0.0 110.896 173.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 70.05 -20.8 0.18 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.338 1.855 . . . . 0.0 114.593 173.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.18 119.15 5.47 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.518 ' OG1' HG23 ' A' ' 39' ' ' THR . 20.5 m -117.9 112.85 20.89 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 171.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 44.0 t -81.86 105.57 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.83 113.67 26.01 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.9 m -99.11 105.34 17.41 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 120.876 0.37 . . . . 0.0 110.035 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.9 mp -77.98 139.38 39.16 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.579 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.474 ' O ' HD11 ' A' ' 54' ' ' ILE . 36.5 t70 -89.48 96.14 10.57 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.752 177.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -155.53 152.2 28.56 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.62 0.724 . . . . 0.0 112.488 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -89.16 -12.42 41.05 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.368 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -74.07 132.82 42.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.009 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -108.35 121.82 45.7 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.729 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -76.8 144.07 39.38 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -59.66 131.11 49.92 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.83 96.76 0.14 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.876 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.443 HD11 ' HA ' ' A' ' 30' ' ' ILE . 2.6 pp -93.71 18.27 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 122.204 1.002 . . . . 0.0 110.388 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -62.87 -32.22 73.42 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.166 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.14 2.48 87.65 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.923 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -103.14 -8.77 20.2 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 117.136 0.468 . . . . 0.0 110.731 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.4 mt -67.57 128.7 31.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.9 t -95.04 107.72 19.78 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -62.89 -23.13 67.19 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.778 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -106.05 111.55 24.22 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mp -102.81 -51.23 3.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.18 137.03 56.72 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -172.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.15 8.1 31.9 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.89 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.443 ' O ' HG22 ' A' ' 118' ' ' VAL . 40.4 t -122.31 150.37 25.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 O-C-N 122.183 -0.598 . . . . 0.0 109.717 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -82.18 122.63 28.14 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -115.0 160.7 19.28 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.98 0.895 . . . . 0.0 113.152 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 37.6 m -122.76 135.51 54.58 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.059 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.5 tp -100.19 124.99 46.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -113.77 117.65 56.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.466 ' HB ' ' OG1' ' A' ' 111' ' ' THR . 23.9 t -112.03 138.17 41.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -136.66 92.62 2.77 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.9 p -138.7 -169.74 2.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.127 -174.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -56.51 -59.34 5.12 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.021 0.928 . . . . 0.0 112.142 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -92.71 -35.62 13.37 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.407 0.622 . . . . 0.0 110.517 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -99.17 84.15 2.98 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.488 0.661 . . . . 0.0 109.765 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.57 111.04 22.63 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.344 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 65.17 37.16 6.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.286 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.466 ' OG1' ' HB ' ' A' ' 103' ' ' VAL . 32.5 p -79.61 94.22 5.63 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.013 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.72 103.41 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.5 tp -117.43 114.31 23.32 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.655 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 0.3 OUTLIER -77.66 143.53 38.09 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.979 177.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 36.0 m -111.43 -31.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 119.949 -0.701 . . . . 0.0 111.844 -176.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.78 -155.03 16.53 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.064 -1.065 . . . . 0.0 111.555 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.92 124.35 10.53 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.845 2.363 . . . . 0.0 111.978 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.461 ' HB ' HD11 ' A' ' 135' ' ' ILE . 35.0 m -96.93 134.07 36.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.348 0.594 . . . . 0.0 110.895 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.6 p -128.38 163.68 24.31 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.755 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.3 ttt -84.47 133.13 34.49 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 118.551 0.614 . . . . 0.0 110.013 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.639 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -82.09 -37.82 25.77 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 121.832 0.825 . . . . 0.0 108.801 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.94 -102.83 2.21 Favored Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.97 149.4 47.52 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.4 pt . . . . . 0 C--N 1.288 -2.069 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.0 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.45 -1.053 0 CA-C-O 121.727 0.636 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.9 t -125.17 118.63 26.51 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -106.35 156.93 18.01 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.581 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 74.22 57.02 0.09 Allowed 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.051 1.341 . . . . 0.0 111.508 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.0 mmt -113.28 143.03 45.11 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 113.064 -1.88 . . . . 0.0 108.832 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 18.1 tt -106.96 141.79 21.31 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.639 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 24.4 ttm-85 -118.96 132.97 56.1 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 122.634 0.374 . . . . 0.0 110.427 -173.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -136.29 134.62 38.18 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.637 172.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -87.84 91.31 8.71 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.869 0.842 . . . . 0.0 110.342 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -158.06 136.68 11.2 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.52 87.29 2.64 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.54 0.686 . . . . 0.0 111.398 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.6 p -94.48 161.09 14.36 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.798 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -118.31 136.16 53.87 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.0 m -61.22 124.98 22.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.594 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 132.45 -15.9 4.92 Favored Glycine 0 C--N 1.299 -1.517 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.681 HE21 ' HA ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -97.79 18.09 16.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.25 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.9 m -62.7 130.92 47.13 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.021 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.43 -1.21 66.47 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.62 138.99 26.87 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.65 124.72 38.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.859 0.838 . . . . 0.0 111.472 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.7 tp -92.19 108.85 20.25 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.5 p -141.75 177.57 8.07 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.172 0.51 . . . . 0.0 111.813 -173.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -152.96 179.52 8.61 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 176.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.9 m -54.71 101.1 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.17 0.588 . . . . 0.0 111.876 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 69.15 23.31 76.22 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.667 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 74.8 mmtt -136.26 118.34 15.41 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 98.7 mt -108.14 129.24 62.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -103.45 -45.47 4.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.262 0.553 . . . . 0.0 110.899 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.516 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 176.82 -157.86 23.36 Favored Glycine 0 N--CA 1.421 -2.359 0 C-N-CA 118.968 -1.587 . . . . 0.0 112.586 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.4 pt -126.49 141.77 44.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -63.58 130.79 45.78 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.216 0.606 . . . . 0.0 110.357 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.0 t -101.14 -49.2 11.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -173.06 160.99 31.97 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.697 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -107.59 129.54 9.7 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -126.86 95.27 4.27 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.27 -125.04 17.5 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -101.44 21.5 14.1 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.318 0.58 . . . . 0.0 111.174 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -122.77 124.47 43.41 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.048 0.451 . . . . 0.0 110.146 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -102.26 131.56 10.65 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -109.12 133.63 52.76 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.524 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 41.9 m -130.62 150.44 51.81 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.759 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -88.81 135.46 33.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -82.96 95.65 8.06 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 123.485 0.49 . . . . 0.0 110.623 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.516 ' HG ' ' HA2' ' A' ' 158' ' ' GLY 0.306 1.0 OUTLIER -83.08 76.46 9.85 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-O 122.745 1.259 . . . . 0.0 112.299 177.909 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -75.71 153.35 37.14 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.209 -1.359 . . . . 0.0 111.88 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -59.7 -23.91 63.53 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.383 1.073 . . . . 0.0 112.046 -174.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -58.87 -22.89 60.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.728 1.211 . . . . 0.0 112.052 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -96.14 -9.83 29.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.937 0.399 . . . . 0.0 111.695 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -111.59 18.48 19.02 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.416 0.627 . . . . 0.0 110.756 -175.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.309 -1.189 0 CA-C-N 115.384 -0.826 . . . . 0.0 108.818 178.367 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--O 1.241 0.666 0 N-CA-C 113.681 0.608 . . . . 0.0 113.681 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -68.44 -30.2 69.02 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.016 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 m -70.36 -41.82 72.64 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.238 0.615 . . . . 0.0 109.357 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.24 -50.11 74.95 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.808 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -65.04 -42.66 94.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.647 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.29 82.89 Favored 'General case' 0 C--O 1.216 -0.684 0 O-C-N 123.516 0.51 . . . . 0.0 110.856 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.63 -39.99 95.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.146 0.498 . . . . 0.0 110.719 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -68.48 -43.48 76.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.005 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.7 tp -68.12 -39.07 82.84 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.276 0.631 . . . . 0.0 109.913 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 7.8 tt -55.31 -47.94 74.86 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.896 0.878 . . . . 0.0 110.25 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -79.09 14.94 1.26 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.978 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 -64.36 0.96 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -116.37 4.49 13.4 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.478 ' CG2' ' HB3' ' A' ' 104' ' ' HIS . 1.7 mp -87.36 115.03 27.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.255 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.407 ' HB3' ' CG2' ' A' ' 49' ' ' VAL . 21.6 mmt -113.21 134.13 54.73 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.043 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 89.8 m -92.8 103.58 15.92 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.7 mt -101.37 121.13 51.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 121.198 0.523 . . . . 0.0 110.544 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -87.41 108.15 18.87 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 41.2 p -102.92 -166.59 1.29 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.51 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.431 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 31.3 t -66.28 -43.15 87.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.071 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -89.39 -9.94 48.4 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -172.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.14 -165.82 33.39 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.19 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -108.59 103.33 12.42 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 146' ' ' CYS . 83.4 m-85 -113.52 175.0 5.64 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.087 -174.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.6 m -93.78 136.33 34.18 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.84 145.31 16.75 Favored Glycine 0 N--CA 1.416 -2.691 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.4 tp -105.4 119.96 40.39 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.206 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.68 139.77 25.03 Favored Glycine 0 N--CA 1.428 -1.847 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 40.4 mm -99.31 -49.73 11.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -174.86 153.99 1.81 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.56 ' OD1' ' HG2' ' A' ' 82' ' ' LYS . 36.1 m-20 51.02 -94.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.575 1.172 . . . . 0.0 113.186 176.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 17.7 ptp180 -127.06 6.11 6.51 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.511 -176.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 64.6 t -92.77 118.71 39.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -132.45 159.92 37.93 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 m -123.27 146.6 28.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 122.155 -0.341 . . . . 0.0 111.011 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.8 tt -158.13 147.12 14.58 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 45.1 Cg_exo -60.75 142.12 96.85 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 122.496 2.131 . . . . 0.0 112.8 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.1 m -59.73 -37.9 80.2 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -71.21 -2.06 14.68 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.41 -30.29 57.39 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 26.9 mt-30 60.46 89.13 0.11 Allowed Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.123 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.41 154.82 28.18 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.206 1.937 . . . . 0.0 110.507 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.32 -166.02 29.88 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.436 -0.887 . . . . 0.0 111.859 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -81.85 -18.7 42.99 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 122.104 0.954 . . . . 0.0 109.126 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 7.7 p-10 -147.37 148.15 31.05 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 m -142.52 -172.81 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 1.2 pt? -138.63 127.64 23.93 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 17' ' ' THR . 5.2 p -115.85 116.1 51.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.757 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 65.56 19.85 11.56 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.051 0.94 . . . . 0.0 109.465 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.23 -15.41 59.07 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.318 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 83.1 mt-30 -78.42 121.66 24.8 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 122.461 0.304 . . . . 0.0 110.263 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' A' ' 48' ' ' LEU . 29.4 mmmt -67.65 126.18 28.56 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.415 HD11 ' O ' ' A' ' 78' ' ' ASP . 9.3 tp -146.19 133.83 15.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.586 0.708 . . . . 0.0 110.551 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 38.7 mtm180 -85.37 145.4 27.5 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.585 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.77 148.31 5.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -97.82 -57.03 2.33 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -141.76 166.96 23.28 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -139.89 95.25 2.87 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.496 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 84.6 m-85 -81.37 111.37 17.68 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.5 103.73 4.95 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.446 HD12 ' HG ' ' A' ' 70' ' ' LEU . 1.3 tm? -80.82 101.83 9.62 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.4 155.7 9.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.69 138.44 83.07 Favored Pre-proline 0 C--N 1.311 -1.068 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -47.4 -29.06 9.32 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.056 3.171 . . . . 0.0 114.442 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -93.16 16.72 12.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.704 0.288 . . . . 0.0 110.986 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 71.87 20.18 4.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.298 1.039 . . . . 0.0 112.327 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.4 mm -87.69 149.89 3.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 131' ' ' THR . 56.4 t30 -69.87 142.89 52.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.573 HD21 ' HD2' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -118.27 -29.72 5.46 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 69.06 17.39 8.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.603 1.161 . . . . 0.0 111.281 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.15 135.43 54.19 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.1 m -128.15 130.29 47.86 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 120.826 0.346 . . . . 0.0 110.13 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 46.4 t -90.46 109.68 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -91.61 121.98 33.77 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.4 m -104.86 105.5 15.59 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 91.8 mt -82.65 168.68 17.04 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.415 ' O ' HD11 ' A' ' 54' ' ' ILE . 18.7 t70 -93.64 89.88 6.4 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 171.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -129.61 116.01 18.24 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.302 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.78 -29.77 36.09 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.53 140.22 51.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.813 -1.54 . . . . 0.0 110.739 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.56 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 60.5 mttm -90.26 105.55 17.89 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -77.64 144.88 37.07 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 166.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -59.04 126.95 29.81 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 124.008 0.818 . . . . 0.0 112.376 -172.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 12.7 p-10 -69.74 102.87 2.0 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.09 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -93.12 23.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.633 -0.667 . . . . 0.0 111.794 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -62.8 -40.11 96.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.067 -175.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.35 -0.48 89.11 Favored Glycine 0 C--N 1.317 -0.511 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.606 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -98.97 -14.11 19.65 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.8 mt -64.46 122.51 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.441 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.1 m -122.89 95.58 4.68 Favored 'General case' 0 N--CA 1.397 -3.112 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.97 -14.92 57.52 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -88.48 95.17 10.12 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 171.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.499 HD22 HD12 ' A' ' 135' ' ' ILE . 2.2 pp -125.79 -21.54 4.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 -162.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.417 ' N ' HD12 ' A' ' 94' ' ' LEU . 12.1 pt-20 -68.44 134.05 49.58 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.797 -1.161 . . . . 0.0 113.656 -172.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.35 -13.99 56.85 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.684 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 118' ' ' VAL . 16.0 t -93.45 157.02 3.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 2.6 p30 -96.22 148.96 22.18 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.8 158.87 38.98 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.034 0.921 . . . . 0.0 112.64 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.0 m -123.63 131.83 53.71 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.076 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.2 tp -94.97 115.83 27.93 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.99 109.24 27.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 47.2 t -113.97 131.89 64.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.478 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 9.7 t60 -140.85 93.71 2.63 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -121.36 179.7 4.34 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.503 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -75.63 -37.73 59.49 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.214 -0.595 . . . . 0.0 111.287 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -86.62 -22.98 25.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.178 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -125.05 76.9 1.58 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.4 m -88.56 129.39 35.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.351 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 57.38 68.03 0.9 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.902 1.281 . . . . 0.0 113.458 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.483 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 27.3 m -107.78 99.8 9.24 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.189 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.4 mt -100.76 96.61 4.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.8 tp -110.34 106.22 15.52 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.546 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.17 115.84 14.12 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.9 m -94.98 -19.63 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.19 -159.5 17.94 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.63 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 98' ' ' ASP . 24.6 Cg_exo -65.01 133.61 36.46 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.42 2.747 . . . . 0.0 112.586 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 137' ' ' TYR . 35.4 m -111.31 159.35 11.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.154 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.5 t -142.11 167.03 23.1 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.6 ttt -87.54 129.35 35.12 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -91.49 -26.13 18.95 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.282 0.563 . . . . 0.0 110.696 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.62 -106.99 2.59 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.51 116.73 23.66 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.2 mm . . . . . 0 C--N 1.302 -1.476 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.782 -179.403 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 N--CA 1.449 -1.135 0 CA-C-O 121.37 0.487 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 24.6 m -121.96 120.46 34.49 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -98.95 158.77 15.42 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.573 ' HD2' HD21 ' A' ' 70' ' ' LEU . 98.9 mtt180 64.27 62.01 0.86 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 122.514 1.15 . . . . 0.0 110.813 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 54.8 ttm -124.78 145.57 49.67 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.566 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.547 HG23 ' HB3' ' A' ' 170' ' ' SER . 1.4 tt -109.38 134.77 50.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 53.0 ttt180 -120.51 140.21 51.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.158 0.504 . . . . 0.0 111.772 -173.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.452 ' HB3' HG12 ' A' ' 118' ' ' VAL . 26.5 p90 -141.74 132.38 25.52 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.466 172.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.37 81.03 4.91 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.976 0.893 . . . . 0.0 109.634 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -144.52 127.74 16.72 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.43 105.88 4.31 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.193 0.52 . . . . 0.0 111.15 -176.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.3 p -89.59 174.36 7.8 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -114.39 172.67 6.88 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.1 t -84.93 146.89 27.02 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.3 56.68 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -106.37 14.77 26.92 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.428 0.633 . . . . 0.0 110.369 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.443 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 47.2 t -71.07 129.46 39.02 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.329 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.15 2.68 62.14 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.327 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.23 131.82 38.94 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.2 t -76.92 109.53 11.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 28.7 tp -88.0 106.0 17.84 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.7 p -136.75 178.36 7.13 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.957 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.83 -178.95 6.17 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.5 m -64.92 97.24 0.22 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.193 0.52 . . . . 0.0 110.931 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.52 11.41 68.8 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.877 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.75 143.11 33.32 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 117.089 0.445 . . . . 0.0 110.749 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 75.8 mt -122.62 130.83 74.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -105.22 -34.12 8.01 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.222 0.534 . . . . 0.0 111.328 -175.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 168.9 -159.6 32.75 Favored Glycine 0 N--CA 1.426 -1.967 0 C-N-CA 119.884 -1.151 . . . . 0.0 112.1 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 27.5 pt -132.58 135.78 57.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.838 0.351 . . . . 0.0 110.663 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -64.84 118.69 9.37 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 123.62 0.768 . . . . 0.0 110.179 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.7 m -90.95 -36.05 7.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 120.87 0.367 . . . . 0.0 110.309 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.88 164.71 31.65 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -129.26 143.89 14.94 Favored Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -132.83 103.8 6.27 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.16 -108.31 2.45 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -104.58 -10.45 17.57 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -85.07 99.26 10.92 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 120.988 0.423 . . . . 0.0 111.451 -174.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.5 113.32 3.81 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -95.95 120.95 37.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 121.3 0.572 . . . . 0.0 109.614 -176.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.547 ' HB3' HG23 ' A' ' 135' ' ' ILE . 35.1 t -119.22 139.14 52.36 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.418 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -76.18 134.17 39.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -79.71 111.48 16.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.71 99.31 10.16 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.454 ' HB3' ' HG2' ' A' ' 176' ' ' GLN . 63.5 mttm -85.69 142.52 28.97 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.372 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -72.55 -19.13 61.56 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.734 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.47 ' O ' HG12 ' A' ' 179' ' ' VAL . 3.4 pt20 -75.16 -5.34 43.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.729 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -76.76 -26.03 54.09 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -106.97 1.02 24.16 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.069 -173.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 176' ' ' GLN . 9.1 p . . . . . 0 N--CA 1.434 -1.243 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo . . . . . 0 CA--C 1.54 0.824 0 N-CA-C 114.621 0.97 . . . . 0.0 114.621 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -72.03 -41.45 67.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.241 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -62.31 -40.28 95.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.626 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.54 -36.83 71.13 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.45 0.167 . . . . 0.0 110.607 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.86 -48.88 79.8 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.47 96.35 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.357 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.4 -44.86 96.41 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.0 0.52 . . . . 0.0 110.419 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -63.03 -48.55 78.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.547 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.71 -41.73 98.0 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.279 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 26.1 tp -56.17 -58.92 5.89 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.809 1.243 . . . . 0.0 111.706 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -76.51 -2.23 31.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.819 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -109.37 -63.88 1.31 Allowed 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -108.96 -10.06 15.07 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -170.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.474 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 58.2 mt -91.77 109.89 21.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.025 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 67.6 mtm -116.39 139.93 49.9 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 120.592 0.234 . . . . 0.0 111.09 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.5 m -82.55 119.42 24.22 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.9 mt -109.11 108.3 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.2 m -81.85 104.79 12.48 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.629 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 77.1 p -91.88 -162.6 0.94 Allowed 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.937 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.7 t -81.41 -14.2 57.41 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -100.39 -34.38 9.99 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.287 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.04 -162.6 36.35 Favored Glycine 0 CA--C 1.502 -0.759 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.743 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.462 ' CD ' ' HB3' ' A' ' 106' ' ' ASN . 82.8 mt-10 -92.7 104.09 16.4 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -107.45 176.61 5.1 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 104' ' ' HIS . 0.0 OUTLIER -117.91 131.58 56.5 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-O 121.11 0.481 . . . . 0.0 109.983 -179.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.44 131.65 10.14 Favored Glycine 0 N--CA 1.416 -2.633 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -98.51 115.72 29.19 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.86 122.35 8.2 Favored Glycine 0 N--CA 1.434 -1.482 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.0 mm -85.8 -57.51 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.315 0.578 . . . . 0.0 109.874 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -155.33 137.21 14.48 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.928 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 62.52 -85.91 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 O-C-N 124.641 1.213 . . . . 0.0 112.455 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -143.2 18.75 1.92 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.264 1.031 . . . . 0.0 109.989 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.6 t -92.51 113.56 27.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.5 p -122.19 155.49 35.7 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.569 ' HB ' HD11 ' A' ' 72' ' ' LEU . 27.1 m -117.73 145.42 23.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 120.732 0.301 . . . . 0.0 110.934 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.2 tt -146.49 141.51 16.37 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -60.4 143.44 99.48 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.724 1.616 . . . . 0.0 111.14 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.2 m -66.99 -40.15 87.31 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.124 0.487 . . . . 0.0 111.577 -174.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -70.97 -1.42 11.94 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.43 -17.5 61.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 122.073 -0.392 . . . . 0.0 110.327 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.629 ' O ' ' HB ' ' A' ' 20' ' ' THR . 16.9 mm100 63.93 74.43 0.43 Allowed Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 124.638 1.175 . . . . 0.0 113.174 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -89.15 -175.19 1.09 Allowed 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 122.67 2.247 . . . . 0.0 109.814 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.95 -160.1 8.23 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -81.67 -20.22 40.0 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.875 0.845 . . . . 0.0 109.232 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -132.41 141.64 48.95 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.76 160.37 42.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 90.5 mt -101.89 102.07 12.59 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.06 100.66 7.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 121.864 0.84 . . . . 0.0 108.894 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.8 t30 63.47 10.7 5.04 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.19 1.396 . . . . 0.0 110.355 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.9 -19.97 8.23 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.737 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -77.95 116.03 18.14 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 120.583 0.23 . . . . 0.0 110.384 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -70.29 111.93 6.24 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.656 0.741 . . . . 0.0 109.914 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 78' ' ' ASP . 9.5 tp -126.05 140.96 47.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.564 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -87.61 143.24 27.29 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.3 133.04 42.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -80.63 -62.78 1.57 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.09 0.472 . . . . 0.0 110.194 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.464 ' H ' ' HB ' ' A' ' 76' ' ' THR . 27.8 m-20 -128.56 148.83 50.79 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.899 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -129.78 117.0 19.56 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.484 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.0 m-85 -111.45 117.63 33.57 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.635 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -76.31 107.72 8.76 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.43 HD23 HD23 ' A' ' 72' ' ' LEU . 37.3 tp -84.2 98.89 10.19 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.979 0.895 . . . . 0.0 109.123 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 69' ' ' ASN . 33.0 m -127.3 160.06 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.412 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 14.3 t70 -67.89 148.3 98.45 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -32.17 -44.88 0.2 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.862 3.708 . . . . 0.0 115.072 173.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.16 16.43 2.42 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.993 -0.442 . . . . 0.0 112.122 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 t30 60.4 48.56 7.69 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 125.626 1.571 . . . . 0.0 109.753 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 56.0 mt -98.43 126.64 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 172.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.525 ' O ' ' HA ' ' A' ' 131' ' ' THR . 16.6 m120 -73.72 133.2 43.3 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.84 -171.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.4 tp -97.25 -2.95 41.61 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 69.54 5.65 5.29 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.452 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.569 HD11 ' HB ' ' A' ' 36' ' ' VAL . 20.0 tp -102.79 131.13 49.86 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.55 -0.719 . . . . 0.0 111.236 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.0 m -111.24 123.79 50.91 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.484 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 55.0 t -86.51 114.11 25.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.1 tp -102.3 111.94 24.43 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.654 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.464 ' HB ' ' H ' ' A' ' 58' ' ' ASP . 26.5 m -87.32 100.09 12.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.408 HD11 ' CG2' ' A' ' 54' ' ' ILE . 15.3 tp -79.79 125.54 29.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.487 ' O ' HD11 ' A' ' 54' ' ' ILE . 31.4 t70 -83.61 78.99 9.59 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.807 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.489 ' HD3' ' OE2' ' A' ' 81' ' ' GLU . 14.5 ttm180 -137.28 134.66 36.37 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -84.06 1.94 41.57 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.489 ' OE2' ' HD3' ' A' ' 79' ' ' ARG . 45.1 mt-10 -77.36 126.0 30.22 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 173.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -102.89 109.14 20.59 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.396 0.617 . . . . 0.0 109.684 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -79.47 173.1 12.93 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.32 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -72.73 143.27 48.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.196 0.522 . . . . 0.0 111.124 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.16 100.22 5.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 171.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 pt -99.15 19.01 2.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 122.559 1.171 . . . . 0.0 108.643 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -70.29 -34.98 73.41 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.421 -1.718 . . . . 0.0 112.645 -171.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.39 -12.48 82.09 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.189 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.66 -11.59 55.62 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.76 123.36 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 m -118.92 103.55 9.7 Favored 'General case' 0 N--CA 1.405 -2.675 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.14 1.52 31.51 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -89.54 119.69 30.19 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.424 HD13 ' HB ' ' A' ' 135' ' ' ILE . 27.3 mt -107.67 -50.41 3.07 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -166.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.66 127.67 32.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -167.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.69 16.31 52.39 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.085 -1.416 . . . . 0.0 114.083 172.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 25.8 t -115.48 132.81 63.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.815 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.97 113.09 4.71 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.173 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.0 150.95 26.48 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.471 0.653 . . . . 0.0 111.459 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.7 m -114.93 131.81 56.76 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 tp -96.43 119.6 35.21 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 111' ' ' THR . 40.5 t -113.15 111.8 37.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-O 121.2 0.524 . . . . 0.0 110.116 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 26.7 t -107.97 147.0 13.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.41 ' O ' ' HB ' ' A' ' 26' ' ' THR . 20.7 t-160 -139.38 103.76 4.8 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.4 p -124.62 175.38 7.23 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.462 ' HB3' ' CD ' ' A' ' 24' ' ' GLU . 3.7 t30 -80.14 -43.6 21.36 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.78 0.324 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -68.63 -35.61 77.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.784 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.532 ' HD2' ' HG1' ' A' ' 111' ' ' THR . 15.3 t80 -133.15 96.58 3.78 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.2 m -96.45 134.83 39.13 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.837 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 71.74 71.28 0.16 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.377 0.671 . . . . 0.0 111.488 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 7.2 m -97.68 93.68 6.53 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.1 mt -105.26 98.55 7.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.5 tp -122.75 125.49 45.61 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.443 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.04 134.95 41.28 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.2 -51.32 8.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 120.988 0.423 . . . . 0.0 111.268 -176.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.03 -162.93 22.49 Favored Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 3.0 Cg_exo -74.31 123.38 8.18 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.925 2.417 . . . . 0.0 111.673 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.8 m -87.79 156.77 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.696 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.3 p -137.05 151.48 48.97 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.719 0.807 . . . . 0.0 110.257 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 56.7 ttp -89.56 126.69 35.7 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.82 -0.55 . . . . 0.0 109.604 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.32 -42.36 11.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.875 0.369 . . . . 0.0 110.436 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.12 -127.81 9.22 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 44.7 tp -95.16 115.59 27.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.244 0.545 . . . . 0.0 110.447 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.1 pt . . . . . 0 C--N 1.297 -1.69 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.595 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo . . . . . 0 N--CA 1.443 -1.498 0 CA-C-O 121.618 0.591 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 28.6 m -129.53 117.99 21.35 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 27.4 p-10 -103.85 163.83 12.09 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.896 -173.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.583 ' HD2' ' OE1' ' A' ' 172' ' ' GLN . 20.5 mmt180 55.73 47.85 19.61 Favored 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 124.59 1.181 . . . . 0.0 112.804 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 98.2 mmm -95.57 147.73 23.27 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.597 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 170' ' ' SER . 3.4 tt -117.73 134.03 62.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 42.1 ptt85 -124.48 157.85 34.26 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.96 0.886 . . . . 0.0 110.405 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -137.42 149.56 47.0 Favored 'General case' 0 C--N 1.26 -3.326 0 CA-C-N 114.0 -1.455 . . . . 0.0 107.689 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.02 99.82 11.76 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -164.22 144.18 7.91 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.467 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -75.36 99.23 4.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.222 0.535 . . . . 0.0 110.94 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.6 t -132.03 177.61 7.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -158.87 168.54 26.52 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 120.728 0.299 . . . . 0.0 111.111 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 54.2 m -64.28 116.85 6.43 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.013 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.72 -35.57 0.54 Allowed Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -87.97 25.59 1.53 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 34.8 m -73.22 127.6 33.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.598 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.405 ' C ' HG23 ' A' ' 26' ' ' THR . . . 93.42 5.95 63.08 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.406 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.23 137.56 17.23 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.3 126.74 37.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.792 0.806 . . . . 0.0 110.764 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 42.5 tp -96.96 103.79 15.74 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 20.8 p -145.1 162.7 36.37 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.512 0.672 . . . . 0.0 112.331 -173.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.44 -176.27 3.55 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.4 p -60.41 99.42 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.343 0.592 . . . . 0.0 111.698 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 76.77 13.7 83.3 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.835 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -135.15 108.01 7.55 Favored 'General case' 0 C--O 1.21 -0.992 0 O-C-N 122.595 -0.356 . . . . 0.0 111.041 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 88.1 mt -98.63 129.68 48.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -101.47 -33.32 10.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.688 0.756 . . . . 0.0 110.603 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 160.9 -151.92 22.45 Favored Glycine 0 N--CA 1.421 -2.31 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.6 pt -133.01 149.3 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -70.72 135.8 48.52 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.606 0.566 . . . . 0.0 111.398 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.29 -58.35 3.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.049 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.69 157.49 22.84 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -137.75 138.21 9.46 Favored Glycine 0 N--CA 1.419 -2.487 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -105.48 84.01 2.03 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 122.304 1.049 . . . . 0.0 110.663 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 80.91 -102.22 2.12 Favored Glycine 0 N--CA 1.419 -2.494 0 CA-C-N 114.398 -1.274 . . . . 0.0 113.013 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -98.42 -0.38 43.7 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -120.97 132.27 54.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -118.83 124.46 6.03 Favored Glycine 0 CA--C 1.476 -2.356 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.018 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -108.99 125.4 52.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.328 1.061 . . . . 0.0 111.645 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.534 ' HB2' HG23 ' A' ' 135' ' ' ILE . 19.8 m -120.56 161.39 21.4 Favored 'General case' 0 C--N 1.275 -2.639 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.36 138.68 32.04 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.583 ' OE1' ' HD2' ' A' ' 133' ' ' ARG . 58.4 tt0 -82.5 105.22 13.37 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.497 0.665 . . . . 0.0 109.63 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.433 HD21 HG21 ' A' ' 36' ' ' VAL . 10.5 mp -86.0 94.0 9.11 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -74.16 144.31 44.89 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -70.99 -21.93 62.24 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -64.48 -19.03 65.32 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.14 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -88.42 -15.1 36.36 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.827 -0.546 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.94 15.51 22.55 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.659 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--N 1.295 -1.772 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.857 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--O 1.241 0.643 0 N-CA-C 111.104 -0.383 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -64.99 -45.59 84.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.483 177.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -59.34 -49.28 78.43 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.52 0.728 . . . . 0.0 109.961 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.73 -36.48 82.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.859 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -65.77 -48.41 71.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.59 95.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.814 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.5 -47.22 79.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.654 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.2 m -62.75 -36.54 83.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.346 0.594 . . . . 0.0 110.746 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.9 tp -66.5 -49.25 67.2 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.062 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 60.8 tp -51.27 -52.59 43.61 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.775 1.23 . . . . 0.0 111.419 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -56.34 -21.03 21.87 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -174.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -137.49 -29.64 0.87 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 118.841 -1.144 . . . . 0.0 113.84 -177.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -107.05 -13.9 15.07 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.499 HG23 HG23 ' A' ' 26' ' ' THR . 27.3 mt -90.71 110.66 22.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.875 0.845 . . . . 0.0 111.562 -177.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.8 mtp -101.6 131.76 47.63 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.216 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 6.6 m -87.3 102.71 14.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 mt -100.35 111.95 31.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 121.64 0.733 . . . . 0.0 112.034 -174.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.3 m -84.05 106.81 15.99 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.378 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 28.0 p -96.69 -167.23 1.53 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.536 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m -73.19 -22.2 60.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 120.852 0.358 . . . . 0.0 110.281 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -92.45 -46.39 7.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.683 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.29 -167.56 33.27 Favored Glycine 0 CA--C 1.503 -0.677 0 C-N-CA 118.862 -1.637 . . . . 0.0 113.401 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -100.69 99.93 10.55 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CD1' ' HB3' ' A' ' 146' ' ' CYS . 67.6 m-85 -115.05 -168.63 1.41 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.173 -175.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.499 HG23 HG23 ' A' ' 15' ' ' ILE . 90.3 m -111.83 135.53 52.33 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-O 121.243 0.544 . . . . 0.0 110.542 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.73 142.22 16.13 Favored Glycine 0 N--CA 1.409 -3.122 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.1 tp -114.52 118.26 33.25 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.321 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.17 119.66 5.0 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 46.5 mm -95.46 -51.81 10.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 117.714 0.757 . . . . 0.0 111.986 -173.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.524 ' O ' HG12 ' A' ' 34' ' ' VAL . 35.4 t-80 -156.28 111.39 2.9 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.566 -173.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 61.4 -77.87 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 170.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.753 ' HD3' HG23 ' A' ' 76' ' ' THR . 1.1 ppt_? -120.02 -2.17 10.29 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 31' ' ' HIS . 14.3 p -100.97 118.85 48.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.719 -176.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.5 m -120.33 164.63 16.03 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.337 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.531 ' CG1' HD11 ' A' ' 72' ' ' LEU . 46.7 t -118.63 134.5 62.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tp -148.02 143.64 17.93 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 25.4 Cg_exo -69.61 155.28 66.84 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.36 2.04 . . . . 0.0 112.858 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.9 m -74.74 -44.58 49.09 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -63.6 -13.93 46.73 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.94 -24.28 63.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.068 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.421 ' O ' ' HB ' ' A' ' 20' ' ' THR . 25.2 mt-30 62.94 84.05 0.19 Allowed Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 123.756 0.822 . . . . 0.0 110.705 -177.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.55 121.46 6.0 Favored 'Trans proline' 0 C--O 1.258 1.505 0 C-N-CA 121.898 1.732 . . . . 0.0 110.179 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.2 -169.13 31.27 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.426 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -86.18 -14.4 44.12 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.426 0.631 . . . . 0.0 109.34 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -143.47 137.25 28.43 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.1 158.46 33.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.054 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 79.0 mt -105.6 115.22 29.88 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 17' ' ' THR . 6.0 p -87.78 90.39 3.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 71.75 -10.42 0.85 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.079 1.751 . . . . 0.0 110.632 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 148.94 -22.99 1.28 Allowed Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.438 ' HB2' HG13 ' A' ' 49' ' ' VAL . 13.7 mm100 -73.44 113.85 11.0 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -75.48 121.27 22.09 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 121.062 0.458 . . . . 0.0 110.799 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.444 ' CG2' HD11 ' A' ' 77' ' ' LEU . 10.6 tp -130.29 141.34 46.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.29 149.56 33.5 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.44 0.638 . . . . 0.0 111.401 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.5 t -94.01 126.97 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 172.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.427 ' HB3' HG22 ' A' ' 76' ' ' THR . 8.0 tmtm? -89.93 -43.81 10.33 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.766 -174.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -156.18 154.09 30.28 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -134.36 127.28 31.33 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.474 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 16.5 m-85 -123.13 108.64 13.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -81.19 136.93 35.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.15 76.2 9.29 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 122.402 1.096 . . . . 0.0 111.682 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.6 p -109.0 118.54 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.271 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.561 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 21.5 t70 -62.47 143.5 96.0 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.619 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.28 -21.24 22.19 Favored 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 123.796 2.997 . . . . 0.0 114.347 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -88.38 7.6 31.79 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.483 0.659 . . . . 0.0 109.242 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.275 40.6 m-80 67.85 63.62 0.39 Allowed 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 125.72 1.608 . . . . 0.0 112.252 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.561 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 18.1 mm -123.55 126.07 72.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 131' ' ' THR . 36.2 t30 -99.75 129.6 45.88 Favored 'General case' 0 C--O 1.203 -1.387 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -170.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.597 HD13 ' O ' ' A' ' 132' ' ' ASN . 40.0 tp -94.57 -8.18 38.92 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 117.607 0.185 . . . . 0.0 111.302 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 66.73 20.77 10.65 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.509 1.147 . . . . 0.0 109.316 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.531 HD11 ' CG1' ' A' ' 36' ' ' VAL . 20.4 tp -126.63 137.08 53.25 Favored 'General case' 0 N--CA 1.426 -1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 110.63 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 46.0 m -124.34 126.28 45.74 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-O 121.506 0.669 . . . . 0.0 110.472 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 91.7 t -79.78 113.64 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 175.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.19 114.96 28.01 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.753 HG23 ' HD3' ' A' ' 33' ' ' ARG . 53.2 m -92.97 115.68 28.35 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.444 HD11 ' CG2' ' A' ' 54' ' ' ILE . 18.1 tp -85.96 142.99 28.41 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.219 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.403 ' O ' HD11 ' A' ' 54' ' ' ILE . 19.3 t70 -81.77 82.27 7.52 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 172.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.601 ' NE ' ' HB3' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -91.51 121.99 33.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -166.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -92.58 -42.85 9.44 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 167.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -98.48 118.28 34.81 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -98.25 158.14 15.75 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.577 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -103.59 146.0 29.21 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.433 ' NH2' ' HB3' ' A' ' 13' ' ' LYS . 57.3 ttp180 -55.44 134.54 50.54 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.692 1.597 . . . . 0.0 111.387 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 10.8 p-10 -75.06 96.05 3.15 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.562 1.172 . . . . 0.0 112.776 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.3 pt -96.99 22.75 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 122.299 1.047 . . . . 0.0 109.068 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.481 ' O ' ' HE3' ' A' ' 175' ' ' LYS . 48.1 ttp180 -60.25 -38.34 83.17 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.844 -175.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.99 -11.31 84.84 Favored Glycine 0 C--N 1.315 -0.588 0 C-N-CA 121.166 -0.54 . . . . 0.0 113.024 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.44 -13.1 50.31 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.593 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.4 mt -67.05 130.94 32.86 Favored 'Isoleucine or valine' 0 C--O 1.25 1.116 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.1 t -118.72 113.45 21.17 Favored 'General case' 0 N--CA 1.4 -2.925 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -75.55 -20.14 58.86 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -86.32 115.65 23.99 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.564 HD13 ' HB ' ' A' ' 135' ' ' ILE . 10.5 mt -108.31 -66.73 1.02 Allowed 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.9 0.857 . . . . 0.0 110.76 -171.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -58.9 134.73 57.19 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.673 -168.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.56 2.28 24.32 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.675 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.2 167.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.11 152.57 18.42 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.45 157.09 42.95 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.714 0.769 . . . . 0.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 26.2 m -112.63 133.58 54.6 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 48.1 tp -101.57 119.71 39.2 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.69 93.96 4.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.468 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 61.9 t -79.84 119.55 29.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -148.17 151.55 35.74 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.1 p -171.62 -174.81 1.45 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -92.32 -11.34 35.36 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.363 -1.335 . . . . 0.0 107.991 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -73.32 -49.78 25.6 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.092 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -136.67 113.11 10.0 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.903 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.9 p -101.27 164.87 11.57 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.195 -176.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 55.8 t30 44.43 70.8 0.3 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.689 1.196 . . . . 0.0 113.453 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.468 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 56.3 m -131.26 92.39 3.18 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.475 -0.766 . . . . 0.0 110.242 176.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.7 mt -88.13 101.49 11.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -120.6 117.3 27.21 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.839 0.352 . . . . 0.0 110.977 -173.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 10.1 pt-20 -74.93 130.03 38.69 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.037 0.446 . . . . 0.0 110.494 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -97.67 -45.04 12.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.905 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.91 -152.93 20.48 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.082 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.82 138.68 34.97 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 122.878 2.385 . . . . 0.0 113.554 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.444 HG12 ' HB3' ' A' ' 137' ' ' TYR . 35.8 m -102.87 146.85 10.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.87 177.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.9 p -130.95 153.7 48.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.618 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 44.0 ttp -96.98 116.28 28.92 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.362 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -82.74 -46.09 13.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.968 -176.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.43 -130.32 9.79 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.47 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.4 HD22 HG21 ' A' ' 68' ' ' ILE . 83.5 mt -93.82 100.28 12.5 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 131' ' ' THR . 38.3 mm . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.41 ' HB2' HG23 ' A' ' 68' ' ' ILE . 56.2 Cg_endo . . . . . 0 N--CA 1.448 -1.169 0 N-CA-C 110.59 -0.581 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 14.6 t -88.77 132.2 34.73 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.22 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.597 ' O ' HD13 ' A' ' 70' ' ' LEU . 34.9 t30 -75.83 81.28 2.75 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 65.58 63.55 0.62 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.64 0.733 . . . . 0.0 112.738 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 28.3 mtt -89.14 164.11 15.15 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.673 HG23 ' HB3' ' A' ' 170' ' ' SER . 6.8 tt -107.84 138.83 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.064 175.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -122.89 140.75 52.63 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.444 ' HB3' HG12 ' A' ' 118' ' ' VAL . 50.5 p90 -132.43 153.46 50.81 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.019 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -89.07 93.22 9.51 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.511 0.507 . . . . 0.0 109.934 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -174.77 135.85 0.4 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 125.395 1.478 . . . . 0.0 108.015 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.09 91.57 7.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.042 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.7 m -97.06 147.84 23.62 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -99.81 172.43 7.25 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -80.17 169.62 17.55 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 175.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 146' ' ' CYS . . . 90.57 -34.38 4.21 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -173.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.455 HE21 HG11 ' A' ' 103' ' ' VAL . 49.2 mt-30 -85.81 33.14 0.58 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.028 1.331 . . . . 0.0 107.622 175.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.522 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 42.8 t -89.51 138.19 31.67 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.737 -175.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 94.88 -1.41 65.46 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.45 127.94 29.62 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.39 115.33 17.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.054 0.454 . . . . 0.0 111.114 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 39.4 tp -89.5 107.86 19.32 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.0 p -146.98 162.49 38.65 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.548 0.69 . . . . 0.0 112.653 -174.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -128.94 -179.07 4.89 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 175.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.2 t -60.4 103.24 0.22 Allowed 'General case' 0 CA--C 1.556 1.192 0 CA-C-O 122.404 1.097 . . . . 0.0 112.072 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 77.35 15.07 81.87 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.629 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -135.35 109.81 8.49 Favored 'General case' 0 C--O 1.207 -1.145 0 O-C-N 122.307 -0.525 . . . . 0.0 111.646 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.6 mt -100.68 129.54 51.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -105.23 -41.41 5.55 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.611 0.719 . . . . 0.0 110.776 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.482 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 173.93 -170.38 43.5 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.63 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.8 pt -119.29 143.64 30.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -70.05 136.5 50.39 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.36 -46.49 3.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.111 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.57 153.6 23.12 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -127.8 152.46 18.95 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.56 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -116.73 96.1 5.33 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.23 -119.03 9.1 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.104 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -84.79 -8.01 58.98 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.745 0.818 . . . . 0.0 110.647 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -108.61 100.95 10.14 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.443 -0.786 . . . . 0.0 111.429 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -79.94 134.65 13.86 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -107.21 129.84 54.81 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 122.121 0.962 . . . . 0.0 110.45 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.673 ' HB3' HG23 ' A' ' 135' ' ' ILE . 30.0 t -118.2 141.31 48.63 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.999 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.37 120.45 23.83 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.466 ' CD ' HD11 ' A' ' 94' ' ' LEU . 6.1 tt0 -78.27 109.0 12.0 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 123.776 0.673 . . . . 0.0 110.393 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 173' ' ' LEU . 3.2 pp -94.05 88.54 5.7 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.265 1.031 . . . . 0.0 109.453 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -80.85 138.72 36.2 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.871 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.505 ' HB2' ' HZ2' ' A' ' 175' ' ' LYS . 4.1 ttmp? -50.88 -35.14 31.31 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.542 1.137 . . . . 0.0 112.267 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -56.47 -25.63 51.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.627 0.771 . . . . 0.0 112.977 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -82.39 -13.74 56.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.673 0.273 . . . . 0.0 111.299 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -96.54 -8.27 32.38 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -173.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 C--N 1.306 -1.303 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.701 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo . . . . . 0 C--O 1.241 0.63 0 CA-C-O 121.045 0.352 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -67.01 -36.48 82.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.64 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 3.0 m -65.41 -48.77 71.66 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.727 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.05 -37.55 87.95 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.833 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -62.12 -48.48 79.97 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.802 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.14 95.05 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 123.932 0.77 . . . . 0.0 111.515 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 4' ' ' THR . 96.0 mt -63.81 -43.35 96.53 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.868 0.365 . . . . 0.0 111.12 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 m -67.1 -31.71 72.37 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.462 0.649 . . . . 0.0 110.412 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.8 tp -74.14 -59.07 2.89 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.524 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.73 ' HA ' HG12 ' A' ' 15' ' ' ILE . 6.8 tt -50.21 -52.4 36.04 Favored 'General case' 0 C--O 1.247 0.957 0 C-N-CA 125.286 1.434 . . . . 0.0 113.341 -175.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -66.59 -4.03 7.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -172.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -129.07 -53.9 1.2 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -84.72 6.99 22.05 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -171.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.73 HG12 ' HA ' ' A' ' 11' ' ' LEU . 48.2 mm -102.4 123.63 55.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.122 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.417 ' O ' HG13 ' A' ' 18' ' ' ILE . 1.8 mpt? -101.71 97.06 7.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.566 ' HA ' HG22 ' A' ' 26' ' ' THR . 23.3 m -70.65 93.17 0.91 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.422 HG23 ' HB ' ' A' ' 47' ' ' VAL . 82.1 mt -93.48 118.55 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.966 -172.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 7.0 m -85.27 106.59 16.79 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.693 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 60.6 p -90.81 -163.32 1.01 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.761 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 m -79.75 -2.96 45.45 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -118.65 -33.25 4.33 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.69 -151.26 20.21 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 119.762 -1.209 . . . . 0.0 112.542 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -86.87 104.2 16.0 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.38 133.86 52.38 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.584 HG21 ' CD2' ' A' ' 104' ' ' HIS . 13.6 p -97.8 130.58 44.73 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-O 121.796 0.808 . . . . 0.0 113.078 -172.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.41 131.11 10.45 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 55.4 tp -89.81 114.06 25.72 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.5 103.89 1.69 Allowed Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.8 mm -71.44 -47.17 60.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 C-N-CA 123.129 0.572 . . . . 0.0 109.857 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -169.95 154.1 5.03 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.581 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t70 50.79 -95.48 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.715 1.26 . . . . 0.0 113.402 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.492 ' HG2' ' HB2' ' A' ' 79' ' ' ARG . 54.6 mtt180 -123.82 4.7 8.78 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 122.817 0.447 . . . . 0.0 111.073 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.05 113.91 26.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.256 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 13.1 p -126.9 137.47 53.16 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -110.75 138.49 38.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.98 149.91 26.29 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.16 149.78 83.11 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 122.248 1.966 . . . . 0.0 112.555 174.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.428 ' HB ' ' OG1' ' A' ' 73' ' ' THR . 8.9 t -79.43 -31.02 42.52 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 122.517 0.327 . . . . 0.0 110.995 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -72.66 -4.97 34.31 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.208 0.528 . . . . 0.0 111.024 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.27 -13.17 60.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.693 ' O ' ' HB ' ' A' ' 20' ' ' THR . 14.2 mm100 66.62 77.78 0.26 Allowed Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 125.145 1.378 . . . . 0.0 113.281 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.17 153.86 18.93 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.198 1.932 . . . . 0.0 110.297 176.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.99 -164.32 13.93 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -83.38 -20.97 33.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.048 0.928 . . . . 0.0 108.59 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.412 ' HB3' ' HG3' ' A' ' 55' ' ' ARG . 4.6 p-10 -143.72 149.6 37.41 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.422 ' HB ' HG23 ' A' ' 18' ' ' ILE . 24.8 m -143.33 170.42 10.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.471 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 73.3 mt -102.31 114.12 28.01 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 m -92.32 97.74 7.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.615 0.721 . . . . 0.0 109.617 174.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 69.53 -10.4 0.58 Allowed 'General case' 0 CA--C 1.564 1.517 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.96 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.84 -25.18 0.63 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 112.285 -0.326 . . . . 0.0 112.285 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -90.42 131.86 35.95 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 122.552 -0.381 . . . . 0.0 110.719 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -77.44 115.21 17.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.481 0.658 . . . . 0.0 109.677 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.8 tp -120.37 143.51 32.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.431 ' N ' ' HD2' ' A' ' 55' ' ' ARG . 2.8 mpt_? -89.87 141.07 28.98 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.685 0.755 . . . . 0.0 111.777 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.404 HG22 ' CD2' ' A' ' 77' ' ' LEU . 20.2 t -97.21 102.99 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -69.16 -62.4 1.39 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 123.675 0.609 . . . . 0.0 110.097 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -111.42 138.39 47.98 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -146.34 105.08 3.85 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-O 121.275 0.56 . . . . 0.0 109.589 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -107.92 129.67 55.08 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.276 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.45 131.43 34.19 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.5 tp -83.49 104.02 13.3 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.788 0.804 . . . . 0.0 109.997 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.53 141.51 43.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.936 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 20.8 t70 -83.49 142.46 43.17 Favored Pre-proline 0 C--N 1.279 -2.492 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.79 -11.69 7.59 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.562 2.841 . . . . 0.0 114.576 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -98.99 18.33 17.52 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.989 -0.444 . . . . 0.0 110.788 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 75.01 17.71 2.66 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.636 1.175 . . . . 0.0 112.65 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 132' ' ' ASN . 34.8 mm -91.08 140.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 131' ' ' THR . 9.1 t-20 -98.1 152.49 19.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.471 ' C ' ' H ' ' A' ' 72' ' ' LEU . 4.0 mm? -112.29 -7.27 14.01 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.55 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 67.77 -21.08 0.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.291 1.436 . . . . 0.0 112.252 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.471 ' H ' ' C ' ' A' ' 70' ' ' LEU . 7.4 tt -79.4 133.3 36.56 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 124.067 0.947 . . . . 0.0 110.371 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.428 ' OG1' ' HB ' ' A' ' 39' ' ' THR . 20.4 m -117.45 133.44 55.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.2 t -98.47 108.79 22.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.3 mt -102.25 132.3 48.28 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 27.6 m -109.56 100.14 9.23 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.404 ' CD2' HG22 ' A' ' 56' ' ' VAL . 82.8 mt -87.04 155.62 20.07 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.768 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.92 93.52 2.68 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.535 ' NE ' ' HA ' ' A' ' 79' ' ' ARG . 2.5 mmp_? -106.55 108.47 19.99 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.393 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -83.19 -29.68 28.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -99.69 107.49 19.6 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 170.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -99.88 166.41 11.08 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.852 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -121.68 169.57 10.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -57.47 142.58 43.63 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.77 1.628 . . . . 0.0 112.117 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 14.6 t70 -75.86 96.0 3.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.885 0.85 . . . . 0.0 109.211 172.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.9 pt -84.91 10.71 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-O 121.813 0.815 . . . . 0.0 110.972 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -68.26 -24.71 64.92 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.4 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.91 -11.4 66.39 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.296 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -103.86 -4.55 23.37 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 117.138 0.469 . . . . 0.0 110.554 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -64.18 121.06 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.703 0.763 . . . . 0.0 110.708 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 m -93.32 114.99 27.57 Favored 'General case' 0 N--CA 1.391 -3.391 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.3 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -2.63 56.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 122.234 1.016 . . . . 0.0 108.958 175.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -113.34 113.72 25.65 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.58 -1.645 . . . . 0.0 107.347 176.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -115.98 -54.5 2.49 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.548 0.69 . . . . 0.0 111.674 -170.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -72.95 127.1 31.56 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.501 -168.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.93 -7.92 41.96 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.301 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 t -104.52 147.51 10.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 5.8 p-10 -89.23 145.45 25.4 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.15 155.59 45.25 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 122.156 0.979 . . . . 0.0 113.286 -175.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 27.1 m -111.27 127.83 55.74 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 113.565 -1.652 . . . . 0.0 107.387 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.9 tp -101.74 117.24 34.47 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.303 0.573 . . . . 0.0 109.933 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 t -94.01 97.14 6.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.481 ' O ' ' HB ' ' A' ' 111' ' ' THR . 15.6 m -88.34 126.63 41.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.584 ' CD2' HG21 ' A' ' 26' ' ' THR . 33.0 p-80 -153.93 153.82 32.71 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.352 0.596 . . . . 0.0 111.394 -173.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.4 p -154.58 -162.63 1.43 Allowed 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -84.91 -35.67 21.97 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 118.741 -1.183 . . . . 0.0 108.63 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -77.77 -36.37 50.66 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.417 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 104' ' ' HIS . 97.1 m-85 -115.37 93.2 4.19 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 m -112.22 150.77 30.41 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 71.76 19.15 4.99 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.687 0.795 . . . . 0.0 112.609 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 103' ' ' VAL . 43.7 m -80.47 101.13 8.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 82.5 mt -102.78 98.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.503 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.4 tp -112.72 105.89 14.13 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.669 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 6.5 pt-20 -79.67 139.65 37.32 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.821 -0.55 . . . . 0.0 111.917 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.0 m -107.63 -42.19 5.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.402 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 126.07 -158.06 20.17 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.615 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 98' ' ' ASP . 24.4 Cg_exo -64.37 126.04 16.21 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.682 2.921 . . . . 0.0 112.892 -178.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -92.08 151.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.371 0.605 . . . . 0.0 111.736 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.4 m -122.28 154.47 37.53 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -94.73 139.56 31.08 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.78 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 134' ' ' MET . . . -91.99 -23.62 19.49 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.06 -123.81 6.24 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.369 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -105.74 108.99 20.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.4 pt . . . . . 0 C--N 1.299 -1.611 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.59 178.677 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 N--CA 1.435 -1.914 0 N-CA-C 108.228 -1.489 . . . . 0.0 108.228 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.4 t -103.27 125.98 50.2 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-O 121.389 0.614 . . . . 0.0 109.523 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.514 ' HB2' HG21 ' A' ' 68' ' ' ILE . 27.6 t30 -83.3 134.42 34.93 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.007 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 63.04 49.78 3.33 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 124.126 0.891 . . . . 0.0 110.166 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.41 ' HB3' ' HB3' ' A' ' 121' ' ' ALA . 8.3 tpt -85.69 143.2 28.51 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 170' ' ' SER . 14.5 tt -112.66 144.97 19.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -132.96 142.62 48.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.289 0.566 . . . . 0.0 111.347 -173.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -134.74 115.96 14.34 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.43 92.56 1.1 Allowed 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -167.86 117.77 0.8 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.63 110.68 1.04 Allowed 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.545 0.688 . . . . 0.0 110.494 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.6 m -121.15 153.51 37.42 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -88.33 123.93 33.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.044 0.449 . . . . 0.0 110.977 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.4 t -78.52 151.43 32.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.9 -15.53 40.42 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -106.84 35.07 3.13 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 10.0 m -69.94 146.67 51.0 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.233 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.92 3.51 42.38 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.54 145.63 40.81 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.86 116.36 31.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 120.924 0.392 . . . . 0.0 110.226 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.2 tp -89.45 104.95 17.46 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.0 p -141.52 -173.73 3.85 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.254 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -161.54 -175.52 4.81 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 175.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.4 m -64.23 99.12 0.26 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 118.355 0.525 . . . . 0.0 110.765 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.15 18.66 71.4 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.98 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 74.5 mmtt -132.93 134.86 45.1 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -129.11 120.97 52.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -96.8 -46.19 6.35 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.8 0.687 . . . . 0.0 111.559 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.547 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 179.54 -176.03 47.37 Favored Glycine 0 N--CA 1.419 -2.477 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.715 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 22.7 pt -109.41 134.31 51.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 O-C-N 123.69 0.288 . . . . 0.0 110.228 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.421 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 11.2 t-80 -58.52 113.47 2.01 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 124.474 1.109 . . . . 0.0 110.25 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.5 t -88.27 -41.6 14.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.599 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.47 127.61 0.95 Allowed Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 119.022 -1.561 . . . . 0.0 113.103 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.462 ' HA2' ' HA2' ' A' ' 168' ' ' GLY . . . -78.68 79.5 1.55 Allowed Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 172.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -93.33 89.01 6.19 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 100.69 -147.3 17.89 Favored Glycine 0 N--CA 1.427 -1.915 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.392 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 43.1 ttm105 -85.57 -0.9 56.38 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.487 0.66 . . . . 0.0 110.223 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -124.52 124.93 43.35 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.887 -0.508 . . . . 0.0 110.064 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.462 ' HA2' ' HA2' ' A' ' 163' ' ' GLY . . . -84.25 126.46 7.62 Favored Glycine 0 N--CA 1.414 -2.8 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -109.71 127.15 54.4 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 121.213 0.53 . . . . 0.0 109.9 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.546 ' HB2' HG23 ' A' ' 135' ' ' ILE . 49.8 m -127.83 159.65 34.2 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -100.04 132.6 45.3 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -76.21 104.15 6.6 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.547 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -80.38 70.99 7.17 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.386 1.089 . . . . 0.0 111.431 177.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -63.1 139.94 58.82 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.186 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -53.14 -30.41 36.79 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 126.513 1.925 . . . . 0.0 111.499 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -62.29 -25.27 67.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -78.13 -20.48 52.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.571 0.701 . . . . 0.0 109.34 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -104.34 21.83 15.93 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.362 -171.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 52.6 t . . . . . 0 C--N 1.304 -1.404 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 173.554 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo . . . . . 0 N--CA 1.487 1.124 0 N-CA-C 116.163 1.563 . . . . 0.0 116.163 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -71.44 -38.58 71.34 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.929 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.443 HG23 HG21 ' A' ' 112' ' ' ILE . 54.2 m -71.25 -29.38 65.04 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.753 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.07 -43.57 74.34 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -64.82 -44.0 91.3 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.424 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -54.77 -49.35 71.11 Favored 'General case' 0 C--O 1.204 -1.318 0 O-C-N 123.97 0.794 . . . . 0.0 110.98 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 tp -63.67 -38.73 92.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.088 0.471 . . . . 0.0 111.423 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -71.12 -37.07 72.34 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.469 0.652 . . . . 0.0 110.893 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.86 -38.76 64.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.411 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.562 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 37.2 tp -49.61 -54.73 16.7 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 125.419 1.488 . . . . 0.0 112.568 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -72.53 -3.8 26.75 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -170.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -133.48 -29.89 1.33 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -120.87 -25.25 5.45 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.562 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 33.7 mt -95.26 105.96 17.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.3 mmt -122.51 149.54 43.77 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.118 0.485 . . . . 0.0 112.123 -175.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 m -80.2 124.46 28.81 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.9 mt -113.1 108.46 25.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.2 m -87.18 104.46 16.38 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.2 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 40.9 p -95.34 -156.6 0.52 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.465 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -75.88 -28.96 58.34 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -81.57 -38.16 26.58 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.27 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.84 -156.7 27.91 Favored Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 119.949 -1.119 . . . . 0.0 111.78 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.18 105.38 16.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.015 0.436 . . . . 0.0 110.703 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -107.66 176.07 5.27 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.0 m -115.56 134.5 55.0 Favored 'General case' 0 N--CA 1.408 -2.538 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.16 139.1 13.01 Favored Glycine 0 N--CA 1.412 -2.924 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.4 tp -102.11 118.24 36.48 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.08 114.31 3.83 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mm -78.77 -50.05 19.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 85' ' ' ASP . 25.0 p80 -167.67 145.38 4.51 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.151 176.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.581 ' HB3' ' HG3' ' A' ' 82' ' ' LYS 0.314 1.2 p30 46.8 -96.11 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 177.259 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 37.4 ptt180 -117.07 2.35 12.66 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.153 0.502 . . . . 0.0 110.882 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.6 t -91.72 106.38 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.631 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.6 m -122.49 162.18 22.21 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 p -133.17 140.81 46.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.62 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.0 tt -153.02 147.53 19.1 Favored Pre-proline 0 CA--C 1.561 1.384 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.75 147.51 94.6 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.417 2.078 . . . . 0.0 112.483 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.4 m -62.05 -44.9 95.69 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.281 0.633 . . . . 0.0 112.612 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -65.46 2.53 0.88 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.36 -23.28 54.16 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.455 ' O ' ' HB ' ' A' ' 20' ' ' THR . 13.4 mm100 64.47 77.35 0.3 Allowed Pre-proline 0 C--O 1.25 1.119 0 C-N-CA 125.228 1.411 . . . . 0.0 111.664 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.34 128.84 9.91 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.673 2.249 . . . . 0.0 110.826 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.52 -163.62 38.65 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.801 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.81 -33.64 75.2 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.657 0.741 . . . . 0.0 110.912 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -139.84 141.03 36.7 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.15 154.0 23.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 120.57 0.224 . . . . 0.0 110.918 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 8.2 mp -96.36 105.28 17.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.026 0.441 . . . . 0.0 111.173 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.59 93.53 4.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 t30 65.88 9.37 6.03 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.682 1.193 . . . . 0.0 110.732 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.69 -22.85 5.44 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.646 HE21 ' HA ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -80.59 107.67 13.59 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -80.62 111.31 16.93 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.836 0.827 . . . . 0.0 109.204 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.1 tp -113.35 135.57 52.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.316 -174.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -68.69 132.8 47.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.858 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.89 126.92 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -77.67 -63.02 1.48 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.457 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -147.22 148.96 32.02 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -112.59 104.02 12.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.539 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.8 m-85 -81.55 95.18 7.06 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -75.23 123.0 24.53 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.11 102.96 15.29 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -177.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.9 132.56 60.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.3 145.25 86.47 Favored Pre-proline 0 C--N 1.307 -1.268 0 O-C-N 123.383 0.427 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.3 -21.98 73.43 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.558 2.172 . . . . 0.0 110.798 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.49 7.81 21.47 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.391 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 71.18 21.54 4.73 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.51 1.524 . . . . 0.0 113.15 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 132' ' ' ASN . 39.5 mm -92.49 152.75 3.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.657 ' O ' ' HA ' ' A' ' 131' ' ' THR . 48.3 t30 -85.5 138.4 32.24 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.43 -19.73 17.53 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 66.29 21.74 10.97 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 122.989 1.376 . . . . 0.0 109.475 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.3 tp -121.16 143.72 48.97 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.373 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.1 m -138.9 126.98 22.5 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.114 0.483 . . . . 0.0 110.388 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 60.6 t -86.87 110.79 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.7 tp -91.75 116.13 28.63 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.712 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.3 m -93.24 106.42 18.38 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.1 0.476 . . . . 0.0 109.882 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.54 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 8.3 mp -81.37 153.78 26.8 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.758 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.467 ' O ' HD11 ' A' ' 54' ' ' ILE . 22.8 t70 -83.41 74.68 10.05 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.84 0.829 . . . . 0.0 109.052 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -114.78 130.71 56.9 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.45 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -95.85 -39.64 9.72 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.72 129.13 38.68 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.578 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.581 ' HG3' ' HB3' ' A' ' 32' ' ' ASP . 51.7 tttp -89.02 102.86 15.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.301 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.45 ' H ' ' HA ' ' A' ' 32' ' ' ASP . 96.5 m-85 -70.47 156.34 39.5 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 172.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -49.7 132.49 21.77 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.779 1.232 . . . . 0.0 113.436 -173.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 31' ' ' HIS . 12.2 t70 -84.62 97.06 9.4 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.613 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -97.79 22.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.854 0.835 . . . . 0.0 110.921 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -60.55 -41.66 94.99 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.138 -174.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.63 1.43 66.89 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 116.11 -0.496 . . . . 0.0 113.72 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -95.83 -6.78 38.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.98 0.39 . . . . 0.0 110.51 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.3 mt -72.04 109.67 4.44 Favored 'Isoleucine or valine' 0 C--O 1.261 1.692 0 CA-C-O 121.308 0.575 . . . . 0.0 110.004 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 p -94.97 105.69 17.63 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.514 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -82.0 -13.05 57.97 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.819 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -94.28 115.62 27.89 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.7 mt -112.73 -56.97 2.35 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.188 -164.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 32.1 tt0 -60.11 112.37 1.87 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -164.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 119.25 -18.87 10.16 Favored Glycine 0 C--O 1.251 1.169 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.529 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.45 147.05 5.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.94 129.24 35.3 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -124.41 160.71 27.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.391 0.615 . . . . 0.0 111.901 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.8 m -121.16 145.02 48.26 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 124.471 1.108 . . . . 0.0 108.721 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.536 HD21 ' HB2' ' A' ' 160' ' ' HIS . 2.3 tm? -103.65 119.37 38.77 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.444 HG21 ' HB1' ' A' ' 7' ' ' ALA . 48.5 t -123.73 130.97 73.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.964 0.412 . . . . 0.0 112.071 -175.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.419 ' CG2' ' HB ' ' A' ' 111' ' ' THR . 17.4 m -125.38 142.84 40.96 Favored 'Isoleucine or valine' 0 C--O 1.254 1.326 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -71.65 -59.38 2.78 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.9 t -153.43 106.46 2.94 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 170.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.502 ' ND2' ' HA ' ' A' ' 145' ' ' GLN . 28.1 t-20 -103.9 -74.59 0.64 Allowed 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -100.11 -26.39 13.97 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.164 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -148.79 156.07 41.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.3 m -84.74 131.89 34.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.601 0.239 . . . . 0.0 111.113 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.422 HD22 ' C ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER 70.12 71.32 0.22 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.812 1.245 . . . . 0.0 111.967 178.013 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.419 ' HB ' ' CG2' ' A' ' 103' ' ' VAL . 34.7 m -111.56 107.92 17.25 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.563 176.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.443 HG21 HG23 ' A' ' 4' ' ' THR . 61.5 mt -117.55 103.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.0 tp -123.46 124.49 43.0 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.307 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.2 140.82 56.1 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.695 0.76 . . . . 0.0 112.894 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.84 -57.16 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.136 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.77 -152.89 17.45 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.0 123.82 11.81 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 123.007 2.472 . . . . 0.0 112.306 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 27.3 m -96.97 157.63 3.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.9 p -133.29 164.83 26.21 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.647 0.379 . . . . 0.0 111.23 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 56.5 ttp -82.04 136.0 35.27 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -99.58 -52.79 3.38 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.521 0.677 . . . . 0.0 110.248 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.98 -110.53 3.76 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.817 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.0 tp -110.91 118.7 36.81 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mm . . . . . 0 C--N 1.302 -1.498 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.136 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.447 -1.247 0 N-CA-C 110.558 -0.593 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.5 m -122.2 127.41 49.96 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.458 ' HB2' HG21 ' A' ' 68' ' ' ILE . 64.1 t30 -111.51 158.96 18.56 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 111.133 0.049 . . . . 0.0 111.133 -174.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 61.7 50.94 4.13 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 122.968 1.366 . . . . 0.0 111.334 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 90.2 mmm -113.87 157.03 22.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.029 -1.896 . . . . 0.0 110.258 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.539 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 12.4 tt -107.37 147.16 12.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.557 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 39.3 ttp85 -126.89 140.95 51.97 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.268 0.627 . . . . 0.0 110.207 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -150.31 148.77 29.24 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.488 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.92 111.48 18.83 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -164.47 146.47 8.56 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.21 93.1 1.42 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.1 t -87.96 145.29 26.09 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.141 -174.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 145' ' ' GLN . 17.8 tppt? -134.73 125.46 27.05 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.2 m -73.29 124.83 26.46 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.59 -41.46 1.28 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.502 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 3.4 pt20 -84.07 42.86 0.89 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.456 1.122 . . . . 0.0 109.604 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 33.4 m -82.82 147.06 28.58 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.835 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.19 7.18 59.67 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -68.92 119.63 9.95 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.04 108.17 6.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 37.0 tp -84.53 107.9 17.01 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.1 p -142.1 164.9 28.92 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.266 0.555 . . . . 0.0 112.049 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.39 178.17 7.61 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.5 t -60.96 102.88 0.22 Allowed 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.756 0.788 . . . . 0.0 111.669 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 84.08 6.23 86.74 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.02 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -134.02 126.55 30.44 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 117.331 0.566 . . . . 0.0 111.275 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 76.2 mt -112.81 122.12 66.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -97.48 -22.17 16.72 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.883 0.373 . . . . 0.0 111.169 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 149.75 -163.8 29.4 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.551 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 148' ' ' GLY . 27.3 pt -128.21 134.11 65.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 120.989 0.424 . . . . 0.0 111.324 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.536 ' HB2' HD21 ' A' ' 101' ' ' LEU . 36.4 t-80 -60.52 133.32 55.98 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 124.852 1.261 . . . . 0.0 111.925 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.33 -6.73 11.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.916 0.389 . . . . 0.0 110.884 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 123.47 -158.59 18.09 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.448 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 156.79 178.13 30.59 Favored Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -134.23 119.08 18.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 100.72 -123.04 7.81 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.433 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -113.26 6.59 17.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.891 0.377 . . . . 0.0 111.472 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -112.76 113.87 26.17 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.478 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.16 133.1 11.62 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -111.32 137.79 48.62 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.555 0.693 . . . . 0.0 109.93 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.539 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 16.2 m -135.41 153.31 51.84 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.915 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.444 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -81.43 132.94 35.34 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -64.7 -9.22 18.39 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.8 mt 49.32 29.39 2.71 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -40.49 121.4 1.41 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.546 1.139 . . . . 0.0 110.632 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -53.58 -25.71 18.47 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.424 ' O ' HG12 ' A' ' 179' ' ' VAL . 28.5 pt20 -63.56 -17.17 62.55 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 123.71 0.804 . . . . 0.0 112.672 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.3 m-30 -73.63 -23.32 59.87 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.758 -0.589 . . . . 0.0 111.012 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.41 12.05 34.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -170.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 176' ' ' GLN . 12.0 p . . . . . 0 C--N 1.301 -1.513 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 CA--C 1.534 0.504 0 CA-C-O 120.979 0.324 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -61.97 -39.5 92.36 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.13 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -69.21 -40.41 78.01 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.572 0.749 . . . . 0.0 109.462 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.76 -44.18 96.86 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.479 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -67.19 -50.26 61.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.254 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.41 84.49 Favored 'General case' 0 C--O 1.209 -1.037 0 C-N-CA 123.204 0.602 . . . . 0.0 111.845 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.01 -39.57 95.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.017 0.437 . . . . 0.0 111.101 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 m -74.86 -32.81 61.99 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.72 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.417 HD11 HD13 ' A' ' 86' ' ' ILE . 57.5 tp -73.38 -40.67 64.16 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.484 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.587 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 2.2 tm? -54.4 -52.89 60.3 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.256 1.422 . . . . 0.0 111.82 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -66.44 -7.59 20.48 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -170.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -126.29 -51.66 1.52 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -104.73 -2.87 24.33 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -170.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.587 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 56.5 mt -114.42 104.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.6 tpt -135.74 154.78 51.14 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.833 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.402 HG23 ' HA ' ' A' ' 105' ' ' SER . 28.4 m -75.39 115.82 15.46 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.071 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 mt -99.58 99.74 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p -80.24 101.62 8.98 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.756 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 82.6 p -89.27 -166.15 1.52 Allowed 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.81 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -73.85 -20.91 60.3 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.879 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -101.18 -49.52 4.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.59 -157.12 8.52 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 118.82 -1.657 . . . . 0.0 113.537 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -109.38 94.72 5.18 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -100.69 160.77 14.09 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.9 m -99.49 123.69 43.98 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.3 123.68 7.94 Favored Glycine 0 N--CA 1.411 -2.996 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.8 tp -101.29 112.84 25.46 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.993 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.45 135.59 16.74 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.1 -50.88 6.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 117.716 0.758 . . . . 0.0 110.74 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -146.14 110.17 4.95 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.754 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.585 ' OD2' ' HG3' ' A' ' 33' ' ' ARG . 24.9 t70 56.73 -81.17 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 171.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.585 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -116.37 0.94 12.95 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.436 0.636 . . . . 0.0 111.61 179.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.0 t -88.57 114.9 27.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.914 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.1 t -125.95 144.63 50.61 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.84 139.86 29.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -148.89 143.5 17.17 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.49 154.72 73.27 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.957 1.772 . . . . 0.0 110.872 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -68.76 -42.15 77.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.563 0.697 . . . . 0.0 109.814 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -73.89 20.38 0.1 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.4 -23.36 21.08 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.319 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.568 ' O ' ' HB ' ' A' ' 20' ' ' THR . 24.6 mm-40 69.4 66.0 0.49 Allowed Pre-proline 0 N--CA 1.486 1.362 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -94.95 135.58 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 122.615 2.21 . . . . 0.0 110.816 172.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.71 -146.8 17.34 Favored Glycine 0 C--N 1.314 -0.652 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.966 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.14 -43.0 55.03 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.621 0.724 . . . . 0.0 109.258 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -123.65 139.63 53.8 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.9 p -125.95 153.04 33.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -92.35 120.41 32.85 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.83 85.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 175.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 t30 70.79 -10.13 0.76 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.509 1.123 . . . . 0.0 112.085 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.73 -39.21 0.57 Allowed Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -78.37 126.78 31.27 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -90.91 146.89 23.52 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.497 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.5 tp -132.64 135.22 57.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -86.19 139.25 31.24 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.186 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -78.01 137.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.506 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -87.63 -48.86 7.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -164.01 151.16 11.97 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.28 101.01 7.87 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.531 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 84.4 m-85 -81.79 125.95 31.27 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.96 116.13 24.0 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -77.43 108.7 10.78 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.553 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.96 130.8 72.28 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -80.75 139.53 50.56 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -56.01 -12.25 6.96 Favored 'Trans proline' 0 CA--C 1.555 1.539 0 C-N-CA 123.725 2.95 . . . . 0.0 114.484 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -83.22 -4.07 58.04 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 121.997 0.903 . . . . 0.0 108.698 174.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.5 t30 67.73 70.29 0.34 Allowed 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.19 1.396 . . . . 0.0 110.257 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.3 mt -141.73 145.1 24.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 131' ' ' THR . 17.1 m120 -76.74 161.65 28.32 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.573 0.546 . . . . 0.0 111.264 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -129.29 -32.07 2.03 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.604 174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 71.17 4.22 4.98 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 123.052 1.406 . . . . 0.0 110.204 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.428 HD13 HD23 ' A' ' 173' ' ' LEU . 70.7 mt -94.96 119.05 32.84 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.045 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.7 m -110.89 117.6 33.82 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 96.7 t -79.52 109.36 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.4 tp -87.01 99.46 11.91 Favored 'General case' 0 N--CA 1.397 -3.123 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.886 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.0 m -85.39 105.5 16.07 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.7 mt -90.34 164.49 14.32 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.473 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.26 130.13 36.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -59.54 99.69 0.07 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.808 0.843 . . . . 0.0 111.878 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -115.51 -65.69 1.16 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -100.94 109.41 21.33 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.419 ' HG3' ' OD1' ' A' ' 32' ' ' ASP . 53.6 tttm -69.4 116.82 10.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.041 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -70.21 145.88 51.11 Favored 'General case' 0 C--O 1.263 1.772 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -66.9 143.59 56.75 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.62 82.56 2.63 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.157 0.503 . . . . 0.0 111.22 -176.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.417 HD13 HD11 ' A' ' 10' ' ' LEU . 47.9 pt -89.83 11.1 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.685 0.755 . . . . 0.0 109.527 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.583 ' O ' ' HE2' ' A' ' 175' ' ' LYS . 57.4 ttp180 -66.85 -24.23 66.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.515 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.44 -24.41 75.1 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.406 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -86.46 -4.74 59.22 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 116.991 0.396 . . . . 0.0 111.167 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 173' ' ' LEU . 87.3 mt -61.92 121.1 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.8 m -99.61 108.93 21.43 Favored 'General case' 0 N--CA 1.382 -3.827 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.346 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -71.45 -25.15 62.18 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.32 111.7 22.6 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.907 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.409 HD11 ' CG ' ' A' ' 172' ' ' GLN . 72.9 mt -107.91 -66.5 1.03 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.515 ' CB ' ' HA ' ' A' ' 119' ' ' THR . 16.5 pt-20 -74.96 152.67 38.78 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -162.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.03 -19.1 38.61 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 114.064 -1.426 . . . . 0.0 111.016 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.6 t -94.37 139.32 18.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.776 0.322 . . . . 0.0 110.316 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.51 119.11 20.64 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 174.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -110.78 164.52 12.68 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.03 0.919 . . . . 0.0 113.453 -174.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.433 HG21 HG23 ' A' ' 112' ' ' ILE . 62.4 m -122.2 140.01 53.09 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.449 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -106.71 122.6 46.68 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.47 121.25 66.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 120.861 0.362 . . . . 0.0 110.044 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.71 145.05 22.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.403 ' HB3' HG22 ' A' ' 15' ' ' ILE . 65.8 t60 -135.65 90.99 2.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.863 0.839 . . . . 0.0 110.433 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.402 ' HA ' HG23 ' A' ' 17' ' ' THR . 25.7 p -120.17 -170.75 2.03 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -87.55 -31.52 19.86 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -70.85 -50.61 33.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.541 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -113.4 86.59 2.42 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.1 m -95.44 109.22 21.44 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.442 -176.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 71.37 35.01 1.6 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.864 0.727 . . . . 0.0 110.788 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.9 m -75.93 105.63 7.08 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 100' ' ' THR . 65.2 mt -103.54 105.93 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.795 -177.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 tp -118.74 118.82 32.63 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 120.715 0.293 . . . . 0.0 111.537 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -74.97 119.65 19.43 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -95.39 -35.31 5.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.22 -170.61 20.79 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.022 -1.085 . . . . 0.0 111.943 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.75 119.46 6.4 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.15 2.567 . . . . 0.0 111.303 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.4 m -82.32 151.74 4.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.515 ' HA ' ' CB ' ' A' ' 95' ' ' GLU . 8.9 t -141.97 163.48 32.77 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 47.7 tpp -86.19 134.86 33.76 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.701 0.286 . . . . 0.0 110.301 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.19 -25.29 14.94 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.11 -94.4 1.58 Allowed Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.554 ' O ' HD12 ' A' ' 123' ' ' LEU . 4.1 pp -147.02 119.66 8.55 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.21 0.528 . . . . 0.0 110.383 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.3 tt . . . . . 0 C--N 1.308 -1.196 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.917 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo . . . . . 0 N--CA 1.431 -2.199 0 CA-C-O 121.335 0.473 . . . . 0.0 112.917 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 2.0 p -100.16 130.48 46.3 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -72.04 132.95 44.94 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -172.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 172' ' ' GLN . 36.1 mmt180 58.97 50.89 7.78 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.656 1.182 . . . . 0.0 110.507 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.3 tpt -79.53 118.86 21.77 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.134 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.564 HG23 ' HB2' ' A' ' 170' ' ' SER . 12.4 tt -90.39 138.17 20.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.257 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -127.83 146.23 50.67 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.803 -169.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -147.5 136.64 22.34 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.138 0.975 . . . . 0.0 108.704 175.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -98.96 110.24 22.88 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 122.239 1.019 . . . . 0.0 110.176 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -171.81 134.13 0.78 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.53 90.1 0.25 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.906 0.86 . . . . 0.0 110.805 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 m -104.64 140.07 38.57 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -62.87 103.45 0.45 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.814 0.816 . . . . 0.0 110.741 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.0 m -74.96 116.94 16.26 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.792 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.39 -25.0 2.02 Favored Glycine 0 C--N 1.312 -0.787 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.737 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -83.1 50.7 1.79 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.248 1.023 . . . . 0.0 110.343 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 30.8 m -60.09 137.67 58.05 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.395 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 109.99 -5.17 30.5 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.358 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.2 134.94 25.35 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.658 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.8 p -76.83 126.41 37.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.522 0.677 . . . . 0.0 110.611 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 51.8 tp -94.57 108.62 20.58 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.9 p -144.7 175.61 10.04 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.239 0.542 . . . . 0.0 111.714 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -154.86 -177.9 6.84 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 175.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.1 t -64.21 103.07 0.58 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.586 0.708 . . . . 0.0 111.386 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.37 26.37 66.01 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.741 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 59.9 mmtt -143.22 114.43 7.86 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.12 0.568 . . . . 0.0 110.626 -177.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 89.2 mt -113.5 123.95 69.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 169.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -99.49 -27.6 13.64 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.503 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 149.88 -149.58 21.52 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.5 pt -131.26 149.11 32.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 117.134 0.467 . . . . 0.0 111.21 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -68.56 115.77 8.34 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.841 0.856 . . . . 0.0 109.129 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.2 t -97.81 -36.44 5.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.07 -149.66 8.96 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -177.41 163.07 31.41 Favored Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -142.58 121.88 13.08 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.19 -126.42 9.41 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -104.6 2.34 30.58 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -92.89 112.64 24.68 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.081 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.18 135.0 13.37 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -117.52 119.8 36.15 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 122.122 0.963 . . . . 0.0 110.962 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.564 ' HB2' HG23 ' A' ' 135' ' ' ILE . 20.8 m -119.7 154.53 33.96 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -104.35 144.7 31.28 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.212 -177.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 133' ' ' ARG . 0.7 OUTLIER -81.89 118.1 22.66 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.189 0.93 . . . . 0.0 108.986 -177.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.428 HD23 HD13 ' A' ' 72' ' ' LEU . 66.9 mt -93.16 74.41 4.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -67.69 146.07 54.16 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.586 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.583 ' HE2' ' O ' ' A' ' 87' ' ' ARG . 94.7 mttt -57.36 -31.0 65.31 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.807 0.813 . . . . 0.0 110.324 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -68.69 -9.01 47.76 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.743 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -92.56 -23.26 19.12 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 121.921 -0.487 . . . . 0.0 110.05 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -102.17 18.82 19.91 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.217 -174.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--N 1.307 -1.277 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.048 179.279 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo . . . . . 0 CA--C 1.532 0.387 0 CA-C-O 120.734 0.223 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -67.53 -37.01 82.11 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.064 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -62.35 -49.58 75.0 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.65 0.78 . . . . 0.0 109.789 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.09 -43.99 90.33 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.949 0.9 . . . . 0.0 110.015 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -58.46 -47.73 83.05 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.007 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -62.39 -48.16 80.96 Favored 'General case' 0 C--O 1.206 -1.185 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.964 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.05 -41.77 88.69 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.304 0.642 . . . . 0.0 110.321 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.0 m -65.29 -43.38 91.34 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.999 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.476 HD11 HD13 ' A' ' 86' ' ' ILE . 59.8 tp -66.53 -43.53 84.93 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.954 0.901 . . . . 0.0 109.666 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 16.5 tp -49.57 -59.57 3.65 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 126.134 1.774 . . . . 0.0 112.755 -176.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -80.49 11.07 3.95 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.141 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -123.01 -56.66 1.74 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.67 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -119.3 4.63 11.24 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 33.4 mt -99.66 98.16 6.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.747 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.92 144.17 30.19 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.369 -175.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 45.5 m -79.95 115.31 19.45 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 172.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.8 mt -115.14 107.46 22.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.438 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.3 m -89.78 113.25 24.76 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 76.7 p -93.87 -157.46 0.55 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.595 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -83.32 0.72 44.57 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -112.52 -52.23 2.79 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.812 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' THR . . . -175.15 -160.14 22.51 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 119.823 -1.179 . . . . 0.0 111.943 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.14 105.88 18.11 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.82 169.42 8.85 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.5 m -99.69 123.45 43.97 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.13 118.89 6.11 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.1 tp -98.38 113.89 26.03 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.504 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.18 112.66 3.84 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.6 mm -86.65 -52.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 116.564 0.182 . . . . 0.0 110.789 -176.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -162.19 141.65 9.62 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.34 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 16.1 t70 59.37 -90.98 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 175.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -135.6 9.08 3.37 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.278 1.037 . . . . 0.0 108.709 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.482 HG13 ' CG1' ' A' ' 74' ' ' VAL . 53.9 t -80.72 108.81 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.777 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.0 m -113.01 145.47 40.79 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.424 ' CG1' HD21 ' A' ' 72' ' ' LEU . 48.8 t -112.5 133.97 56.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 O-C-N 122.185 -0.322 . . . . 0.0 111.29 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 tt -153.88 145.17 16.43 Favored Pre-proline 0 CA--C 1.566 1.571 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.616 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 31.3 Cg_exo -65.16 150.18 87.97 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.356 2.037 . . . . 0.0 113.009 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.0 m -58.1 -43.01 86.89 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.6 0.76 . . . . 0.0 112.686 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -69.59 -1.65 9.39 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.65 -32.7 62.34 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.431 ' O ' ' HB ' ' A' ' 20' ' ' THR . 25.6 mt-30 52.15 82.48 0.24 Allowed Pre-proline 0 C--O 1.248 1.024 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.46 143.13 16.96 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.965 2.443 . . . . 0.0 110.559 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.59 -136.41 7.54 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.559 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.33 -31.03 30.1 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 5.2 p-10 -136.55 153.4 51.0 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.24 -1.345 . . . . 0.0 107.622 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.53 158.39 42.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 76.7 mt -99.48 103.08 14.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 17' ' ' THR . 72.6 t -83.45 91.73 2.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 175.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 62.78 15.81 8.48 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.079 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.01 -18.36 7.95 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.251 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -84.63 119.73 25.56 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.262 0.225 . . . . 0.0 110.772 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -71.74 119.05 15.36 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.959 0.409 . . . . 0.0 111.986 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.451 HD11 ' O ' ' A' ' 78' ' ' ASP . 16.7 tt -132.72 139.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 174.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 41.7 mtp180 -82.25 157.45 23.89 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.527 0.679 . . . . 0.0 112.481 -177.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.58 140.4 16.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.439 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -93.8 -54.24 3.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' H ' ' HB ' ' A' ' 76' ' ' THR . 7.5 t70 -146.24 165.73 28.35 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -140.38 95.1 2.82 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.0 m-85 -83.3 100.59 10.73 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.7 102.3 2.27 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 tt -83.39 102.83 12.3 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-O 122.065 0.936 . . . . 0.0 109.143 -171.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 67.3 t -109.86 139.52 32.71 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.05 141.64 86.26 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.7 -10.22 2.34 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 123.513 2.808 . . . . 0.0 114.838 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -97.5 7.24 46.86 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 121.676 0.75 . . . . 0.0 109.862 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 73.61 23.26 2.44 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.123 1.369 . . . . 0.0 114.394 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.3 mm -96.89 140.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 131' ' ' THR . 5.0 m-20 -66.24 133.32 50.36 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 120.892 0.377 . . . . 0.0 111.341 -177.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 133' ' ' ARG . 58.7 tp -94.37 -15.36 24.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 170.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 61.58 27.28 16.8 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.986 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.424 HD21 ' CG1' ' A' ' 36' ' ' VAL . 2.7 tm? -125.07 140.84 52.54 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.171 -173.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.419 ' N ' HD13 ' A' ' 72' ' ' LEU . 93.9 m -134.32 130.2 36.64 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.373 0.606 . . . . 0.0 110.264 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 51.5 t -87.02 108.7 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -89.5 113.56 24.96 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -175.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.413 ' HB ' ' H ' ' A' ' 58' ' ' ASP . 16.3 m -90.66 97.46 11.19 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.401 HD11 ' CG2' ' A' ' 54' ' ' ILE . 17.6 tp -78.11 150.16 33.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.451 ' O ' HD11 ' A' ' 54' ' ' ILE . 35.5 t70 -79.91 95.77 6.18 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 119.019 -1.073 . . . . 0.0 109.765 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' A' ' 79' ' ' ARG . 4.4 mmp_? -133.12 110.07 9.92 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.315 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -85.92 -28.25 24.45 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 168.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -78.2 91.02 4.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 171.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 24.3 pttm -78.53 150.81 32.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -170.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -86.82 160.46 18.76 Favored 'General case' 0 C--O 1.256 1.403 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.811 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -81.35 140.97 34.45 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 5.5 p-10 -76.32 106.74 8.12 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 122.376 1.084 . . . . 0.0 110.19 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.476 HD13 HD11 ' A' ' 10' ' ' LEU . 22.7 pt -88.13 17.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 122.192 0.996 . . . . 0.0 109.468 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -63.21 -27.51 69.41 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.812 -1.54 . . . . 0.0 111.947 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.61 -16.82 78.99 Favored Glycine 0 C--N 1.317 -0.483 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.708 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -93.36 -3.4 53.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.731 0.3 . . . . 0.0 110.384 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.5 mt -66.08 135.72 27.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.155 0.502 . . . . 0.0 110.564 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.8 t -125.63 103.75 8.01 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -87.54 -8.59 56.15 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.593 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.24 123.15 36.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.414 HD11 ' CD ' ' A' ' 172' ' ' GLN . 20.1 mt -106.38 -71.06 0.76 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -164.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 11.1 pt-20 -50.45 137.09 19.62 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -165.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.34 -14.05 33.26 Favored Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.658 174.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.05 144.06 18.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 122.415 -0.462 . . . . 0.0 110.368 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.13 116.87 21.25 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.28 159.5 14.95 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.396 0.617 . . . . 0.0 110.731 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.2 m -129.39 133.52 47.41 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.37 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.7 mt -90.91 125.72 35.84 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.422 ' HB ' ' CG1' ' A' ' 149' ' ' VAL . 30.5 t -117.69 107.63 22.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.414 HG22 ' HA3' ' A' ' 148' ' ' GLY . 10.6 t -109.02 147.71 13.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.534 ' CE1' HG23 ' A' ' 109' ' ' THR . 2.6 t-80 -140.0 106.91 5.41 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.41 ' HA ' HG23 ' A' ' 17' ' ' THR . 52.8 p -128.74 -170.47 2.27 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -89.91 -34.94 15.87 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 176.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -63.06 -45.5 91.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.788 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . 0.265 9.3 p90 -133.53 96.55 3.73 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.603 1.192 . . . . 0.0 112.509 175.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.534 HG23 ' CE1' ' A' ' 104' ' ' HIS . 90.8 m -83.43 122.58 28.69 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.943 178.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.01 71.24 0.52 Allowed 'General case' 0 C--O 1.245 0.867 0 C-N-CA 124.321 1.048 . . . . 0.0 112.867 176.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.5 m -102.15 99.15 9.25 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.998 176.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.4 mt -95.19 110.62 24.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.7 tp -128.9 108.23 10.26 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.864 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -68.28 124.9 24.77 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.0 m -99.05 -27.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.613 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.92 -164.8 12.19 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 119.81 -1.186 . . . . 0.0 112.119 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.08 129.98 19.33 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.014 2.476 . . . . 0.0 112.668 -177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 31.2 m -96.27 161.54 2.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.381 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.8 p -144.35 164.69 30.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.738 1.215 . . . . 0.0 108.683 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 52.2 ttm -86.93 139.28 30.78 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.637 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -105.37 -40.57 5.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.739 0.305 . . . . 0.0 111.465 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.73 -113.51 3.7 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.606 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.7 mt -93.22 120.6 33.68 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.009 0.524 . . . . 0.0 110.049 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.739 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 C--O 1.248 0.977 0 CA-C-O 121.141 0.392 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 22.3 p -109.1 135.03 50.91 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.814 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -111.27 164.35 12.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.447 ' HG3' ' HB2' ' A' ' 172' ' ' GLN . 12.7 tpp180 66.38 27.49 9.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.577 1.151 . . . . 0.0 108.976 173.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.2 mmt -79.57 150.44 31.08 Favored 'General case' 0 C--O 1.251 1.152 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.429 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.541 HG23 ' HB2' ' A' ' 170' ' ' SER . 8.6 tt -115.57 141.87 30.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 173.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.637 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 39.4 ttt180 -127.25 139.34 52.98 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 123.216 0.606 . . . . 0.0 111.319 -171.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -149.23 144.02 26.27 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.01 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.67 107.41 19.16 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.886 0.741 . . . . 0.0 110.171 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -173.02 138.17 0.75 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.75 92.08 2.45 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.511 0.672 . . . . 0.0 110.103 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.2 t -79.19 165.92 22.75 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.531 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -120.25 163.13 18.24 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.6 t -78.56 153.63 31.05 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.78 -9.11 63.97 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -89.32 4.5 48.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.204 0.526 . . . . 0.0 111.315 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.616 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 48.0 t -58.11 120.74 9.15 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.453 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.43 -12.52 56.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.02 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.414 ' HA3' HG22 ' A' ' 103' ' ' VAL . . . -68.29 131.99 27.63 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.456 ' HA ' HG22 ' A' ' 159' ' ' ILE . 7.4 p -70.21 124.59 26.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.699 0.761 . . . . 0.0 111.219 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.1 tp -94.2 98.71 11.14 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 22.6 p -140.07 156.44 46.58 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.312 0.577 . . . . 0.0 111.586 -174.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -121.24 -173.18 2.56 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 t -71.75 79.51 0.85 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.005 0.907 . . . . 0.0 112.952 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 105.91 8.96 33.39 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.98 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -137.31 104.44 5.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 84.4 mt -93.86 120.14 42.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -94.82 -34.06 12.62 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.577 0.703 . . . . 0.0 110.538 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 165.19 -149.08 15.15 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.309 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' A' ' 149' ' ' VAL . 46.0 pt -135.01 149.21 28.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -66.63 133.36 50.12 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.295 0.638 . . . . 0.0 110.71 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 86.6 t -108.46 -59.69 3.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.09 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -159.58 153.39 24.42 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.282 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -115.56 125.86 6.88 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.409 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -112.24 97.49 6.67 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.7 -113.33 5.19 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -99.91 -6.35 26.85 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.963 0.411 . . . . 0.0 110.497 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -96.18 102.35 14.13 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.343 0.592 . . . . 0.0 110.792 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.24 119.7 4.96 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -105.41 123.84 48.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.854 0.835 . . . . 0.0 110.213 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.541 ' HB2' HG23 ' A' ' 135' ' ' ILE . 14.6 m -123.94 166.17 16.14 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.908 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.517 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -98.42 131.0 45.04 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.447 ' HB2' ' HG3' ' A' ' 133' ' ' ARG . 46.5 mt-30 -73.39 121.54 20.64 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 123.869 0.73 . . . . 0.0 109.885 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.414 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 89.0 mt -95.44 85.0 4.1 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -72.34 146.02 47.39 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.458 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -65.7 -24.99 67.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -48.18 -39.1 19.84 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.232 1.813 . . . . 0.0 111.56 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -83.35 -9.9 58.79 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.05 -0.406 . . . . 0.0 111.477 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -122.42 18.16 10.54 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 121.126 -0.229 . . . . 0.0 111.157 -174.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.242 0.671 0 CA-C-O 121.845 0.831 . . . . 0.0 111.662 179.401 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo . . . . . 0 C--O 1.243 0.753 0 CA-C-O 121.42 0.508 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -66.92 -34.21 77.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.738 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.9 m -67.64 -43.68 79.76 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.672 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.54 -43.0 95.36 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.929 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -61.4 -45.48 94.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.02 82.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.01 0.433 . . . . 0.0 111.269 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.5 -44.02 75.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.986 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 p -73.78 -34.53 64.71 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 120.722 0.296 . . . . 0.0 111.594 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.35 -40.72 95.32 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.737 0.815 . . . . 0.0 109.494 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.5 tp -48.97 -61.0 2.3 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 125.209 1.403 . . . . 0.0 113.649 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -80.91 11.85 3.69 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -172.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -127.0 -53.57 1.41 Allowed 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.16 0.505 . . . . 0.0 111.512 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -107.01 -9.6 16.18 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -171.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.3 mt -105.05 125.65 60.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 120.731 0.3 . . . . 0.0 110.932 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.08 135.73 27.6 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.934 0.397 . . . . 0.0 111.131 177.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.465 ' HA ' HG22 ' A' ' 26' ' ' THR . 4.5 m -68.1 132.78 47.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.662 176.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.89 113.1 31.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 121.002 0.43 . . . . 0.0 110.161 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 24.9 m -78.08 104.83 8.89 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.6 p -90.89 -165.11 1.28 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.412 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.1 m -84.7 -7.6 59.16 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 121.049 0.452 . . . . 0.0 111.028 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -108.98 -46.21 3.65 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.223 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -166.17 -173.08 34.25 Favored Glycine 0 CA--C 1.497 -1.07 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.198 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -98.94 97.22 8.42 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -104.91 -173.69 2.36 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.55 HG23 ' HA ' ' A' ' 105' ' ' SER . 2.2 p -124.52 145.28 49.65 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.58 150.26 18.7 Favored Glycine 0 N--CA 1.412 -2.964 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -107.48 118.81 37.71 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.75 119.9 5.1 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mm -83.66 -49.38 16.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 117.205 0.503 . . . . 0.0 109.656 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -170.56 157.12 5.7 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.174 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 5.3 m-20 53.75 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.292 1.037 . . . . 0.0 112.974 177.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -139.16 11.77 2.6 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.672 0.749 . . . . 0.0 109.078 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.0 t -88.25 112.79 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.893 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.4 m -128.82 152.85 48.03 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.426 ' HB ' HD11 ' A' ' 72' ' ' LEU . 29.9 m -115.65 148.97 18.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.0 tp -151.96 148.62 21.87 Favored Pre-proline 0 CA--C 1.564 1.499 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -67.26 147.77 79.06 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 121.92 1.746 . . . . 0.0 111.899 174.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.8 m -66.11 -41.36 90.67 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.036 0.446 . . . . 0.0 112.202 -176.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -65.76 -13.26 59.05 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.73 -26.95 63.61 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 62.79 87.37 0.13 Allowed Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.622 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.12 151.23 15.97 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 122.325 2.017 . . . . 0.0 110.066 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.14 -168.88 24.03 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.49 -13.47 59.82 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.205 0.526 . . . . 0.0 111.885 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -148.08 138.82 23.07 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.61 160.65 42.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 81.2 mt -93.31 107.68 19.46 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.3 p -90.07 84.22 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-O 122.864 1.316 . . . . 0.0 109.354 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.5 t30 62.36 20.69 12.01 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.614 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.87 -47.85 0.98 Allowed Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.545 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -66.9 124.7 23.7 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -80.22 123.23 27.76 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.432 HD11 ' O ' ' A' ' 78' ' ' ASP . 8.6 tp -122.35 125.68 73.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 55' ' ' ARG . 53.5 mtt180 -72.88 123.83 24.19 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.478 0.656 . . . . 0.0 109.379 175.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.0 t -93.66 116.23 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 28.7 ttpp -68.4 -72.09 0.19 Allowed 'General case' 0 C--N 1.293 -1.883 0 O-C-N 123.499 0.499 . . . . 0.0 111.023 -175.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.487 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.4 m-20 -108.63 146.12 33.87 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 122.039 -0.413 . . . . 0.0 110.925 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -116.69 102.7 9.66 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.56 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 91.7 m-85 -89.56 94.63 9.94 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.613 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -71.18 98.64 1.73 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 174.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.526 HD23 HD23 ' A' ' 72' ' ' LEU . 36.3 tp -77.05 108.15 9.92 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 122.252 1.025 . . . . 0.0 112.563 -167.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.84 151.09 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.796 0 CA-C-N 113.415 -1.72 . . . . 0.0 107.225 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.39 140.11 89.91 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.13 -21.36 9.06 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.496 2.798 . . . . 0.0 114.821 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.22 8.54 23.58 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.053 0.454 . . . . 0.0 110.978 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.2 t30 73.36 68.03 0.11 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.821 1.649 . . . . 0.0 112.004 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.512 HG21 ' HB2' ' A' ' 132' ' ' ASN . 55.0 mt -143.2 147.3 20.56 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -90.52 156.1 18.41 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.418 1.008 . . . . 0.0 111.987 -174.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' A' ' 133' ' ' ARG . 8.7 mp -112.33 -11.73 13.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.479 174.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 68.26 25.07 7.27 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 123.267 1.508 . . . . 0.0 108.284 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.526 HD23 HD23 ' A' ' 62' ' ' LEU . 58.3 tp -125.19 142.08 51.71 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.417 -1.719 . . . . 0.0 109.426 -174.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.0 m -135.82 134.04 38.48 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 43.2 t -102.08 125.67 56.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.37 138.19 42.99 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.106 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.2 m -98.65 99.16 10.25 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.8 mt -80.44 104.97 11.34 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.432 ' O ' HD11 ' A' ' 54' ' ' ILE . 33.9 t70 -81.36 92.82 6.47 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -146.49 175.25 10.71 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.77 -22.75 23.13 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -78.97 123.07 26.93 Favored 'General case' 0 C--O 1.247 0.969 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.012 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 20.4 pttp -100.22 139.51 35.78 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.051 -177.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -75.78 157.11 33.86 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.477 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -64.97 131.34 46.36 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.966 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.58 93.29 2.01 Favored 'General case' 0 C--O 1.2 -1.549 0 CA-C-O 122.029 0.918 . . . . 0.0 112.565 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.4 pt -96.24 21.27 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 O-C-N 120.83 -1.168 . . . . 0.0 109.584 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -69.4 -31.71 70.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.664 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -79.73 -7.37 88.56 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.129 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 64.7 m-85 -97.94 -0.8 44.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.245 0.545 . . . . 0.0 109.897 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.57 116.94 8.03 Favored 'Isoleucine or valine' 0 C--O 1.254 1.316 0 CA-C-O 121.229 0.538 . . . . 0.0 110.853 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.6 t -102.26 107.15 18.1 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.53 ' HG2' ' HA ' ' A' ' 174' ' ' LYS . 32.5 mt-10 -87.95 -6.56 57.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -95.15 118.01 31.21 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 175.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.444 HD11 ' CD ' ' A' ' 172' ' ' GLN . 12.8 mt -116.11 -60.56 1.85 Allowed 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.968 0.89 . . . . 0.0 110.966 -170.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 34.5 tt0 -64.8 120.04 11.75 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.651 -167.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 112.36 -22.1 18.33 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.529 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.1 t -91.57 141.42 14.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.82 123.96 28.68 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -110.43 158.58 18.32 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.674 0.749 . . . . 0.0 111.355 -177.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.8 m -123.86 123.96 41.6 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.858 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.6 tp -95.78 116.32 28.72 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.42 104.15 14.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.513 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 93.5 t -84.21 115.51 26.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.422 ' CD2' HG21 ' A' ' 26' ' ' THR . 37.2 p-80 -153.17 156.6 38.9 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.55 ' HA ' HG23 ' A' ' 26' ' ' THR . 78.1 p -175.49 -152.69 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -84.61 -25.87 28.28 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 119.273 0.942 . . . . 0.0 108.585 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -87.48 -48.86 7.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.98 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -94.39 144.14 25.81 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 23.4 m -148.81 124.42 10.42 Favored 'General case' 0 C--N 1.281 -2.403 0 O-C-N 121.356 -0.84 . . . . 0.0 110.311 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.63 30.86 20.51 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.068 0.855 . . . . 0.0 113.073 173.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.513 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 95.3 m -83.88 87.35 7.09 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-O 122.08 0.943 . . . . 0.0 108.741 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 75.4 mt -77.16 102.22 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.174 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.3 tp -109.51 103.83 12.78 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.104 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -76.13 121.6 23.08 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.9 m -104.19 -10.16 9.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.11 -153.12 24.23 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.632 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.29 124.87 11.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.544 2.163 . . . . 0.0 112.704 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 16.6 m -92.58 160.12 2.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.199 177.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.407 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . 13.9 p -130.91 159.11 38.38 Favored 'General case' 0 C--O 1.251 1.169 0 O-C-N 123.346 0.404 . . . . 0.0 111.155 -177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 25.3 ttt -79.65 118.06 21.13 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -75.4 -42.17 54.43 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 176.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.2 -100.21 2.65 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.171 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 124' ' ' ILE . 7.1 tt -130.52 145.56 51.88 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.46 ' N ' HD23 ' A' ' 123' ' ' LEU . 14.8 tt . . . . . 0 C--N 1.291 -1.938 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 N--CA 1.442 -1.508 0 CA-C-O 121.373 0.489 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.8 m -119.28 133.39 55.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.512 ' HB2' HG21 ' A' ' 68' ' ' ILE . 3.0 t-20 -131.08 170.72 14.14 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HB2' ' HG ' ' A' ' 70' ' ' LEU . 30.6 mmt180 64.48 41.62 5.51 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.211 1.004 . . . . 0.0 108.925 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.524 ' SD ' ' HB3' ' A' ' 169' ' ' PHE . 48.3 ttm -109.56 149.63 29.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.634 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 170' ' ' SER . 13.2 tt -115.19 147.61 18.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 123.765 0.826 . . . . 0.0 108.856 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.57 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 43.7 ttp180 -127.62 143.95 51.12 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.116 0.484 . . . . 0.0 111.089 -174.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -149.14 136.23 19.9 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 171.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.97 91.01 7.07 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.867 1.317 . . . . 0.0 111.905 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -156.3 125.88 6.28 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.93 89.79 1.43 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.531 0.52 . . . . 0.0 110.624 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.0 p -79.27 170.1 17.12 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.885 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -110.14 141.8 42.52 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.346 0.593 . . . . 0.0 111.423 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.8 m -71.22 125.98 28.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 125.52 -25.32 5.68 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -174.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -87.16 24.31 1.6 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.6 m -75.39 128.13 34.68 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.55 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.74 1.4 49.43 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.264 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.79 135.8 28.74 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 86.5 t -90.32 120.09 38.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 CA-C-O 121.18 0.514 . . . . 0.0 110.58 -174.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.4 tp -92.1 106.71 18.66 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.9 p -142.22 -178.9 5.95 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.306 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.75 -175.42 5.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.3 m -61.02 101.8 0.17 Allowed 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 122.602 0.361 . . . . 0.0 111.617 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 73.11 22.7 78.79 Favored Glycine 0 C--O 1.244 0.734 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.12 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 58.2 mttp -140.81 114.17 8.66 Favored 'General case' 0 C--O 1.206 -1.213 0 O-C-N 122.887 -0.184 . . . . 0.0 111.115 -175.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.29 126.85 57.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.08 -38.07 9.89 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.719 0.771 . . . . 0.0 109.504 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 165.11 -160.22 33.48 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.849 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.74 145.29 33.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 120.704 0.288 . . . . 0.0 110.402 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -66.13 130.98 45.09 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.88 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.0 t -95.9 -56.68 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.43 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.17 164.09 29.26 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.03 125.35 8.54 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -111.16 81.75 1.49 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.93 -123.65 6.38 Favored Glycine 0 N--CA 1.422 -2.235 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -89.17 -13.94 37.21 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.208 0.527 . . . . 0.0 109.7 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -98.26 122.85 41.94 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.065 0.459 . . . . 0.0 111.424 -177.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.19 121.99 6.54 Favored Glycine 0 N--CA 1.422 -2.245 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.524 ' HB3' ' SD ' ' A' ' 134' ' ' MET . 84.3 m-85 -108.82 134.91 50.87 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.435 0.636 . . . . 0.0 110.993 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.486 ' HB2' HG23 ' A' ' 135' ' ' ILE . 18.8 m -133.11 158.99 41.4 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.966 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.498 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -92.71 140.9 29.05 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.444 ' CD ' HD11 ' A' ' 94' ' ' LEU . 78.6 mt-30 -84.58 124.49 31.48 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 121.475 0.655 . . . . 0.0 111.325 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.456 HD23 HD21 ' A' ' 72' ' ' LEU . 98.2 mt -93.63 92.78 7.7 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.53 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 68.2 mttm -87.09 150.45 23.99 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.509 ' O ' HG13 ' A' ' 179' ' ' VAL . 10.0 ptpp? -77.12 -13.68 59.91 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.958 -176.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -58.81 -22.43 58.51 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.602 1.161 . . . . 0.0 111.11 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 174' ' ' LYS . 45.5 m-85 -91.1 -8.74 47.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.196 0.522 . . . . 0.0 110.331 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -119.58 10.93 11.91 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.547 -175.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 175' ' ' LYS . 31.6 m . . . . . 0 C--N 1.313 -0.981 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo . . . . . 0 N--CA 1.483 0.872 0 N-CA-C 115.477 1.299 . . . . 0.0 115.477 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -59.14 -49.84 76.32 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.7 m -64.8 -39.54 93.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.89 0.476 . . . . 0.0 111.088 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.79 -41.79 78.23 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.006 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -62.35 -43.4 98.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.66 98.45 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.114 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.06 -33.06 75.14 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-O 121.246 0.546 . . . . 0.0 111.187 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -71.32 -53.57 13.74 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.9 tp -53.86 -44.37 70.3 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.8 0.84 . . . . 0.0 109.891 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.498 ' HA ' HD12 ' A' ' 15' ' ' ILE . 44.4 tp -51.65 -58.46 6.29 Favored 'General case' 0 C--O 1.206 -1.191 0 C-N-CA 125.522 1.529 . . . . 0.0 112.644 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -87.73 0.2 56.06 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -172.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -112.81 -44.1 3.35 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -121.75 3.49 10.07 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 11' ' ' LEU . 59.0 mt -112.72 130.23 66.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.166 0.508 . . . . 0.0 110.52 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.75 165.51 26.25 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.398 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.7 m -98.99 118.34 35.54 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.63 120.87 55.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.487 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 24.1 m -79.9 101.39 8.55 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.352 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.2 p -104.53 -174.31 2.51 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.281 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -75.16 -35.0 61.65 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -91.03 3.54 54.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.23 -174.32 27.96 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.167 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 19' ' ' THR . 38.8 mt-10 -112.51 94.3 4.85 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -92.63 179.86 5.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.504 -171.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 20.3 m -86.61 124.28 32.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.719 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.0 130.81 10.38 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 175.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.0 tp -110.16 119.09 38.17 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.964 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.08 123.5 6.23 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 174.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mm -87.52 -44.11 15.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -171.85 144.18 1.73 Allowed 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.534 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.508 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 37.1 t70 60.32 -89.24 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.657 1.223 . . . . 0.0 112.083 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.652 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 36.0 ptt180 -140.25 11.13 2.36 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.998 0.904 . . . . 0.0 109.937 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.0 t -79.88 112.97 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.237 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 m -123.29 151.69 42.15 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 124.013 0.821 . . . . 0.0 110.235 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 74' ' ' VAL . 21.9 t -125.77 141.85 44.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.7 tt -157.22 150.61 18.88 Favored Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -71.6 155.31 59.31 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.019 1.812 . . . . 0.0 112.202 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.6 m -71.16 -33.14 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.266 -0.271 . . . . 0.0 110.301 -177.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -66.15 -2.76 4.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.28 -28.23 59.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 69.38 81.06 0.2 Allowed Pre-proline 0 C--O 1.232 0.144 0 C-N-CA 125.336 1.454 . . . . 0.0 112.559 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -96.96 171.2 0.86 Allowed 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.777 2.318 . . . . 0.0 111.788 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.72 -143.31 6.95 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -91.1 -29.96 17.01 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.671 0.748 . . . . 0.0 110.075 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -141.23 135.33 30.6 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.75 -172.62 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.392 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.7 mt -113.25 128.14 56.38 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.39 96.88 4.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 58.29 20.37 7.16 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.188 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.02 -36.3 2.87 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.347 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -74.54 134.45 42.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.705 0.253 . . . . 0.0 110.832 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -75.83 111.89 11.67 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.52 HD11 ' O ' ' A' ' 78' ' ' ASP . 11.1 tp -120.14 140.22 44.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.074 0.464 . . . . 0.0 111.142 -174.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.529 ' N ' ' HD2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -97.85 138.84 34.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.8 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 75' ' ' LEU . 48.4 t -100.32 109.63 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -70.02 -71.77 0.22 Allowed 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.904 0.753 . . . . 0.0 110.564 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' H ' ' HB ' ' A' ' 76' ' ' THR . 20.8 m-20 -102.98 141.36 35.92 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -126.95 96.15 4.54 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -96.1 107.59 19.93 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -93.55 116.71 29.23 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.455 ' HB3' HD12 ' A' ' 70' ' ' LEU . 4.2 mm? -77.69 115.1 17.18 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.786 0.803 . . . . 0.0 111.534 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.21 145.5 32.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.466 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 14.7 t70 -70.99 145.81 92.07 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -46.33 -31.36 9.29 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.784 2.989 . . . . 0.0 113.981 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -82.5 5.9 19.2 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.03 0.443 . . . . 0.0 111.553 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 71.24 68.58 0.17 Allowed 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 125.281 1.432 . . . . 0.0 111.122 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 67.6 mt -131.16 139.87 49.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' A' ' 131' ' ' THR . 0.9 OUTLIER -73.55 137.85 44.6 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -176.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' A' ' 62' ' ' LEU . 72.2 mt -111.49 -2.16 15.61 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 63.72 -21.68 0.06 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 127.222 2.209 . . . . 0.0 113.812 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 70' ' ' LEU . 82.8 mt -70.28 118.98 13.79 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.17 0.51 . . . . 0.0 111.618 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.9 m -112.71 115.93 29.33 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 36' ' ' VAL . 59.0 t -100.99 121.53 51.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.45 ' HB3' HG13 ' A' ' 56' ' ' VAL . 2.4 mm? -113.53 133.19 55.38 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.492 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.513 ' HB ' ' H ' ' A' ' 58' ' ' ASP . 96.0 m -86.08 82.85 7.93 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 169.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.652 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 18.8 tp -76.87 132.18 39.0 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.52 ' O ' HD11 ' A' ' 54' ' ' ILE . 27.8 t70 -76.22 77.52 3.02 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 117.669 -1.612 . . . . 0.0 112.336 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -96.37 94.89 7.7 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -68.8 -12.71 61.81 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.449 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -98.29 100.97 12.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.496 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 8.2 ptpp? -62.43 136.83 58.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -172.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -81.62 152.79 27.0 Favored 'General case' 0 C--O 1.257 1.456 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.529 175.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -69.86 144.56 52.49 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.625 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.01 97.45 1.88 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.916 0.865 . . . . 0.0 111.49 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.3 pt -91.2 18.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 121.596 0.712 . . . . 0.0 110.403 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -69.41 -30.87 68.92 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.774 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.39 -10.82 86.02 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.44 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -97.76 -5.18 35.54 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.7 mt -70.39 113.53 6.6 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 CA-C-O 121.301 0.572 . . . . 0.0 111.317 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -104.09 93.73 5.0 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.42 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 5.6 pt-20 -90.93 1.6 56.89 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.905 0.86 . . . . 0.0 111.049 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -97.17 110.2 22.79 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 167.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.509 HD13 ' HB ' ' A' ' 135' ' ' ILE . 6.4 mt -106.38 -57.36 2.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -164.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -42.02 113.94 0.49 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.445 1.498 . . . . 0.0 114.499 -168.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 -13.22 65.53 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.858 -1.064 . . . . 0.0 113.624 174.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 40.3 t -91.23 141.86 13.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 117.143 0.472 . . . . 0.0 110.68 -177.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -75.31 146.25 41.15 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.69 0.796 . . . . 0.0 111.614 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -138.61 170.46 15.97 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.053 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.5 m -135.39 148.47 49.37 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 tp -108.98 121.11 44.44 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 109.373 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.06 105.83 19.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.5 t -105.27 127.55 59.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -136.55 87.7 2.32 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 29.4 p -115.87 -172.38 2.15 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -79.49 -44.86 20.45 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 117.763 -1.575 . . . . 0.0 107.414 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.64 -42.19 78.36 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.809 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -105.89 91.39 3.72 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.0 m -87.76 100.38 12.8 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.591 -175.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 70.0 71.29 0.23 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.211 1.005 . . . . 0.0 113.203 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.1 m -108.83 95.33 5.58 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.6 mt -95.78 96.02 5.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.1 tp -113.42 123.42 50.03 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.977 -173.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.91 145.04 55.87 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.69 -39.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.559 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.62 -164.02 19.81 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.71 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 51.9 Cg_exo -58.38 129.35 32.27 Favored 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 123.712 2.941 . . . . 0.0 113.163 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.9 m -104.31 163.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.188 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.436 ' O ' HG13 ' A' ' 135' ' ' ILE . 42.8 p -129.61 174.75 9.38 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -116.71 131.35 56.97 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -93.57 -36.42 12.41 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.816 0.341 . . . . 0.0 111.227 -175.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.8 -105.76 3.19 Favored Glycine 0 CA--C 1.486 -1.74 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.82 138.58 51.01 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.464 HG13 ' HG3' ' A' ' 134' ' ' MET . 2.8 pp . . . . . 0 C--N 1.292 -1.901 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 N--CA 1.444 -1.41 0 CA-C-O 121.259 0.441 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 9.9 m -119.12 129.55 55.11 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -113.52 165.36 12.56 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.154 0.582 . . . . 0.0 109.944 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? 72.03 28.44 2.53 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.309 1.444 . . . . 0.0 109.402 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.464 ' HG3' HG13 ' A' ' 124' ' ' ILE . 95.4 mmm -86.92 126.24 34.56 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.616 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.585 HG23 ' HB3' ' A' ' 170' ' ' SER . 2.8 tt -99.26 143.77 12.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 43.4 ttp180 -132.28 139.79 48.37 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.95 0.405 . . . . 0.0 111.138 -170.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.485 ' CE1' ' HA3' ' A' ' 168' ' ' GLY . 37.0 p90 -140.41 135.86 32.49 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -93.72 117.31 29.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -176.09 143.52 0.55 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.74 92.86 0.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.911 0.862 . . . . 0.0 110.861 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.2 m -121.25 138.38 54.26 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -108.6 152.27 25.01 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.882 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -74.06 154.47 39.2 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 109.54 -16.67 31.45 Favored Glycine 0 C--N 1.307 -1.08 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -173.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -92.22 21.65 5.0 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 37.3 m -68.22 135.73 52.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.174 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.563 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 95.94 -4.74 65.78 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.15 135.82 30.09 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.24 115.22 25.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.278 0.561 . . . . 0.0 110.664 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.3 tp -85.38 101.53 12.66 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 18.0 p -151.73 168.94 23.46 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.675 0.75 . . . . 0.0 111.958 -172.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.85 -177.9 6.05 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.9 t -60.12 105.42 0.4 Allowed 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.976 0.893 . . . . 0.0 112.03 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.17 19.1 78.39 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.555 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -141.44 92.59 2.48 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 116.826 0.313 . . . . 0.0 110.683 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.3 mt -99.56 122.8 51.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -95.74 -36.12 11.29 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.591 0.71 . . . . 0.0 110.43 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.478 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 165.2 -156.33 28.24 Favored Glycine 0 N--CA 1.424 -2.166 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.663 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.9 pt -124.02 145.09 31.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -69.9 131.11 43.93 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 123.279 0.631 . . . . 0.0 110.135 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.65 11.11 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.762 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -129.86 -119.38 2.13 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.213 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 103.68 51.09 0.98 Allowed Glycine 0 CA--C 1.494 -1.261 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -106.92 96.81 6.7 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.83 -109.43 2.83 Favored Glycine 0 C--N 1.314 -0.668 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 41.3 mtm105 -111.38 14.67 21.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.017 0.437 . . . . 0.0 109.91 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -112.26 110.12 20.18 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.129 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' A' ' 137' ' ' TYR . . . -90.99 112.16 4.08 Favored Glycine 0 N--CA 1.411 -2.989 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -101.6 130.18 47.88 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.585 ' HB3' HG23 ' A' ' 135' ' ' ILE . 29.8 t -129.94 158.9 38.26 Favored 'General case' 0 C--N 1.265 -3.096 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.53 137.18 49.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -70.67 116.6 11.17 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 123.821 0.701 . . . . 0.0 112.174 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.478 HD13 ' HA2' ' A' ' 158' ' ' GLY . 10.2 mp -85.63 81.3 8.7 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.503 175.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -67.53 129.4 39.79 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.42 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 7.8 ptpp? -63.3 -16.21 59.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.768 0.318 . . . . 0.0 111.485 -177.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -58.37 -29.66 66.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.4 1.08 . . . . 0.0 110.73 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -80.75 -17.33 51.29 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.331 0.586 . . . . 0.0 110.29 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -111.68 0.33 16.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.284 -173.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.428 -1.539 0 CA-C-O 121.891 0.853 . . . . 0.0 109.027 177.442 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo . . . . . 0 N--CA 1.481 0.776 0 N-CA-C 112.827 0.28 . . . . 0.0 112.827 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -68.67 -39.66 80.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.956 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m -65.02 -46.71 80.23 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 122.938 0.495 . . . . 0.0 110.76 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.89 -29.17 58.38 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -63.91 -49.64 71.87 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.77 86.02 Favored 'General case' 0 C--O 1.194 -1.822 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.621 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.8 tp -57.47 -52.02 67.09 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.404 0.681 . . . . 0.0 111.446 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -67.9 -31.03 70.53 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.453 0.644 . . . . 0.0 110.302 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.7 tp -70.34 -52.94 18.99 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.42 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.487 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.4 tp -53.1 -54.5 34.68 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 126.344 1.858 . . . . 0.0 113.123 -176.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.2 mtp85 -62.21 -7.16 3.76 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -171.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -137.56 -50.65 0.62 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.416 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -91.36 -7.16 51.66 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -167.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 60.1 mt -115.89 113.58 43.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 42.1 ttm -140.37 136.98 33.69 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.771 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 50.7 m -63.6 135.31 56.7 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.202 0.601 . . . . 0.0 111.394 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 75.5 mt -129.11 126.53 64.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 92.1 m -89.6 110.24 21.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 72.4 p -91.99 -162.52 0.93 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.796 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 t -83.14 -1.14 52.13 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -104.51 -55.95 2.26 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.92 -158.02 21.18 Favored Glycine 0 CA--C 1.502 -0.727 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.817 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -89.85 113.58 25.2 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 116.773 0.287 . . . . 0.0 110.928 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -122.45 -172.65 2.51 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 104' ' ' HIS . 8.8 t -128.23 138.65 52.54 Favored 'General case' 0 N--CA 1.403 -2.79 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.257 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.96 148.59 18.22 Favored Glycine 0 N--CA 1.418 -2.54 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -111.08 118.32 35.68 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.61 111.55 3.44 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.3 mm -77.46 -45.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 85' ' ' ASP . 1.5 p-80 -179.58 161.54 1.04 Allowed 'General case' 0 CA--C 1.484 -1.585 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.601 177.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 52.17 -104.94 0.2 Allowed 'General case' 0 CA--C 1.554 1.125 0 O-C-N 124.511 1.132 . . . . 0.0 112.732 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -119.43 5.48 11.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.063 0.459 . . . . 0.0 109.872 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.1 t -85.59 107.54 16.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.704 -174.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -119.13 141.72 48.56 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.429 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.1 t -117.73 140.53 40.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 122.904 0.481 . . . . 0.0 111.536 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.424 HG22 HD21 ' A' ' 75' ' ' LEU . 15.6 tt -156.69 147.71 16.54 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 175.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 72.1 Cg_exo -55.87 154.4 26.96 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.736 2.291 . . . . 0.0 112.503 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -79.19 -28.86 42.68 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.099 -0.376 . . . . 0.0 111.407 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -73.31 -7.13 50.27 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.068 0.461 . . . . 0.0 111.178 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.78 -19.55 60.16 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.502 ' O ' ' HB ' ' A' ' 20' ' ' THR . 27.6 mt-30 53.11 78.61 0.39 Allowed Pre-proline 0 C--O 1.247 0.942 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 177.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -84.79 146.14 10.39 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.134 1.889 . . . . 0.0 110.097 173.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.81 -143.19 14.03 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.139 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -94.43 -20.53 19.63 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.16 0.505 . . . . 0.0 110.841 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -146.19 135.13 22.52 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.51 165.76 29.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 123.508 0.505 . . . . 0.0 110.408 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 78.3 mt -97.12 104.72 16.76 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -90.28 85.85 2.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 122.372 1.082 . . . . 0.0 109.739 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 66.76 14.96 10.01 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.514 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.51 -50.48 0.82 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.86 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.07 132.59 48.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.825 0.45 . . . . 0.0 111.28 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -78.66 124.84 28.6 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 77' ' ' LEU . 9.8 tp -132.39 134.91 58.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.989 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -86.21 137.69 32.45 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.968 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.61 127.3 41.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -65.92 -62.8 1.3 Allowed 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.783 0.677 . . . . 0.0 109.661 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -152.87 148.44 27.16 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -132.93 151.55 52.03 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -172.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -125.37 123.18 38.8 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.933 -176.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -81.06 104.66 11.71 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 167.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.478 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 50.0 tp -88.44 111.24 21.56 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.33 179.91 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.813 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -77.19 140.66 65.97 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.79 -28.78 13.49 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.771 2.981 . . . . 0.0 114.766 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -87.9 10.41 18.81 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.472 0.653 . . . . 0.0 110.595 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.4 t30 65.49 70.15 0.45 Allowed 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 125.379 1.472 . . . . 0.0 111.274 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.8 mt -137.7 145.98 28.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' A' ' 131' ' ' THR . 58.6 t30 -65.73 132.5 48.9 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.997 0.427 . . . . 0.0 110.742 -176.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 50.6 tp -105.72 -7.11 18.6 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 14.8 tp10 62.9 28.55 16.4 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.844 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.51 125.35 47.63 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.104 -172.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.1 m -123.15 123.02 39.87 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.6 t -100.84 120.4 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.424 HD21 HG22 ' A' ' 37' ' ' ILE . 2.5 mm? -105.5 128.63 53.67 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.3 m -85.92 86.71 7.35 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.432 HD11 HG23 ' A' ' 54' ' ' ILE . 15.4 tp -86.34 120.3 27.54 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -175.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.451 ' O ' ' HD2' ' A' ' 79' ' ' ARG . 33.1 t70 -63.42 101.79 0.35 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.326 0.584 . . . . 0.0 111.116 -177.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 26.9 mmm180 -126.42 117.89 23.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -77.05 -37.37 54.82 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -97.11 104.89 16.95 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -93.87 154.13 17.89 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -168.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -74.82 170.21 16.35 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.287 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -85.92 143.8 28.0 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 31' ' ' HIS . 9.6 t70 -71.43 95.78 1.4 Allowed 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.043 0.925 . . . . 0.0 110.004 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.1 pt -86.82 9.37 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.117 0.961 . . . . 0.0 109.682 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -73.2 -28.08 61.98 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.32 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.54 -18.79 68.28 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.876 174.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -100.07 2.67 43.46 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 110.549 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.5 mt -76.43 127.15 37.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -94.66 112.68 24.43 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.2 0.52 28.1 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.179 -0.609 . . . . 0.0 112.311 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -113.76 122.57 47.5 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.08 -66.93 0.98 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -166.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -69.11 148.38 50.07 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -167.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.59 48.76 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 114.794 -1.093 . . . . 0.0 112.704 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.3 136.32 30.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 122.453 -0.439 . . . . 0.0 111.223 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.97 125.0 21.97 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.887 0.875 . . . . 0.0 109.974 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -120.2 161.03 21.75 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.518 0.675 . . . . 0.0 111.88 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 25.8 m -118.95 137.1 53.72 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 124.913 1.285 . . . . 0.0 107.941 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.3 tp -102.86 120.65 40.99 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 111' ' ' THR . 25.6 m -113.21 121.48 65.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.478 0.656 . . . . 0.0 110.715 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.45 143.88 37.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.311 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.465 ' O ' ' HB ' ' A' ' 26' ' ' THR . 17.4 t60 -146.94 90.56 1.91 Allowed 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.8 m -150.8 -177.91 6.27 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -64.47 -29.42 70.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.804 0.335 . . . . 0.0 111.044 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -59.76 -32.98 71.09 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.779 0.831 . . . . 0.0 112.046 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -175.73 128.47 0.24 Allowed 'General case' 0 C--O 1.245 0.845 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 p -93.14 123.41 36.39 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.45 ' OD1' HD21 ' A' ' 11' ' ' LEU . 93.8 m-20 65.0 71.0 0.46 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 90.8 m -115.52 117.83 31.46 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 174.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 66.4 mt -119.15 90.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.6 tp -127.16 132.66 50.47 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.522 -174.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 30.5 mp0 -66.35 136.65 56.1 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 124.266 1.027 . . . . 0.0 109.636 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.28 -7.65 12.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.46 -171.72 19.66 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.914 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.47 118.65 5.42 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.063 2.509 . . . . 0.0 112.038 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 150' ' ' LEU . 27.1 m -71.46 145.52 12.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.882 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.5 m -125.75 150.56 47.62 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 21.7 ttt -71.97 135.69 46.52 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.4 -40.76 6.93 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.2 -99.87 2.34 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tt -138.28 118.91 13.97 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.415 HG22 ' HG2' ' A' ' 134' ' ' MET . 10.8 tp . . . . . 0 C--N 1.295 -1.785 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.453 -0.902 0 CA-C-O 121.163 0.401 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 15.9 p -115.22 125.22 53.1 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.517 177.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -101.1 155.5 17.96 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 69.18 36.66 2.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.565 1.146 . . . . 0.0 107.932 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.415 ' HG2' HG22 ' A' ' 124' ' ' ILE . 8.4 tpt -85.21 147.58 26.52 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.515 -175.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.488 HG23 ' HB2' ' A' ' 170' ' ' SER . 14.7 tt -130.11 144.42 38.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -143.62 165.17 28.35 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.315 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -145.98 149.34 33.97 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -89.16 104.06 16.63 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.092 0.948 . . . . 0.0 110.424 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -167.89 136.17 2.38 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.92 91.21 4.17 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.528 0.68 . . . . 0.0 110.304 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -104.38 161.6 13.93 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.694 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -92.45 176.89 6.3 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.1 t -115.13 168.26 10.09 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 94.21 -4.89 71.12 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.918 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.448 ' HB2' ' CD2' ' A' ' 160' ' ' HIS . 16.8 mt-30 -95.1 15.1 19.89 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 8.1 m -59.01 118.17 5.51 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.39 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 113.95 -2.48 24.27 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -176.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.77 148.69 43.67 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 174.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.428 ' HB ' ' CG2' ' A' ' 102' ' ' VAL . 28.4 t -93.59 122.86 45.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.276 0.56 . . . . 0.0 110.745 -175.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.41 HD21 HG11 ' A' ' 118' ' ' VAL . 49.4 tp -94.86 105.02 16.93 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 14.3 p -145.8 170.9 15.61 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.031 0.443 . . . . 0.0 112.11 -172.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.03 178.83 6.99 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.1 t -55.62 106.22 0.23 Allowed 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 121.86 0.838 . . . . 0.0 111.959 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.8 19.08 76.51 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.238 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -143.28 106.05 4.49 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -92.46 128.1 44.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -98.66 -38.16 9.23 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.425 0.631 . . . . 0.0 110.863 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.416 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 170.58 -159.84 32.25 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.454 -1.355 . . . . 0.0 112.387 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.508 HG23 HD11 ' A' ' 173' ' ' LEU . 25.8 pt -118.64 144.08 27.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 120.96 0.41 . . . . 0.0 110.533 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.448 ' CD2' ' HB2' ' A' ' 145' ' ' GLN . 52.8 t60 -74.56 132.2 41.61 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.698 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.25 -6.13 11.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.278 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 149.0 -154.56 25.88 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 119.859 -1.162 . . . . 0.0 112.429 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.67 160.66 25.13 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -155.96 118.25 4.09 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.72 -117.38 4.58 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 166' ' ' ARG . 20.7 mmt180 -110.62 8.31 22.71 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.061 0.458 . . . . 0.0 110.846 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -112.86 126.78 55.82 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.023 0.439 . . . . 0.0 110.416 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -99.85 138.23 13.73 Favored Glycine 0 CA--C 1.476 -2.361 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -113.5 132.81 55.54 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.773 0.797 . . . . 0.0 111.961 -173.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.488 ' HB2' HG23 ' A' ' 135' ' ' ILE . 54.3 m -141.08 164.2 30.91 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.821 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.31 138.4 47.83 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.436 ' OE1' ' HE3' ' A' ' 174' ' ' LYS . 79.5 mt-30 -74.41 116.99 15.71 Favored 'General case' 0 C--O 1.244 0.781 0 O-C-N 123.431 0.457 . . . . 0.0 111.253 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.508 HD11 HG23 ' A' ' 159' ' ' ILE . 63.6 mt -90.92 89.8 7.61 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.436 ' HE3' ' OE1' ' A' ' 172' ' ' GLN . 97.5 mttt -88.63 124.98 34.6 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.901 176.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -52.02 -17.73 1.14 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.136 1.374 . . . . 0.0 114.144 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -60.33 -27.76 67.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.406 1.082 . . . . 0.0 111.139 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -79.12 -19.27 51.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.802 0.334 . . . . 0.0 111.7 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -100.01 14.71 29.66 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 C--N 1.293 -1.882 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.35 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo . . . . . 0 N--CA 1.472 0.243 0 N-CA-C 110.194 -0.733 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -59.94 -36.33 76.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.919 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 m -70.05 -39.11 75.89 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 120.978 0.418 . . . . 0.0 110.133 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -69.94 -41.48 74.52 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.979 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -63.27 -42.74 99.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.501 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.43 -44.12 96.09 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.91 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.43 -48.53 81.35 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.096 0.559 . . . . 0.0 110.803 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 p -71.72 -37.58 70.59 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.9 tp -65.14 -45.98 82.78 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.624 0.77 . . . . 0.0 109.413 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.461 ' HA ' HD13 ' A' ' 15' ' ' ILE . 42.8 tp -48.7 -52.75 21.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.454 1.501 . . . . 0.0 112.526 -177.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -76.74 -3.1 36.4 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.86 -53.86 2.61 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.849 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -104.04 -17.25 15.03 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -169.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 11' ' ' LEU . 1.7 mp -87.35 113.27 24.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.542 0.687 . . . . 0.0 110.418 -178.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 90.3 mmm -116.16 153.28 32.1 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 m -101.11 121.54 41.99 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -112.61 123.8 68.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 O-C-N 121.928 -0.482 . . . . 0.0 111.603 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 18.5 m -80.82 102.9 10.29 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.254 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.2 p -102.31 -169.46 1.67 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -72.78 -20.54 61.15 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.997 0.427 . . . . 0.0 110.685 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -100.43 3.34 43.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.996 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.89 -175.62 16.53 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.994 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 30.7 mp0 -83.5 115.83 22.27 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 146' ' ' CYS . 72.8 m-85 -122.36 -175.14 3.06 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 25.5 m -91.4 130.24 37.27 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.9 128.26 7.59 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -100.18 119.49 38.43 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.03 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.97 115.43 4.02 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 174.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.9 mm -84.52 -55.43 6.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 117.018 0.409 . . . . 0.0 111.169 -173.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -163.0 150.54 13.3 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.574 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 23.2 t70 54.7 -99.87 0.1 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.449 1.093 . . . . 0.0 111.98 173.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.574 ' HG2' ' OD2' ' A' ' 32' ' ' ASP . 14.1 ptp180 -126.65 14.56 7.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.697 0.76 . . . . 0.0 110.073 177.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.9 t -92.25 115.93 32.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.211 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -124.55 151.03 45.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.33 141.16 47.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 117.82 0.282 . . . . 0.0 111.752 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.3 tt -155.15 142.07 13.53 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 99.2 Cg_exo -49.03 144.17 16.42 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 123.702 2.935 . . . . 0.0 115.467 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.406 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 27.6 m -65.74 -37.21 85.76 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.432 -176.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -63.61 -5.08 3.46 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.38 -18.05 29.23 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 54.94 86.77 0.16 Allowed Pre-proline 0 C--O 1.242 0.697 0 C-N-CA 124.959 1.304 . . . . 0.0 112.93 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -81.47 127.68 5.88 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.982 1.788 . . . . 0.0 110.119 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.54 -176.63 47.61 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.099 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -67.1 -37.2 83.51 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 120.855 0.36 . . . . 0.0 110.487 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 5.5 p-10 -130.69 114.54 15.52 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.841 0.829 . . . . 0.0 109.716 175.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.94 176.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.162 -174.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 57.8 mt -113.34 112.65 24.05 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.38 89.36 2.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 59.57 30.92 20.59 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.287 1.435 . . . . 0.0 109.981 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.41 -33.71 5.0 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.045 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -71.52 118.54 14.46 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.457 0.303 . . . . 0.0 111.081 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 53' ' ' LYS . 12.1 mptt -75.25 132.92 41.41 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.405 HD13 ' HE ' ' A' ' 79' ' ' ARG . 6.6 tp -153.28 132.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.869 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 33.7 ttt85 -90.79 134.72 34.22 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -78.02 119.84 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.77 -66.72 0.85 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -102.66 128.47 49.34 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -106.15 118.21 36.03 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.436 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.1 m-85 -114.78 94.45 4.77 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -75.57 118.78 18.79 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.79 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.448 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 3.5 mm? -87.4 83.77 7.27 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-O 122.842 1.305 . . . . 0.0 112.699 -177.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.51 148.71 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 172.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.46 135.45 41.08 Favored Pre-proline 0 C--N 1.269 -2.897 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.2 -25.32 4.37 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 124.034 3.156 . . . . 0.0 114.766 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -81.63 16.27 1.82 Allowed 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.976 -0.453 . . . . 0.0 111.582 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.0 m120 75.87 17.77 2.19 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.664 1.586 . . . . 0.0 112.383 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.3 mt -95.87 120.14 44.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.413 HD22 ' N ' ' A' ' 69' ' ' ASN . 0.8 OUTLIER -78.07 156.23 30.15 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 122.132 -0.355 . . . . 0.0 111.699 -174.002 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 60.4 tp -121.68 -9.96 8.83 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 13.6 tp10 65.44 20.01 11.67 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.931 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.21 144.89 41.92 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.323 -0.861 . . . . 0.0 110.577 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.4 m -124.0 117.79 25.53 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 54.5 t -94.61 118.51 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 CA-C-O 121.709 0.766 . . . . 0.0 108.999 177.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 74.2 mt -106.08 124.0 48.9 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.268 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 m -97.24 98.34 9.92 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -70.79 136.47 48.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.227 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.541 ' HA ' ' NH1' ' A' ' 33' ' ' ARG . 38.7 t70 -84.41 73.87 10.44 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.623 1.202 . . . . 0.0 110.137 177.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.405 ' HE ' HD13 ' A' ' 54' ' ' ILE . 24.1 mmt180 -127.47 132.59 50.0 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.191 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -79.49 -20.75 46.51 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.39 109.85 9.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.281 -1.327 . . . . 0.0 107.848 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -106.78 170.73 7.77 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -113.37 169.33 9.04 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.411 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -73.5 125.7 28.55 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -72.81 104.78 4.11 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.21 1.005 . . . . 0.0 111.331 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.5 pt -94.12 21.93 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.959 0.885 . . . . 0.0 109.675 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -63.14 -32.98 74.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.602 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.49 0.42 89.17 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 116.178 -0.465 . . . . 0.0 113.507 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -103.77 -2.49 26.31 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 117.251 0.526 . . . . 0.0 110.551 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.67 126.68 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.342 0.591 . . . . 0.0 110.126 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.7 t -104.1 107.68 18.68 Favored 'General case' 0 N--CA 1.397 -3.099 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -87.03 -4.53 59.17 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.176 0.989 . . . . 0.0 108.488 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -94.17 115.82 28.15 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.445 HD21 ' CG ' ' A' ' 172' ' ' GLN . 26.3 mt -110.65 -63.32 1.41 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -169.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 17.0 pt-20 -58.26 121.99 12.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -168.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.28 -8.62 24.74 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.14 -0.936 . . . . 0.0 113.417 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.435 ' O ' HG22 ' A' ' 118' ' ' VAL . 21.9 t -108.81 144.65 16.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 117.34 0.57 . . . . 0.0 110.324 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.09 127.4 35.12 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -112.54 160.67 17.59 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.986 0.898 . . . . 0.0 112.042 -176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.1 m -122.73 137.65 54.85 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 tp -103.95 109.27 20.97 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.6 t -103.93 116.38 47.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.347 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.495 HG12 ' CA ' ' A' ' 148' ' ' GLY . 28.3 m -122.0 151.91 25.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.282 0.563 . . . . 0.0 111.473 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -149.39 68.4 1.03 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 m -93.99 -150.25 0.29 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.57 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 22.2 t-20 -73.18 -66.12 0.72 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.582 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -81.2 -36.85 29.58 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.48 86.09 6.68 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.392 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.5 p -97.15 117.2 30.82 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.21 42.97 5.13 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.448 1.118 . . . . 0.0 108.698 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.452 ' HB ' ' CG2' ' A' ' 103' ' ' VAL . 23.8 m -94.89 106.67 18.67 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.328 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.4 mt -97.86 98.45 7.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.5 tp -114.94 122.87 47.61 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.225 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -83.38 134.02 34.91 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 122.282 -0.261 . . . . 0.0 110.342 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 m -108.58 -14.49 9.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -175.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.97 -160.12 19.44 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.061 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.75 127.22 12.8 Favored 'Trans proline' 0 C--O 1.243 0.772 0 C-N-CA 123.498 2.799 . . . . 0.0 112.502 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 97' ' ' VAL . 27.5 m -96.9 157.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.458 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.434 ' O ' HG13 ' A' ' 135' ' ' ILE . 7.1 p -139.72 173.05 11.93 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 124.373 1.069 . . . . 0.0 108.542 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -92.01 128.8 37.98 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -83.17 -38.53 22.21 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.177 0.513 . . . . 0.0 111.624 -174.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 132' ' ' ASN . . . 82.93 -102.78 2.41 Favored Glycine 0 N--CA 1.421 -2.355 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -176.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.78 133.06 54.25 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.717 0.77 . . . . 0.0 112.136 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.428 HG23 ' HB ' ' A' ' 131' ' ' THR . 7.2 tp . . . . . 0 C--N 1.292 -1.932 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 168.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 N--CA 1.441 -1.598 0 N-CA-C 113.582 0.57 . . . . 0.0 113.582 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.428 ' HB ' HG23 ' A' ' 124' ' ' ILE . 25.1 m -119.54 116.79 26.79 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 171.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 51.8 t30 -115.4 163.61 15.47 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.417 -173.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 73.7 28.11 1.67 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.106 1.362 . . . . 0.0 109.36 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.421 ' HG3' HG22 ' A' ' 124' ' ' ILE . 91.2 mmm -88.09 158.3 18.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.745 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.606 HG23 ' HB2' ' A' ' 170' ' ' SER . 7.7 tt -116.33 138.73 45.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 122.927 0.491 . . . . 0.0 109.951 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 66.4 ttt180 -118.57 139.74 51.0 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.158 0.983 . . . . 0.0 111.975 -170.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.404 ' HB3' HG12 ' A' ' 118' ' ' VAL . 45.4 p90 -149.7 147.97 28.71 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -93.66 103.07 15.25 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -168.36 125.37 1.06 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.07 94.83 1.55 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.512 0.673 . . . . 0.0 109.769 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.0 t -80.03 176.06 10.08 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.001 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -119.94 156.36 30.96 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.7 m -76.04 114.9 15.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.01 -15.56 2.15 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.94 11.87 5.61 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.754 -0.262 . . . . 0.0 111.011 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 43.3 t -58.17 122.34 12.9 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.049 0.54 . . . . 0.0 110.083 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 86.32 10.02 75.03 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.233 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.495 ' CA ' HG12 ' A' ' 103' ' ' VAL . . . -72.16 137.17 24.78 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.437 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 25.4 t -79.08 107.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.186 0.517 . . . . 0.0 109.947 -177.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.6 tp -87.64 102.65 14.82 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 16.9 p -147.09 168.19 22.22 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.473 -173.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -137.89 -174.59 3.83 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 174.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 t -63.37 100.35 0.24 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 121.89 0.853 . . . . 0.0 112.058 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.87 10.22 85.9 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.198 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -128.91 98.28 4.91 Favored 'General case' 0 C--O 1.208 -1.118 0 O-C-N 122.491 -0.417 . . . . 0.0 109.969 -174.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 74.6 mt -99.02 117.81 44.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -90.53 -39.88 12.31 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.458 0.647 . . . . 0.0 110.365 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.444 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 164.92 -152.94 22.85 Favored Glycine 0 N--CA 1.422 -2.266 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.11 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 148' ' ' GLY . 28.1 pt -129.18 146.61 33.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.93 0.365 . . . . 0.0 110.808 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . 0.41 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 46.9 t-80 -69.48 134.48 48.95 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.446 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.1 t -99.84 -71.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.722 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.29 127.39 1.39 Allowed Glycine 0 N--CA 1.424 -2.125 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.25 153.15 20.67 Favored Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.693 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -131.7 100.57 5.16 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.75 -122.54 5.93 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -90.7 -12.16 37.51 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.041 0.448 . . . . 0.0 110.53 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -98.77 111.71 24.01 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.161 -175.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.61 119.99 5.43 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -105.97 116.65 32.3 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.573 0.701 . . . . 0.0 110.959 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.606 ' HB2' HG23 ' A' ' 135' ' ' ILE . 39.4 m -117.62 167.37 11.39 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.25 142.1 43.9 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 118.433 0.56 . . . . 0.0 110.374 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.666 ' OE1' ' HG2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -93.66 109.15 20.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.444 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.8 OUTLIER -82.86 91.11 7.02 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.213 1.006 . . . . 0.0 111.079 178.288 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.666 ' HG2' ' OE1' ' A' ' 172' ' ' GLN . 6.8 mtpm? -65.01 148.1 52.26 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.336 -176.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -66.65 -22.46 66.1 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.024 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -68.24 -10.26 53.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.301 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -94.07 -20.62 19.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.671 0.748 . . . . 0.0 109.268 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -104.06 0.11 29.38 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.506 -173.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 66.8 t . . . . . 0 C--N 1.298 -1.632 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 175.036 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 5' ' ' GLU . 80.9 Cg_exo . . . . . 0 CA--C 1.545 1.069 0 N-CA-C 113.169 0.411 . . . . 0.0 113.169 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -60.84 -55.85 28.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.097 0.475 . . . . 0.0 110.508 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -59.25 -38.22 79.5 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.774 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 2' ' ' PRO . 31.9 tt0 -57.9 -55.46 34.56 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.604 1.161 . . . . 0.0 110.567 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.76 -46.95 86.29 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.003 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.67 -35.64 74.86 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.89 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.3 tp -71.42 -38.23 71.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.708 0.29 . . . . 0.0 110.821 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -73.1 -33.56 65.66 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.569 0.699 . . . . 0.0 109.167 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.6 tp -68.23 -41.96 80.45 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.215 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' A' ' 15' ' ' ILE . 58.5 tp -49.96 -54.17 21.62 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 125.076 1.351 . . . . 0.0 112.01 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.4 mtt-85 -80.32 13.35 2.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.606 -173.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -129.09 -64.25 0.92 Allowed 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.418 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -104.18 -2.87 25.13 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -173.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.507 HD12 ' HA ' ' A' ' 11' ' ' LEU . 43.0 mt -99.93 134.75 38.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -154.38 144.85 22.22 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 122.484 0.314 . . . . 0.0 110.613 -173.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 m -80.23 118.13 21.63 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.0 mt -106.05 115.6 48.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-O 121.265 0.555 . . . . 0.0 109.569 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -83.08 97.28 8.69 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 79.1 p -91.95 -170.09 2.45 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.2 m -82.59 -13.34 56.71 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 120.706 0.289 . . . . 0.0 110.929 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -98.33 -24.08 15.36 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 110.417 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.63 -154.71 25.56 Favored Glycine 0 CA--C 1.501 -0.808 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.53 112.79 20.36 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 117.298 0.549 . . . . 0.0 109.531 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.455 ' HB3' ' O ' ' A' ' 146' ' ' CYS . 80.7 m-85 -120.66 -173.45 2.59 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 147' ' ' GLY . 5.9 t -113.93 136.91 52.37 Favored 'General case' 0 N--CA 1.406 -2.653 0 C-N-CA 118.959 -1.097 . . . . 0.0 109.934 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.02 136.89 13.64 Favored Glycine 0 N--CA 1.41 -3.092 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.5 tp -105.1 118.65 37.07 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.76 132.53 14.13 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 108.406 -1.878 . . . . 0.0 108.406 173.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.5 mm -96.08 -59.28 3.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 117.753 0.776 . . . . 0.0 109.902 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -162.12 147.37 12.87 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 55.53 -95.32 0.05 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 124.276 0.985 . . . . 0.0 111.21 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 18.9 ptp180 -132.84 10.87 4.31 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 122.044 0.926 . . . . 0.0 109.663 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -84.22 118.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.4 m -131.72 147.02 52.47 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.2 t -109.71 134.55 51.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.793 0.33 . . . . 0.0 111.727 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.434 ' HB ' ' CD2' ' A' ' 75' ' ' LEU . 6.7 mm -137.93 141.88 34.11 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 125.364 1.466 . . . . 0.0 108.358 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.06 146.57 93.86 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 121.975 1.784 . . . . 0.0 111.797 175.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.6 m -70.21 -33.35 71.58 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 123.214 0.605 . . . . 0.0 109.415 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -77.17 -4.74 46.15 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.579 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.62 -16.04 49.86 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.58 ' O ' ' HB ' ' A' ' 20' ' ' THR . 21.4 mt-30 58.14 82.67 0.23 Allowed Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.414 1.086 . . . . 0.0 112.877 176.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.08 -174.83 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.752 2.301 . . . . 0.0 111.287 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.59 179.19 18.44 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.55 -17.7 44.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.513 0.673 . . . . 0.0 110.313 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -141.71 135.92 30.31 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 12.7 p -141.6 149.98 19.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.514 -171.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -85.69 111.94 20.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.258 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.2 83.14 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.3 t30 68.65 -1.78 1.86 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.492 1.517 . . . . 0.0 111.364 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.11 -33.45 0.94 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.09 110.73 15.77 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 14.7 ptpt -78.68 137.38 37.78 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 116.819 -1.952 . . . . 0.0 109.101 174.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.413 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.5 tp -128.99 150.69 34.85 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -91.24 142.84 27.28 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.8 t -108.73 131.19 60.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -78.29 -79.01 0.13 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.797 0.332 . . . . 0.0 111.286 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -113.75 140.17 48.5 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -104.5 93.51 4.82 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.569 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.5 m-85 -80.8 94.02 6.34 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -76.09 94.15 3.42 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 32.7 tp -85.46 103.53 14.42 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-O 121.616 0.722 . . . . 0.0 109.521 -172.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.06 178.9 2.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.71 139.29 58.24 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.2 -21.61 13.42 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 123.557 2.838 . . . . 0.0 114.542 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.3 6.1 24.23 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.2 m120 77.37 12.28 2.12 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.289 1.436 . . . . 0.0 112.747 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.0 mt -77.64 146.16 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -70.33 142.74 52.15 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 120.995 0.426 . . . . 0.0 111.622 -174.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 60.9 tp -117.38 -17.6 10.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 171.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 75.72 -17.02 0.54 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.284 1.434 . . . . 0.0 112.909 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 173' ' ' LEU . 10.1 mp -80.06 113.15 18.02 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.6 m -100.24 116.86 33.23 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 168.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 68.0 t -95.84 107.07 19.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.434 ' CD2' ' HB ' ' A' ' 37' ' ' ILE . 2.9 mm? -91.66 132.47 36.33 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.254 -178.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 m -83.68 80.3 9.17 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 171.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.633 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.7 tp -74.54 103.3 4.81 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.413 ' O ' HD11 ' A' ' 54' ' ' ILE . 12.9 t70 -73.8 84.07 1.66 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.432 0.634 . . . . 0.0 112.51 -168.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.425 ' HG3' ' CE2' ' A' ' 83' ' ' PHE . 31.4 mmt180 -99.14 125.08 44.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.197 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -74.78 -34.41 62.44 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -92.04 95.84 10.01 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -74.51 161.04 30.14 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.788 -1.096 . . . . 0.0 113.562 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.425 ' CE2' ' HG3' ' A' ' 79' ' ' ARG . 88.9 m-85 -91.27 172.57 8.45 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.042 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -73.88 137.57 43.8 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.07 95.32 1.2 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.222 0.534 . . . . 0.0 109.572 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -93.61 14.55 2.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 122.693 1.235 . . . . 0.0 109.975 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -31.13 59.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.018 -1.901 . . . . 0.0 108.764 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.07 -6.61 74.48 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 114.893 -1.048 . . . . 0.0 112.428 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -109.9 4.31 21.43 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.156 -0.614 . . . . 0.0 110.943 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.1 mt -73.22 125.95 33.06 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 CA-C-O 121.052 0.453 . . . . 0.0 110.292 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.0 t -115.24 106.8 14.46 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE2' ' HE3' ' A' ' 174' ' ' LYS . 7.9 pt-20 -88.53 -5.37 58.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.941 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -85.78 105.93 16.66 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 168.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.433 HD13 ' HB ' ' A' ' 135' ' ' ILE . 31.9 mt -99.98 -53.84 3.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -164.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -58.93 135.33 57.54 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.8 -38.83 3.13 Favored Glycine 0 N--CA 1.434 -1.443 0 CA-C-N 114.891 -1.05 . . . . 0.0 113.415 174.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 21.3 t -73.49 144.01 13.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 120.539 0.209 . . . . 0.0 110.906 -174.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.47 120.89 24.5 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.62 17.72 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 122.02 0.914 . . . . 0.0 111.444 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 28.1 m -127.39 131.31 50.35 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.52 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.427 HD21 HE21 ' A' ' 145' ' ' GLN . 55.4 tp -102.85 126.31 49.94 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.819 -175.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.41 107.66 19.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 145' ' ' GLN . 46.4 t -93.37 108.18 20.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.611 -178.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -133.77 124.71 27.08 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.3 t -174.98 -175.17 0.84 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -87.02 -15.29 39.11 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -94.93 -24.53 16.93 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.535 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.64 103.73 3.96 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.8 m -105.02 111.77 24.67 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 71.06 33.58 2.03 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.796 0.838 . . . . 0.0 113.238 169.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.435 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 16.2 m -93.31 109.44 20.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.512 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.0 mt -100.55 125.77 54.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.7 tp -140.69 129.36 22.89 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.942 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 4.2 mp0 -69.39 135.92 50.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.78 -19.54 6.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.21 -176.74 16.34 Favored Glycine 0 N--CA 1.433 -1.548 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.482 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 37.4 Cg_endo -68.07 129.01 18.59 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.688 2.259 . . . . 0.0 111.625 178.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.8 m -97.26 165.03 2.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.468 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.3 t -147.99 155.54 41.65 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 53.8 ttp -90.73 134.65 34.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.33 -28.52 15.52 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.308 0.575 . . . . 0.0 110.086 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.4 -87.25 1.17 Allowed Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -137.24 133.22 34.85 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.2 tp . . . . . 0 C--N 1.296 -1.724 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -176.657 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo . . . . . 0 C--O 1.254 1.294 0 CA-C-O 121.019 0.341 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 m -131.06 131.1 44.02 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -99.19 162.92 12.78 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 8.0 mpt_? 66.82 35.72 4.84 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.579 1.152 . . . . 0.0 110.749 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 95.6 mmm -94.23 139.76 30.63 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.949 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.559 HG23 ' HB2' ' A' ' 170' ' ' SER . 3.0 tt -116.38 140.42 38.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 124.649 1.179 . . . . 0.0 109.102 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -121.53 143.83 49.05 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.054 0.542 . . . . 0.0 110.767 -171.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.485 ' HE2' ' HG ' ' A' ' 170' ' ' SER . 28.0 p90 -152.95 152.41 31.41 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 122.95 0.5 . . . . 0.0 111.049 172.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -89.58 105.42 17.78 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.308 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -172.49 132.85 0.61 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 125.05 1.34 . . . . 0.0 108.479 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.13 100.63 5.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.353 0.597 . . . . 0.0 109.651 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.2 p -79.83 137.58 36.99 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.665 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 93.4 mttt -93.03 108.69 20.21 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.2 m -53.79 129.43 33.45 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.595 0.758 . . . . 0.0 111.692 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 134.25 -18.63 4.17 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -100.74 34.1 2.56 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.373 0.606 . . . . 0.0 112.101 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 25' ' ' PHE . 66.6 m -65.8 117.26 7.95 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.304 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 26' ' ' THR . . . 109.88 5.57 29.02 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.07 134.82 37.05 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.63 115.5 18.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.183 0.516 . . . . 0.0 111.149 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.61 108.87 21.17 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.6 p -142.0 179.25 6.99 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 120.907 0.384 . . . . 0.0 111.911 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.09 178.88 8.54 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.8 t -64.77 102.32 0.57 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.999 0.904 . . . . 0.0 111.843 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.08 73.65 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.416 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -145.27 120.6 10.25 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 81.7 mt -108.28 128.9 63.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 171.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.49 -47.56 6.21 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.413 0.625 . . . . 0.0 110.3 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.55 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 171.65 -149.37 11.95 Favored Glycine 0 N--CA 1.417 -2.61 0 C-N-CA 119.932 -1.127 . . . . 0.0 111.899 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.8 pt -130.59 142.19 44.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -73.87 125.74 28.87 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.7 m -107.81 -46.0 7.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.303 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 169' ' ' PHE . . . -157.26 136.47 4.91 Favored Glycine 0 CA--C 1.487 -1.697 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.072 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.3 140.64 11.05 Favored Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -123.95 132.15 53.67 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.79 -108.33 2.07 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.922 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 166' ' ' ARG . 47.4 mtt180 -113.29 12.17 18.82 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -118.55 132.76 56.2 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.023 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -104.3 120.84 6.78 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 99.4 m-85 -109.11 117.08 33.22 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.19 0.995 . . . . 0.0 109.424 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.559 ' HB2' HG23 ' A' ' 135' ' ' ILE . 18.5 m -117.6 164.28 15.17 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.079 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.08 139.61 49.74 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 3.4 pt20 -90.23 131.67 35.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.784 0.802 . . . . 0.0 110.927 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.55 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -94.26 85.06 4.53 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.305 175.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.44 ' HE3' ' OE2' ' A' ' 92' ' ' GLU . 57.2 mtpt -54.05 134.49 43.77 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.13 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.426 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 16.7 ptmt -72.17 -19.37 61.76 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.29 -174.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.539 ' HA ' HG12 ' A' ' 179' ' ' VAL . 13.4 mm100 -67.93 -9.66 47.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.281 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -89.11 -21.52 23.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.761 0.315 . . . . 0.0 110.2 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -109.68 -28.83 8.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.281 0.563 . . . . 0.0 111.839 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 176' ' ' GLN . 11.0 p . . . . . 0 C--N 1.315 -0.895 0 CA-C-O 121.218 0.532 . . . . 0.0 109.996 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.39 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.94 -23.99 40.17 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.586 2.19 . . . . 0.0 111.027 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -66.92 -39.29 87.32 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.417 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 m -67.89 -44.47 76.93 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.688 0.795 . . . . 0.0 110.237 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -68.53 -36.31 78.66 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.451 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -63.17 -42.72 99.45 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.772 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.47 83.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.251 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.3 tp -69.96 -32.76 71.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.371 0.605 . . . . 0.0 110.504 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.4 m -76.9 -37.28 55.73 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.643 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.2 tp -68.44 -34.53 76.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.4 tp -54.09 -55.66 25.47 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 123.909 0.884 . . . . 0.0 111.568 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -72.97 -17.5 61.46 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.084 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -61.66 1.63 Allowed 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.95 -172.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -124.97 9.35 8.13 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -171.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 65.0 mt -110.81 134.72 52.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.706 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.65 167.38 23.93 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.833 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 m -92.49 125.97 37.37 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.1 mt -113.59 123.24 69.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.564 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 9.7 m -84.99 98.63 10.5 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.6 p -99.93 -170.25 1.86 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 30.1 t -71.53 -33.98 69.64 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.851 0.358 . . . . 0.0 110.495 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -75.59 -26.02 57.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.39 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.08 -171.3 30.06 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.493 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 19' ' ' THR . 36.2 mt-10 -91.75 104.19 16.67 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -114.02 -169.7 1.57 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.003 -174.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.54 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 10.9 m -92.05 128.9 38.07 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.965 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.94 127.23 7.71 Favored Glycine 0 N--CA 1.421 -2.312 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 174.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.4 tp -103.45 122.85 45.75 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.66 137.19 18.47 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.436 HG13 ' CE1' ' A' ' 178' ' ' PHE . 47.4 mm -97.66 -55.87 5.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -164.08 150.61 11.42 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.4 t70 58.29 -98.67 0.09 Allowed 'General case' 0 C--O 1.213 -0.839 0 O-C-N 124.21 0.944 . . . . 0.0 112.113 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.44 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 7.5 mpt_? -129.02 9.34 5.74 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.4 t -83.4 118.61 31.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.378 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.6 t -123.48 169.8 11.03 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.12 141.1 39.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.4 tp -151.15 150.59 27.65 Favored Pre-proline 0 CA--C 1.572 1.817 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.12 159.87 44.64 Favored 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 122.341 2.027 . . . . 0.0 112.771 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.8 m -82.01 -48.51 11.35 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -66.89 -8.48 29.52 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.38 -23.31 61.87 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 96.6 mt-30 58.85 84.01 0.21 Allowed Pre-proline 0 C--O 1.252 1.198 0 C-N-CA 125.601 1.561 . . . . 0.0 113.103 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -88.53 136.28 3.23 Favored 'Trans proline' 0 N--CA 1.438 -1.791 0 C-N-CA 122.816 2.344 . . . . 0.0 109.558 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.34 -176.83 51.61 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.91 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -75.03 -25.4 58.69 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.441 1.115 . . . . 0.0 108.042 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -129.5 138.38 51.35 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 p -141.89 167.28 16.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 41.8 mt -100.93 114.33 28.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.16 109.5 23.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.4 m120 61.78 23.8 14.05 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.544 0.688 . . . . 0.0 110.976 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 -13.68 63.55 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.564 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.404 HE21 ' HB2' ' A' ' 52' ' ' GLN . 14.4 mt-30 -85.15 128.21 34.57 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.442 0.697 . . . . 0.0 109.779 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.31 128.92 37.82 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.57 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.6 tp -144.53 150.24 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -105.64 147.99 27.86 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.934 0.397 . . . . 0.0 109.968 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.3 129.9 43.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -79.87 -53.17 7.02 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -132.73 133.74 43.87 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.222 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.78 110.42 12.15 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.927 -174.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -111.29 99.34 8.18 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -75.63 102.41 5.32 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.463 HD21 ' CD1' ' A' ' 177' ' ' TYR . 41.4 tp -97.29 105.02 17.1 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 122.078 0.942 . . . . 0.0 112.415 -167.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.39 -179.85 3.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.532 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 11.8 t70 -79.87 137.34 54.07 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -42.02 -34.73 2.79 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 124.306 3.337 . . . . 0.0 114.014 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.06 22.06 1.25 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 71.43 18.14 5.58 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.186 0.994 . . . . 0.0 112.857 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 55.6 mt -84.93 132.87 30.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 131' ' ' THR . 0.8 OUTLIER -80.91 126.19 31.05 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -170.131 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.1 tp -99.06 -15.74 18.92 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 169.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 60.89 30.16 19.47 Favored 'General case' 0 C--N 1.363 1.154 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.854 175.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 18.7 tp -124.91 144.23 50.44 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.886 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.7 m -137.5 122.48 18.99 Favored 'General case' 0 C--N 1.286 -2.193 0 O-C-N 121.894 -0.504 . . . . 0.0 109.762 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.3 t -101.68 131.19 50.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -139.38 140.92 37.57 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.665 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.5 m -97.44 107.46 19.98 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.44 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 15.6 tp -86.45 143.14 27.92 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -175.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.57 ' O ' HD11 ' A' ' 54' ' ' ILE . 38.0 t70 -84.64 80.91 9.08 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 119.266 -0.974 . . . . 0.0 112.057 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -120.22 142.65 48.82 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -61.32 -59.88 4.61 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -70.92 149.36 46.81 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.06 0.457 . . . . 0.0 111.347 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -101.01 149.85 23.51 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.967 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -81.12 145.81 30.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.3 tpt85 -70.52 128.93 37.84 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -61.47 96.72 0.06 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.469 0.652 . . . . 0.0 111.368 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -92.44 20.71 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 122.095 0.95 . . . . 0.0 109.538 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -73.95 -35.06 64.51 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.959 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.5 -5.37 85.83 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 120.146 -1.026 . . . . 0.0 110.992 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -103.55 5.74 36.89 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.484 0.659 . . . . 0.0 109.639 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.3 mt -74.81 133.6 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.6 t -111.03 100.62 9.27 Favored 'General case' 0 N--CA 1.396 -3.158 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -87.6 1.6 53.21 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.913 0.863 . . . . 0.0 110.131 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.82 112.27 24.17 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 168.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.2 mt -116.56 -61.11 1.77 Allowed 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.581 0.705 . . . . 0.0 112.029 -168.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 33.4 tt0 -63.69 123.2 18.27 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.355 -168.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.13 -11.66 51.95 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.13 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.9 t -95.65 142.36 13.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -77.46 128.84 34.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -122.7 151.51 41.47 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.753 0.787 . . . . 0.0 111.22 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 m -116.02 135.38 54.01 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.948 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 160' ' ' HIS . 2.4 tm? -97.01 111.45 23.67 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -107.58 105.72 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.8 p -111.59 130.36 65.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-O 121.217 0.532 . . . . 0.0 110.966 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.41 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 75.3 t60 -130.92 92.19 3.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.065 0.936 . . . . 0.0 108.657 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.1 m -115.42 -175.27 2.67 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -69.69 -36.81 76.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -77.89 -60.07 2.52 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.817 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -84.9 87.06 7.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.778 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.6 p -80.66 88.86 5.72 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 121.361 0.6 . . . . 0.0 112.347 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.41 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 28.8 t-20 58.97 70.2 0.67 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.43 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 33.1 m -97.13 108.41 21.13 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 69.2 mt -98.29 100.34 10.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.0 tp -113.63 115.25 27.61 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.728 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.53 120.89 19.75 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.9 m -102.13 -20.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.3 -158.87 14.08 Favored Glycine 0 N--CA 1.432 -1.622 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.152 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.14 127.08 9.01 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.849 2.366 . . . . 0.0 111.944 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 20.9 m -89.42 149.46 4.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.751 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.3 p -128.21 166.01 19.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.362 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.5 ttt -98.46 127.05 44.22 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.688 -0.632 . . . . 0.0 111.187 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.02 -52.13 5.61 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.09 -122.99 7.7 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 131' ' ' THR . 6.0 tt -111.29 112.02 23.5 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 124' ' ' ILE . 0.2 OUTLIER -133.05 163.0 39.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -108.57 144.67 35.96 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.5 tp -121.06 99.86 6.74 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.8 m 59.98 46.52 10.86 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.443 0.697 . . . . 0.0 111.071 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m 80.81 -12.69 1.0 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.348 1.459 . . . . 0.0 112.697 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.5 m -83.66 110.81 27.42 Favored Pre-proline 0 N--CA 1.44 -0.955 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.06 124.53 6.73 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.815 1.677 . . . . 0.0 111.371 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.536 ' HB ' ' SD ' ' A' ' 134' ' ' MET . 18.4 p -117.4 132.83 56.5 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.857 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.403 ' HB2' HG21 ' A' ' 68' ' ' ILE . 50.8 t30 -123.3 132.07 53.88 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -176.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 74.63 47.97 0.12 Allowed 'General case' 0 C--O 1.239 0.533 0 O-C-N 124.801 1.313 . . . . 0.0 111.825 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.536 ' SD ' ' HB ' ' A' ' 131' ' ' THR . 0.1 OUTLIER -97.64 139.28 33.77 Favored 'General case' 0 C--O 1.256 1.408 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.253 174.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.606 HG23 ' HB3' ' A' ' 170' ' ' SER . 3.4 tt -101.43 130.07 51.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -128.09 132.13 49.01 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.343 0.592 . . . . 0.0 111.128 -171.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.433 ' HB3' HG12 ' A' ' 118' ' ' VAL . 16.3 p90 -120.62 134.13 55.31 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.188 175.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 166' ' ' ARG . 10.7 t70 -83.95 96.31 8.8 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -156.45 124.15 5.51 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.868 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . . . -64.5 99.7 0.32 Allowed 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 124.175 0.922 . . . . 0.0 109.44 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.2 t -105.61 147.31 28.59 Favored 'General case' 0 N--CA 1.407 -2.576 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.365 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -87.28 94.19 9.6 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.1 t -45.76 143.83 1.92 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 124.548 1.139 . . . . 0.0 113.526 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.19 -2.27 2.31 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.079 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -90.3 40.29 1.0 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.719 0.408 . . . . 0.0 112.071 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 74.8 m -60.97 117.31 5.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.175 0.512 . . . . 0.0 110.954 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.54 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 101.45 2.28 53.56 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.68 122.96 31.43 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 112.203 -0.359 . . . . 0.0 112.203 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.581 HG12 ' SG ' ' A' ' 151' ' ' CYS . 54.3 t -74.15 108.1 5.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 124.005 0.922 . . . . 0.0 109.264 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.2 tp -88.67 104.17 16.62 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.669 ' SG ' HG13 ' A' ' 156' ' ' ILE . 84.0 m -145.49 174.92 10.73 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -173.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.31 -177.4 5.74 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 32.6 m -59.53 102.39 0.14 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.035 0.445 . . . . 0.0 111.819 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.91 26.64 72.18 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.18 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -141.4 105.56 4.8 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.669 HG13 ' SG ' ' A' ' 151' ' ' CYS . 2.5 mp -91.81 119.88 39.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -92.24 -34.88 14.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.974 0.892 . . . . 0.0 109.809 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.73 -156.35 27.52 Favored Glycine 0 N--CA 1.413 -2.846 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.6 pt -134.19 140.81 45.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.779 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.573 ' HB2' HD21 ' A' ' 101' ' ' LEU . 20.9 t60 -67.96 105.42 2.0 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.41 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.41 -38.39 13.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.42 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 178.49 87.8 0.07 OUTLIER Glycine 0 N--CA 1.426 -2.019 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.649 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.88 155.67 21.22 Favored Glycine 0 N--CA 1.428 -1.847 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -151.77 135.21 16.09 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 65.97 -133.26 34.24 Favored Glycine 0 C--N 1.313 -0.74 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 99.2 mtt180 -87.21 6.17 34.46 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -117.05 101.72 8.72 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.86 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' A' ' 137' ' ' TYR . . . -85.31 107.37 3.09 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -93.31 118.91 31.84 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.777 0.799 . . . . 0.0 111.751 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.606 ' HB3' HG23 ' A' ' 135' ' ' ILE . 30.9 t -120.12 151.09 39.57 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.398 -1.273 . . . . 0.0 107.578 176.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.3 142.72 27.45 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -80.42 105.63 11.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 123.869 0.73 . . . . 0.0 110.575 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.03 88.09 7.45 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -90.51 151.06 21.52 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -60.17 -26.61 66.45 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -50.4 -37.11 35.91 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.36 1.064 . . . . 0.0 112.094 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.463 ' CD1' HD21 ' A' ' 62' ' ' LEU . 46.7 m-85 -75.86 -17.82 59.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.991 0.424 . . . . 0.0 111.846 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.436 ' CE1' HG13 ' A' ' 30' ' ' ILE . 73.9 m-85 -109.51 8.79 25.31 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.46 -174.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 83.0 t -72.63 112.5 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -56.75 -57.05 14.12 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 123.64 0.588 . . . . 0.0 112.384 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.67 125.97 47.9 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.318 177.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.871 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.624 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.4 -32.18 93.25 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.075 2.517 . . . . 0.0 112.663 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.21 -38.83 91.66 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.256 0.55 . . . . 0.0 110.036 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 m -71.77 -41.38 68.42 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.199 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.15 -49.27 78.52 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.225 0.61 . . . . 0.0 111.207 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -63.78 -44.41 93.47 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.082 0.468 . . . . 0.0 110.845 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.07 -41.92 90.1 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.594 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.0 tp -66.79 -33.51 75.78 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.092 0.557 . . . . 0.0 111.428 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -78.51 -46.05 20.49 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 120.749 0.309 . . . . 0.0 110.299 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.7 tp -55.82 -35.67 66.61 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.952 0.901 . . . . 0.0 109.835 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.434 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 50.7 tp -52.68 -50.02 64.13 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.473 1.509 . . . . 0.0 112.791 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -81.05 -22.79 39.03 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.386 0.612 . . . . 0.0 110.738 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -91.0 -46.55 8.08 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.056 -169.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -128.73 3.27 5.46 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 53.8 mt -115.83 137.15 50.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.464 -176.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.82 169.4 21.78 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.905 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 94.8 m -98.23 123.15 42.16 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 65.5 mt -110.56 115.52 50.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 11.4 m -88.57 103.81 16.25 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.673 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 81.6 p -89.87 -165.8 1.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.865 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -69.42 -19.69 63.79 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.221 0.534 . . . . 0.0 110.127 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -97.7 -45.07 6.5 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.83 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.31 -179.73 48.49 Favored Glycine 0 CA--C 1.497 -1.031 0 C-N-CA 119.242 -1.456 . . . . 0.0 112.592 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 2.8 mp0 -78.27 107.94 11.24 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.481 ' HB3' ' O ' ' A' ' 146' ' ' CYS . 26.5 m-85 -117.01 -177.57 3.23 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 33.0 m -97.34 138.37 34.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.14 143.23 16.02 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 tp -113.56 122.0 45.92 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.31 110.21 3.54 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 175.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.1 mm -71.77 -51.27 33.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 122.354 0.262 . . . . 0.0 110.963 -174.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -170.85 147.33 2.71 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.449 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 38.1 t70 60.53 -81.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.968 1.307 . . . . 0.0 112.943 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.57 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 14.4 ptp180 -149.85 13.19 0.8 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.769 0.795 . . . . 0.0 110.246 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.44 113.79 26.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.68 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.7 m -120.12 156.13 31.66 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -137.44 144.65 31.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 117.885 0.311 . . . . 0.0 110.544 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.521 HG22 HD21 ' A' ' 75' ' ' LEU . 14.7 tt -157.12 146.7 15.3 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 6.8 Cg_endo -51.45 141.41 41.56 Favored 'Trans proline' 0 C--N 1.363 1.304 0 C-N-CA 122.907 2.405 . . . . 0.0 113.393 177.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.3 m -57.07 -48.19 79.15 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.929 0.892 . . . . 0.0 113.123 -176.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -66.75 -1.5 3.92 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.47 -25.08 60.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.673 ' O ' ' HB ' ' A' ' 20' ' ' THR . 29.4 mm-40 61.6 82.43 0.22 Allowed Pre-proline 0 N--CA 1.467 0.396 0 C-N-CA 125.462 1.505 . . . . 0.0 114.425 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -85.17 124.75 2.92 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.793 2.329 . . . . 0.0 109.984 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.96 -125.51 0.67 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.776 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -96.11 -59.77 1.77 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.616 0.722 . . . . 0.0 109.293 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 42.4 p-10 -124.19 125.5 44.53 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.449 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.84 148.18 16.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.532 -173.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 93.1 mt -79.93 102.14 9.02 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.938 0.399 . . . . 0.0 110.175 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 17' ' ' THR . 7.5 p -94.29 90.0 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 122.063 0.935 . . . . 0.0 109.055 176.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.2 m120 62.39 8.1 2.64 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.934 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.43 -32.47 1.96 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.932 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -82.77 125.14 30.94 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -88.05 96.6 10.57 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 46' ' ' ASP . 10.4 tp -101.31 132.65 46.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.359 -171.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.7 mtt85 -82.44 121.52 26.85 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.095 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.419 HG11 HD12 ' A' ' 75' ' ' LEU . 55.8 t -84.06 132.93 30.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -79.31 -48.16 14.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.968 0.413 . . . . 0.0 110.963 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.26 138.71 31.58 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -115.47 98.65 6.85 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.462 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 80.0 m-85 -84.07 129.88 34.89 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.758 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -84.42 112.15 20.1 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 173.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 53.1 tp -90.31 99.0 12.1 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.539 0.685 . . . . 0.0 109.346 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.86 148.47 16.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.378 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.26 141.26 57.39 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.57 -3.22 0.55 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 123.944 3.096 . . . . 0.0 114.546 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.88 -2.86 41.84 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.0 t30 77.89 6.45 2.75 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 125.683 1.593 . . . . 0.0 111.273 175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.574 ' HB ' ' ND2' ' A' ' 132' ' ' ASN . 50.9 mm -96.43 150.44 4.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 131' ' ' THR . 52.9 t30 -70.83 126.92 30.91 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -177.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 54.1 tp -92.08 -13.22 31.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 21.1 tp10 66.96 23.95 9.71 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.566 175.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.5 mt -117.42 135.19 54.06 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.563 -0.711 . . . . 0.0 111.753 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.5 m -114.38 130.25 56.68 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 94.1 t -102.04 120.47 51.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.521 HD21 HG22 ' A' ' 37' ' ' ILE . 2.4 mm? -103.51 127.11 50.97 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.392 -175.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 m -87.53 88.91 7.8 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.4 tt -89.99 124.26 34.6 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.409 ' O ' HD11 ' A' ' 54' ' ' ILE . 32.7 t70 -74.9 80.84 2.14 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-O 121.995 0.903 . . . . 0.0 110.275 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -100.41 131.57 46.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.31 -175.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -74.77 -24.49 58.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.586 0.708 . . . . 0.0 109.82 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -88.82 119.6 29.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.153 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -77.31 113.28 14.91 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -62.67 138.68 58.56 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -74.65 142.97 44.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 87' ' ' ARG . 10.0 t70 -67.66 99.06 0.75 Allowed 'General case' 0 C--N 1.311 -1.101 0 O-C-N 123.414 0.446 . . . . 0.0 111.535 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -90.65 19.14 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.781 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.493 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . 85.3 mtm180 -71.44 -24.94 62.11 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.607 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.48 -19.22 79.64 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.817 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -93.54 -12.51 29.43 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.606 -0.349 . . . . 0.0 111.22 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.8 mt -64.76 120.93 12.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.318 0.58 . . . . 0.0 110.26 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 155' ' ' LYS . 5.7 p -105.67 112.56 25.69 Favored 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.712 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -84.43 -10.0 57.9 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.356 0.598 . . . . 0.0 110.316 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -85.76 117.74 24.82 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 173.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.5 mt -117.34 -53.71 2.43 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -168.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.18 115.11 5.18 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -167.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.88 1.29 58.62 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.524 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.6 t -93.17 160.49 2.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -73.33 155.12 39.75 Favored 'General case' 0 C--O 1.21 -0.981 0 C-N-CA 123.396 0.678 . . . . 0.0 109.605 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -159.05 152.22 22.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.759 0.79 . . . . 0.0 112.146 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.413 HG23 ' HA ' ' A' ' 114' ' ' GLU . 94.9 m -143.96 132.81 22.61 Favored 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 125.801 1.64 . . . . 0.0 107.916 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.2 tp -98.16 119.98 37.76 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.9 t -100.96 116.61 44.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.05 123.98 66.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.489 ' HA ' ' H ' ' A' ' 110' ' ' ASN . 28.1 t60 -130.12 79.8 1.92 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.6 m -139.85 -165.81 1.96 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.83 -175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -71.42 -53.75 12.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -67.66 -39.6 84.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.13 0.49 . . . . 0.0 111.321 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -126.43 95.0 4.22 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.5 m -92.32 120.54 32.96 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.138 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.489 ' H ' ' HA ' ' A' ' 104' ' ' HIS . 4.3 t30 61.97 42.89 9.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.858 0.837 . . . . 0.0 109.186 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.9 m -108.22 115.88 30.93 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.088 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 87.3 mt -90.09 109.19 20.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.3 tp -108.45 114.62 28.61 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 123.041 0.536 . . . . 0.0 109.983 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.413 ' HA ' HG23 ' A' ' 100' ' ' THR . 43.8 mt-10 -71.38 145.77 49.17 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.834 0.349 . . . . 0.0 111.781 -178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.5 t -115.47 -51.43 4.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.841 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 113.0 -121.56 5.58 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -98.29 135.4 0.33 Allowed 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 122.989 2.459 . . . . 0.0 113.044 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.4 m -103.63 155.53 5.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.899 -0.501 . . . . 0.0 112.278 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.446 ' O ' HG13 ' A' ' 135' ' ' ILE . 17.5 p -131.88 178.75 6.53 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.65 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 46.5 ttm -114.2 140.32 48.65 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 121.483 -0.76 . . . . 0.0 111.165 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -104.75 -53.64 2.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.36 -117.69 5.95 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.798 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.9 tp -96.14 114.78 26.51 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.201 0.6 . . . . 0.0 109.892 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.0 pt -137.42 166.58 24.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -109.54 101.16 10.12 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.4 tp -117.07 134.61 54.54 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.5 t 63.43 34.56 12.78 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.5 m 63.0 21.33 12.84 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 124.429 1.092 . . . . 0.0 111.31 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.6 m -126.97 130.13 23.85 Favored Pre-proline 0 N--CA 1.43 -1.426 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -64.44 114.51 2.73 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 122.196 1.931 . . . . 0.0 109.823 173.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 20.8 p -127.21 128.97 46.93 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.179 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.574 ' ND2' ' HB ' ' A' ' 68' ' ' ILE . 41.8 p30 -110.25 171.07 7.67 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.715 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.493 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 3.9 mpt_? 67.32 23.8 9.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.813 0.845 . . . . 0.0 110.884 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.8 mmt -81.84 128.62 34.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.583 0.706 . . . . 0.0 111.687 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 170' ' ' SER . 3.4 tt -96.88 136.84 26.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.629 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 34.7 ttm180 -116.61 135.97 53.36 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.501 0.501 . . . . 0.0 111.097 -170.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.5 140.34 31.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.659 -0.496 . . . . 0.0 109.659 173.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.26 110.04 19.36 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -163.32 147.92 11.05 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.56 87.26 2.12 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.0 p -81.2 128.61 33.97 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.984 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -76.63 111.99 12.71 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.7 m -70.53 129.5 39.38 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.333 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 129.38 -37.38 2.2 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.601 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -75.37 52.03 0.59 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.077 0.951 . . . . 0.0 112.913 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 25' ' ' PHE . 56.9 m -63.4 147.86 50.07 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.395 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 93.53 1.25 66.37 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.749 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.98 129.56 38.35 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.6 109.2 8.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-O 121.195 0.521 . . . . 0.0 110.56 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 49.7 tp -89.33 99.71 12.65 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 23.4 p -126.82 -172.6 2.68 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.561 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -157.79 -169.57 2.89 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.417 ' O ' ' HG3' ' A' ' 155' ' ' LYS . 20.7 p -62.79 96.02 0.08 Allowed 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.708 0.63 . . . . 0.0 110.849 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.23 25.17 76.05 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.549 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 39.1 mttp -142.56 154.78 44.75 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 117.279 0.54 . . . . 0.0 109.665 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 151' ' ' CYS . 86.4 mt -137.22 128.17 40.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 171.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -100.25 -43.81 6.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.623 0.725 . . . . 0.0 110.23 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 172.92 -154.59 21.1 Favored Glycine 0 N--CA 1.416 -2.668 0 C-N-CA 120.283 -0.961 . . . . 0.0 111.14 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.6 pt -131.98 143.31 40.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 120.567 0.222 . . . . 0.0 110.628 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -58.58 126.2 26.61 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 124.352 1.061 . . . . 0.0 110.691 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.1 t -110.08 -63.88 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.32 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.44 108.79 0.61 Allowed Glycine 0 N--CA 1.421 -2.312 0 C-N-CA 119.901 -1.143 . . . . 0.0 112.293 -175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.94 115.0 4.37 Favored Glycine 0 N--CA 1.427 -1.954 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 175.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -114.74 97.61 6.37 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.487 0.661 . . . . 0.0 110.502 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.13 -98.49 0.64 Allowed Glycine 0 N--CA 1.425 -2.034 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.654 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 6.4 mpt_? -110.98 -0.7 16.62 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.619 -0.291 . . . . 0.0 111.055 -174.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -119.18 120.62 37.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.602 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.28 120.77 5.84 Favored Glycine 0 N--CA 1.418 -2.538 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -108.14 118.67 37.35 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.574 0.702 . . . . 0.0 109.931 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.546 ' HB2' HG23 ' A' ' 135' ' ' ILE . 28.6 m -115.83 157.5 24.33 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.693 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -98.81 132.54 44.09 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 10.8 pt20 -87.64 103.3 15.44 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.947 0.88 . . . . 0.0 110.655 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.434 ' H ' HD13 ' A' ' 173' ' ' LEU 0.337 0.0 OUTLIER -85.11 79.79 9.47 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.18 0.991 . . . . 0.0 111.716 177.155 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -57.86 145.01 36.75 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.526 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.486 ' O ' HG23 ' A' ' 179' ' ' VAL . 20.2 ptmt -56.13 -25.41 45.96 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.358 -177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -58.66 -29.99 67.0 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.843 0.857 . . . . 0.0 112.311 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -74.81 -20.5 59.75 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.112 0.482 . . . . 0.0 110.78 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -101.68 11.14 39.35 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.501 0.667 . . . . 0.0 109.498 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 175' ' ' LYS . 92.5 t -97.1 134.93 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 174.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.58 -43.41 80.66 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.403 0.621 . . . . 0.0 109.638 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -104.79 90.56 3.52 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.547 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 . . . . . 0 C--N 1.31 -1.127 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.792 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.503 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -57.34 -32.26 93.34 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.197 2.598 . . . . 0.0 112.935 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -69.51 -40.64 76.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.66 -40.59 97.24 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.931 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -64.23 -40.05 95.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.857 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -65.18 -42.91 93.17 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.126 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.96 82.27 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.112 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.87 -35.68 80.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -82.84 -37.4 24.44 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.877 -0.514 . . . . 0.0 111.332 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.02 -41.17 96.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.404 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 54.5 tp -53.51 -51.42 62.88 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.638 1.175 . . . . 0.0 112.335 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -70.54 -12.82 61.82 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -125.38 -42.01 2.0 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -106.46 -18.06 14.09 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -169.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.404 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 46.5 mt -89.16 105.36 15.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.29 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.2 mtp -105.45 140.22 38.88 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.325 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 m -99.38 116.03 30.59 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.3 mt -111.02 118.48 57.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.352 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 99.8 m -85.4 109.12 18.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.623 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 73.3 p -96.02 -157.54 0.59 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.505 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.5 m -84.01 3.31 34.96 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 121.193 0.521 . . . . 0.0 109.946 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -115.66 -39.52 3.51 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.158 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 160.61 -153.14 23.99 Favored Glycine 0 CA--C 1.498 -1.022 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -92.76 115.58 28.24 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.263 0.554 . . . . 0.0 110.823 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -116.48 169.6 9.2 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 57.6 m -98.54 127.8 44.62 Favored 'General case' 0 N--CA 1.41 -2.443 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.268 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.68 129.44 9.29 Favored Glycine 0 N--CA 1.412 -2.956 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -100.08 116.43 32.09 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.023 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.6 113.98 4.66 Favored Glycine 0 C--O 1.212 -1.253 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.536 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.1 mm -90.87 -50.64 12.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 116.964 0.382 . . . . 0.0 111.593 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -156.09 121.22 4.75 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.831 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.441 ' OD1' ' HG3' ' A' ' 82' ' ' LYS . 28.9 t70 67.18 -79.98 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.148 0.905 . . . . 0.0 113.266 168.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -140.46 11.88 2.33 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.794 0.838 . . . . 0.0 109.54 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.435 HG13 HG13 ' A' ' 74' ' ' VAL . 87.4 t -91.95 115.22 30.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.305 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -120.78 139.22 53.43 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.4 t -114.64 135.27 55.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 120.581 0.229 . . . . 0.0 111.082 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.5 tt -146.54 145.03 21.98 Favored Pre-proline 0 CA--C 1.554 1.104 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 59.9 Cg_exo -57.8 138.91 88.41 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.465 2.11 . . . . 0.0 112.415 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.677 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 21.5 m -60.94 -41.69 96.76 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -71.01 -0.27 9.03 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.91 -15.5 60.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.623 ' O ' ' HB ' ' A' ' 20' ' ' THR . 82.8 mm-40 60.44 82.0 0.23 Allowed Pre-proline 0 CA--C 1.518 -0.283 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 175.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.19 158.98 11.33 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.46 2.107 . . . . 0.0 109.579 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.36 -141.55 11.1 Favored Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.446 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -88.21 -15.22 36.53 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.02 151.77 39.07 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.13 153.98 39.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 7.2 mp -103.57 105.4 15.63 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.829 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.51 92.97 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 66.09 8.24 5.34 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.596 1.558 . . . . 0.0 110.564 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.63 -24.83 3.31 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.66 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 46.5 mt-30 -75.12 106.73 6.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.594 0.197 . . . . 0.0 111.062 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -68.9 103.53 1.83 Allowed 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.4 tp -112.06 121.46 64.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-O 121.241 0.543 . . . . 0.0 109.693 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -75.48 110.32 9.77 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 49.9 t -65.9 135.4 28.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.58 -63.14 1.31 Allowed 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -144.77 144.46 31.19 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -108.14 111.0 22.79 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.503 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 61.9 m-85 -96.59 113.18 24.72 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -77.15 114.18 15.68 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -88.92 94.86 10.09 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.1 t -112.33 149.29 14.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -65.48 142.08 98.22 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.56 -22.55 17.06 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.498 2.799 . . . . 0.0 114.193 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -94.83 14.45 21.39 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 122.058 0.933 . . . . 0.0 109.761 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 66.54 26.69 9.85 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.61 1.164 . . . . 0.0 111.943 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.407 HG21 ' HB2' ' A' ' 132' ' ' ASN . 34.8 mm -86.3 137.27 21.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 131' ' ' THR . 63.3 t30 -92.13 135.0 34.33 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.811 -171.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -123.01 2.45 9.33 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.701 172.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.677 ' OE2' ' HB ' ' A' ' 39' ' ' THR . 4.9 tp10 62.84 23.35 13.94 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.179 1.392 . . . . 0.0 111.864 174.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.7 tt -95.8 120.89 36.87 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 121.666 -0.646 . . . . 0.0 110.141 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 m -114.89 127.39 55.67 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 60.8 t -99.74 107.75 21.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.5 mt -95.69 117.76 31.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.9 m -97.6 103.69 15.65 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -78.17 141.04 38.95 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.257 0.551 . . . . 0.0 111.479 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -91.32 83.25 5.45 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.574 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 11.0 mmm180 -134.06 175.14 9.75 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.806 -174.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -108.33 -28.6 9.32 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 123.325 0.391 . . . . 0.0 111.073 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.574 ' OE1' ' HB3' ' A' ' 79' ' ' ARG . 1.5 pm0 -70.4 127.25 32.11 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-O 121.281 0.562 . . . . 0.0 111.192 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.441 ' HG3' ' OD1' ' A' ' 32' ' ' ASP . 41.4 tttp -92.33 109.54 20.92 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -73.35 139.39 45.97 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.586 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -49.94 123.19 7.68 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.525 1.13 . . . . 0.0 110.001 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -81.49 114.73 20.41 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.892 178.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.9 pt -93.8 25.57 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.997 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -68.3 -27.02 65.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.911 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.73 -9.23 86.45 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.252 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -100.86 -8.97 22.07 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.77 124.51 22.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.5 t -113.3 114.25 26.42 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.452 ' OE2' ' HG3' ' A' ' 176' ' ' GLN . 45.8 mt-10 -84.47 -20.25 32.02 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.233 0.539 . . . . 0.0 110.186 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -90.04 123.74 34.18 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 170.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.469 ' HB3' HD12 ' A' ' 135' ' ' ILE . 8.7 mt -113.93 -56.75 2.36 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.981 0.896 . . . . 0.0 111.228 -168.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 119' ' ' THR . 35.1 tt0 -59.68 126.53 27.98 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.618 -170.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.78 -27.1 8.07 Favored Glycine 0 N--CA 1.436 -1.304 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.117 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.02 156.82 3.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-O 120.834 0.349 . . . . 0.0 110.384 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -89.21 143.67 26.67 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.71 162.25 33.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.658 0.742 . . . . 0.0 112.097 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 88.3 m -124.93 141.62 52.0 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.904 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -107.88 120.87 43.5 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 111' ' ' THR . 37.8 t -116.51 111.32 34.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 120.894 0.378 . . . . 0.0 110.059 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.4 p -113.21 141.04 30.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -133.45 95.72 3.56 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.725 0.774 . . . . 0.0 109.37 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.2 t -104.44 -172.86 2.18 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -88.59 -42.84 11.8 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.54 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -70.44 -49.48 48.25 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -95.57 79.44 3.39 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.9 m -79.96 107.83 13.05 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.171 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.0 t30 58.77 71.82 0.56 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.016 0.926 . . . . 0.0 113.02 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 22.7 m -98.77 107.74 20.26 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.9 mt -95.62 94.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.404 HD21 ' CE2' ' A' ' 139' ' ' TYR . 65.1 tp -103.76 114.43 28.69 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.636 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -80.56 96.38 6.8 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.08 -35.82 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.979 -176.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.419 ' HA3' ' HD3' ' A' ' 117' ' ' PRO . . . 113.4 -135.17 12.38 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.579 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.419 ' HD3' ' HA3' ' A' ' 116' ' ' GLY . 3.1 Cg_exo -77.95 130.01 10.15 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 123.038 2.492 . . . . 0.0 112.345 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.566 ' HB ' HD11 ' A' ' 135' ' ' ILE . 31.2 m -105.57 138.23 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-O 121.531 0.682 . . . . 0.0 111.129 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . 30.4 m -122.59 145.52 48.27 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.019 -177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 57.9 ttp -83.45 122.0 27.93 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -82.36 -32.61 29.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.121 0.486 . . . . 0.0 111.364 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.78 -86.59 1.51 Allowed Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -152.03 138.27 18.38 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.9 mm -126.72 155.05 37.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -105.56 113.49 27.09 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.7 mt -114.52 85.83 2.31 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.354 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.6 m 55.88 77.03 0.25 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.463 1.105 . . . . 0.0 112.273 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.1 m 67.72 -19.68 0.13 Allowed 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 124.962 1.305 . . . . 0.0 113.476 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 91.8 m -92.83 117.59 67.61 Favored Pre-proline 0 N--CA 1.427 -1.606 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -83.58 121.34 2.93 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 121.616 1.544 . . . . 0.0 109.574 174.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.525 ' HB ' ' SD ' ' A' ' 134' ' ' MET . 33.3 p -107.59 102.76 11.99 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-O 121.764 0.792 . . . . 0.0 110.226 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.407 ' HB2' HG21 ' A' ' 68' ' ' ILE . 46.2 t30 -103.65 164.0 11.95 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -178.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.402 ' HD3' ' OH ' ' A' ' 177' ' ' TYR . 46.1 mtt180 67.81 38.12 2.99 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.736 0.814 . . . . 0.0 109.437 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.525 ' SD ' ' HB ' ' A' ' 131' ' ' THR . 57.1 mtt -119.24 164.23 15.94 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-O 121.798 0.809 . . . . 0.0 113.105 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.566 HD11 ' HB ' ' A' ' 118' ' ' VAL . 12.9 tt -123.15 151.42 27.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 124.712 1.205 . . . . 0.0 108.317 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -128.29 142.56 51.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.067 0.46 . . . . 0.0 111.889 -174.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -144.56 137.34 26.72 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.892 169.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.96 104.65 16.48 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.792 0.806 . . . . 0.0 111.662 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.404 ' CE2' HD21 ' A' ' 113' ' ' LEU . 56.8 t80 -162.56 138.07 7.12 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 125.808 1.643 . . . . 0.0 107.45 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.04 98.97 2.64 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.5 m -53.03 138.51 30.45 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 124.951 1.3 . . . . 0.0 112.836 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 145' ' ' GLN . 62.8 tttp -99.85 140.22 34.37 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.7 m -63.92 139.12 58.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 122.529 0.332 . . . . 0.0 110.263 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.34 33.47 9.4 Favored Glycine 0 C--O 1.219 -0.823 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 3.4 tp-100 -116.89 -6.13 11.49 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.603 0.716 . . . . 0.0 109.432 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.41 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 42.2 t -69.78 129.0 38.37 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.704 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.405 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 100.34 -7.66 58.39 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.095 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.75 140.28 42.22 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.526 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.34 120.67 35.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.729 0.776 . . . . 0.0 110.774 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 42.3 tp -88.2 106.04 17.93 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.0 p -140.99 168.67 19.23 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.747 0.784 . . . . 0.0 112.577 -172.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.54 -179.1 6.71 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.4 t -57.41 101.22 0.06 Allowed 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.938 0.875 . . . . 0.0 111.937 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 71.3 14.88 74.52 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.275 -1.33 . . . . 0.0 113.092 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -135.64 108.74 7.69 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 117.251 0.526 . . . . 0.0 111.045 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.13 126.26 57.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -97.87 -33.63 11.16 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 123.896 0.747 . . . . 0.0 110.959 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 165.54 -159.85 33.11 Favored Glycine 0 N--CA 1.42 -2.382 0 C-N-CA 119.441 -1.361 . . . . 0.0 112.675 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.561 HG23 HD11 ' A' ' 173' ' ' LEU . 19.6 pt -121.86 137.75 54.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -69.34 125.96 28.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.0 p -96.69 -46.7 12.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.316 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.77 156.34 11.36 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -131.08 156.73 21.91 Favored Glycine 0 N--CA 1.428 -1.852 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.528 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -154.95 144.16 21.09 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.97 -122.68 5.9 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -117.84 13.21 14.03 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -121.43 136.88 54.91 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.017 0.437 . . . . 0.0 111.971 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -106.94 130.14 10.03 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -112.44 140.71 46.95 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.198 0.523 . . . . 0.0 109.96 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.528 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 18.6 m -131.15 154.7 48.07 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -90.41 139.56 30.56 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.67 116.35 19.8 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 123.37 0.419 . . . . 0.0 110.964 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.561 HD11 HG23 ' A' ' 159' ' ' ILE . 81.9 mt -89.02 94.38 9.93 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -84.08 140.66 31.67 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.093 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -69.16 -20.84 64.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.442 0.639 . . . . 0.0 109.6 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.452 ' HG3' ' OE2' ' A' ' 92' ' ' GLU . 69.4 mt-30 -58.21 -21.75 49.07 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 125.506 1.523 . . . . 0.0 112.23 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.402 ' OH ' ' HD3' ' A' ' 133' ' ' ARG . 34.6 m-85 -86.99 -23.42 25.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.93 0.395 . . . . 0.0 110.726 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.406 ' CG ' HG21 ' A' ' 30' ' ' ILE . 49.2 m-85 -106.5 18.72 21.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.154 0.502 . . . . 0.0 112.017 -169.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 24.0 m -100.12 -179.81 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.629 176.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -81.5 -37.85 27.23 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.215 0.531 . . . . 0.0 110.127 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -91.45 106.29 18.38 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.426 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--N 1.303 -1.449 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.195 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.358 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.63 -27.6 76.31 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.012 2.474 . . . . 0.0 111.106 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -61.21 -37.27 82.39 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.057 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.4 m -64.52 -37.43 87.52 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.506 0.722 . . . . 0.0 109.608 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.35 -44.83 82.18 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.915 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.83 -45.98 88.75 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.944 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.424 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -62.02 -43.48 98.75 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.02 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.84 -37.7 85.45 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 123.346 0.658 . . . . 0.0 110.438 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.3 m -76.41 -31.62 58.03 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.527 0.679 . . . . 0.0 110.325 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -73.69 -31.14 63.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.303 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.575 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 62.2 tp -51.68 -56.32 14.37 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.436 1.094 . . . . 0.0 112.05 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -83.02 10.26 8.41 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.221 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -117.91 -59.79 1.87 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -122.72 -6.81 8.56 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -171.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 50.5 mt -89.19 103.32 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.115 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 mmt -115.58 126.03 53.7 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 121.25 0.548 . . . . 0.0 111.002 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 24' ' ' GLU . 2.4 m -70.2 96.82 1.13 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.864 177.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 58.5 mt -89.86 111.9 23.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 121.16 0.505 . . . . 0.0 109.908 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.8 m -86.5 107.6 18.17 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 80.5 p -89.74 -157.75 0.48 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.776 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 t -85.57 -9.45 57.32 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -106.3 -38.06 6.35 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.03 -160.4 27.45 Favored Glycine 0 CA--C 1.493 -1.326 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.804 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HB3' HG22 ' A' ' 17' ' ' THR . 7.8 mp0 -99.86 112.27 24.54 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -112.73 159.3 19.08 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 17.9 m -86.65 116.26 24.65 Favored 'General case' 0 N--CA 1.408 -2.556 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.47 129.26 9.81 Favored Glycine 0 N--CA 1.417 -2.624 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.2 tp -105.4 115.9 31.04 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 120.839 0.352 . . . . 0.0 110.549 -178.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.7 136.48 23.17 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.418 ' HA ' HD11 ' A' ' 86' ' ' ILE . 50.3 mm -100.61 -56.34 5.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 117.566 0.683 . . . . 0.0 109.537 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.601 ' NE2' ' HB3' ' A' ' 178' ' ' PHE . 0.1 OUTLIER -172.97 167.94 4.95 Favored 'General case' 0 CA--C 1.46 -2.494 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 52.06 -135.57 1.47 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.67 25.73 10.44 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -92.61 112.87 26.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.272 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 43.2 t -122.14 139.71 53.42 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.15 140.77 26.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 122.225 0.21 . . . . 0.0 110.585 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 tt -151.78 147.44 20.05 Favored Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -63.94 147.26 92.02 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.158 1.905 . . . . 0.0 112.066 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.0 m -64.44 -37.66 88.29 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -76.09 5.24 7.01 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.42 -19.65 57.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' A' ' 20' ' ' THR . 78.6 mt-30 57.22 76.6 0.47 Allowed Pre-proline 0 C--O 1.251 1.158 0 C-N-CA 125.414 1.486 . . . . 0.0 113.361 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -92.29 164.8 3.02 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 122.346 2.031 . . . . 0.0 110.724 175.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.34 -152.09 10.96 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.06 -1.44 54.41 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -144.87 126.13 14.76 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.18 155.39 39.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.063 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 8.8 mp -92.26 102.06 14.56 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.3 p -87.82 105.46 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.052 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 74.03 -3.9 2.41 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.611 0.764 . . . . 0.0 110.81 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.51 -9.3 11.78 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -97.67 118.26 33.79 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 48' ' ' LEU . 14.9 ptpt -77.19 134.63 38.59 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 118.28 -1.368 . . . . 0.0 112.738 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.478 HG12 ' HB3' ' A' ' 77' ' ' LEU . 5.3 tp -131.49 141.12 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 114.251 -1.341 . . . . 0.0 108.346 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -86.47 139.66 30.68 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.6 t -93.01 139.93 17.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -79.68 -71.34 0.45 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -126.15 139.38 53.41 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -99.88 90.97 4.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.447 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 93.8 m-85 -79.2 109.97 14.03 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.155 0.502 . . . . 0.0 110.523 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -77.14 104.42 7.63 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.7 tp -80.26 87.89 5.53 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 122.181 0.991 . . . . 0.0 109.245 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.4 m -119.64 163.52 16.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 113.848 -1.523 . . . . 0.0 108.397 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.58 137.15 48.05 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.53 -23.9 11.55 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.667 2.911 . . . . 0.0 114.348 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -82.77 13.53 3.79 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 122.379 0.272 . . . . 0.0 111.384 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.9 m120 79.21 10.19 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 125.383 1.473 . . . . 0.0 112.347 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.5 mt -86.47 119.84 35.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.628 ' O ' ' HA ' ' A' ' 131' ' ' THR . 74.6 m-20 -81.07 157.67 25.32 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.882 -173.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -109.36 -0.97 18.78 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 61.72 30.05 18.29 Favored 'General case' 0 C--N 1.364 1.218 0 CA-C-O 122.83 1.3 . . . . 0.0 108.634 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.464 HD21 HD11 ' A' ' 173' ' ' LEU . 14.9 tp -133.01 142.89 49.07 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.584 -170.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.0 m -138.08 140.3 39.92 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.255 0.55 . . . . 0.0 110.657 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 92.7 t -105.98 122.25 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.8 mt -102.38 113.69 27.23 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.7 m -87.6 107.55 18.65 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.478 ' HB3' HG12 ' A' ' 54' ' ' ILE . 66.0 mt -80.48 141.31 35.34 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.725 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.52 74.72 10.35 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 122.045 0.926 . . . . 0.0 111.6 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -125.12 161.59 26.49 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.436 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -93.23 -49.57 5.9 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -66.96 148.16 52.3 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -119.27 173.18 7.1 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.388 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -82.56 179.64 7.72 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -73.75 127.93 34.13 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.01 90.16 1.15 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.418 HD11 ' HA ' ' A' ' 30' ' ' ILE . 2.4 pp -92.61 20.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.755 -0.591 . . . . 0.0 112.162 -176.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -68.69 -29.74 68.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.811 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.72 -27.54 73.77 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -85.1 -8.82 58.48 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 122.9 -0.177 . . . . 0.0 110.699 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.4 mt -66.54 131.69 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.02 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 t -124.44 111.48 15.78 Favored 'General case' 0 N--CA 1.387 -3.589 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -86.84 5.46 36.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.495 1.14 . . . . 0.0 108.935 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.83 110.57 22.02 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 169.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.5 -29.76 0.62 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -171.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -68.1 103.02 1.43 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.113 0.482 . . . . 0.0 111.747 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.38 -0.43 34.94 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.604 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.0 t -91.53 138.71 19.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -79.7 116.72 20.05 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -115.59 172.25 7.23 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.821 0.82 . . . . 0.0 112.097 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.6 m -128.79 141.25 51.37 Favored 'General case' 0 N--CA 1.422 -1.857 0 C-N-CA 124.908 1.283 . . . . 0.0 108.719 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.8 tp -106.12 122.19 45.69 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.424 HG21 ' HB1' ' A' ' 7' ' ' ALA . 43.5 t -113.96 107.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.815 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.4 m -107.85 138.91 31.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -139.28 107.99 5.93 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.325 0.583 . . . . 0.0 110.002 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.3 p -144.27 -172.58 3.81 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.46 -25.76 41.85 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.401 176.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -73.68 -51.27 17.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.419 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -115.79 84.35 2.09 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.8 m -80.14 96.32 6.49 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.355 0.597 . . . . 0.0 111.005 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.2 t30 60.15 70.71 0.61 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.755 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.3 m -101.34 108.03 19.54 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.08 108.67 24.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.0 tp -125.15 123.88 40.6 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.875 0.369 . . . . 0.0 111.563 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.86 102.65 4.8 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.1 m -78.39 -26.54 14.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.243 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 106.85 -149.53 16.6 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 119.94 -1.124 . . . . 0.0 111.1 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.95 122.25 8.63 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.745 2.297 . . . . 0.0 112.901 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.8 m -89.57 145.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.949 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 135' ' ' ILE . 11.5 p -128.45 172.8 10.79 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.246 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 28.2 ttt -114.45 136.64 52.78 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.74 -26.84 12.58 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.335 0.588 . . . . 0.0 109.419 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.53 -88.89 1.46 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 131' ' ' THR . 4.9 mp -131.99 155.99 47.0 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 130' ' ' PRO . 11.1 tt -144.05 128.18 13.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -91.17 95.48 10.08 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.2 tp -107.13 121.99 45.6 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.5 p 50.05 49.68 19.91 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.753 0.821 . . . . 0.0 112.776 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 26.3 m 62.9 17.85 10.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.622 0.769 . . . . 0.0 112.599 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 96.1 m -129.93 106.58 16.69 Favored Pre-proline 0 N--CA 1.42 -1.949 0 CA-C-O 121.163 0.506 . . . . 0.0 109.894 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 50.7 Cg_endo -78.84 131.28 10.04 Favored 'Trans proline' 0 N--CA 1.428 -2.358 0 C-N-CA 121.451 1.434 . . . . 0.0 110.816 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.1 p -103.69 133.45 48.67 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.415 ' OD1' ' HD2' ' A' ' 133' ' ' ARG . 29.0 t-20 -108.19 159.9 16.24 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -175.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.494 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 5.5 mpt_? 65.72 38.8 5.1 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.563 1.145 . . . . 0.0 110.638 -177.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.425 ' HG3' HG22 ' A' ' 124' ' ' ILE . 16.5 mmt -85.55 118.42 25.06 Favored 'General case' 0 C--O 1.252 1.214 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.256 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.575 HG23 ' HB2' ' A' ' 170' ' ' SER . 5.4 tt -99.84 136.34 31.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 144.58 51.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.752 0.31 . . . . 0.0 111.311 -172.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.409 ' HE2' ' HG ' ' A' ' 170' ' ' SER . 6.3 p90 -138.95 163.81 31.38 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.907 176.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -91.27 99.95 12.84 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 124.227 0.955 . . . . 0.0 108.669 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -171.34 124.35 0.6 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.485 1.114 . . . . 0.0 109.65 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -70.46 102.81 2.29 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.941 176.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.8 t -119.81 155.73 32.0 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -127.21 165.44 19.61 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.721 0.296 . . . . 0.0 110.505 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.4 m -60.74 129.38 41.22 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.287 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.27 -20.41 9.04 Favored Glycine 0 C--O 1.215 -1.049 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -93.42 23.71 4.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.183 0.992 . . . . 0.0 108.386 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 31.1 m -79.12 137.88 37.68 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.415 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.566 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 97.55 0.43 59.35 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -178.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.57 126.58 37.81 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 121.566 -0.349 . . . . 0.0 112.643 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -73.25 113.0 10.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 123.318 0.647 . . . . 0.0 109.465 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 52.3 tp -94.18 106.45 18.42 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.5 p -147.02 163.23 36.91 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.675 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.77 177.8 6.58 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.1 t -64.38 108.46 1.63 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.956 0.884 . . . . 0.0 110.946 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 83.27 2.37 90.36 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.262 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -136.35 108.38 7.18 Favored 'General case' 0 C--O 1.211 -0.956 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.1 mt -97.68 130.92 45.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -103.41 -31.97 9.75 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.147 0.498 . . . . 0.0 110.691 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.4 -154.84 25.91 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.283 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.9 pt -132.28 148.08 32.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 116.911 0.355 . . . . 0.0 110.597 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.408 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 23.8 t-80 -68.14 131.16 44.91 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.203 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.6 m -105.47 -59.96 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.56 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -156.93 142.89 9.06 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.019 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -131.67 143.99 15.57 Favored Glycine 0 N--CA 1.423 -2.232 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.894 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -119.76 105.99 11.68 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.638 0.732 . . . . 0.0 109.911 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 74.2 -130.76 12.75 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -177.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 34.0 ptt180 -90.14 9.09 29.67 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.961 0.41 . . . . 0.0 110.982 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -111.37 94.72 5.12 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.618 0.723 . . . . 0.0 110.063 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.9 123.93 6.9 Favored Glycine 0 N--CA 1.422 -2.283 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.55 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -104.27 127.52 51.91 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.951 0.881 . . . . 0.0 109.557 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.575 ' HB2' HG23 ' A' ' 135' ' ' ILE . 19.4 m -124.62 166.29 16.38 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.36 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -100.56 129.49 46.5 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 4.0 pt20 -85.18 115.88 23.22 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.922 0.868 . . . . 0.0 110.319 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.464 HD11 HD21 ' A' ' 72' ' ' LEU . 4.3 mm? -87.09 93.4 9.35 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.954 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -73.3 146.73 45.12 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -75.3 -6.3 49.12 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.334 0.588 . . . . 0.0 110.907 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.09 -33.42 74.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.077 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -75.33 -27.0 59.07 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.173 0.511 . . . . 0.0 110.899 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.601 ' HB3' ' NE2' ' A' ' 31' ' ' HIS . 82.7 m-85 -102.1 0.99 35.75 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.897 -170.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.7 p -92.74 136.37 25.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -65.79 -46.26 79.37 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.185 0.517 . . . . 0.0 110.883 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.24 146.56 45.94 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.344 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 C--N 1.285 -2.2 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.544 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.522 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.4 -27.51 71.07 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 123.048 2.499 . . . . 0.0 113.272 -176.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -76.56 -40.13 50.69 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -60.89 -46.21 91.54 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.851 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.45 -49.52 77.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.332 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -58.57 -46.8 86.15 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 123.498 0.499 . . . . 0.0 110.781 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.61 -35.14 78.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.6 tp -71.38 -42.14 68.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.049 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -70.73 -33.09 70.47 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 122.022 -0.423 . . . . 0.0 111.46 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.412 HD11 HD13 ' A' ' 86' ' ' ILE . 50.6 tp -67.27 -40.53 86.2 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.733 0.813 . . . . 0.0 108.927 177.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.511 HD22 HD22 ' A' ' 110' ' ' ASN . 18.5 tp -53.51 -50.49 65.3 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.742 1.217 . . . . 0.0 111.591 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -73.36 -3.61 28.3 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.783 -1.098 . . . . 0.0 113.447 -171.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -126.42 -47.98 1.57 Allowed 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -115.84 -10.49 11.69 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -171.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 29.8 mt -99.19 115.34 39.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.101 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.2 mmt -127.65 146.37 50.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.465 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 22.7 m -78.56 132.41 37.15 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.7 mt -125.93 110.8 24.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 98.4 m -77.03 103.72 7.12 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.2 p -94.55 -168.68 1.88 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.008 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -71.12 -16.11 62.54 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 120.842 0.353 . . . . 0.0 111.047 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -110.11 9.63 24.03 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.84 -162.41 14.01 Favored Glycine 0 C--N 1.31 -0.869 0 C-N-CA 119.49 -1.338 . . . . 0.0 113.642 175.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -86.48 101.27 13.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.312 0.577 . . . . 0.0 111.738 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -106.92 -179.25 3.88 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 t -127.44 139.28 52.92 Favored 'General case' 0 N--CA 1.408 -2.571 0 C-N-CA 119.005 -1.078 . . . . 0.0 109.028 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.59 137.63 14.41 Favored Glycine 0 N--CA 1.415 -2.737 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.7 tp -101.84 118.41 36.86 Favored 'General case' 0 C--N 1.29 -2.01 0 O-C-N 123.811 0.359 . . . . 0.0 110.175 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.47 132.38 22.76 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mm -100.11 -53.03 8.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 117.624 0.712 . . . . 0.0 109.933 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -161.94 151.02 15.69 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.495 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.488 ' HA ' ' HG3' ' A' ' 82' ' ' LYS . 4.6 t70 53.72 -92.24 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 125.333 1.453 . . . . 0.0 112.695 177.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 32' ' ' ASP . 9.3 mpt_? -132.0 7.74 4.36 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.398 0.618 . . . . 0.0 110.033 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.446 HG13 HG13 ' A' ' 74' ' ' VAL . 84.0 t -77.82 112.83 16.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.573 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.7 m -121.94 142.84 49.88 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.3 p -115.91 141.39 33.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 120.743 0.306 . . . . 0.0 110.571 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 tt -154.47 149.42 20.24 Favored Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.57 144.9 95.13 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 122.279 1.986 . . . . 0.0 112.781 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.594 ' HB ' ' OG1' ' A' ' 73' ' ' THR . 9.6 t -86.52 -10.29 54.39 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -79.02 -2.51 40.67 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.282 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.73 -27.74 20.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.001 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 13.5 mm-40 60.04 87.46 0.14 Allowed Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.653 1.181 . . . . 0.0 114.171 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.48 149.08 18.74 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.156 1.904 . . . . 0.0 109.194 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.01 -157.35 30.09 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.478 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -82.2 -30.24 31.0 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.402 ' OD2' ' HD2' ' A' ' 53' ' ' LYS . 8.6 p-10 -139.58 136.29 34.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 23.9 m -136.68 157.68 36.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-O 120.755 0.312 . . . . 0.0 111.644 -174.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 86.6 mt -89.81 109.88 20.85 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 17' ' ' THR . 81.8 t -97.77 88.55 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.251 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 63.52 18.47 11.09 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.519 1.152 . . . . 0.0 109.934 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.18 -38.69 2.03 Favored Glycine 0 N--CA 1.436 -1.3 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.128 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -81.03 120.11 24.39 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.773 -0.251 . . . . 0.0 110.371 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 39.1 ttpt -80.59 110.41 16.04 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.2 tp -103.82 150.19 7.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -99.52 139.52 35.06 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 118.272 -1.371 . . . . 0.0 107.824 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.43 124.96 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.407 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 57.7 tttm -70.86 -52.25 21.47 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.34 0.59 . . . . 0.0 109.839 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.2 m-20 -138.71 138.25 37.55 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.602 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -115.55 112.51 22.3 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.47 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 63.9 m-85 -109.88 111.62 23.15 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.527 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -78.6 116.24 18.84 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.567 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 37.8 tp -90.73 101.97 14.72 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.1 t -123.89 140.8 46.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -81.78 130.94 58.98 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.98 5.23 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.081 3.187 . . . . 0.0 116.044 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.7 14.57 16.74 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.9 t30 70.66 40.06 1.06 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.011 1.324 . . . . 0.0 109.007 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 53.3 mt -120.06 122.02 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.605 -1.179 . . . . 0.0 108.62 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 131' ' ' THR . 50.4 t30 -64.54 150.29 47.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.598 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.567 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 39.1 tp -126.52 -9.58 6.26 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.716 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 72.5 -20.59 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.673 1.189 . . . . 0.0 113.108 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.67 118.69 11.99 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.594 ' OG1' ' HB ' ' A' ' 39' ' ' THR . 55.0 m -106.83 114.28 28.28 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 64.2 t -92.97 104.88 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.808 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.75 124.42 42.1 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.253 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 59.8 m -98.05 93.78 6.48 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -71.05 137.55 49.07 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.23 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.78 76.89 10.17 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.429 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -101.47 128.84 47.51 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 113.305 -1.771 . . . . 0.0 107.23 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.55 -50.74 64.04 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.365 0.415 . . . . 0.0 111.457 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -74.02 160.09 31.79 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 121.242 0.544 . . . . 0.0 110.62 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.488 ' HG3' ' HA ' ' A' ' 32' ' ' ASP . 58.1 tttm -99.52 142.55 30.85 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.604 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -80.8 162.3 24.1 Favored 'General case' 0 C--O 1.257 1.448 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 175.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -77.18 132.48 38.79 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -80.24 96.17 6.52 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.785 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.412 HD13 HD11 ' A' ' 10' ' ' LEU . 38.4 pt -96.0 20.32 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.767 0.794 . . . . 0.0 109.523 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -65.32 -28.16 69.12 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.837 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.72 -5.99 89.42 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.643 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -96.16 -3.06 45.1 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.282 0.563 . . . . 0.0 110.584 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.6 mt -70.22 120.07 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.987 176.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 p -108.68 105.08 14.53 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.546 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 1.0 OUTLIER -80.2 -12.48 59.64 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.299 177.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.35 118.98 21.76 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.526 HD11 ' NE2' ' A' ' 172' ' ' GLN . 21.6 mt -112.65 -63.84 1.38 Allowed 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.394 0.616 . . . . 0.0 112.3 -169.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 16.9 pt-20 -54.69 126.95 26.03 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -166.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.87 -38.28 3.2 Favored Glycine 0 N--CA 1.432 -1.582 0 CA-C-N 114.488 -1.233 . . . . 0.0 113.011 177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.3 t -78.52 138.64 19.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.997 0.427 . . . . 0.0 110.897 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -80.97 102.4 10.12 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.9 163.54 24.24 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.554 0.693 . . . . 0.0 111.16 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.6 m -129.28 139.04 51.94 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.5 tp -112.65 125.09 53.91 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 111' ' ' THR . 7.6 p -117.89 122.4 69.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.412 0.625 . . . . 0.0 110.832 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 t -111.72 139.13 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.743 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.409 ' HB3' HG22 ' A' ' 15' ' ' ILE . 76.5 t60 -126.5 79.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.258 1.028 . . . . 0.0 109.806 175.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.9 t -116.91 -177.82 3.29 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -71.33 -45.28 63.38 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.091 0.472 . . . . 0.0 110.374 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -82.28 -47.39 12.46 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.515 0.674 . . . . 0.0 109.885 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -88.69 76.6 8.04 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.761 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 22.5 m -94.44 101.11 13.02 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.921 0.391 . . . . 0.0 110.008 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.511 HD22 HD22 ' A' ' 11' ' ' LEU . 27.1 t-20 64.45 62.9 0.78 Allowed 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 122.927 1.346 . . . . 0.0 110.033 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 24.6 m -96.54 96.15 8.48 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.344 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.417 HD11 HD21 ' A' ' 110' ' ' ASN . 54.1 mt -100.99 97.03 5.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.7 tp -120.2 137.17 54.35 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -68.67 146.08 53.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.2 t -102.72 -51.4 9.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 119.54 -168.58 13.56 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.59 116.8 4.13 Favored 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.704 2.27 . . . . 0.0 112.278 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 26.8 m -87.29 155.72 3.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.091 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.0 p -136.84 169.61 17.46 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 123.129 0.572 . . . . 0.0 109.592 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.2 ttt -87.82 142.68 27.62 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -95.84 -39.54 9.78 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.037 0.446 . . . . 0.0 110.976 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 133' ' ' ARG . . . 99.36 -111.68 4.27 Favored Glycine 0 N--CA 1.429 -1.799 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 130' ' ' PRO . 2.5 pt? -134.94 112.19 10.43 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.284 1.04 . . . . 0.0 110.911 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 7.6 tp -162.82 156.67 2.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 129' ' ' THR . 2.6 t-20 -159.27 -77.56 0.07 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -161.08 151.55 17.94 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 51.9 p 50.1 33.96 7.73 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.346 1.058 . . . . 0.0 113.826 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.3 m 60.53 60.59 1.93 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 122.161 0.982 . . . . 0.0 110.089 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.531 ' O ' ' HB3' ' A' ' 125' ' ' ASN . 61.2 m -142.78 128.8 10.47 Favored Pre-proline 0 N--CA 1.412 -2.367 0 N-CA-C 101.688 -3.449 . . . . 0.0 101.688 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.43 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 44.9 Cg_endo -100.37 148.56 0.41 Allowed 'Trans proline' 0 N--CA 1.441 -1.573 0 N-CA-C 117.017 1.891 . . . . 0.0 117.017 -170.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 97.6 m -92.01 130.73 37.69 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 164.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.31 97.18 0.39 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 20.3 mtm-85 62.76 80.35 0.23 Allowed 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 122.255 1.026 . . . . 0.0 110.767 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.5 ttt -103.61 169.75 8.34 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.415 -172.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.52 HG23 ' HB2' ' A' ' 170' ' ' SER . 7.7 tt -117.32 142.34 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.017 0.527 . . . . 0.0 109.869 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.517 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 46.8 ttp180 -137.37 146.53 44.62 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 123.719 0.807 . . . . 0.0 109.659 -174.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' A' ' 118' ' ' VAL . 6.9 p90 -151.4 159.51 44.21 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 120.373 0.13 . . . . 0.0 111.287 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -83.22 113.51 20.72 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -165.55 126.12 1.86 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -174.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.45 101.96 1.34 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 44.4 m -78.77 138.94 38.46 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.923 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -111.3 154.47 24.46 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.9 t -86.76 138.69 31.4 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.0 -13.87 28.94 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.124 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.31 5.72 50.93 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.376 0.607 . . . . 0.0 111.432 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 41.9 t -62.32 135.12 57.31 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.524 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 103.57 -14.53 53.82 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.848 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.71 141.9 46.24 Favored Glycine 0 C--O 1.241 0.562 0 O-C-N 123.969 0.452 . . . . 0.0 113.726 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.5 t -81.27 114.46 22.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.319 0.58 . . . . 0.0 109.771 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 39.5 tp -87.35 106.27 17.83 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.6 p -140.82 -171.71 3.3 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.205 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -157.16 -173.47 4.45 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.8 t -70.48 99.57 1.64 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.283 1.04 . . . . 0.0 111.297 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.99 12.58 70.91 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.595 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -137.21 140.69 41.9 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 85.9 mt -126.95 124.34 64.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -96.98 -35.45 10.85 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.131 0.491 . . . . 0.0 110.629 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.527 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 164.01 -154.32 25.14 Favored Glycine 0 N--CA 1.427 -1.925 0 C-N-CA 119.305 -1.426 . . . . 0.0 113.16 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.5 pt -125.01 134.06 67.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 122.56 0.344 . . . . 0.0 111.15 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.434 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 68.9 t60 -67.42 128.58 36.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.441 0.696 . . . . 0.0 109.828 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.49 -15.42 9.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.29 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.25 -159.63 24.44 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 176.9 -176.5 48.05 Favored Glycine 0 C--N 1.294 -1.777 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -147.93 145.83 28.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.2 -110.62 3.35 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.024 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 46.0 mtm105 -120.27 7.71 10.78 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -110.69 129.13 55.91 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.835 0.35 . . . . 0.0 110.276 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -105.31 142.39 15.51 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.0 143.77 49.7 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.536 0.684 . . . . 0.0 110.827 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.52 ' HB2' HG23 ' A' ' 135' ' ' ILE . 74.1 m -138.79 159.8 41.23 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.348 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -96.58 119.15 34.54 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.526 ' NE2' HD11 ' A' ' 94' ' ' LEU . 3.0 pt20 -76.56 122.01 24.0 Favored 'General case' 0 C--O 1.253 1.274 0 CA-C-O 121.948 0.88 . . . . 0.0 111.315 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.527 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 95.4 mt -83.57 99.88 10.45 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -88.55 138.24 31.6 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.546 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 9.7 ptpp? -69.55 -13.88 62.56 Favored 'General case' 0 C--O 1.21 -0.995 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.877 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -61.35 -22.85 65.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.931 1.292 . . . . 0.0 110.562 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -85.34 -33.62 22.02 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.379 0.609 . . . . 0.0 109.428 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -91.76 3.5 54.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.016 -169.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.56 115.71 49.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -90.16 -30.83 17.37 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.641 0.734 . . . . 0.0 109.278 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -93.74 84.97 4.7 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.319 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 C--N 1.308 -1.235 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.482 -178.768 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.466 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.43 -36.96 63.2 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.528 2.152 . . . . 0.0 112.405 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -79.92 -32.39 40.15 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.602 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 19.3 m -61.48 -44.5 96.97 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.428 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -54.94 -51.55 65.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.055 0.942 . . . . 0.0 109.038 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.04 -45.19 94.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.432 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.39 75.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.331 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 4' ' ' THR . 92.8 mt -61.8 -47.67 84.06 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.058 0.456 . . . . 0.0 109.878 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 m -66.21 -49.98 65.43 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.309 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.9 tp -57.08 -45.65 83.17 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.58 0.752 . . . . 0.0 111.292 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.587 HD13 HD22 ' A' ' 110' ' ' ASN . 9.3 tt -64.59 -43.84 92.55 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -76.25 -9.39 58.6 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -99.93 -65.63 0.95 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.896 0.379 . . . . 0.0 111.247 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -108.71 -5.48 16.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -168.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.512 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 47.6 mt -95.82 139.7 18.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.336 -176.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.546 ' HB3' HG13 ' A' ' 49' ' ' VAL . 57.1 mtm -140.53 163.16 33.58 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.047 0.939 . . . . 0.0 109.306 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 96.5 m -103.11 119.74 39.41 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 71.1 mt -110.96 112.63 41.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.076 0.465 . . . . 0.0 110.179 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 59.9 m -80.35 107.9 13.52 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.5 p -97.6 -166.96 1.45 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.362 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -78.65 -2.89 41.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.348 0.594 . . . . 0.0 110.302 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -106.44 -43.09 4.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.295 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.59 -160.44 33.94 Favored Glycine 0 C--O 1.246 0.889 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.651 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -81.83 96.09 7.51 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.336 0.654 . . . . 0.0 109.422 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 146' ' ' CYS . 6.6 m-85 -99.64 159.53 14.97 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.43 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 95.0 m -94.5 127.74 40.63 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.91 121.73 7.03 Favored Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.96 113.02 26.26 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.8 134.94 21.07 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 50.8 mm -100.97 -48.85 11.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 117.298 0.549 . . . . 0.0 110.219 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.601 ' CD2' ' HB3' ' A' ' 85' ' ' ASP . 22.8 t-80 -166.66 139.81 3.82 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.131 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.431 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 28.8 t70 61.21 -92.62 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.631 0 O-C-N 124.257 0.973 . . . . 0.0 112.745 173.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 81.0 mtt180 -131.86 5.75 4.26 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.406 0.622 . . . . 0.0 109.975 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.8 t -85.51 117.42 30.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.675 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.4 m -125.45 157.24 37.41 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.3 145.06 23.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 120.771 0.319 . . . . 0.0 111.67 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 tt -160.34 140.56 8.53 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.755 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 73.7 Cg_exo -57.66 134.58 63.96 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.909 2.406 . . . . 0.0 113.46 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.489 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 25.3 m -64.02 -33.58 76.06 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 124.276 1.031 . . . . 0.0 112.727 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -64.19 -12.25 38.65 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.19 -25.76 59.88 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 53.35 84.89 0.2 Allowed Pre-proline 0 C--O 1.242 0.667 0 C-N-CA 124.936 1.295 . . . . 0.0 112.816 -176.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -83.88 152.22 12.89 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 C-N-CA 121.935 1.756 . . . . 0.0 110.619 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.59 -162.35 37.07 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.162 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -93.37 10.03 33.9 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.083 0.944 . . . . 0.0 110.415 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -160.36 124.75 3.71 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.65 149.76 29.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.533 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 93.9 mt -85.48 114.11 22.26 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 17' ' ' THR . 39.2 t -102.28 102.32 13.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.217 175.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.6 m120 59.04 25.06 13.4 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.621 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.01 -7.38 44.35 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.943 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -106.83 118.62 37.17 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.542 -0.387 . . . . 0.0 110.48 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -73.44 124.69 26.29 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.68 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.424 ' CD1' ' HB3' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -119.94 122.8 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.925 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -71.52 124.69 25.22 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.309 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.7 t -84.22 139.99 16.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.48 -176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.439 ' NZ ' ' HB3' ' A' ' 57' ' ' LYS . 8.6 mtpm? -97.87 -69.77 0.75 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.032 0.92 . . . . 0.0 109.785 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -116.04 143.47 45.42 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.926 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -146.32 96.96 2.86 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -106.58 139.33 41.21 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.411 ' H ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -97.87 128.53 44.54 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.074 174.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.03 110.21 14.05 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.86 129.45 69.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.544 ' HB2' HD21 ' A' ' 70' ' ' LEU . 22.1 t70 -66.33 143.92 98.48 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -175.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.31 -17.25 0.5 Allowed 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 123.917 3.078 . . . . 0.0 115.141 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HG2' ' OD2' ' A' ' 64' ' ' ASP . 19.0 mm-40 -83.47 3.78 30.69 Favored 'General case' 0 CA--C 1.555 1.158 0 O-C-N 121.633 -0.667 . . . . 0.0 111.178 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.7 t30 73.78 18.8 3.32 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 125.435 1.494 . . . . 0.0 109.343 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.401 HG21 ' HB2' ' A' ' 132' ' ' ASN . 30.0 mm -99.44 136.1 32.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 131' ' ' THR . 91.7 m-20 -73.51 148.39 43.14 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.591 0.234 . . . . 0.0 111.411 -176.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.544 HD21 ' HB2' ' A' ' 64' ' ' ASP . 73.0 mt -103.97 -13.22 16.41 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 172.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.489 ' OE1' ' HB ' ' A' ' 39' ' ' THR . 2.7 tp10 60.05 31.25 20.53 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 114.176 -1.374 . . . . 0.0 109.34 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.0 tp -115.82 120.58 39.73 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.881 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -104.38 130.94 52.22 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -91.86 100.28 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 171.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.6 tp -96.54 116.28 28.82 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.771 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.6 m -104.93 109.43 21.42 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.574 0.702 . . . . 0.0 109.107 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 88.7 mt -93.82 153.46 18.27 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.765 -175.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -88.22 80.08 7.67 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -118.3 115.02 23.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.756 -1.565 . . . . 0.0 108.014 -171.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -81.43 -10.13 59.58 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.521 0.677 . . . . 0.0 112.627 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -90.74 87.84 6.84 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 24.9 pttm -78.64 139.69 38.51 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.994 -0.683 . . . . 0.0 111.721 -172.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -77.33 147.63 36.06 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.57 -172.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -70.76 140.24 51.28 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.347 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.601 ' HB3' ' CD2' ' A' ' 31' ' ' HIS . 6.5 p-10 -70.45 107.0 3.62 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.952 0.882 . . . . 0.0 109.399 173.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.8 pt -93.47 22.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.4 ttt-85 -66.1 -30.77 71.34 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.645 -174.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.38 -12.77 84.24 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.357 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -91.11 -10.45 41.9 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.434 -0.451 . . . . 0.0 110.227 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.5 mt -66.58 133.71 30.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.571 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.3 t -113.54 110.59 20.51 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.4 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 42.9 mt-10 -87.78 4.41 44.46 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.663 0.744 . . . . 0.0 110.818 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -114.36 119.51 37.17 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 104.88 -2.266 . . . . 0.0 104.88 172.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.421 ' HB3' HD12 ' A' ' 135' ' ' ILE . 3.0 mp -120.5 -49.66 2.24 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -169.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -57.24 129.91 43.87 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.83 -1.78 78.78 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.5 173.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.487 ' O ' HG22 ' A' ' 118' ' ' VAL . 22.1 t -101.16 155.78 4.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 3.0 p-10 -95.59 148.48 22.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 118.718 0.69 . . . . 0.0 110.545 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.83 165.83 25.5 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.949 0.88 . . . . 0.0 112.823 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.522 ' OG1' ' HG2' ' A' ' 114' ' ' GLU . 26.7 m -122.86 138.56 54.62 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 125.002 1.321 . . . . 0.0 108.749 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.7 tp -99.2 117.11 32.93 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -113.27 112.06 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.85 142.75 24.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.189 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -136.6 100.48 4.35 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.704 0.764 . . . . 0.0 109.096 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.6 p -136.07 176.16 8.94 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.71 -30.73 71.45 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.849 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -77.39 -50.11 13.45 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.002 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -109.02 81.08 1.39 Allowed 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.19 98.28 9.28 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 120.793 0.33 . . . . 0.0 111.294 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.587 HD22 HD13 ' A' ' 11' ' ' LEU . 27.1 t-20 68.48 70.6 0.3 Allowed 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.175 0.988 . . . . 0.0 110.349 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 51.6 m -108.75 107.97 18.62 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.445 HG21 ' HA ' ' A' ' 4' ' ' THR . 73.0 mt -108.92 102.25 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.712 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.0 tp -123.13 113.92 19.63 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.727 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.522 ' HG2' ' OG1' ' A' ' 100' ' ' THR . 45.6 mt-10 -73.88 123.41 24.18 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.7 m -91.24 -43.45 14.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.839 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.69 -152.11 19.77 Favored Glycine 0 N--CA 1.422 -2.287 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 98' ' ' ASP . 59.9 Cg_endo -71.87 144.3 43.06 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.921 2.414 . . . . 0.0 112.121 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 97' ' ' VAL . 35.5 m -106.53 137.98 34.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.24 0.543 . . . . 0.0 110.973 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.3 p -110.16 173.73 6.19 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.982 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 38.9 tpp -110.41 132.68 53.97 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.676 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.504 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -99.4 -45.02 5.98 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.302 0.572 . . . . 0.0 109.585 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.09 -79.5 0.53 Allowed Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.46 155.43 41.18 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.0 tt -163.21 152.31 3.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 120.885 0.374 . . . . 0.0 110.018 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -79.81 94.18 5.75 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -93.0 98.83 11.6 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.4 p 52.16 66.65 1.15 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.346 1.058 . . . . 0.0 113.506 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.0 m 63.36 7.54 2.98 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.212 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.2 m -120.27 105.13 42.41 Favored Pre-proline 0 N--CA 1.427 -1.583 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -61.38 110.87 0.98 Allowed 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 121.922 1.748 . . . . 0.0 110.144 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 9.6 m -120.74 138.55 53.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.332 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.401 ' HB2' HG21 ' A' ' 68' ' ' ILE . 55.0 t30 -119.74 168.37 11.14 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 172' ' ' GLN . 11.0 tpp180 65.62 42.84 3.48 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.673 1.589 . . . . 0.0 109.605 175.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 57.1 mtp -108.12 140.94 40.58 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-O 121.978 0.894 . . . . 0.0 112.301 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.64 HG23 ' HB3' ' A' ' 170' ' ' SER . 5.9 tt -105.02 146.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.894 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.504 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 23.8 ttm180 -128.97 137.23 51.25 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -173.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -131.51 131.27 43.3 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -80.88 97.0 7.2 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.773 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -156.09 134.81 11.78 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -72.78 109.41 6.36 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 13.1 t -140.03 171.29 14.4 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 143' ' ' THR . 37.9 ttpt -114.82 142.57 46.37 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.427 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 13.4 t -80.36 165.43 22.28 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 146' ' ' CYS . . . 105.69 -17.78 41.91 Favored Glycine 0 C--N 1.303 -1.298 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -174.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -94.09 28.61 2.41 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.755 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 33.7 t -76.74 141.64 40.74 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 113.14 -1.845 . . . . 0.0 109.241 -174.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.43 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 93.04 -4.26 74.44 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.62 134.35 26.03 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.6 p -76.12 119.48 24.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 122.086 0.946 . . . . 0.0 111.348 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.3 tp -90.1 102.0 14.71 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 20.3 p -147.66 174.22 11.98 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.38 0.609 . . . . 0.0 111.929 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.92 172.91 12.06 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.7 t -64.74 103.74 0.74 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.962 0.887 . . . . 0.0 111.297 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 91.18 6.14 66.94 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.621 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -140.56 103.02 4.45 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 117.239 0.52 . . . . 0.0 111.428 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 88.2 mt -97.28 123.8 49.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -95.93 -42.83 8.1 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.36 0.6 . . . . 0.0 110.336 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.414 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 171.78 -157.7 28.07 Favored Glycine 0 N--CA 1.425 -2.098 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.46 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 28.3 pt -127.21 145.87 34.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -63.76 129.3 39.57 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 123.502 0.721 . . . . 0.0 109.426 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.433 ' HA ' ' SG ' ' A' ' 146' ' ' CYS . 62.1 t -117.27 -48.69 4.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 O-C-N 123.212 0.32 . . . . 0.0 110.754 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -133.64 108.33 0.73 Allowed Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.314 -1.422 . . . . 0.0 112.86 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 143' ' ' THR . . . -95.19 108.25 3.66 Favored Glycine 0 C--N 1.3 -1.437 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -120.01 90.65 3.37 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 59.65 -106.63 1.01 Allowed Glycine 0 C--O 1.229 -0.192 0 O-C-N 123.821 0.7 . . . . 0.0 113.185 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 140' ' ' ALA . 77.8 mtm180 -94.81 8.2 43.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -122.29 115.8 22.97 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.102 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -97.05 115.91 5.36 Favored Glycine 0 N--CA 1.42 -2.423 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -102.0 129.28 48.25 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.159 0.504 . . . . 0.0 110.276 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.64 ' HB3' HG23 ' A' ' 135' ' ' ILE . 29.0 t -127.25 156.69 41.49 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.257 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.412 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -101.43 140.72 35.34 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 133' ' ' ARG . 66.6 mt-30 -76.26 121.19 22.58 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 123.517 0.511 . . . . 0.0 110.974 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.414 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 89.9 mt -94.58 85.27 4.47 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -83.63 144.61 29.32 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.449 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.4 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 10.2 ptpp? -73.68 -14.64 61.19 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.925 0.393 . . . . 0.0 110.595 -176.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -65.58 -19.32 65.87 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.632 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -79.78 -25.4 40.97 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 121.932 -0.48 . . . . 0.0 109.917 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -101.24 50.37 0.86 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.788 0.804 . . . . 0.0 110.327 -174.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 30.7 m -103.67 169.85 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.472 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -83.86 -54.54 4.81 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -120.79 144.09 48.49 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.099 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 . . . . . 0 C--N 1.305 -1.344 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.114 -177.534 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.422 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.93 -32.51 85.8 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.19 2.594 . . . . 0.0 111.871 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -63.31 -41.94 98.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.455 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 m -63.38 -40.4 97.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.651 0.78 . . . . 0.0 109.521 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -64.31 -43.6 94.18 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.236 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -63.56 -46.26 86.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.966 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 11' ' ' LEU . . . -54.33 -50.23 67.9 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 124.074 0.859 . . . . 0.0 111.699 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -64.95 -35.38 80.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 m -72.26 -42.48 65.55 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.016 0.436 . . . . 0.0 110.699 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.8 tp -65.79 -39.94 91.45 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.779 0.832 . . . . 0.0 109.535 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.539 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 6.0 tt -56.0 -50.9 69.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.299 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -83.56 15.03 3.33 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -123.95 -56.27 1.66 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -118.09 -5.22 10.96 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -171.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.539 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 42.2 mt -96.53 121.46 47.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.935 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 19.8 ptp -140.85 153.94 45.98 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.726 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.419 HG22 ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -85.84 111.53 20.27 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.3 mt -104.7 113.25 41.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.777 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 10.6 m -76.44 107.46 8.72 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 75.9 p -87.56 -149.88 0.16 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.3 p -52.91 -42.03 64.96 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.122 0.569 . . . . 0.0 112.094 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -129.56 -60.66 1.04 Allowed 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.25 158.5 20.55 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 119.643 -1.265 . . . . 0.0 114.467 -172.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 40.5 mt-10 -86.74 112.15 21.4 Favored 'General case' 0 CA--C 1.495 -1.17 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -105.77 174.4 5.9 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.472 ' HB ' ' C ' ' A' ' 147' ' ' GLY . 35.1 m -87.3 114.99 24.41 Favored 'General case' 0 N--CA 1.411 -2.399 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.595 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.59 110.8 3.9 Favored Glycine 0 N--CA 1.41 -3.036 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.6 tp -94.32 109.08 20.94 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.28 133.19 28.28 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 48.0 mm -109.82 -54.51 5.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 117.331 0.565 . . . . 0.0 111.148 -177.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -154.53 123.26 6.2 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.737 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 66.72 -86.28 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.865 0.728 . . . . 0.0 112.82 169.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 77' ' ' LEU . 83.7 mtm180 -132.7 10.52 4.33 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.93 0.871 . . . . 0.0 109.463 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.562 HG13 HG13 ' A' ' 74' ' ' VAL . 50.2 t -91.65 123.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.838 -1.073 . . . . 0.0 111.184 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.9 p -127.01 148.36 50.11 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -106.07 130.38 57.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.264 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.7 mm -130.26 136.24 28.69 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 124.584 1.154 . . . . 0.0 108.43 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 31.4 Cg_exo -61.88 142.97 95.11 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.292 1.994 . . . . 0.0 111.387 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.1 m -62.51 -47.32 84.47 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 122.145 0.178 . . . . 0.0 111.435 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -61.77 -14.83 36.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.675 0.79 . . . . 0.0 112.838 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.76 -25.19 60.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.403 ' O ' ' HB ' ' A' ' 20' ' ' THR . 29.9 mm-40 58.09 88.0 0.13 Allowed Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 124.594 1.158 . . . . 0.0 113.863 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -83.1 149.66 13.62 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.864 1.709 . . . . 0.0 109.835 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -157.35 33.06 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.459 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.72 -17.25 27.06 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.973 0.892 . . . . 0.0 110.093 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -137.12 131.03 32.06 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 169.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 m -117.17 164.24 13.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 5.7 mp -113.49 110.59 20.52 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.146 178.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.7 t -87.75 94.24 4.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 t30 51.75 62.33 2.76 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 124.549 1.14 . . . . 0.0 109.024 -174.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.06 -34.36 3.42 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.018 -0.992 . . . . 0.0 114.03 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 24.1 mt-30 -72.21 108.89 5.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.169 0.485 . . . . 0.0 111.993 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -68.78 122.62 18.95 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.415 HD12 HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -134.4 127.7 50.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -78.18 127.68 32.63 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.784 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.2 140.39 18.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.573 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 60.5 tttm -89.32 -59.01 2.33 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.277 0.561 . . . . 0.0 110.16 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.2 m-20 -136.34 149.78 48.55 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.357 -177.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -132.23 107.87 8.87 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -117.53 126.68 53.0 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -77.0 133.28 39.19 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.459 -0.896 . . . . 0.0 108.871 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.426 ' HG ' HD12 ' A' ' 70' ' ' LEU . 31.9 tp -91.24 104.5 17.04 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.62 0.724 . . . . 0.0 109.44 -176.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 69' ' ' ASN . 20.5 m -119.62 160.02 20.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.406 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.01 147.42 47.98 Favored Pre-proline 0 C--N 1.289 -2.022 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -45.2 -13.95 0.08 OUTLIER 'Trans proline' 0 CA--C 1.564 1.982 0 C-N-CA 124.266 3.311 . . . . 0.0 116.074 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -77.19 -2.32 33.9 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.486 -0.759 . . . . 0.0 111.011 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 75.63 12.52 3.07 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.962 1.705 . . . . 0.0 109.998 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 49.5 mm -90.41 134.44 29.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 114.119 -1.4 . . . . 0.0 107.405 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.55 ' O ' ' HA ' ' A' ' 131' ' ' THR . 57.3 t30 -79.99 147.55 31.51 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.999 0.428 . . . . 0.0 111.395 -173.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.426 HD12 ' HG ' ' A' ' 62' ' ' LEU . 63.0 mt -99.32 -6.18 28.37 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 17.1 tp10 75.39 16.35 2.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 123.169 1.462 . . . . 0.0 109.823 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.25 136.27 50.58 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.669 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.0 m -116.52 128.94 55.9 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.562 HG13 HG13 ' A' ' 34' ' ' VAL . 59.5 t -82.99 101.18 7.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -98.08 111.88 24.04 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -175.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.2 m -94.77 110.92 22.73 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.77 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.48 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 95.8 mt -86.32 142.32 28.58 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.863 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -88.68 86.84 7.07 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 170.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -122.65 131.76 53.96 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -68.34 -34.5 76.22 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.298 0.374 . . . . 0.0 111.222 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -86.45 104.31 15.8 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -79.1 142.36 36.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.302 0.573 . . . . 0.0 110.445 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -83.63 145.48 28.79 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.31 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -57.27 120.17 7.68 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.112 -1.403 . . . . 0.0 108.69 175.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 4.6 p30 -74.85 117.7 16.98 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.234 -1.387 . . . . 0.0 109.906 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.0 pt -97.17 28.53 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.52 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.8 ttm105 -59.94 -37.14 78.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.99 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -72.96 -7.45 70.65 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.489 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -96.74 -10.54 26.6 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.425 0.612 . . . . 0.0 110.943 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 78.6 mt -66.53 123.54 19.76 Favored 'Isoleucine or valine' 0 C--O 1.247 0.964 0 CA-C-O 121.144 0.497 . . . . 0.0 110.315 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.8 p -100.74 115.92 31.41 Favored 'General case' 0 N--CA 1.407 -2.623 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.552 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.589 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 1.3 pm0 -71.38 -29.77 65.34 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.536 175.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.12 115.44 18.79 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.429 ' HB3' HD12 ' A' ' 135' ' ' ILE . 33.1 mt -106.83 -60.77 1.63 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.875 -174.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.93 131.53 45.66 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.157 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.02 -22.29 33.73 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.661 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.8 t -92.29 148.31 4.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.02 125.23 38.53 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.695 0.76 . . . . 0.0 109.835 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.76 154.37 18.68 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 122.08 0.943 . . . . 0.0 113.121 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.9 m -127.38 125.91 41.52 Favored 'General case' 0 N--CA 1.417 -2.079 0 C-N-CA 125.432 1.493 . . . . 0.0 107.95 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -95.48 118.85 32.95 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -111.91 112.49 40.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.484 HG11 ' NE2' ' A' ' 145' ' ' GLN . 7.4 p -114.89 135.78 53.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.6 0.714 . . . . 0.0 111.101 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -129.58 84.82 2.25 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.8 t -130.51 174.94 9.4 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.018 -174.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.473 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 26.9 t-20 -70.64 -31.54 68.52 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -69.74 -51.92 29.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.952 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.573 ' HB3' ' OG1' ' A' ' 111' ' ' THR . 79.1 m-85 -138.5 119.85 14.8 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.124 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.2 m -107.66 112.76 25.62 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.78 -175.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 74.06 27.16 1.61 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.457 1.103 . . . . 0.0 111.221 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.573 ' OG1' ' HB3' ' A' ' 108' ' ' PHE . 13.7 m -79.8 117.06 20.34 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.658 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.2 mt -101.59 99.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.8 tp -102.31 111.83 24.28 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.279 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -82.52 108.56 16.02 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.84 -54.61 9.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.431 -172.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 125.43 -164.12 19.13 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.32 135.94 52.77 Favored 'Trans proline' 0 C--O 1.244 0.8 0 C-N-CA 122.935 2.424 . . . . 0.0 112.771 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.419 HG12 ' HB3' ' A' ' 137' ' ' TYR . 22.1 m -110.81 160.34 10.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.273 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.7 t -143.36 159.71 41.87 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 26.8 ttt -89.24 131.49 35.33 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -90.91 -50.32 5.94 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.57 0.7 . . . . 0.0 109.206 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.48 -103.56 0.76 Allowed Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.407 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 2.9 pp -126.58 158.18 36.92 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 120.563 0.22 . . . . 0.0 111.448 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.8 tt -161.27 137.56 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.502 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -113.38 113.81 25.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -133.6 139.49 46.56 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.6 t 61.64 30.61 18.63 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 76.1 p 62.76 10.86 4.5 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.783 2.033 . . . . 0.0 112.837 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m -96.28 108.86 44.32 Favored Pre-proline 0 N--CA 1.427 -1.607 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.43 112.28 3.43 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 122.099 1.866 . . . . 0.0 110.013 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 31.7 p -112.06 143.02 43.76 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.52 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 123' ' ' LEU . 10.9 t30 -139.13 159.49 42.04 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -177.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 16.2 mtp180 75.98 27.25 0.94 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.604 1.562 . . . . 0.0 109.126 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 131.56 36.15 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.062 -175.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.603 HG23 ' HB3' ' A' ' 170' ' ' SER . 2.0 tt -98.91 136.54 29.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 114.049 -1.432 . . . . 0.0 107.764 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.408 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 49.8 ttp180 -121.69 142.9 49.7 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.432 0.634 . . . . 0.0 111.522 -172.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.419 ' HB3' HG12 ' A' ' 118' ' ' VAL . 3.5 p90 -134.16 140.51 46.6 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.252 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 166' ' ' ARG . 16.8 t70 -94.91 105.31 17.23 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -159.23 143.54 15.3 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.21 100.19 0.44 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.181 0.515 . . . . 0.0 109.664 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.0 p -65.39 161.02 20.66 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -133.68 137.82 45.52 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.5 m -84.39 152.15 24.23 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.01 -7.32 76.54 Favored Glycine 0 N--CA 1.459 0.209 0 C-N-CA 119.979 -1.105 . . . . 0.0 111.601 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.484 ' NE2' HG11 ' A' ' 103' ' ' VAL . 11.9 mm100 -92.1 2.69 56.42 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.048 0.928 . . . . 0.0 108.676 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 27.8 m -61.92 127.37 31.08 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.882 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.472 ' C ' ' HB ' ' A' ' 26' ' ' THR . . . 103.52 -11.7 54.08 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.153 -1.023 . . . . 0.0 111.192 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.12 137.93 36.33 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.4 p -77.61 123.83 34.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.743 0.782 . . . . 0.0 111.277 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 28.4 tp -91.84 100.28 12.99 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 19.6 p -125.57 -173.86 2.93 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.885 -173.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -155.07 -175.84 5.64 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.2 t -62.45 99.7 0.15 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.828 0.823 . . . . 0.0 111.311 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.2 20.75 79.29 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.568 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 97.4 mttt -138.44 148.06 43.99 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.648 0.379 . . . . 0.0 110.369 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 91.1 mt -132.45 126.45 55.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -96.14 -49.98 5.02 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.731 0.776 . . . . 0.0 109.637 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.552 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 178.81 -152.18 11.06 Favored Glycine 0 N--CA 1.42 -2.387 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.055 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 pt -126.46 151.97 33.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 117.121 0.461 . . . . 0.0 110.352 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -63.46 118.42 8.09 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.0 t -91.7 -62.06 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.33 -139.8 5.11 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.973 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.81 137.99 5.32 Favored Glycine 0 C--N 1.288 -2.128 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -110.13 130.38 55.55 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.24 -125.26 8.42 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.642 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 138' ' ' ASP . 10.9 mtm180 -106.21 -7.08 18.03 Favored 'General case' 0 C--O 1.214 -0.777 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.461 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -96.31 106.24 18.43 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.611 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.66 132.02 11.07 Favored Glycine 0 N--CA 1.418 -2.562 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -115.61 127.82 55.49 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.684 0.755 . . . . 0.0 110.695 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.603 ' HB3' HG23 ' A' ' 135' ' ' ILE . 37.7 t -120.34 155.09 34.07 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.453 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -108.74 134.27 51.69 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 11.0 pt20 -78.07 117.36 19.31 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 124.015 0.822 . . . . 0.0 110.725 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.552 ' HG ' ' HA2' ' A' ' 158' ' ' GLY 0.304 0.7 OUTLIER -99.37 75.35 1.97 Allowed 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.226 1.013 . . . . 0.0 111.831 177.282 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -59.49 144.74 46.31 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.324 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -61.17 -20.21 62.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.832 0.853 . . . . 0.0 110.94 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -59.33 -29.05 67.37 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.689 1.195 . . . . 0.0 110.925 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -82.14 -8.04 59.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.715 0.293 . . . . 0.0 111.341 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -128.46 28.1 5.48 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 182' ' ' GLN . 16.0 m -57.1 150.29 3.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-O 121.324 0.583 . . . . 0.0 112.507 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -80.75 -23.7 39.2 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.118 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -120.08 104.73 10.36 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.989 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.473 ' HB2' HG23 ' A' ' 179' ' ' VAL . 23.2 tt0 . . . . . 0 C--N 1.297 -1.691 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.883 0 CA-C-O 118.621 -1.099 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -37.61 -63.47 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 125.21 3.94 . . . . 0.0 116.262 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -70.03 -34.27 73.05 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.52 -174.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.5 m -72.72 -33.64 66.57 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.136 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -61.9 -48.29 81.11 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.536 0.735 . . . . 0.0 109.376 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -63.81 -47.94 78.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.011 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.48 81.0 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.473 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 tp -65.62 -36.72 84.53 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 122.794 0.438 . . . . 0.0 111.232 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -71.87 -44.41 63.81 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.949 0.404 . . . . 0.0 110.414 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.9 tp -65.84 -36.97 84.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.522 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.49 ' HA ' HD12 ' A' ' 15' ' ' ILE . 37.4 tp -51.57 -56.82 11.32 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.364 1.465 . . . . 0.0 112.254 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -79.18 7.81 6.98 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -131.37 -49.98 1.0 Allowed 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -118.05 0.11 11.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 11' ' ' LEU . 50.0 mt -113.18 106.83 21.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.882 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -123.35 160.16 27.35 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.925 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.492 ' CG2' ' HB3' ' A' ' 24' ' ' GLU . 80.5 m -90.3 121.5 32.36 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 174.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.3 mt -106.5 124.48 62.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.56 HG22 ' HG2' ' A' ' 24' ' ' GLU . 6.0 p -79.31 98.97 6.9 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.741 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.2 p -98.59 -173.61 2.59 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 21.1 t -69.93 -34.82 73.97 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -84.77 -5.29 59.32 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.77 -162.82 24.48 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.081 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HG2' HG22 ' A' ' 19' ' ' THR . 40.2 mt-10 -94.53 111.13 22.88 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.893 0.378 . . . . 0.0 110.861 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -116.67 -178.77 3.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.384 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.7 m -98.11 136.81 37.82 Favored 'General case' 0 N--CA 1.415 -2.176 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.7 126.47 6.63 Favored Glycine 0 N--CA 1.418 -2.549 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.8 tp -96.79 119.59 35.55 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.5 121.94 5.59 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 176.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' HA ' HD11 ' A' ' 86' ' ' ILE . 44.6 mm -85.04 -53.94 9.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 117.388 0.594 . . . . 0.0 109.788 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -164.53 154.69 14.25 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 54.27 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 16.3 ptt180 -139.64 10.48 2.46 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.705 1.202 . . . . 0.0 108.956 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -95.15 114.55 31.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.125 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -125.11 156.36 38.41 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -117.09 135.5 57.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.1 tp -141.53 148.73 51.52 Favored Pre-proline 0 CA--C 1.559 1.309 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -76.2 145.4 27.44 Favored 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 121.964 1.776 . . . . 0.0 112.787 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.518 HG23 ' OG1' ' A' ' 73' ' ' THR . 0.2 OUTLIER -74.41 -18.56 60.64 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -73.47 -21.42 60.44 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.658 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.55 -26.15 45.61 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 96.1 mt-30 63.44 90.63 0.09 OUTLIER Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.735 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.14 152.48 24.23 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 121.962 1.775 . . . . 0.0 110.203 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.61 -157.65 26.72 Favored Glycine 0 N--CA 1.437 -1.259 0 C-N-CA 119.971 -1.109 . . . . 0.0 113.142 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.74 -34.41 30.49 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.573 0.702 . . . . 0.0 110.902 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -137.84 138.88 39.59 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.71 144.95 36.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.224 0.535 . . . . 0.0 111.311 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 51' ' ' GLY . 6.0 tt -84.74 101.26 12.07 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 174.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.5 p -96.98 94.55 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 122.033 0.92 . . . . 0.0 110.492 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.6 t30 55.97 23.42 6.67 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.134 1.374 . . . . 0.0 112.019 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.407 ' H ' HD23 ' A' ' 48' ' ' LEU . . . 139.52 -49.67 0.8 Allowed Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.808 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -85.09 119.2 25.21 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -174.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.12 108.45 12.62 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.474 HD11 ' O ' ' A' ' 78' ' ' ASP . 9.4 tp -112.76 143.54 22.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.439 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -78.94 131.59 36.42 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.114 0.483 . . . . 0.0 110.783 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.5 t -89.68 125.94 42.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -78.66 -59.52 2.75 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.462 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -136.21 159.64 41.13 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -140.74 100.55 3.87 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -174.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.514 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 59.4 m-85 -97.08 113.56 25.13 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -82.56 111.19 18.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.31 104.55 6.89 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -174.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.87 133.9 62.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -71.63 145.07 89.44 Favored Pre-proline 0 C--N 1.308 -1.205 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.73 -20.02 4.14 Favored 'Trans proline' 0 CA--C 1.552 1.39 0 C-N-CA 123.867 3.045 . . . . 0.0 115.3 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -86.58 9.12 19.49 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.752 -0.592 . . . . 0.0 111.175 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 71.78 26.38 3.04 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 123.433 1.587 . . . . 0.0 109.931 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.4 mt -97.57 127.94 49.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.516 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 131' ' ' THR . 21.0 m-80 -89.06 155.33 19.53 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.059 -177.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.253 0.0 OUTLIER -132.22 18.94 4.45 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.795 0.807 . . . . 0.0 110.896 173.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 70.05 -20.8 0.18 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 126.338 1.855 . . . . 0.0 114.593 173.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.18 119.15 5.47 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.518 ' OG1' HG23 ' A' ' 39' ' ' THR . 20.5 m -117.9 112.85 20.89 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 171.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 44.0 t -81.86 105.57 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.83 113.67 26.01 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.9 m -99.11 105.34 17.41 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 120.876 0.37 . . . . 0.0 110.035 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.9 mp -77.98 139.38 39.16 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.579 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.474 ' O ' HD11 ' A' ' 54' ' ' ILE . 36.5 t70 -89.48 96.14 10.57 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.752 177.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -155.53 152.2 28.56 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.62 0.724 . . . . 0.0 112.488 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -89.16 -12.42 41.05 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.368 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -74.07 132.82 42.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.009 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -108.35 121.82 45.7 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.729 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -76.8 144.07 39.38 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 170.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -59.66 131.11 49.92 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.83 96.76 0.14 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.876 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.443 HD11 ' HA ' ' A' ' 30' ' ' ILE . 2.6 pp -93.71 18.27 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 122.204 1.002 . . . . 0.0 110.388 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -62.87 -32.22 73.42 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.166 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.14 2.48 87.65 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.923 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -103.14 -8.77 20.2 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 117.136 0.468 . . . . 0.0 110.731 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.4 mt -67.57 128.7 31.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.9 t -95.04 107.72 19.78 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -62.89 -23.13 67.19 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.778 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -106.05 111.55 24.22 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mp -102.81 -51.23 3.33 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.18 137.03 56.72 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -172.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.15 8.1 31.9 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.89 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.443 ' O ' HG22 ' A' ' 118' ' ' VAL . 40.4 t -122.31 150.37 25.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 O-C-N 122.183 -0.598 . . . . 0.0 109.717 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -82.18 122.63 28.14 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -115.0 160.7 19.28 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.98 0.895 . . . . 0.0 113.152 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 37.6 m -122.76 135.51 54.58 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.328 -1.305 . . . . 0.0 109.059 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.5 tp -100.19 124.99 46.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -113.77 117.65 56.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.466 ' HB ' ' OG1' ' A' ' 111' ' ' THR . 23.9 t -112.03 138.17 41.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -136.66 92.62 2.77 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 33.9 p -138.7 -169.74 2.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.127 -174.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -56.51 -59.34 5.12 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.021 0.928 . . . . 0.0 112.142 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -92.71 -35.62 13.37 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.407 0.622 . . . . 0.0 110.517 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -99.17 84.15 2.98 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.488 0.661 . . . . 0.0 109.765 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.57 111.04 22.63 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.344 -178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 65.17 37.16 6.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.286 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.466 ' OG1' ' HB ' ' A' ' 103' ' ' VAL . 32.5 p -79.61 94.22 5.63 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.013 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.72 103.41 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.5 tp -117.43 114.31 23.32 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.655 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 0.3 OUTLIER -77.66 143.53 38.09 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.979 177.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 36.0 m -111.43 -31.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 119.949 -0.701 . . . . 0.0 111.844 -176.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.78 -155.03 16.53 Favored Glycine 0 N--CA 1.424 -2.123 0 C-N-CA 120.064 -1.065 . . . . 0.0 111.555 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.92 124.35 10.53 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.845 2.363 . . . . 0.0 111.978 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.461 ' HB ' HD11 ' A' ' 135' ' ' ILE . 35.0 m -96.93 134.07 36.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.348 0.594 . . . . 0.0 110.895 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.6 p -128.38 163.68 24.31 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.755 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.3 ttt -84.47 133.13 34.49 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 118.551 0.614 . . . . 0.0 110.013 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.639 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -82.09 -37.82 25.77 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 121.832 0.825 . . . . 0.0 108.801 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 103.94 -102.83 2.21 Favored Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.97 149.4 47.52 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.4 pt -132.53 172.16 16.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.55 138.76 51.16 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -127.4 112.98 15.62 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 16.4 t 61.81 36.18 16.25 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 121.834 0.826 . . . . 0.0 108.985 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.8 m 69.37 10.08 7.58 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.137 1.375 . . . . 0.0 111.996 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.7 m -98.91 118.53 62.71 Favored Pre-proline 0 N--CA 1.425 -1.722 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.38 127.4 17.3 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.231 1.954 . . . . 0.0 112.064 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.9 t -125.17 118.63 26.51 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -106.35 156.93 18.01 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.581 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 74.22 57.02 0.09 Allowed 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.051 1.341 . . . . 0.0 111.508 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.0 mmt -113.28 143.03 45.11 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 113.064 -1.88 . . . . 0.0 108.832 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 18.1 tt -106.96 141.79 21.31 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.639 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 24.4 ttm-85 -118.96 132.97 56.1 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 122.634 0.374 . . . . 0.0 110.427 -173.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -136.29 134.62 38.18 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.637 172.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -87.84 91.31 8.71 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.869 0.842 . . . . 0.0 110.342 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -158.06 136.68 11.2 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.52 87.29 2.64 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.54 0.686 . . . . 0.0 111.398 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.6 p -94.48 161.09 14.36 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.798 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -118.31 136.16 53.87 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.0 m -61.22 124.98 22.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.594 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 132.45 -15.9 4.92 Favored Glycine 0 C--N 1.299 -1.517 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.681 HE21 ' HA ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -97.79 18.09 16.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.25 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.9 m -62.7 130.92 47.13 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.021 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.43 -1.21 66.47 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.62 138.99 26.87 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.65 124.72 38.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.859 0.838 . . . . 0.0 111.472 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.7 tp -92.19 108.85 20.25 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.5 p -141.75 177.57 8.07 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.172 0.51 . . . . 0.0 111.813 -173.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -152.96 179.52 8.61 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 176.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.9 m -54.71 101.1 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.17 0.588 . . . . 0.0 111.876 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 69.15 23.31 76.22 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.667 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 74.8 mmtt -136.26 118.34 15.41 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 98.7 mt -108.14 129.24 62.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -103.45 -45.47 4.85 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.262 0.553 . . . . 0.0 110.899 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.516 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 176.82 -157.86 23.36 Favored Glycine 0 N--CA 1.421 -2.359 0 C-N-CA 118.968 -1.587 . . . . 0.0 112.586 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.4 pt -126.49 141.77 44.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -63.58 130.79 45.78 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 123.216 0.606 . . . . 0.0 110.357 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.0 t -101.14 -49.2 11.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -173.06 160.99 31.97 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.697 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -107.59 129.54 9.7 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -126.86 95.27 4.27 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.27 -125.04 17.5 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -101.44 21.5 14.1 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.318 0.58 . . . . 0.0 111.174 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -122.77 124.47 43.41 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.048 0.451 . . . . 0.0 110.146 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -102.26 131.56 10.65 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -109.12 133.63 52.76 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.524 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 41.9 m -130.62 150.44 51.81 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.759 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -88.81 135.46 33.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -82.96 95.65 8.06 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 123.485 0.49 . . . . 0.0 110.623 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.516 ' HG ' ' HA2' ' A' ' 158' ' ' GLY 0.306 1.0 OUTLIER -83.08 76.46 9.85 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-O 122.745 1.259 . . . . 0.0 112.299 177.909 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -75.71 153.35 37.14 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.209 -1.359 . . . . 0.0 111.88 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -59.7 -23.91 63.53 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.383 1.073 . . . . 0.0 112.046 -174.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -58.87 -22.89 60.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.728 1.211 . . . . 0.0 112.052 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -96.14 -9.83 29.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.937 0.399 . . . . 0.0 111.695 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -111.59 18.48 19.02 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.416 0.627 . . . . 0.0 110.756 -175.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.81 117.94 22.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.384 -0.826 . . . . 0.0 108.818 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -71.52 -38.64 71.09 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.268 0.556 . . . . 0.0 109.741 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -86.57 79.88 8.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.349 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 C--N 1.298 -1.668 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -177.305 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.542 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.92 -44.56 46.11 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.602 2.868 . . . . 0.0 113.681 -175.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -68.44 -30.2 69.02 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.016 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 m -70.36 -41.82 72.64 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 123.238 0.615 . . . . 0.0 109.357 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.24 -50.11 74.95 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.808 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -65.04 -42.66 94.07 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.647 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.29 82.89 Favored 'General case' 0 C--O 1.216 -0.684 0 O-C-N 123.516 0.51 . . . . 0.0 110.856 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.63 -39.99 95.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.146 0.498 . . . . 0.0 110.719 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -68.48 -43.48 76.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.005 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.7 tp -68.12 -39.07 82.84 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.276 0.631 . . . . 0.0 109.913 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 7.8 tt -55.31 -47.94 74.86 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.896 0.878 . . . . 0.0 110.25 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -79.09 14.94 1.26 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.978 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 -64.36 0.96 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -116.37 4.49 13.4 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.478 ' CG2' ' HB3' ' A' ' 104' ' ' HIS . 1.7 mp -87.36 115.03 27.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.255 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.407 ' HB3' ' CG2' ' A' ' 49' ' ' VAL . 21.6 mmt -113.21 134.13 54.73 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.043 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 89.8 m -92.8 103.58 15.92 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.7 mt -101.37 121.13 51.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 121.198 0.523 . . . . 0.0 110.544 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -87.41 108.15 18.87 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 41.2 p -102.92 -166.59 1.29 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.51 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.431 ' HB3' ' HB2' ' A' ' 42' ' ' GLN . 31.3 t -66.28 -43.15 87.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.071 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -89.39 -9.94 48.4 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -172.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.14 -165.82 33.39 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 119.403 -1.379 . . . . 0.0 113.19 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -108.59 103.33 12.42 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 146' ' ' CYS . 83.4 m-85 -113.52 175.0 5.64 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.087 -174.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.6 m -93.78 136.33 34.18 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.84 145.31 16.75 Favored Glycine 0 N--CA 1.416 -2.691 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.4 tp -105.4 119.96 40.39 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.206 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.68 139.77 25.03 Favored Glycine 0 N--CA 1.428 -1.847 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 40.4 mm -99.31 -49.73 11.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -174.86 153.99 1.81 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.56 ' OD1' ' HG2' ' A' ' 82' ' ' LYS . 36.1 m-20 51.02 -94.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.575 1.172 . . . . 0.0 113.186 176.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 17.7 ptp180 -127.06 6.11 6.51 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.511 -176.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 64.6 t -92.77 118.71 39.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.4 m -132.45 159.92 37.93 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 m -123.27 146.6 28.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 122.155 -0.341 . . . . 0.0 111.011 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.8 tt -158.13 147.12 14.58 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 45.1 Cg_exo -60.75 142.12 96.85 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 122.496 2.131 . . . . 0.0 112.8 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.1 m -59.73 -37.9 80.2 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -71.21 -2.06 14.68 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.41 -30.29 57.39 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 26.9 mt-30 60.46 89.13 0.11 Allowed Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.123 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.41 154.82 28.18 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.206 1.937 . . . . 0.0 110.507 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.32 -166.02 29.88 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.436 -0.887 . . . . 0.0 111.859 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -81.85 -18.7 42.99 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 122.104 0.954 . . . . 0.0 109.126 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 7.7 p-10 -147.37 148.15 31.05 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 m -142.52 -172.81 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 1.2 pt? -138.63 127.64 23.93 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 17' ' ' THR . 5.2 p -115.85 116.1 51.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.757 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 65.56 19.85 11.56 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.051 0.94 . . . . 0.0 109.465 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.23 -15.41 59.07 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.318 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 83.1 mt-30 -78.42 121.66 24.8 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 122.461 0.304 . . . . 0.0 110.263 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' A' ' 48' ' ' LEU . 29.4 mmmt -67.65 126.18 28.56 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.415 HD11 ' O ' ' A' ' 78' ' ' ASP . 9.3 tp -146.19 133.83 15.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.586 0.708 . . . . 0.0 110.551 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 38.7 mtm180 -85.37 145.4 27.5 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.585 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.77 148.31 5.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -97.82 -57.03 2.33 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -141.76 166.96 23.28 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -139.89 95.25 2.87 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.496 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 84.6 m-85 -81.37 111.37 17.68 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.5 103.73 4.95 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.446 HD12 ' HG ' ' A' ' 70' ' ' LEU . 1.3 tm? -80.82 101.83 9.62 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.4 155.7 9.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.69 138.44 83.07 Favored Pre-proline 0 C--N 1.311 -1.068 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -47.4 -29.06 9.32 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.056 3.171 . . . . 0.0 114.442 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -93.16 16.72 12.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.704 0.288 . . . . 0.0 110.986 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 71.87 20.18 4.57 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.298 1.039 . . . . 0.0 112.327 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 51.4 mm -87.69 149.89 3.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 131' ' ' THR . 56.4 t30 -69.87 142.89 52.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.573 HD21 ' HD2' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -118.27 -29.72 5.46 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 69.06 17.39 8.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.603 1.161 . . . . 0.0 111.281 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.15 135.43 54.19 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.1 m -128.15 130.29 47.86 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 120.826 0.346 . . . . 0.0 110.13 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 46.4 t -90.46 109.68 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -91.61 121.98 33.77 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.4 m -104.86 105.5 15.59 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 91.8 mt -82.65 168.68 17.04 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.415 ' O ' HD11 ' A' ' 54' ' ' ILE . 18.7 t70 -93.64 89.88 6.4 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 171.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -129.61 116.01 18.24 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.302 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -80.78 -29.77 36.09 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.53 140.22 51.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.813 -1.54 . . . . 0.0 110.739 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.56 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 60.5 mttm -90.26 105.55 17.89 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -77.64 144.88 37.07 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 166.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -59.04 126.95 29.81 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 124.008 0.818 . . . . 0.0 112.376 -172.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 12.7 p-10 -69.74 102.87 2.0 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.09 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -93.12 23.34 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.633 -0.667 . . . . 0.0 111.794 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -62.8 -40.11 96.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.067 -175.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.35 -0.48 89.11 Favored Glycine 0 C--N 1.317 -0.511 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.606 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -98.97 -14.11 19.65 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 53.8 mt -64.46 122.51 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.441 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.1 m -122.89 95.58 4.68 Favored 'General case' 0 N--CA 1.397 -3.112 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.97 -14.92 57.52 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -88.48 95.17 10.12 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 171.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.499 HD22 HD12 ' A' ' 135' ' ' ILE . 2.2 pp -125.79 -21.54 4.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 -162.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.417 ' N ' HD12 ' A' ' 94' ' ' LEU . 12.1 pt-20 -68.44 134.05 49.58 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.797 -1.161 . . . . 0.0 113.656 -172.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.35 -13.99 56.85 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.684 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 118' ' ' VAL . 16.0 t -93.45 157.02 3.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 2.6 p30 -96.22 148.96 22.18 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.8 158.87 38.98 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.034 0.921 . . . . 0.0 112.64 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.0 m -123.63 131.83 53.71 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.076 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.2 tp -94.97 115.83 27.93 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.99 109.24 27.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 47.2 t -113.97 131.89 64.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.478 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 9.7 t60 -140.85 93.71 2.63 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.2 m -121.36 179.7 4.34 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.503 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -75.63 -37.73 59.49 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.214 -0.595 . . . . 0.0 111.287 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -86.62 -22.98 25.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.178 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -125.05 76.9 1.58 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.4 m -88.56 129.39 35.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.351 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 57.38 68.03 0.9 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.902 1.281 . . . . 0.0 113.458 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.483 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 27.3 m -107.78 99.8 9.24 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.189 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.4 mt -100.76 96.61 4.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.8 tp -110.34 106.22 15.52 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.546 -174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -74.17 115.84 14.12 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.9 m -94.98 -19.63 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.19 -159.5 17.94 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.63 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 98' ' ' ASP . 24.6 Cg_exo -65.01 133.61 36.46 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.42 2.747 . . . . 0.0 112.586 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 137' ' ' TYR . 35.4 m -111.31 159.35 11.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.154 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.5 t -142.11 167.03 23.1 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.6 ttt -87.54 129.35 35.12 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -91.49 -26.13 18.95 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.282 0.563 . . . . 0.0 110.696 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.62 -106.99 2.59 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.51 116.73 23.66 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.2 mm -104.67 122.03 57.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.782 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -106.94 85.73 2.19 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 122.106 0.955 . . . . 0.0 110.967 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.1 tp -97.66 133.72 41.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 40.8 m 61.05 32.48 19.79 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.677 0.751 . . . . 0.0 109.43 -176.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.3 m 64.23 12.96 7.55 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.749 1.22 . . . . 0.0 111.522 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 44.9 m -102.62 107.08 52.81 Favored Pre-proline 0 N--CA 1.428 -1.528 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.65 121.67 6.86 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.687 2.258 . . . . 0.0 112.602 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 24.6 m -121.96 120.46 34.49 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -98.95 158.77 15.42 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.573 ' HD2' HD21 ' A' ' 70' ' ' LEU . 98.9 mtt180 64.27 62.01 0.86 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 122.514 1.15 . . . . 0.0 110.813 176.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 54.8 ttm -124.78 145.57 49.67 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.566 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.547 HG23 ' HB3' ' A' ' 170' ' ' SER . 1.4 tt -109.38 134.77 50.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 53.0 ttt180 -120.51 140.21 51.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.158 0.504 . . . . 0.0 111.772 -173.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.452 ' HB3' HG12 ' A' ' 118' ' ' VAL . 26.5 p90 -141.74 132.38 25.52 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.466 172.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.37 81.03 4.91 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.976 0.893 . . . . 0.0 109.634 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -144.52 127.74 16.72 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.43 105.88 4.31 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.193 0.52 . . . . 0.0 111.15 -176.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.3 p -89.59 174.36 7.8 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -114.39 172.67 6.88 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.1 t -84.93 146.89 27.02 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.3 56.68 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -106.37 14.77 26.92 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.428 0.633 . . . . 0.0 110.369 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.443 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 47.2 t -71.07 129.46 39.02 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.329 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.15 2.68 62.14 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.327 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.23 131.82 38.94 Favored Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.2 t -76.92 109.53 11.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 28.7 tp -88.0 106.0 17.84 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.7 p -136.75 178.36 7.13 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.957 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.83 -178.95 6.17 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.5 m -64.92 97.24 0.22 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.193 0.52 . . . . 0.0 110.931 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.52 11.41 68.8 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.877 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.75 143.11 33.32 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 117.089 0.445 . . . . 0.0 110.749 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 75.8 mt -122.62 130.83 74.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -105.22 -34.12 8.01 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.222 0.534 . . . . 0.0 111.328 -175.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 168.9 -159.6 32.75 Favored Glycine 0 N--CA 1.426 -1.967 0 C-N-CA 119.884 -1.151 . . . . 0.0 112.1 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 27.5 pt -132.58 135.78 57.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-O 120.838 0.351 . . . . 0.0 110.663 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -64.84 118.69 9.37 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 123.62 0.768 . . . . 0.0 110.179 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.7 m -90.95 -36.05 7.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 120.87 0.367 . . . . 0.0 110.309 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 177.88 164.71 31.65 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -129.26 143.89 14.94 Favored Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -132.83 103.8 6.27 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.16 -108.31 2.45 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -104.58 -10.45 17.57 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -85.07 99.26 10.92 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 120.988 0.423 . . . . 0.0 111.451 -174.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.5 113.32 3.81 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -95.95 120.95 37.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 121.3 0.572 . . . . 0.0 109.614 -176.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.547 ' HB3' HG23 ' A' ' 135' ' ' ILE . 35.1 t -119.22 139.14 52.36 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.418 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -76.18 134.17 39.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -79.71 111.48 16.05 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.71 99.31 10.16 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.454 ' HB3' ' HG2' ' A' ' 176' ' ' GLN . 63.5 mttm -85.69 142.52 28.97 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.372 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -72.55 -19.13 61.56 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.734 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.47 ' O ' HG12 ' A' ' 179' ' ' VAL . 3.4 pt20 -75.16 -5.34 43.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.729 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -76.76 -26.03 54.09 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -106.97 1.02 24.16 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.069 -173.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 176' ' ' GLN . 9.1 p -74.27 130.51 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -93.86 -16.19 24.31 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.691 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -110.79 107.72 17.33 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.957 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 . . . . . 0 C--N 1.295 -1.776 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 177.203 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.001 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.58 -62.24 0.47 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.553 2.836 . . . . 0.0 114.621 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -72.03 -41.45 67.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.241 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -62.31 -40.28 95.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.626 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.54 -36.83 71.13 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.45 0.167 . . . . 0.0 110.607 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.86 -48.88 79.8 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.64 -44.47 96.35 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.357 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.4 -44.86 96.41 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.0 0.52 . . . . 0.0 110.419 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -63.03 -48.55 78.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.547 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.71 -41.73 98.0 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.279 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 26.1 tp -56.17 -58.92 5.89 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 124.809 1.243 . . . . 0.0 111.706 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -76.51 -2.23 31.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.819 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -109.37 -63.88 1.31 Allowed 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -108.96 -10.06 15.07 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -170.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.474 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 58.2 mt -91.77 109.89 21.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.025 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 67.6 mtm -116.39 139.93 49.9 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 120.592 0.234 . . . . 0.0 111.09 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.5 m -82.55 119.42 24.22 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.9 mt -109.11 108.3 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.2 m -81.85 104.79 12.48 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.629 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 77.1 p -91.88 -162.6 0.94 Allowed 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.937 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.7 t -81.41 -14.2 57.41 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -100.39 -34.38 9.99 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.287 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.04 -162.6 36.35 Favored Glycine 0 CA--C 1.502 -0.759 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.743 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' CD ' ' HB3' ' A' ' 106' ' ' ASN . 82.8 mt-10 -92.7 104.09 16.4 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -107.45 176.61 5.1 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 104' ' ' HIS . 0.0 OUTLIER -117.91 131.58 56.5 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-O 121.11 0.481 . . . . 0.0 109.983 -179.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.44 131.65 10.14 Favored Glycine 0 N--CA 1.416 -2.633 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -98.51 115.72 29.19 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.86 122.35 8.2 Favored Glycine 0 N--CA 1.434 -1.482 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.0 mm -85.8 -57.51 4.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.315 0.578 . . . . 0.0 109.874 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -155.33 137.21 14.48 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.928 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 62.52 -85.91 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 O-C-N 124.641 1.213 . . . . 0.0 112.455 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -143.2 18.75 1.92 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.264 1.031 . . . . 0.0 109.989 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.6 t -92.51 113.56 27.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.5 p -122.19 155.49 35.7 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.569 ' HB ' HD11 ' A' ' 72' ' ' LEU . 27.1 m -117.73 145.42 23.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 120.732 0.301 . . . . 0.0 110.934 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.2 tt -146.49 141.51 16.37 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -60.4 143.44 99.48 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.724 1.616 . . . . 0.0 111.14 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.2 m -66.99 -40.15 87.31 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.124 0.487 . . . . 0.0 111.577 -174.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -70.97 -1.42 11.94 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.43 -17.5 61.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 122.073 -0.392 . . . . 0.0 110.327 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.629 ' O ' ' HB ' ' A' ' 20' ' ' THR . 16.9 mm100 63.93 74.43 0.43 Allowed Pre-proline 0 C--O 1.245 0.817 0 C-N-CA 124.638 1.175 . . . . 0.0 113.174 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -89.15 -175.19 1.09 Allowed 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 122.67 2.247 . . . . 0.0 109.814 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.95 -160.1 8.23 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -81.67 -20.22 40.0 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.875 0.845 . . . . 0.0 109.232 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -132.41 141.64 48.95 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.76 160.37 42.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 90.5 mt -101.89 102.07 12.59 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -84.06 100.66 7.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 121.864 0.84 . . . . 0.0 108.894 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.8 t30 63.47 10.7 5.04 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.19 1.396 . . . . 0.0 110.355 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.9 -19.97 8.23 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.737 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -77.95 116.03 18.14 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 120.583 0.23 . . . . 0.0 110.384 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -70.29 111.93 6.24 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.656 0.741 . . . . 0.0 109.914 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 78' ' ' ASP . 9.5 tp -126.05 140.96 47.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.564 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -87.61 143.24 27.29 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.3 133.04 42.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -80.63 -62.78 1.57 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.09 0.472 . . . . 0.0 110.194 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.464 ' H ' ' HB ' ' A' ' 76' ' ' THR . 27.8 m-20 -128.56 148.83 50.79 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.899 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -129.78 117.0 19.56 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.484 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.0 m-85 -111.45 117.63 33.57 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.635 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -76.31 107.72 8.76 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.43 HD23 HD23 ' A' ' 72' ' ' LEU . 37.3 tp -84.2 98.89 10.19 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.979 0.895 . . . . 0.0 109.123 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 69' ' ' ASN . 33.0 m -127.3 160.06 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.412 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 14.3 t70 -67.89 148.3 98.45 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -32.17 -44.88 0.2 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.862 3.708 . . . . 0.0 115.072 173.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.16 16.43 2.42 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.993 -0.442 . . . . 0.0 112.122 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 t30 60.4 48.56 7.69 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 125.626 1.571 . . . . 0.0 109.753 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 56.0 mt -98.43 126.64 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 172.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.525 ' O ' ' HA ' ' A' ' 131' ' ' THR . 16.6 m120 -73.72 133.2 43.3 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.84 -171.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.4 tp -97.25 -2.95 41.61 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 69.54 5.65 5.29 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.452 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.569 HD11 ' HB ' ' A' ' 36' ' ' VAL . 20.0 tp -102.79 131.13 49.86 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.55 -0.719 . . . . 0.0 111.236 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.0 m -111.24 123.79 50.91 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.484 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 55.0 t -86.51 114.11 25.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.1 tp -102.3 111.94 24.43 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.654 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.464 ' HB ' ' H ' ' A' ' 58' ' ' ASP . 26.5 m -87.32 100.09 12.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.408 HD11 ' CG2' ' A' ' 54' ' ' ILE . 15.3 tp -79.79 125.54 29.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.487 ' O ' HD11 ' A' ' 54' ' ' ILE . 31.4 t70 -83.61 78.99 9.59 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.807 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.489 ' HD3' ' OE2' ' A' ' 81' ' ' GLU . 14.5 ttm180 -137.28 134.66 36.37 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -84.06 1.94 41.57 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.489 ' OE2' ' HD3' ' A' ' 79' ' ' ARG . 45.1 mt-10 -77.36 126.0 30.22 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 173.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -102.89 109.14 20.59 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.396 0.617 . . . . 0.0 109.684 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -79.47 173.1 12.93 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.32 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -72.73 143.27 48.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.196 0.522 . . . . 0.0 111.124 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.16 100.22 5.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 171.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 pt -99.15 19.01 2.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 122.559 1.171 . . . . 0.0 108.643 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -70.29 -34.98 73.41 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.421 -1.718 . . . . 0.0 112.645 -171.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.39 -12.48 82.09 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.189 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -84.66 -11.59 55.62 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.76 123.36 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 m -118.92 103.55 9.7 Favored 'General case' 0 N--CA 1.405 -2.675 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -81.14 1.52 31.51 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -89.54 119.69 30.19 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.424 HD13 ' HB ' ' A' ' 135' ' ' ILE . 27.3 mt -107.67 -50.41 3.07 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -166.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.66 127.67 32.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -167.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.69 16.31 52.39 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.085 -1.416 . . . . 0.0 114.083 172.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 25.8 t -115.48 132.81 63.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.815 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.97 113.09 4.71 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.173 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.0 150.95 26.48 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.471 0.653 . . . . 0.0 111.459 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.7 m -114.93 131.81 56.76 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 tp -96.43 119.6 35.21 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 111' ' ' THR . 40.5 t -113.15 111.8 37.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-O 121.2 0.524 . . . . 0.0 110.116 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 26.7 t -107.97 147.0 13.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.41 ' O ' ' HB ' ' A' ' 26' ' ' THR . 20.7 t-160 -139.38 103.76 4.8 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.4 p -124.62 175.38 7.23 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.462 ' HB3' ' CD ' ' A' ' 24' ' ' GLU . 3.7 t30 -80.14 -43.6 21.36 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.78 0.324 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -68.63 -35.61 77.51 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.784 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.532 ' HD2' ' HG1' ' A' ' 111' ' ' THR . 15.3 t80 -133.15 96.58 3.78 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.2 m -96.45 134.83 39.13 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.837 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 71.74 71.28 0.16 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.377 0.671 . . . . 0.0 111.488 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 7.2 m -97.68 93.68 6.53 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.1 mt -105.26 98.55 7.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 32.5 tp -122.75 125.49 45.61 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.443 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.04 134.95 41.28 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.2 -51.32 8.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 120.988 0.423 . . . . 0.0 111.268 -176.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.03 -162.93 22.49 Favored Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 3.0 Cg_exo -74.31 123.38 8.18 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.925 2.417 . . . . 0.0 111.673 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.8 m -87.79 156.77 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.696 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.3 p -137.05 151.48 48.97 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.719 0.807 . . . . 0.0 110.257 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 56.7 ttp -89.56 126.69 35.7 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.82 -0.55 . . . . 0.0 109.604 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.32 -42.36 11.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.875 0.369 . . . . 0.0 110.436 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 94.12 -127.81 9.22 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 44.7 tp -95.16 115.59 27.62 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.244 0.545 . . . . 0.0 110.447 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.1 pt -111.4 153.79 13.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -127.83 109.46 11.64 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 121.681 0.753 . . . . 0.0 109.434 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 48.4 tp -125.68 119.03 26.9 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.378 -175.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.7 p 49.83 64.59 1.71 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.284 1.034 . . . . 0.0 113.565 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.7 m 61.94 15.96 7.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.649 -1.16 . . . . 0.0 112.714 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.3 m -126.18 118.74 23.55 Favored Pre-proline 0 N--CA 1.431 -1.394 0 O-C-N 122.157 -0.34 . . . . 0.0 110.899 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -85.38 126.95 3.22 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 122.374 2.05 . . . . 0.0 110.846 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 28.6 m -129.53 117.99 21.35 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . 27.4 p-10 -103.85 163.83 12.09 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.896 -173.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.583 ' HD2' ' OE1' ' A' ' 172' ' ' GLN . 20.5 mmt180 55.73 47.85 19.61 Favored 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 124.59 1.181 . . . . 0.0 112.804 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 98.2 mmm -95.57 147.73 23.27 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.597 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 170' ' ' SER . 3.4 tt -117.73 134.03 62.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 168' ' ' GLY . 42.1 ptt85 -124.48 157.85 34.26 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.96 0.886 . . . . 0.0 110.405 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -137.42 149.56 47.0 Favored 'General case' 0 C--N 1.26 -3.326 0 CA-C-N 114.0 -1.455 . . . . 0.0 107.689 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.02 99.82 11.76 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -164.22 144.18 7.91 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.467 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 165' ' ' GLY . . . -75.36 99.23 4.06 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.222 0.535 . . . . 0.0 110.94 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.6 t -132.03 177.61 7.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -158.87 168.54 26.52 Favored 'General case' 0 C--O 1.25 1.085 0 CA-C-O 120.728 0.299 . . . . 0.0 111.111 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 54.2 m -64.28 116.85 6.43 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.013 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 157.72 -35.57 0.54 Allowed Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -87.97 25.59 1.53 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 34.8 m -73.22 127.6 33.08 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.598 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.405 ' C ' HG23 ' A' ' 26' ' ' THR . . . 93.42 5.95 63.08 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.406 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.23 137.56 17.23 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.3 126.74 37.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.792 0.806 . . . . 0.0 110.764 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 42.5 tp -96.96 103.79 15.74 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 20.8 p -145.1 162.7 36.37 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.512 0.672 . . . . 0.0 112.331 -173.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.44 -176.27 3.55 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.4 p -60.41 99.42 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.343 0.592 . . . . 0.0 111.698 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 76.77 13.7 83.3 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.835 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -135.15 108.01 7.55 Favored 'General case' 0 C--O 1.21 -0.992 0 O-C-N 122.595 -0.356 . . . . 0.0 111.041 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 88.1 mt -98.63 129.68 48.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -101.47 -33.32 10.01 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.688 0.756 . . . . 0.0 110.603 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 160.9 -151.92 22.45 Favored Glycine 0 N--CA 1.421 -2.31 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.6 pt -133.01 149.3 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -70.72 135.8 48.52 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.606 0.566 . . . . 0.0 111.398 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.29 -58.35 3.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.049 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.69 157.49 22.84 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -137.75 138.21 9.46 Favored Glycine 0 N--CA 1.419 -2.487 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -105.48 84.01 2.03 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 122.304 1.049 . . . . 0.0 110.663 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 140' ' ' ALA . . . 80.91 -102.22 2.12 Favored Glycine 0 N--CA 1.419 -2.494 0 CA-C-N 114.398 -1.274 . . . . 0.0 113.013 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -98.42 -0.38 43.7 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -120.97 132.27 54.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 136' ' ' ARG . . . -118.83 124.46 6.03 Favored Glycine 0 CA--C 1.476 -2.356 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.018 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -108.99 125.4 52.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.328 1.061 . . . . 0.0 111.645 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.534 ' HB2' HG23 ' A' ' 135' ' ' ILE . 19.8 m -120.56 161.39 21.4 Favored 'General case' 0 C--N 1.275 -2.639 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.36 138.68 32.04 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.583 ' OE1' ' HD2' ' A' ' 133' ' ' ARG . 58.4 tt0 -82.5 105.22 13.37 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.497 0.665 . . . . 0.0 109.63 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.433 HD21 HG21 ' A' ' 36' ' ' VAL . 10.5 mp -86.0 94.0 9.11 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -74.16 144.31 44.89 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -70.99 -21.93 62.24 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -64.48 -19.03 65.32 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.14 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -88.42 -15.1 36.36 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.827 -0.546 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.94 15.51 22.55 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.659 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.9 128.66 75.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -72.67 -64.37 0.97 Allowed 'General case' 0 CA--C 1.487 -1.452 0 CA-C-O 121.823 0.82 . . . . 0.0 110.653 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -87.3 134.84 33.5 Favored 'General case' 0 N--CA 1.398 -3.029 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.581 -172.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 N--CA 1.419 -1.976 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 173.236 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.861 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.93 -36.61 99.2 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 123.13 2.553 . . . . 0.0 111.104 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -64.99 -45.59 84.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.483 177.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -59.34 -49.28 78.43 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.52 0.728 . . . . 0.0 109.961 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.73 -36.48 82.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.859 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -65.77 -48.41 71.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.59 95.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.814 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.5 -47.22 79.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.654 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.2 m -62.75 -36.54 83.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.346 0.594 . . . . 0.0 110.746 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.9 tp -66.5 -49.25 67.2 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.062 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 60.8 tp -51.27 -52.59 43.61 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.775 1.23 . . . . 0.0 111.419 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -56.34 -21.03 21.87 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -174.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -137.49 -29.64 0.87 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 118.841 -1.144 . . . . 0.0 113.84 -177.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -107.05 -13.9 15.07 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.499 HG23 HG23 ' A' ' 26' ' ' THR . 27.3 mt -90.71 110.66 22.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.875 0.845 . . . . 0.0 111.562 -177.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 79.8 mtp -101.6 131.76 47.63 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.216 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 6.6 m -87.3 102.71 14.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 mt -100.35 111.95 31.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 121.64 0.733 . . . . 0.0 112.034 -174.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.3 m -84.05 106.81 15.99 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.378 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 28.0 p -96.69 -167.23 1.53 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.536 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m -73.19 -22.2 60.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 120.852 0.358 . . . . 0.0 110.281 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -92.45 -46.39 7.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.683 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.29 -167.56 33.27 Favored Glycine 0 CA--C 1.503 -0.677 0 C-N-CA 118.862 -1.637 . . . . 0.0 113.401 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -100.69 99.93 10.55 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CD1' ' HB3' ' A' ' 146' ' ' CYS . 67.6 m-85 -115.05 -168.63 1.41 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.173 -175.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.499 HG23 HG23 ' A' ' 15' ' ' ILE . 90.3 m -111.83 135.53 52.33 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-O 121.243 0.544 . . . . 0.0 110.542 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.73 142.22 16.13 Favored Glycine 0 N--CA 1.409 -3.122 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.1 tp -114.52 118.26 33.25 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.321 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.17 119.66 5.0 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 46.5 mm -95.46 -51.81 10.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 117.714 0.757 . . . . 0.0 111.986 -173.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.524 ' O ' HG12 ' A' ' 34' ' ' VAL . 35.4 t-80 -156.28 111.39 2.9 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.566 -173.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 61.4 -77.87 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 170.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.753 ' HD3' HG23 ' A' ' 76' ' ' THR . 1.1 ppt_? -120.02 -2.17 10.29 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 31' ' ' HIS . 14.3 p -100.97 118.85 48.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.719 -176.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.5 m -120.33 164.63 16.03 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.337 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.531 ' CG1' HD11 ' A' ' 72' ' ' LEU . 46.7 t -118.63 134.5 62.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tp -148.02 143.64 17.93 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 25.4 Cg_exo -69.61 155.28 66.84 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.36 2.04 . . . . 0.0 112.858 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.9 m -74.74 -44.58 49.09 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -63.6 -13.93 46.73 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.94 -24.28 63.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.068 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.421 ' O ' ' HB ' ' A' ' 20' ' ' THR . 25.2 mt-30 62.94 84.05 0.19 Allowed Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 123.756 0.822 . . . . 0.0 110.705 -177.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.55 121.46 6.0 Favored 'Trans proline' 0 C--O 1.258 1.505 0 C-N-CA 121.898 1.732 . . . . 0.0 110.179 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.2 -169.13 31.27 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.426 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -86.18 -14.4 44.12 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.426 0.631 . . . . 0.0 109.34 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -143.47 137.25 28.43 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.1 158.46 33.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.054 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 79.0 mt -105.6 115.22 29.88 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 17' ' ' THR . 6.0 p -87.78 90.39 3.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 71.75 -10.42 0.85 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.079 1.751 . . . . 0.0 110.632 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 148.94 -22.99 1.28 Allowed Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.438 ' HB2' HG13 ' A' ' 49' ' ' VAL . 13.7 mm100 -73.44 113.85 11.0 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -75.48 121.27 22.09 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 121.062 0.458 . . . . 0.0 110.799 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.444 ' CG2' HD11 ' A' ' 77' ' ' LEU . 10.6 tp -130.29 141.34 46.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.29 149.56 33.5 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.44 0.638 . . . . 0.0 111.401 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.5 t -94.01 126.97 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.675 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 172.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.427 ' HB3' HG22 ' A' ' 76' ' ' THR . 8.0 tmtm? -89.93 -43.81 10.33 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.766 -174.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -156.18 154.09 30.28 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -134.36 127.28 31.33 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.474 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 16.5 m-85 -123.13 108.64 13.09 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -81.19 136.93 35.9 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.15 76.2 9.29 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 122.402 1.096 . . . . 0.0 111.682 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.6 p -109.0 118.54 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.35 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.271 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.561 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 21.5 t70 -62.47 143.5 96.0 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.619 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.28 -21.24 22.19 Favored 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 123.796 2.997 . . . . 0.0 114.347 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -88.38 7.6 31.79 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.483 0.659 . . . . 0.0 109.242 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.275 40.6 m-80 67.85 63.62 0.39 Allowed 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 125.72 1.608 . . . . 0.0 112.252 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.561 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 18.1 mm -123.55 126.07 72.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 131' ' ' THR . 36.2 t30 -99.75 129.6 45.88 Favored 'General case' 0 C--O 1.203 -1.387 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -170.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.597 HD13 ' O ' ' A' ' 132' ' ' ASN . 40.0 tp -94.57 -8.18 38.92 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 117.607 0.185 . . . . 0.0 111.302 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 66.73 20.77 10.65 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.509 1.147 . . . . 0.0 109.316 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.531 HD11 ' CG1' ' A' ' 36' ' ' VAL . 20.4 tp -126.63 137.08 53.25 Favored 'General case' 0 N--CA 1.426 -1.651 0 O-C-N 121.535 -0.728 . . . . 0.0 110.63 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 46.0 m -124.34 126.28 45.74 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-O 121.506 0.669 . . . . 0.0 110.472 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 91.7 t -79.78 113.64 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 175.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.19 114.96 28.01 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.753 HG23 ' HD3' ' A' ' 33' ' ' ARG . 53.2 m -92.97 115.68 28.35 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.444 HD11 ' CG2' ' A' ' 54' ' ' ILE . 18.1 tp -85.96 142.99 28.41 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.219 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.403 ' O ' HD11 ' A' ' 54' ' ' ILE . 19.3 t70 -81.77 82.27 7.52 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 172.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.601 ' NE ' ' HB3' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -91.51 121.99 33.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -166.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -92.58 -42.85 9.44 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 167.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -98.48 118.28 34.81 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -98.25 158.14 15.75 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.577 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -103.59 146.0 29.21 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.433 ' NH2' ' HB3' ' A' ' 13' ' ' LYS . 57.3 ttp180 -55.44 134.54 50.54 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.692 1.597 . . . . 0.0 111.387 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 10.8 p-10 -75.06 96.05 3.15 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.562 1.172 . . . . 0.0 112.776 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.3 pt -96.99 22.75 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 122.299 1.047 . . . . 0.0 109.068 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.481 ' O ' ' HE3' ' A' ' 175' ' ' LYS . 48.1 ttp180 -60.25 -38.34 83.17 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.844 -175.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -75.99 -11.31 84.84 Favored Glycine 0 C--N 1.315 -0.588 0 C-N-CA 121.166 -0.54 . . . . 0.0 113.024 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.44 -13.1 50.31 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.593 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.4 mt -67.05 130.94 32.86 Favored 'Isoleucine or valine' 0 C--O 1.25 1.116 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.1 t -118.72 113.45 21.17 Favored 'General case' 0 N--CA 1.4 -2.925 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -75.55 -20.14 58.86 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -86.32 115.65 23.99 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.564 HD13 ' HB ' ' A' ' 135' ' ' ILE . 10.5 mt -108.31 -66.73 1.02 Allowed 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.9 0.857 . . . . 0.0 110.76 -171.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -58.9 134.73 57.19 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.673 -168.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.56 2.28 24.32 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.675 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.2 167.6 23.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.11 152.57 18.42 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.45 157.09 42.95 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.714 0.769 . . . . 0.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 26.2 m -112.63 133.58 54.6 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 48.1 tp -101.57 119.71 39.2 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.69 93.96 4.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.468 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 61.9 t -79.84 119.55 29.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -148.17 151.55 35.74 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.1 p -171.62 -174.81 1.45 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -92.32 -11.34 35.36 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.363 -1.335 . . . . 0.0 107.991 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -73.32 -49.78 25.6 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.092 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -136.67 113.11 10.0 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.903 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 18.9 p -101.27 164.87 11.57 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.195 -176.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 55.8 t30 44.43 70.8 0.3 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.689 1.196 . . . . 0.0 113.453 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.468 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 56.3 m -131.26 92.39 3.18 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.475 -0.766 . . . . 0.0 110.242 176.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.7 mt -88.13 101.49 11.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.3 tp -120.6 117.3 27.21 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.839 0.352 . . . . 0.0 110.977 -173.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 10.1 pt-20 -74.93 130.03 38.69 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.037 0.446 . . . . 0.0 110.494 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -97.67 -45.04 12.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.905 -175.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.91 -152.93 20.48 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.082 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.82 138.68 34.97 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 122.878 2.385 . . . . 0.0 113.554 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.444 HG12 ' HB3' ' A' ' 137' ' ' TYR . 35.8 m -102.87 146.85 10.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.87 177.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.9 p -130.95 153.7 48.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.618 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 44.0 ttp -96.98 116.28 28.92 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.362 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -82.74 -46.09 13.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.968 -176.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.43 -130.32 9.79 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.47 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.4 HD22 HG21 ' A' ' 68' ' ' ILE . 83.5 mt -93.82 100.28 12.5 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 131' ' ' THR . 38.3 mm -118.33 133.02 66.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -95.33 83.91 3.94 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.507 1.146 . . . . 0.0 111.493 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 62.4 tp -79.94 120.06 23.63 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.446 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.1 t 61.36 32.86 19.05 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.6 m 70.12 8.29 6.59 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.648 1.579 . . . . 0.0 112.771 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 29.2 m -98.72 111.76 61.09 Favored Pre-proline 0 N--CA 1.438 -1.061 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.41 ' HB2' HG23 ' A' ' 68' ' ' ILE . 56.2 Cg_endo -69.7 118.39 5.65 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 121.737 1.625 . . . . 0.0 110.59 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 14.6 t -88.77 132.2 34.73 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.22 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.597 ' O ' HD13 ' A' ' 70' ' ' LEU . 34.9 t30 -75.83 81.28 2.75 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -176.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 65.58 63.55 0.62 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.64 0.733 . . . . 0.0 112.738 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 28.3 mtt -89.14 164.11 15.15 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.673 HG23 ' HB3' ' A' ' 170' ' ' SER . 6.8 tt -107.84 138.83 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.064 175.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -122.89 140.75 52.63 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.444 ' HB3' HG12 ' A' ' 118' ' ' VAL . 50.5 p90 -132.43 153.46 50.81 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.019 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -89.07 93.22 9.51 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.511 0.507 . . . . 0.0 109.934 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -174.77 135.85 0.4 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 125.395 1.478 . . . . 0.0 108.015 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.09 91.57 7.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.042 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.7 m -97.06 147.84 23.62 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -99.81 172.43 7.25 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -80.17 169.62 17.55 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 175.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 146' ' ' CYS . . . 90.57 -34.38 4.21 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -173.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.455 HE21 HG11 ' A' ' 103' ' ' VAL . 49.2 mt-30 -85.81 33.14 0.58 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.028 1.331 . . . . 0.0 107.622 175.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.522 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 42.8 t -89.51 138.19 31.67 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.737 -175.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 94.88 -1.41 65.46 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -176.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.45 127.94 29.62 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.39 115.33 17.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.054 0.454 . . . . 0.0 111.114 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 39.4 tp -89.5 107.86 19.32 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 13.0 p -146.98 162.49 38.65 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.548 0.69 . . . . 0.0 112.653 -174.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -128.94 -179.07 4.89 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 175.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.2 t -60.4 103.24 0.22 Allowed 'General case' 0 CA--C 1.556 1.192 0 CA-C-O 122.404 1.097 . . . . 0.0 112.072 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 77.35 15.07 81.87 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.629 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -135.35 109.81 8.49 Favored 'General case' 0 C--O 1.207 -1.145 0 O-C-N 122.307 -0.525 . . . . 0.0 111.646 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.6 mt -100.68 129.54 51.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -105.23 -41.41 5.55 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.611 0.719 . . . . 0.0 110.776 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.482 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 173.93 -170.38 43.5 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.63 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.8 pt -119.29 143.64 30.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -70.05 136.5 50.39 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.36 -46.49 3.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.111 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.57 153.6 23.12 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -127.8 152.46 18.95 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.56 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -116.73 96.1 5.33 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 69.23 -119.03 9.1 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.104 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -84.79 -8.01 58.98 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.745 0.818 . . . . 0.0 110.647 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -108.61 100.95 10.14 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.443 -0.786 . . . . 0.0 111.429 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -79.94 134.65 13.86 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -107.21 129.84 54.81 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 122.121 0.962 . . . . 0.0 110.45 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.673 ' HB3' HG23 ' A' ' 135' ' ' ILE . 30.0 t -118.2 141.31 48.63 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.999 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.37 120.45 23.83 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.466 ' CD ' HD11 ' A' ' 94' ' ' LEU . 6.1 tt0 -78.27 109.0 12.0 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 123.776 0.673 . . . . 0.0 110.393 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 173' ' ' LEU . 3.2 pp -94.05 88.54 5.7 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.265 1.031 . . . . 0.0 109.453 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -80.85 138.72 36.2 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.871 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.505 ' HB2' ' HZ2' ' A' ' 175' ' ' LYS . 4.1 ttmp? -50.88 -35.14 31.31 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.542 1.137 . . . . 0.0 112.267 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -56.47 -25.63 51.58 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.627 0.771 . . . . 0.0 112.977 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -82.39 -13.74 56.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.673 0.273 . . . . 0.0 111.299 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -96.54 -8.27 32.38 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -173.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 29.3 m -87.25 170.65 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -74.05 -48.13 32.01 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.791 0.329 . . . . 0.0 110.866 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -98.64 113.5 25.58 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.394 0.886 . . . . 0.0 113.394 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 . . . . . 0 C--O 1.254 1.319 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.122 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.784 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -62.46 -36.79 63.84 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.923 2.416 . . . . 0.0 111.266 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -67.01 -36.48 82.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.64 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 3.0 m -65.41 -48.77 71.66 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.727 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.05 -37.55 87.95 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.833 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -62.12 -48.48 79.97 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.802 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.14 95.05 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 123.932 0.77 . . . . 0.0 111.515 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 4' ' ' THR . 96.0 mt -63.81 -43.35 96.53 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.868 0.365 . . . . 0.0 111.12 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 m -67.1 -31.71 72.37 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.462 0.649 . . . . 0.0 110.412 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.8 tp -74.14 -59.07 2.89 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.524 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.73 ' HA ' HG12 ' A' ' 15' ' ' ILE . 6.8 tt -50.21 -52.4 36.04 Favored 'General case' 0 C--O 1.247 0.957 0 C-N-CA 125.286 1.434 . . . . 0.0 113.341 -175.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -66.59 -4.03 7.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -172.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -129.07 -53.9 1.2 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -84.72 6.99 22.05 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -171.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.73 HG12 ' HA ' ' A' ' 11' ' ' LEU . 48.2 mm -102.4 123.63 55.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.122 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.417 ' O ' HG13 ' A' ' 18' ' ' ILE . 1.8 mpt? -101.71 97.06 7.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.566 ' HA ' HG22 ' A' ' 26' ' ' THR . 23.3 m -70.65 93.17 0.91 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.422 HG23 ' HB ' ' A' ' 47' ' ' VAL . 82.1 mt -93.48 118.55 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.966 -172.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 7.0 m -85.27 106.59 16.79 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.693 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 60.6 p -90.81 -163.32 1.01 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.761 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 m -79.75 -2.96 45.45 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -118.65 -33.25 4.33 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.69 -151.26 20.21 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 119.762 -1.209 . . . . 0.0 112.542 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -86.87 104.2 16.0 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.38 133.86 52.38 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.584 HG21 ' CD2' ' A' ' 104' ' ' HIS . 13.6 p -97.8 130.58 44.73 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-O 121.796 0.808 . . . . 0.0 113.078 -172.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.41 131.11 10.45 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 55.4 tp -89.81 114.06 25.72 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.5 103.89 1.69 Allowed Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.8 mm -71.44 -47.17 60.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 C-N-CA 123.129 0.572 . . . . 0.0 109.857 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -169.95 154.1 5.03 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.581 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t70 50.79 -95.48 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.715 1.26 . . . . 0.0 113.402 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.492 ' HG2' ' HB2' ' A' ' 79' ' ' ARG . 54.6 mtt180 -123.82 4.7 8.78 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 122.817 0.447 . . . . 0.0 111.073 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.9 t -90.05 113.91 26.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.256 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 28' ' ' LEU . 13.1 p -126.9 137.47 53.16 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -110.75 138.49 38.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.3 tt -150.98 149.91 26.29 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.16 149.78 83.11 Favored 'Trans proline' 0 CA--C 1.552 1.415 0 C-N-CA 122.248 1.966 . . . . 0.0 112.555 174.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.428 ' HB ' ' OG1' ' A' ' 73' ' ' THR . 8.9 t -79.43 -31.02 42.52 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 122.517 0.327 . . . . 0.0 110.995 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -72.66 -4.97 34.31 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.208 0.528 . . . . 0.0 111.024 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.27 -13.17 60.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.693 ' O ' ' HB ' ' A' ' 20' ' ' THR . 14.2 mm100 66.62 77.78 0.26 Allowed Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 125.145 1.378 . . . . 0.0 113.281 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.17 153.86 18.93 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.198 1.932 . . . . 0.0 110.297 176.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.99 -164.32 13.93 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -83.38 -20.97 33.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.048 0.928 . . . . 0.0 108.59 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.412 ' HB3' ' HG3' ' A' ' 55' ' ' ARG . 4.6 p-10 -143.72 149.6 37.41 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.422 ' HB ' HG23 ' A' ' 18' ' ' ILE . 24.8 m -143.33 170.42 10.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.471 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 73.3 mt -102.31 114.12 28.01 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 m -92.32 97.74 7.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.615 0.721 . . . . 0.0 109.617 174.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 69.53 -10.4 0.58 Allowed 'General case' 0 CA--C 1.564 1.517 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.96 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.84 -25.18 0.63 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 112.285 -0.326 . . . . 0.0 112.285 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -90.42 131.86 35.95 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 122.552 -0.381 . . . . 0.0 110.719 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -77.44 115.21 17.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.481 0.658 . . . . 0.0 109.677 176.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.8 tp -120.37 143.51 32.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.431 ' N ' ' HD2' ' A' ' 55' ' ' ARG . 2.8 mpt_? -89.87 141.07 28.98 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.685 0.755 . . . . 0.0 111.777 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.404 HG22 ' CD2' ' A' ' 77' ' ' LEU . 20.2 t -97.21 102.99 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -69.16 -62.4 1.39 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 123.675 0.609 . . . . 0.0 110.097 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -111.42 138.39 47.98 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -146.34 105.08 3.85 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-O 121.275 0.56 . . . . 0.0 109.589 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -107.92 129.67 55.08 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.276 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.45 131.43 34.19 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.5 tp -83.49 104.02 13.3 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.788 0.804 . . . . 0.0 109.997 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.53 141.51 43.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.936 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 20.8 t70 -83.49 142.46 43.17 Favored Pre-proline 0 C--N 1.279 -2.492 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.79 -11.69 7.59 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.562 2.841 . . . . 0.0 114.576 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -98.99 18.33 17.52 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.989 -0.444 . . . . 0.0 110.788 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 75.01 17.71 2.66 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.636 1.175 . . . . 0.0 112.65 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 132' ' ' ASN . 34.8 mm -91.08 140.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 131' ' ' THR . 9.1 t-20 -98.1 152.49 19.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.471 ' C ' ' H ' ' A' ' 72' ' ' LEU . 4.0 mm? -112.29 -7.27 14.01 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.55 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 67.77 -21.08 0.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.291 1.436 . . . . 0.0 112.252 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.471 ' H ' ' C ' ' A' ' 70' ' ' LEU . 7.4 tt -79.4 133.3 36.56 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 124.067 0.947 . . . . 0.0 110.371 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.428 ' OG1' ' HB ' ' A' ' 39' ' ' THR . 20.4 m -117.45 133.44 55.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.2 t -98.47 108.79 22.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.3 mt -102.25 132.3 48.28 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 27.6 m -109.56 100.14 9.23 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.404 ' CD2' HG22 ' A' ' 56' ' ' VAL . 82.8 mt -87.04 155.62 20.07 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.768 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.92 93.52 2.68 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.535 ' NE ' ' HA ' ' A' ' 79' ' ' ARG . 2.5 mmp_? -106.55 108.47 19.99 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.393 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -83.19 -29.68 28.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -99.69 107.49 19.6 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 170.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -99.88 166.41 11.08 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.852 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -121.68 169.57 10.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -57.47 142.58 43.63 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.77 1.628 . . . . 0.0 112.117 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 14.6 t70 -75.86 96.0 3.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.885 0.85 . . . . 0.0 109.211 172.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.9 pt -84.91 10.71 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-O 121.813 0.815 . . . . 0.0 110.972 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -68.26 -24.71 64.92 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.4 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.91 -11.4 66.39 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.296 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -103.86 -4.55 23.37 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 117.138 0.469 . . . . 0.0 110.554 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 67.6 mt -64.18 121.06 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.703 0.763 . . . . 0.0 110.708 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 m -93.32 114.99 27.57 Favored 'General case' 0 N--CA 1.391 -3.391 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.3 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -2.63 56.58 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 122.234 1.016 . . . . 0.0 108.958 175.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -113.34 113.72 25.65 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 113.58 -1.645 . . . . 0.0 107.347 176.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -115.98 -54.5 2.49 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.548 0.69 . . . . 0.0 111.674 -170.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -72.95 127.1 31.56 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.501 -168.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.93 -7.92 41.96 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.301 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 t -104.52 147.51 10.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 5.8 p-10 -89.23 145.45 25.4 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -129.15 155.59 45.25 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 122.156 0.979 . . . . 0.0 113.286 -175.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 27.1 m -111.27 127.83 55.74 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 113.565 -1.652 . . . . 0.0 107.387 176.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.9 tp -101.74 117.24 34.47 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.303 0.573 . . . . 0.0 109.933 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 t -94.01 97.14 6.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.481 ' O ' ' HB ' ' A' ' 111' ' ' THR . 15.6 m -88.34 126.63 41.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.584 ' CD2' HG21 ' A' ' 26' ' ' THR . 33.0 p-80 -153.93 153.82 32.71 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.352 0.596 . . . . 0.0 111.394 -173.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.4 p -154.58 -162.63 1.43 Allowed 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -84.91 -35.67 21.97 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 118.741 -1.183 . . . . 0.0 108.63 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -77.77 -36.37 50.66 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.417 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 104' ' ' HIS . 97.1 m-85 -115.37 93.2 4.19 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.6 m -112.22 150.77 30.41 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 71.76 19.15 4.99 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.687 0.795 . . . . 0.0 112.609 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 103' ' ' VAL . 43.7 m -80.47 101.13 8.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 82.5 mt -102.78 98.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.503 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.4 tp -112.72 105.89 14.13 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.669 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 6.5 pt-20 -79.67 139.65 37.32 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.821 -0.55 . . . . 0.0 111.917 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.0 m -107.63 -42.19 5.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.402 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 126.07 -158.06 20.17 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.615 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 98' ' ' ASP . 24.4 Cg_exo -64.37 126.04 16.21 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 123.682 2.921 . . . . 0.0 112.892 -178.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -92.08 151.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.371 0.605 . . . . 0.0 111.736 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.4 m -122.28 154.47 37.53 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -94.73 139.56 31.08 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.78 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 134' ' ' MET . . . -91.99 -23.62 19.49 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 80.06 -123.81 6.24 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.369 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -105.74 108.99 20.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.4 pt -120.7 153.17 23.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.59 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -102.9 115.62 30.95 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.304 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 98.9 mt -113.11 92.03 3.86 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.7 m 51.49 72.74 0.35 Allowed 'General case' 0 C--O 1.252 1.205 0 C-N-CA 124.095 0.958 . . . . 0.0 113.028 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.2 m 61.68 14.61 6.22 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.621 -1.172 . . . . 0.0 112.566 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.2 m -121.32 96.3 48.06 Favored Pre-proline 0 N--CA 1.414 -2.273 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.83 115.82 4.41 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 121.978 1.785 . . . . 0.0 108.228 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.4 t -103.27 125.98 50.2 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-O 121.389 0.614 . . . . 0.0 109.523 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.514 ' HB2' HG21 ' A' ' 68' ' ' ILE . 27.6 t30 -83.3 134.42 34.93 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.007 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 63.04 49.78 3.33 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 124.126 0.891 . . . . 0.0 110.166 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.41 ' HB3' ' HB3' ' A' ' 121' ' ' ALA . 8.3 tpt -85.69 143.2 28.51 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 170' ' ' SER . 14.5 tt -112.66 144.97 19.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -132.96 142.62 48.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.289 0.566 . . . . 0.0 111.347 -173.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -134.74 115.96 14.34 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.43 92.56 1.1 Allowed 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -167.86 117.77 0.8 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -176.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.63 110.68 1.04 Allowed 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.545 0.688 . . . . 0.0 110.494 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.6 m -121.15 153.51 37.42 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -88.33 123.93 33.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.044 0.449 . . . . 0.0 110.977 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.4 t -78.52 151.43 32.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.9 -15.53 40.42 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -106.84 35.07 3.13 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 10.0 m -69.94 146.67 51.0 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.233 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.92 3.51 42.38 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.54 145.63 40.81 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 43.1 t -90.86 116.36 31.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 120.924 0.392 . . . . 0.0 110.226 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 41.2 tp -89.45 104.95 17.46 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.0 p -141.52 -173.73 3.85 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.254 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -161.54 -175.52 4.81 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 175.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.4 m -64.23 99.12 0.26 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 118.355 0.525 . . . . 0.0 110.765 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 80.15 18.66 71.4 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.98 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 74.5 mmtt -132.93 134.86 45.1 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -129.11 120.97 52.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -96.8 -46.19 6.35 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.8 0.687 . . . . 0.0 111.559 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.547 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 179.54 -176.03 47.37 Favored Glycine 0 N--CA 1.419 -2.477 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.715 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 22.7 pt -109.41 134.31 51.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 O-C-N 123.69 0.288 . . . . 0.0 110.228 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.421 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 11.2 t-80 -58.52 113.47 2.01 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 124.474 1.109 . . . . 0.0 110.25 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 53.5 t -88.27 -41.6 14.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.599 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.47 127.61 0.95 Allowed Glycine 0 N--CA 1.418 -2.508 0 C-N-CA 119.022 -1.561 . . . . 0.0 113.103 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.462 ' HA2' ' HA2' ' A' ' 168' ' ' GLY . . . -78.68 79.5 1.55 Allowed Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 172.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -93.33 89.01 6.19 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 100.69 -147.3 17.89 Favored Glycine 0 N--CA 1.427 -1.915 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.392 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 43.1 ttm105 -85.57 -0.9 56.38 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.487 0.66 . . . . 0.0 110.223 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -124.52 124.93 43.35 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.887 -0.508 . . . . 0.0 110.064 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.462 ' HA2' ' HA2' ' A' ' 163' ' ' GLY . . . -84.25 126.46 7.62 Favored Glycine 0 N--CA 1.414 -2.8 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 178.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -109.71 127.15 54.4 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 121.213 0.53 . . . . 0.0 109.9 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.546 ' HB2' HG23 ' A' ' 135' ' ' ILE . 49.8 m -127.83 159.65 34.2 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -100.04 132.6 45.3 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -76.21 104.15 6.6 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.547 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -80.38 70.99 7.17 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.386 1.089 . . . . 0.0 111.431 177.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -63.1 139.94 58.82 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.186 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -53.14 -30.41 36.79 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 126.513 1.925 . . . . 0.0 111.499 -175.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -62.29 -25.27 67.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -78.13 -20.48 52.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.571 0.701 . . . . 0.0 109.34 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -104.34 21.83 15.93 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.362 -171.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 52.6 t -75.63 115.65 17.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 173.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -69.91 -30.83 68.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.262 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -80.66 125.41 29.99 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.457 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 . . . . . 0 C--N 1.293 -1.856 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 176.602 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.504 ' O ' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 C--O 1.215 -1.065 0 CA-C-O 118.342 -1.254 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -35.23 -54.93 0.64 Allowed 'Trans proline' 0 C--N 1.361 1.212 1 C-N-CA 125.342 4.028 . . . . 0.0 116.163 -173.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -71.44 -38.58 71.34 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.929 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.443 HG23 HG21 ' A' ' 112' ' ' ILE . 54.2 m -71.25 -29.38 65.04 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.753 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 1' ' ' GLY . 4.9 mm-40 -69.07 -43.57 74.34 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -64.82 -44.0 91.3 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.424 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -54.77 -49.35 71.11 Favored 'General case' 0 C--O 1.204 -1.318 0 O-C-N 123.97 0.794 . . . . 0.0 110.98 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 tp -63.67 -38.73 92.22 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.088 0.471 . . . . 0.0 111.423 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -71.12 -37.07 72.34 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.469 0.652 . . . . 0.0 110.893 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.86 -38.76 64.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.411 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.562 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 37.2 tp -49.61 -54.73 16.7 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 125.419 1.488 . . . . 0.0 112.568 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -72.53 -3.8 26.75 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -170.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -133.48 -29.89 1.33 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -120.87 -25.25 5.45 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.562 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 33.7 mt -95.26 105.96 17.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.3 mmt -122.51 149.54 43.77 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.118 0.485 . . . . 0.0 112.123 -175.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 m -80.2 124.46 28.81 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.9 mt -113.1 108.46 25.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.2 m -87.18 104.46 16.38 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.2 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 40.9 p -95.34 -156.6 0.52 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.465 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -75.88 -28.96 58.34 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -81.57 -38.16 26.58 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.27 -175.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.84 -156.7 27.91 Favored Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 119.949 -1.119 . . . . 0.0 111.78 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -86.18 105.38 16.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.015 0.436 . . . . 0.0 110.703 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -107.66 176.07 5.27 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.0 m -115.56 134.5 55.0 Favored 'General case' 0 N--CA 1.408 -2.538 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.16 139.1 13.01 Favored Glycine 0 N--CA 1.412 -2.924 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.4 tp -102.11 118.24 36.48 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.08 114.31 3.83 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mm -78.77 -50.05 19.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 85' ' ' ASP . 25.0 p80 -167.67 145.38 4.51 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.151 176.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.581 ' HB3' ' HG3' ' A' ' 82' ' ' LYS 0.314 1.2 p30 46.8 -96.11 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 177.259 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 37.4 ptt180 -117.07 2.35 12.66 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.153 0.502 . . . . 0.0 110.882 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.6 t -91.72 106.38 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.631 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.6 m -122.49 162.18 22.21 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 p -133.17 140.81 46.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.62 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.0 tt -153.02 147.53 19.1 Favored Pre-proline 0 CA--C 1.561 1.384 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.75 147.51 94.6 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.417 2.078 . . . . 0.0 112.483 176.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.4 m -62.05 -44.9 95.69 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.281 0.633 . . . . 0.0 112.612 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -65.46 2.53 0.88 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.36 -23.28 54.16 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.455 ' O ' ' HB ' ' A' ' 20' ' ' THR . 13.4 mm100 64.47 77.35 0.3 Allowed Pre-proline 0 C--O 1.25 1.119 0 C-N-CA 125.228 1.411 . . . . 0.0 111.664 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.34 128.84 9.91 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.673 2.249 . . . . 0.0 110.826 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.52 -163.62 38.65 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.801 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.81 -33.64 75.2 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.657 0.741 . . . . 0.0 110.912 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -139.84 141.03 36.7 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.15 154.0 23.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 120.57 0.224 . . . . 0.0 110.918 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 8.2 mp -96.36 105.28 17.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.026 0.441 . . . . 0.0 111.173 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.59 93.53 4.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 t30 65.88 9.37 6.03 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.682 1.193 . . . . 0.0 110.732 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 127.69 -22.85 5.44 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.646 HE21 ' HA ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -80.59 107.67 13.59 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -80.62 111.31 16.93 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.836 0.827 . . . . 0.0 109.204 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.1 tp -113.35 135.57 52.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.316 -174.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -68.69 132.8 47.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.858 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.89 126.92 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -77.67 -63.02 1.48 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.457 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -147.22 148.96 32.02 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -112.59 104.02 12.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.539 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.8 m-85 -81.55 95.18 7.06 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -75.23 123.0 24.53 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.11 102.96 15.29 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -177.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.9 132.56 60.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.3 145.25 86.47 Favored Pre-proline 0 C--N 1.307 -1.268 0 O-C-N 123.383 0.427 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.3 -21.98 73.43 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.558 2.172 . . . . 0.0 110.798 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.49 7.81 21.47 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.391 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 71.18 21.54 4.73 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.51 1.524 . . . . 0.0 113.15 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 132' ' ' ASN . 39.5 mm -92.49 152.75 3.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.657 ' O ' ' HA ' ' A' ' 131' ' ' THR . 48.3 t30 -85.5 138.4 32.24 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.43 -19.73 17.53 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 66.29 21.74 10.97 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 122.989 1.376 . . . . 0.0 109.475 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.3 tp -121.16 143.72 48.97 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.373 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.1 m -138.9 126.98 22.5 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.114 0.483 . . . . 0.0 110.388 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 60.6 t -86.87 110.79 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.7 tp -91.75 116.13 28.63 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.712 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.3 m -93.24 106.42 18.38 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.1 0.476 . . . . 0.0 109.882 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.54 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 8.3 mp -81.37 153.78 26.8 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.758 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.467 ' O ' HD11 ' A' ' 54' ' ' ILE . 22.8 t70 -83.41 74.68 10.05 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.84 0.829 . . . . 0.0 109.052 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -114.78 130.71 56.9 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.45 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -95.85 -39.64 9.72 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.72 129.13 38.68 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.578 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.581 ' HG3' ' HB3' ' A' ' 32' ' ' ASP . 51.7 tttp -89.02 102.86 15.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.301 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.45 ' H ' ' HA ' ' A' ' 32' ' ' ASP . 96.5 m-85 -70.47 156.34 39.5 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 172.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -49.7 132.49 21.77 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.779 1.232 . . . . 0.0 113.436 -173.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 31' ' ' HIS . 12.2 t70 -84.62 97.06 9.4 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.613 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -97.79 22.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.854 0.835 . . . . 0.0 110.921 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -60.55 -41.66 94.99 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.138 -174.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.63 1.43 66.89 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 116.11 -0.496 . . . . 0.0 113.72 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -95.83 -6.78 38.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.98 0.39 . . . . 0.0 110.51 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.3 mt -72.04 109.67 4.44 Favored 'Isoleucine or valine' 0 C--O 1.261 1.692 0 CA-C-O 121.308 0.575 . . . . 0.0 110.004 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 p -94.97 105.69 17.63 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.514 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -82.0 -13.05 57.97 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.819 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -94.28 115.62 27.89 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.7 mt -112.73 -56.97 2.35 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.188 -164.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 32.1 tt0 -60.11 112.37 1.87 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -164.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 119.25 -18.87 10.16 Favored Glycine 0 C--O 1.251 1.169 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.529 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.45 147.05 5.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -87.94 129.24 35.3 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -124.41 160.71 27.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.391 0.615 . . . . 0.0 111.901 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.8 m -121.16 145.02 48.26 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 124.471 1.108 . . . . 0.0 108.721 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.536 HD21 ' HB2' ' A' ' 160' ' ' HIS . 2.3 tm? -103.65 119.37 38.77 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.444 HG21 ' HB1' ' A' ' 7' ' ' ALA . 48.5 t -123.73 130.97 73.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.964 0.412 . . . . 0.0 112.071 -175.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.419 ' CG2' ' HB ' ' A' ' 111' ' ' THR . 17.4 m -125.38 142.84 40.96 Favored 'Isoleucine or valine' 0 C--O 1.254 1.326 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -71.65 -59.38 2.78 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.9 t -153.43 106.46 2.94 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 170.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.502 ' ND2' ' HA ' ' A' ' 145' ' ' GLN . 28.1 t-20 -103.9 -74.59 0.64 Allowed 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -100.11 -26.39 13.97 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.164 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -148.79 156.07 41.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.3 m -84.74 131.89 34.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.601 0.239 . . . . 0.0 111.113 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.422 HD22 ' C ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER 70.12 71.32 0.22 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.812 1.245 . . . . 0.0 111.967 178.013 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.419 ' HB ' ' CG2' ' A' ' 103' ' ' VAL . 34.7 m -111.56 107.92 17.25 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.563 176.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.443 HG21 HG23 ' A' ' 4' ' ' THR . 61.5 mt -117.55 103.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.0 tp -123.46 124.49 43.0 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.307 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.2 140.82 56.1 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.695 0.76 . . . . 0.0 112.894 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.84 -57.16 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.136 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.77 -152.89 17.45 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.0 123.82 11.81 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 123.007 2.472 . . . . 0.0 112.306 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 27.3 m -96.97 157.63 3.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.9 p -133.29 164.83 26.21 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.647 0.379 . . . . 0.0 111.23 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 56.5 ttp -82.04 136.0 35.27 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -99.58 -52.79 3.38 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.521 0.677 . . . . 0.0 110.248 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.98 -110.53 3.76 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.317 -0.944 . . . . 0.0 110.817 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.0 tp -110.91 118.7 36.81 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mm -123.62 121.15 61.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 130' ' ' PRO . 47.2 t-20 -100.32 109.13 21.32 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 69.0 tp -129.17 126.75 39.93 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.4 t 60.93 47.92 7.15 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.974 0.91 . . . . 0.0 109.151 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.8 m 61.55 13.28 5.05 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.117 1.367 . . . . 0.0 112.108 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.7 m -117.72 109.51 41.47 Favored Pre-proline 0 N--CA 1.425 -1.691 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.243 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 125' ' ' ASN . 60.8 Cg_endo -76.68 122.62 6.49 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.385 2.057 . . . . 0.0 110.558 176.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 8.5 m -122.2 127.41 49.96 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.458 ' HB2' HG21 ' A' ' 68' ' ' ILE . 64.1 t30 -111.51 158.96 18.56 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 111.133 0.049 . . . . 0.0 111.133 -174.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 61.7 50.94 4.13 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 122.968 1.366 . . . . 0.0 111.334 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 90.2 mmm -113.87 157.03 22.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.029 -1.896 . . . . 0.0 110.258 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.539 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 12.4 tt -107.37 147.16 12.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.557 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 39.3 ttp85 -126.89 140.95 51.97 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 123.268 0.627 . . . . 0.0 110.207 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -150.31 148.77 29.24 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.488 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.92 111.48 18.83 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -164.47 146.47 8.56 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -171.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.21 93.1 1.42 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.1 t -87.96 145.29 26.09 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.141 -174.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 145' ' ' GLN . 17.8 tppt? -134.73 125.46 27.05 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.2 m -73.29 124.83 26.46 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.59 -41.46 1.28 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.502 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 3.4 pt20 -84.07 42.86 0.89 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.456 1.122 . . . . 0.0 109.604 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 33.4 m -82.82 147.06 28.58 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.835 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.19 7.18 59.67 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -68.92 119.63 9.95 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.04 108.17 6.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 37.0 tp -84.53 107.9 17.01 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.1 p -142.1 164.9 28.92 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.266 0.555 . . . . 0.0 112.049 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.39 178.17 7.61 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.5 t -60.96 102.88 0.22 Allowed 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 121.756 0.788 . . . . 0.0 111.669 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 84.08 6.23 86.74 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.02 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -134.02 126.55 30.44 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 117.331 0.566 . . . . 0.0 111.275 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 76.2 mt -112.81 122.12 66.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -97.48 -22.17 16.72 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.883 0.373 . . . . 0.0 111.169 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 149.75 -163.8 29.4 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.551 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 148' ' ' GLY . 27.3 pt -128.21 134.11 65.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 120.989 0.424 . . . . 0.0 111.324 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.536 ' HB2' HD21 ' A' ' 101' ' ' LEU . 36.4 t-80 -60.52 133.32 55.98 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 124.852 1.261 . . . . 0.0 111.925 -178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.33 -6.73 11.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.916 0.389 . . . . 0.0 110.884 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 123.47 -158.59 18.09 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.448 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 156.79 178.13 30.59 Favored Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -134.23 119.08 18.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 100.72 -123.04 7.81 Favored Glycine 0 N--CA 1.434 -1.461 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.433 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -113.26 6.59 17.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.891 0.377 . . . . 0.0 111.472 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -112.76 113.87 26.17 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.478 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.16 133.1 11.62 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -111.32 137.79 48.62 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.555 0.693 . . . . 0.0 109.93 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.539 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 16.2 m -135.41 153.31 51.84 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.915 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.444 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -81.43 132.94 35.34 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -64.7 -9.22 18.39 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.8 mt 49.32 29.39 2.71 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -40.49 121.4 1.41 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.546 1.139 . . . . 0.0 110.632 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -53.58 -25.71 18.47 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.424 ' O ' HG12 ' A' ' 179' ' ' VAL . 28.5 pt20 -63.56 -17.17 62.55 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 123.71 0.804 . . . . 0.0 112.672 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.3 m-30 -73.63 -23.32 59.87 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.758 -0.589 . . . . 0.0 111.012 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.41 12.05 34.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -170.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 176' ' ' GLN . 12.0 p -110.94 132.8 58.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.84 -39.27 80.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.014 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -77.02 109.5 10.9 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 . . . . . 0 C--O 1.248 1.025 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.838 -171.745 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.391 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.06 -22.78 75.78 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.754 2.303 . . . . 0.0 111.429 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -61.97 -39.5 92.36 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.13 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -69.21 -40.41 78.01 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.572 0.749 . . . . 0.0 109.462 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.76 -44.18 96.86 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.479 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -67.19 -50.26 61.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.254 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.41 84.49 Favored 'General case' 0 C--O 1.209 -1.037 0 C-N-CA 123.204 0.602 . . . . 0.0 111.845 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.01 -39.57 95.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.017 0.437 . . . . 0.0 111.101 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 m -74.86 -32.81 61.99 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.72 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.417 HD11 HD13 ' A' ' 86' ' ' ILE . 57.5 tp -73.38 -40.67 64.16 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.484 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.587 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 2.2 tm? -54.4 -52.89 60.3 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.256 1.422 . . . . 0.0 111.82 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -66.44 -7.59 20.48 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -170.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -126.29 -51.66 1.52 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -104.73 -2.87 24.33 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -170.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.587 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 56.5 mt -114.42 104.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.6 tpt -135.74 154.78 51.14 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.833 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.402 HG23 ' HA ' ' A' ' 105' ' ' SER . 28.4 m -75.39 115.82 15.46 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.071 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 mt -99.58 99.74 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p -80.24 101.62 8.98 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.756 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 82.6 p -89.27 -166.15 1.52 Allowed 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.81 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -73.85 -20.91 60.3 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.879 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -101.18 -49.52 4.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -160.59 -157.12 8.52 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 118.82 -1.657 . . . . 0.0 113.537 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -109.38 94.72 5.18 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -100.69 160.77 14.09 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.9 m -99.49 123.69 43.98 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.3 123.68 7.94 Favored Glycine 0 N--CA 1.411 -2.996 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.8 tp -101.29 112.84 25.46 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.993 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.45 135.59 16.74 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.1 -50.88 6.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 117.716 0.758 . . . . 0.0 110.74 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -146.14 110.17 4.95 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.754 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.585 ' OD2' ' HG3' ' A' ' 33' ' ' ARG . 24.9 t70 56.73 -81.17 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 171.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.585 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -116.37 0.94 12.95 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.436 0.636 . . . . 0.0 111.61 179.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.0 t -88.57 114.9 27.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.914 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.1 t -125.95 144.63 50.61 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.84 139.86 29.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -148.89 143.5 17.17 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.49 154.72 73.27 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.957 1.772 . . . . 0.0 110.872 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -68.76 -42.15 77.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.563 0.697 . . . . 0.0 109.814 -177.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -73.89 20.38 0.1 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.4 -23.36 21.08 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.319 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.568 ' O ' ' HB ' ' A' ' 20' ' ' THR . 24.6 mm-40 69.4 66.0 0.49 Allowed Pre-proline 0 N--CA 1.486 1.362 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -94.95 135.58 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 122.615 2.21 . . . . 0.0 110.816 172.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.71 -146.8 17.34 Favored Glycine 0 C--N 1.314 -0.652 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.966 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.14 -43.0 55.03 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.621 0.724 . . . . 0.0 109.258 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -123.65 139.63 53.8 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.9 p -125.95 153.04 33.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.6 mt -92.35 120.41 32.85 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.83 85.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 175.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 t30 70.79 -10.13 0.76 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.509 1.123 . . . . 0.0 112.085 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.73 -39.21 0.57 Allowed Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -78.37 126.78 31.27 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -90.91 146.89 23.52 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.497 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.5 tp -132.64 135.22 57.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -86.19 139.25 31.24 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.186 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -78.01 137.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.506 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -87.63 -48.86 7.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -164.01 151.16 11.97 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.28 101.01 7.87 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.531 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 84.4 m-85 -81.79 125.95 31.27 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -85.96 116.13 24.0 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.5 mt -77.43 108.7 10.78 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.553 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.96 130.8 72.28 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -80.75 139.53 50.56 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -56.01 -12.25 6.96 Favored 'Trans proline' 0 CA--C 1.555 1.539 0 C-N-CA 123.725 2.95 . . . . 0.0 114.484 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -83.22 -4.07 58.04 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 121.997 0.903 . . . . 0.0 108.698 174.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.5 t30 67.73 70.29 0.34 Allowed 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 125.19 1.396 . . . . 0.0 110.257 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.3 mt -141.73 145.1 24.79 Favored 'Isoleucine or valine' 0 C--O 1.25 1.125 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 131' ' ' THR . 17.1 m120 -76.74 161.65 28.32 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.573 0.546 . . . . 0.0 111.264 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -129.29 -32.07 2.03 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.604 174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 71.17 4.22 4.98 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 123.052 1.406 . . . . 0.0 110.204 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.428 HD13 HD23 ' A' ' 173' ' ' LEU . 70.7 mt -94.96 119.05 32.84 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.045 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.7 m -110.89 117.6 33.82 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 96.7 t -79.52 109.36 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.4 tp -87.01 99.46 11.91 Favored 'General case' 0 N--CA 1.397 -3.123 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.886 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.0 m -85.39 105.5 16.07 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.7 mt -90.34 164.49 14.32 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.473 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.26 130.13 36.81 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -59.54 99.69 0.07 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.808 0.843 . . . . 0.0 111.878 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -115.51 -65.69 1.16 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -100.94 109.41 21.33 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.419 ' HG3' ' OD1' ' A' ' 32' ' ' ASP . 53.6 tttm -69.4 116.82 10.27 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.041 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -70.21 145.88 51.11 Favored 'General case' 0 C--O 1.263 1.772 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -66.9 143.59 56.75 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.62 82.56 2.63 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.157 0.503 . . . . 0.0 111.22 -176.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.417 HD13 HD11 ' A' ' 10' ' ' LEU . 47.9 pt -89.83 11.1 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.685 0.755 . . . . 0.0 109.527 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.583 ' O ' ' HE2' ' A' ' 175' ' ' LYS . 57.4 ttp180 -66.85 -24.23 66.12 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.515 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.44 -24.41 75.1 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.406 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -86.46 -4.74 59.22 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 116.991 0.396 . . . . 0.0 111.167 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 173' ' ' LEU . 87.3 mt -61.92 121.1 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.8 m -99.61 108.93 21.43 Favored 'General case' 0 N--CA 1.382 -3.827 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.346 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -71.45 -25.15 62.18 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.32 111.7 22.6 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.907 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.409 HD11 ' CG ' ' A' ' 172' ' ' GLN . 72.9 mt -107.91 -66.5 1.03 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.515 ' CB ' ' HA ' ' A' ' 119' ' ' THR . 16.5 pt-20 -74.96 152.67 38.78 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -162.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.03 -19.1 38.61 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 114.064 -1.426 . . . . 0.0 111.016 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.6 t -94.37 139.32 18.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.776 0.322 . . . . 0.0 110.316 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.51 119.11 20.64 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 174.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -110.78 164.52 12.68 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 122.03 0.919 . . . . 0.0 113.453 -174.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.433 HG21 HG23 ' A' ' 112' ' ' ILE . 62.4 m -122.2 140.01 53.09 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.449 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -106.71 122.6 46.68 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.47 121.25 66.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 120.861 0.362 . . . . 0.0 110.044 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.71 145.05 22.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.403 ' HB3' HG22 ' A' ' 15' ' ' ILE . 65.8 t60 -135.65 90.99 2.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.863 0.839 . . . . 0.0 110.433 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.402 ' HA ' HG23 ' A' ' 17' ' ' THR . 25.7 p -120.17 -170.75 2.03 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -87.55 -31.52 19.86 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -70.85 -50.61 33.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.541 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -113.4 86.59 2.42 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.1 m -95.44 109.22 21.44 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.442 -176.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 71.37 35.01 1.6 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.864 0.727 . . . . 0.0 110.788 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.9 m -75.93 105.63 7.08 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 100' ' ' THR . 65.2 mt -103.54 105.93 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.795 -177.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.9 tp -118.74 118.82 32.63 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 120.715 0.293 . . . . 0.0 111.537 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -74.97 119.65 19.43 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -95.39 -35.31 5.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.22 -170.61 20.79 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.022 -1.085 . . . . 0.0 111.943 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.75 119.46 6.4 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.15 2.567 . . . . 0.0 111.303 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.4 m -82.32 151.74 4.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.515 ' HA ' ' CB ' ' A' ' 95' ' ' GLU . 8.9 t -141.97 163.48 32.77 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 47.7 tpp -86.19 134.86 33.76 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.701 0.286 . . . . 0.0 110.301 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.19 -25.29 14.94 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.11 -94.4 1.58 Allowed Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.554 ' O ' HD12 ' A' ' 123' ' ' LEU . 4.1 pp -147.02 119.66 8.55 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.21 0.528 . . . . 0.0 110.383 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.3 tt 176.0 147.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 129' ' ' THR . 48.5 t-20 -158.4 -86.16 0.04 OUTLIER 'General case' 0 C--O 1.241 0.636 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -129.68 108.39 10.16 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -171.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.4 p 43.69 73.12 0.15 Allowed 'General case' 0 C--O 1.248 0.991 0 C-N-CA 124.746 1.219 . . . . 0.0 113.999 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.5 m 65.13 24.62 12.42 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.231 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.432 ' O ' ' HB3' ' A' ' 125' ' ' ASN . 32.1 m -111.46 102.9 54.31 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.88 125.74 3.23 Favored 'Trans proline' 0 N--CA 1.431 -2.199 0 C-N-CA 121.819 1.679 . . . . 0.0 112.917 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 2.0 p -100.16 130.48 46.3 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -72.04 132.95 44.94 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -172.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 172' ' ' GLN . 36.1 mmt180 58.97 50.89 7.78 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 124.656 1.182 . . . . 0.0 110.507 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.3 tpt -79.53 118.86 21.77 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.134 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.564 HG23 ' HB2' ' A' ' 170' ' ' SER . 12.4 tt -90.39 138.17 20.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.257 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -127.83 146.23 50.67 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.803 -169.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -147.5 136.64 22.34 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.138 0.975 . . . . 0.0 108.704 175.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -98.96 110.24 22.88 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 122.239 1.019 . . . . 0.0 110.176 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -171.81 134.13 0.78 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.53 90.1 0.25 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.906 0.86 . . . . 0.0 110.805 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 m -104.64 140.07 38.57 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -62.87 103.45 0.45 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.814 0.816 . . . . 0.0 110.741 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.0 m -74.96 116.94 16.26 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.792 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.39 -25.0 2.02 Favored Glycine 0 C--N 1.312 -0.787 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.737 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -83.1 50.7 1.79 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.248 1.023 . . . . 0.0 110.343 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 30.8 m -60.09 137.67 58.05 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.262 -1.336 . . . . 0.0 111.395 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 109.99 -5.17 30.5 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.358 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.2 134.94 25.35 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.658 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.8 p -76.83 126.41 37.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.522 0.677 . . . . 0.0 110.611 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 51.8 tp -94.57 108.62 20.58 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 11.9 p -144.7 175.61 10.04 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 121.239 0.542 . . . . 0.0 111.714 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -154.86 -177.9 6.84 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 175.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.1 t -64.21 103.07 0.58 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.586 0.708 . . . . 0.0 111.386 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.37 26.37 66.01 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.741 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 59.9 mmtt -143.22 114.43 7.86 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 123.12 0.568 . . . . 0.0 110.626 -177.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 89.2 mt -113.5 123.95 69.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 169.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -99.49 -27.6 13.64 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.503 -174.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 149.88 -149.58 21.52 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 36.5 pt -131.26 149.11 32.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 117.134 0.467 . . . . 0.0 111.21 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -68.56 115.77 8.34 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.841 0.856 . . . . 0.0 109.129 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.2 t -97.81 -36.44 5.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.07 -149.66 8.96 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -177.41 163.07 31.41 Favored Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -142.58 121.88 13.08 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.19 -126.42 9.41 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -104.6 2.34 30.58 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -92.89 112.64 24.68 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.081 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.18 135.0 13.37 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -117.52 119.8 36.15 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 122.122 0.963 . . . . 0.0 110.962 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.564 ' HB2' HG23 ' A' ' 135' ' ' ILE . 20.8 m -119.7 154.53 33.96 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.429 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -104.35 144.7 31.28 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.212 -177.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 133' ' ' ARG . 0.7 OUTLIER -81.89 118.1 22.66 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.189 0.93 . . . . 0.0 108.986 -177.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.428 HD23 HD13 ' A' ' 72' ' ' LEU . 66.9 mt -93.16 74.41 4.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -67.69 146.07 54.16 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.586 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.583 ' HE2' ' O ' ' A' ' 87' ' ' ARG . 94.7 mttt -57.36 -31.0 65.31 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.807 0.813 . . . . 0.0 110.324 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -68.69 -9.01 47.76 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.743 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -92.56 -23.26 19.12 Favored 'General case' 0 CA--C 1.518 -0.288 0 O-C-N 121.921 -0.487 . . . . 0.0 110.05 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -102.17 18.82 19.91 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.217 -174.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 27.3 m -80.71 152.17 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.048 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -89.1 -40.81 12.67 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -84.52 104.21 14.32 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.683 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 . . . . . 0 C--N 1.31 -1.133 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.072 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.714 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.71 -49.04 4.61 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.509 2.139 . . . . 0.0 112.143 -175.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -67.53 -37.01 82.11 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.064 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -62.35 -49.58 75.0 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 123.65 0.78 . . . . 0.0 109.789 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.09 -43.99 90.33 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.949 0.9 . . . . 0.0 110.015 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -58.46 -47.73 83.05 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.007 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . -62.39 -48.16 80.96 Favored 'General case' 0 C--O 1.206 -1.185 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.964 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.05 -41.77 88.69 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.304 0.642 . . . . 0.0 110.321 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.0 m -65.29 -43.38 91.34 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.999 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.476 HD11 HD13 ' A' ' 86' ' ' ILE . 59.8 tp -66.53 -43.53 84.93 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.954 0.901 . . . . 0.0 109.666 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 16.5 tp -49.57 -59.57 3.65 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 126.134 1.774 . . . . 0.0 112.755 -176.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -80.49 11.07 3.95 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.141 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -123.01 -56.66 1.74 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.67 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -119.3 4.63 11.24 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 33.4 mt -99.66 98.16 6.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.747 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.92 144.17 30.19 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.369 -175.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 45.5 m -79.95 115.31 19.45 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 172.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.8 mt -115.14 107.46 22.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.438 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 20.3 m -89.78 113.25 24.76 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 76.7 p -93.87 -157.46 0.55 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.595 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -83.32 0.72 44.57 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -112.52 -52.23 2.79 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.812 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' THR . . . -175.15 -160.14 22.51 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 119.823 -1.179 . . . . 0.0 111.943 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -97.14 105.88 18.11 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.82 169.42 8.85 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 83.5 m -99.69 123.45 43.97 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.13 118.89 6.11 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.1 tp -98.38 113.89 26.03 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.504 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.18 112.66 3.84 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 85' ' ' ASP . 49.6 mm -86.65 -52.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 116.564 0.182 . . . . 0.0 110.789 -176.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -162.19 141.65 9.62 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.34 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 16.1 t70 59.37 -90.98 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 175.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -135.6 9.08 3.37 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.278 1.037 . . . . 0.0 108.709 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.482 HG13 ' CG1' ' A' ' 74' ' ' VAL . 53.9 t -80.72 108.81 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.777 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.0 m -113.01 145.47 40.79 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.424 ' CG1' HD21 ' A' ' 72' ' ' LEU . 48.8 t -112.5 133.97 56.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 O-C-N 122.185 -0.322 . . . . 0.0 111.29 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 tt -153.88 145.17 16.43 Favored Pre-proline 0 CA--C 1.566 1.571 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.616 ' HG2' ' SG ' ' A' ' 146' ' ' CYS . 31.3 Cg_exo -65.16 150.18 87.97 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.356 2.037 . . . . 0.0 113.009 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.0 m -58.1 -43.01 86.89 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.6 0.76 . . . . 0.0 112.686 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -69.59 -1.65 9.39 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.65 -32.7 62.34 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.431 ' O ' ' HB ' ' A' ' 20' ' ' THR . 25.6 mt-30 52.15 82.48 0.24 Allowed Pre-proline 0 C--O 1.248 1.024 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.46 143.13 16.96 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.965 2.443 . . . . 0.0 110.559 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.59 -136.41 7.54 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.559 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.33 -31.03 30.1 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 5.2 p-10 -136.55 153.4 51.0 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.24 -1.345 . . . . 0.0 107.622 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.53 158.39 42.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 76.7 mt -99.48 103.08 14.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 17' ' ' THR . 72.6 t -83.45 91.73 2.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 175.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 62.78 15.81 8.48 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.079 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.01 -18.36 7.95 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.251 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -84.63 119.73 25.56 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.262 0.225 . . . . 0.0 110.772 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -71.74 119.05 15.36 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.959 0.409 . . . . 0.0 111.986 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.451 HD11 ' O ' ' A' ' 78' ' ' ASP . 16.7 tt -132.72 139.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 174.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 41.7 mtp180 -82.25 157.45 23.89 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.527 0.679 . . . . 0.0 112.481 -177.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.58 140.4 16.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.439 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -93.8 -54.24 3.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' H ' ' HB ' ' A' ' 76' ' ' THR . 7.5 t70 -146.24 165.73 28.35 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -140.38 95.1 2.82 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.0 m-85 -83.3 100.59 10.73 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.7 102.3 2.27 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 tt -83.39 102.83 12.3 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-O 122.065 0.936 . . . . 0.0 109.143 -171.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 67.3 t -109.86 139.52 32.71 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -59.05 141.64 86.26 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.7 -10.22 2.34 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 123.513 2.808 . . . . 0.0 114.838 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -97.5 7.24 46.86 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 121.676 0.75 . . . . 0.0 109.862 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 73.61 23.26 2.44 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.123 1.369 . . . . 0.0 114.394 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.3 mm -96.89 140.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 131' ' ' THR . 5.0 m-20 -66.24 133.32 50.36 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 120.892 0.377 . . . . 0.0 111.341 -177.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 133' ' ' ARG . 58.7 tp -94.37 -15.36 24.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 170.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 61.58 27.28 16.8 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.986 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.424 HD21 ' CG1' ' A' ' 36' ' ' VAL . 2.7 tm? -125.07 140.84 52.54 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.171 -173.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.419 ' N ' HD13 ' A' ' 72' ' ' LEU . 93.9 m -134.32 130.2 36.64 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.373 0.606 . . . . 0.0 110.264 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 51.5 t -87.02 108.7 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -89.5 113.56 24.96 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -175.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.413 ' HB ' ' H ' ' A' ' 58' ' ' ASP . 16.3 m -90.66 97.46 11.19 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.401 HD11 ' CG2' ' A' ' 54' ' ' ILE . 17.6 tp -78.11 150.16 33.74 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.451 ' O ' HD11 ' A' ' 54' ' ' ILE . 35.5 t70 -79.91 95.77 6.18 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 119.019 -1.073 . . . . 0.0 109.765 178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' A' ' 79' ' ' ARG . 4.4 mmp_? -133.12 110.07 9.92 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.315 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -85.92 -28.25 24.45 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 168.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -78.2 91.02 4.32 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 171.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 24.3 pttm -78.53 150.81 32.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -170.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -86.82 160.46 18.76 Favored 'General case' 0 C--O 1.256 1.403 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.811 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -81.35 140.97 34.45 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 5.5 p-10 -76.32 106.74 8.12 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 122.376 1.084 . . . . 0.0 110.19 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.476 HD13 HD11 ' A' ' 10' ' ' LEU . 22.7 pt -88.13 17.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 122.192 0.996 . . . . 0.0 109.468 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -63.21 -27.51 69.41 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.812 -1.54 . . . . 0.0 111.947 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.61 -16.82 78.99 Favored Glycine 0 C--N 1.317 -0.483 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.708 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -93.36 -3.4 53.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.731 0.3 . . . . 0.0 110.384 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.5 mt -66.08 135.72 27.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.155 0.502 . . . . 0.0 110.564 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.8 t -125.63 103.75 8.01 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -87.54 -8.59 56.15 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.593 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.24 123.15 36.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.414 HD11 ' CD ' ' A' ' 172' ' ' GLN . 20.1 mt -106.38 -71.06 0.76 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -164.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 11.1 pt-20 -50.45 137.09 19.62 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -165.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.34 -14.05 33.26 Favored Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.658 174.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.05 144.06 18.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 122.415 -0.462 . . . . 0.0 110.368 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.13 116.87 21.25 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.28 159.5 14.95 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.396 0.617 . . . . 0.0 110.731 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.2 m -129.39 133.52 47.41 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.37 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.7 mt -90.91 125.72 35.84 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.422 ' HB ' ' CG1' ' A' ' 149' ' ' VAL . 30.5 t -117.69 107.63 22.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.414 HG22 ' HA3' ' A' ' 148' ' ' GLY . 10.6 t -109.02 147.71 13.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.534 ' CE1' HG23 ' A' ' 109' ' ' THR . 2.6 t-80 -140.0 106.91 5.41 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.41 ' HA ' HG23 ' A' ' 17' ' ' THR . 52.8 p -128.74 -170.47 2.27 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -89.91 -34.94 15.87 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 176.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -63.06 -45.5 91.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.788 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . 0.265 9.3 p90 -133.53 96.55 3.73 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.603 1.192 . . . . 0.0 112.509 175.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.534 HG23 ' CE1' ' A' ' 104' ' ' HIS . 90.8 m -83.43 122.58 28.69 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.943 178.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.01 71.24 0.52 Allowed 'General case' 0 C--O 1.245 0.867 0 C-N-CA 124.321 1.048 . . . . 0.0 112.867 176.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.5 m -102.15 99.15 9.25 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.998 176.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.4 mt -95.19 110.62 24.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.7 tp -128.9 108.23 10.26 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.864 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -68.28 124.9 24.77 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.0 m -99.05 -27.65 3.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.613 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.92 -164.8 12.19 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 119.81 -1.186 . . . . 0.0 112.119 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.08 129.98 19.33 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 123.014 2.476 . . . . 0.0 112.668 -177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 31.2 m -96.27 161.54 2.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.381 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.8 p -144.35 164.69 30.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.738 1.215 . . . . 0.0 108.683 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 52.2 ttm -86.93 139.28 30.78 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.637 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -105.37 -40.57 5.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.739 0.305 . . . . 0.0 111.465 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.73 -113.51 3.7 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.606 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.7 mt -93.22 120.6 33.68 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.009 0.524 . . . . 0.0 110.049 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.4 mm -131.71 134.42 60.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -94.67 86.39 4.75 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp -88.04 105.84 17.74 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.862 -175.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 45.1 m 61.9 39.14 13.94 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.829 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.5 t 73.89 11.45 4.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.748 1.219 . . . . 0.0 112.039 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.5 m -108.81 115.97 56.55 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.24 106.97 2.27 Favored 'Trans proline' 0 C--O 1.248 0.977 0 C-N-CA 121.997 1.798 . . . . 0.0 111.434 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 22.3 p -109.1 135.03 50.91 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.814 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -111.27 164.35 12.98 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.447 ' HG3' ' HB2' ' A' ' 172' ' ' GLN . 12.7 tpp180 66.38 27.49 9.96 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.577 1.151 . . . . 0.0 108.976 173.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 25.2 mmt -79.57 150.44 31.08 Favored 'General case' 0 C--O 1.251 1.152 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.429 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.541 HG23 ' HB2' ' A' ' 170' ' ' SER . 8.6 tt -115.57 141.87 30.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 173.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.637 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 39.4 ttt180 -127.25 139.34 52.98 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 123.216 0.606 . . . . 0.0 111.319 -171.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -149.23 144.02 26.27 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.01 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -90.67 107.41 19.16 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.886 0.741 . . . . 0.0 110.171 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -173.02 138.17 0.75 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.75 92.08 2.45 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.511 0.672 . . . . 0.0 110.103 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.2 t -79.19 165.92 22.75 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.531 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -120.25 163.13 18.24 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.6 t -78.56 153.63 31.05 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.78 -9.11 63.97 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -89.32 4.5 48.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.204 0.526 . . . . 0.0 111.315 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.616 ' SG ' ' HG2' ' A' ' 38' ' ' PRO . 48.0 t -58.11 120.74 9.15 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.453 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.43 -12.52 56.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.02 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.414 ' HA3' HG22 ' A' ' 103' ' ' VAL . . . -68.29 131.99 27.63 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.456 ' HA ' HG22 ' A' ' 159' ' ' ILE . 7.4 p -70.21 124.59 26.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.699 0.761 . . . . 0.0 111.219 -177.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.1 tp -94.2 98.71 11.14 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 22.6 p -140.07 156.44 46.58 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.312 0.577 . . . . 0.0 111.586 -174.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -121.24 -173.18 2.56 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 t -71.75 79.51 0.85 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.005 0.907 . . . . 0.0 112.952 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 105.91 8.96 33.39 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.98 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -137.31 104.44 5.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 84.4 mt -93.86 120.14 42.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -94.82 -34.06 12.62 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.577 0.703 . . . . 0.0 110.538 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 165.19 -149.08 15.15 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.309 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.456 HG22 ' HA ' ' A' ' 149' ' ' VAL . 46.0 pt -135.01 149.21 28.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -66.63 133.36 50.12 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.295 0.638 . . . . 0.0 110.71 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 86.6 t -108.46 -59.69 3.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.09 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -159.58 153.39 24.42 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.282 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -115.56 125.86 6.88 Favored Glycine 0 N--CA 1.432 -1.6 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.409 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -112.24 97.49 6.67 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.7 -113.33 5.19 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -99.91 -6.35 26.85 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.963 0.411 . . . . 0.0 110.497 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -96.18 102.35 14.13 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.343 0.592 . . . . 0.0 110.792 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.24 119.7 4.96 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -105.41 123.84 48.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.854 0.835 . . . . 0.0 110.213 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.541 ' HB2' HG23 ' A' ' 135' ' ' ILE . 14.6 m -123.94 166.17 16.14 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.908 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.517 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -98.42 131.0 45.04 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.447 ' HB2' ' HG3' ' A' ' 133' ' ' ARG . 46.5 mt-30 -73.39 121.54 20.64 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 123.869 0.73 . . . . 0.0 109.885 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.414 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 89.0 mt -95.44 85.0 4.1 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -72.34 146.02 47.39 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.458 -176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -65.7 -24.99 67.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -48.18 -39.1 19.84 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.232 1.813 . . . . 0.0 111.56 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -83.35 -9.9 58.79 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.05 -0.406 . . . . 0.0 111.477 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -122.42 18.16 10.54 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 121.126 -0.229 . . . . 0.0 111.157 -174.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.8 m -60.98 134.93 26.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-O 121.845 0.831 . . . . 0.0 111.662 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -79.28 -27.07 42.26 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.864 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 181' ' ' LYS . 0.1 OUTLIER -106.79 123.77 48.64 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.324 175.148 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 C--N 1.299 -1.603 0 CA-C-O 118.307 -0.854 . . . . 0.0 109.118 -179.36 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.544 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -63.11 -27.21 73.24 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.856 2.371 . . . . 0.0 111.304 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -66.92 -34.21 77.28 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.738 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.9 m -67.64 -43.68 79.76 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.672 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.54 -43.0 95.36 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.929 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -61.4 -45.48 94.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.02 82.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.01 0.433 . . . . 0.0 111.269 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.5 -44.02 75.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.986 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 p -73.78 -34.53 64.71 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 120.722 0.296 . . . . 0.0 111.594 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.35 -40.72 95.32 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.737 0.815 . . . . 0.0 109.494 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.5 tp -48.97 -61.0 2.3 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 125.209 1.403 . . . . 0.0 113.649 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -80.91 11.85 3.69 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -172.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -127.0 -53.57 1.41 Allowed 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.16 0.505 . . . . 0.0 111.512 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -107.01 -9.6 16.18 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -171.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.3 mt -105.05 125.65 60.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 120.731 0.3 . . . . 0.0 110.932 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.08 135.73 27.6 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.934 0.397 . . . . 0.0 111.131 177.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.465 ' HA ' HG22 ' A' ' 26' ' ' THR . 4.5 m -68.1 132.78 47.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.662 176.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.89 113.1 31.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 121.002 0.43 . . . . 0.0 110.161 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 24.9 m -78.08 104.83 8.89 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.6 p -90.89 -165.11 1.28 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.412 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.1 m -84.7 -7.6 59.16 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 121.049 0.452 . . . . 0.0 111.028 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -108.98 -46.21 3.65 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.223 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -166.17 -173.08 34.25 Favored Glycine 0 CA--C 1.497 -1.07 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.198 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -98.94 97.22 8.42 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -104.91 -173.69 2.36 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.55 HG23 ' HA ' ' A' ' 105' ' ' SER . 2.2 p -124.52 145.28 49.65 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.58 150.26 18.7 Favored Glycine 0 N--CA 1.412 -2.964 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.9 tp -107.48 118.81 37.71 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.75 119.9 5.1 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mm -83.66 -49.38 16.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 117.205 0.503 . . . . 0.0 109.656 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -170.56 157.12 5.7 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.174 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 5.3 m-20 53.75 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.292 1.037 . . . . 0.0 112.974 177.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -139.16 11.77 2.6 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.672 0.749 . . . . 0.0 109.078 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.0 t -88.25 112.79 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.893 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.4 m -128.82 152.85 48.03 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -177.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.426 ' HB ' HD11 ' A' ' 72' ' ' LEU . 29.9 m -115.65 148.97 18.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.0 tp -151.96 148.62 21.87 Favored Pre-proline 0 CA--C 1.564 1.499 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -67.26 147.77 79.06 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 121.92 1.746 . . . . 0.0 111.899 174.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.8 m -66.11 -41.36 90.67 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.036 0.446 . . . . 0.0 112.202 -176.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -65.76 -13.26 59.05 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.73 -26.95 63.61 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 62.79 87.37 0.13 Allowed Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 114.792 -1.094 . . . . 0.0 112.622 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.12 151.23 15.97 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 122.325 2.017 . . . . 0.0 110.066 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.14 -168.88 24.03 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.49 -13.47 59.82 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.205 0.526 . . . . 0.0 111.885 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -148.08 138.82 23.07 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.61 160.65 42.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 81.2 mt -93.31 107.68 19.46 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.3 p -90.07 84.22 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.847 0 CA-C-O 122.864 1.316 . . . . 0.0 109.354 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.5 t30 62.36 20.69 12.01 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.614 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.87 -47.85 0.98 Allowed Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.545 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -66.9 124.7 23.7 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -80.22 123.23 27.76 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.432 HD11 ' O ' ' A' ' 78' ' ' ASP . 8.6 tp -122.35 125.68 73.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 55' ' ' ARG . 53.5 mtt180 -72.88 123.83 24.19 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.478 0.656 . . . . 0.0 109.379 175.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.0 t -93.66 116.23 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 28.7 ttpp -68.4 -72.09 0.19 Allowed 'General case' 0 C--N 1.293 -1.883 0 O-C-N 123.499 0.499 . . . . 0.0 111.023 -175.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 3.4 m-20 -108.63 146.12 33.87 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 122.039 -0.413 . . . . 0.0 110.925 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -116.69 102.7 9.66 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.56 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 91.7 m-85 -89.56 94.63 9.94 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.613 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -71.18 98.64 1.73 Allowed 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 174.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.526 HD23 HD23 ' A' ' 72' ' ' LEU . 36.3 tp -77.05 108.15 9.92 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 122.252 1.025 . . . . 0.0 112.563 -167.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -114.84 151.09 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.796 0 CA-C-N 113.415 -1.72 . . . . 0.0 107.225 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.39 140.11 89.91 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.13 -21.36 9.06 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.496 2.798 . . . . 0.0 114.821 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.22 8.54 23.58 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.053 0.454 . . . . 0.0 110.978 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.2 t30 73.36 68.03 0.11 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.821 1.649 . . . . 0.0 112.004 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.512 HG21 ' HB2' ' A' ' 132' ' ' ASN . 55.0 mt -143.2 147.3 20.56 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.031 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -90.52 156.1 18.41 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.418 1.008 . . . . 0.0 111.987 -174.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' A' ' 133' ' ' ARG . 8.7 mp -112.33 -11.73 13.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.479 174.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 68.26 25.07 7.27 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 123.267 1.508 . . . . 0.0 108.284 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.526 HD23 HD23 ' A' ' 62' ' ' LEU . 58.3 tp -125.19 142.08 51.71 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.417 -1.719 . . . . 0.0 109.426 -174.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.0 m -135.82 134.04 38.48 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 43.2 t -102.08 125.67 56.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.37 138.19 42.99 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.106 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.2 m -98.65 99.16 10.25 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.8 mt -80.44 104.97 11.34 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.432 ' O ' HD11 ' A' ' 54' ' ' ILE . 33.9 t70 -81.36 92.82 6.47 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -146.49 175.25 10.71 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.77 -22.75 23.13 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -78.97 123.07 26.93 Favored 'General case' 0 C--O 1.247 0.969 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.012 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 20.4 pttp -100.22 139.51 35.78 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.051 -177.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -75.78 157.11 33.86 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.477 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -64.97 131.34 46.36 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.966 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.58 93.29 2.01 Favored 'General case' 0 C--O 1.2 -1.549 0 CA-C-O 122.029 0.918 . . . . 0.0 112.565 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.4 pt -96.24 21.27 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 O-C-N 120.83 -1.168 . . . . 0.0 109.584 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -69.4 -31.71 70.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.664 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -79.73 -7.37 88.56 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.129 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 64.7 m-85 -97.94 -0.8 44.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.245 0.545 . . . . 0.0 109.897 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.57 116.94 8.03 Favored 'Isoleucine or valine' 0 C--O 1.254 1.316 0 CA-C-O 121.229 0.538 . . . . 0.0 110.853 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.6 t -102.26 107.15 18.1 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.53 ' HG2' ' HA ' ' A' ' 174' ' ' LYS . 32.5 mt-10 -87.95 -6.56 57.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -95.15 118.01 31.21 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 175.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.444 HD11 ' CD ' ' A' ' 172' ' ' GLN . 12.8 mt -116.11 -60.56 1.85 Allowed 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.968 0.89 . . . . 0.0 110.966 -170.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 34.5 tt0 -64.8 120.04 11.75 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.194 -1.366 . . . . 0.0 112.651 -167.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 112.36 -22.1 18.33 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.529 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.1 t -91.57 141.42 14.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.82 123.96 28.68 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -110.43 158.58 18.32 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.674 0.749 . . . . 0.0 111.355 -177.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.8 m -123.86 123.96 41.6 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.858 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.6 tp -95.78 116.32 28.72 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.42 104.15 14.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.513 ' HB ' ' HB ' ' A' ' 111' ' ' THR . 93.5 t -84.21 115.51 26.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.422 ' CD2' HG21 ' A' ' 26' ' ' THR . 37.2 p-80 -153.17 156.6 38.9 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.55 ' HA ' HG23 ' A' ' 26' ' ' THR . 78.1 p -175.49 -152.69 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -84.61 -25.87 28.28 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 119.273 0.942 . . . . 0.0 108.585 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -87.48 -48.86 7.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.98 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -94.39 144.14 25.81 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 23.4 m -148.81 124.42 10.42 Favored 'General case' 0 C--N 1.281 -2.403 0 O-C-N 121.356 -0.84 . . . . 0.0 110.311 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.63 30.86 20.51 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 124.068 0.855 . . . . 0.0 113.073 173.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.513 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 95.3 m -83.88 87.35 7.09 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-O 122.08 0.943 . . . . 0.0 108.741 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 75.4 mt -77.16 102.22 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.174 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.3 tp -109.51 103.83 12.78 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.104 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -76.13 121.6 23.08 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.9 m -104.19 -10.16 9.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.11 -153.12 24.23 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.632 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.29 124.87 11.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.544 2.163 . . . . 0.0 112.704 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 16.6 m -92.58 160.12 2.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.199 177.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.407 ' HA ' ' HG3' ' A' ' 95' ' ' GLU . 13.9 p -130.91 159.11 38.38 Favored 'General case' 0 C--O 1.251 1.169 0 O-C-N 123.346 0.404 . . . . 0.0 111.155 -177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 25.3 ttt -79.65 118.06 21.13 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -75.4 -42.17 54.43 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 176.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 90.2 -100.21 2.65 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.171 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 124' ' ' ILE . 7.1 tt -130.52 145.56 51.88 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.46 ' N ' HD23 ' A' ' 123' ' ' LEU . 14.8 tt -138.35 138.07 43.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -100.69 115.24 29.78 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.7 mt -112.59 89.58 3.11 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.649 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.4 p 50.13 75.78 0.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.646 1.178 . . . . 0.0 113.075 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.7 t 65.51 3.69 2.48 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.136 0.974 . . . . 0.0 112.115 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.4 m -116.51 101.94 53.53 Favored Pre-proline 0 N--CA 1.431 -1.417 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.43 129.13 15.39 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 121.61 1.54 . . . . 0.0 110.858 178.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.8 m -119.28 133.39 55.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.512 ' HB2' HG21 ' A' ' 68' ' ' ILE . 3.0 t-20 -131.08 170.72 14.14 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HB2' ' HG ' ' A' ' 70' ' ' LEU . 30.6 mmt180 64.48 41.62 5.51 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.211 1.004 . . . . 0.0 108.925 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.524 ' SD ' ' HB3' ' A' ' 169' ' ' PHE . 48.3 ttm -109.56 149.63 29.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.634 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 170' ' ' SER . 13.2 tt -115.19 147.61 18.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 123.765 0.826 . . . . 0.0 108.856 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.57 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 43.7 ttp180 -127.62 143.95 51.12 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.116 0.484 . . . . 0.0 111.089 -174.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -149.14 136.23 19.9 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 171.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.97 91.01 7.07 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.867 1.317 . . . . 0.0 111.905 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -156.3 125.88 6.28 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.93 89.79 1.43 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.531 0.52 . . . . 0.0 110.624 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.0 p -79.27 170.1 17.12 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.885 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -110.14 141.8 42.52 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.346 0.593 . . . . 0.0 111.423 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.8 m -71.22 125.98 28.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 125.52 -25.32 5.68 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -174.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -87.16 24.31 1.6 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.6 m -75.39 128.13 34.68 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.55 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 102.74 1.4 49.43 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.264 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.79 135.8 28.74 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 86.5 t -90.32 120.09 38.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 CA-C-O 121.18 0.514 . . . . 0.0 110.58 -174.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 43.4 tp -92.1 106.71 18.66 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 10.9 p -142.22 -178.9 5.95 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.306 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -158.75 -175.42 5.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.3 m -61.02 101.8 0.17 Allowed 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 122.602 0.361 . . . . 0.0 111.617 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 73.11 22.7 78.79 Favored Glycine 0 C--O 1.244 0.734 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.12 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 89' ' ' PHE . 58.2 mttp -140.81 114.17 8.66 Favored 'General case' 0 C--O 1.206 -1.213 0 O-C-N 122.887 -0.184 . . . . 0.0 111.115 -175.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.29 126.85 57.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.08 -38.07 9.89 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.719 0.771 . . . . 0.0 109.504 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 171' ' ' ALA . . . 165.11 -160.22 33.48 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.849 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.74 145.29 33.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 120.704 0.288 . . . . 0.0 110.402 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -66.13 130.98 45.09 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.88 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.0 t -95.9 -56.68 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.43 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.17 164.09 29.26 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.03 125.35 8.54 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -111.16 81.75 1.49 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.93 -123.65 6.38 Favored Glycine 0 N--CA 1.422 -2.235 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -89.17 -13.94 37.21 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.208 0.527 . . . . 0.0 109.7 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -98.26 122.85 41.94 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.065 0.459 . . . . 0.0 111.424 -177.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.19 121.99 6.54 Favored Glycine 0 N--CA 1.422 -2.245 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.524 ' HB3' ' SD ' ' A' ' 134' ' ' MET . 84.3 m-85 -108.82 134.91 50.87 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.435 0.636 . . . . 0.0 110.993 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.486 ' HB2' HG23 ' A' ' 135' ' ' ILE . 18.8 m -133.11 158.99 41.4 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.966 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.498 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . -92.71 140.9 29.05 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.444 ' CD ' HD11 ' A' ' 94' ' ' LEU . 78.6 mt-30 -84.58 124.49 31.48 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 121.475 0.655 . . . . 0.0 111.325 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.456 HD23 HD21 ' A' ' 72' ' ' LEU . 98.2 mt -93.63 92.78 7.7 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.53 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 68.2 mttm -87.09 150.45 23.99 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.509 ' O ' HG13 ' A' ' 179' ' ' VAL . 10.0 ptpp? -77.12 -13.68 59.91 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.958 -176.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -58.81 -22.43 58.51 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.602 1.161 . . . . 0.0 111.11 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 174' ' ' LYS . 45.5 m-85 -91.1 -8.74 47.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.196 0.522 . . . . 0.0 110.331 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -119.58 10.93 11.91 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.547 -175.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 175' ' ' LYS . 31.6 m -97.5 160.91 2.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -74.84 -43.75 52.86 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -121.16 144.89 48.34 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 . . . . . 0 C--N 1.31 -1.111 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.73 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.626 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -40.17 -56.84 1.35 Allowed 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 124.858 3.705 . . . . 0.0 115.477 -174.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -59.14 -49.84 76.32 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.7 m -64.8 -39.54 93.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.89 0.476 . . . . 0.0 111.088 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.79 -41.79 78.23 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.006 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -62.35 -43.4 98.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.66 98.45 Favored 'General case' 0 C--O 1.202 -1.413 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.114 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.06 -33.06 75.14 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-O 121.246 0.546 . . . . 0.0 111.187 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -71.32 -53.57 13.74 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.9 tp -53.86 -44.37 70.3 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.8 0.84 . . . . 0.0 109.891 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.498 ' HA ' HD12 ' A' ' 15' ' ' ILE . 44.4 tp -51.65 -58.46 6.29 Favored 'General case' 0 C--O 1.206 -1.191 0 C-N-CA 125.522 1.529 . . . . 0.0 112.644 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -87.73 0.2 56.06 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -172.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -112.81 -44.1 3.35 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -121.75 3.49 10.07 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 11' ' ' LEU . 59.0 mt -112.72 130.23 66.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.166 0.508 . . . . 0.0 110.52 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.75 165.51 26.25 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.398 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.7 m -98.99 118.34 35.54 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.63 120.87 55.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.487 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 24.1 m -79.9 101.39 8.55 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.352 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.2 p -104.53 -174.31 2.51 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.281 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -75.16 -35.0 61.65 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -91.03 3.54 54.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.23 -174.32 27.96 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.167 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 19' ' ' THR . 38.8 mt-10 -112.51 94.3 4.85 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -92.63 179.86 5.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.504 -171.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 20.3 m -86.61 124.28 32.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.719 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.0 130.81 10.38 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 175.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.0 tp -110.16 119.09 38.17 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.964 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.08 123.5 6.23 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 174.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mm -87.52 -44.11 15.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -171.85 144.18 1.73 Allowed 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.534 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.508 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 37.1 t70 60.32 -89.24 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.657 1.223 . . . . 0.0 112.083 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.652 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 36.0 ptt180 -140.25 11.13 2.36 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.998 0.904 . . . . 0.0 109.937 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.0 t -79.88 112.97 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.237 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 m -123.29 151.69 42.15 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 124.013 0.821 . . . . 0.0 110.235 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 74' ' ' VAL . 21.9 t -125.77 141.85 44.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.7 tt -157.22 150.61 18.88 Favored Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -71.6 155.31 59.31 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.019 1.812 . . . . 0.0 112.202 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.6 m -71.16 -33.14 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.266 -0.271 . . . . 0.0 110.301 -177.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -66.15 -2.76 4.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.28 -28.23 59.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 69.38 81.06 0.2 Allowed Pre-proline 0 C--O 1.232 0.144 0 C-N-CA 125.336 1.454 . . . . 0.0 112.559 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -96.96 171.2 0.86 Allowed 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.777 2.318 . . . . 0.0 111.788 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.72 -143.31 6.95 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -91.1 -29.96 17.01 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.671 0.748 . . . . 0.0 110.075 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -141.23 135.33 30.6 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.75 -172.62 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.392 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.7 mt -113.25 128.14 56.38 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.39 96.88 4.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 58.29 20.37 7.16 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.188 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.02 -36.3 2.87 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.347 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -74.54 134.45 42.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.705 0.253 . . . . 0.0 110.832 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -75.83 111.89 11.67 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.52 HD11 ' O ' ' A' ' 78' ' ' ASP . 11.1 tp -120.14 140.22 44.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.074 0.464 . . . . 0.0 111.142 -174.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.529 ' N ' ' HD2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -97.85 138.84 34.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.8 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 75' ' ' LEU . 48.4 t -100.32 109.63 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -70.02 -71.77 0.22 Allowed 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.904 0.753 . . . . 0.0 110.564 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' H ' ' HB ' ' A' ' 76' ' ' THR . 20.8 m-20 -102.98 141.36 35.92 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -126.95 96.15 4.54 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -96.1 107.59 19.93 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -93.55 116.71 29.23 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' HB3' HD12 ' A' ' 70' ' ' LEU . 4.2 mm? -77.69 115.1 17.18 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.786 0.803 . . . . 0.0 111.534 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.21 145.5 32.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.466 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . 14.7 t70 -70.99 145.81 92.07 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -46.33 -31.36 9.29 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.784 2.989 . . . . 0.0 113.981 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -82.5 5.9 19.2 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.03 0.443 . . . . 0.0 111.553 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 71.24 68.58 0.17 Allowed 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 125.281 1.432 . . . . 0.0 111.122 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 64' ' ' ASP . 67.6 mt -131.16 139.87 49.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' A' ' 131' ' ' THR . 0.9 OUTLIER -73.55 137.85 44.6 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -176.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' A' ' 62' ' ' LEU . 72.2 mt -111.49 -2.16 15.61 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 63.72 -21.68 0.06 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 127.222 2.209 . . . . 0.0 113.812 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 70' ' ' LEU . 82.8 mt -70.28 118.98 13.79 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.17 0.51 . . . . 0.0 111.618 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.9 m -112.71 115.93 29.33 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 36' ' ' VAL . 59.0 t -100.99 121.53 51.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.45 ' HB3' HG13 ' A' ' 56' ' ' VAL . 2.4 mm? -113.53 133.19 55.38 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.492 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.513 ' HB ' ' H ' ' A' ' 58' ' ' ASP . 96.0 m -86.08 82.85 7.93 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 169.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.652 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 18.8 tp -76.87 132.18 39.0 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.52 ' O ' HD11 ' A' ' 54' ' ' ILE . 27.8 t70 -76.22 77.52 3.02 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 117.669 -1.612 . . . . 0.0 112.336 -177.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -96.37 94.89 7.7 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -68.8 -12.71 61.81 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.449 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -98.29 100.97 12.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.496 ' HB2' ' HA ' ' A' ' 32' ' ' ASP . 8.2 ptpp? -62.43 136.83 58.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -172.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -81.62 152.79 27.0 Favored 'General case' 0 C--O 1.257 1.456 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.529 175.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -69.86 144.56 52.49 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.625 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.01 97.45 1.88 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.916 0.865 . . . . 0.0 111.49 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.3 pt -91.2 18.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 121.596 0.712 . . . . 0.0 110.403 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -69.41 -30.87 68.92 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.774 -175.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.39 -10.82 86.02 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.44 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -97.76 -5.18 35.54 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.7 mt -70.39 113.53 6.6 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 CA-C-O 121.301 0.572 . . . . 0.0 111.317 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -104.09 93.73 5.0 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.42 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 5.6 pt-20 -90.93 1.6 56.89 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.905 0.86 . . . . 0.0 111.049 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -97.17 110.2 22.79 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 167.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.509 HD13 ' HB ' ' A' ' 135' ' ' ILE . 6.4 mt -106.38 -57.36 2.06 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -164.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -42.02 113.94 0.49 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.445 1.498 . . . . 0.0 114.499 -168.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 -13.22 65.53 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.858 -1.064 . . . . 0.0 113.624 174.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 40.3 t -91.23 141.86 13.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 117.143 0.472 . . . . 0.0 110.68 -177.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -75.31 146.25 41.15 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.69 0.796 . . . . 0.0 111.614 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -138.61 170.46 15.97 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.053 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.5 m -135.39 148.47 49.37 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 tp -108.98 121.11 44.44 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 109.373 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.06 105.83 19.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 37.5 t -105.27 127.55 59.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -136.55 87.7 2.32 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 29.4 p -115.87 -172.38 2.15 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -79.49 -44.86 20.45 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 117.763 -1.575 . . . . 0.0 107.414 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.64 -42.19 78.36 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.809 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -105.89 91.39 3.72 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.0 m -87.76 100.38 12.8 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.591 -175.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 70.0 71.29 0.23 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.211 1.005 . . . . 0.0 113.203 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.1 m -108.83 95.33 5.58 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.6 mt -95.78 96.02 5.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 175.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 39.1 tp -113.42 123.42 50.03 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.977 -173.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.91 145.04 55.87 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.69 -39.46 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.559 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.62 -164.02 19.81 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.71 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 51.9 Cg_exo -58.38 129.35 32.27 Favored 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 123.712 2.941 . . . . 0.0 113.163 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.9 m -104.31 163.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.188 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.436 ' O ' HG13 ' A' ' 135' ' ' ILE . 42.8 p -129.61 174.75 9.38 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -116.71 131.35 56.97 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -93.57 -36.42 12.41 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.816 0.341 . . . . 0.0 111.227 -175.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.8 -105.76 3.19 Favored Glycine 0 CA--C 1.486 -1.74 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.82 138.58 51.01 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.464 HG13 ' HG3' ' A' ' 134' ' ' MET . 2.8 pp -128.09 141.37 46.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -102.46 105.07 15.58 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.1 tp -112.03 109.38 19.1 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.6 m 64.02 32.98 12.57 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.859 0.838 . . . . 0.0 108.911 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.7 t 69.92 12.38 7.87 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.637 -1.62 . . . . 0.0 111.513 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.3 m -97.04 108.61 44.82 Favored Pre-proline 0 N--CA 1.428 -1.534 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.32 120.99 5.85 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.677 1.584 . . . . 0.0 111.222 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 9.9 m -119.12 129.55 55.11 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -113.52 165.36 12.56 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.154 0.582 . . . . 0.0 109.944 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? 72.03 28.44 2.53 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.309 1.444 . . . . 0.0 109.402 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.464 ' HG3' HG13 ' A' ' 124' ' ' ILE . 95.4 mmm -86.92 126.24 34.56 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.616 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.585 HG23 ' HB3' ' A' ' 170' ' ' SER . 2.8 tt -99.26 143.77 12.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 43.4 ttp180 -132.28 139.79 48.37 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.95 0.405 . . . . 0.0 111.138 -170.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.485 ' CE1' ' HA3' ' A' ' 168' ' ' GLY . 37.0 p90 -140.41 135.86 32.49 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -93.72 117.31 29.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -176.09 143.52 0.55 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.74 92.86 0.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.911 0.862 . . . . 0.0 110.861 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.2 m -121.25 138.38 54.26 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -108.6 152.27 25.01 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.882 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -74.06 154.47 39.2 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 109.54 -16.67 31.45 Favored Glycine 0 C--N 1.307 -1.08 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -173.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -92.22 21.65 5.0 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 37.3 m -68.22 135.73 52.48 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.174 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.563 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 95.94 -4.74 65.78 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.15 135.82 30.09 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.24 115.22 25.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.278 0.561 . . . . 0.0 110.664 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.3 tp -85.38 101.53 12.66 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 18.0 p -151.73 168.94 23.46 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.675 0.75 . . . . 0.0 111.958 -172.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.85 -177.9 6.05 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.9 t -60.12 105.42 0.4 Allowed 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.976 0.893 . . . . 0.0 112.03 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 72.17 19.1 78.39 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.555 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -141.44 92.59 2.48 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 116.826 0.313 . . . . 0.0 110.683 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 77.3 mt -99.56 122.8 51.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -95.74 -36.12 11.29 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.591 0.71 . . . . 0.0 110.43 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.478 ' HA2' HD13 ' A' ' 173' ' ' LEU . . . 165.2 -156.33 28.24 Favored Glycine 0 N--CA 1.424 -2.166 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.663 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.9 pt -124.02 145.09 31.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -69.9 131.11 43.93 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 123.279 0.631 . . . . 0.0 110.135 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.65 11.11 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.762 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -129.86 -119.38 2.13 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.213 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 103.68 51.09 0.98 Allowed Glycine 0 CA--C 1.494 -1.261 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -106.92 96.81 6.7 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.83 -109.43 2.83 Favored Glycine 0 C--N 1.314 -0.668 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 41.3 mtm105 -111.38 14.67 21.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.017 0.437 . . . . 0.0 109.91 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -112.26 110.12 20.18 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.129 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' A' ' 137' ' ' TYR . . . -90.99 112.16 4.08 Favored Glycine 0 N--CA 1.411 -2.989 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -101.6 130.18 47.88 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.585 ' HB3' HG23 ' A' ' 135' ' ' ILE . 29.8 t -129.94 158.9 38.26 Favored 'General case' 0 C--N 1.265 -3.096 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.53 137.18 49.7 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -70.67 116.6 11.17 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 123.821 0.701 . . . . 0.0 112.174 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.478 HD13 ' HA2' ' A' ' 158' ' ' GLY . 10.2 mp -85.63 81.3 8.7 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.503 175.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -67.53 129.4 39.79 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.42 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 7.8 ptpp? -63.3 -16.21 59.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.768 0.318 . . . . 0.0 111.485 -177.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -58.37 -29.66 66.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.4 1.08 . . . . 0.0 110.73 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -80.75 -17.33 51.29 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.331 0.586 . . . . 0.0 110.29 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -111.68 0.33 16.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.284 -173.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.18 108.6 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 CA-C-O 121.891 0.853 . . . . 0.0 109.027 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.88 -48.06 40.61 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.165 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -117.79 115.79 25.7 Favored 'General case' 0 N--CA 1.405 -2.685 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.531 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.58 ' HA ' HE21 ' A' ' 182' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.424 -1.741 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 173.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.783 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.74 -46.7 30.36 Favored 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 123.07 2.514 . . . . 0.0 112.827 -176.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -68.67 -39.66 80.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.956 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m -65.02 -46.71 80.23 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 122.938 0.495 . . . . 0.0 110.76 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.89 -29.17 58.38 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -63.91 -49.64 71.87 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.96 -37.77 86.02 Favored 'General case' 0 C--O 1.194 -1.822 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.621 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.8 tp -57.47 -52.02 67.09 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.404 0.681 . . . . 0.0 111.446 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.9 t -67.9 -31.03 70.53 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.453 0.644 . . . . 0.0 110.302 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.7 tp -70.34 -52.94 18.99 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.42 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.487 ' HA ' ' HB ' ' A' ' 15' ' ' ILE . 55.4 tp -53.1 -54.5 34.68 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 126.344 1.858 . . . . 0.0 113.123 -176.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.2 mtp85 -62.21 -7.16 3.76 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -171.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -137.56 -50.65 0.62 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.416 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -91.36 -7.16 51.66 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -167.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 11' ' ' LEU . 60.1 mt -115.89 113.58 43.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 42.1 ttm -140.37 136.98 33.69 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.771 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 50.7 m -63.6 135.31 56.7 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.202 0.601 . . . . 0.0 111.394 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 75.5 mt -129.11 126.53 64.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 92.1 m -89.6 110.24 21.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 72.4 p -91.99 -162.52 0.93 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.796 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 t -83.14 -1.14 52.13 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -104.51 -55.95 2.26 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.92 -158.02 21.18 Favored Glycine 0 CA--C 1.502 -0.727 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.817 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -89.85 113.58 25.2 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 116.773 0.287 . . . . 0.0 110.928 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -122.45 -172.65 2.51 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 104' ' ' HIS . 8.8 t -128.23 138.65 52.54 Favored 'General case' 0 N--CA 1.403 -2.79 0 C-N-CA 118.529 -1.268 . . . . 0.0 109.257 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.96 148.59 18.22 Favored Glycine 0 N--CA 1.418 -2.54 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -111.08 118.32 35.68 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.61 111.55 3.44 Favored Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.3 mm -77.46 -45.96 28.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 85' ' ' ASP . 1.5 p-80 -179.58 161.54 1.04 Allowed 'General case' 0 CA--C 1.484 -1.585 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.601 177.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.1 t70 52.17 -104.94 0.2 Allowed 'General case' 0 CA--C 1.554 1.125 0 O-C-N 124.511 1.132 . . . . 0.0 112.732 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -119.43 5.48 11.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.063 0.459 . . . . 0.0 109.872 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.1 t -85.59 107.54 16.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.704 -174.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -119.13 141.72 48.56 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.429 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.1 t -117.73 140.53 40.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 122.904 0.481 . . . . 0.0 111.536 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.424 HG22 HD21 ' A' ' 75' ' ' LEU . 15.6 tt -156.69 147.71 16.54 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 175.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 72.1 Cg_exo -55.87 154.4 26.96 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.736 2.291 . . . . 0.0 112.503 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -79.19 -28.86 42.68 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.099 -0.376 . . . . 0.0 111.407 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -73.31 -7.13 50.27 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.068 0.461 . . . . 0.0 111.178 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.78 -19.55 60.16 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.502 ' O ' ' HB ' ' A' ' 20' ' ' THR . 27.6 mt-30 53.11 78.61 0.39 Allowed Pre-proline 0 C--O 1.247 0.942 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 177.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -84.79 146.14 10.39 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.134 1.889 . . . . 0.0 110.097 173.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.81 -143.19 14.03 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.139 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -94.43 -20.53 19.63 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.16 0.505 . . . . 0.0 110.841 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -146.19 135.13 22.52 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.51 165.76 29.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 123.508 0.505 . . . . 0.0 110.408 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 78.3 mt -97.12 104.72 16.76 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 176.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -90.28 85.85 2.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 122.372 1.082 . . . . 0.0 109.739 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 66.76 14.96 10.01 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.514 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.51 -50.48 0.82 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.86 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.07 132.59 48.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.825 0.45 . . . . 0.0 111.28 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -78.66 124.84 28.6 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 77' ' ' LEU . 9.8 tp -132.39 134.91 58.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.989 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -86.21 137.69 32.45 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.968 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.61 127.3 41.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -65.92 -62.8 1.3 Allowed 'General case' 0 C--N 1.308 -1.215 0 O-C-N 123.783 0.677 . . . . 0.0 109.661 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -152.87 148.44 27.16 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -132.93 151.55 52.03 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -172.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -125.37 123.18 38.8 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.933 -176.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -81.06 104.66 11.71 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 167.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.478 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 50.0 tp -88.44 111.24 21.56 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.33 179.91 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.813 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -77.19 140.66 65.97 Favored Pre-proline 0 C--N 1.291 -1.963 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.79 -28.78 13.49 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.771 2.981 . . . . 0.0 114.766 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -87.9 10.41 18.81 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.472 0.653 . . . . 0.0 110.595 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.4 t30 65.49 70.15 0.45 Allowed 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 125.379 1.472 . . . . 0.0 111.274 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.8 mt -137.7 145.98 28.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' A' ' 131' ' ' THR . 58.6 t30 -65.73 132.5 48.9 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.997 0.427 . . . . 0.0 110.742 -176.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 50.6 tp -105.72 -7.11 18.6 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 14.8 tp10 62.9 28.55 16.4 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.844 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.51 125.35 47.63 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.104 -172.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.1 m -123.15 123.02 39.87 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.6 t -100.84 120.4 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.424 HD21 HG22 ' A' ' 37' ' ' ILE . 2.5 mm? -105.5 128.63 53.67 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.3 m -85.92 86.71 7.35 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.432 HD11 HG23 ' A' ' 54' ' ' ILE . 15.4 tp -86.34 120.3 27.54 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -175.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.451 ' O ' ' HD2' ' A' ' 79' ' ' ARG . 33.1 t70 -63.42 101.79 0.35 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.326 0.584 . . . . 0.0 111.116 -177.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 78' ' ' ASP . 26.9 mmm180 -126.42 117.89 23.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -77.05 -37.37 54.82 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -97.11 104.89 16.95 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -93.87 154.13 17.89 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -168.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -74.82 170.21 16.35 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.287 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -85.92 143.8 28.0 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 31' ' ' HIS . 9.6 t70 -71.43 95.78 1.4 Allowed 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.043 0.925 . . . . 0.0 110.004 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.1 pt -86.82 9.37 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-O 122.117 0.961 . . . . 0.0 109.682 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -73.2 -28.08 61.98 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.32 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.54 -18.79 68.28 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.876 174.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -100.07 2.67 43.46 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 110.549 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.5 mt -76.43 127.15 37.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -94.66 112.68 24.43 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.2 0.52 28.1 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.179 -0.609 . . . . 0.0 112.311 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -113.76 122.57 47.5 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.08 -66.93 0.98 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 -166.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -69.11 148.38 50.07 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -167.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.59 48.76 Favored Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 114.794 -1.093 . . . . 0.0 112.704 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.3 136.32 30.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 122.453 -0.439 . . . . 0.0 111.223 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.97 125.0 21.97 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.887 0.875 . . . . 0.0 109.974 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -120.2 161.03 21.75 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.518 0.675 . . . . 0.0 111.88 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 25.8 m -118.95 137.1 53.72 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 124.913 1.285 . . . . 0.0 107.941 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.3 tp -102.86 120.65 40.99 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 111' ' ' THR . 25.6 m -113.21 121.48 65.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.478 0.656 . . . . 0.0 110.715 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.45 143.88 37.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.311 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.465 ' O ' ' HB ' ' A' ' 26' ' ' THR . 17.4 t60 -146.94 90.56 1.91 Allowed 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.8 m -150.8 -177.91 6.27 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -64.47 -29.42 70.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.804 0.335 . . . . 0.0 111.044 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -59.76 -32.98 71.09 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.779 0.831 . . . . 0.0 112.046 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -175.73 128.47 0.24 Allowed 'General case' 0 C--O 1.245 0.845 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 p -93.14 123.41 36.39 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.45 ' OD1' HD21 ' A' ' 11' ' ' LEU . 93.8 m-20 65.0 71.0 0.46 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 90.8 m -115.52 117.83 31.46 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 174.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 66.4 mt -119.15 90.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.6 tp -127.16 132.66 50.47 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.522 -174.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 30.5 mp0 -66.35 136.65 56.1 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 124.266 1.027 . . . . 0.0 109.636 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.28 -7.65 12.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.46 -171.72 19.66 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.914 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.47 118.65 5.42 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.063 2.509 . . . . 0.0 112.038 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 150' ' ' LEU . 27.1 m -71.46 145.52 12.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.882 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.5 m -125.75 150.56 47.62 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 21.7 ttt -71.97 135.69 46.52 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.4 -40.76 6.93 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.2 -99.87 2.34 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 tt -138.28 118.91 13.97 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.415 HG22 ' HG2' ' A' ' 134' ' ' MET . 10.8 tp -130.82 158.54 43.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 130' ' ' PRO . 10.1 p30 -114.14 114.75 26.48 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.419 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp -102.84 118.39 36.73 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.9 t 59.82 39.69 20.32 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.1 m 65.74 10.83 7.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.437 1.495 . . . . 0.0 112.971 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.8 m -101.74 108.03 54.28 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 125' ' ' ASN . 60.5 Cg_endo -73.49 124.66 9.53 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.096 1.864 . . . . 0.0 111.92 -178.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 69' ' ' ASN . 15.9 p -115.22 125.22 53.1 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.517 177.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -101.1 155.5 17.96 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 69.18 36.66 2.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.565 1.146 . . . . 0.0 107.932 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.415 ' HG2' HG22 ' A' ' 124' ' ' ILE . 8.4 tpt -85.21 147.58 26.52 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.515 -175.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.488 HG23 ' HB2' ' A' ' 170' ' ' SER . 14.7 tt -130.11 144.42 38.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -143.62 165.17 28.35 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.315 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -145.98 149.34 33.97 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -89.16 104.06 16.63 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.092 0.948 . . . . 0.0 110.424 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -167.89 136.17 2.38 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.92 91.21 4.17 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.528 0.68 . . . . 0.0 110.304 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -104.38 161.6 13.93 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.694 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -92.45 176.89 6.3 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.1 t -115.13 168.26 10.09 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 94.21 -4.89 71.12 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.918 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.448 ' HB2' ' CD2' ' A' ' 160' ' ' HIS . 16.8 mt-30 -95.1 15.1 19.89 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 160' ' ' HIS . 8.1 m -59.01 118.17 5.51 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.39 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 113.95 -2.48 24.27 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -176.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.77 148.69 43.67 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 174.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.428 ' HB ' ' CG2' ' A' ' 102' ' ' VAL . 28.4 t -93.59 122.86 45.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.276 0.56 . . . . 0.0 110.745 -175.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.41 HD21 HG11 ' A' ' 118' ' ' VAL . 49.4 tp -94.86 105.02 16.93 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 14.3 p -145.8 170.9 15.61 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.031 0.443 . . . . 0.0 112.11 -172.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.03 178.83 6.99 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.1 t -55.62 106.22 0.23 Allowed 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 121.86 0.838 . . . . 0.0 111.959 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 70.8 19.08 76.51 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.238 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -143.28 106.05 4.49 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 79.5 mt -92.46 128.1 44.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -98.66 -38.16 9.23 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.425 0.631 . . . . 0.0 110.863 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.416 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 170.58 -159.84 32.25 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.454 -1.355 . . . . 0.0 112.387 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.508 HG23 HD11 ' A' ' 173' ' ' LEU . 25.8 pt -118.64 144.08 27.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 120.96 0.41 . . . . 0.0 110.533 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.448 ' CD2' ' HB2' ' A' ' 145' ' ' GLN . 52.8 t60 -74.56 132.2 41.61 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.698 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.25 -6.13 11.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.278 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 149.0 -154.56 25.88 Favored Glycine 0 N--CA 1.429 -1.782 0 C-N-CA 119.859 -1.162 . . . . 0.0 112.429 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 178.67 160.66 25.13 Favored Glycine 0 N--CA 1.427 -1.941 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -155.96 118.25 4.09 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.72 -117.38 4.58 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 166' ' ' ARG . 20.7 mmt180 -110.62 8.31 22.71 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.061 0.458 . . . . 0.0 110.846 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -112.86 126.78 55.82 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.023 0.439 . . . . 0.0 110.416 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -99.85 138.23 13.73 Favored Glycine 0 CA--C 1.476 -2.361 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -113.5 132.81 55.54 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.773 0.797 . . . . 0.0 111.961 -173.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.488 ' HB2' HG23 ' A' ' 135' ' ' ILE . 54.3 m -141.08 164.2 30.91 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.821 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.31 138.4 47.83 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.436 ' OE1' ' HE3' ' A' ' 174' ' ' LYS . 79.5 mt-30 -74.41 116.99 15.71 Favored 'General case' 0 C--O 1.244 0.781 0 O-C-N 123.431 0.457 . . . . 0.0 111.253 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.508 HD11 HG23 ' A' ' 159' ' ' ILE . 63.6 mt -90.92 89.8 7.61 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.436 ' HE3' ' OE1' ' A' ' 172' ' ' GLN . 97.5 mttt -88.63 124.98 34.6 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.901 176.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -52.02 -17.73 1.14 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.136 1.374 . . . . 0.0 114.144 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -60.33 -27.76 67.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.406 1.082 . . . . 0.0 111.139 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -79.12 -19.27 51.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.802 0.334 . . . . 0.0 111.7 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -100.01 14.71 29.66 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.2 p -119.32 128.29 75.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -84.59 -14.36 49.0 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.086 0.469 . . . . 0.0 111.552 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -97.55 108.39 21.09 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.25 1.129 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.238 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.366 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.7 -31.87 68.93 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.652 2.235 . . . . 0.0 110.194 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -59.94 -36.33 76.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.919 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 m -70.05 -39.11 75.89 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 120.978 0.418 . . . . 0.0 110.133 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -69.94 -41.48 74.52 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.979 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -63.27 -42.74 99.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.501 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.43 -44.12 96.09 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.91 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.43 -48.53 81.35 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.096 0.559 . . . . 0.0 110.803 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 p -71.72 -37.58 70.59 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.9 tp -65.14 -45.98 82.78 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.624 0.77 . . . . 0.0 109.413 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.461 ' HA ' HD13 ' A' ' 15' ' ' ILE . 42.8 tp -48.7 -52.75 21.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.454 1.501 . . . . 0.0 112.526 -177.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -76.74 -3.1 36.4 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.86 -53.86 2.61 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.849 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -104.04 -17.25 15.03 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -169.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 11' ' ' LEU . 1.7 mp -87.35 113.27 24.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.542 0.687 . . . . 0.0 110.418 -178.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 90.3 mmm -116.16 153.28 32.1 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 m -101.11 121.54 41.99 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -112.61 123.8 68.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 O-C-N 121.928 -0.482 . . . . 0.0 111.603 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 48' ' ' LEU . 18.5 m -80.82 102.9 10.29 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.254 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.2 p -102.31 -169.46 1.67 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -72.78 -20.54 61.15 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.997 0.427 . . . . 0.0 110.685 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -100.43 3.34 43.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.996 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.89 -175.62 16.53 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.994 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 30.7 mp0 -83.5 115.83 22.27 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 146' ' ' CYS . 72.8 m-85 -122.36 -175.14 3.06 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 147' ' ' GLY . 25.5 m -91.4 130.24 37.27 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.9 128.26 7.59 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.9 tp -100.18 119.49 38.43 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.03 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.97 115.43 4.02 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 174.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.9 mm -84.52 -55.43 6.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 117.018 0.409 . . . . 0.0 111.169 -173.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -163.0 150.54 13.3 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.574 ' OD2' ' HG2' ' A' ' 33' ' ' ARG . 23.2 t70 54.7 -99.87 0.1 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.449 1.093 . . . . 0.0 111.98 173.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.574 ' HG2' ' OD2' ' A' ' 32' ' ' ASP . 14.1 ptp180 -126.65 14.56 7.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.697 0.76 . . . . 0.0 110.073 177.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.9 t -92.25 115.93 32.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.211 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -124.55 151.03 45.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.33 141.16 47.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 117.82 0.282 . . . . 0.0 111.752 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.3 tt -155.15 142.07 13.53 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 99.2 Cg_exo -49.03 144.17 16.42 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 123.702 2.935 . . . . 0.0 115.467 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.406 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 27.6 m -65.74 -37.21 85.76 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.432 -176.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -63.61 -5.08 3.46 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.38 -18.05 29.23 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 54.94 86.77 0.16 Allowed Pre-proline 0 C--O 1.242 0.697 0 C-N-CA 124.959 1.304 . . . . 0.0 112.93 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -81.47 127.68 5.88 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.982 1.788 . . . . 0.0 110.119 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.54 -176.63 47.61 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.099 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -67.1 -37.2 83.51 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 120.855 0.36 . . . . 0.0 110.487 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 5.5 p-10 -130.69 114.54 15.52 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.841 0.829 . . . . 0.0 109.716 175.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -108.94 176.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.162 -174.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 57.8 mt -113.34 112.65 24.05 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.38 89.36 2.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 59.57 30.92 20.59 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.287 1.435 . . . . 0.0 109.981 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.41 -33.71 5.0 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.045 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -71.52 118.54 14.46 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.457 0.303 . . . . 0.0 111.081 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 53' ' ' LYS . 12.1 mptt -75.25 132.92 41.41 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.405 HD13 ' HE ' ' A' ' 79' ' ' ARG . 6.6 tp -153.28 132.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.869 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 46' ' ' ASP . 33.7 ttt85 -90.79 134.72 34.22 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.9 t -78.02 119.84 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.77 -66.72 0.85 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -102.66 128.47 49.34 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -106.15 118.21 36.03 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.436 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 81.1 m-85 -114.78 94.45 4.77 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -75.57 118.78 18.79 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.79 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.448 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 3.5 mm? -87.4 83.77 7.27 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-O 122.842 1.305 . . . . 0.0 112.699 -177.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.51 148.71 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 172.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.46 135.45 41.08 Favored Pre-proline 0 C--N 1.269 -2.897 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.2 -25.32 4.37 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 124.034 3.156 . . . . 0.0 114.766 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -81.63 16.27 1.82 Allowed 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.976 -0.453 . . . . 0.0 111.582 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.0 m120 75.87 17.77 2.19 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.664 1.586 . . . . 0.0 112.383 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.3 mt -95.87 120.14 44.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.413 HD22 ' N ' ' A' ' 69' ' ' ASN . 0.8 OUTLIER -78.07 156.23 30.15 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 122.132 -0.355 . . . . 0.0 111.699 -174.002 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 60.4 tp -121.68 -9.96 8.83 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 168.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' PRO . 13.6 tp10 65.44 20.01 11.67 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.931 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.21 144.89 41.92 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.323 -0.861 . . . . 0.0 110.577 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.4 m -124.0 117.79 25.53 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 54.5 t -94.61 118.51 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 CA-C-O 121.709 0.766 . . . . 0.0 108.999 177.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 74.2 mt -106.08 124.0 48.9 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.268 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 m -97.24 98.34 9.92 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -70.79 136.47 48.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.227 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.541 ' HA ' ' NH1' ' A' ' 33' ' ' ARG . 38.7 t70 -84.41 73.87 10.44 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.623 1.202 . . . . 0.0 110.137 177.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.405 ' HE ' HD13 ' A' ' 54' ' ' ILE . 24.1 mmt180 -127.47 132.59 50.0 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.191 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -79.49 -20.75 46.51 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -75.39 109.85 9.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.281 -1.327 . . . . 0.0 107.848 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -106.78 170.73 7.77 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -113.37 169.33 9.04 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.411 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -73.5 125.7 28.55 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -72.81 104.78 4.11 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.21 1.005 . . . . 0.0 111.331 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.5 pt -94.12 21.93 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.959 0.885 . . . . 0.0 109.675 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -63.14 -32.98 74.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.602 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -82.49 0.42 89.17 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 116.178 -0.465 . . . . 0.0 113.507 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -103.77 -2.49 26.31 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 117.251 0.526 . . . . 0.0 110.551 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 86.0 mt -68.67 126.68 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 121.342 0.591 . . . . 0.0 110.126 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.7 t -104.1 107.68 18.68 Favored 'General case' 0 N--CA 1.397 -3.099 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -87.03 -4.53 59.17 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.176 0.989 . . . . 0.0 108.488 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -94.17 115.82 28.15 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.445 HD21 ' CG ' ' A' ' 172' ' ' GLN . 26.3 mt -110.65 -63.32 1.41 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -169.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 118' ' ' VAL . 17.0 pt-20 -58.26 121.99 12.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -168.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.28 -8.62 24.74 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.14 -0.936 . . . . 0.0 113.417 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.435 ' O ' HG22 ' A' ' 118' ' ' VAL . 21.9 t -108.81 144.65 16.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 117.34 0.57 . . . . 0.0 110.324 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.09 127.4 35.12 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -112.54 160.67 17.59 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.986 0.898 . . . . 0.0 112.042 -176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.1 m -122.73 137.65 54.85 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 tp -103.95 109.27 20.97 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.6 t -103.93 116.38 47.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.347 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.495 HG12 ' CA ' ' A' ' 148' ' ' GLY . 28.3 m -122.0 151.91 25.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.282 0.563 . . . . 0.0 111.473 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -149.39 68.4 1.03 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 m -93.99 -150.25 0.29 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.57 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 22.2 t-20 -73.18 -66.12 0.72 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.582 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -81.2 -36.85 29.58 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.48 86.09 6.68 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.392 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.5 p -97.15 117.2 30.82 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.21 42.97 5.13 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.448 1.118 . . . . 0.0 108.698 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.452 ' HB ' ' CG2' ' A' ' 103' ' ' VAL . 23.8 m -94.89 106.67 18.67 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.328 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 67.4 mt -97.86 98.45 7.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 48.5 tp -114.94 122.87 47.61 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.225 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -83.38 134.02 34.91 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 122.282 -0.261 . . . . 0.0 110.342 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 m -108.58 -14.49 9.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -175.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.97 -160.12 19.44 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.061 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.75 127.22 12.8 Favored 'Trans proline' 0 C--O 1.243 0.772 0 C-N-CA 123.498 2.799 . . . . 0.0 112.502 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 97' ' ' VAL . 27.5 m -96.9 157.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.458 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.434 ' O ' HG13 ' A' ' 135' ' ' ILE . 7.1 p -139.72 173.05 11.93 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 124.373 1.069 . . . . 0.0 108.542 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -92.01 128.8 37.98 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . . . -83.17 -38.53 22.21 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.177 0.513 . . . . 0.0 111.624 -174.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 132' ' ' ASN . . . 82.93 -102.78 2.41 Favored Glycine 0 N--CA 1.421 -2.355 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -176.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.78 133.06 54.25 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.717 0.77 . . . . 0.0 112.136 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.428 HG23 ' HB ' ' A' ' 131' ' ' THR . 7.2 tp -126.84 129.4 71.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 168.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -112.99 126.54 55.61 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.707 -173.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -110.22 96.89 6.5 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.7 m 56.23 65.85 1.34 Allowed 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.823 0.849 . . . . 0.0 111.095 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.7 t 64.86 -3.78 0.54 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.752 1.221 . . . . 0.0 112.721 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.1 m -95.99 113.85 62.98 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.89 137.9 11.33 Favored 'Trans proline' 0 N--CA 1.441 -1.598 0 C-N-CA 122.591 2.194 . . . . 0.0 113.582 -175.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.428 ' HB ' HG23 ' A' ' 124' ' ' ILE . 25.1 m -119.54 116.79 26.79 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 171.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 51.8 t30 -115.4 163.61 15.47 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.417 -173.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 73.7 28.11 1.67 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.106 1.362 . . . . 0.0 109.36 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.421 ' HG3' HG22 ' A' ' 124' ' ' ILE . 91.2 mmm -88.09 158.3 18.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.745 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.606 HG23 ' HB2' ' A' ' 170' ' ' SER . 7.7 tt -116.33 138.73 45.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 122.927 0.491 . . . . 0.0 109.951 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 66.4 ttt180 -118.57 139.74 51.0 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.158 0.983 . . . . 0.0 111.975 -170.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.404 ' HB3' HG12 ' A' ' 118' ' ' VAL . 45.4 p90 -149.7 147.97 28.71 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -93.66 103.07 15.25 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -168.36 125.37 1.06 Allowed 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.07 94.83 1.55 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.512 0.673 . . . . 0.0 109.769 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.0 t -80.03 176.06 10.08 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.001 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -119.94 156.36 30.96 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.7 m -76.04 114.9 15.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.01 -15.56 2.15 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.94 11.87 5.61 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.754 -0.262 . . . . 0.0 111.011 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 43.3 t -58.17 122.34 12.9 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.049 0.54 . . . . 0.0 110.083 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 86.32 10.02 75.03 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.233 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.495 ' CA ' HG12 ' A' ' 103' ' ' VAL . . . -72.16 137.17 24.78 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.437 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 25.4 t -79.08 107.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.186 0.517 . . . . 0.0 109.947 -177.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 35.6 tp -87.64 102.65 14.82 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 16.9 p -147.09 168.19 22.22 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.473 -173.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -137.89 -174.59 3.83 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 174.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 t -63.37 100.35 0.24 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 121.89 0.853 . . . . 0.0 112.058 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.87 10.22 85.9 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.858 -1.065 . . . . 0.0 112.198 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -128.91 98.28 4.91 Favored 'General case' 0 C--O 1.208 -1.118 0 O-C-N 122.491 -0.417 . . . . 0.0 109.969 -174.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 74.6 mt -99.02 117.81 44.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -90.53 -39.88 12.31 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.458 0.647 . . . . 0.0 110.365 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.444 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 164.92 -152.94 22.85 Favored Glycine 0 N--CA 1.422 -2.266 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.11 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 148' ' ' GLY . 28.1 pt -129.18 146.61 33.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.93 0.365 . . . . 0.0 110.808 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.41 ' HA ' ' OG ' ' A' ' 170' ' ' SER . 46.9 t-80 -69.48 134.48 48.95 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.446 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.1 t -99.84 -71.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.722 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.29 127.39 1.39 Allowed Glycine 0 N--CA 1.424 -2.125 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.25 153.15 20.67 Favored Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.693 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -131.7 100.57 5.16 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 84.75 -122.54 5.93 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -90.7 -12.16 37.51 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.041 0.448 . . . . 0.0 110.53 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -98.77 111.71 24.01 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.161 -175.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.61 119.99 5.43 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -105.97 116.65 32.3 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.573 0.701 . . . . 0.0 110.959 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.606 ' HB2' HG23 ' A' ' 135' ' ' ILE . 39.4 m -117.62 167.37 11.39 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -111.25 142.1 43.9 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 118.433 0.56 . . . . 0.0 110.374 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.666 ' OE1' ' HG2' ' A' ' 174' ' ' LYS . 0.0 OUTLIER -93.66 109.15 20.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.444 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.8 OUTLIER -82.86 91.11 7.02 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.213 1.006 . . . . 0.0 111.079 178.288 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.666 ' HG2' ' OE1' ' A' ' 172' ' ' GLN . 6.8 mtpm? -65.01 148.1 52.26 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.336 -176.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -66.65 -22.46 66.1 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.024 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -68.24 -10.26 53.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.301 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -94.07 -20.62 19.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.671 0.748 . . . . 0.0 109.268 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -104.06 0.11 29.38 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.506 -173.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 66.8 t -115.8 126.59 73.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -63.84 -40.29 96.22 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -83.65 118.62 23.97 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 118.405 -0.807 . . . . 0.0 108.948 -177.645 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.631 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 5' ' ' GLU . 80.9 Cg_exo -49.77 -34.61 36.4 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 123.93 3.087 . . . . 0.0 113.169 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -60.84 -55.85 28.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.097 0.475 . . . . 0.0 110.508 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -59.25 -38.22 79.5 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.774 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 2' ' ' PRO . 31.9 tt0 -57.9 -55.46 34.56 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.604 1.161 . . . . 0.0 110.567 177.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.76 -46.95 86.29 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.003 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.67 -35.64 74.86 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.89 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.3 tp -71.42 -38.23 71.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.708 0.29 . . . . 0.0 110.821 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -73.1 -33.56 65.66 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.569 0.699 . . . . 0.0 109.167 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.6 tp -68.23 -41.96 80.45 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.215 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.507 ' HA ' HD12 ' A' ' 15' ' ' ILE . 58.5 tp -49.96 -54.17 21.62 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 125.076 1.351 . . . . 0.0 112.01 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.4 mtt-85 -80.32 13.35 2.43 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.606 -173.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -129.09 -64.25 0.92 Allowed 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.418 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -104.18 -2.87 25.13 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -173.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.507 HD12 ' HA ' ' A' ' 11' ' ' LEU . 43.0 mt -99.93 134.75 38.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -154.38 144.85 22.22 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 122.484 0.314 . . . . 0.0 110.613 -173.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 m -80.23 118.13 21.63 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.0 mt -106.05 115.6 48.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-O 121.265 0.555 . . . . 0.0 109.569 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -83.08 97.28 8.69 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 79.1 p -91.95 -170.09 2.45 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.2 m -82.59 -13.34 56.71 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 120.706 0.289 . . . . 0.0 110.929 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -98.33 -24.08 15.36 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 110.417 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 165.63 -154.71 25.56 Favored Glycine 0 CA--C 1.501 -0.808 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.53 112.79 20.36 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 117.298 0.549 . . . . 0.0 109.531 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.455 ' HB3' ' O ' ' A' ' 146' ' ' CYS . 80.7 m-85 -120.66 -173.45 2.59 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 147' ' ' GLY . 5.9 t -113.93 136.91 52.37 Favored 'General case' 0 N--CA 1.406 -2.653 0 C-N-CA 118.959 -1.097 . . . . 0.0 109.934 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.02 136.89 13.64 Favored Glycine 0 N--CA 1.41 -3.092 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.5 tp -105.1 118.65 37.07 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.76 132.53 14.13 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 108.406 -1.878 . . . . 0.0 108.406 173.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.5 mm -96.08 -59.28 3.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 117.753 0.776 . . . . 0.0 109.902 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -162.12 147.37 12.87 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 55.53 -95.32 0.05 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 124.276 0.985 . . . . 0.0 111.21 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' A' ' 77' ' ' LEU . 18.9 ptp180 -132.84 10.87 4.31 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 122.044 0.926 . . . . 0.0 109.663 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.0 t -84.22 118.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.4 m -131.72 147.02 52.47 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.2 t -109.71 134.55 51.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.793 0.33 . . . . 0.0 111.727 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.434 ' HB ' ' CD2' ' A' ' 75' ' ' LEU . 6.7 mm -137.93 141.88 34.11 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 125.364 1.466 . . . . 0.0 108.358 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -59.06 146.57 93.86 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 121.975 1.784 . . . . 0.0 111.797 175.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.6 m -70.21 -33.35 71.58 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 123.214 0.605 . . . . 0.0 109.415 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -77.17 -4.74 46.15 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.579 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.62 -16.04 49.86 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.58 ' O ' ' HB ' ' A' ' 20' ' ' THR . 21.4 mt-30 58.14 82.67 0.23 Allowed Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.414 1.086 . . . . 0.0 112.877 176.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.08 -174.83 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.752 2.301 . . . . 0.0 111.287 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.59 179.19 18.44 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.55 -17.7 44.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.513 0.673 . . . . 0.0 110.313 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -141.71 135.92 30.31 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 12.7 p -141.6 149.98 19.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.514 -171.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -85.69 111.94 20.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.258 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.2 83.14 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.3 t30 68.65 -1.78 1.86 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.492 1.517 . . . . 0.0 111.364 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.11 -33.45 0.94 Allowed Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.09 110.73 15.77 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 14.7 ptpt -78.68 137.38 37.78 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 116.819 -1.952 . . . . 0.0 109.101 174.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.413 HD11 ' O ' ' A' ' 78' ' ' ASP . 10.5 tp -128.99 150.69 34.85 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -91.24 142.84 27.28 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.8 t -108.73 131.19 60.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -78.29 -79.01 0.13 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.797 0.332 . . . . 0.0 111.286 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -113.75 140.17 48.5 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -104.5 93.51 4.82 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.569 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 94.5 m-85 -80.8 94.02 6.34 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -76.09 94.15 3.42 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 70' ' ' LEU . 32.7 tp -85.46 103.53 14.42 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-O 121.616 0.722 . . . . 0.0 109.521 -172.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.06 178.9 2.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.71 139.29 58.24 Favored Pre-proline 0 C--N 1.293 -1.865 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.2 -21.61 13.42 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 123.557 2.838 . . . . 0.0 114.542 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.3 6.1 24.23 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.2 m120 77.37 12.28 2.12 Favored 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.289 1.436 . . . . 0.0 112.747 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 65.0 mt -77.64 146.16 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -70.33 142.74 52.15 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 120.995 0.426 . . . . 0.0 111.622 -174.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 60.9 tp -117.38 -17.6 10.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 171.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 75.72 -17.02 0.54 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.284 1.434 . . . . 0.0 112.909 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 173' ' ' LEU . 10.1 mp -80.06 113.15 18.02 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.6 m -100.24 116.86 33.23 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 168.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 60' ' ' TYR . 68.0 t -95.84 107.07 19.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.434 ' CD2' ' HB ' ' A' ' 37' ' ' ILE . 2.9 mm? -91.66 132.47 36.33 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.254 -178.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 m -83.68 80.3 9.17 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 171.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.633 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 7.7 tp -74.54 103.3 4.81 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -176.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.413 ' O ' HD11 ' A' ' 54' ' ' ILE . 12.9 t70 -73.8 84.07 1.66 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.432 0.634 . . . . 0.0 112.51 -168.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.425 ' HG3' ' CE2' ' A' ' 83' ' ' PHE . 31.4 mmt180 -99.14 125.08 44.62 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.197 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -74.78 -34.41 62.44 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -92.04 95.84 10.01 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 173.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -74.51 161.04 30.14 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.788 -1.096 . . . . 0.0 113.562 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.425 ' CE2' ' HG3' ' A' ' 79' ' ' ARG . 88.9 m-85 -91.27 172.57 8.45 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.042 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -73.88 137.57 43.8 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.07 95.32 1.2 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.222 0.534 . . . . 0.0 109.572 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -93.61 14.55 2.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-O 122.693 1.235 . . . . 0.0 109.975 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -31.13 59.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.018 -1.901 . . . . 0.0 108.764 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.07 -6.61 74.48 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 114.893 -1.048 . . . . 0.0 112.428 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -109.9 4.31 21.43 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 122.156 -0.614 . . . . 0.0 110.943 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.1 mt -73.22 125.95 33.06 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 CA-C-O 121.052 0.453 . . . . 0.0 110.292 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.0 t -115.24 106.8 14.46 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE2' ' HE3' ' A' ' 174' ' ' LYS . 7.9 pt-20 -88.53 -5.37 58.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.941 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -85.78 105.93 16.66 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 168.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.433 HD13 ' HB ' ' A' ' 135' ' ' ILE . 31.9 mt -99.98 -53.84 3.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -164.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -58.93 135.33 57.54 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.8 -38.83 3.13 Favored Glycine 0 N--CA 1.434 -1.443 0 CA-C-N 114.891 -1.05 . . . . 0.0 113.415 174.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 117' ' ' PRO . 21.3 t -73.49 144.01 13.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 120.539 0.209 . . . . 0.0 110.906 -174.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.47 120.89 24.5 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.62 17.72 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 122.02 0.914 . . . . 0.0 111.444 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 28.1 m -127.39 131.31 50.35 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.52 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.427 HD21 HE21 ' A' ' 145' ' ' GLN . 55.4 tp -102.85 126.31 49.94 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.819 -175.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.41 107.66 19.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 145' ' ' GLN . 46.4 t -93.37 108.18 20.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.611 -178.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -133.77 124.71 27.08 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 18.3 t -174.98 -175.17 0.84 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -87.02 -15.29 39.11 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -94.93 -24.53 16.93 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.535 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.64 103.73 3.96 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.8 m -105.02 111.77 24.67 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 71.06 33.58 2.03 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.796 0.838 . . . . 0.0 113.238 169.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.435 ' HB ' ' HB ' ' A' ' 103' ' ' VAL . 16.2 m -93.31 109.44 20.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.512 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.0 mt -100.55 125.77 54.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.7 tp -140.69 129.36 22.89 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.942 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 4.2 mp0 -69.39 135.92 50.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.1 m -107.78 -19.54 6.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 117.21 -176.74 16.34 Favored Glycine 0 N--CA 1.433 -1.548 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.482 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 37.4 Cg_endo -68.07 129.01 18.59 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.688 2.259 . . . . 0.0 111.625 178.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.8 m -97.26 165.03 2.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.468 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.3 t -147.99 155.54 41.65 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 53.8 ttp -90.73 134.65 34.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -94.33 -28.52 15.52 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.308 0.575 . . . . 0.0 110.086 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.4 -87.25 1.17 Allowed Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -137.24 133.22 34.85 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 9.2 tp -132.15 156.41 42.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -106.41 115.26 29.91 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.09 90.82 4.29 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.4 m 53.32 72.7 0.41 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.793 0.837 . . . . 0.0 111.51 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.0 m 61.85 16.61 8.13 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.365 0.666 . . . . 0.0 112.411 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.2 m -121.25 107.8 36.78 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -80.2 128.77 7.41 Favored 'Trans proline' 0 C--O 1.254 1.294 0 C-N-CA 122.332 2.021 . . . . 0.0 112.018 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 m -131.06 131.1 44.02 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -99.19 162.92 12.78 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 172' ' ' GLN . 8.0 mpt_? 66.82 35.72 4.84 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.579 1.152 . . . . 0.0 110.749 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 95.6 mmm -94.23 139.76 30.63 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.949 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.559 HG23 ' HB2' ' A' ' 170' ' ' SER . 3.0 tt -116.38 140.42 38.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 124.649 1.179 . . . . 0.0 109.102 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -121.53 143.83 49.05 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.054 0.542 . . . . 0.0 110.767 -171.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.485 ' HE2' ' HG ' ' A' ' 170' ' ' SER . 28.0 p90 -152.95 152.41 31.41 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 122.95 0.5 . . . . 0.0 111.049 172.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -89.58 105.42 17.78 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.308 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -172.49 132.85 0.61 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 125.05 1.34 . . . . 0.0 108.479 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.13 100.63 5.81 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.353 0.597 . . . . 0.0 109.651 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.2 p -79.83 137.58 36.99 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.665 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 93.4 mttt -93.03 108.69 20.21 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.2 m -53.79 129.43 33.45 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.595 0.758 . . . . 0.0 111.692 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 134.25 -18.63 4.17 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -100.74 34.1 2.56 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.373 0.606 . . . . 0.0 112.101 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 25' ' ' PHE . 66.6 m -65.8 117.26 7.95 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.304 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 26' ' ' THR . . . 109.88 5.57 29.02 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.07 134.82 37.05 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.63 115.5 18.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 121.183 0.516 . . . . 0.0 111.149 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.61 108.87 21.17 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 12.6 p -142.0 179.25 6.99 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-O 120.907 0.384 . . . . 0.0 111.911 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.09 178.88 8.54 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.8 t -64.77 102.32 0.57 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.999 0.904 . . . . 0.0 111.843 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.79 18.08 73.65 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.416 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -145.27 120.6 10.25 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 81.7 mt -108.28 128.9 63.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 171.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.49 -47.56 6.21 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.413 0.625 . . . . 0.0 110.3 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.55 ' HA2' ' HG ' ' A' ' 173' ' ' LEU . . . 171.65 -149.37 11.95 Favored Glycine 0 N--CA 1.417 -2.61 0 C-N-CA 119.932 -1.127 . . . . 0.0 111.899 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.8 pt -130.59 142.19 44.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -73.87 125.74 28.87 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.7 m -107.81 -46.0 7.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.303 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 169' ' ' PHE . . . -157.26 136.47 4.91 Favored Glycine 0 CA--C 1.487 -1.697 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.072 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.3 140.64 11.05 Favored Glycine 0 N--CA 1.422 -2.272 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -123.95 132.15 53.67 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.79 -108.33 2.07 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.922 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 166' ' ' ARG . 47.4 mtt180 -113.29 12.17 18.82 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -118.55 132.76 56.2 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.023 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -104.3 120.84 6.78 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 99.4 m-85 -109.11 117.08 33.22 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 122.19 0.995 . . . . 0.0 109.424 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.559 ' HB2' HG23 ' A' ' 135' ' ' ILE . 18.5 m -117.6 164.28 15.17 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.079 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -115.08 139.61 49.74 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 133' ' ' ARG . 3.4 pt20 -90.23 131.67 35.92 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.784 0.802 . . . . 0.0 110.927 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.55 ' HG ' ' HA2' ' A' ' 158' ' ' GLY . 0.4 OUTLIER -94.26 85.06 4.53 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.305 175.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.44 ' HE3' ' OE2' ' A' ' 92' ' ' GLU . 57.2 mtpt -54.05 134.49 43.77 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.13 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.426 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 16.7 ptmt -72.17 -19.37 61.76 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.29 -174.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.539 ' HA ' HG12 ' A' ' 179' ' ' VAL . 13.4 mm100 -67.93 -9.66 47.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.281 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -89.11 -21.52 23.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.761 0.315 . . . . 0.0 110.2 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -109.68 -28.83 8.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.281 0.563 . . . . 0.0 111.839 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 176' ' ' GLN . 11.0 p -75.3 167.25 2.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.218 0.532 . . . . 0.0 109.996 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -76.87 -4.41 43.61 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 124.705 1.202 . . . . 0.0 110.064 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.447 ' H ' HG13 ' A' ' 179' ' ' VAL . 55.9 mtpt -103.05 138.92 39.27 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.241 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 . . . . . 0 C--N 1.287 -2.133 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 174.274 . . . . . . . . 0 0 . 1 stop_ save_